Citrus Sinensis ID: 045067
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 347 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LSV3 | 433 | Putative wall-associated | no | no | 0.910 | 0.729 | 0.343 | 3e-45 | |
| Q9LMN8 | 741 | Wall-associated receptor | no | no | 0.902 | 0.422 | 0.344 | 3e-44 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.930 | 0.424 | 0.342 | 4e-44 | |
| Q9LMP1 | 732 | Wall-associated receptor | no | no | 0.925 | 0.438 | 0.336 | 4e-44 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.896 | 0.421 | 0.339 | 5e-44 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.933 | 0.433 | 0.355 | 7e-44 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.896 | 0.424 | 0.347 | 9e-44 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.956 | 0.461 | 0.340 | 1e-43 | |
| Q39191 | 735 | Wall-associated receptor | no | no | 0.896 | 0.423 | 0.338 | 2e-43 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.907 | 0.412 | 0.315 | 2e-43 |
| >sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 182 bits (463), Expect = 3e-45, Method: Compositional matrix adjust.
Identities = 112/326 (34%), Positives = 184/326 (56%), Gaps = 10/326 (3%)
Query: 20 KADRKAFLMRNGK-MFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESSIFRL 78
K R+ F +NG M +ERL + + N + + F+ ++++ ATN Y I+ + + +
Sbjct: 64 KIQRQLFFEKNGGGMLIERLSGAGSSNID-FKIFTEEDMKEATNGYDVSRILGQGGQWTV 122
Query: 79 CQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138
+G+LPD +I +K + + N ++ SQ++H NV++L+GCCLE E+P+LV+E
Sbjct: 123 YKGILPDNSIVAIKKTRLGDNNQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYE 182
Query: 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198
G+L D L S S L +HRL+IA+E+A AYLH G S PI+ RD+K+ IL
Sbjct: 183 FITGGSLFDHLHGSMFVSS--LTWEHRLEIAIEVAGAIAYLHSGASIPIIHRDIKTENIL 240
Query: 199 VSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLL 258
+ E K+ +F S P + + V+GT G + PEY T LNEK DVYSFG++L+
Sbjct: 241 LDENLTAKVADFGASKLKPMDKEQLTTMVQGTLGYLDPEYYTTWLLNEKSDVYSFGVVLM 300
Query: 259 QLLSTGEDL-FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFE 317
+L+S + L F R + FV ENR + I+D +++ +E + ++ +
Sbjct: 301 ELISGQKALCFE---RPETSKHLVSYFVLATKENR-LHEIIDDQVLNEE-NQREIHEAAR 355
Query: 318 LAFQCQSASAEDRPTMIDVAKQIKKM 343
+A +C E+RP MI+VA +++ +
Sbjct: 356 VAVECTRLKGEERPRMIEVAAELETL 381
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (453), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 113/328 (34%), Positives = 182/328 (55%), Gaps = 15/328 (4%)
Query: 20 KADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESSIFRLC 79
K R+ F G M ++RL + N + + F+ + ++ ATN Y I+ + +
Sbjct: 372 KLRRQFFEQNGGGMLIQRLSGAGLSNID-FKIFTEEGMKEATNGYDESRILGQGGQGTVY 430
Query: 80 QGVLPDRTISVVK---FIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136
+G+LPD TI +K D D + + ++ SQ++H NV++++GCCLE E+P+LV
Sbjct: 431 KGILPDNTIVAIKKARLADSRQVDQF---IHEVLVLSQINHRNVVKILGCCLETEVPLLV 487
Query: 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSY 196
+E G L D L S S L +HRL+IA+E+A AYLH S PI+ RD+K++
Sbjct: 488 YEFITNGTLFDHLHGSIFDSS--LTWEHRLRIAIEVAGTLAYLHSSASIPIIHRDIKTAN 545
Query: 197 ILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLL 256
IL+ E K+ +F S IP + + V+GT G + PEY TG LNEK DVYSFG++
Sbjct: 546 ILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEYYTTGLLNEKSDVYSFGVV 605
Query: 257 LLQLLSTGEDL-FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSS 315
L++LLS + L F R + FV ENR + I+D +++ ++ L+ ++Q +
Sbjct: 606 LMELLSGQKALCFE---RPQASKHLVSYFVSATEENR-LHEIIDDQVLNEDNLK-EIQEA 660
Query: 316 FELAFQCQSASAEDRPTMIDVAKQIKKM 343
+A +C E+RP M +VA +++ +
Sbjct: 661 ARIAAECTRLMGEERPRMKEVAAKLEAL 688
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 178 bits (452), Expect = 4e-44, Method: Compositional matrix adjust.
Identities = 114/333 (34%), Positives = 187/333 (56%), Gaps = 10/333 (3%)
Query: 16 KNREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESSI 75
K R + + F RNG M L++ ++ GN + FS+ ELE+AT+N++ ++ +
Sbjct: 376 KQRRSSRMRVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRVLGQGGQ 435
Query: 76 FRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135
+ +G+L D I VK D + N +V +Q++H N+++L+GCCLE E+PVL
Sbjct: 436 GTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVL 495
Query: 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSS 195
V+E G+L L+ + + + RL IA+EIA +YLH S PI RD+K++
Sbjct: 496 VYEFVPNGDLCKRLRDECDDYI--MTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTT 553
Query: 196 YILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGL 255
IL+ E+Y K+ +F S S+ +T++ V GT G V PEY ++ +K DVYSFG+
Sbjct: 554 NILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDKSDVYSFGV 613
Query: 256 LLLQLLSTGEDLFNMGLRLNGDES--FEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQ 313
+L++L+ TG+ N R+ +E+ F FV ENR F IVD R I DE ++
Sbjct: 614 VLVELI-TGK---NPSSRVQSEENRGFAAHFVAAVKENR-FLDIVDER-IKDECNLDQVM 667
Query: 314 SSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+ +LA +C + + RP M +V+ +++++ S
Sbjct: 668 AVAKLAKRCLNRKGKKRPNMREVSVELERIRSS 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 178 bits (452), Expect = 4e-44, Method: Compositional matrix adjust.
Identities = 111/330 (33%), Positives = 184/330 (55%), Gaps = 9/330 (2%)
Query: 16 KNREKAD-RKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESS 74
K+R+ + R+ F +NG L + +S + ++ F+ K ++ ATN YH I+ +
Sbjct: 355 KHRKNTELRQKFFEQNGGGMLIQRVSGAGPSNVDVKIFTEKGMKEATNGYHESRILGQGG 414
Query: 75 IFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134
+ +G+LPD +I +K + N ++ SQ++H NV++++GCCLE E+P+
Sbjct: 415 QGTVYKGILPDNSIVAIKKARLGNRSQVEQFINEVLVLSQINHRNVVKVLGCCLETEVPL 474
Query: 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKS 194
LV+E G L D L S S L +HRL+IA E+A AYLH S PI+ RD+K+
Sbjct: 475 LVYEFINSGTLFDHLHGSLYDSS--LTWEHRLRIATEVAGSLAYLHSSASIPIIHRDIKT 532
Query: 195 SYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFG 254
+ IL+ + K+ +F S IP + + V+GT G + PEY TG LNEK DVYSFG
Sbjct: 533 ANILLDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGYLDPEYYNTGLLNEKSDVYSFG 592
Query: 255 LLLLQLLSTGEDL-FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQ 313
++L++LLS + L F R + ++ F NR F+ I+D +++ +E + ++Q
Sbjct: 593 VVLMELLSGQKALCFE---RPHCPKNLVSCFASATKNNR-FHEIIDGQVM-NEDNQREIQ 647
Query: 314 SSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
+ +A +C E+RP M +VA +++ +
Sbjct: 648 EAARIAAECTRLMGEERPRMKEVAAELEAL 677
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 178 bits (452), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 117/345 (33%), Positives = 191/345 (55%), Gaps = 34/345 (9%)
Query: 12 MCNSKNREKADRKAFLMRNGK-MFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNII 70
M N+K+ E R+ F +NG M ++RL + N + ++ F+ + ++ AT+ Y I+
Sbjct: 360 MKNTKDTEL--RQQFFEQNGGGMLMQRLSGAGPSNVD-VKIFTEEGMKEATDGYDENRIL 416
Query: 71 TESSIFRLCQGVLPDRTISVVK---FIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCC 127
+ + +G+LPD +I +K D S + + N ++ SQ++H NV++L+GCC
Sbjct: 417 GQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQF---INEVLVLSQINHRNVVKLLGCC 473
Query: 128 LEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPI 187
LE E+P+LV+E G L D L S S L +HRL++A+EIA AYLH S PI
Sbjct: 474 LETEVPLLVYEFISSGTLFDHLHGSMFDSS--LTWEHRLRMAVEIAGTLAYLHSSASIPI 531
Query: 188 VFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEK 247
+ RD+K++ IL+ E K+ +F S IP + + V+GT G + PEY TG LNEK
Sbjct: 532 IHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTLGYLDPEYYNTGLLNEK 591
Query: 248 CDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI---------ENRGFNGIV 298
DVYSFG++L++LLS + L FE K+I ENR + I+
Sbjct: 592 SDVYSFGVVLMELLSGQKAL-----------CFERPQTSKHIVSYFASATKENR-LHEII 639
Query: 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
D +++ +E + ++Q + +A +C + E+RP M +VA +++ +
Sbjct: 640 DGQVM-NENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEAL 683
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (450), Expect = 7e-44, Method: Compositional matrix adjust.
Identities = 118/332 (35%), Positives = 184/332 (55%), Gaps = 8/332 (2%)
Query: 16 KNREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESSI 75
K R+ + F RNG M L++ ++ GN R FS+ ELE+AT+N++ ++ +
Sbjct: 368 KRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQ 427
Query: 76 FRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135
+ +G+L D I VK D + N +V +Q++H N+++L+GCCLE E+PVL
Sbjct: 428 GTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVL 487
Query: 136 VFESAEYGNLHDLLKRSY-QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKS 194
V+E G DL KR + +S + + RL IA+EIA +YLH S PI RD+K+
Sbjct: 488 VYEFVPNG---DLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKT 544
Query: 195 SYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFG 254
+ IL+ ER K+ +F S S+ +T++ V GT G V PEY ++ EK DVYSFG
Sbjct: 545 TNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFG 604
Query: 255 LLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQS 314
++L++LL TGE + +R + FV+ ENR + IVD R I DE ++ S
Sbjct: 605 VVLVELL-TGEKPSSR-VRSEENRGLAAHFVEAVKENRVLD-IVDDR-IKDECNMDQVMS 660
Query: 315 SFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
LA +C + + RP M +V+ +++ + S
Sbjct: 661 VANLARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (450), Expect = 9e-44, Method: Compositional matrix adjust.
Identities = 113/325 (34%), Positives = 184/325 (56%), Gaps = 14/325 (4%)
Query: 23 RKAFLMRNGK-MFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESSIFRLCQG 81
R+ F +NG M ++RL + N + ++ F+ + ++ AT+ Y+ I+ + + +G
Sbjct: 367 RQQFFEQNGGGMLIQRLSGAGPSNVD-VKIFTEEGMKEATDGYNESRILGQGGQGTVYKG 425
Query: 82 VLPDRTISVVK---FIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138
+L D +I +K D S + + N ++ SQ++H NV++L+GCCLE E+P+LV+E
Sbjct: 426 ILQDNSIVAIKKARLGDRSQVEQF---INEVLVLSQINHRNVVKLLGCCLETEVPLLVYE 482
Query: 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198
G L D L S S L +HRL+IA+E+A AYLH S PI+ RD+K++ IL
Sbjct: 483 FISSGTLFDHLHGSMFDSS--LTWEHRLRIAIEVAGTLAYLHSYASIPIIHRDVKTANIL 540
Query: 199 VSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLL 258
+ E K+ +F S IP + + V+GT G + PEY TG LNEK DVYSFG++L+
Sbjct: 541 LDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLM 600
Query: 259 QLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFEL 318
+LLS GE R + FV ENR + I+D +++ +E + ++Q S +
Sbjct: 601 ELLS-GEKALCFE-RPQSSKHLVSYFVSAMKENR-LHEIIDGQVM-NEYNQREIQESARI 656
Query: 319 AFQCQSASAEDRPTMIDVAKQIKKM 343
A +C E+RP+M +VA +++ +
Sbjct: 657 AVECTRIMGEERPSMKEVAAELEAL 681
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (449), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 115/338 (34%), Positives = 188/338 (55%), Gaps = 6/338 (1%)
Query: 6 GQTSLFMCNSKNREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYH 65
G L N K + ++ F RNG + L++ S +G+ N + FS+ +LE AT+ ++
Sbjct: 332 GMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFN 391
Query: 66 YRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIG 125
I+ + + +G+L D I VK + + N I+ SQ++H NV++++G
Sbjct: 392 ASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILG 451
Query: 126 CCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR 185
CCLE E+P+LV+E NL D L S P+ + RL IA E+A+ +YLH S
Sbjct: 452 CCLETEVPILVYEFIPNRNLFDHLHNP--SEDFPMSWEVRLCIACEVADALSYLHSAVSI 509
Query: 186 PIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLN 245
PI RD+KS+ IL+ E++ K+ +F +S S+ +T++ V+GT G V PEY ++ +
Sbjct: 510 PIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFT 569
Query: 246 EKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGD 305
K DVYSFG+LL++LL TGE ++ LR F++ + N + I+D R I +
Sbjct: 570 GKSDVYSFGVLLIELL-TGEKPVSL-LRRQEVRMLGAYFLEA-MRNDRLHEILDAR-IKE 625
Query: 306 ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
E ++ + +LA +C S ++E RPTM DV ++ +M
Sbjct: 626 ECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRM 663
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 176 bits (446), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 110/325 (33%), Positives = 179/325 (55%), Gaps = 14/325 (4%)
Query: 23 RKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESSIFRLCQGV 82
R+ F +NG L + +S + ++ F+ +++ATN Y I+ + + +G+
Sbjct: 368 REQFFEQNGGGMLTQRLSGAGPSNVDVKIFTEDGMKKATNGYAESRILGQGGQGTVYKGI 427
Query: 83 LPDRTISVVK---FIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139
LPD +I +K D S + + N ++ SQ++H NV++L+GCCLE E+P+LV+E
Sbjct: 428 LPDNSIVAIKKARLGDSSQVEQF---INEVLVLSQINHRNVVKLLGCCLETEVPLLVYEF 484
Query: 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199
G L D L S S L +HRLKIA+E+A AYLH S PI+ RD+K++ IL+
Sbjct: 485 ITNGTLFDHLHGSMIDSS--LTWEHRLKIAIEVAGTLAYLHSSASIPIIHRDIKTANILL 542
Query: 200 SERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQ 259
K+ +F S IP + ++ V+GT G + PEY TG LNEK DVYSFG++L++
Sbjct: 543 DVNLTAKVADFGASRLIPMDKEELETMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLME 602
Query: 260 LLSTGEDL-FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFEL 318
LLS + L F R + F ENR + I+ ++ ++ L+ ++Q + +
Sbjct: 603 LLSGQKALCFK---RPQSSKHLVSYFATATKENR-LDEIIGGEVMNEDNLK-EIQEAARI 657
Query: 319 AFQCQSASAEDRPTMIDVAKQIKKM 343
A +C E+RP M +VA +++ +
Sbjct: 658 AAECTRLMGEERPRMKEVAAKLEAL 682
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (446), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 106/336 (31%), Positives = 186/336 (55%), Gaps = 21/336 (6%)
Query: 16 KNREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESSI 75
K R ++ F RNG + L++ +++ G + FS++ELE+AT+N++ +I +
Sbjct: 406 KRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIGQGGQ 465
Query: 76 FRLCQGVLPD-RTISVVK--FIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132
+ +G+L D R+++V K +D + N ++ SQ++H +V++L+GCCLE E+
Sbjct: 466 GTVYKGMLVDGRSVAVKKSNVVDEDKLQEF---INEVIILSQINHRHVVKLLGCCLETEV 522
Query: 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDL 192
P+LV+E GNL L + ++ L R++IA++I+ F+YLH PI RD+
Sbjct: 523 PILVYEFIPNGNLFQHLHEEFDDYTA--LWGVRMRIAVDISGAFSYLHTAACSPIYHRDI 580
Query: 193 KSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYS 252
KS+ IL+ E+Y K+ +F S S+ T+ + GT G V PEY + + EK DVYS
Sbjct: 581 KSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYS 640
Query: 253 FGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI-----ENRGFNGIVDPRIIGDEL 307
FG++L++L++ + + + E+ E+ + Y ENR F I+D RI D
Sbjct: 641 FGVVLVELITGEKPVITL------SETQEITGLADYFRLAMRENRLFE-IIDARIRNDCK 693
Query: 308 LEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
LE + + LA +C + + RP M +V+ ++++
Sbjct: 694 LEQVIAVA-NLALRCLKKTGKTRPDMREVSTALERI 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 347 | ||||||
| 255582635 | 331 | receptor protein kinase, putative [Ricin | 0.933 | 0.978 | 0.498 | 1e-80 | |
| 224123144 | 344 | predicted protein [Populus trichocarpa] | 0.942 | 0.950 | 0.446 | 3e-72 | |
| 255542662 | 330 | serine-threonine protein kinase, plant-t | 0.919 | 0.966 | 0.457 | 8e-70 | |
| 255542656 | 331 | serine-threonine protein kinase, plant-t | 0.927 | 0.972 | 0.443 | 5e-64 | |
| 255542658 | 356 | serine-threonine protein kinase, plant-t | 0.959 | 0.935 | 0.411 | 9e-63 | |
| 359493231 | 497 | PREDICTED: inactive serine/threonine-pro | 0.925 | 0.645 | 0.419 | 6e-61 | |
| 296081092 | 1111 | unnamed protein product [Vitis vinifera] | 0.951 | 0.297 | 0.411 | 1e-60 | |
| 359495252 | 343 | PREDICTED: probable inactive receptor-li | 0.927 | 0.938 | 0.411 | 7e-54 | |
| 297740944 | 375 | unnamed protein product [Vitis vinifera] | 0.878 | 0.813 | 0.380 | 7e-53 | |
| 225460075 | 380 | PREDICTED: wall-associated receptor kina | 0.878 | 0.802 | 0.380 | 7e-53 |
| >gi|255582635|ref|XP_002532098.1| receptor protein kinase, putative [Ricinus communis] gi|223528232|gb|EEF30288.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 305 bits (782), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 165/331 (49%), Positives = 226/331 (68%), Gaps = 7/331 (2%)
Query: 17 NREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESSIF 76
N +KA+ + + NG+M LE+LI+SC+G NPIR FSA EL RAT++Y R IIT+ S +
Sbjct: 2 NHKKAESERISLMNGRMLLEKLIASCDGRCNPIRIFSADELSRATDDYDPRKIITQDSGY 61
Query: 77 RLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVL 135
+L G+L +RTISV KF D S + Y C+N+I+FA+QMS H N L+L+GCCLE +IPVL
Sbjct: 62 KLYNGLLHERTISVKKFKDKS--EQYKYCYNDIMFATQMSKHKNFLKLLGCCLETQIPVL 119
Query: 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSS 195
VFE EYG L L ++ +PLL +HRLKIA+EIAN +YLH FSRPIVFR++K
Sbjct: 120 VFEPIEYGTLAGRLYGPNKTLYQPLLWRHRLKIAVEIANAVSYLHTAFSRPIVFRNIKPL 179
Query: 196 YILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGL 255
I + E +V KL +FSL+ SIPEGE+++ D + G G++APEYA+T NE DVY+FG+
Sbjct: 180 NIFLDECHVAKLSDFSLAVSIPEGESHVKDMLAGAWGLIAPEYAKTSCFNESQDVYNFGV 239
Query: 256 LLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHK---L 312
LL LL TG+ + + G+E +D VKK+I + F VD I+G+ L K L
Sbjct: 240 FLLMLL-TGQKVVDSYRPQAGEELGLVDHVKKFIADDRFYETVDSIILGEGSLPEKDQQL 298
Query: 313 QSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
Q+ L+F+C S + EDRP MIDVAK+++K+
Sbjct: 299 QAFTLLSFRCISEADEDRPMMIDVAKELRKI 329
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123144|ref|XP_002319005.1| predicted protein [Populus trichocarpa] gi|222857381|gb|EEE94928.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 278 bits (710), Expect = 3e-72, Method: Compositional matrix adjust.
Identities = 150/336 (44%), Positives = 218/336 (64%), Gaps = 9/336 (2%)
Query: 15 SKNREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESS 74
+K +K +++ ++NG LE+L+ C+G N IRSFSA EL++ATNNY + I+T S
Sbjct: 7 TKKDKKVNKETAFIKNGSKLLEKLVDICDGKCNSIRSFSATELKKATNNYDPQKILTGDS 66
Query: 75 IFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIP 133
++L +G L R +SV KF D + Y+ CFN+IV+AS+MS H + ++L+GCCLE IP
Sbjct: 67 GYKLYKGFLQGRPVSVKKFKDDD--EQYEYCFNDIVYASKMSVHKSFMKLLGCCLEARIP 124
Query: 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLK 193
+LVFE L D L S ++ +PLL R KIAM++AN A+LH FS+PIVFR++K
Sbjct: 125 ILVFEYVGDWTLSDFLWGSEEARCQPLLWIPRSKIAMDMANAVAFLHAAFSKPIVFRNIK 184
Query: 194 SSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSF 253
IL+ + + KL +FS+S SIP+GE+++ D V G +G++APEY TG NEK DV++F
Sbjct: 185 PLNILLDDNHEAKLSDFSISISIPKGESHVRDSVAGATGLIAPEYLTTGNFNEKQDVFNF 244
Query: 254 GLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELL---EH 310
G+ LL LLS G+ + + E D VKK IE+ FN ++D II + E
Sbjct: 245 GVFLLVLLS-GQMVVDFS--RPEKEILLQDHVKKCIEDDRFNKVIDSTIIAEGTWPGKEQ 301
Query: 311 KLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+LQ+ L+ +C S AEDRPTMIDV+K+++K+Y S
Sbjct: 302 QLQAYTALSLRCISELAEDRPTMIDVSKELRKIYWS 337
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542662|ref|XP_002512394.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548355|gb|EEF49846.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 270 bits (690), Expect = 8e-70, Method: Compositional matrix adjust.
Identities = 150/328 (45%), Positives = 210/328 (64%), Gaps = 9/328 (2%)
Query: 23 RKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESSIFRLCQGV 82
++AFL+ NG LE+ ++ CNG NPIR+FS++ELE+AT NY+ + ++ F L +G
Sbjct: 4 KEAFLI-NGSKLLEKSVAFCNGRCNPIRNFSSEELEKATRNYNEKQVLKLDGYFELYKGF 62
Query: 83 LPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVFESAE 141
L DR + V KF++ V N IV+AS MS H N ++L+GCCLE P+LVFESA+
Sbjct: 63 LQDRPVIVKKFLEVGV---EQLAINEIVYASAMSVHINSIKLLGCCLETPSPILVFESAK 119
Query: 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE 201
L D + H EP+ K RLKI +IANV Y+H F RPIV R++K+S IL+ E
Sbjct: 120 EKTLADRIIDRNDDHFEPVKWKLRLKIVADIANVVVYIHTAFPRPIVHRNIKASNILLDE 179
Query: 202 RYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLL 261
YV KL +FSL SIPEG++ + D + GT G++A E TGY NEK DVYSFG++LL +L
Sbjct: 180 DYVAKLSDFSLCVSIPEGKSRVRDIMAGTMGLIASESLATGYFNEKSDVYSFGVVLLVVL 239
Query: 262 STGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHK---LQSSFEL 318
TG+ F+ G++ ++ VKK+IE GF +VDP I+ +E K L+ +L
Sbjct: 240 -TGQRSFDFSRTETGEQFLLVNHVKKHIETGGFKEMVDPIIVAEEAGNRKGQELEDFRDL 298
Query: 319 AFQCQSASAEDRPTMIDVAKQIKKMYKS 346
A +C SAE+RPTMI+VAKQ++ +Y S
Sbjct: 299 ALRCIHDSAEERPTMIEVAKQLRHIYLS 326
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542656|ref|XP_002512391.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548352|gb|EEF49843.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 251 bits (640), Expect = 5e-64, Method: Compositional matrix adjust.
Identities = 152/343 (44%), Positives = 204/343 (59%), Gaps = 21/343 (6%)
Query: 10 LFMCNSKNR-EKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRN 68
+F C ++ EKA LMRNG+ LE+ ++ NG NP+R FS KEL+ ATN+Y N
Sbjct: 1 MFSCFGDSKYEKA-----LMRNGRSLLEKSVALNNGRGNPVRCFSVKELQNATNSYSQHN 55
Query: 69 IITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCC 127
+ RL +G++ DR + V K+ + ++IV AS+MS H NVL+L+GCC
Sbjct: 56 VFYIDGTCRLYKGLIRDRPVIVKKY---DYKHPSEDPVSDIVIASEMSVHRNVLKLLGCC 112
Query: 128 LEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPI 187
LE EIP+ VFE AE G L D ++++ LL K RLKIA+++A+V AYLH F RPI
Sbjct: 113 LESEIPIPVFEYAEKGTLEDYVQKT------ALLWKDRLKIAVDVASVIAYLHTAFPRPI 166
Query: 188 VFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEK 247
V RD+ + IL+ E K+ FSLS SIPEGET+I+D V GT G VAPEY NEK
Sbjct: 167 VHRDISLASILLDEDCAAKVTGFSLSISIPEGETHIEDEVAGTIGYVAPEYFMKRMFNEK 226
Query: 248 CDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDEL 307
DVYSFG++LL LL TG N + + FV+ I+N FN I+DP I+ +
Sbjct: 227 IDVYSFGVVLLVLL-TGHGPILRSPTTNESHALVV-FVEAKIKNERFNEIIDPAILEEGP 284
Query: 308 L---EHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347
E +L+S LA QC EDRP + DVAKQ++ +Y S
Sbjct: 285 WPEKEQQLKSFLTLAMQCTRKDEEDRPEITDVAKQLRHIYHSL 327
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542658|ref|XP_002512392.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548353|gb|EEF49844.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 246 bits (629), Expect = 9e-63, Method: Compositional matrix adjust.
Identities = 148/360 (41%), Positives = 206/360 (57%), Gaps = 27/360 (7%)
Query: 10 LFMCNSKNREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNI 69
+F C N + + + LMRNG + LE+ I+ NG NPIR FS EL+ ATN+Y N+
Sbjct: 1 MFSCFRDNMD--ENETALMRNGGILLEKSIAFNNGRGNPIRWFSVDELQTATNSYSQNNV 58
Query: 70 ITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCL 128
I E L +G L DR + +VK ++ + C N+IVFAS+MS H NVL+L+GCCL
Sbjct: 59 IYEGGWHTLYKGFLRDRPV-IVKRYRNNIHERV-CPINDIVFASEMSRHKNVLKLLGCCL 116
Query: 129 EVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIV 188
E EIP+LVFE AE G L D + ++ + PLL K RLKIA++ ANV AYLH RP+V
Sbjct: 117 ESEIPILVFEYAEKGKLQDYIYKTDSASFRPLLWKSRLKIAVDAANVIAYLHTACPRPVV 176
Query: 189 FRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKC 248
RD+ S I + E YV K+ +F++S SI EGET+I+D V GT G APEY R+G NEK
Sbjct: 177 HRDITLSNIWLDEDYVAKVTDFTVSMSILEGETHIEDFVLGTCGYAAPEYVRSGIFNEKI 236
Query: 249 DVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG--------------- 293
DV+SFG+LLL LL+ + + D F+ + + I +G
Sbjct: 237 DVFSFGVLLLVLLTDQKPFQGNWENILKDARFD-EIIGSLIVEKGLWSEKEQLETFLTRT 295
Query: 294 ---FNGIVDPRIIGDELL---EHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347
+ +DP I+ + E +L++ L QC E+RP + DVAKQ++ Y S+
Sbjct: 296 RQKLDLTIDPIIVEEGPWPEKEQQLKAFLMLGVQCIDPDEENRPEITDVAKQLRHFYLSY 355
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493231|ref|XP_002265528.2| PREDICTED: inactive serine/threonine-protein kinase At1g67470-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 240 bits (613), Expect = 6e-61, Method: Compositional matrix adjust.
Identities = 139/331 (41%), Positives = 201/331 (60%), Gaps = 10/331 (3%)
Query: 23 RKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESSIFRLCQGV 82
R+ F ++NG + LE+L+SS NG NPIR+FS KELE+ATN Y+ I + +G
Sbjct: 5 REEFFLKNGSLLLEKLVSSLNGRSNPIRNFSIKELEQATNKYNSSLIFDRWTYSEWYKGS 64
Query: 83 LPDRTISVVKFIDGSVFDAY-DCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVFESA 140
L R +SV KF + DA+ + I FA+Q+S H NVL+L GCCLE + PVLV+E
Sbjct: 65 LEGRFVSVRKF-HPVIDDAFLERVIKEITFATQLSAHKNVLKLFGCCLETQTPVLVYEYP 123
Query: 141 EYG--NLHDLLKRSYQSHS-EPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYI 197
G L+D++ S S + L K RL+I+ +IA+V AYLH F R I+ R++ S+
Sbjct: 124 VNGVVPLYDVIHPSTDGKSRQRLPWKSRLRISGDIAHVIAYLHTAFPRAIIHREVTLSFF 183
Query: 198 LVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLL 257
+ E VPKL NF + ++PEG Y+ DGV G G +APEY TG + EK DV+SFG LL
Sbjct: 184 FLDEDCVPKLSNFFFAIALPEGRKYVVDGVMGIEGFIAPEYEMTGMVTEKVDVFSFGKLL 243
Query: 258 LQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRII--GDELLEH-KLQS 314
L+LL TG + G N E D +K Y+E+ +G VD I+ G E+ E +L +
Sbjct: 244 LELL-TGRRTIDFGPLGNDGELLLQDCIKTYVEDHELDGFVDASILPRGGEIHEELQLLA 302
Query: 315 SFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345
+LA +C +AE RPTM+++AK+++++ +
Sbjct: 303 VTKLALRCIMTAAEQRPTMVEIAKELRRIQR 333
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296081092|emb|CBI18286.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 239 bits (611), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 140/340 (41%), Positives = 203/340 (59%), Gaps = 10/340 (2%)
Query: 14 NSKNREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITES 73
+K R+ F ++NG + LE+L+SS NG NPIR+FS KELE+ATN Y+ I
Sbjct: 610 QTKKLMAKKREEFFLKNGSLLLEKLVSSLNGRSNPIRNFSIKELEQATNKYNSSLIFDRW 669
Query: 74 SIFRLCQGVLPDRTISVVKFIDGSVFDAY-DCCFNNIVFASQMS-HNNVLRLIGCCLEVE 131
+ +G L R +SV KF + DA+ + I FA+Q+S H NVL+L GCCLE +
Sbjct: 670 TYSEWYKGSLEGRFVSVRKF-HPVIDDAFLERVIKEITFATQLSAHKNVLKLFGCCLETQ 728
Query: 132 IPVLVFESAEYG--NLHDLLKRSYQSHS-EPLLLKHRLKIAMEIANVFAYLHIGFSRPIV 188
PVLV+E G L+D++ S S + L K RL+I+ +IA+V AYLH F R I+
Sbjct: 729 TPVLVYEYPVNGVVPLYDVIHPSTDGKSRQRLPWKSRLRISGDIAHVIAYLHTAFPRAII 788
Query: 189 FRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKC 248
R++ S+ + E VPKL NF + ++PEG Y+ DGV G G +APEY TG + EK
Sbjct: 789 HREVTLSFFFLDEDCVPKLSNFFFAIALPEGRKYVVDGVMGIEGFIAPEYEMTGMVTEKV 848
Query: 249 DVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRII--GDE 306
DV+SFG LLL+LL TG + G N E D +K Y+E+ +G VD I+ G E
Sbjct: 849 DVFSFGKLLLELL-TGRRTIDFGPLGNDGELLLQDCIKTYVEDHELDGFVDASILPRGGE 907
Query: 307 LLEH-KLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345
+ E +L + +LA +C +AE RPTM+++AK+++++ +
Sbjct: 908 IHEELQLLAVTKLALRCIMTAAEQRPTMVEIAKELRRIQR 947
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359495252|ref|XP_002271790.2| PREDICTED: probable inactive receptor-like protein kinase At1g65250-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 217 bits (552), Expect = 7e-54, Method: Compositional matrix adjust.
Identities = 141/343 (41%), Positives = 203/343 (59%), Gaps = 21/343 (6%)
Query: 20 KADRKAFLMRNGKMFLERLISSCNGNY-NPIRSFSAKELERATNNYHYRNII-TESSIFR 77
K +RK ++RNG + L++ IS NG Y NP+RSFSAKEL++AT+NY++ N+I T S F+
Sbjct: 3 KKERKECILRNGGLLLQKRISYFNGKYSNPMRSFSAKELQKATDNYNHGNLIFTCLSRFK 62
Query: 78 LCQGVLPDRTISVVKFIDGSV-------FDAYDCCFNNIVFASQMS-HNNVLRLIGCCLE 129
+G L R + V K+ D S+ + N + A+Q+S H N L+L+GCCLE
Sbjct: 63 WYKGCLEGRVVFVKKYFDHSIATHSRGFLADPEMVTNEMSVAAQVSGHKNSLKLLGCCLE 122
Query: 130 VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVF 189
+IP LVFE GNL D L+ S+ L K RLKIA EIA+V YLH F RPI+
Sbjct: 123 TQIPTLVFEFPMNGNLGDQLR----SNPTGLSWKSRLKIANEIASVLTYLHTAFPRPIIH 178
Query: 190 RDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD-GVKGTSGIVAPEYARTGYLNEKC 248
RD+ + + KL +F+L ++PEG+T + + GT G +APE R +EK
Sbjct: 179 RDIYPGNFYLDQDLCAKLSDFTLCMALPEGKTQVQSLRISGTVGYLAPEVLRLCVYSEKS 238
Query: 249 DVYSFGLLLLQLLSTG---EDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRII-- 303
DV+ FGLLL LL+ E + + G + E + MD ++ YI N G NGIVDP I+
Sbjct: 239 DVFGFGLLLFDLLTGKDYRELVVSKGSMDDLKEDYLMDCIQSYIRNHGINGIVDPTILAE 298
Query: 304 -GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345
G H+ Q+ F L +C+ +AE+RP M+DVAKQ++++ +
Sbjct: 299 GGGVPHHHQFQAVFRLILKCRRMNAEERPIMLDVAKQLRRIQR 341
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740944|emb|CBI31256.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 214 bits (544), Expect = 7e-53, Method: Compositional matrix adjust.
Identities = 126/331 (38%), Positives = 192/331 (58%), Gaps = 26/331 (7%)
Query: 27 LMRNGKMFLERLISSCNGNY-NPIRSFSAKELERATNNYHYRNIITE--SSIFRLCQGVL 83
+++NG + LE+ IS G Y NPI +FS +E++RAT+N++ I + SS ++ +G L
Sbjct: 16 MLKNGSLLLEKRISYFGGRYSNPIHNFSIQEIQRATDNFNGNLIFNDDVSSFYKWYKGSL 75
Query: 84 PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVFESAEY 142
R I + K S + N I A+QMS H N L+L+GCCLE +P+LV+E +
Sbjct: 76 EGRVICIRKIFRSSFAENPQIVTNEIAVATQMSSHKNALKLLGCCLETRVPILVYE---F 132
Query: 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER 202
+ L ++ + + EP LK RLKIA EIA+V AYLH F RPI+ RD+K + +
Sbjct: 133 SSCEPLAEKIFDCN-EPFPLKGRLKIAYEIASVIAYLHTAFPRPIIHRDIKPHHFFLDNG 191
Query: 203 YVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS 262
PKL NF LS ++PEGET + D +GT G +APE Y EK DV+SFG L+L+LL+
Sbjct: 192 STPKLSNFELSIALPEGETRVKDVPRGTLGYLAPELFSWEY-TEKTDVFSFGTLILELLT 250
Query: 263 TGEDLF-----NMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRII---GDELLEHKLQS 314
F + +R +G++ +IE G + I+DP + G L + + ++
Sbjct: 251 RRRASFLAKRKGVSMRKHGED---------HIETYGIHDILDPSSLVEGGGVLEQQQFEA 301
Query: 315 SFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345
+LA +C AEDRPT++D AK+I+++ +
Sbjct: 302 VCQLALKCTEEFAEDRPTIVDAAKEIRRIQR 332
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225460075|ref|XP_002271888.1| PREDICTED: wall-associated receptor kinase-like 8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 214 bits (544), Expect = 7e-53, Method: Compositional matrix adjust.
Identities = 126/331 (38%), Positives = 192/331 (58%), Gaps = 26/331 (7%)
Query: 27 LMRNGKMFLERLISSCNGNY-NPIRSFSAKELERATNNYHYRNIITE--SSIFRLCQGVL 83
+++NG + LE+ IS G Y NPI +FS +E++RAT+N++ I + SS ++ +G L
Sbjct: 16 MLKNGSLLLEKRISYFGGRYSNPIHNFSIQEIQRATDNFNGNLIFNDDVSSFYKWYKGSL 75
Query: 84 PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVFESAEY 142
R I + K S + N I A+QMS H N L+L+GCCLE +P+LV+E +
Sbjct: 76 EGRVICIRKIFRSSFAENPQIVTNEIAVATQMSSHKNALKLLGCCLETRVPILVYE---F 132
Query: 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER 202
+ L ++ + + EP LK RLKIA EIA+V AYLH F RPI+ RD+K + +
Sbjct: 133 SSCEPLAEKIFDCN-EPFPLKGRLKIAYEIASVIAYLHTAFPRPIIHRDIKPHHFFLDNG 191
Query: 203 YVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS 262
PKL NF LS ++PEGET + D +GT G +APE Y EK DV+SFG L+L+LL+
Sbjct: 192 STPKLSNFELSIALPEGETRVKDVPRGTLGYLAPELFSWEY-TEKTDVFSFGTLILELLT 250
Query: 263 TGEDLF-----NMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRII---GDELLEHKLQS 314
F + +R +G++ +IE G + I+DP + G L + + ++
Sbjct: 251 RRRASFLAKRKGVSMRKHGED---------HIETYGIHDILDPSSLVEGGGVLEQQQFEA 301
Query: 315 SFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345
+LA +C AEDRPT++D AK+I+++ +
Sbjct: 302 VCQLALKCTEEFAEDRPTIVDAAKEIRRIQR 332
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 347 | ||||||
| TAIR|locus:2076596 | 340 | AT3G57700 [Arabidopsis thalian | 0.948 | 0.967 | 0.386 | 6.5e-51 | |
| TAIR|locus:2076681 | 359 | AT3G57720 [Arabidopsis thalian | 0.965 | 0.933 | 0.350 | 7.7e-48 | |
| TAIR|locus:2076671 | 355 | AT3G57730 [Arabidopsis thalian | 0.936 | 0.915 | 0.362 | 1.2e-47 | |
| TAIR|locus:2076586 | 351 | AT3G57710 [Arabidopsis thalian | 0.933 | 0.923 | 0.349 | 3.3e-47 | |
| TAIR|locus:2076646 | 334 | AT3G57750 [Arabidopsis thalian | 0.919 | 0.955 | 0.364 | 1.5e-44 | |
| TAIR|locus:2094468 | 433 | AT3G25490 [Arabidopsis thalian | 0.910 | 0.729 | 0.337 | 2.5e-42 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.933 | 0.431 | 0.345 | 8.3e-42 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.962 | 0.446 | 0.342 | 2.2e-41 | |
| TAIR|locus:2014897 | 741 | WAK3 "wall associated kinase 3 | 0.925 | 0.433 | 0.334 | 3.5e-41 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.971 | 0.468 | 0.326 | 3.9e-41 |
| TAIR|locus:2076596 AT3G57700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 529 (191.3 bits), Expect = 6.5e-51, P = 6.5e-51
Identities = 133/344 (38%), Positives = 202/344 (58%)
Query: 10 LFMCNSKNREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNI 69
L + K ++K + + L +NG + LE LI++ G YNPIR+FS+ ++ +ATN++ + +
Sbjct: 2 LRLFRKKKKQKKEEEINLQKNGSLLLEELIATSGGIYNPIRTFSSDQILQATNHFDWNYV 61
Query: 70 ITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCL 128
I+E F +G++ +R + + KF D SVFDA D + +I +S MS H NVL+L+GCCL
Sbjct: 62 ISEDR-FVWYKGMIENRPVLIKKFQDCSVFDA-DNFYRDIAVSSLMSSHKNVLKLLGCCL 119
Query: 129 EVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIV 188
E PVLV E E+G L+ + S P + RL+IA EIA+ AYLH F R I+
Sbjct: 120 EFPRPVLVCEYPEHGALNCIRCGKEGVRSFPWNV--RLRIAKEIADAVAYLHTEFPRTII 177
Query: 189 FRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKC 248
RDLK + I + E + KL +FSLS +PEGET ++D V TS + P+Y TG + E
Sbjct: 178 HRDLKLANIFLDENWSAKLSSFSLSIVLPEGETGVNDMVCRTSSYIEPDYFNTGLVTENV 237
Query: 249 DVYSFGXXXXXXXSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRII---GD 305
D+YS G TG+ +N + + +V K++E ++DP I+ D
Sbjct: 238 DIYSLGIIMLIIL-TGKSEYNSEVAVY--LPVLPVYVGKFLERGLLTELIDPSILDSTSD 294
Query: 306 ELLEH-KLQ-SSF-ELAFQC-QSASAEDRPTMIDVAKQIKKMYK 345
++ +H +LQ +F ELAF+C + E+ P MIDVAK++KK+ K
Sbjct: 295 DIPKHSRLQMEAFIELAFRCVRFRPGENVPRMIDVAKELKKIEK 338
|
|
| TAIR|locus:2076681 AT3G57720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 500 (181.1 bits), Expect = 7.7e-48, P = 7.7e-48
Identities = 121/345 (35%), Positives = 190/345 (55%)
Query: 9 SLFMCNSKNREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRN 68
SL K ++ + K FL NG +FL+ LI+ CNG PIR+FS+ ++ +AT+N+
Sbjct: 16 SLEKRKEKEKDIQEEKWFL-DNGSIFLKELIADCNGKSIPIRNFSSDQILKATSNFGSSC 74
Query: 69 IITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCC--FNNIVFASQMS-HNNVLRLIG 125
+T + +G++ DR+ + +F + V Y +N IV +++MS HNN L+LIG
Sbjct: 75 FVTAEGFYVWYKGIIEDRSYMIKRFSEYKVTQ-YRVAEVYNEIVLSARMSNHNNFLKLIG 133
Query: 126 CCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR 185
CLE +PVLVFE AE+G L+ L L RLKI EIAN YLH+ F +
Sbjct: 134 FCLEFSLPVLVFEYAEHGVLNHRGGVIVNGEEVILPLSLRLKIGKEIANAVTYLHMAFPK 193
Query: 186 PIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID-DGVKGTSGIVAPEYARTGYL 244
++ R +K + + E + PKL +FS+S ++PEG++ I+ + V+GT G + P Y T +
Sbjct: 194 ILIHRHIKPRNVFLDENWTPKLSDFSISINLPEGKSRIEVECVQGTIGYLDPVYYTTKMV 253
Query: 245 NEKCDVYSFGXXXXXXXSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIG 304
E DVYSFG TG+ +GD +VK + EN +G++DP+++
Sbjct: 254 TEYTDVYSFGVFLMVIL-TGKPAL-ASTSSDGDYKHIASYVKGFHENGQLDGVIDPKVME 311
Query: 305 DELLEHKL--QSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347
D K+ ++ LA +C E+RP MI +AK++K++ F
Sbjct: 312 DITSAQKVHVEACVVLALRCCELRDENRPKMIQIAKELKQIETLF 356
|
|
| TAIR|locus:2076671 AT3G57730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 1.2e-47, P = 1.2e-47
Identities = 121/334 (36%), Positives = 184/334 (55%)
Query: 16 KNREKADRKA-FLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESS 74
K +EK+ +K + + NG +FL+ LI CNG PIRSF++ ++ +AT N+ + E
Sbjct: 18 KKKEKSMKKERWFLENGSIFLKELIVDCNGKSIPIRSFTSSQIRKATKNFDLSCFVAEEG 77
Query: 75 IFRLCQGVLPDRTISVVKFIDGSVFD-AYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEI 132
+ +GV+ DR+ + +F + V D + +IV +++MS HNN L+L+GCCLE
Sbjct: 78 FYIWYKGVIEDRSYMIKRFSEYKVTDYRVSEVYKDIVLSARMSNHNNFLKLLGCCLEFPF 137
Query: 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDL 192
PVLVFE AE+G L+ + L L RLKI EIAN AYLH+ F + I++RD+
Sbjct: 138 PVLVFEFAEHGVLNYRGGITVNGEESLLPLSLRLKIGKEIANALAYLHMAFPKIIIYRDV 197
Query: 193 KSSYILVSERYVPKLFNFSLSASIPEGETYID-DGVKGTSGIVAPEYARTGYLNEKCDVY 251
K ++ + + KL + S S S+ EG++ I+ + V GT G + P Y T + E DVY
Sbjct: 198 KPLHVFLDNNWTAKLSDLSFSISLEEGKSQIEAEDVLGTYGYLDPLYFATRIVTEYTDVY 257
Query: 252 SFGXXXXXXXSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHK 311
SFG TG ++ G +G + ++K EN N IV P I+ + +
Sbjct: 258 SFGVFLMVVI-TGISVYFTGS--DGYPVGILGYMKGLAENGKLNEIVYPMIMKEMTSAQR 314
Query: 312 LQ--SSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
LQ + LA +C EDRP MI VAK++K++
Sbjct: 315 LQVEACVLLALRCCEERVEDRPKMIQVAKELKRI 348
|
|
| TAIR|locus:2076586 AT3G57710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 3.3e-47, P = 3.3e-47
Identities = 118/338 (34%), Positives = 190/338 (56%)
Query: 18 REKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESSIFR 77
+EK K + + NG +FL L++ CNG PIRSFS +++ +ATNN+ +++ ++
Sbjct: 14 KEKDKAKRWFLDNGSIFLRELVADCNGKSIPIRSFSPEQILKATNNFDSSCFVSQDVYYK 73
Query: 78 LCQGVLPDRTISVVKFIDGSVFDAYDCC---FNNIVFASQMS-HNNVLRLIGCCLEVEIP 133
+G + DR+ + +F + + +N+IV +++MS H+N L+L+GCCLE P
Sbjct: 74 WYRGEIEDRSYMIKRFSEDEITGKRHRVKEVYNDIVLSARMSNHSNFLQLLGCCLEFPFP 133
Query: 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKH--RLKIAMEIANVFAYLHIGFSRPIVFRD 191
VLVFE AE+G ++ + + E LL RLKI EIAN YLH F + I+ RD
Sbjct: 134 VLVFEFAEHGAMNQ--RGGVIVNGEESLLPWSVRLKIGKEIANAVTYLHTAFPKIIIHRD 191
Query: 192 LKSSYILVSERYVPKLFNFSLSASIPEGETYID-DGVKGTSGIVAPEYARTGYLNEKCDV 250
+K ++ + + + KL + S S S+PEG++ I+ + V GT G + P Y +T ++ E DV
Sbjct: 192 VKPMHVFLDKNWTAKLSDLSFSISLPEGKSRIEAEWVLGTFGYIDPLYHKTCFVTEYTDV 251
Query: 251 YSFGXXXXXXXSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEH 310
YSFG TG+ M + +GD + V++ EN + ++DPR++ D
Sbjct: 252 YSFGICLLVII-TGKPAI-MTIS-DGDLQGILSLVRELCENGKLDEVIDPRLMKDITSGQ 308
Query: 311 KLQ--SSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+LQ + LA +C EDRP MI VAK++K++ S
Sbjct: 309 RLQVEACVVLALRCCKERDEDRPKMIQVAKELKQIEAS 346
|
|
| TAIR|locus:2076646 AT3G57750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 469 (170.2 bits), Expect = 1.5e-44, P = 1.5e-44
Identities = 125/343 (36%), Positives = 190/343 (55%)
Query: 15 SKNREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESS 74
SKN +K ++ + ++NG + LE LI+S +G NPIR FS+ ++ +AT+N+ II+
Sbjct: 2 SKNNKK--KRRWDLKNGGILLEELIASFDGKTNPIRCFSSDQILKATDNFSESRIISSWG 59
Query: 75 IFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIP 133
F +GV+ +R +S+ K+ ++ ++ + +I +SQMS H N L+LIGCCLE ++P
Sbjct: 60 YFIWYKGVIEERQVSIKKWSSQNL-SSFTEAYRDISVSSQMSGHKNALKLIGCCLEFDLP 118
Query: 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLK 193
LV E E+G L+ + S L K RLKIA EIA+ YLH F IV R++
Sbjct: 119 ALVCEYTEHGPLN---RDGGLSSGVVLPWKVRLKIAKEIASSVTYLHTAFPETIVHRNIN 175
Query: 194 SSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSF 253
+ I + E + KL +F +IPEGE Y++D VKG G V P+Y T + EK D+YSF
Sbjct: 176 PTNIFIDENWTAKLSDFWFCVAIPEGELYVEDDVKGVIGFVDPDYYWTMKVTEKVDIYSF 235
Query: 254 GXXXXXXXSTGEDLFNMGLRLNGDESFEM---DFVKKYIENRGFNGIVDPRI---IG--D 305
G S +FN G + M D V + +E F+ IVD I +G D
Sbjct: 236 GVVMLVLLSGRAAVFN------GPDEAPMSLNDHVSEVMEKGEFDEIVDKEIWNDLGGDD 289
Query: 306 ELLEHKLQ-SSF-ELAFQCQSASAEDRPT-MIDVAKQIKKMYK 345
+L+ + Q +F LA +C ED + M++VAK++K + K
Sbjct: 290 DLVLRRSQVKAFLRLALRCVRYKKEDPVSGMLEVAKELKLIEK 332
|
|
| TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 2.5e-42, P = 2.5e-42
Identities = 110/326 (33%), Positives = 177/326 (54%)
Query: 20 KADRKAFLMRNGK-MFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESSIFRL 78
K R+ F +NG M +ERL + + N + + F+ ++++ ATN Y I+ + + +
Sbjct: 64 KIQRQLFFEKNGGGMLIERLSGAGSSNID-FKIFTEEDMKEATNGYDVSRILGQGGQWTV 122
Query: 79 CQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138
+G+LPD +I +K + + N ++ SQ++H NV++L+GCCLE E+P+LV+E
Sbjct: 123 YKGILPDNSIVAIKKTRLGDNNQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPLLVYE 182
Query: 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198
G+L D L S S L +HRL+IA+E+A AYLH G S PI+ RD+K+ IL
Sbjct: 183 FITGGSLFDHLHGSMFVSS--LTWEHRLEIAIEVAGAIAYLHSGASIPIIHRDIKTENIL 240
Query: 199 VSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGXXXX 258
+ E K+ +F S P + + V+GT G + PEY T LNEK DVYSFG
Sbjct: 241 LDENLTAKVADFGASKLKPMDKEQLTTMVQGTLGYLDPEYYTTWLLNEKSDVYSFGVVLM 300
Query: 259 XXXSTGEDL-FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFE 317
S + L F R + FV ENR + I+D +++ +E + ++ +
Sbjct: 301 ELISGQKALCFE---RPETSKHLVSYFVLATKENR-LHEIIDDQVLNEEN-QREIHEAAR 355
Query: 318 LAFQCQSASAEDRPTMIDVAKQIKKM 343
+A +C E+RP MI+VA +++ +
Sbjct: 356 VAVECTRLKGEERPRMIEVAAELETL 381
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 8.3e-42, P = 8.3e-42
Identities = 115/333 (34%), Positives = 181/333 (54%)
Query: 16 KNREKADRKA-FLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITESS 74
K R K RK F RNG + L++ +++ GN + FS+KELE+AT+N++ ++ +
Sbjct: 372 KKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGG 431
Query: 75 IFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134
+ +G+L D I VK D + N + SQ++H N+++L+GCCLE E+P+
Sbjct: 432 QGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPI 491
Query: 135 LVFESAEYGNLHDLLKR-SYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLK 193
LV+E G DL KR + S + RL+I++EIA AYLH S P+ RD+K
Sbjct: 492 LVYEHIPNG---DLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVK 548
Query: 194 SSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSF 253
++ IL+ E+Y K+ +F S SI +T++ V GT G + PEY +T +K DVYSF
Sbjct: 549 TTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSF 608
Query: 254 GXXXXXXXSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQ 313
G TGE F++ +R + F + +NR + IVD RI LE L
Sbjct: 609 GVVLVELI-TGEKPFSV-MRPEENRGLVSHFNEAMKQNRVLD-IVDSRIKEGCTLEQVLA 665
Query: 314 SSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+ +LA +C S + RP M +V+ +++++ S
Sbjct: 666 VA-KLARRCLSLKGKKRPNMREVSVELERIRSS 697
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 445 (161.7 bits), Expect = 2.2e-41, P = 2.2e-41
Identities = 117/342 (34%), Positives = 180/342 (52%)
Query: 6 GQTSLFMCNSKNREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYH 65
G L+ K R+ + F RNG M L++ ++ GN R FS+ ELE+AT+N++
Sbjct: 358 GIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFN 417
Query: 66 YRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIG 125
++ + + +G+L D I VK D + N +V +Q++H N+++L+G
Sbjct: 418 KNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLG 477
Query: 126 CCLEVEIPVLVFESAEYGNLHDLLKRSY-QSHSEPLLLKHRLKIAMEIANVFAYLHIGFS 184
CCLE E+PVLV+E G DL KR + +S + + RL IA+EIA +YLH S
Sbjct: 478 CCLETEVPVLVYEFVPNG---DLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAAS 534
Query: 185 RPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYL 244
PI RD+K++ IL+ ER K+ +F S S+ +T++ V GT G V PEY ++
Sbjct: 535 FPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKF 594
Query: 245 NEKCDVYSFGXXXXXXXSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIG 304
EK DVYSFG TGE + +R + FV+ ENR + IVD RI
Sbjct: 595 TEKSDVYSFGVVLVELL-TGEKPSSR-VRSEENRGLAAHFVEAVKENRVLD-IVDDRI-K 650
Query: 305 DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
DE ++ S LA +C + + RP M +V+ +++ + S
Sbjct: 651 DECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
|
| TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 443 (161.0 bits), Expect = 3.5e-41, P = 3.5e-41
Identities = 111/332 (33%), Positives = 178/332 (53%)
Query: 15 SKNRE--KADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERATNNYHYRNIITE 72
+K R+ K R+ F G M ++RL + N + + F+ + ++ ATN Y I+ +
Sbjct: 365 TKQRKYTKLRRQFFEQNGGGMLIQRLSGAGLSNID-FKIFTEEGMKEATNGYDESRILGQ 423
Query: 73 SSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132
+ +G+LPD TI +K + D + ++ SQ++H NV++++GCCLE E+
Sbjct: 424 GGQGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLSQINHRNVVKILGCCLETEV 483
Query: 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDL 192
P+LV+E G L D L S S L +HRL+IA+E+A AYLH S PI+ RD+
Sbjct: 484 PLLVYEFITNGTLFDHLHGSIFDSS--LTWEHRLRIAIEVAGTLAYLHSSASIPIIHRDI 541
Query: 193 KSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYS 252
K++ IL+ E K+ +F S IP + + V+GT G + PEY TG LNEK DVYS
Sbjct: 542 KTANILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEYYTTGLLNEKSDVYS 601
Query: 253 FGXXXXXXXSTGEDL-FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHK 311
FG S + L F R + FV ENR + I+D +++ ++ L+ +
Sbjct: 602 FGVVLMELLSGQKALCFE---RPQASKHLVSYFVSATEENR-LHEIIDDQVLNEDNLK-E 656
Query: 312 LQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
+Q + +A +C E+RP M +VA +++ +
Sbjct: 657 IQEAARIAAECTRLMGEERPRMKEVAAKLEAL 688
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 442 (160.7 bits), Expect = 3.9e-41, P = 3.9e-41
Identities = 112/343 (32%), Positives = 183/343 (53%)
Query: 1 MALCTGQTSLFMCNSKNREKADRKAFLMRNGKMFLERLISSCNGNYNPIRSFSAKELERA 60
+ L G L N K + ++ F RNG + L++ S +G+ N + FS+ +LE A
Sbjct: 327 LLLIFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENA 386
Query: 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV 120
T+ ++ I+ + + +G+L D I VK + + N I+ SQ++H NV
Sbjct: 387 TDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNV 446
Query: 121 LRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLH 180
++++GCCLE E+P+LV+E NL D L S P+ + RL IA E+A+ +YLH
Sbjct: 447 VKILGCCLETEVPILVYEFIPNRNLFDHLHNP--SEDFPMSWEVRLCIACEVADALSYLH 504
Query: 181 IGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYAR 240
S PI RD+KS+ IL+ E++ K+ +F +S S+ +T++ V+GT G V PEY +
Sbjct: 505 SAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQ 564
Query: 241 TGYLNEKCDVYSFGXXXXXXXSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300
+ + K DVYSFG TGE ++ LR F++ + N + I+D
Sbjct: 565 SNHFTGKSDVYSFGVLLIELL-TGEKPVSL-LRRQEVRMLGAYFLEA-MRNDRLHEILDA 621
Query: 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
RI +E ++ + +LA +C S ++E RPTM DV ++ +M
Sbjct: 622 RI-KEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRM 663
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 347 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-25 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-25 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-17 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-14 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-12 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-10 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-09 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-08 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-08 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-07 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-07 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-06 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-06 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-06 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-05 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-05 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-05 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-04 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-04 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-04 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.001 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 0.001 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.002 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.002 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.002 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 0.002 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 0.002 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.002 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 0.003 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 0.003 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.003 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.003 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 0.003 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 0.004 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.004 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.004 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 32/231 (13%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
++ H NV++L+G C E E +V E E G+L L++ + L L L A++I
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK----NRPKLSLSDLLSFALQI 111
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
A YL S+ + RDL + LV E V K+ +F LS + + + Y G K
Sbjct: 112 ARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP-- 166
Query: 233 IV---APEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289
+ APE + G K DV+SFG+LL ++ + GE + ++ +E V +Y+
Sbjct: 167 -IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY---PGMSNEE------VLEYL 216
Query: 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340
+N P EL ++L QC + EDRPT ++ + +
Sbjct: 217 KNGYRLPQ--PPNCPPEL--------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 74/238 (31%), Positives = 108/238 (45%), Gaps = 35/238 (14%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEP----LLLKHRLKI 168
++ H NV+RL+G C E E LV E E G+L D L++S P L LK L
Sbjct: 51 KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
A++IA YL S+ V RDL + LV E V K+ +F LS + + + Y K
Sbjct: 111 AIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY----RK 163
Query: 229 GTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283
T G + APE + G K DV+SFG+LL ++ + G + GL
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-GLSNEE------- 215
Query: 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341
V +Y+ + P DEL +EL C EDRPT ++ ++++
Sbjct: 216 -VLEYLRKGYR--LPKPEYCPDEL--------YELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 3e-28
Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 31/231 (13%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
++ H N+++L+G C E E ++V E G+L D L+ ++ + L L L A++I
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR---KNRPKELSLSDLLSFALQI 112
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
A YL S+ + RDL + LV E V K+ +F LS + + + Y G K
Sbjct: 113 ARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP-- 167
Query: 233 IV---APEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289
+ APE + G K DV+SFG+LL ++ + GE+ + ++ E V +Y+
Sbjct: 168 -IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPY---PGMSNAE------VLEYL 217
Query: 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340
+ P EL ++L QC + EDRPT ++ + +
Sbjct: 218 KKGYRLPK--PPNCPPEL--------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 57/158 (36%), Positives = 84/158 (53%), Gaps = 16/158 (10%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
++SH N++RL+G C + E +V E G+L D L++ H E L LK L++A++I
Sbjct: 56 KKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK----HGEKLTLKDLLQMALQI 111
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
A YL S+ V RDL + LV+E V K+ +F LS I E + Y K G
Sbjct: 112 AKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----RKRGGG 164
Query: 233 IV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
+ APE + G K DV+SFG+LL ++ + GE
Sbjct: 165 KLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGE 202
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 11/174 (6%)
Query: 90 VVKFIDGSVFDAYDCCFNN-IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDL 148
+K I + I +++H N+++L G + LV E E G+L DL
Sbjct: 22 AIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDL 81
Query: 149 LKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-YVPKL 207
LK + SE L+I ++I YLH S I+ RDLK IL+ KL
Sbjct: 82 LKENEGKLSE----DEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKL 134
Query: 208 FNFSLSASIPEGETYIDDGVKGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQL 260
+F LS + ++ + V GT +APE GY +EK D++S G++L +L
Sbjct: 135 ADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
++ H N++RL + + LV E E G+L DLLK+ L +I
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFYLRQI 106
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
+ YLH S+ IV RDLK IL+ E KL +F L+ + GE GT
Sbjct: 107 LSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPE 161
Query: 233 IVAPE-YARTGYLNEKCDVYSFGLLLLQLLSTGEDLF 268
+APE GY + D++S G++L +LL TG+ F
Sbjct: 162 YMAPEVLLGKGY-GKAVDIWSLGVILYELL-TGKPPF 196
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 68/231 (29%), Positives = 102/231 (44%), Gaps = 32/231 (13%)
Query: 115 MSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174
+SH N++RLI + + LV E E G+L D L R PL KIA++I
Sbjct: 55 LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILR 109
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIV 234
YLH S I+ RDLK IL+ E V K+ +F L+ + + + + V GT +
Sbjct: 110 GLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYM 165
Query: 235 APE--YARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292
APE GY K DV+S G++L +LL TG+ F+ L+ +
Sbjct: 166 APEVLLGGNGYG-PKVDVWSLGVILYELL-TGKPPFSGENILDQLQLIRR---------- 213
Query: 293 GFNGIVDPRIIGDELLEHKLQSSF-ELAFQCQSASAEDRPTMIDVAKQIKK 342
I+ P + DE +L +C + RPT A++I +
Sbjct: 214 ----ILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPT----AEEILQ 256
|
Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 10/154 (6%)
Query: 111 FASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM 170
+ + H N+++L+G L+ +V E G+L D L+ ++ + L +L A+
Sbjct: 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV---ITLAQQLGFAL 109
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
++ YL + V RDL + +LVSE V K+ +F L+ +G+ VK T
Sbjct: 110 DVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT 166
Query: 231 SGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
APE R + K DV+SFG+LL ++ S G
Sbjct: 167 ----APEALREKKFSTKSDVWSFGILLWEIYSFG 196
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-15
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 30/221 (13%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
++SH +++L G C E LVFE E+G L D L+ S+ L L + +++
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL----LGMCLDVC 110
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
AYL S ++ RDL + LV E V K+ +F ++ + + + G K
Sbjct: 111 EGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKW 167
Query: 234 VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293
+PE + K DV+SFG+L+ ++ S G K ENR
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEG---------------------KTPYENRS 206
Query: 294 FNGIVDPRIIGDELLEHKL--QSSFELAFQCQSASAEDRPT 332
+ +V+ G L + +L QS +EL C EDRP+
Sbjct: 207 NSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 37/235 (15%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q H N+++LIG C++ + +V E G+L L++ L +K L+++++ A
Sbjct: 48 QYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK----KNRLTVKKLLQMSLDAA 103
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG-----VK 228
YL S+ + RDL + LV E V K+ +F +S G + DG +K
Sbjct: 104 AGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK 160
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLF-NMGLRLNGDESFEMDFVKK 287
T APE G + DV+S+G+LL + S G+ + M + ++ E
Sbjct: 161 WT----APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM----SNQQTRER----- 207
Query: 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342
IE G+ R+ +L ++ + L QC + E+RP+ ++ +++
Sbjct: 208 -IE-SGY------RMPAPQLCPEEI---YRLMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 115 MSHNNVLRLIGCCLEV--EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
+ H N+++ G C + L+ E G+L D L+R H + + LK L + +I
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR----HRDQINLKRLLLFSSQI 118
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILV-SERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
YL S+ + RDL + ILV SE V K+ +F L+ +PE + Y G S
Sbjct: 119 CKGMDYLG---SQRYIHRDLAARNILVESEDLV-KISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 232 GI--VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
I APE RT + DV+SFG+ L +L + G+
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 59/227 (25%), Positives = 103/227 (45%), Gaps = 33/227 (14%)
Query: 115 MSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174
+ H N++RL G L + ++V E A G+L D L+ + L+ A++IAN
Sbjct: 53 LDHENLIRLYGVVLTHPL-MMVTELAPLGSLLDRLR---KDALGHFLISTLCDYAVQIAN 108
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY--IDDGVKGTSG 232
YL S+ + RDL + IL++ K+ +F L ++P+ E + +++ +K
Sbjct: 109 GMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA 165
Query: 233 IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292
APE RT + DV+ FG+ L ++ + GE+ + L+G + + K I+
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW---AGLSGSQ------ILKKIDKE 216
Query: 293 GFNGIVDPRIIGDELLEHK---LQSSFELAFQCQSASAEDRPTMIDV 336
G E LE Q + + QC + + DRPT +
Sbjct: 217 G------------ERLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-14
Identities = 61/266 (22%), Positives = 105/266 (39%), Gaps = 74/266 (27%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS-------------------YQ 154
Q++H +V++L G C + +L+ E A+YG+L L+ S
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 155 SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214
L + + A +I+ YL +V RDL + +LV+E K+ +F LS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 215 SIPEGETYIDDGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTG----- 264
+ E ++Y VK + G + A E + DV+SFG+LL ++++ G
Sbjct: 176 DVYEEDSY----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
Query: 265 ----EDLFNM---GLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFE 317
E LFN+ G R+ E+ + +
Sbjct: 232 GIAPERLFNLLKTGYRMERPENCS-------------------------------EEMYN 260
Query: 318 LAFQCQSASAEDRPTMIDVAKQIKKM 343
L C + RPT D++K+++KM
Sbjct: 261 LMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 50/156 (32%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVL-VF-ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM 170
S + H N++R G + E L +F E G+L LLK+ + EP++ K+
Sbjct: 54 SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKY----TR 108
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG-VKG 229
+I AYLH S IV RD+K + ILV V KL +F + + + ET G V+G
Sbjct: 109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 230 TSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
T +APE R D++S G ++++ TG+
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA-TGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 23/164 (14%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKR--------SY---QSHSEPLLLKHR 165
H N++ L+G C + +V E A +GNL D L+ S + E L K
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
+ A ++A +L S+ + RDL + +LV+E +V K+ +F L+ I +ID
Sbjct: 135 VSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDI----HHIDY 187
Query: 226 GVKGTSG-----IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
K T+G +APE + DV+SFG+LL ++ + G
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVF 176
H +++ L C E ++ E E G+L L+ + L + + +A ++A
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLR---SPEGQVLPVASLIDMACQVAEGM 117
Query: 177 AYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAP 236
AYL + + RDL + ILV E V K+ +F L+ I E + Y+ K AP
Sbjct: 118 AYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKIPYKWTAP 173
Query: 237 EYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
E A G + K DV+SFG+LL ++ + G+
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQ 202
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
++ H+ +++L C E E +V E G+L D LK L L + +A +IA
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK---LRLPQLVDMAAQIA 113
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
AYL SR + RDL + ILV E V K+ +F L+ I + E +G K
Sbjct: 114 EGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKW 170
Query: 234 VAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
APE A G K DV+SFG+LL ++++ G
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYG 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 19/234 (8%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
++ H N+++LIG C + L+ E E NL ++L+ L + R KIA+ IA
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIA 790
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
+LH S +V +L I++ + P L S+P G D +S
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-----RLSLP-GLLCTDTKCFISSAY 844
Query: 234 VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293
VAPE T + EK D+Y FGL+L++LL TG+ + ++G +++ + +
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELL-TGKSPADAEFGVHGS---IVEWARYCYSDCH 900
Query: 294 FNGIVDPRIIGDELL-EHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+ +DP I GD + ++++ LA C + RP DV K ++ +S
Sbjct: 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954
|
Length = 968 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 58/233 (24%), Positives = 107/233 (45%), Gaps = 29/233 (12%)
Query: 114 QMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
++ H N+++L+G C E P ++ E YGNL D L+ + ++L L +A +I
Sbjct: 58 EIKHPNLVQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQI 113
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD-GVKGTS 231
++ YL + + RDL + LV E ++ K+ +F L + + G+TY G K
Sbjct: 114 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPI 169
Query: 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291
APE + K DV++FG+LL ++ + G + ++ V + +E
Sbjct: 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------PGIDLSQVYELLEK 220
Query: 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344
G+ R+ E K+ +EL C + DRP+ ++ + + M+
Sbjct: 221 -GY------RMERPEGCPPKV---YELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 19/165 (11%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKR---------SYQSHSEPLLLK 163
+ H N+++ G C E + P++VFE E+G+L+ L+ S S L L
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 164 HRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223
L+IA++IA+ YL S+ V RDL + LV V K+ +F +S + + Y
Sbjct: 123 QLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY- 178
Query: 224 DDGVKGTSGI----VAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
V G + + + PE + DV+SFG++L ++ + G
Sbjct: 179 --RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYG 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 63/248 (25%), Positives = 98/248 (39%), Gaps = 58/248 (23%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD-LLKRSYQSHSEPLLLKHRLKIAME 171
+Q+ H ++RLIG C E +LV E A G L L KR S+ L H++ + M
Sbjct: 51 AQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGM- 108
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
AYL S+ V RDL + +L+ R+ K+ +F +S ++ G Y + T+
Sbjct: 109 -----AYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY----YRATT 156
Query: 232 G------IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285
APE G + K DV+S+G+ L + S G
Sbjct: 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGA-------------------- 196
Query: 286 KKYIENRGFNGIVDPRIIGDELLEHKL---------QSSFELAFQCQSASAEDRPTMIDV 336
K Y E +G +I +LE Q + + C EDRPT ++
Sbjct: 197 KPYGEMKG------AEVI--AMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
Query: 337 AKQIKKMY 344
++
Sbjct: 249 ESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q H N+++LIG C + + +V E G+ L++ + L K +K A++ A
Sbjct: 48 QYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK----KDELKTKQLVKFALDAA 103
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
AYL S+ + RDL + LV E V K+ +F +S DDG+ +SG+
Sbjct: 104 AGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQE-------DDGIYSSSGL 153
Query: 234 -------VAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
APE G + + DV+S+G+LL + S G
Sbjct: 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLG 191
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 65/247 (26%), Positives = 103/247 (41%), Gaps = 47/247 (19%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR----------- 165
H N++ L+G C + E A YGNL D L++S ++P K
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
L+ A ++A YL + + RDL + +LV E K+ +F LS E Y
Sbjct: 122 LQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRG---EEVY--- 172
Query: 226 GVKGTSGIVAPEYARTGYLN-----EKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESF 280
VK T G + + LN K DV+SFG+LL +++S G G
Sbjct: 173 -VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLG-----------GTPYC 220
Query: 281 EMDFVKKYIE-NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339
M + Y + +G+ + PR DE+ +EL QC +RP ++ Q
Sbjct: 221 GMTCAELYEKLPQGYR-MEKPRNCDDEV--------YELMRQCWRDRPYERPPFAQISVQ 271
Query: 340 IKKMYKS 346
+ +M ++
Sbjct: 272 LSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 7/157 (4%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLL----KRSYQSHSEPLLLKHRLKI 168
++SH NV+RL+G C E E ++ E + G+L L + + PL K ++ +
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
+IA H+ +R V RDL + LVS + K+ SLS + E Y
Sbjct: 123 CTQIALGMD--HLSNAR-FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
+APE + + K DV+SFG+L+ ++ + GE
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 9/178 (5%)
Query: 84 PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYG 143
+K I + + N I + H N+++ G L+ + +V E G
Sbjct: 23 RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82
Query: 144 NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY 203
+L DLLK S ++ L + E+ YLH S I+ RD+K++ IL++
Sbjct: 83 SLKDLLK----STNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDG 135
Query: 204 VPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLL 261
KL +F LSA + + + + + GT +APE + K D++S G+ ++L
Sbjct: 136 EVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA 191
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 6/148 (4%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVF 176
H +++L C E +V E +YG+L + L+ L L + +A ++A+
Sbjct: 60 HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVASGM 116
Query: 177 AYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAP 236
AYL ++ + RDL + +LV E + K+ +F L+ I E +G K AP
Sbjct: 117 AYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAP 173
Query: 237 EYARTGYLNEKCDVYSFGLLLLQLLSTG 264
E A + K DV+SFG+LL ++++ G
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYG 201
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 65/240 (27%), Positives = 101/240 (42%), Gaps = 44/240 (18%)
Query: 58 ERATNNYHYRNIITESSIFRLCQ----GVLPDR--TISVVKFI-DGSVFDAYDCCFNNIV 110
E NN Y I + + R+ Q G+LP T+ VK + + + D
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 111 FASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKR--SYQSHSE---------- 158
++ H N+++L+G C + L+FE YG+L++ L+ S
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 159 -----PLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213
PL +L IA ++A AYL R V RDL + LV E V K+ +F LS
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 214 ASIPEGETYIDDGVKGTSG------IVAPE---YARTGYLNEKCDVYSFGLLLLQLLSTG 264
+I Y D K + + PE Y R Y E DV+++G++L ++ S G
Sbjct: 178 RNI-----YSADYYKASENDAIPIRWMPPESIFYNR--YTTES-DVWAYGVVLWEIFSYG 229
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 11/155 (7%)
Query: 118 NNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK--RSYQSHSEPLLLKHRLKI---AMEI 172
++V+RL+G + ++V E G+L L+ R ++ L K A EI
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
A+ AYL ++ V RDL + +V+E K+ +F ++ I E + Y G KG
Sbjct: 129 ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG-KGLLP 184
Query: 233 I--VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
+ +APE + G K DV+SFG++L ++ + E
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAE 219
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK-RSYQSHSEPLLLKHRLKIAME 171
+++ H N++RL+G L + + V E GNL + L+ R S LL+ +++
Sbjct: 54 TKLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQ----FSLD 108
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
+A YL S+ +V RDL + ILVSE V K+ +F L+ G VK T
Sbjct: 109 VAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT- 164
Query: 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
APE + + K DV+S+G+LL ++ S G
Sbjct: 165 ---APEALKHKKFSSKSDVWSYGVLLWEVFSYG 194
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 7/151 (4%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
++ H +++L E I +V E G+L D LK + L L + +A +IA
Sbjct: 57 KLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIA 112
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
+ AY+ V RDL+++ ILV E V K+ +F L+ I + E G K
Sbjct: 113 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 234 VAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
APE A G K DV+SFG+LL +L + G
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKG 200
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-11
Identities = 62/243 (25%), Positives = 97/243 (39%), Gaps = 45/243 (18%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEP-----------LLLKHR 165
H N++ L+G C L E A +GNL D L++S ++P L +
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
L A ++A YL + + RDL + ILV E YV K+ +F LS E Y
Sbjct: 115 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVY--- 165
Query: 226 GVKGTSGIVAPEYARTGYLN-----EKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESF 280
VK T G + + LN DV+S+G+LL +++S G G
Sbjct: 166 -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----------GTPYC 213
Query: 281 EMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340
M + Y + + P DE+ ++L QC +RP+ + +
Sbjct: 214 GMTCAELYEKLPQGYRLEKPLNCDDEV--------YDLMRQCWREKPYERPSFAQILVSL 265
Query: 341 KKM 343
+M
Sbjct: 266 NRM 268
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 54/227 (23%), Positives = 95/227 (41%), Gaps = 44/227 (19%)
Query: 115 MSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174
+ H+ +++L + I ++ E G+L D LK S + +PL + + +IA
Sbjct: 58 LQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLK-SDEGSKQPL--PKLIDFSAQIAE 113
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIV 234
A++ R + RDL+++ ILVS V K+ +F L+ I + E +G K
Sbjct: 114 GMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 170
Query: 235 APEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294
APE G K DV+SFG+LL+++++ G +
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRI--------------------------PY 204
Query: 295 NGIVDPRIIGDELLEHKL---------QSSFELAFQCQSASAEDRPT 332
G+ +P +I LE + + + +C E+RPT
Sbjct: 205 PGMSNPEVI--RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 50/162 (30%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGN-LHDLLKRSYQSHSEPLL-LKHRLKIAM 170
S +H N+++L+G CL E ++ E E G+ L L + PLL LK L I +
Sbjct: 54 SNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSE-----RYVPKLFNFSLSASIPEGETYIDD 225
++A YL + RDL + LVSE V K+ +F L+ I + + Y +
Sbjct: 114 DVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170
Query: 226 GVKGTSGI--VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
G +G + +APE G + DV+SFG+L+ ++L+ G+
Sbjct: 171 G-EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ 211
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 7/151 (4%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
++ H+ ++ L E I +V E G+L D LK + L L + +A +IA
Sbjct: 57 KLRHDKLVPLYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKY---LKLPQLVDMAAQIA 112
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
+ AY+ + RDL+++ ILV + V K+ +F L+ I + E G K
Sbjct: 113 DGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 234 VAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
APE A G K DV+SFG+LL +L++ G
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKG 200
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 8e-11
Identities = 63/243 (25%), Positives = 106/243 (43%), Gaps = 36/243 (14%)
Query: 115 MSHNNVLRLIGCCLEV--EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
+ H N+++ GCC E + L+ E G+L D L + + ++ LL A +I
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLF------AQQI 116
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
AYLH S+ + RDL + +L+ + K+ +F L+ ++PEG Y G S
Sbjct: 117 CEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173
Query: 233 IV--APEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290
+ A E + + DV+SFG+ L +LL+ + +S F +
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELLT----------HCDSKQSPPKKFEEMIGP 223
Query: 291 NRGFNGIVDPRIIGDELLEHKL---------QSSFELAFQCQSASAEDRPTMIDVAKQIK 341
+G +V R+I ELLE + Q + L C A+ RPT + +K
Sbjct: 224 KQGQMTVV--RLI--ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
Query: 342 KMY 344
+M+
Sbjct: 280 EMH 282
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 115 MSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174
+ H+ ++RL + E ++ E G+L D LK +LL + + +IA
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGK---VLLPKLIDFSAQIAE 114
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIV 234
AY+ + + RDL+++ +LVSE + K+ +F L+ I + E +G K
Sbjct: 115 GMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT 171
Query: 235 APEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
APE G K DV+SFG+LL ++++ G+
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVTYGK 202
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 33/200 (16%)
Query: 95 DGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQ 154
+ SV + C ++V+RL+G + + ++V E +G+L L RS +
Sbjct: 59 EASVMKGFTC-------------HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLR 104
Query: 155 SHSE------PLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLF 208
+E P L+ +++A EIA+ AYL+ ++ V RDL + +V+ + K+
Sbjct: 105 PEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIG 161
Query: 209 NFSLSASIPEGETYIDDGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLST 263
+F ++ I E + Y KG G++ APE + G D++SFG++L ++ S
Sbjct: 162 DFGMTRDIYETDYY----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSL 217
Query: 264 GEDLFNMGLRLNGDESFEMD 283
E + GL F MD
Sbjct: 218 AEQPYQ-GLSNEQVLKFVMD 236
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 22/159 (13%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q SH N++RLIG C + + +V E + G+ L ++ L +K +++ A
Sbjct: 49 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL----RTEGPRLKVKELIQMVENAA 104
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG- 232
YL S+ + RDL + LV+E+ V K+ +F +S +DGV ++G
Sbjct: 105 AGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREE-------EDGVYASTGG 154
Query: 233 -------IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
APE G + + DV+SFG+LL + S G
Sbjct: 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLG 193
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 7/151 (4%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q+ H ++RL + I ++ E E G+L D LK L + + +A +IA
Sbjct: 57 QLQHPRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPEGIK---LTINKLIDMAAQIA 112
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
A++ + + RDL+++ ILVSE K+ +F L+ I + E +G K
Sbjct: 113 EGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169
Query: 234 VAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
APE G K DV+SFG+LL ++++ G
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYG 200
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 61.3 bits (147), Expect = 2e-10
Identities = 47/162 (29%), Positives = 75/162 (46%), Gaps = 15/162 (9%)
Query: 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANV 175
N+++L + LV E + G+L DLLK+ + PL L I +I +
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKG--PLSESEALFILAQILSA 113
Query: 176 FAYLHIGFSRPIVFRDLK-SSYILVSERYVPKLFNFSLSASIPEGET-----YIDDGVKG 229
YLH S+ I+ RD+K + +L + V KL +F L+ +P+ + + G
Sbjct: 114 LEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 230 TSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLF 268
T G +APE Y + D++S G+ L +LL TG F
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL-TGLPPF 211
|
Length = 384 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 17/162 (10%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK--RSYQSHSEPLLLKHRLKIAM 170
S+ +H N++RLIG E ++ E G+L L+ R L +K L A
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSER---YVPKLFNFSLSASIPEGETYIDDG- 226
++A YL + RD+ + L++ + V K+ +F ++ I Y G
Sbjct: 124 DVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 227 ----VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
+K PE G K DV+SFG+LL ++ S G
Sbjct: 181 AMLPIKWMP----PEAFLDGIFTSKTDVWSFGVLLWEIFSLG 218
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 47/154 (30%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRL-KIAM 170
+Q+ H+N+++L+G +E + + +V E G+L D L+ S +L L K ++
Sbjct: 54 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR----SRGRSVLGGDCLLKFSL 109
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
++ YL + V RDL + +LVSE V K+ +F L+ + VK T
Sbjct: 110 DVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 166
Query: 231 SGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
APE R + K DV+SFG+LL ++ S G
Sbjct: 167 ----APEALREKKFSTKSDVWSFGILLWEIYSFG 196
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 65/246 (26%), Positives = 111/246 (45%), Gaps = 43/246 (17%)
Query: 112 ASQMSHNN---VLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSE------PLLL 162
AS M N V+RL+G + + +++ E G+L L RS + E P L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVQAPPSL 118
Query: 163 KHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222
K +++A EIA+ AYL+ + V RDL + +V+E + K+ +F ++ I E + Y
Sbjct: 119 KKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 175
Query: 223 IDDGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD 277
KG G++ +PE + G DV+SFG++L ++ + E + G+
Sbjct: 176 ----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-GMSNEQV 230
Query: 278 ESFEMDFVKKYIENRGFNGIVD-PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
F M+ G++D P D L FEL C + + RP+ +++
Sbjct: 231 LRFVME-----------GGLLDKPDNCPDML--------FELMRMCWQYNPKMRPSFLEI 271
Query: 337 AKQIKK 342
IK+
Sbjct: 272 ISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 47/151 (31%), Positives = 74/151 (49%), Gaps = 7/151 (4%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
++ H+ +++L E I +V E G+L D LK L L + + +A ++A
Sbjct: 57 KLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLK---DGEGRALKLPNLVDMAAQVA 112
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
AY+ + RDL+S+ ILV + V K+ +F L+ I + E G K
Sbjct: 113 AGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169
Query: 234 VAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
APE A G K DV+SFG+LL +L++ G
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKG 200
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 8e-10
Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 21/174 (12%)
Query: 106 FNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD-LLKRSYQSHSE------ 158
S + H N++ L+G C + + ++FE +G+LH+ L++ S S
Sbjct: 56 RQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 159 ----PLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214
L L IA++IA YL S V RDL + LV E K+ +F LS
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
Query: 215 SIPEGETYIDDGVKGTSGI----VAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
I + Y V+ S + + PE G + D++SFG++L ++ S G
Sbjct: 173 DIYSADYY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYG 223
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 26/164 (15%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEP-LLLKHR---------- 165
H N++ L+G C L E A +GNL D L++S ++P + +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
L A ++A YL + + RDL + ILV E YV K+ +F LS E Y
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVY--- 177
Query: 226 GVKGTSGIVAPEYARTGYLN-----EKCDVYSFGLLLLQLLSTG 264
VK T G + + LN DV+S+G+LL +++S G
Sbjct: 178 -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 220
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-10
Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 33/238 (13%)
Query: 111 FASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLL--KRSYQSHSEPLLLKHRLKI 168
Q+ + ++R+IG C E E +LV E A G L+ L K+ + S + L H++ +
Sbjct: 48 IMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM 106
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
M+ YL + V RDL + +L+ ++ K+ +F LS ++ ++Y
Sbjct: 107 GMK------YLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157
Query: 229 GTSGI--VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286
G + APE + + DV+S+G+ + + S G+ + ++ G E V
Sbjct: 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK---KMKGPE------VM 208
Query: 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344
+IE + P E+ + L C EDRP V ++++ Y
Sbjct: 209 SFIE--QGKRLDCPAECPPEM--------YALMKDCWIYKWEDRPNFAKVEERMRTYY 256
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 22/178 (12%)
Query: 110 VFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIA 169
V AS + H +V+RL+G CL ++ L+ + G L D ++ +H + + ++ L
Sbjct: 62 VMAS-VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVR----NHKDNIGSQYLLNWC 115
Query: 170 MEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET-YIDDGVK 228
++IA +YL + +V RDL + +LV K+ +F L+ + E Y +G K
Sbjct: 116 VQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE------------DLFNMGLRL 274
+A E K DV+S+G+ + +L++ G DL G RL
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL 230
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 30/238 (12%)
Query: 114 QMSHNNVLRLIGCCLEVE------IPVLVFESAEYGNLHDLLKRS-YQSHSEPLLLKHRL 166
H NV++LIG C E P+++ ++G+LH L S E L L+ L
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 167 KIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG 226
K ++IA YL +R + RDL + ++ E + +F LS I G+ Y
Sbjct: 117 KFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 227 V-KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285
+ K +A E K DV++FG+ + ++ + G+ + G E+ E+
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY------PGVENHEI--- 224
Query: 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
Y R N + P E L ++L + C A +DRPT + + ++ +
Sbjct: 225 --YDYLRHGNRLKQP--------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 84 PDRTISV-VKFI--DGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF-ES 139
PD+T++V VK + + + D D + H N++ L+G C + E P+ V E
Sbjct: 41 PDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEY 99
Query: 140 AEYGNLHDLLKRSY-----------QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIV 188
A GNL + L+ + E L K + A ++A YL SR +
Sbjct: 100 AAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCI 156
Query: 189 FRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG-----IVAPEYARTGY 243
RDL + +LV+E V K+ +F L+ G ID K ++G +APE
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLA----RGVHDIDYYKKTSNGRLPVKWMAPEALFDRV 212
Query: 244 LNEKCDVYSFGLLLLQLLSTG---------EDLFNM 270
+ DV+SFG+L+ ++ + G E+LF +
Sbjct: 213 YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 79 CQGVLP--DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136
C +LP D+ + VK + + A + + H +++R G C E ++V
Sbjct: 26 CHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85
Query: 137 FESAEYGNLHDLLKRSYQSHSE-----------PLLLKHRLKIAMEIANVFAYLHIGFSR 185
FE +G+L+ L RS+ ++ L L L IA +IA+ YL S
Sbjct: 86 FEYMRHGDLNRFL-RSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SL 141
Query: 186 PIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI----VAPEYART 241
V RDL + LV + V K+ +F +S I + Y V G + + + PE
Sbjct: 142 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILY 198
Query: 242 GYLNEKCDVYSFGLLLLQLLSTGE 265
+ D++SFG++L ++ + G+
Sbjct: 199 RKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 42/153 (27%), Positives = 78/153 (50%), Gaps = 13/153 (8%)
Query: 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANV 175
+H N++ L+G C +++ E YG+L + L+R +S L L+ L + ++A
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF---LTLEDLLSFSYQVAKG 153
Query: 176 FAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI-- 233
A+L S+ + RDL + +L++ + K+ +F L+ I Y+ VKG + +
Sbjct: 154 MAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPV 207
Query: 234 --VAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
+APE + DV+S+G+LL ++ S G
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLG 240
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 16/155 (10%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
+ H N+++ IG + ++ E AE G+L ++K+ + E L +A+ +
Sbjct: 54 KNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK-FGPFPESL-------VAVYV 105
Query: 173 ANV---FAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKG 229
V AYLH + ++ RD+K++ IL ++ V KL +F ++ + + D V G
Sbjct: 106 YQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DASVVG 161
Query: 230 TSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
T +APE + D++S G +++LL TG
Sbjct: 162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELL-TG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 39/156 (25%), Positives = 74/156 (47%), Gaps = 8/156 (5%)
Query: 106 FNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
N I+ H N++ L + +V E + G+L D++ +++ +EP
Sbjct: 63 INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP----QI 118
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
+ E+ YLH S+ ++ RD+KS IL+S+ KL +F +A + + E +
Sbjct: 119 AYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK-EKSKRN 174
Query: 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLL 261
V GT +APE + K D++S G++ +++
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 45/153 (29%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 114 QMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSY-QSHSEPLLLKHRLKIAME 171
Q H ++++LIG E PV +V E A G L RSY Q + L L + + +
Sbjct: 63 QFDHPHIVKLIGVI--TENPVWIVMELAPLGEL-----RSYLQVNKYSLDLASLILYSYQ 115
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
++ AYL S+ V RD+ + +LVS KL +F LS + + Y K
Sbjct: 116 LSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI 172
Query: 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
+APE DV+ FG+ + ++L G
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLG 205
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 45/172 (26%), Positives = 83/172 (48%), Gaps = 16/172 (9%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLL-LKHRLKIAMEI 172
Q+ + ++R+IG C E E +LV E AE G L+ L+++ + + L H++ + M+
Sbjct: 52 QLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKY 110
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
++H RDL + +L+ ++ K+ +F LS ++ E Y G
Sbjct: 111 LEETNFVH---------RDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP 161
Query: 233 I--VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282
+ APE + K DV+SFG+L+ + S G+ + + G+E +M
Sbjct: 162 VKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY---KGMKGNEVTQM 210
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 116 SHNNVLRLIGCCLEVE-IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174
SH NVL L+G CL E P++V ++G+L + ++ S + +K + +++A
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIR----SETHNPTVKDLIGFGLQVAK 109
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI---DDGVKGTS 231
YL S+ V RDL + ++ E + K+ +F L+ I + E Y G K
Sbjct: 110 GMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
Query: 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
+A E +T K DV+SFG+LL +L++ G
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 199
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 57/241 (23%), Positives = 105/241 (43%), Gaps = 38/241 (15%)
Query: 114 QMSHNNVLRLIGCCLE------VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRL- 166
+ H NV+RLIG CL+ PV++ ++G+LH L S + P L ++
Sbjct: 56 EFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-RLGDCPQYLPTQML 114
Query: 167 -KIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
K +IA+ YL S+ + RDL + +++E + +F LS I G+ Y
Sbjct: 115 VKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG 171
Query: 226 GV-KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM-D 283
+ K +A E K DV+SFG+ + ++ + G+ + G E+ E+ D
Sbjct: 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY------PGVENSEIYD 225
Query: 284 FVKKYIENRGFNGIVDPRIIGDELLEHK--LQSSFELAFQCQSASAEDRPTMIDVAKQIK 341
++++ G+ L + L + L C + +DRP+ + +++
Sbjct: 226 YLRQ----------------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
Query: 342 K 342
K
Sbjct: 270 K 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM-- 170
S++ H N+++ +G E + + E G+L LLK+ Y S EP+ I +
Sbjct: 57 SKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK-YGSFPEPV-------IRLYT 108
Query: 171 -EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKG 229
+I YLH R V RD+K + ILV V KL +F ++ + E KG
Sbjct: 109 RQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA--KSFKG 163
Query: 230 TSGIVAPEY-ARTGYLNEKCDVYSFGLLLLQLLSTG 264
+ +APE A+ G D++S G +L++ +
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 53/231 (22%), Positives = 87/231 (37%), Gaps = 34/231 (14%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI--AME 171
++SH N+++L G C + +V E G L + L+ LL + AME
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
++H RDL + LV E V K+ +F L+ + + + G K
Sbjct: 115 YLESNGFIH---------RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV 165
Query: 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291
PE + K DV+SFG+L+ ++ S G K E
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEG---------------------KMPYER 204
Query: 292 RGFNGIVDPRIIGDELLEHKLQSS--FELAFQCQSASAEDRPTMIDVAKQI 340
+ +V+ G L KL + + + + C EDRP + Q+
Sbjct: 205 FSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 26/169 (15%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS---------YQSHSEP 159
+ S++S N+ RL+G C ++ E E G+L+ L++
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 160 LLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219
L + +A +IA+ YL S V RDL + LV + Y K+ +F +S ++
Sbjct: 130 STLLY---MATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 220 ETYIDDGVKGTSGIVAP------EYARTGYLNEKCDVYSFGLLLLQLLS 262
+ Y G P E G K DV++FG+ L ++L+
Sbjct: 184 DYYRVQG-----RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
+ F Q+ H N + GC L+ LV E G+ DLL + H +PL I
Sbjct: 72 VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAI 126
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
AYLH S ++ RD+K+ IL++E KL +F ++ +++
Sbjct: 127 THGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV----- 178
Query: 229 GTSGIVAPEY---ARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270
GT +APE G + K DV+S G+ ++L LFNM
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (130), Expect = 3e-08
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 8/100 (8%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
++ H N+++L+ LVFE + +L L + P L+K I ++
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDK-RPGPLSPNLIKS---IMYQLL 108
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213
AY H S I+ RDLK IL++ V KL +F L+
Sbjct: 109 RGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 32/179 (17%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK--------RSYQSHSEP---LLLKHR 165
H N++ L+G C + ++ E A GNL + L+ Y P L K
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
+ A ++A YL S+ + RDL + +LV+E V K+ +F L+ I +ID
Sbjct: 143 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 195
Query: 226 GVKGTSG-----IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG---------EDLFNM 270
K T+G +APE + DV+SFG+LL ++ + G E+LF +
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 10/154 (6%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q H N++RL G + +++ E E G+L L+ + + + + IA
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE----NDGKFTVGQLVGMLRGIA 116
Query: 174 NVFAYL-HIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE-TYIDDGVKGTS 231
+ YL + + V RDL + ILV+ V K+ +F LS + + E TY G K
Sbjct: 117 SGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172
Query: 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
APE DV+SFG+++ +++S GE
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 32/179 (17%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKR--------SY---QSHSEPLLLKHR 165
H N++ L+G C + ++ E A GNL + L+ SY + E + K
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
+ ++A YL S+ + RDL + +LV+E V K+ +F L+ + ID
Sbjct: 140 VSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNN----IDY 192
Query: 226 GVKGTSG-----IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG---------EDLFNM 270
K T+G +APE + DV+SFG+L+ ++ + G E+LF +
Sbjct: 193 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 6e-08
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
+ F ++ H N + GC L LV E G+ DLL + H +PL I
Sbjct: 76 VKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAI 130
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
AYLH S ++ RD+K+ IL++E KL +F ++ +++
Sbjct: 131 THGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV----- 182
Query: 229 GTSGIVAPEY---ARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMG-----LRLNGDESF 280
GT +APE G + K DV+S G+ ++L LFNM + +ES
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 242
Query: 281 EM------DFVKKYIENRGFNGIVDPRIIGDELLEH 310
+ D+ + ++++ I R +ELL+H
Sbjct: 243 TLQSNEWSDYFRNFVDS-CLQKIPQDRPTSEELLKH 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 23/169 (13%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK------------RSYQSHSEPL 160
+ + H ++++ G C + + ++VFE ++G+L+ L+ + Q+ E L
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE-L 120
Query: 161 LLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220
L L IA +IA+ YL S+ V RDL + LV + K+ +F +S + +
Sbjct: 121 GLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 177
Query: 221 TYIDDGVKGTSGI----VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
Y V G + + + PE + DV+SFG++L ++ + G+
Sbjct: 178 YY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 17/156 (10%)
Query: 111 FASQMSHNNVLRLIGCCL---EVEIPVLVFESAEYGNLHDLLKRSYQSH---SEPLLLKH 164
+++ G L I + + E E G+L + K+ + E +L K
Sbjct: 52 INKSCKSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGK- 109
Query: 165 RLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID 224
IA + +YLH SR I+ RD+K S IL++ + KL +F +S E +
Sbjct: 110 ---IAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLA 160
Query: 225 DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQL 260
GTS +APE + + DV+S GL LL++
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 32/172 (18%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQS--HSEPLL---LK 163
+ SQ +H NV++ + + LV G+L D++K SY E ++ LK
Sbjct: 50 VQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK 109
Query: 164 HRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG---- 219
E+ YLH S + RD+K+ IL+ E K+ +F +SAS+ +G
Sbjct: 110 -------EVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159
Query: 220 ----ETYIDDGVKGTSGIVAPE--YARTGYLNEKCDVYSFGLLLLQLLSTGE 265
+T++ GT +APE GY + K D++SFG+ ++ L+TG
Sbjct: 160 RKVRKTFV-----GTPCWMAPEVMEQVHGY-DFKADIWSFGITAIE-LATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (126), Expect = 1e-07
Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSH---SEPLLLKHRLKIA 169
+++H N+++ E +V E A+ G+L +K+ + E +L +++
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 170 MEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL--FNFS--LSASIPEGETYIDD 225
+ + YLH SR I+ RD+K I ++ + KL F S LS+++ +T +
Sbjct: 114 LALK----YLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-- 164
Query: 226 GVKGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLS 262
GT ++PE Y N K D++S G +L +L +
Sbjct: 165 ---GTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCT 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 45/202 (22%)
Query: 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKS 194
+V E + G+L DLLK+ EP+L IA +I YLH R I+ RD+K
Sbjct: 76 IVLEYMDGGSLADLLKK-VGKIPEPVLAY----IARQILKGLDYLH--TKRHIIHRDIKP 128
Query: 195 SYILVSERYVPKLFNFSLSASIPEG----ETYIDDGVKGTSGIVAPEYARTGYLNEKCDV 250
S +L++ + K+ +F +S + T++ GT ++PE + + D+
Sbjct: 129 SNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPERIQGESYSYAADI 183
Query: 251 YSFGLLLLQLLSTGE---------DLFNMGLRLNGDESFEM----------DFVKKYIEN 291
+S GL LL+ G+ F + + + DF+ ++
Sbjct: 184 WSLGLTLLECA-LGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQK 242
Query: 292 RGFNGIVDP--RIIGDELLEHK 311
DP R ELL+H
Sbjct: 243 -------DPKKRPSAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 41/218 (18%)
Query: 84 PDRTISV-VKFIDGSVFDAYDCCFNNIVFASQM-----SHNNVLRLIGCCLEVEIPVLVF 137
P++ ++V VK + DA D +++V +M H N++ L+G C + ++
Sbjct: 41 PNKPVTVAVKMLKD---DATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLV 97
Query: 138 ESAEYGNLHDLLKR--------SYQS---HSEPLLLKHRLKIAMEIANVFAYLHIGFSRP 186
E A GNL + L+ S+ + E L K + A ++A YL S+
Sbjct: 98 EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQK 154
Query: 187 IVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG-----IVAPEYART 241
+ RDL + +LV+E V K+ +F L+ + ID K T+G +APE
Sbjct: 155 CIHRDLAARNVLVTEDNVMKIADFGLARDVHN----IDYYKKTTNGRLPVKWMAPEALFD 210
Query: 242 GYLNEKCDVYSFGLLLLQLLSTG---------EDLFNM 270
+ DV+SFG+LL ++ + G E+LF +
Sbjct: 211 RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 30/172 (17%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
+ F ++ H N ++ GC L LV E G+ DLL + H +PL
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQ------- 113
Query: 169 AMEIANV-------FAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221
+EIA V AYLH S ++ RD+K+ IL+SE + KL +F ++ +
Sbjct: 114 EVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170
Query: 222 YIDDGVKGTSGIVAPEY---ARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270
++ GT +APE G + K DV+S G+ ++L LFNM
Sbjct: 171 FV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 50/188 (26%), Positives = 83/188 (44%), Gaps = 38/188 (20%)
Query: 88 ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD 147
I V+K G D ++ I + H N++ G L + +V E G+L D
Sbjct: 33 IKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD 89
Query: 148 LLKRSYQSHSEPLLLKHRLKIAMEIANV-------FAYLHIGFSRPIVFRDLKSSYILVS 200
+ + + SE IA V AYLH + RD+K + IL++
Sbjct: 90 IYQVTRGPLSELQ-----------IAYVCRETLKGLAYLH---ETGKIHRDIKGANILLT 135
Query: 201 ERYVPKLFNFSLSA----SIPEGETYIDDGVKGTSGIVAPEYA----RTGYLNEKCDVYS 252
E KL +F +SA +I + +++I GT +APE A + GY + KCD+++
Sbjct: 136 EDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAVERKGGY-DGKCDIWA 189
Query: 253 FGLLLLQL 260
G+ ++L
Sbjct: 190 LGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 47/157 (29%), Positives = 72/157 (45%), Gaps = 15/157 (9%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIA--ME 171
Q SH+N++RL G + + +++ E E G L L+ S L+ IA M+
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMK 121
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI---PEGETYIDDGVK 228
+ Y+H RDL + ILV+ K+ +F LS + PEG TY G K
Sbjct: 122 YLSDMNYVH---------RDLAARNILVNSNLECKVSDFGLSRVLEDDPEG-TYTTSGGK 171
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
APE DV+SFG+++ +++S GE
Sbjct: 172 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 43/178 (24%), Positives = 80/178 (44%), Gaps = 9/178 (5%)
Query: 85 DRTISVVKFIDGSVFDAYD--CCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142
D+ + +K ID S + + + +++ + ++R L+ +V E AE
Sbjct: 24 DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83
Query: 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER 202
G+LH LLK PL + ++I A+LH S+ I+ RD+KS + +
Sbjct: 84 GDLHKLLKMQRGR---PLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAY 137
Query: 203 YVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQL 260
K+ + + A + T + + GT ++PE NEK DV++ G++L +
Sbjct: 138 DNVKIGDLGV-AKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYEC 194
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 34/231 (14%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI--AME 171
++SH +++L G C + + +V E E G L + L++ S+ +LL + ME
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME 114
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
+++H RDL + LVS V K+ +F ++ + + E G K
Sbjct: 115 YLERNSFIH---------RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPV 165
Query: 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291
PE + K DV+SFG+L+ ++ + G +M F E
Sbjct: 166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG----------------KMPF-----EK 204
Query: 292 RGFNGIVDPRIIGDELLEHKLQSS--FELAFQCQSASAEDRPTMIDVAKQI 340
+ +V+ G L KL S +E+ + C E RPT ++ + I
Sbjct: 205 KSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 20/201 (9%)
Query: 79 CQGVLP--DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136
C + P D+ + VK + + +A + + H ++++ G C+E + ++V
Sbjct: 26 CYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85
Query: 137 FESAEYGNLHDLLKRS-----YQSHSEP---LLLKHRLKIAMEIANVFAYLHIGFSRPIV 188
FE ++G+L+ L+ + L L IA +IA YL S+ V
Sbjct: 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFV 142
Query: 189 FRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI----VAPEYARTGYL 244
RDL + LV E + K+ +F +S + + Y V G + + + PE
Sbjct: 143 HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKF 199
Query: 245 NEKCDVYSFGLLLLQLLSTGE 265
+ DV+S G++L ++ + G+
Sbjct: 200 TTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 38/157 (24%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 107 NNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRL 166
N IV S + H N++ ++ ++ E A G L+D + + L + +
Sbjct: 48 NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEM 102
Query: 167 KIAM--EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID 224
+ +I + +Y+H I+ RD+K+ I +++ + KL +F +S I E +
Sbjct: 103 VLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGIS-KILGSEYSMA 158
Query: 225 DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLL 261
+ V GT ++PE + N K D+++ G +L +LL
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 37/200 (18%)
Query: 109 IVFASQMSHN---NVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
+ SQ+ + N+ + G L+ ++ E AE G++ L+K P+ K+
Sbjct: 50 VALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG------PIAEKYI 103
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG----ET 221
I E+ Y+H ++ RD+K++ ILV+ KL +F ++A + + T
Sbjct: 104 SVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160
Query: 222 YIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLS-----TGEDLFN-MGL-- 272
++ GT +APE G Y + K D++S G+ + ++ + + D F M L
Sbjct: 161 FV-----GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP 215
Query: 273 -----RLNGDE-SFEM-DFV 285
RL + S + +FV
Sbjct: 216 KSKPPRLEDNGYSKLLREFV 235
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 44/184 (23%), Positives = 83/184 (45%), Gaps = 14/184 (7%)
Query: 83 LPDRTISVVKFIDGSVFDAYDC-----CFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137
L D + +K + +F+ D C I Q+ H NV++ + +E +V
Sbjct: 24 LLDGRVVALKKVQ--IFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81
Query: 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYI 197
E A+ G+L ++K ++ + + K +++ + ++H S+ I+ RD+K + +
Sbjct: 82 ELADAGDLSRMIKH-FKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANV 137
Query: 198 LVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLL 256
++ V KL + L T V GT ++PE GY N K D++S G L
Sbjct: 138 FITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGY-NFKSDIWSLGCL 195
Query: 257 LLQL 260
L ++
Sbjct: 196 LYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 22/166 (13%)
Query: 111 FASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM 170
F Q+ H N + GC L LV E G+ D+L + H +PL ++IA
Sbjct: 68 FLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDIL----EVHKKPL---QEVEIAA 119
Query: 171 EIANVF---AYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGV 227
AYLH S + RD+K+ IL++E KL +F ++ + +++
Sbjct: 120 ICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV---- 172
Query: 228 KGTSGIVAPEY---ARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270
GT +APE G + K DV+S G+ ++L LFNM
Sbjct: 173 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 30/221 (13%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
++SH +++L G C + +V E G L + L R + +P L L++ ++
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQL---LEMCKDVC 110
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
AYL S+ + RDL + LV ++ K+ +F LS + + E G K
Sbjct: 111 EGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167
Query: 234 VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293
PE + K DV++FG+L+ ++ S G+ + R N E
Sbjct: 168 SPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE---RFNNSE--------------- 209
Query: 294 FNGIVDPRIIGDELLEHKLQSS--FELAFQCQSASAEDRPT 332
V+ G L L S + + + C AE+RPT
Sbjct: 210 ---TVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPT 247
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 37/159 (23%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
I ++ H N+++ +G L+ + + E G++ LL +Y + E L+ ++ ++
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLV-RNFVR- 113
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG-- 226
+I YLH +R I+ RD+K + ILV + K+ +F +S +
Sbjct: 114 --QILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 227 ---VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS 262
++G+ +APE + K D++S G L++++L+
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 58/265 (21%), Positives = 108/265 (40%), Gaps = 29/265 (10%)
Query: 85 DRTISVVKFIDGSVFDAYDC-----CFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139
D +K + +FD D C I Q++H NV++ +E +V E
Sbjct: 26 DGVPVALKKV--QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83
Query: 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199
A+ G+L ++ + ++ + K K +++ + ++H SR ++ RD+K + + +
Sbjct: 84 ADAGDLSRMI-KHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFI 139
Query: 200 SERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQ 259
+ V KL + L +T + GT ++PE N K D++S G LL +
Sbjct: 140 TATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 260 LLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELA 319
+ + + GD+ KK IE + P + D H + +L
Sbjct: 199 MAALQSPFY-------GDKMNLYSLCKK-IEQCDY-----PPLPSD----HYSEELRQLV 241
Query: 320 FQCQSASAEDRPTMIDVAKQIKKMY 344
C + E RP + V K+M+
Sbjct: 242 NMCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 36/161 (22%), Positives = 72/161 (44%), Gaps = 17/161 (10%)
Query: 107 NNIVFASQMSHNNVLR-----LIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLL 161
N I + ++H N++ L G L +V E A +G+L + + + + +
Sbjct: 48 NEIRILASVNHPNIISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKR-KKKRKLIP 101
Query: 162 LKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221
+ +I +++ LH + I+ RDLKS+ IL+ + K+ + +S + +
Sbjct: 102 EQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA 158
Query: 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS 262
GT +APE + + K D++S G LL ++ +
Sbjct: 159 KT---QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 22/184 (11%)
Query: 158 EPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217
EPL L+ + + ++A +L SR + RDL + IL+SE V K+ +F L+ I
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 218 EGETYIDDG-VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG 276
+ Y+ G + +APE + DV+SFG+LL ++ S G + G+++
Sbjct: 225 KDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP-GVQI-- 281
Query: 277 DESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
DE +F ++ E P E+ + + C + EDRPT ++
Sbjct: 282 DE----EFCRRLKEGTRMRA---P--------EYATPEIYSIMLDCWHNNPEDRPTFSEL 326
Query: 337 AKQI 340
+ +
Sbjct: 327 VEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 3e-06
Identities = 40/130 (30%), Positives = 58/130 (44%), Gaps = 13/130 (10%)
Query: 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLK-IAMEIANVFAYLHIGFSRPIVFRDLK 193
LV E A G L L + E + R + A EI YLH S I++RDLK
Sbjct: 70 LVLEYAPGGELFSHLSK------EGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLK 120
Query: 194 SSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEY-ARTGYLNEKCDVYS 252
IL+ KL +F L+ + + + GT +APE GY + D +S
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGY-GKAVDWWS 178
Query: 253 FGLLLLQLLS 262
G+LL ++L+
Sbjct: 179 LGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 13/156 (8%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q H N++ L G + + ++V E E G+L L++ H + + + IA
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK----HDGQFTVIQLVGMLRGIA 116
Query: 174 NVFAYLH-IGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI---PEGETYIDDGVKG 229
+ YL +G+ V RDL + ILV+ V K+ +F LS + PE Y G K
Sbjct: 117 SGMKYLSDMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKI 171
Query: 230 TSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
APE DV+S+G+++ +++S GE
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 47/154 (30%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 113 SQMSHNNVLRLIGCCLEVEIP--VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM 170
+ H+N+++ G C LV E YG+L D L Q H E L + L A
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL----QKHRERLDHRKLLLYAS 115
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
+I YL S+ V RDL + ILV K+ +F L+ +P+ + Y G
Sbjct: 116 QICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGE 172
Query: 231 SGIV--APEYARTGYLNEKCDVYSFGLLLLQLLS 262
S I APE + DV+SFG++L +L +
Sbjct: 173 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 57/235 (24%), Positives = 105/235 (44%), Gaps = 28/235 (11%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK----RSYQSHSEPL---L 161
I S++ + N++RL+G C+ + ++ E E G+L+ L S +H+ +
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 162 LKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221
+ + L +A++IA+ YL S V RDL + LV Y K+ +F +S ++ G+
Sbjct: 128 IANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 222 YIDDGVKGTSGI----VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD 277
Y ++G + + +A E G DV++FG+ L ++ + L +
Sbjct: 185 Y---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT-----------LCKE 230
Query: 278 ESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT 332
+ + + ++ IEN G R I F+L +C S +DRPT
Sbjct: 231 QPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 16/126 (12%)
Query: 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER 202
G+L +LK E +L K IA+ + YLH I+ RD+K S ILV+ R
Sbjct: 84 GSLDKILKEVQGRIPERILGK----IAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSR 137
Query: 203 YVPKLFNFSLSASIPEGETYIDDGVK---GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQ 259
KL +F +S + ++ K GTS +APE + + K D++S GL L++
Sbjct: 138 GQIKLCDFGVSGQL------VNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIE 191
Query: 260 LLSTGE 265
L+TG
Sbjct: 192 -LATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 23/190 (12%)
Query: 88 ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD 147
I V+K G F I+ H+N++ G L + + E G+L D
Sbjct: 39 IKVIKLEPGEDFAVVQ---QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD 95
Query: 148 LLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207
+ + PL ++ E YLH S+ + RD+K + IL+++ KL
Sbjct: 96 IYHVT-----GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKL 147
Query: 208 FNFSLSA----SIPEGETYIDDGVKGTSGIVAPEYA---RTGYLNEKCDVYSFGLLLLQL 260
+F +SA +I + +++I GT +APE A R G N+ CD+++ G+ ++L
Sbjct: 148 ADFGVSAQITATIAKRKSFI-----GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
Query: 261 LSTGEDLFNM 270
+F++
Sbjct: 203 AELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 7e-06
Identities = 61/267 (22%), Positives = 114/267 (42%), Gaps = 38/267 (14%)
Query: 91 VKFIDGSVFDAYDC--CFNNIVFASQMSHNNVLRLIGCCLE------VEIPVLVFESAEY 142
VK + +F + D + H NV++LIG L + IP+++ ++
Sbjct: 32 VKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKH 91
Query: 143 GNLHDLLKRSYQSHSEP--LLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS 200
G+LH L S + EP L L+ ++ ++IA+ YL S+ + RDL + +++
Sbjct: 92 GDLHTFLLMS-RIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLN 147
Query: 201 ERYVPKLFNFSLSASIPEGETYIDDGV-KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQ 259
E + +F LS I G+ Y K +A E DV++FG+ + +
Sbjct: 148 ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWE 207
Query: 260 LLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHK--LQSSFE 317
+++ G+ + G E+ E I + I G+ L + L+ +E
Sbjct: 208 IMTRGQTPY------AGVENSE---------------IYNYLIKGNRLKQPPDCLEDVYE 246
Query: 318 LAFQCQSASAEDRPTMIDVAKQIKKMY 344
L QC S + RP+ + Q++ ++
Sbjct: 247 LMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q+ H N++ L LVFE E L +LL+ P ++ ++
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEA-SPGGLPPDAVR---SYIWQLL 110
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG-ETYIDDGVKGTSG 232
AY H S I+ RD+K ILVSE V KL +F + ++ + + D V T
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRW 166
Query: 233 IVAPEYARTGYLN--EKCDVYSFGLLLLQLLSTGEDLF 268
APE G N + DV++ G ++ +LL GE LF
Sbjct: 167 YRAPELL-VGDTNYGKPVDVWAIGCIMAELL-DGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 36/106 (33%), Positives = 53/106 (50%), Gaps = 10/106 (9%)
Query: 167 KIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE--TYID 224
KIA+ + YL+ I+ RD+K S ILV+ R KL +F +S GE I
Sbjct: 107 KIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIA 159
Query: 225 DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270
D GTS ++PE + G K DV+S G+ +++L G+ F
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA-LGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 48/218 (22%), Positives = 90/218 (41%), Gaps = 36/218 (16%)
Query: 115 MSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174
+ H N+++ +G CL+ + E G++ +L R + EP+ K+ +I +
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR-FGPLPEPVFCKY----TKQILD 113
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS-----ASIPEGETYIDDGVKG 229
AYLH + +V RD+K + +++ + KL +F + + + + + G
Sbjct: 114 GVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 230 TSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNM-------------GLRLN 275
T +APE +GY K D++S G + ++ + L +M GL
Sbjct: 171 TPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229
Query: 276 GDESFE---MDFVKKYIENRGFNGIVDPRIIGDELLEH 310
+SF +DFV + R +LL H
Sbjct: 230 LPDSFSAAAIDFVTSCLTRDQ-----HERPSALQLLRH 262
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 18/183 (9%)
Query: 84 PDRTISVVK--FIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141
P T+ VK +D + I+ + Q+ H N+L + + +V
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE 201
YG+ DLLK + L + LK ++ N Y+H S+ + R +K+S+IL+S
Sbjct: 83 YGSCEDLLKTHFPEGLPELAIAFILK---DVLNALDYIH---SKGFIHRSVKASHILLSG 136
Query: 202 RYVPKLFNFSLSASIPEG---ETYIDDGVKGTSGIV---APEYART---GYLNEKCDVYS 252
L S S+ + + + D K + + +PE + GY NEK D+YS
Sbjct: 137 DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYS 195
Query: 253 FGL 255
G+
Sbjct: 196 VGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 9/153 (5%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q H+N++RL G ++V E G L L++ H L+ + + +A
Sbjct: 62 QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK----HEGQLVAGQLMGMLPGLA 117
Query: 174 NVFAYL-HIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
+ YL +G+ V + L + +LV+ V K+ F Y K
Sbjct: 118 SGMKYLSEMGY----VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173
Query: 233 IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
APE + + + DV+SFG+++ +++S GE
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-05
Identities = 30/107 (28%), Positives = 47/107 (43%), Gaps = 14/107 (13%)
Query: 114 QMSHNNVLRLIGCCLEVEIP--VLVFESAEYGNLHDL--LKRSYQSHSEPLLLKHRLKIA 169
++ H N++RL +VFE + HDL L S + +K +K
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMK-- 107
Query: 170 MEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216
++ YLH S I+ RD+K S IL++ V KL +F L+
Sbjct: 108 -QLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPY 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 12/165 (7%)
Query: 106 FNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
FN +V H NV+ + L + +V E E G L D++ + + +
Sbjct: 67 FNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA----- 121
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
+ + + +YLH ++ ++ RD+KS IL++ KL +F A + + E
Sbjct: 122 -TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK-EVPKRK 176
Query: 226 GVKGTSGIVAPEY-ARTGYLNEKCDVYSFGLLLLQLLSTGEDLFN 269
+ GT +APE +R Y E D++S G+++++++ FN
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 1e-05
Identities = 45/177 (25%), Positives = 69/177 (38%), Gaps = 38/177 (21%)
Query: 117 HNNVLRLIGC-----CLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
H +++L L V E A G L +++ Y S E R A E
Sbjct: 61 HPGIIKLYYTFQDEENL-----YFVLEYAPNGELLQYIRK-YGSLDEKCT---RFYAA-E 110
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF---------SLSASIPEGETY 222
I YLH S+ I+ RDLK IL+ + K+ +F S S T
Sbjct: 111 ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 223 IDDGVK----------GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFN 269
ID ++ GT+ V+PE + D+++ G ++ Q+L TG+ F
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML-TGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 38/164 (23%), Positives = 71/164 (43%), Gaps = 10/164 (6%)
Query: 106 FNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
FN +V H NV+ + L + +V E E G L D++ + + +
Sbjct: 65 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ------- 117
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
IA V L + ++ ++ RD+KS IL++ KL +F A + + E
Sbjct: 118 --IAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRK 174
Query: 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFN 269
+ GT +APE + D++S G+++++++ FN
Sbjct: 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 58/249 (23%), Positives = 105/249 (42%), Gaps = 49/249 (19%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSY-------------QSHSEP 159
S++ N++RL+G C++ + ++ E E G+L+ L + +H P
Sbjct: 74 SRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLP 133
Query: 160 LL-LKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218
+ L +A++IA+ YL S V RDL + LV E K+ +F +S ++
Sbjct: 134 AISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 219 GETYIDDGVKGTSGI----VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL 274
G+ Y ++G + + +A E G DV++FG+ L ++L L
Sbjct: 191 GDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM-----------L 236
Query: 275 NGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKL-------QSSFELAFQCQSASA 327
++ + ++ IEN G D+ + L Q +EL QC S
Sbjct: 237 CKEQPYGELTDEQVIENAG-------EFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDC 289
Query: 328 EDRPTMIDV 336
+RP+ D+
Sbjct: 290 RERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 46/190 (24%), Positives = 84/190 (44%), Gaps = 20/190 (10%)
Query: 88 ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD 147
++ VK I D + I + H N++ G L E + E G+L D
Sbjct: 36 LAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD 95
Query: 148 LLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207
+ + PL + E AYLH S+ + RD+K + IL+++ KL
Sbjct: 96 IYHVT-----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKL 147
Query: 208 FNF----SLSASIPEGETYIDDGVKGTSGIVAPEYA---RTGYLNEKCDVYSFGLLLLQL 260
+F ++A+I + +++I GT +APE A + G N+ CD+++ G+ ++L
Sbjct: 148 ADFGVAAKITATIAKRKSFI-----GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
Query: 261 LSTGEDLFNM 270
+F++
Sbjct: 203 AELQPPMFDL 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 69/248 (27%), Positives = 104/248 (41%), Gaps = 40/248 (16%)
Query: 106 FNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
I Q+ H N++ LI + LVFE ++ L DL K Y + + ++
Sbjct: 48 MREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK--YPNGLDESRVR-- 103
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL--FNFSLSASIPEGETYI 223
K +I + H S I+ RD+K ILVS+ V KL F F+ + + P GE Y
Sbjct: 104 -KYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYT 158
Query: 224 DDGVKGTSGIVAPEY--ARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFE 281
D T APE T Y D+++ G L+ ++L TGE LF GD +
Sbjct: 159 D--YVATRWYRAPELLVGDTKY-GRAVDIWAVGCLVTEML-TGEPLF------PGDSDID 208
Query: 282 M---------DFVKKYIE----NRGFNGIVDPRIIGDELLEHKL----QSSFELAFQCQS 324
+ + ++ E N F G+ P + E LE + +LA QC
Sbjct: 209 QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLR 268
Query: 325 ASAEDRPT 332
+DRP+
Sbjct: 269 IDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 36/126 (28%), Positives = 63/126 (50%), Gaps = 7/126 (5%)
Query: 156 HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215
+ + L L+ + + ++A +L SR + RDL + IL+SE V K+ +F L+
Sbjct: 172 YKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARD 228
Query: 216 IPEGETYIDDG-VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL 274
I + Y+ G + +APE + DV+SFG+LL ++ S G + G+++
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKI 287
Query: 275 NGDESF 280
DE F
Sbjct: 288 --DEEF 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD-LLKRSYQ-----SHSEPLLLKHRL 166
+++ H N++ L+G + + ++FE G+LH+ L+ RS S E +K L
Sbjct: 62 AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121
Query: 167 K------IAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220
IA++IA YL F V +DL + IL+ E+ K+ + LS I +
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 221 TYIDDGVKGTSGI----VAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
Y V+ S + + PE G + D++SFG++L ++ S G
Sbjct: 179 YY---RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFG 223
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 21/142 (14%)
Query: 130 VEIPVLVFESAEYGNLHDLLK------RSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF 183
V + LV + A G+L +K R+++ H LL V +H
Sbjct: 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF----------IQVLLAVHHVH 160
Query: 184 SRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK---GTSGIVAPEYAR 240
S+ ++ RD+KS+ IL+ + KL +F S T DD + GT VAPE R
Sbjct: 161 SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY--AATVSDDVGRTFCGTPYYVAPEIWR 218
Query: 241 TGYLNEKCDVYSFGLLLLQLLS 262
++K D++S G+LL +LL+
Sbjct: 219 RKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 11/153 (7%)
Query: 114 QMSHNNVLRLIGCCLEV--EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
+ H N+++ G C E L+ E G+L + L R+ + LK +LK A++
Sbjct: 62 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQ 117
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY--IDDGVKG 229
I YL SR V RDL + +LV + K+ +F L+ +I + Y + D +
Sbjct: 118 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 230 TSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS 262
APE DV+SFG+ L +LL+
Sbjct: 175 PVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 107 NNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLL-KRSYQSHSEPLLLKHR 165
N +SH N++ LE + ++V E A G L + + KR E +L
Sbjct: 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF 107
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-YVPKLFNFSLSASI-PEGETYI 223
++I + + +V L I+ RDLK+ IL+ + V K+ +F +S + + + Y
Sbjct: 108 VQILLALHHVHTKL-------ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160
Query: 224 DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS 262
V GT ++PE N+K D+++ G +L +L S
Sbjct: 161 ---VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 36/182 (19%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 86 RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145
+ ++ V+ + + I ++++H +++R++G E L E G++
Sbjct: 31 KQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSV 90
Query: 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV-SERYV 204
LL + Y + E +++ + ++ ++ YLH I+ RD+K + +L+ S
Sbjct: 91 SHLLSK-YGAFKEAVIINYTEQLLRGLS----YLH---ENQIIHRDVKGANLLIDSTGQR 142
Query: 205 PKLFNFSLSASIPEGETYIDD---GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLL 261
++ +F +A + T + + GT +APE R CDV+S G +++++
Sbjct: 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA 202
Query: 262 ST 263
+
Sbjct: 203 TA 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 106 FNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
FN +V H N++ + L + +V E E G L D++ ++ +E +
Sbjct: 64 FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAT-- 119
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
+ + + ++LH ++ ++ RD+KS IL++ KL +F A + + E
Sbjct: 120 --VCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVPRRK 173
Query: 226 GVKGTSGIVAPEY-ARTGYLNEKCDVYSFGLLLLQLLSTGEDLFN 269
+ GT +APE +R Y E D++S G+++++++ FN
Sbjct: 174 SLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
++ AS M H +++RL+G CL I LV + +G L D + + LLL
Sbjct: 61 LIMAS-MDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW---- 114
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE--TYIDDG 226
++IA YL R +V RDL + +LV K+ +F L A + EG+ Y DG
Sbjct: 115 CVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGL-ARLLEGDEKEYNADG 170
Query: 227 VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
K +A E + DV+S+G+ + +L++ G
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 5e-05
Identities = 31/94 (32%), Positives = 46/94 (48%), Gaps = 13/94 (13%)
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE---TYIDDGVK 228
+ F YLH +R I++RDLK +L+ KL +F + + G+ T+
Sbjct: 102 VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC----- 153
Query: 229 GTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLL 261
GT VAPE GY + D +S G+LL +LL
Sbjct: 154 GTPEYVAPEIILNKGY-DFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 35/123 (28%), Positives = 64/123 (52%), Gaps = 11/123 (8%)
Query: 159 PLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218
PL ++ + + ++A +L SR + RDL + IL+SE V K+ +F L+ I +
Sbjct: 170 PLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 219 GETYIDDGVKGTSGI----VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL 274
Y+ KG++ + +APE + DV+SFG+LL ++ S G + G+++
Sbjct: 227 DPDYVR---KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP-GVQI 282
Query: 275 NGD 277
N +
Sbjct: 283 NEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
I SQ + R G L+ ++ E G+ DLLK PL + I
Sbjct: 53 ITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATI 106
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
EI YLH S + RD+K++ +L+SE+ KL +F ++ + + + + V
Sbjct: 107 LREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV- 162
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE----DLFNMGLRL----NGDESF 280
GT +APE + + K D++S G+ ++ L+ GE DL M + N +
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIE-LAKGEPPNSDLHPMRVLFLIPKNSPPTL 221
Query: 281 EMDFVKKYIENRGFNGIVDPRI--IGDELLEHKL 312
E + K + E DPR ELL+HK
Sbjct: 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 7e-05
Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 14/89 (15%)
Query: 177 AYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG----ETYIDDGVKGTSG 232
YLH S + RD+K+ IL++E KL +F +S + + T I GT
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-----GTPF 164
Query: 233 IVAPEY-ARTGYLNEKCDVYSFGLLLLQL 260
+APE GY N K D++S G+ +++
Sbjct: 165 WMAPEVIQEIGY-NNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 46/177 (25%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 91 VKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK 150
VK +D + FN +V H NV+ + L E ++ E + G L D++
Sbjct: 51 VKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV- 109
Query: 151 RSYQSHSEPLLLKHRLKIAME-IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209
S+ L + ++ E + YLH S+ ++ RD+KS IL++ KL +
Sbjct: 110 ------SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSD 160
Query: 210 FSLSASI----PEGETYIDDGVKGTSGIVAPEY-ARTGYLNEKCDVYSFGLLLLQLL 261
F A I P+ ++ + GT +APE +RT Y E D++S G+++++++
Sbjct: 161 FGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 36/156 (23%), Positives = 73/156 (46%), Gaps = 5/156 (3%)
Query: 105 CFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKH 164
C I Q++H NV++ + +E +V E A+ G+L ++K ++ + +
Sbjct: 49 CVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKY-FKKQKRLIPERT 107
Query: 165 RLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID 224
K +++ + ++H SR ++ RD+K + + ++ V KL + L +T
Sbjct: 108 VWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAA 163
Query: 225 DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQL 260
+ GT ++PE N K D++S G LL ++
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 21/70 (30%), Positives = 38/70 (54%), Gaps = 8/70 (11%)
Query: 115 MSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSH----SEPLLLKHRLKIAM 170
++H NVL+ +G C+E +LV E G+L + L RS + ++ +L ++A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVL---QRMAC 107
Query: 171 EIANVFAYLH 180
E+A+ +LH
Sbjct: 108 EVASGLLWLH 117
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 20/166 (12%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKR------SYQSHSEPLLL 162
I S++ N++RL+ C+ + ++ E E G+L+ L R + ++ +
Sbjct: 70 IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129
Query: 163 KHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222
+ +A +IA+ YL S V RDL + LV + Y K+ +F +S ++ G+ Y
Sbjct: 130 STLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186
Query: 223 IDDGVKGTSGIVAP------EYARTGYLNEKCDVYSFGLLLLQLLS 262
++G + V P E G DV++FG+ L ++L+
Sbjct: 187 ---RIQGRA--VLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 62/271 (22%), Positives = 105/271 (38%), Gaps = 39/271 (14%)
Query: 80 QGVLPDRTISVVKFIDGSVFDAYDCCFNNIV-----FASQMSHNNVLRLIGCCLE---VE 131
Q +L + I+V G D +IV Q+ H N++R LE +
Sbjct: 26 QNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLY 85
Query: 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRD 191
I + + E A G + LK Q +E + I +++ YLH + IV RD
Sbjct: 86 IVMDLIEGAPLGEHFNSLKEKKQRFTE----ERIWNIFVQMVLALRYLHK--EKRIVHRD 139
Query: 192 LKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVY 251
L + I++ E + +F L+ E+ + V GT PE + EK DV+
Sbjct: 140 LTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTSVV-GTILYSCPEIVKNEPYGEKADVW 197
Query: 252 SFGLLLLQLLSTGEDLF--NMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLE 309
+FG +L Q+ + + NM S V + +P + + +
Sbjct: 198 AFGCILYQMCTLQPPFYSTNM-------LSLATKIV---------EAVYEP--LPEGMYS 239
Query: 310 HKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340
+ ++ C + AE RP +I V+ I
Sbjct: 240 EDVT---DVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 46/170 (27%), Positives = 72/170 (42%), Gaps = 24/170 (14%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
I S + H N+++ +G E + E G+L LL+ S PL + I
Sbjct: 56 IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLR----SKWGPLKDNEQTII 111
Query: 169 --AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLFNFSLSASI----PEGET 221
+I YLH IV RD+K +LV+ V K+ +F S + P ET
Sbjct: 112 FYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET 168
Query: 222 YIDDGVKGTSGIVAPE---YARTGYLNEKCDVYSFGLLLLQLLSTGEDLF 268
+ GT +APE GY D++S G +++ ++TG+ F
Sbjct: 169 F-----TGTLQYMAPEVIDKGPRGY-GAPADIWSLGCTIVE-MATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 26/75 (34%), Positives = 39/75 (52%), Gaps = 2/75 (2%)
Query: 187 IVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNE 246
IV+RDLK IL+ +R ++ + L+ IPEGET G GT G +APE
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV--RGRVGTVGYMAPEVINNEKYTF 180
Query: 247 KCDVYSFGLLLLQLL 261
D + G L+ +++
Sbjct: 181 SPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 5/94 (5%)
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
A EI LH IV+RDLK IL+ + ++ + L+ +PEG+T G
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI--KGRV 162
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS 262
GT G +APE + D ++ G LL ++++
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 34/126 (26%), Positives = 63/126 (50%), Gaps = 10/126 (7%)
Query: 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKS 194
+ E + G+L +LK + + E L K+++ + AYL I+ RD+K
Sbjct: 80 ICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLRE--KHQIMHRDVKP 132
Query: 195 SYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFG 254
S ILV+ R KL +F +S + + + + GT ++PE + + + + D++S G
Sbjct: 133 SNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMG 189
Query: 255 LLLLQL 260
L L++L
Sbjct: 190 LSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 43/166 (25%), Positives = 67/166 (40%), Gaps = 36/166 (21%)
Query: 116 SHNNVLRLIGCCLEVEIPV------LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLK-- 167
+H N+ G ++ P LV E G++ DL+K RLK
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL-------RKKGKRLKEE 113
Query: 168 ----IAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI--PEGE- 220
I E AYLH ++ RD+K IL+++ KL +F +SA + G
Sbjct: 114 WIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 221 -TYIDDGVKGTSGIVAPE-----YARTGYLNEKCDVYSFGLLLLQL 260
T+I GT +APE + + DV+S G+ ++L
Sbjct: 171 NTFI-----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 23/162 (14%)
Query: 113 SQMSHNNVLRLIGCCLEVEIP-VLVFESAEY---GNLHDLLKRSYQSHSEPLLLKHRLKI 168
+ H N+++ G +EV V +F EY G L +LL+ + +
Sbjct: 54 ELLKHPNLVKYYG--VEVHREKVYIFM--EYCSGGTLEELLE---HGRILDEHVIRVYTL 106
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
+ AYLH S IV RD+K + I + V KL +F + + T + + V+
Sbjct: 107 QLLEG--LAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ 161
Query: 229 GTSGI---VAPEYARTGYLNEK---CDVYSFGLLLLQLLSTG 264
+G +APE G D++S G ++L++ TG
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA-TG 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 31/112 (27%), Positives = 57/112 (50%), Gaps = 10/112 (8%)
Query: 157 SEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216
S PL L L+ + ++A +L S+ + RD+ + +L+++ V K+ +F L+ I
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDI 262
Query: 217 PEGETYIDDGVKGTSGI----VAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
Y+ VKG + + +APE + DV+S+G+LL ++ S G
Sbjct: 263 MNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 311
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 41/170 (24%), Positives = 72/170 (42%), Gaps = 33/170 (19%)
Query: 113 SQMSHNNVLRLI--GCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM 170
+++ H N++ L+ G + VFE L ++L + L ++ +
Sbjct: 33 ARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVL-----AADGALPAGETGRLML 86
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV---PKLFNFSLSASIP---------- 217
++ + A H ++ IV RDLK I+VS+ V K+ +F + +P
Sbjct: 87 QVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 218 --EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
E V GT APE R + D+Y++GL+ L+ L TG+
Sbjct: 144 TRTTE------VLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECL-TGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 41/191 (21%), Positives = 83/191 (43%), Gaps = 28/191 (14%)
Query: 157 SEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216
SE L L ++A +L S+ V RDL + +L+++ + K+ +F L+ I
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDI 287
Query: 217 PEGETYIDDGVKGTSGI----VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGL 272
Y+ KG++ + +APE DV+S+G+LL ++ S G + G+
Sbjct: 288 MHDSNYVS---KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP-GM 343
Query: 273 RLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT 332
+ D +F Y + P +H Q +++ +C ++ E RP+
Sbjct: 344 IV--DSTFYNKIKSGY-------RMAKP--------DHATQEVYDIMVKCWNSEPEKRPS 386
Query: 333 MIDVAKQIKKM 343
+ ++ ++ +
Sbjct: 387 FLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 7e-04
Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 26/155 (16%)
Query: 117 HNNVLRLIGCC----LEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM- 170
H N++RL+ C + E+ + LVFE + +L L + +P L +K M
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK----CPKPGLPPETIKDLMR 114
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
++ +LH S IV RDLK ILV+ K+ +F L+ Y + T
Sbjct: 115 QLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLA------RIY-SFEMALT 164
Query: 231 SGIV-----APEYARTGYLNEKCDVYSFGLLLLQL 260
S +V APE D++S G + +L
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 26/105 (24%), Positives = 46/105 (43%), Gaps = 9/105 (8%)
Query: 167 KIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG 226
+ E+ LH R I+ RD+K +L+ + KL +F LS + E + ++
Sbjct: 101 QYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV--- 154
Query: 227 VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMG 271
GT +APE ++ D +S G ++ + L G F+
Sbjct: 155 --GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL-FGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 22/161 (13%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIP----VLVFESAEYGNLHDLLKRSYQSHSEPLLLKH 164
I +++H N+++L L+V LVFE + +L+ L+K L
Sbjct: 49 IKLLKELNHPNIIKL----LDVFRHKGDLYLVFEFMDT-DLYKLIKDR----QRGLPESL 99
Query: 165 RLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI-PEGETYI 223
++ A+ H S I+ RDLK +L++ V KL +F L+ S Y
Sbjct: 100 IKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156
Query: 224 DDGVKGTSGIVAPE--YARTGYLNEKCDVYSFGLLLLQLLS 262
V T APE GY + D++S G + +LLS
Sbjct: 157 HYVV--TRWYRAPELLLGDKGY-STPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 26/94 (27%), Positives = 42/94 (44%), Gaps = 5/94 (5%)
Query: 168 IAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGV 227
EI YLH S+ I+ RD+K IL+ E+ + +F++ A+ +T
Sbjct: 105 WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNI-ATKVTPDTLTTSTS 160
Query: 228 KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLL 261
GT G +APE + D +S G+ + L
Sbjct: 161 -GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL 193
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 168 IAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGV 227
I EI YLH S + RD+K++ +L+SE KL +F ++ + + + + V
Sbjct: 106 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162
Query: 228 KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQL 260
GT +APE + + K D++S G+ ++L
Sbjct: 163 -GTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 15/152 (9%)
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
EI YLH S + RD+K++ +L+SE+ KL +F ++ + + + + V GT
Sbjct: 109 EILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GT 164
Query: 231 SGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE----DLFNMGLRL----NGDESFEM 282
+APE + + K D++S G+ ++ L+ GE D+ M + N +
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIE-LAKGEPPNSDMHPMRVLFLIPKNNPPTLTG 223
Query: 283 DFVKKYIENRGFNGIVDP--RIIGDELLEHKL 312
+F K + E DP R ELL+HK
Sbjct: 224 EFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 37/170 (21%), Positives = 76/170 (44%), Gaps = 27/170 (15%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLL--------------KRSYQSHSE 158
S++ H N++ L+G + + ++F + +LH+ L ++ +S E
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 159 PLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218
P H I +IA +L S +V +DL + +LV ++ K+ + L +
Sbjct: 123 PADFVH---IVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176
Query: 219 GETYIDDGVKGTSGI----VAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264
+ Y + G S + ++PE G + D++S+G++L ++ S G
Sbjct: 177 ADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYG 223
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 39/159 (24%), Positives = 73/159 (45%), Gaps = 16/159 (10%)
Query: 107 NNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSH----SEPLLL 162
++ ++M H N++ E +V E + G DL+KR + SE +L
Sbjct: 48 KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG---DLMKRINRQRGVLFSEDQIL 104
Query: 163 KHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-YVPKLFNFSLSASIPEGET 221
++I++ + ++ R I+ RD+KS I +S+ V KL +F ++ + +
Sbjct: 105 SWFVQISLGLKHIH-------DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157
Query: 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQL 260
V GT ++PE + N K D++S G +L +L
Sbjct: 158 LAYTCV-GTPYYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 27/70 (38%), Positives = 40/70 (57%), Gaps = 9/70 (12%)
Query: 115 MSHNNVLRLIGCCLEVEIP-VLVFESAEYGNLHDLLKRSYQSH---SEPLLLKHRLKIAM 170
+ H N+L+ +G C+E IP +LVFE E G+L L Q H S+ LLL+ ++A
Sbjct: 52 LQHPNILQCLGQCVEA-IPYLLVFEYCELGDLKSYL-SQEQWHRRNSQLLLLQ---RMAC 106
Query: 171 EIANVFAYLH 180
EIA ++H
Sbjct: 107 EIAAGVTHMH 116
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 12/155 (7%)
Query: 115 MSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174
++H +V+R+ + I +V +L+ L + S PL + L I +I
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTK----RSRPLPIDQALIIEKQILE 168
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIV 234
YLH ++ I+ RD+K+ I +++ + + +A P G+ GT
Sbjct: 169 GLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAP-AFLGLAGTVETN 223
Query: 235 APE-YARTGYLNEKCDVYSFGLLLLQLLSTGEDLF 268
APE AR Y N K D++S G++L ++L+ +F
Sbjct: 224 APEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIF 257
|
Length = 357 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 31/86 (36%), Positives = 42/86 (48%), Gaps = 12/86 (13%)
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
A EI LH IV+RDLK IL+ + ++ + L+ IPEGET G
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI--RGRV 162
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFG 254
GT G +APE + NE+ Y+F
Sbjct: 163 GTVGYMAPEVVK----NER---YTFS 181
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 37/161 (22%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 115 MSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174
+ H ++RL+G C + LV + + G+L D +++ S LL ++IA
Sbjct: 66 LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAK 120
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI-PEGETYIDDGVKGTSGI 233
YL +V R+L + IL+ + ++ +F ++ + P+ + Y K
Sbjct: 121 GMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 234 VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL 274
+A E G + DV+S+G+ + +++S G + + G+R
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA-GMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 25/91 (27%), Positives = 48/91 (52%), Gaps = 7/91 (7%)
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
E+ F YLH S+ I++RDLK +L+ + K+ +F + +P+ T+ + GT
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-RTFT---LCGT 178
Query: 231 SGIVAPEYARTGYLNEKCDVYSFGLLLLQLL 261
+APE ++ + D ++ G+LL + +
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 39/154 (25%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 115 MSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174
+ H N+++ +G E + E G++ L R+Y E L+ + ++
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLV-RF---FTEQVLE 119
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG---VKGTS 231
AYLH S+ I+ RDLK+ +LV + K+ +F +S + Y +D ++G+
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGSV 174
Query: 232 GIVAPEY---ARTGYLNEKCDVYSFGLLLLQLLS 262
+APE GY + K D++S G ++L++ +
Sbjct: 175 FWMAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFA 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 39/129 (30%), Positives = 57/129 (44%), Gaps = 22/129 (17%)
Query: 141 EYGNLHDLLKRSYQSH--SEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198
EY N DL+ +S EP A EI +LH R I++RDLK +L
Sbjct: 76 EYVNGGDLMFHIQRSGRFDEP----RARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVL 128
Query: 199 V-SERYVPKLFNFSLSASIPEGETYIDDGVK-----GTSGIVAPEYARTGYLNEKCDVYS 252
+ SE ++ K+ +F + EG I GV GT +APE D ++
Sbjct: 129 LDSEGHI-KIADFGMCK---EG---ILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWA 181
Query: 253 FGLLLLQLL 261
G+LL ++L
Sbjct: 182 LGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 14/110 (12%)
Query: 153 YQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212
Y+ E +L + IA+ + YL +S I+ RD+K S +LV+ R KL +F +
Sbjct: 89 YRKIPEHVLGR----IAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGV 141
Query: 213 SASIPE--GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQL 260
S + +TY+ GT+ +APE DV+S G+ ++L
Sbjct: 142 STQLVNSIAKTYV-----GTNAYMAPERISGEQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 34/106 (32%), Positives = 47/106 (44%), Gaps = 7/106 (6%)
Query: 165 RLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID 224
R+ IA EI +LH I++RD+K IL+ L +F LS E
Sbjct: 108 RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163
Query: 225 DGVKGTSGIVAPEYARTGYL--NEKCDVYSFGLLLLQLLSTGEDLF 268
GT +APE R G ++ D +S G+L +LL TG F
Sbjct: 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL-TGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 53/228 (23%), Positives = 101/228 (44%), Gaps = 37/228 (16%)
Query: 115 MSHNNVLRLIGCCLEV-EIPVLVFESAEYGNLHDLLKR-SYQSHSEPLLLKHR--LKIAM 170
+SH N+L ++ C+E E P +++ +GNL L++ + P L + + +A+
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI-PEGETYIDDGVKG 229
+IA +YLH R ++ +D+ + ++ E K+ + +LS + P + D
Sbjct: 125 QIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181
Query: 230 TSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG----EDLFNMGLRLNGDESFEM-DF 284
+A E + DV+SFG+LL +L++ G ++ + FEM +
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI----------DPFEMAAY 231
Query: 285 VKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT 332
+K G+ + P DEL F + C + E+RP+
Sbjct: 232 LKD-----GYR-LAQPINCPDEL--------FAVMACCWALDPEERPS 265
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 34/123 (27%), Positives = 59/123 (47%), Gaps = 2/123 (1%)
Query: 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS 200
EYG+ DL K+ Q E L + ++ + + L SR ++ RDLKS+ I +
Sbjct: 145 EYGSGGDLNKQIKQRLKEHLPFQEY-EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM 203
Query: 201 ERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQ 259
+ KL +F S + + + GT +APE ++K D++S G++L +
Sbjct: 204 PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYE 263
Query: 260 LLS 262
LL+
Sbjct: 264 LLT 266
|
Length = 478 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.003
Identities = 28/107 (26%), Positives = 49/107 (45%), Gaps = 12/107 (11%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY--GNLHDLLKRSYQSHSEPLLLKHRL 166
I H V++L+ VLV E Y +L ++L+ + E + +
Sbjct: 50 IKALQACQHPYVVKLLDVFPHGSGFVLVME---YMPSDLSEVLRDEERPLPEAQV---KS 103
Query: 167 KIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213
+ M + V AY+H + I+ RDLK + +L+S V K+ +F L+
Sbjct: 104 YMRMLLKGV-AYMH---ANGIMHRDLKPANLLISADGVLKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 24/94 (25%), Positives = 45/94 (47%), Gaps = 5/94 (5%)
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
A +I +LH R IV+RDLK +L+ + ++ + L+ + G+ G
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--KGRA 155
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS 262
GT G +APE + + D ++ G L ++++
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 15/158 (9%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIA--ME 171
Q H N++ L G + +++ E E G L L+++ + L+ IA M+
Sbjct: 61 QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE---TYIDD-GV 227
+ Y+H RDL + ILV+ V K+ +F LS + + TY G
Sbjct: 121 YLSEMNYVH---------RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 228 KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
K APE DV+S+G+++ +++S GE
Sbjct: 172 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 4/93 (4%)
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
A EI +LH + I++RDLK +L+ + K+ +F + GE
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FC 157
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLL 261
GT +APE + NE D +SFG+LL ++L
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 33/141 (23%), Positives = 54/141 (38%), Gaps = 26/141 (18%)
Query: 145 LHDLLKRSYQSHSEPLLLKHR------LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198
L LLK +Q S L + L I +I Y+H S+ ++ RDLK IL
Sbjct: 89 LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNIL 145
Query: 199 V---SE-----------RYVPKLFNFSLSASIPE---GETYIDDGVKGTSGIVAPEYART 241
+ E + + + + I + GT +APE
Sbjct: 146 LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205
Query: 242 GYLNEKCDVYSFGLLLLQLLS 262
+E D+Y+ G++L Q+L+
Sbjct: 206 VPASESTDIYALGVILYQMLT 226
|
Length = 932 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 347 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.53 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.52 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.39 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.29 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.24 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.09 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.98 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.97 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.92 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.65 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.52 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.46 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.46 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.46 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.46 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.43 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.43 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.43 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.36 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.11 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.1 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.02 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.99 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.99 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.97 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.96 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.92 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.9 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.84 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.79 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.74 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.61 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.58 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.51 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.46 | |
| PLN02236 | 344 | choline kinase | 97.41 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.35 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.19 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.05 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.96 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.89 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.77 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.69 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.51 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.43 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.34 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.22 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.09 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.99 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.84 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.62 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.18 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.17 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.0 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-58 Score=417.02 Aligned_cols=289 Identities=38% Similarity=0.580 Sum_probs=247.2
Q ss_pred CccccCHHHHHHHhccCCCCCeecccCceEEEEEEeCC-ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeee
Q 045067 48 PIRSFSAKELERATNNYHYRNIITESSIFRLCQGVLPD-RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGC 126 (347)
Q Consensus 48 ~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 126 (347)
..+.|++.|+..+|++|+..++||+|+||.||+|..++ ..+|||+........ ..+|.+|+.++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 67889999999999999999999999999999999965 456666554444332 3569999999999999999999999
Q ss_pred eeeCC-ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 127 CLEVE-IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 127 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
|.+.+ ..+||+|||++|+|.+++.... . .+++|..+++|+.++|.||+|||+.+..+||||||||+|||+|+++++
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~--~-~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKK--G-EPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCC--C-CCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99988 5999999999999999998741 1 189999999999999999999998777789999999999999999999
Q ss_pred EEecCCCCccCCC-CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 206 KLFNFSLSASIPE-GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 206 kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
||+|||+|+..+. ........ .||.+|+|||+...+..+.|+|||||||++.|++ +|+.+.+.... .....+..|
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEli-tgr~~~d~~~~--~~~~~l~~w 292 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELI-TGRKAVDQSRP--RGELSLVEW 292 (361)
T ss_pred EccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHH-hCCcccCCCCC--cccccHHHH
Confidence 9999999976654 22221111 7999999999999999999999999999999999 88888765432 334448899
Q ss_pred HHHHHhccCcccccCCccCCchhh-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 285 VKKYIENRGFNGIVDPRIIGDELL-EHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
+...+..+.+.+++|+++...... ......+..++.+|++.+|.+||+|.||++.|+.+.
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999989999999998733333 256778999999999999999999999999997765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-52 Score=373.41 Aligned_cols=259 Identities=26% Similarity=0.348 Sum_probs=209.4
Q ss_pred ccCCCCCeecccCceEEEEEEeCCce-EEEEEEccCCCc-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-ccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDRT-ISVVKFIDGSVF-DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE-IPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~v~k~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 138 (347)
..+...+.||+|+||+||+|.+.+.. +++|++...... ...+.|.+|+.+|.+++|||||+++|+|.++. .++||||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 33444566999999999999998888 555554443321 12468999999999999999999999999988 7999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEeccCCCCCeEECCCC-ceEEecCCCCccC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP-IVFRDLKSSYILVSERY-VPKLFNFSLSASI 216 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~ 216 (347)
|+++|+|.+++.+. ....+++..+++++.|||.|++||| +.+ ||||||||+|||++.++ ++||+|||+++..
T Consensus 121 y~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 99999999999772 2378999999999999999999999 888 99999999999999998 9999999999876
Q ss_pred CCCCceeeccccccCCcccccccc--cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYAR--TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.... ...+...||+.|||||++. ...|+.|+||||||+++|||+ +|+.||..... .+........+..
T Consensus 195 ~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~-t~~~Pf~~~~~--------~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 195 VISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELL-TGEIPFEDLAP--------VQVASAVVVGGLR 264 (362)
T ss_pred cccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHH-HCCCCCCCCCH--------HHHHHHHHhcCCC
Confidence 5432 1223368999999999999 569999999999999999999 99999975321 2233333222221
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.. + +...++.+..++.+||+.||+.||++.+++..|+.+...
T Consensus 265 p~-----~-----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 265 PP-----I-----PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CC-----C-----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 11 1 112456788999999999999999999999999988764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=360.34 Aligned_cols=252 Identities=19% Similarity=0.226 Sum_probs=210.6
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc-cEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI-PVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~ 139 (347)
+++..+.||+|..|+||++.+ .++.++++|.+... .....+++.+|++++++.+||+||.++|.|.++.. ..|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 445567899999999999999 78888888877544 34456789999999999999999999999999984 9999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
|++|+|.+.+... +.+++....+++.+++.||.|||+ +++||||||||+|||++..|.+||+|||.+..+...
T Consensus 160 MDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999875 789999999999999999999993 499999999999999999999999999999877554
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
..++..||..|||||-+.+..|+.++||||||+.++|+. .|+.||.... .........+.....+. .
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a-~GrfP~~~~~---~~~~~~~~Ll~~Iv~~p------p 299 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELA-IGRFPYPPPN---PPYLDIFELLCAIVDEP------P 299 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHh-hCCCCCCCcC---CCCCCHHHHHHHHhcCC------C
Confidence 446688999999999999999999999999999999999 9999997541 12222333333333221 1
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
|+++.. ..++++.+++..||++||.+|||+.|+++
T Consensus 300 P~lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 PRLPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 222111 35678999999999999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=373.48 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=211.8
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
..|...+.||+|||+.||.++. +.+.+++.|++++. .....+.+.+|+++.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4689999999999999999999 88888888877763 2345578999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|+|+.++|..+++.. .++++.++..++.||+.||.||| +.+|+|||||..|+|++++.++||+|||+|+.+.
T Consensus 98 ELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999999865 78999999999999999999999 9999999999999999999999999999999887
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.+.. ...+.||||.|.|||++....++..+||||+||++|-|+ .|+|||.... ..+...+.-.. +.
T Consensus 170 ~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL-~G~PPFetk~--------vkety~~Ik~~----~Y 235 (592)
T KOG0575|consen 170 YDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLL-VGRPPFETKT--------VKETYNKIKLN----EY 235 (592)
T ss_pred Cccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhh-hCCCCcccch--------HHHHHHHHHhc----Cc
Confidence 5432 345689999999999999999999999999999999999 9999997431 11222222111 11
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .+...+.++.+||.++|+.||.+|||+++|+.
T Consensus 236 ---~-----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 ---S-----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---c-----cccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 11244567889999999999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-51 Score=368.25 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=215.8
Q ss_pred cCCCCCeecccCceEEEEEEeCCc-eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 63 NYHYRNIITESSIFRLCQGVLPDR-TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
.+...+.||+|-||.||.|.+++. .++++.+..... ..+.|.+|+.+|.+|+|+|||+++|+|..++.++||||||+
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 344457799999999999999666 666666555432 22778999999999999999999999999889999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
.|+|.+++... .+..+...+.+.++.|||+|++||+ ++++|||||.+.||||+++..+||+|||+|+.+.++..
T Consensus 285 ~GsLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 285 KGSLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cCcHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 99999999863 4577999999999999999999999 99999999999999999999999999999996665555
Q ss_pred eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
....+..-++.|.|||.+..+.+|.|||||||||+||||+|.|+.||.... ..+.+....++. +
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--------n~ev~~~le~Gy--------R 422 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--------NEEVLELLERGY--------R 422 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--------HHHHHHHHhccC--------c
Confidence 555556677899999999999999999999999999999999999986543 234444443332 2
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
++.+ +.++..+.+++..||..+|++|||++.+...|+++..
T Consensus 423 lp~P---~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 423 LPRP---EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCC---CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 2222 2456789999999999999999999999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=356.96 Aligned_cols=254 Identities=20% Similarity=0.247 Sum_probs=207.3
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCch-------hHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFD-------AYDCCFNNIVFASQMSHNNVLRLIGCCLEV 130 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 130 (347)
...+.|...+.||+|+||.|-+|.. .++..+++|++++.... ......+|+++|.+|+|||||++++++..+
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3456678889999999999999999 67777777776543211 123357999999999999999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC---CceEE
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER---YVPKL 207 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~---~~~kl 207 (347)
+..|+||||+.||+|.+.+-.+ +.+.+.....++.|++.|+.||| +.||+||||||+|||+..+ ..+||
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred CceEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEe
Confidence 9999999999999999999875 77888899999999999999999 9999999999999999866 78999
Q ss_pred ecCCCCccCCCCCceeeccccccCCcccccccccCCC---CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 208 FNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYL---NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
+|||+|+.... .....+.||||.|.|||++.+..+ ..+.|+||+||+||-++ +|.+||..... .+.
T Consensus 321 tDFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcL-sG~pPFS~~~~----~~s---- 389 (475)
T KOG0615|consen 321 TDFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCL-SGYPPFSEEYT----DPS---- 389 (475)
T ss_pred cccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEe-ccCCCcccccC----Ccc----
Confidence 99999998763 334577999999999998876533 34789999999999999 99999986433 111
Q ss_pred HHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 285 VKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.+.+..+.+. -.+......+++..+|+.+||..||++|||+.|+++
T Consensus 390 l~eQI~~G~y~-------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 390 LKEQILKGRYA-------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHHhcCccc-------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 12222222221 122344566788999999999999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=351.01 Aligned_cols=202 Identities=24% Similarity=0.379 Sum_probs=178.7
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCce-EEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRT-ISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~-~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
..++|...+.||+|+||+||+|++ .++. ||+|++.... .....+.+..|+.+|+.++|||||.+++++.+++.+|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 356788889999999999999999 4445 4455444443 455667889999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC------CceEEecC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER------YVPKLFNF 210 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~------~~~kl~Df 210 (347)
||||.||+|.++|... +.+++.++..++.|++.||++|| +++||||||||+|||++.+ -.+||+||
T Consensus 88 MEyC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 9999999999999875 68999999999999999999999 9999999999999999865 46899999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCc
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGL 272 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~ 272 (347)
|+|+.+..+ ....+.+|++.|||||++....|+.|+|+||+|+++|+++ +|++||....
T Consensus 160 GfAR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l-~g~~Pf~a~t 218 (429)
T KOG0595|consen 160 GFARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCL-TGKPPFDAET 218 (429)
T ss_pred chhhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHH-hCCCCccccC
Confidence 999988743 3346789999999999999999999999999999999999 9999998543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-52 Score=344.54 Aligned_cols=257 Identities=21% Similarity=0.287 Sum_probs=206.6
Q ss_pred cCCCCCeecccCceEEEEEEe--CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeee-eeeeCC-ccEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIG-CCLEVE-IPVLVF 137 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~-~~~lv~ 137 (347)
+|.+.++||+|+||+||++.+ ++..+|.|++.-. ......+....|+.+|++|+|||||++++ .+.++. .++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 466678899999999999999 5556666665432 23445577899999999999999999998 444444 489999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||.+|+|...|+.. +.....+++..+++++.|++.||.++|+... .-|+||||||.||+++.+|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~-K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHF-KKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHH-HhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999875 4455779999999999999999999995322 23999999999999999999999999999988
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
....+ ......|||.||+||.+.+..|++||||||+||++|||. .-++||... ....+.+.+..+.+..
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMc-aL~~PF~g~---------n~~~L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMC-ALQSPFYGD---------NLLSLCKKIEQGDYPP 247 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHH-hcCCCcccc---------cHHHHHHHHHcCCCCC
Confidence 76543 345688999999999999999999999999999999999 889999642 1234455555554432
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
+. ....+..+..++..|+.+||+.||+...+++.+
T Consensus 248 ~p---------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 248 LP---------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred Cc---------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 21 134567888999999999999999965555444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-50 Score=344.17 Aligned_cols=243 Identities=21% Similarity=0.213 Sum_probs=207.0
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
..++|+..++||+|+||.||.++. +++..+++|++++.. ....+...+|..+|.+++||+||+++..|++.+.+|+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 356799999999999999999999 889999999887653 2345778999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
|+||+.||.|..+|++. +.+++..+.-++..|+.||.||| +.|||||||||+|||+|.+|+++|+|||+++.
T Consensus 103 Vld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence 99999999999999875 78999999999999999999999 99999999999999999999999999999986
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
..... ....+.+||+.|||||++.+..|+..+|+||+|+++|||+ +|.+||..... .....+..+...
T Consensus 175 ~~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML-~G~pPF~~~~~--------~~~~~~I~~~k~-- 242 (357)
T KOG0598|consen 175 DLKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEML-TGKPPFYAEDV--------KKMYDKILKGKL-- 242 (357)
T ss_pred cccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHh-hCCCCCcCccH--------HHHHHHHhcCcC--
Confidence 54332 2345589999999999999999999999999999999999 99999976432 233333333220
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP 331 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP 331 (347)
.. .+...+.+..+++.+.|..||++|.
T Consensus 243 ------~~---~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 ------PL---PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ------CC---CCccCCHHHHHHHHHHhccCHHHhc
Confidence 01 1112345678999999999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=326.87 Aligned_cols=262 Identities=19% Similarity=0.257 Sum_probs=205.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCCCch-hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGSVFD-AYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
+.|+...++|+|+||.||++++ +++ -||+||........ ..+-.+||+.+|++++|||+|.++.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 3577788999999999999999 555 45556665544423 34557899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
||+. ++.+-++.. ...++...+..++.|++.|+.|+| ++++|||||||+|||+..+|.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERY----PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecch-HHHHHHHhc----cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9997 666666664 367999999999999999999999 99999999999999999999999999999998874
Q ss_pred CCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH--------
Q 045067 219 GETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI-------- 289 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------- 289 (347)
. ....+.+..|.+|.|||.+.+ ..|.+..||||+||++.||+ +|.+.|...+..+ ....+.+.+
T Consensus 154 p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~-~G~pL~PG~SDiD-----QLy~I~ktLG~L~prhq 226 (396)
T KOG0593|consen 154 P-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELL-TGEPLWPGRSDID-----QLYLIRKTLGNLIPRHQ 226 (396)
T ss_pred C-cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHh-cCCcCCCCcchHH-----HHHHHHHHHcccCHHHH
Confidence 2 223466889999999998877 68999999999999999999 9999998654311 111111111
Q ss_pred ----hccCcccccCCccCCchhh----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 290 ----ENRGFNGIVDPRIIGDELL----EHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 290 ----~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
++.-+..+.-|.....+.. +.....+++++..||+.||.+|++.+|++.
T Consensus 227 ~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 227 SIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1222222222222222222 223447899999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=333.98 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=198.2
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC--ccEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE--IPVLVF 137 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 137 (347)
..++...+.||+|+||+||.+.. +++...++|..........+.+.+|+.+|.+++|||||+++|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 34567788999999999999999 445555555444332222577999999999999999999999855544 689999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-CCceEEecCCCCccC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-RYVPKLFNFSLSASI 216 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~~ 216 (347)
||+++|+|.+++.+. . ..+++..+.+++.|++.||.||| ++||+||||||+|||++. ++.+||+|||++...
T Consensus 96 Ey~~~GsL~~~~~~~---g-~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY---G-GKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eccCCCcHHHHHHHc---C-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 999999999999885 1 27999999999999999999999 999999999999999999 799999999999876
Q ss_pred CC--CCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 217 PE--GETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 217 ~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.. ..........||+.|||||++.++ ...+++||||+||++.||+ +|.+||... ...............
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~-Tg~~PW~~~-------~~~~~~~~~ig~~~~ 240 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEML-TGKPPWSEF-------FEEAEALLLIGREDS 240 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEecc-CCCCcchhh-------cchHHHHHHHhccCC
Confidence 63 111222347899999999998853 4446999999999999999 999999742 001111111111111
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
. | ..+...+.++.+++.+|+..+|++||||+++++.-
T Consensus 241 ~-----P-----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 241 L-----P-----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred C-----C-----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1 1 12223466788999999999999999999998753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=342.17 Aligned_cols=263 Identities=18% Similarity=0.168 Sum_probs=207.6
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--Ccc
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIP 133 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 133 (347)
.-.+.|+..++||+|.||.||+|+. .++ .||+||+.-.. ..+......+||.||++|+||||+++.+...+. ..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3456677888999999999999999 444 55566654333 233345578999999999999999999998876 689
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
|+|+|||+. +|..++.. ..-.++..++..++.|++.||+|+| .+||+|||||.+|||||++|.+||+|||+|
T Consensus 194 YlVFeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLA 265 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLA 265 (560)
T ss_pred EEEEecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccce
Confidence 999999997 99999976 3467999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc-
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN- 291 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 291 (347)
+.+........+...-|.+|.|||++.|. .|+++.|+||.|||+.||+ .|+++|..... ..++...++-
T Consensus 266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~-~gkPI~~G~tE--------veQl~kIfklc 336 (560)
T KOG0600|consen 266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELF-LGKPILQGRTE--------VEQLHKIFKLC 336 (560)
T ss_pred eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHH-cCCCCcCCccH--------HHHHHHHHHHh
Confidence 98876665556677889999999987764 8999999999999999999 99999976432 3333333331
Q ss_pred cCc----cc--------ccCCccCCc----hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGF----NG--------IVDPRIIGD----ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~----~~--------~~~~~~~~~----~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.. +. .+.+.-.-. +.....++..++|+..+|..||.+|.|+.++++
T Consensus 337 GSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 337 GSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 10 111110000 112233457899999999999999999998875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=339.94 Aligned_cols=252 Identities=21% Similarity=0.255 Sum_probs=209.3
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCc
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 132 (347)
....++|..++.||+|+|++|++|+. ..+..+++|+..+.. ..-.+-+.+|-.+|.+| .||.|++|+..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45667899999999999999999999 777777777766532 11124467888899999 89999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
+|+|+||+++|+|.++|.+. +.+++.....++.+|+.||+||| +.|||||||||+|||+|.+++++|.|||.
T Consensus 149 LYFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccc
Confidence 99999999999999999986 88999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCce----------ee--ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCch
Q 045067 213 SASIPEGETY----------ID--DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESF 280 (347)
Q Consensus 213 a~~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~ 280 (347)
|+.+...... .. ...+||..|.+||++..+..++.+|+|+|||++|+|+ .|.+||.+...
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQml-aG~PPFra~Ne------- 292 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQML-AGQPPFRAANE------- 292 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHh-cCCCCCccccH-------
Confidence 9887542211 11 3477999999999999999999999999999999999 99999976432
Q ss_pred HHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 281 EMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
....++.+.-. - +.++..++.+.+|+.+.|..||++|+|+.+|-+
T Consensus 293 -yliFqkI~~l~-------y-----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 293 -YLIFQKIQALD-------Y-----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred -HHHHHHHHHhc-------c-----cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 22333333311 1 112233466789999999999999999988765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=339.69 Aligned_cols=264 Identities=18% Similarity=0.227 Sum_probs=206.1
Q ss_pred HhccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCC-ccEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVE-IPVL 135 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 135 (347)
..+.|...+.||.|+||.||+|+. +++.||+||+.++-..-..-.-.||+..|++|+ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 345677888999999999999999 455666666655543221122468999999998 999999999999888 9999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
|||||+. +|.++++.. +..+++..+..|+.||+.||+|+| .+|+.|||+||+|||+..+..+||+|||+|+.
T Consensus 88 VfE~Md~-NLYqLmK~R----~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eHHhhhh-hHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccc
Confidence 9999986 999999874 478999999999999999999999 99999999999999999999999999999998
Q ss_pred CCCCCceeeccccccCCcccccc-cccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEY-ARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
+.....+ +.+..|.+|.|||+ ++.+.|+.+.|+|++||+++|+. .-++.|...... ....-+...+.....
T Consensus 160 v~SkpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~-sLrPLFPG~sE~-----Dqi~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 160 VRSKPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELY-SLRPLFPGASEI-----DQIYKICEVLGTPDK 231 (538)
T ss_pred cccCCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHH-HhcccCCCCcHH-----HHHHHHHHHhCCCcc
Confidence 8766554 56889999999995 56779999999999999999999 889999764331 111111122211110
Q ss_pred cc------------ccCCccC---CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 295 NG------------IVDPRII---GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 295 ~~------------~~~~~~~---~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.. +--|... -....+..+.++.+++.+|+..||.+||||.|+++.
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00 0001111 112223356789999999999999999999999863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=309.36 Aligned_cols=260 Identities=19% Similarity=0.204 Sum_probs=207.3
Q ss_pred ccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCCch-hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSVFD-AYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
+.|...++||+|.||.||+|+. .+..||+||+......+ ......||+..|+.++||||+.++++|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577888999999999999999 67788888887654332 23568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|++. +|...+++ ....++..++..++.++++||+||| .+.|+||||||.|+|++.+|.+||+|||+|+....
T Consensus 82 fm~t-dLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred eccc-cHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 9985 99999987 3477899999999999999999999 99999999999999999999999999999998875
Q ss_pred CCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc---cC-
Q 045067 219 GETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN---RG- 293 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~- 293 (347)
...... ....|.+|.|||.+.| +.|+...||||.||++.||+ .+.|.|..... .+++...+.. ..
T Consensus 154 p~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELl-lr~P~fpG~sD--------idQL~~If~~LGTP~~ 223 (318)
T KOG0659|consen 154 PNRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELL-LRVPFFPGDSD--------IDQLSKIFRALGTPTP 223 (318)
T ss_pred CCcccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHH-ccCCCCCCCch--------HHHHHHHHHHcCCCCc
Confidence 543322 2368999999996665 58999999999999999999 99998875432 2222222221 10
Q ss_pred --ccc---ccC-------CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 294 --FNG---IVD-------PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 294 --~~~---~~~-------~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+.+ +.| |............+++.+|+..+|..||.+|+|+.|+++.
T Consensus 224 ~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 224 DQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 111 111 1111112333445678999999999999999999998863
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=358.98 Aligned_cols=263 Identities=23% Similarity=0.348 Sum_probs=216.3
Q ss_pred hccCCCCCeecccCceEEEEEEeC------Cc-eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLP------DR-TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
..+....+.||+|.||.||+|... .. .|+||.+......+..++|.+|+.++..++|||||+++|+|..++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344555678999999999999872 12 35555555555555778999999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhcc-----CC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc
Q 045067 134 VLVFESAEYGNLHDLLKRSYQ-----SH----SEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV 204 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~-----~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~ 204 (347)
++|+|||..|+|.++|..... .. ..+++..+.+.|+.|||.|+.||- ++.+|||||-..|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence 999999999999999975321 11 233889999999999999999999 999999999999999999999
Q ss_pred eEEecCCCCccCCCCCceeec-cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 205 PKLFNFSLSASIPEGETYIDD-GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
+||+|||+++.+-...-+... ...-.++|||||.+..+.||.+||||||||+|||++|.|.-||..... +
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---------~ 712 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---------Q 712 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---------H
Confidence 999999999987665544332 334578999999999999999999999999999999999999975443 3
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
.+-..++.+... ..++.++.++++|+..||+.+|++||+++||-..|+..-+
T Consensus 713 EVIe~i~~g~lL----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 713 EVIECIRAGQLL----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHHHcCCcc----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 344444444321 1234567789999999999999999999999999988654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=325.90 Aligned_cols=267 Identities=21% Similarity=0.242 Sum_probs=212.8
Q ss_pred HHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 55 KELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 55 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
.++....++|+..++||.|..++||+|.+ +.+.+|++|.++-.. ....+.+.+|+..|+.++||||++++.+|..+..
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 34445567899999999999999999999 656766666665443 3345889999999999999999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
+|+||.||.+|++.+.+.... ...+++..+..+..++++||.||| .+|.||||||+.||||+.+|.+||+|||.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYY---PDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCcee
Confidence 999999999999999998753 345999999999999999999999 99999999999999999999999999998
Q ss_pred CccCCCCCcee--e-ccccccCCccccccccc--CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 213 SASIPEGETYI--D-DGVKGTSGIVAPEYART--GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 213 a~~~~~~~~~~--~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
+..+....... . +...||+.|||||++.. ..|+.|+||||||++..||. +|..||....+ ...+..
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA-~G~aPf~k~pP--------mkvLl~ 243 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELA-HGHAPFSKYPP--------MKVLLL 243 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHh-cCCCCcccCCh--------HHHHHH
Confidence 77665543211 1 45689999999998443 47899999999999999999 99999976433 222233
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+++.... .+......+........+.+++..||+.||++|||+++++.
T Consensus 244 tLqn~pp~--~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 244 TLQNDPPT--LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HhcCCCCC--cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 33322110 01111122223334558899999999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=339.11 Aligned_cols=250 Identities=23% Similarity=0.260 Sum_probs=203.9
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC----Cc-hhHHHHHHHHHHHHhcC-CCceeeeeeeeeeC
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS----VF-DAYDCCFNNIVFASQMS-HNNVLRLIGCCLEV 130 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 130 (347)
....+.|...+.||+|+||.|+.|.+ .++..+++|+++.. .. ...+.+.+|+.++++++ ||||++++.++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 34567899999999999999999988 44444444465553 11 23456778999999998 99999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC-CceEEec
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-YVPKLFN 209 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~-~~~kl~D 209 (347)
...++||||+.||+|.+++.+. +.+.+..+..++.|++.|++||| ++||+||||||+|||+|.+ +++||+|
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~D 164 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSD 164 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEec
Confidence 9999999999999999999874 78999999999999999999999 9999999999999999999 9999999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCC-CC-CccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGY-LN-EKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
||++.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|+ +|+.||.+.. ......+
T Consensus 165 FG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml-~G~~PF~d~~--------~~~l~~k 234 (370)
T KOG0583|consen 165 FGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL-CGRLPFDDSN--------VPNLYRK 234 (370)
T ss_pred cccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH-hCCCCCCCcc--------HHHHHHH
Confidence 99998774 2223346689999999999999876 75 7899999999999999 9999997622 1222222
Q ss_pred HHhccCcccccCCccCCchhhHHH-HHHHHHHHHHhccCCCCCCCCHHHHH
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHK-LQSSFELAFQCQSASAEDRPTMIDVA 337 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~cl~~~P~~RPs~~ell 337 (347)
+..+.+ .-+ ... +.++.+++.+||+.||.+|+|+.+++
T Consensus 235 -i~~~~~--------~~p---~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 235 -IRKGEF--------KIP---SYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -HhcCCc--------cCC---CCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 222111 111 111 56788999999999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=340.55 Aligned_cols=246 Identities=22% Similarity=0.280 Sum_probs=211.8
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCc--hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF--DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++|...+.||+|+||+||+|+. .+..++++|.+.+... .....+.+|++|++.++||||+.++++|++..++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5688888999999999999999 6778888888776543 345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+.| +|+.+++.. +.+++..+..++.+++.||.||| +.+|+|||+||.|||++.+|.+|++|||+|+....
T Consensus 82 ~a~g-~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9986 999999875 78999999999999999999999 99999999999999999999999999999998876
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
+. ...+...|||.|||||+..+++|+..+|+||+||++||++ .|+|||-... ..+.++....+...
T Consensus 153 ~t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~-~G~PPF~a~s--------i~~Lv~~I~~d~v~---- 218 (808)
T KOG0597|consen 153 NT-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELY-VGQPPFYARS--------ITQLVKSILKDPVK---- 218 (808)
T ss_pred Cc-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHh-cCCCCchHHH--------HHHHHHHHhcCCCC----
Confidence 54 3456678999999999999999999999999999999999 9999996432 22333333332211
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+...+..+..++...|..||..|.|+.+++.
T Consensus 219 --------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 --------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred --------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11245667899999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=337.93 Aligned_cols=265 Identities=20% Similarity=0.364 Sum_probs=203.0
Q ss_pred hccCCCCCeecccCceEEEEEEe------CCc-eEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCC-
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL------PDR-TISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVE- 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 131 (347)
.++|...+.||+|+||.||+|.+ ..+ .+|+|++.........+.+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45688889999999999999975 122 34444443333334446789999999999 8999999999887644
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccC--------------------------------------------------------
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQS-------------------------------------------------------- 155 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 155 (347)
.++++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 688999999999999998753100
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee-eccccccCCc
Q 045067 156 -HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGI 233 (347)
Q Consensus 156 -~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y 233 (347)
...++++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......... .....+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0134788899999999999999999 9999999999999999999999999999998654332221 2234467889
Q ss_pred ccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHH
Q 045067 234 VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQ 313 (347)
Q Consensus 234 ~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (347)
+|||++.+..++.++|||||||++|||++.|..||..... ... .......+... .. +...++
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~-------~~~-~~~~~~~~~~~-----~~-----~~~~~~ 304 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI-------NEE-FCQRLKDGTRM-----RA-----PENATP 304 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc-------cHH-HHHHHhcCCCC-----CC-----CCCCCH
Confidence 9999999899999999999999999999669999965321 111 11222222111 00 112245
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 314 SSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 314 ~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 688999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=312.53 Aligned_cols=236 Identities=20% Similarity=0.253 Sum_probs=203.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||.|+||+|..++. .++.++++|++.+.. ....+...+|-.+|+.+.||+++++++.+.+.+.+++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 3577778999999999999999 778899999887653 334567889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||.+||.|++++++. +.++++.+.-++.+|+.||+||| +.+|++|||||+|||+|.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999986 78999999999999999999999 9999999999999999999999999999999876
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.. .-+.||||.|+|||.++...|+.++|.|||||++|||+ .|.+||.+..+ .....+......
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMl-aG~pPF~~~~~--------~~iY~KI~~~~v---- 258 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEML-AGYPPFYDDNP--------IQIYEKILEGKV---- 258 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHH-cCCCCCcCCCh--------HHHHHHHHhCcc----
Confidence 54 23579999999999999999999999999999999999 99999975433 233333333211
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCC
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDR 330 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~R 330 (347)
..+.....++.+|+...|+.|-.+|
T Consensus 259 --------~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --------KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1222335567899999999998888
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=333.45 Aligned_cols=248 Identities=17% Similarity=0.198 Sum_probs=203.1
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
...++|+...+||+|+||.||.|.- +++.++++|+++++. ....+.+..|-.+|...++|+||+++..|++.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3568899999999999999999999 899999999988765 334567889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
|||||++||++..+|.+. +.|++..+..++.+++.|++.|| +.|+|||||||+|+|||..|++||+|||++.
T Consensus 218 LiMEylPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEecCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999875 78999999999999999999999 9999999999999999999999999999985
Q ss_pred cCCC-----------------------CCce---ee--------------------ccccccCCcccccccccCCCCCcc
Q 045067 215 SIPE-----------------------GETY---ID--------------------DGVKGTSGIVAPEYARTGYLNEKC 248 (347)
Q Consensus 215 ~~~~-----------------------~~~~---~~--------------------~~~~gt~~y~aPE~~~~~~~~~~~ 248 (347)
-+.. .... .. ....|||-|+|||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 4311 0000 00 124599999999999999999999
Q ss_pred chHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCC
Q 045067 249 DVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAE 328 (347)
Q Consensus 249 Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~ 328 (347)
|+||+|||+|||+ .|.|||....+ ....++...-... +..|. + .....++.+||.+|+. ||+
T Consensus 370 DwWSLG~ImyEmL-vGyPPF~s~tp--------~~T~rkI~nwr~~--l~fP~---~---~~~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 370 DWWSLGCIMYEML-VGYPPFCSETP--------QETYRKIVNWRET--LKFPE---E---VDLSDEAKDLITRLLC-DPE 431 (550)
T ss_pred cHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHHHhhh--ccCCC---c---CcccHHHHHHHHHHhc-CHH
Confidence 9999999999999 99999986543 2222222211100 00110 0 1223678899999999 999
Q ss_pred CCCC
Q 045067 329 DRPT 332 (347)
Q Consensus 329 ~RPs 332 (347)
+|.-
T Consensus 432 ~RLG 435 (550)
T KOG0605|consen 432 NRLG 435 (550)
T ss_pred HhcC
Confidence 9975
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=339.72 Aligned_cols=270 Identities=25% Similarity=0.313 Sum_probs=217.5
Q ss_pred cccCHHHHHHHhccCCCCCeecccCceEEEEEEe--CCc--eE-EEEEEccC---CCchhHHHHHHHHHHHHhcCCCcee
Q 045067 50 RSFSAKELERATNNYHYRNIITESSIFRLCQGVL--PDR--TI-SVVKFIDG---SVFDAYDCCFNNIVFASQMSHNNVL 121 (347)
Q Consensus 50 ~~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~--~~-~v~k~~~~---~~~~~~~~~~~E~~~l~~l~h~niv 121 (347)
+......|+...++-...++||+|+||.||+|++ .++ .. |++|.... .......++++|+++|++++|||||
T Consensus 145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 4456667777778888889999999999999999 322 22 45554443 3355668899999999999999999
Q ss_pred eeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC
Q 045067 122 RLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE 201 (347)
Q Consensus 122 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~ 201 (347)
+++|++.....++||||+|.||+|.++|.+. ...++..+..+++.+.|.||+||| +++++||||-.+|+|++.
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~ 297 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSK 297 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecC
Confidence 9999999999999999999999999999885 246999999999999999999999 999999999999999999
Q ss_pred CCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchH
Q 045067 202 RYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFE 281 (347)
Q Consensus 202 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~ 281 (347)
++.+||+|||+++....- ........-+..|+|||.+....||+++|||||||++||+++.|..||.....
T Consensus 298 ~~~vKISDFGLs~~~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-------- 368 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-------- 368 (474)
T ss_pred CCeEEeCccccccCCcce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--------
Confidence 999999999998765411 11111224678999999999999999999999999999999888999875432
Q ss_pred HHHHHHHH-hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 282 MDFVKKYI-ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 282 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
..+.... .++... ..+ ...+..+..++.+||..+|++||||.++.+.|+.+.+.
T Consensus 369 -~~v~~kI~~~~~r~-------~~~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 369 -YEVKAKIVKNGYRM-------PIP---SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred -HHHHHHHHhcCccC-------CCC---CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 2333333 322111 111 13355677899999999999999999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=362.31 Aligned_cols=263 Identities=24% Similarity=0.393 Sum_probs=218.5
Q ss_pred ccCCCCCeecccCceEEEEEEe--CCce-----EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL--PDRT-----ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~-----~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
++.+..+.||+|.||.||.|+. ..+. |++|++....+.+....|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 3445668899999999999999 2232 66777766667777789999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 135 LVFESAEYGNLHDLLKRSYQSH--SEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
|++|||.+|+|..+|++.+... ...+...+.+.++.|||+|+.||+ ++++|||||..+|+|++....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998753221 356889999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCceeeccc-cccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 213 SASIPEGETYIDDGV-KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 213 a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
|+.+.....+..... .-...|||||.+..+.++.|+|||||||++||++|.|..||..... .+....+...
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--------~~v~~~~~~g 920 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--------FEVLLDVLEG 920 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--------HHHHHHHHhC
Confidence 997665554444333 3456999999999999999999999999999999999999975433 2333334444
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
+. +.. +..++..+++++.+||+.+|++||++..|++.+..+.+.
T Consensus 921 gR--------L~~---P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 921 GR--------LDP---PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred Cc--------cCC---CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 32 211 234566789999999999999999999999999888654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=338.37 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=207.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
..|.....||+|+.|.||.|.. .++..+++|..........+-+.+|+.+|+..+|+|||++++.|.-.+.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 3466667899999999999998 555555555555544455577899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
+||+|.|.+.. -.+++.++..++.+++.||+||| .++|+|||||.+|||++.+|.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 99999999987 46999999999999999999999 9999999999999999999999999999998887655
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
. ...+..|||.|||||+.....|+++.||||||++++||+ .|++||-...+ ....++ ...++. +
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMv-eGEPPYlnE~P------lrAlyL--Ia~ng~------P 487 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMV-EGEPPYLNENP------LRALYL--IATNGT------P 487 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHh-cCCCCccCCCh------HHHHHH--HhhcCC------C
Confidence 4 345678999999999999999999999999999999999 99999953221 111111 111211 1
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+ ...+..++.+.+++.+||+.|+++|||+.|||+
T Consensus 488 ~l---k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 KL---KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred Cc---CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 11 223345678999999999999999999999986
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=321.67 Aligned_cols=263 Identities=17% Similarity=0.236 Sum_probs=207.6
Q ss_pred CCccccCHHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeee
Q 045067 47 NPIRSFSAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLI 124 (347)
Q Consensus 47 ~~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~ 124 (347)
..++.++.+++.. .....||+|+++.||+|.+++..+++|++..... ....+.+.+|+.++.+++||||++++
T Consensus 10 ~~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 10 NDIKCIESDDIDK-----YTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred CcceecCHHHcCC-----CCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 4466677777632 3336799999999999999877777776544322 12246788999999999999999999
Q ss_pred eeeee----CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEE
Q 045067 125 GCCLE----VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILV 199 (347)
Q Consensus 125 ~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill 199 (347)
|++.+ ....++||||+++|+|.+++... ..+++.....++.+++.||.||| + .+++||||||+||++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill 156 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLV 156 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEE
Confidence 99877 34689999999999999999764 57899999999999999999999 6 489999999999999
Q ss_pred CCCCceEEecCCCCccCCCCCceeeccccccCCccccccccc--CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCC
Q 045067 200 SERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART--GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD 277 (347)
Q Consensus 200 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~ 277 (347)
+.++.+||+|||+++...... ....+++.|+|||++.+ ..++.++|||||||++|||+ +|..||.....
T Consensus 157 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~-~g~~Pf~~~~~---- 227 (283)
T PHA02988 157 TENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF-TGKIPFENLTT---- 227 (283)
T ss_pred CCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH-HCCCCCCCCCH----
Confidence 999999999999987654322 23468899999999876 68899999999999999999 89999974321
Q ss_pred CchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 278 ESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
............. .... ...+..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 228 ----~~~~~~i~~~~~~-----~~~~-----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 228 ----KEIYDLIINKNNS-----LKLP-----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ----HHHHHHHHhcCCC-----CCCC-----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1222222221110 1111 1235568899999999999999999999999998864
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=319.20 Aligned_cols=256 Identities=19% Similarity=0.252 Sum_probs=201.9
Q ss_pred ccCCCCCeecccCceEEEEEEeC----CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVLP----DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
++|+..+.||+|+||.||+|.+. .+..+++|..... .......+.+|+..+.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999862 2345555554443 333446789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++|||.+...
T Consensus 85 ~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999763 257899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
............++..|+|||.+.+..++.++|||||||++||++++|..||..... ..... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~~-~~~~~~~-- 226 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVIK-AVEDGFR-- 226 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHH-HHHCCCC--
Confidence 322221122234567899999999999999999999999999988679999964321 11111 1222110
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
.. .+...+..+.+++.+||+.+|++|||+.++.+.|+++
T Consensus 227 ---~~-----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ---LP-----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CC-----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 0112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=318.33 Aligned_cols=260 Identities=18% Similarity=0.239 Sum_probs=203.0
Q ss_pred hccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----cc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE-----IP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 133 (347)
.-.|...+++|+|+||.||+|.. +++.+|+||+.+..... .+|+.+|+.++|||||++..+|.... ..
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 34567788999999999999999 56889999998876543 38999999999999999988887532 45
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC-CceEEecCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-YVPKLFNFSL 212 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~ 212 (347)
.+||||+|. +|.+.++.. ...+..++...+.-++.|+.+||+||| +.+|+||||||+|+|+|.+ |.+||||||.
T Consensus 98 nlVleymP~-tL~~~~r~~-~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHY-TRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHhchH-HHHHHHHHH-hhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCc
Confidence 699999996 999999852 223367898899999999999999999 9999999999999999966 8999999999
Q ss_pred CccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
|+.+..+... ..+..|..|.|||.+.| ..|+.+.||||.||++.||+ .|++.|...+. ......+.+.+.-
T Consensus 173 AK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl-~g~plFpG~s~-----~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 173 AKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELL-KGQPLFPGDSS-----VDQLVEIIKVLGT 244 (364)
T ss_pred ceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHh-cCCcccCCCCH-----HHHHHHHHHHhCC
Confidence 9998776554 45788999999997765 58999999999999999999 99999986432 1111111122111
Q ss_pred c----------CcccccCCccCCch----hhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 R----------GFNGIVDPRIIGDE----LLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~----------~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ...+...+.+.... ......++..+++.++|+++|.+|.++.|++.
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1 11111222222221 22344568899999999999999999999875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=335.90 Aligned_cols=247 Identities=21% Similarity=0.238 Sum_probs=208.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
+-|..++-||+|+-|.|-.|++ .+|..|++|++.+.. ......+.+|+.+|+-|.|||++++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4466778899999999999999 788888888877652 222356889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|.|++++-.. +++++..+.++++||+.|+.|+| ..+|+||||||+|+|+|..+++||+|||+|....
T Consensus 92 Eyv~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EecCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 999999999999765 88999999999999999999999 9999999999999999999999999999997755
Q ss_pred CCCceeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.+.- ..+.||+|.|+|||++.|..| +.++||||.|||||.|+ +|+.||++.. ....+.++ +.|.++
T Consensus 164 ~gkl--LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALL-tG~LPFdDdN--------ir~LLlKV-~~G~f~- 230 (786)
T KOG0588|consen 164 PGKL--LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALL-TGKLPFDDDN--------IRVLLLKV-QRGVFE- 230 (786)
T ss_pred CCcc--ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHH-hCCCCCCCcc--------HHHHHHHH-HcCccc-
Confidence 4432 356799999999999999877 48899999999999999 9999997421 22222332 333321
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.+...+.++.+|+.+|+..||++|.|+.||++.
T Consensus 231 ----------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 ----------MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----------CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 223446678999999999999999999999863
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=336.04 Aligned_cols=242 Identities=23% Similarity=0.305 Sum_probs=202.6
Q ss_pred CCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCC
Q 045067 64 YHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYG 143 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 143 (347)
....+.||+|+.|.||+|.+.+..|||||+.... ..+++.|++|+||||+.+.|+|....-++|+||||+.|
T Consensus 126 IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeeccCceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 3445789999999999999999999999976543 25788899999999999999999999999999999999
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee
Q 045067 144 NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223 (347)
Q Consensus 144 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 223 (347)
-|...|+.. ..+.......|..+||.|++||| .+.|||||||.-||||..+..+||+|||-++...... .
T Consensus 198 qL~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--T 267 (904)
T KOG4721|consen 198 QLYEVLKAG-----RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--T 267 (904)
T ss_pred cHHHHHhcc-----CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhh--h
Confidence 999999875 78888999999999999999999 9999999999999999999999999999887665432 2
Q ss_pred eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccC
Q 045067 224 DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRII 303 (347)
Q Consensus 224 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (347)
....+||..|||||++.+.+.+.|+||||||||||||+ +|..||.+-.. ....+. . .....
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmL-T~EiPYkdVds--sAIIwG-----------V-----GsNsL 328 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEML-TGEIPYKDVDS--SAIIWG-----------V-----GSNSL 328 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHH-hcCCCccccch--heeEEe-----------c-----cCCcc
Confidence 33478999999999999999999999999999999999 99999975332 000000 0 00111
Q ss_pred CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 304 GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
.-..+..+++-+.-|+++||+..|.+|||+.+++..|+=
T Consensus 329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 112223455667789999999999999999999998863
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=333.50 Aligned_cols=269 Identities=22% Similarity=0.302 Sum_probs=212.1
Q ss_pred CHHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 045067 53 SAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE 131 (347)
Q Consensus 53 ~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 131 (347)
+.++++...+.+.....||+|+||+||+|.| .|.||||.+--.. +....+.|.+|+..+++-+|.||+-+.|+|..+.
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w-hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRW-HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccc-ccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3456666667777788999999999999999 4556666553332 3345688999999999999999999999999887
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
. .||+-+|.|.+|..+++.. +..+...+.+.|+.|++.|+.||| .++|||||||..||++++++++||+|||
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred e-eeeehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccc
Confidence 7 9999999999999999864 366889999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCC-CceeeccccccCCccccccccc---CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 212 LSASIPEG-ETYIDDGVKGTSGIVAPEYART---GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 212 ~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
++..-..- .........|...|||||+++. .+|++.+||||||+++|||+ +|..||..... ....+.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELl-tg~lPysi~~~--dqIifm------ 604 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELL-TGELPYSIQNR--DQIIFM------ 604 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHH-hCcCCcCCCCh--hheEEE------
Confidence 98654322 1112234668899999998874 47899999999999999999 99999983322 000000
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
...+ .-+.|.. ......++++.+|+..||..++++||.+.+|+..|+++..+
T Consensus 605 -VGrG--~l~pd~s----~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 605 -VGRG--YLMPDLS----KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -eccc--ccCccch----hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 0011 0011111 12234566889999999999999999999999999988764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=320.35 Aligned_cols=266 Identities=21% Similarity=0.314 Sum_probs=199.2
Q ss_pred ccCCCCCeecccCceEEEEEEeC-----------------CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeee
Q 045067 62 NNYHYRNIITESSIFRLCQGVLP-----------------DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRL 123 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 123 (347)
++|...+.||+|+||.||+|.+. ++..+++|..... .......+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46788899999999999999862 1224555555443 33345679999999999999999999
Q ss_pred eeeeeeCCccEEEEEeCCCCCHHHHHhhhcc--------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 045067 124 IGCCLEVEIPVLVFESAEYGNLHDLLKRSYQ--------------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVF 189 (347)
Q Consensus 124 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH 189 (347)
++++.+.+..++||||+++|+|.+++..... .....+++..+..++.|++.||.||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 9999999999999999999999999865311 01134788899999999999999999 999999
Q ss_pred ccCCCCCeEECCCCceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHh-cCCCc
Q 045067 190 RDLKSSYILVSERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS-TGEDL 267 (347)
Q Consensus 190 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~-~g~~p 267 (347)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ .+..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999765443322 1223456789999999888889999999999999999983 25667
Q ss_pred cccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 268 FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
|..... ................. .... ..+..+..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 242 ~~~~~~-----~~~~~~~~~~~~~~~~~-~~~~------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTD-----EQVIENAGEFFRDQGRQ-VYLF------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCH-----HHHHHHHHHHhhhcccc-cccc------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 753211 11111111211111100 0000 011234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=325.33 Aligned_cols=248 Identities=23% Similarity=0.243 Sum_probs=208.8
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
..|...+.||+|+||.||+|.. ..++++++|+++-.. ....+.+.+|+.+|.+++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566778999999999999999 778888888877553 44567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
|.||++.+.++.. ..+++....-++++++.||.||| ..+.+|||||+.|||+..+|.+|++|||.+......
T Consensus 93 ~~gGsv~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG-----NILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred hcCcchhhhhccC-----CCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999864 44588888889999999999999 999999999999999999999999999999877654
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
... ..+..||+.|||||++.+..|+.|+||||||++.+||. +|.||+....+ ....+ .+.+-..
T Consensus 165 ~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla-~GePP~s~~hP--mrvlf------------lIpk~~P 228 (467)
T KOG0201|consen 165 VKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELA-KGEPPHSKLHP--MRVLF------------LIPKSAP 228 (467)
T ss_pred hhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHh-cCCCCCcccCc--ceEEE------------eccCCCC
Confidence 443 36788999999999999999999999999999999999 99999986543 00000 0111122
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
|.+. ...++.+.+++..||+.||+.||||.+++.
T Consensus 229 P~L~-----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLD-----GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred Cccc-----cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2222 244667899999999999999999999986
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=318.72 Aligned_cols=268 Identities=18% Similarity=0.206 Sum_probs=198.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++|+..+.||+|+||.||+|+. .++..+++|..... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4688889999999999999999 45555555544432 12234668899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|++++.+..+... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9998766655433 256899999999999999999999 99999999999999999999999999999987654
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCC-------CCchHHHHHHHHHhc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG-------DESFEMDFVKKYIEN 291 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~~~~~~ 291 (347)
..........||+.|+|||++.+..++.++||||+||++|||+ +|++||........ ...............
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELS-DGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 3332233457899999999998888999999999999999999 89999975321000 000000011111111
Q ss_pred cCcccccCCccCCch-----hhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGFNGIVDPRIIGDE-----LLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........+...... .....+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111111110000 01123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=329.04 Aligned_cols=263 Identities=19% Similarity=0.340 Sum_probs=202.9
Q ss_pred HhccCCCCCeecccCceEEEEEEe------CCceEEEEEEccC-CCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCC
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL------PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVE 131 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 131 (347)
..++|+..+.||+|+||.||+|++ +++..+++|.+.. ......+.+.+|+.++..+ +||||+++++++.++.
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345688889999999999999974 2344455555543 3333446788999999999 8999999999999999
Q ss_pred ccEEEEEeCCCCCHHHHHhhhcc---------------------------------------------------------
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQ--------------------------------------------------------- 154 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 154 (347)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999865210
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 155 -------------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 155 -------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
.....+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 01125788899999999999999999 99999999999999999999999999999987654332
Q ss_pred ee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 222 YI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 222 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
.. .....++..|+|||++.+..++.++|||||||++|||++.|..||..... .. ...+....+.. ...+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~-------~~-~~~~~~~~~~~--~~~~ 339 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV-------DS-KFYKMIKEGYR--MLSP 339 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc-------hH-HHHHHHHhCcc--CCCC
Confidence 21 12234567899999999999999999999999999999669999864321 11 11122222211 0011
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
...+.++.+++.+||+.||++|||+.||++.|++.
T Consensus 340 --------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 --------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=312.26 Aligned_cols=257 Identities=22% Similarity=0.331 Sum_probs=204.0
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.++|+..+.||+|+||.||+|...++..+++|....... ..+.+.+|+.++++++||||+++++++.+.+..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 356888899999999999999985444455554443332 3477899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... ....+++..+..++.+++.||+||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 84 AKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999763 2356889999999999999999999 9999999999999999999999999999998765433
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
........++..|+|||++.+..++.++|||||||++|+|++.|..||..... ............. +
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---------~~~~~~~~~~~~~----~ 224 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---------SDVMSALQRGYRM----P 224 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---------HHHHHHHHcCCCC----C
Confidence 22223344677899999998888999999999999999999449999964221 1111222221100 1
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
. ....+.++.+++.+||+.+|++|||++++.+.|+++
T Consensus 225 ~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 R------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 012345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=311.77 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=204.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.+|+..+.||+|+||.||+|.. +.+..+++|...... .....+.+|+.++++++||||+++++++..+...+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3477788999999999999998 555556666555433 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... ....+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 85 TYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999753 2356899999999999999999999 9999999999999999999999999999987765433
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
........+++.|+|||.+.+..++.++|||||||++|||++.|..||..... .... ....... . .
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~-~~~~~~~-~----~ 224 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVY-ELLEKGY-R----M 224 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH-HHHHCCC-C----C
Confidence 22222334567899999999899999999999999999999449999864211 1111 1111111 0 0
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
. .+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 225 ~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 E-----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred C-----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0 1112345788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=317.05 Aligned_cols=251 Identities=18% Similarity=0.238 Sum_probs=196.4
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
+|...+.||+|+||.||+|.. .++..+++|.+.... ......+.+|+.++++++|+||+++++++.+++..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999998 455555555443221 2223457899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999999888643 2246899999999999999999999 99999999999999999999999999999977543
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
... .....||+.|+|||++.+..++.++|||||||++|+|+ +|+.||..... ...............
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~-~g~~pf~~~~~-----~~~~~~~~~~~~~~~----- 221 (285)
T cd05631 155 GET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMI-QGQSPFRKRKE-----RVKREEVDRRVKEDQ----- 221 (285)
T ss_pred CCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHH-hCCCCCCCCCc-----chhHHHHHHHhhccc-----
Confidence 322 23457899999999999999999999999999999999 89999975322 001111111111100
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-----MIDVAK 338 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-----~~ell~ 338 (347)
.......+..+.+|+.+||+.||++||+ ++++++
T Consensus 222 ------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 ------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0011123456789999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=330.77 Aligned_cols=266 Identities=20% Similarity=0.369 Sum_probs=203.9
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe------CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL------PDRTISVVKFID-GSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLE 129 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 129 (347)
.-..++|+..+.||+|+||.||+|.. ++...+++|.+. .......+.+.+|+.+++.+ +||||+++++++..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 33445788899999999999999985 122344555444 33334456788999999999 89999999999999
Q ss_pred CCccEEEEEeCCCCCHHHHHhhhcc-------------------------------------------------------
Q 045067 130 VEIPVLVFESAEYGNLHDLLKRSYQ------------------------------------------------------- 154 (347)
Q Consensus 130 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 154 (347)
....++||||+++|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999864210
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee-
Q 045067 155 ----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI- 223 (347)
Q Consensus 155 ----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 223 (347)
....++++..+.+++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 01134788899999999999999999 9999999999999999999999999999997664432221
Q ss_pred eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccC
Q 045067 224 DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRII 303 (347)
Q Consensus 224 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (347)
.....+++.|+|||++.+..++.++|||||||++|+|++.|..||..... . .........+. ....+
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~-------~-~~~~~~~~~~~--~~~~~--- 337 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV-------N-SKFYKMVKRGY--QMSRP--- 337 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc-------c-HHHHHHHHccc--CccCC---
Confidence 12234567899999998889999999999999999999559999965321 0 01111111111 00011
Q ss_pred CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 304 GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
...+.++.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 338 -----~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 -----DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 112456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=343.11 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=215.4
Q ss_pred CCCCCeecccCceEEEEEEe--CC---ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 64 YHYRNIITESSIFRLCQGVL--PD---RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~--~~---~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
..+.++||.|.||.|++|++ ++ ..||+|.+....+......|+.|+.||.+++||||++|.|+....+.++||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 34668999999999999999 33 24555555555566667889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
||++|+|+.+|.. +++.+.+.+...++++|+.|+.||. +.++|||||.+.|||++.+-..|++|||+++.+.+
T Consensus 711 yMENGsLDsFLR~----~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 711 YMENGSLDSFLRQ----NDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhCCcHHHHHhh----cCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999987 4577999999999999999999999 99999999999999999999999999999998765
Q ss_pred CCceeec--cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 219 GETYIDD--GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 219 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
+.....+ +..-.++|.|||.+..+.++.+|||||||+++||.+|.|..||-+... .+++....++
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--------QdVIkaIe~g----- 850 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVIKAIEQG----- 850 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--------HHHHHHHHhc-----
Confidence 5432222 233467999999999999999999999999999999999999876543 2333333332
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
-+++. +.+++..+..|+.+||++|-.+||.+.+|+..|++++.
T Consensus 851 ---yRLPp---PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 851 ---YRLPP---PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred ---cCCCC---CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 22322 23567789999999999999999999999999999875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=310.16 Aligned_cols=252 Identities=20% Similarity=0.317 Sum_probs=199.7
Q ss_pred ccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
++|+..+.||+|+||.||+|.+.++..+++|....... ..+.+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45778889999999999999995554455555443332 23678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
+|+|.+++... ...+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||.++.......
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 83 NGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 99999998753 246899999999999999999999 99999999999999999999999999999876644332
Q ss_pred eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
.......++..|+|||.+.+..++.++|+||||+++|+|++.|++||..... ............ ...+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~~~~---~~~~~ 224 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISRGFR---LYRPK 224 (256)
T ss_pred eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCC---CCCCC
Confidence 2222334567899999998888999999999999999999448999864321 122222221111 11111
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
..+..+.+++.+||+.+|++|||+.++++.|
T Consensus 225 --------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 --------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1234678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.72 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=203.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc-----eEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR-----TISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~-----~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
++|+..+.||+|+||.||+|.. ... ..+++|... .......+.+.+|+.++.+++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4677888999999999999987 222 344444443 333344567899999999999999999999999989999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCC-----------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHS-----------EPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY 203 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~ 203 (347)
++|||+++|+|.+++........ ..+++..+..++.|++.||.||| +.+++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence 99999999999999976421111 45888999999999999999999 99999999999999999999
Q ss_pred ceEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH
Q 045067 204 VPKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282 (347)
Q Consensus 204 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~ 282 (347)
.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++.|..||..... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------Q 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999876543322 1223345688999999988888999999999999999999559999864321 1
Q ss_pred HHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 283 DFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
. ....+..+... ......+.++.+++.+||+.+|.+||++.||++.|+.
T Consensus 234 ~-~~~~i~~~~~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 E-VIEMIRSRQLL----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H-HHHHHHcCCcC----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 11222222111 0112345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=318.87 Aligned_cols=247 Identities=19% Similarity=0.213 Sum_probs=208.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
...|+..+.||+|.||.|-+|.. ..+.++++|.+.++. ..+.-.+.+|++||+.|+||||+.++.+|.+.+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45677778899999999999998 666667777666543 33445688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||..+|.|.|++... +.+++..+..+++||+.|+.|+| .++++|||||.+|||+|.++++||+|||++..+
T Consensus 132 MEYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 132 MEYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhh
Confidence 9999999999999876 88999999999999999999999 999999999999999999999999999999777
Q ss_pred CCCCceeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
..... .++.||++.|.+||.+.|.+| .+..|.||+||+||-|+ .|.+||+..+. ..+-..+..+.+.
T Consensus 204 ~~~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLV-yGtMPFDG~Dh---------k~lvrQIs~GaYr 271 (668)
T KOG0611|consen 204 ADKKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLV-YGTMPFDGRDH---------KRLVRQISRGAYR 271 (668)
T ss_pred ccccH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHh-hcccccCCchH---------HHHHHHhhccccc
Confidence 65443 356899999999999999877 48899999999999999 99999975432 2233334444332
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+ ++.+..+.-||.+||..||++|.|+.+|...
T Consensus 272 E------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 E------------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred C------------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 2 1223456789999999999999999998764
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=318.31 Aligned_cols=198 Identities=19% Similarity=0.250 Sum_probs=173.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.++|+..+.||+|+||.||++.. .++..+++|..... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 36788899999999999999999 56666777766544 23344679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR-PIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|+++|+|.+++... ..+++..+..++.+++.||.||| +. +|+||||||+|||++.++.++|+|||++....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 84 HMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999999764 56899999999999999999999 64 69999999999999999999999999987654
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
... .....||+.|+|||++.+..++.++|||||||++|||+ +|+.||..
T Consensus 156 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~-tg~~p~~~ 204 (331)
T cd06649 156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELA-IGRYPIPP 204 (331)
T ss_pred ccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHH-hCCCCCCC
Confidence 322 23456899999999999999999999999999999999 99999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=309.31 Aligned_cols=257 Identities=23% Similarity=0.327 Sum_probs=203.9
Q ss_pred hccCCCCCeecccCceEEEEEEeC----CceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLP----DRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
.++|+..+.||+|+||.||+|.+. +...+++|.... ........+.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357888999999999999999982 233455555443 333445678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
+|||+++++|.+++... ...+++..+..++.+++.||.||| +.+|+||||||+||+++.++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 83 ITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 99999999999999763 247899999999999999999999 99999999999999999999999999999987
Q ss_pred CCCC-CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 216 IPEG-ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 216 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.... .........+++.|+|||.+.+..++.++||||||+++|+|++.|..||..... .. ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~-~~~~~~~~~~ 226 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QD-VIKAVEDGYR 226 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--------HH-HHHHHHcCCC
Confidence 7522 222222334567899999999889999999999999999999559999854221 11 1122221110
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
. +. ....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 227 ~----~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 L----PP------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C----CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00 112345678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=312.53 Aligned_cols=263 Identities=19% Similarity=0.313 Sum_probs=207.8
Q ss_pred ccCCCCCeecccCceEEEEEEe------CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL------PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|...+.||+|+||.||++.. .++..+++|..........+.+.+|+.++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5688889999999999999985 2334566666655554555779999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhcc--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEE
Q 045067 136 VFESAEYGNLHDLLKRSYQ--------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl 207 (347)
|+||+++++|.+++..... .....+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence 9999999999999975311 11235899999999999999999999 999999999999999999999999
Q ss_pred ecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 208 FNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++.|.+||..... .....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~~~ 233 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVIE 233 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence 999998766433221 122344578899999999889999999999999999999449999864321 11111
Q ss_pred HHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
. ...+..... + ...+.++.+++.+||+.+|.+|||+.++.+.|+++.++
T Consensus 234 ~-i~~~~~~~~--~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 C-ITQGRVLQR--P--------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred H-HHcCCcCCC--C--------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 2 122211110 0 11234688999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=319.25 Aligned_cols=245 Identities=20% Similarity=0.221 Sum_probs=197.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||+|.. .++..+++|..... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3688889999999999999999 44555555554332 1223456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 999999999999764 57899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
... ....||+.|+|||.+.+..++.++|||||||++|+|+ +|+.||..... .......... ..
T Consensus 153 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~-~g~~pf~~~~~--------~~~~~~i~~~-~~--- 215 (291)
T cd05612 153 DRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML-VGYPPFFDDNP--------FGIYEKILAG-KL--- 215 (291)
T ss_pred CCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhC-Cc---
Confidence 322 2356899999999999888999999999999999999 89999964321 1222222211 10
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-----MIDVAKQ 339 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-----~~ell~~ 339 (347)
.. +......+.+++.+||+.||.+||+ ++++++.
T Consensus 216 ---~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 ---EF-----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CC-----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00 1112346789999999999999995 8887653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=310.12 Aligned_cols=257 Identities=21% Similarity=0.313 Sum_probs=203.2
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.++|+..+.||+|++|.||+|...++..+++|....... ..+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 456888899999999999999985444455555554332 2367899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... ....+++..+..++.+++.||.||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 84 KYGSLLEYLQGG---AGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cCCcHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999763 2346899999999999999999999 9999999999999999999999999999998765332
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
.........+..|+|||++.+..++.++|+||||+++|+|++.|+.||..... .. ......... . .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~-~~~~~~~~~-~-~--- 223 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AE-VLQQVDQGY-R-M--- 223 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HH-HHHHHHcCC-C-C---
Confidence 22122223356899999999889999999999999999999449999964221 11 111111111 0 0
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
. .....+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 224 ~-----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 P-----CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred C-----CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 0112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=312.50 Aligned_cols=258 Identities=21% Similarity=0.318 Sum_probs=208.4
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
..++|+..+.||.|+||.||+|...++..+++|..........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45568888999999999999999955666777776665554457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++.+. ....+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.+||+|||.+......
T Consensus 84 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 84 MEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred cccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999763 2356899999999999999999999 999999999999999999999999999999776443
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
... .....++..|+|||.+.+..++.++||||||+++|+|++.|+.||..... ............
T Consensus 158 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~------ 222 (261)
T cd05148 158 VYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQITAGYR------ 222 (261)
T ss_pred ccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHHhCCc------
Confidence 222 22344677899999998889999999999999999999558999964321 111121111100
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
.. .....+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 223 ~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 MP-----CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CC-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 00 0112345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=309.35 Aligned_cols=266 Identities=19% Similarity=0.238 Sum_probs=206.1
Q ss_pred HHhccCCCCCeecccCceEEEEEEe--CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeee-----C
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE-----V 130 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 130 (347)
.+...|...+.||+|+||.|+.++. ++..||+||+.+. ......++..+|+.+|++++|+||+.+.+.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3445566678899999999999999 6778888888744 334456889999999999999999999998875 3
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
+.+|+|+|+|. .+|...++.+ ..++...+..++.|++.||.|+| +.+++||||||+|+|++.+..+||+||
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccc
Confidence 47899999996 5999999874 55999999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCC-ceeeccccccCCccccccc-ccCCCCCccchHHHHHHHHHHHhcCCCccccCccCC---------C-CC
Q 045067 211 SLSASIPEGE-TYIDDGVKGTSGIVAPEYA-RTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN---------G-DE 278 (347)
Q Consensus 211 g~a~~~~~~~-~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~---------~-~~ 278 (347)
|+|+...... ....+.+..|.+|.|||.+ ....|+.+.||||+|||+.||+ +|++.|....... + ..
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL-~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEML-TGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHH-cCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 9999876431 1223568899999999955 5679999999999999999999 9999998654311 0 01
Q ss_pred chHHH-----HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 279 SFEMD-----FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 279 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... .++.++++-.. -+...-....+...+.+++|+.+||..||.+|+|++|.++
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~----~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQ----IPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCC----CCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 10111 11222221110 0111111122344567899999999999999999999876
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=324.07 Aligned_cols=253 Identities=17% Similarity=0.177 Sum_probs=200.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||+|.. .++..+++|++.... ....+.+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3688889999999999999999 445555555544321 223466889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 999999999999764 57899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
. ......||+.|+|||++.+..++.++|||||||++|||+ +|..||..... ............. .
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~--------~~~~~~i~~~~~~--~ 217 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFL-CGFPPFSGSTP--------NETWENLKYWKET--L 217 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhh-hCCCCCCCCCH--------HHHHHHHHhcccc--c
Confidence 3 223467999999999999999999999999999999999 99999964321 1111111110000 0
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
..+... ......+.++.+++.+||..+|.+||++.++++.
T Consensus 218 ~~~~~~--~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 218 QRPVYD--DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCCCCC--ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 011110 0001235578899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=325.52 Aligned_cols=244 Identities=17% Similarity=0.239 Sum_probs=196.5
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|...+.||+|+||.||+|.. .++..+++|..... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5688889999999999999999 45555555554432 1223467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 98 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999764 57899999999999999999999 9999999999999999999999999999997664
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
... ....||+.|+|||++.+..++.++|||||||++|+|+ +|..||..... ........ .+...
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~--------~~~~~~i~-~~~~~-- 233 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI-AGYPPFFDDTP--------FRIYEKIL-AGRLK-- 233 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHH-cCCCCCCCCCH--------HHHHHHHh-cCCcC--
Confidence 332 2357899999999999999999999999999999999 99999964221 11112211 11110
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-----MIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-----~~ell~ 338 (347)
+ + ......+.+++.+||+.||.+||+ +.+++.
T Consensus 234 ~-p--------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 F-P--------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred C-C--------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 1 112345779999999999999997 577663
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=324.48 Aligned_cols=260 Identities=17% Similarity=0.126 Sum_probs=194.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
+.|...+.||+|+||.||++.. .++..+++|... .+.+.+|+.++++++||||+++++++..+...++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5799999999999999999998 455555555332 145789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
. ++|..++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 166 ~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 166 K-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred C-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 6 6899888653 56899999999999999999999 9999999999999999999999999999987543322
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh-ccCcc----
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE-NRGFN---- 295 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---- 295 (347)
........||+.|+|||++.+..++.++||||+||++|||+ +|..||-......+...... ....... .+...
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~-~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA-TCHDSLFEKDGLDGDCDSDR-QIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHH-HCCCCcCCcccccccCchhH-HHHHHHHHhcCChhhcC
Confidence 22233467999999999999899999999999999999999 77766543222111110000 0000000 00000
Q ss_pred -----------------cccCCcc-CCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 -----------------GIVDPRI-IGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 -----------------~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
....+.. .........+.++.+++.+||+.||++|||+.|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 000111234557889999999999999999999985
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=321.66 Aligned_cols=241 Identities=16% Similarity=0.156 Sum_probs=192.9
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYG 143 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 143 (347)
+.||+|+||.||++.. .++..+++|++... .......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999998 55555555555432 1233456789999999999999999999999999999999999999
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee
Q 045067 144 NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223 (347)
Q Consensus 144 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 223 (347)
+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 151 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-c
Confidence 999999764 67899999999999999999999 99999999999999999999999999999875432221 1
Q ss_pred eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccC
Q 045067 224 DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRII 303 (347)
Q Consensus 224 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (347)
.....||+.|+|||++.+..++.++||||+||++|||+ +|..||..... ...... ...... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-tg~~Pf~~~~~--------~~~~~~-~~~~~~------~~- 214 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDH--------EKLFEL-ILMEEI------RF- 214 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhh-cCCCCCCCCCH--------HHHHHH-HHcCCC------CC-
Confidence 23457999999999999999999999999999999999 99999964221 111111 111110 11
Q ss_pred CchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 304 GDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
+.....++.+++.+||+.||++|| ++.++++
T Consensus 215 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 ----PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ----CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 112345678999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=331.74 Aligned_cols=244 Identities=16% Similarity=0.201 Sum_probs=204.8
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCcc
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 133 (347)
...++|...++||+|+||.|+++.. .++.++++|++++.. .++.+..+.|-.|+... +||.+++++.+|++.+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 3456899999999999999999999 677788888887653 45668889999999877 599999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++||||+.||++..+.+. ..+++..+.-++..|+.||.||| +++||+||||.+|||+|.+|.+||+|||++
T Consensus 445 ~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccc
Confidence 999999999995555543 68999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
+..-... ...++.+|||.|+|||++.+..|+.++|.|||||++|||+ .|++||..... .+.......+..
T Consensus 516 Ke~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML-~Gq~PF~gddE--------ee~FdsI~~d~~ 585 (694)
T KOG0694|consen 516 KEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEML-VGESPFPGDDE--------EEVFDSIVNDEV 585 (694)
T ss_pred cccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHH-cCCCCCCCCCH--------HHHHHHHhcCCC
Confidence 8754332 2456789999999999999999999999999999999999 99999975332 222222222211
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM 333 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~ 333 (347)
-.+...+.+..+++.++|..+|++|.-+
T Consensus 586 ------------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 ------------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1122446678899999999999999866
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=312.99 Aligned_cols=262 Identities=16% Similarity=0.194 Sum_probs=195.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|...+.||+|+||.||+|.. .++..+++|.+.. ........+.+|+.++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4688889999999999999998 4455555554443 2223335678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++ +|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 85 LDS-DLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCc-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 985 999988653 245789999999999999999999 999999999999999999999999999998765432
Q ss_pred CceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh--------
Q 045067 220 ETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE-------- 290 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 290 (347)
.. ......+++.|+|||++.+ ..++.++||||+||++|+|+ +|++||..... ............
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~-~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMA-TGRPMFPGSTV-----KEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHH-hCCCCCCCCCH-----HHHHHHHHHHhCCCChHHhh
Confidence 21 1233568999999998765 56899999999999999999 99999965321 000000100000
Q ss_pred ----ccCcccccCCccCCch---hhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 ----NRGFNGIVDPRIIGDE---LLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ----~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...+.....+...... .......++.+++.+||+.||.+|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0001111111110000 01122456789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=316.14 Aligned_cols=257 Identities=19% Similarity=0.300 Sum_probs=201.2
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCce----EEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRT----ISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
.+|+..+.||+|+||.||+|++ .++. .+++|... .......+.+.+|+.+++.++||||++++|++..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 4588889999999999999997 3333 14444444 33334457789999999999999999999998764 5789
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
++||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 86 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999763 256889999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 216 IPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 216 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
........ .....++..|+|||.+.+..++.++|||||||++|||++.|..||..... .. ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~-~~~~~~~~~~ 229 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SE-ISSILEKGER 229 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HH-HHHHHhCCCC
Confidence 65433221 22334567899999999999999999999999999999559999864211 11 1222222111
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
. ..+ ......+.+++.+||+.+|.+|||+.+++..|.++.+
T Consensus 230 ~--~~~--------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 230 L--PQP--------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred C--CCC--------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 0 001 1123457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=311.35 Aligned_cols=249 Identities=29% Similarity=0.422 Sum_probs=191.5
Q ss_pred CCeecccCceEEEEEEeC-----CceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 67 RNIITESSIFRLCQGVLP-----DRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~-----~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.+.||.|.||.||+|.+. .+..+++|.+.. ......+.+.+|+..+++++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999995 233444455543 34444688999999999999999999999999888899999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++|+|.+++... ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus 84 ~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 84 PGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 999999999874 3467999999999999999999999 8999999999999999999999999999998763322
Q ss_pred c-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 221 T-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 221 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
. ...........|+|||.+.+..++.++||||||+++||+++.++.||.... ........ ..+....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------~~~~~~~~-~~~~~~~--- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------NEEIIEKL-KQGQRLP--- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------HHHHHHHH-HTTEETT---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccc-cccccce---
Confidence 2 222345577899999999988899999999999999999954889885432 22333333 2221110
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
.....+..+.+++.+||+.+|++|||+.++++.|
T Consensus 226 -------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112345678999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=322.89 Aligned_cols=245 Identities=19% Similarity=0.224 Sum_probs=196.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
.++|...+.||+|+||.||+|.+ . +...+++|.+... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 34688889999999999999987 3 3344444544321 22334678899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 109 v~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999764 57899999999999999999999 99999999999999999999999999999976
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
..... ....||+.|+|||++.+..++.++||||+||++|||+ +|.+||..... ........ .+...
T Consensus 181 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell-~G~~Pf~~~~~--------~~~~~~i~-~~~~~ 246 (340)
T PTZ00426 181 VDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL-VGCPPFYANEP--------LLIYQKIL-EGIIY 246 (340)
T ss_pred cCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHh-cCCCCCCCCCH--------HHHHHHHh-cCCCC
Confidence 54322 2357999999999999888999999999999999999 99999964321 11111211 11110
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
. +......+.+++.+||+.+|++|+ ++.++++
T Consensus 247 --~---------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 247 --F---------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred --C---------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 0 011234577999999999999995 8888865
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=320.59 Aligned_cols=251 Identities=20% Similarity=0.221 Sum_probs=208.6
Q ss_pred ccCCCCCeecccCceEEEEEEe--CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc-cEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI-PVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 137 (347)
++|...+++|+|+||.++..++ ++..+++|++.-. .+....+...+|+.++++++|||||.+.+.|..++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788899999999999999988 4445555554332 233444578999999999999999999999998887 99999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
+||+||+|.+.+... .+..+++..+..|+.|++.|+.||| +..|+|||||++||++..++.++|+|||+|+...
T Consensus 84 ~Y~eGg~l~~~i~~~---k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ---KGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 999999999999886 3567999999999999999999999 9999999999999999999999999999999887
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... ...+..||+.||+||.+.+.+|+.|+||||+||++|||+ +-+++|..... ...+.+.....
T Consensus 158 ~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~-~lk~aF~a~~m--------~~Li~ki~~~~----- 222 (426)
T KOG0589|consen 158 PEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC-TLKPAFKASNM--------SELILKINRGL----- 222 (426)
T ss_pred Cchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHH-hcccccCccch--------HHHHHHHhhcc-----
Confidence 6542 345688999999999999999999999999999999999 99999975432 22222222211
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.. ..+...+.++..++..||+.+|+.||++.+++..
T Consensus 223 ~~------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YS------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CC------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11 1122346678999999999999999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=324.15 Aligned_cols=266 Identities=18% Similarity=0.311 Sum_probs=205.9
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-C-C-----ceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeC
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-P-D-----RTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEV 130 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~-~-----~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 130 (347)
...+.|...+.||+|+||.||+|+. . + ..+++|++.........+.+.+|+.+++++. ||||+++++++.+.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 3456788889999999999999986 1 1 1355555544444444567999999999996 99999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccC-------------------------------------------------------
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQS------------------------------------------------------- 155 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------- 155 (347)
...++||||+++|+|.+++......
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999998653100
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 045067 156 ------------------------------------HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199 (347)
Q Consensus 156 ------------------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill 199 (347)
....+++..+..++.|++.||+||| +.+++||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEE
Confidence 0134788889999999999999999 9999999999999999
Q ss_pred CCCCceEEecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCC
Q 045067 200 SERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278 (347)
Q Consensus 200 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~ 278 (347)
+.++.+||+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||++.|..||.....
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~----- 345 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV----- 345 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch-----
Confidence 999999999999987654332221 22345678899999998889999999999999999999668899864321
Q ss_pred chHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
..........+.. .. .....+..+.+++.+||+.+|++|||+.+|.+.|+++.+
T Consensus 346 ---~~~~~~~~~~~~~-----~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 346 ---DSTFYNKIKSGYR-----MA-----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---hHHHHHHHhcCCC-----CC-----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0111111221110 00 111235578899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=319.24 Aligned_cols=238 Identities=19% Similarity=0.187 Sum_probs=190.0
Q ss_pred ecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 70 ITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 70 lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
||+|+||.||+|.. .++..+++|.+... .......+.+|+.++.+++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999 45555555554432 223346688999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeec
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 225 (347)
.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++....... ...
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 151 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTN 151 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccc
Confidence 9999764 57899999999999999999999 99999999999999999999999999999875432221 223
Q ss_pred cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCc
Q 045067 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGD 305 (347)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (347)
...||+.|+|||++.+..++.++||||+||++|+|+ +|.+||..... ........... . .
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~-tg~~pf~~~~~--------~~~~~~~~~~~-~------~---- 211 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML-TGLPPFYDENV--------NEMYRKILQEP-L------R---- 211 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHH-hCCCCcCCCCH--------HHHHHHHHcCC-C------C----
Confidence 467999999999999999999999999999999999 99999964321 12222222111 0 0
Q ss_pred hhhHHHHHHHHHHHHHhccCCCCCCCC---HHHHH
Q 045067 306 ELLEHKLQSSFELAFQCQSASAEDRPT---MIDVA 337 (347)
Q Consensus 306 ~~~~~~~~~~~~l~~~cl~~~P~~RPs---~~ell 337 (347)
.+...+..+.+++.+||+.||++||+ +.|++
T Consensus 212 -~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 212 -FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred -CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 11123456789999999999999986 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=293.22 Aligned_cols=248 Identities=18% Similarity=0.222 Sum_probs=207.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+.++.||+|-||.||.|+. .+.-++++|+..++. .+...++.+|++|.+.|+||||+++++++.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 4688899999999999999999 667777777765542 223367899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||.+.|+|...+... ....+++.....++.|+|.||.|+| .++++||||||+|+|++..+.+|++|||.+...+
T Consensus 102 Eya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999854 3367889999999999999999999 9999999999999999999999999999886544
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
. ....+.+||..|.|||+..+..++...|+|++|++.||++ .|.+||.+... ....+...+ .++
T Consensus 176 ~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl-vg~ppFes~~~--------~etYkrI~k----~~~ 239 (281)
T KOG0580|consen 176 S---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFL-VGLPPFESQSH--------SETYKRIRK----VDL 239 (281)
T ss_pred C---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHH-hcCCchhhhhh--------HHHHHHHHH----ccc
Confidence 2 2345689999999999999999999999999999999999 99999975321 122222222 122
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.+| ...+..+.+++.+|+..+|.+|.+..|+++.
T Consensus 240 ~~p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 KFP--------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cCC--------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 222 2335567899999999999999999998864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=303.32 Aligned_cols=259 Identities=19% Similarity=0.183 Sum_probs=197.9
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCch-h-HHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFD-A-YDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 136 (347)
+.|+..+.|++|+||.||+|.. .++.++++|.++..... . --...||+.+|.+++|||||.+-.+.... +.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4466778899999999999999 56666666555543321 1 12357999999999999999998877643 479999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
||||+. +|.+++... .+++...++.-++.|++.|++||| ...|+||||||+|+|++..|.+||+|||+|+.+
T Consensus 156 Me~~Eh-DLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHHh-hHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence 999997 999999874 368999999999999999999999 999999999999999999999999999999998
Q ss_pred CCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc-c--
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN-R-- 292 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~-- 292 (347)
...... .+...-|.+|.|||.+.+ ..|++..|+||+|||+.||+ .+.|.|..... .+.+.+.++. +
T Consensus 228 gsp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l-~~kPlf~G~sE--------~dQl~~If~llGtP 297 (419)
T KOG0663|consen 228 GSPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELL-TQKPLFPGKSE--------IDQLDKIFKLLGTP 297 (419)
T ss_pred cCCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHH-hcCCCCCCCch--------HHHHHHHHHHhCCC
Confidence 765332 344678999999997776 47999999999999999999 99999975432 2222222221 0
Q ss_pred ---CcccccCCccC-------Cch-h----hHH--HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 ---GFNGIVDPRII-------GDE-L----LEH--KLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 ---~~~~~~~~~~~-------~~~-~----~~~--~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+..+...... .+. . ... ..+...+|+..+|.+||.+|.|++|.++
T Consensus 298 te~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 298 SEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11111110000 000 0 000 2356789999999999999999999875
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=314.54 Aligned_cols=261 Identities=16% Similarity=0.184 Sum_probs=194.3
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.++|...+.||+|+||.||+|.. .++..+++|.+... .......+.+|+.++++++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46789999999999999999999 44554555554432 22223467899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|++ ++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 84 YVH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CCC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 997 5888888653 256889999999999999999999 99999999999999999999999999999875432
Q ss_pred CCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh---ccC-
Q 045067 219 GETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE---NRG- 293 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~- 293 (347)
.. .......+|+.|+|||.+.+ ..++.++||||+||++|+|+ +|.+||..... .......... ...
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~ 226 (303)
T cd07869 156 PS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI-QGVAAFPGMKD-------IQDQLERIFLVLGTPNE 226 (303)
T ss_pred CC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCcc-------HHHHHHHHHHHhCCCCh
Confidence 22 11234568999999998765 46889999999999999999 99999974321 1111111110 000
Q ss_pred --ccc-----ccCCc-c--CCchhhH------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 --FNG-----IVDPR-I--IGDELLE------HKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 --~~~-----~~~~~-~--~~~~~~~------~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.. ...+. . ..+.... ..+..+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 00000 0 0000000 11246789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=292.07 Aligned_cols=263 Identities=19% Similarity=0.216 Sum_probs=206.7
Q ss_pred HhccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----c
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE-----I 132 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 132 (347)
..+.|.+.+.||+|||+-||.+.. +++.+|+||+...+ .++.+..++|++..++++|||+++++++...+. .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 346788899999999999999997 55566666666555 455688999999999999999999999876543 4
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEECCCCceEEecC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP--IVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
.||+++|...|+|.+.++.. ...+..+++.+.+.|+.+++.||.+|| +.. +.||||||.|||+.+.+.+++.||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~-k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERL-KIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred EEEEeehhccccHHHHHHHH-hhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEec
Confidence 89999999999999999875 444567999999999999999999999 665 999999999999999999999999
Q ss_pred CCCccCCCCCcee--------eccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCc
Q 045067 211 SLSASIPEGETYI--------DDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDES 279 (347)
Q Consensus 211 g~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~ 279 (347)
|.++......... ......|..|.|||.+. +...+.++|||||||++|+|+ .|..||+..... ++..
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~m-f~~sPfe~~~~~-GgSl 251 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMM-FGESPFERIYQQ-GGSL 251 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHH-HcCCcchHHhhc-CCeE
Confidence 9987765321111 11244799999999886 446789999999999999999 999999754331 1110
Q ss_pred hHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 280 FEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
- -......+.-+.. ...++.+.+++.+|+++||..||++.+++..++++.
T Consensus 252 a--------------LAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 A--------------LAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred E--------------EeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0 0111111111111 124667899999999999999999999999999875
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=306.91 Aligned_cols=257 Identities=18% Similarity=0.313 Sum_probs=198.8
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCce-----EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRT-----ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~-----~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|...+.||+|+||.||+|.+ .++. +++|+...........++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 3567778999999999999998 3332 344443323223334667888889999999999999998764 55789
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
++||+++|+|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 99999999999999753 256899999999999999999999 99999999999999999999999999999976
Q ss_pred CCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 216 IPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 216 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
...... .......++..|+|||.+.+..++.++|||||||++||+++.|..||..... .........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---------~~~~~~~~~~~~ 229 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---------HEVPDLLEKGER 229 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHHHHCCCc
Confidence 643322 1223345778899999998889999999999999999999559999864321 111222222211
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
...+. .....+.+++.+||..+|++|||+.|+++.|..+.+
T Consensus 230 --~~~~~--------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 --LAQPQ--------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --CCCCC--------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11111 123456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=315.85 Aligned_cols=198 Identities=18% Similarity=0.243 Sum_probs=172.7
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.++|+..+.||+|+||.||++.. .++.++++|..... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 36788999999999999999999 56666777766543 33344678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|+++|+|.+++... ..+++..+..++.+++.||.||| + .+++|+||||+|||++.++.+||+|||++....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999764 56899999999999999999999 6 479999999999999999999999999987653
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
... .....|+..|+|||++.+..++.++|||||||++|+|+ +|+.||..
T Consensus 156 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~-~g~~p~~~ 204 (333)
T cd06650 156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA-IGRYPIPP 204 (333)
T ss_pred hhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHH-HCCCCCCC
Confidence 321 23356899999999999889999999999999999999 89999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=331.98 Aligned_cols=252 Identities=18% Similarity=0.206 Sum_probs=200.0
Q ss_pred cCCCCCeecccCceEEEEEEe-CC-ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PD-RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~-~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.|...+.||+|++|.||+|.. .+ +..+++|............+.+|+.+++.++||||+++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 388889999999999999988 33 4444555444444444466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++|+|.+++... .....++++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 148 ~gg~L~~~l~~~-~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 148 SGGDLNKQIKQR-LKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCHHHHHHHH-HhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999988653 122356889999999999999999999 9999999999999999999999999999998765432
Q ss_pred c-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 221 T-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 221 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
. .......||+.|+|||++.+..++.++|||||||++|+|+ +|..||..... .......... ...
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~-tg~~Pf~~~~~--------~~~~~~~~~~-~~~---- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL-TLHRPFKGPSQ--------REIMQQVLYG-KYD---- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhC-CCC----
Confidence 2 1233457999999999999999999999999999999999 89999964221 1222222221 111
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+ .....+..+.+++.+||+.+|++|||+.+++.
T Consensus 290 ~------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 P------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred C------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 01122456889999999999999999999875
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.19 Aligned_cols=253 Identities=20% Similarity=0.293 Sum_probs=199.3
Q ss_pred ccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
++|...+.||+|+||.||.|.+.++..+++|.+..... ..+.+.+|+.++.+++||||+++++++......+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 45777889999999999999985554444454444332 23678999999999999999999999998889999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
+|+|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 83 NGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 99999999763 246899999999999999999999 99999999999999999999999999999876654433
Q ss_pred eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
.......++..|+|||.+.+..++.++|||||||++|+|++.|..||..... .......... ... ..+
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~-~~~--~~~- 223 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVSQG-LRL--YRP- 223 (256)
T ss_pred eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHhcC-CCC--CCC-
Confidence 2222344667899999998888999999999999999999449999864221 1111222111 110 000
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 224 -------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 -------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112456889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=309.09 Aligned_cols=261 Identities=21% Similarity=0.318 Sum_probs=200.4
Q ss_pred HhccCCCCCeecccCceEEEEEEeC------CceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLP------DRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
.+++|+..+.||+|+||.||+|.+. .+..+++|... .........+.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5677999999999999999999862 12334444443 3333344668899999999999999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEE
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQS-----HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl 207 (347)
.++||||+++|+|.+++.+.... ....+++..+..++.|++.||.||| +.+++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999753110 0234678889999999999999999 999999999999999999999999
Q ss_pred ecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 208 FNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|||++.|..||..... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~~~ 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVLR 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence 9999987654433221 12234578899999999889999999999999999999447888853211 11111
Q ss_pred HHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
... ....... ....+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 233 ~~~-~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVM-EGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHH-cCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111 1111110 11224568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=308.36 Aligned_cols=263 Identities=18% Similarity=0.281 Sum_probs=207.5
Q ss_pred ccCCCCCeecccCceEEEEEEe------CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL------PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
.+|...+.||+|+||.||+|.. .+...+++|..........+.+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 3577778999999999999985 1334455666655554455678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc
Q 045067 136 VFESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV 204 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~ 204 (347)
||||+++++|.+++..... .....+++..++.++.|++.||+||| +++++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence 9999999999999975311 11245899999999999999999999 999999999999999999999
Q ss_pred eEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 205 PKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++.|..||..... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~ 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------TE 233 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence 99999999976544322 1223345678899999999899999999999999999999449999864321 11
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.......+..... ....+..+.+++.+||+.+|++|||+.++++.|+++.++
T Consensus 234 -~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 234 -VIECITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHHHHhCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1112222221110 111245688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=306.64 Aligned_cols=261 Identities=21% Similarity=0.290 Sum_probs=204.3
Q ss_pred ccCCCCCeecccCceEEEEEEe--CCceEEEEEEccC--CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDG--SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||+|+. ++..+++|++... ........+.+|+.++++++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788899999999999999998 4455555544321 22333456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ......++...+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYF-KKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHh-hhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999988643 112245889999999999999999999 9999999999999999999999999999987664
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... ......+++.|+|||.+.+..++.++|+||+|+++|+|+ +|..||..... ........ ......
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~-~g~~p~~~~~~------~~~~~~~~-~~~~~~--- 225 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA-ALQSPFYGDKM------NLFSLCQK-IEQCDY--- 225 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh-cCCCCCccccc------cHHHHHHH-HhcCCC---
Confidence 3322 122346888999999998888999999999999999999 88888853211 11122222 111111
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
+.. .....+..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 226 --~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 --PPL----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCC----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111 11233456889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.18 Aligned_cols=251 Identities=20% Similarity=0.321 Sum_probs=197.6
Q ss_pred cCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 63 NYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+|+..+.||+|+||.||+|.+.++..+++|....... ..+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4777889999999999999985554455555443322 225688999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
++|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 84 GCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999999753 246899999999999999999999 999999999999999999999999999998766433222
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......++..|+|||.+.+..++.++|+||||+++|++++.|..||..... ...... ..... ....+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~-~~~~~--~~~~~-- 223 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEVVES-VSAGY--RLYRP-- 223 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHHHHH-HHcCC--cCCCC--
Confidence 222233456899999999889999999999999999999448999864321 111111 11110 00001
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 224 ------~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 ------KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 12345688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=302.79 Aligned_cols=255 Identities=24% Similarity=0.307 Sum_probs=198.9
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.++|+..+.||+|+||.||+|...++..+++|....... ..+.+.+|+.++++++|||++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 346788899999999999999885444445554443322 2367899999999999999999999875 45689999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... ....+++..+..++.+++.||.||| +.+++||||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 83 SKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999753 2356899999999999999999999 9999999999999999999999999999997665433
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
........++..|+|||.+.+..++.++|+||||+++|+|++.|.+||..... ...... ...... .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~-~~~~~~-----~ 222 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQ-VERGYR-----M 222 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHH-HHcCCC-----C
Confidence 22222334567899999988888999999999999999999449999964221 111111 111110 0
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
. .....+..+.+++.+||+++|++|||+.++.+.|++
T Consensus 223 ~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 P-----CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred C-----CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 011234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=303.50 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=201.0
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.++|...+.||+|+||.||+|.+.+...+++|....... ..+.+.+|+.++++++||||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 356888999999999999999984443455555544332 2367899999999999999999999875 45679999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++|+|.+++... ....+++..+..++.+++.||+||| +.+++||||||+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 83 SKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999753 2245789999999999999999999 9999999999999999999999999999997665433
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
........++..|+|||+..+..++.++|+||||+++|+|++.|..||..... ....... ..... .
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~-~~~~~-----~ 222 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQV-ERGYR-----M 222 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHH-hcCCC-----C
Confidence 22223345677899999998888999999999999999999448999864321 1111111 11100 0
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
......+..+.+++.+||+.+|++|||+.++++.|++..
T Consensus 223 -----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 011234557889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=307.50 Aligned_cols=262 Identities=22% Similarity=0.333 Sum_probs=203.8
Q ss_pred cCCCCCeecccCceEEEEEEeC------CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 63 NYHYRNIITESSIFRLCQGVLP------DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
+|+..+.||+|+||.||+|+.. +..++++|..... .....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999862 2245566655443 33345678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhcc-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 045067 136 VFESAEYGNLHDLLKRSYQ-------------------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSY 196 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~N 196 (347)
++||+++|+|.+++..... .....+++..+..++.|++.||.||| +.+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 9999999999999865311 11235789999999999999999999 9999999999999
Q ss_pred eEECCCCceEEecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCC
Q 045067 197 ILVSERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN 275 (347)
Q Consensus 197 ill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~ 275 (347)
|++++++.++|+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++.|..||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 999999999999999987654332221 12234567899999988888999999999999999999449999864221
Q ss_pred CCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 276 GDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
............ ... ....+..+.+++.+||+.+|++||++.++++.|+++..+
T Consensus 236 -------~~~~~~~~~~~~-----~~~-----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 -------ERLFNLLKTGYR-----MER-----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred -------HHHHHHHhCCCC-----CCC-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 111222221110 000 112245688999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=300.87 Aligned_cols=248 Identities=24% Similarity=0.291 Sum_probs=193.6
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
+.||+|+||.||+|+. .++..+++|... .........+.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999998 455555555443 33334446789999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceee-
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID- 224 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~- 224 (347)
.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 81 LTFLRTE----GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 9999652 246899999999999999999999 99999999999999999999999999999876543211111
Q ss_pred ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCC
Q 045067 225 DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIG 304 (347)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (347)
.....+..|+|||.+.++.++.++|||||||++|+|++.|..||..... ............ .
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---------~~~~~~~~~~~~-----~---- 215 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---------QQTREAIEQGVR-----L---- 215 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---------HHHHHHHHcCCC-----C----
Confidence 1122346799999999888999999999999999999558888864221 111111111100 0
Q ss_pred chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 305 DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 305 ~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
......+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 216 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 216 -PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 011122456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=315.98 Aligned_cols=245 Identities=19% Similarity=0.236 Sum_probs=190.3
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||.||+|.. .++..+++|++... .....+.+.+|+.++.++ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999998 55555555555432 223345678899988877 799999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|..++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 9999988764 67999999999999999999999 99999999999999999999999999999875432211
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++|||||||++|+|+ +|..||...............+.......... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~ 224 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM-AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHh-hCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC
Confidence 123457899999999999999999999999999999999 89999964322111112222222222222111 11
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTM 333 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~ 333 (347)
+......+.+++.+||+.||++||++
T Consensus 225 -----p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 -----PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -----CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11224467899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=316.27 Aligned_cols=241 Identities=16% Similarity=0.162 Sum_probs=191.1
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYG 143 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 143 (347)
+.||+|+||.||++.. .++..+++|.+... .......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999998 45555555544432 1223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee
Q 045067 144 NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223 (347)
Q Consensus 144 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 223 (347)
+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 151 (323)
T cd05595 81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-c
Confidence 999998764 57899999999999999999999 99999999999999999999999999999875432221 1
Q ss_pred eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccC
Q 045067 224 DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRII 303 (347)
Q Consensus 224 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (347)
.....||+.|+|||.+.+..++.++|||||||++|||+ +|+.||..... ......... ... .+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell-~g~~Pf~~~~~--------~~~~~~~~~-~~~------~~- 214 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDH--------ERLFELILM-EEI------RF- 214 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHH-hCCCCCCCCCH--------HHHHHHHhc-CCC------CC-
Confidence 23456999999999999899999999999999999999 89999964321 111111111 110 01
Q ss_pred CchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 304 GDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
+...++.+.+++.+||+.||++|| ++.++++
T Consensus 215 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 ----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ----CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 112245678999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=306.74 Aligned_cols=259 Identities=21% Similarity=0.319 Sum_probs=201.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CC-----ceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PD-----RTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~-----~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
++|...+.||+|+||.||+|.. +. +..+++|..... .....+.+.+|+.++++++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 4577788999999999999987 22 244444544443 3334578999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 135 LVFESAEYGNLHDLLKRSY---------QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
+||||+++++|.+++.... ......+++..+..++.+++.||.||| +.+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 9999999999999997531 112345789999999999999999999 9999999999999999999999
Q ss_pred EEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 206 KLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
+|+|||++........ .......+++.|+|||++.+..+++++|||||||++|||++.|..||..... ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--------~~~ 233 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--------EEV 233 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHH
Confidence 9999999876543322 1122344678899999999999999999999999999999449999864321 111
Q ss_pred HHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 285 VKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
. .....+..... ....+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 234 ~-~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 I-ECITQGRLLQR----------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H-HHHHcCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 11112111110 11234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=315.50 Aligned_cols=250 Identities=19% Similarity=0.234 Sum_probs=194.2
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
++||+|+||.||+|.. .++..+++|++... .....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999 55555566655432 222345678999999988 799999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~- 151 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence 9999998764 67999999999999999999999 99999999999999999999999999999865322211
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++|+||+||++|+|+ +|+.||...............+.......... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~-~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 224 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM-AGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHH-HCCCCcccccccccccccchHHHHHHHHcCCC------CC
Confidence 223467999999999999999999999999999999999 89999974332211122222233222222211 01
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCC------HHHHHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPT------MIDVAK 338 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs------~~ell~ 338 (347)
+ ...+..+.+++.+||+.||.+||| +.++++
T Consensus 225 p-----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 P-----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred C-----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1 112446789999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=321.94 Aligned_cols=254 Identities=15% Similarity=0.203 Sum_probs=199.3
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
..++|+..+.||+|+||.||++.. .++..+++|.+... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 456799999999999999999998 55656666655432 12233557889999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++|+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999999965 46888999999999999999999 99999999999999999999999999999977
Q ss_pred CCCCCceeeccccccCCcccccccccC----CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTG----YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
.............||+.|+|||++.+. .++.++|||||||++|||+ +|.+||..... ..........
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyell-tG~~Pf~~~~~--------~~~~~~i~~~ 262 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYADSL--------VGTYSKIMDH 262 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHH-hCCCCcCCCCH--------HHHHHHHHcC
Confidence 654332223446799999999987643 4789999999999999999 99999964321 1122222221
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAED--RPTMIDVAKQ 339 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~--RPs~~ell~~ 339 (347)
... +..+ . ....+.++.+++.+||+.+|.+ |||+.|+++.
T Consensus 263 ~~~--~~~~---~---~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 263 KNS--LTFP---D---DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCc--CCCC---C---cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 110 0000 0 0123456789999999999987 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=315.95 Aligned_cols=242 Identities=15% Similarity=0.151 Sum_probs=192.5
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYG 143 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 143 (347)
+.||+|+||.||++.. .++..+++|++... .......+.+|+.+++.++||||+++++++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999998 45555555555432 2233467889999999999999999999999999999999999999
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee
Q 045067 144 NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223 (347)
Q Consensus 144 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 223 (347)
+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 151 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-T 151 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-c
Confidence 999998764 57899999999999999999999 99999999999999999999999999999875432221 1
Q ss_pred eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccC
Q 045067 224 DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRII 303 (347)
Q Consensus 224 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (347)
.....||+.|+|||++.+..++.++|||||||++|+|+ +|+.||..... ......... .. ..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell-tG~~Pf~~~~~--------~~~~~~~~~-~~------~~~- 214 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDH--------EKLFELILM-ED------IKF- 214 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHh-hCCCCCCCCCH--------HHHHHHhcc-CC------ccC-
Confidence 23457999999999999889999999999999999999 89999964221 111111111 10 001
Q ss_pred CchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 045067 304 GDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAKQ 339 (347)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~~ 339 (347)
+...+..+.+++.+||+.||++|| ++.++++.
T Consensus 215 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 ----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112245678999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=308.27 Aligned_cols=261 Identities=21% Similarity=0.315 Sum_probs=200.8
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCce--EEEEEEccC-CCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRT--ISVVKFIDG-SVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~--~~v~k~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 136 (347)
++|+..++||+|+||.||+|.. +++. .+++|.... ......+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 5688889999999999999988 3332 234444443 3334456789999999999 799999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 137 FESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
+||+++++|.+++..... .....+++..+..++.|++.||+||| +.+++||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 999999999999965311 01135889999999999999999999 9999999999999999999999
Q ss_pred EEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 206 KLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
||+|||++....... .......+..|+|||+..+..++.++|||||||++|||++.|..||..... ....
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AELY 228 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence 999999986432211 111123356799999998888999999999999999999559999864321 1112
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
..... +.. ... ....+..+.+++.+||+.+|.+|||++++++.|+++..+
T Consensus 229 ~~~~~-~~~-----~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 229 EKLPQ-GYR-----MEK-----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHHhc-CCC-----CCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 22111 100 000 112345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=302.46 Aligned_cols=257 Identities=22% Similarity=0.305 Sum_probs=201.4
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
..++|...++||+|+||.||+|...++..+++|....... ..+.+.+|+.++++++|||++++++++. .+..++++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3467888899999999999999985555555555544332 2367899999999999999999999864 4678999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++... .+..+++.++..++.+++.||+||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 82 MENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999998653 3356899999999999999999999 999999999999999999999999999998766533
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
.........++..|+|||++.+..++.++||||||+++||+++.|++||..... ..... ........
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~-~~~~~~~~---- 222 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQ-NLERGYRM---- 222 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHH-HHHcCCCC----
Confidence 222222344677899999998888999999999999999999339999964321 11111 11111100
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
.. ....+.++.+++.+||+.+|++|||++++++.|+++
T Consensus 223 -~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 223 -PR-----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred -CC-----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 00 112245688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=315.30 Aligned_cols=265 Identities=21% Similarity=0.350 Sum_probs=202.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-----CceEEEEEEccC-CCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC-C
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-----DRTISVVKFIDG-SVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV-E 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-----~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 131 (347)
.+.|...+.||+|+||.||+|.. + ++..+++|.+.. ......+.+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 34688889999999999999975 2 123444554443 2333446688999999999 899999999988654 5
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccC--------------------------------------------------------
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQS-------------------------------------------------------- 155 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 155 (347)
.+++++||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998642100
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee-eccccccCCcc
Q 045067 156 HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGIV 234 (347)
Q Consensus 156 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~ 234 (347)
....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++..+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0136889999999999999999999 9999999999999999999999999999998764433222 22345677899
Q ss_pred cccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHH
Q 045067 235 APEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQS 314 (347)
Q Consensus 235 aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (347)
|||++.+..++.++|||||||++|||++.|..||..... ..........+... .. ......+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~--~~--------~~~~~~~ 304 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--------DEEFCRRLKEGTRM--RA--------PEYATPE 304 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc--------cHHHHHHHhccCCC--CC--------CccCCHH
Confidence 999999999999999999999999999559999864221 01111222221110 00 1122456
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 315 SFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 315 ~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
+.+++.+||+.+|++||++.|+++.|+++.+.
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 88999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=299.90 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=194.6
Q ss_pred eecccCceEEEEEEe---CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCC
Q 045067 69 IITESSIFRLCQGVL---PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYG 143 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~---~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 143 (347)
.||+|+||.||+|.+ .++..+++|+..... ....+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999976 345566666654332 233467899999999999999999999875 45678999999999
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee
Q 045067 144 NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223 (347)
Q Consensus 144 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 223 (347)
+|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 999999754 56899999999999999999999 9999999999999999999999999999998765443221
Q ss_pred e--ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 224 D--DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 224 ~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
. ....+++.|+|||.+....++.++|+|||||++|||++.|.+||..... ...... ...+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~-i~~~~~~~----- 218 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQM-IESGERME----- 218 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH-HHCCCCCC-----
Confidence 1 2233467899999988888999999999999999999449999964321 112222 22211111
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
. +...+.++.+++.+||++||++||++++|.+.|++.
T Consensus 219 ~-----~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 C-----PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C-----CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1 112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=297.65 Aligned_cols=264 Identities=19% Similarity=0.190 Sum_probs=199.7
Q ss_pred hccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCc-eeeeeeeeeeCC-----
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNN-VLRLIGCCLEVE----- 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 131 (347)
...|...++||+|+||+||+|+. ++..||+||+.-... ++......+|+.++++++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34455667799999999999999 455666666544333 233355789999999999999 999999999877
Q ss_pred -ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 132 -IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 132 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
.+++|+||+.. +|..++....... ..++...+..++.|++.||+||| +++|+||||||+|||++++|.+||+||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeecc
Confidence 78999999985 9999998752111 46777899999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
|+|+........ .+...+|.+|.|||++.+. .|++..||||+||++.||+ ++++.|..... .+.....+
T Consensus 165 GlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~-~~~~LFpG~se--------~~ql~~If 234 (323)
T KOG0594|consen 165 GLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMF-TRRPLFPGDSE--------IDQLFRIF 234 (323)
T ss_pred chHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHH-hCCCCCCCCcH--------HHHHHHHH
Confidence 999876543322 2446789999999988776 8999999999999999999 89999975432 22222222
Q ss_pred hc---c---Ccccc---cC-----CccC-CchhhH---HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 290 EN---R---GFNGI---VD-----PRII-GDELLE---HKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 290 ~~---~---~~~~~---~~-----~~~~-~~~~~~---~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.- . .+... .+ +... ...... .......+++.+||+.+|.+|.|+...++.
T Consensus 235 ~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 235 RLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 21 0 01000 00 0110 001111 111367899999999999999999998875
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=291.88 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=206.6
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCCc-------hhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSVF-------DAYDCCFNNIVFASQM-SHNNVLRLIGCC 127 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~~-------~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 127 (347)
....+.|...++||.|..++|-++.+ .++..++|++....+. ...+.-.+|+.||+++ .||+|+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34556788889999999999999988 4566777776543321 1234567899999998 699999999999
Q ss_pred eeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEE
Q 045067 128 LEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207 (347)
Q Consensus 128 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl 207 (347)
.++..+++|+|.|+.|.|+|++... -.+++....+|+.|+..|+.||| .++||||||||+|||+|++.+++|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEE
Confidence 9999999999999999999999875 67999999999999999999999 999999999999999999999999
Q ss_pred ecCCCCccCCCCCceeeccccccCCccccccccc------CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchH
Q 045067 208 FNFSLSASIPEGETYIDDGVKGTSGIVAPEYART------GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFE 281 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~ 281 (347)
+|||+|+.+..+... ...||||+|+|||.+.. ..|+...|+|+.||++|.|+ .|.+||-....
T Consensus 165 sDFGFa~~l~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL-aGcpPFwHRkQ-------- 233 (411)
T KOG0599|consen 165 SDFGFACQLEPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL-AGCPPFWHRKQ-------- 233 (411)
T ss_pred eccceeeccCCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH-cCCCchhHHHH--------
Confidence 999999998776543 45899999999998763 35788899999999999999 99999864321
Q ss_pred HHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 282 MDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...+ ..+.++.+ ++- ++...+.+..+.+|+.+||+.||.+|.|+.|+++
T Consensus 234 mlML-R~ImeGky-qF~------speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 234 MLML-RMIMEGKY-QFR------SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHH-HHHHhccc-ccC------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1111 22223322 111 1223455667889999999999999999999886
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=315.88 Aligned_cols=251 Identities=16% Similarity=0.177 Sum_probs=195.6
Q ss_pred cCCCCCeecccCceEEEEEEe----CCceEEEEEEccCC----CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCcc
Q 045067 63 NYHYRNIITESSIFRLCQGVL----PDRTISVVKFIDGS----VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~~v~k~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 133 (347)
+|+..+.||+|+||.||++.. .++..+++|+.... .....+.+.+|+.++.++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999886 24555666655432 122345678999999999 599999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999999764 57899999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
+..............||+.|+|||++.+. .++.++|||||||++|||+ +|..||..... ..............
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~----~~~~~~~~~~~~~~- 226 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL-TGASPFTLEGE----RNTQSEVSRRILKC- 226 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhh-cCCCCCCCCCC----CCCHHHHHHHHhcC-
Confidence 76544333333346799999999988765 4789999999999999999 99999964321 11111222221111
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
++.+ ....+..+.+++.+||+.||++|| ++.++++
T Consensus 227 ------~~~~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 ------DPPF-----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ------CCCC-----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111 112244678999999999999999 6677764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=304.44 Aligned_cols=254 Identities=19% Similarity=0.257 Sum_probs=198.5
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
++|+..+.||+|+||.||+|.. .++..+++|............+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688899999999999999998 556666666655444344467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 89 GGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998754 57899999999999999999999 9999999999999999999999999999987654322
Q ss_pred ceeeccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 221 TYIDDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
. ......+++.|+|||.+. ...++.++|+||+||++|||+ +|..||........ .. ..... ..
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~-~g~~p~~~~~~~~~--------~~-~~~~~---~~ 226 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA-ELQPPMFDLHPMRA--------LF-LMSKS---NF 226 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH-hCCCCccccchhhh--------he-eeecC---CC
Confidence 1 123356889999999874 445788999999999999999 88888853321000 00 00000 00
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
..+.... ....+..+.+++.+||+.+|++|||++++++.|
T Consensus 227 ~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKLKD---KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCcc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1111111 112345788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=307.63 Aligned_cols=259 Identities=18% Similarity=0.214 Sum_probs=191.9
Q ss_pred ccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCC--chhHHHHHHHHHHHHhc---CCCceeeeeeeeee-----
Q 045067 62 NNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQM---SHNNVLRLIGCCLE----- 129 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 129 (347)
++|...+.||+|+||.||+|.. .++..+++|...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688889999999999999987 345555555443321 22234567788887766 69999999998852
Q ss_pred CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 130 VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 130 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
...+++||||++ ++|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 346899999997 5999998753 2345899999999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
||++....... ......||+.|+|||.+.+..++.++|||||||++|||+ +|.+||..... ........
T Consensus 154 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~~f~~~~~--------~~~~~~i~ 222 (290)
T cd07862 154 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSD--------VDQLGKIL 222 (290)
T ss_pred ccceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHH-cCCCCcCCCCH--------HHHHHHHH
Confidence 99987654331 223456899999999998889999999999999999999 99999975322 11111111
Q ss_pred hcc------Cc-------ccccCCccC--CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 290 ENR------GF-------NGIVDPRII--GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 290 ~~~------~~-------~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... .+ ...+.+... .....+.....+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 223 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 100 00 000000000 00111123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=320.00 Aligned_cols=251 Identities=16% Similarity=0.176 Sum_probs=193.0
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.|...+.||+|+||+||+|.. .++..+++|.+... .....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999998 55555555555432 12334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 99999999999764 56899999999999999999999 99999999999999999999999999999754311
Q ss_pred CC----------------------------------------------ceeeccccccCCcccccccccCCCCCccchHH
Q 045067 219 GE----------------------------------------------TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYS 252 (347)
Q Consensus 219 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 252 (347)
.. ........||+.|+|||.+.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 00 00012346999999999999888999999999
Q ss_pred HHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHH--hccCCCCCC
Q 045067 253 FGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQ--CQSASAEDR 330 (347)
Q Consensus 253 ~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--cl~~~P~~R 330 (347)
|||++|||+ +|.+||..... .............. ..... ...+.++.+++.+ |+..+|..|
T Consensus 234 lG~il~ell-tG~~Pf~~~~~--------~~~~~~i~~~~~~~-----~~~~~---~~~s~~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 234 VGVILFEML-VGQPPFLAPTP--------TETQLKVINWENTL-----HIPPQ---VKLSPEAVDLITKLCCSAEERLGR 296 (381)
T ss_pred hhhHHHHHH-hCCCCCcCCCH--------HHHHHHHHcccccc-----CCCCC---CCCCHHHHHHHHHHccCcccccCC
Confidence 999999999 99999965321 11111111100000 00000 1123457788887 556677779
Q ss_pred CCHHHHHH
Q 045067 331 PTMIDVAK 338 (347)
Q Consensus 331 Ps~~ell~ 338 (347)
|++.++++
T Consensus 297 ~~~~~~l~ 304 (381)
T cd05626 297 NGADDIKA 304 (381)
T ss_pred CCHHHHhc
Confidence 99999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=321.20 Aligned_cols=251 Identities=16% Similarity=0.186 Sum_probs=195.7
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||+||+|.. .++..+++|.+... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688899999999999999999 45555555555432 1223356789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++....
T Consensus 81 E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999999764 56999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCce-------------------------------------eeccccccCCcccccccccCCCCCccchHHHHHHHHHH
Q 045067 218 EGETY-------------------------------------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQL 260 (347)
Q Consensus 218 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el 260 (347)
..... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 21100 00124589999999999988999999999999999999
Q ss_pred HhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC---HHHHH
Q 045067 261 LSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT---MIDVA 337 (347)
Q Consensus 261 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs---~~ell 337 (347)
+ +|.+||..... ............ ....+ ... ..++.+.+++.+|+. +|.+|++ +.|++
T Consensus 233 ~-~G~~Pf~~~~~--------~~~~~~i~~~~~--~~~~~---~~~---~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 233 L-VGYPPFCSDNP--------QETYRKIINWKE--TLQFP---DEV---PLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred h-cCCCCCCCCCH--------HHHHHHHHcCCC--ccCCC---CCC---CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 9 99999964321 111122111110 00000 000 124467799999996 8999998 88887
Q ss_pred H
Q 045067 338 K 338 (347)
Q Consensus 338 ~ 338 (347)
+
T Consensus 295 ~ 295 (364)
T cd05599 295 S 295 (364)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=307.22 Aligned_cols=266 Identities=21% Similarity=0.304 Sum_probs=206.3
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEeC------CceEEEEEEccC-CCchhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVLP------DRTISVVKFIDG-SVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCL 128 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 128 (347)
+....++|+..+.||+|+||.||+|... +...+++|.... ........+.+|+.++.++ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3344566888899999999999999872 224555555543 3334446688999999999 7999999999999
Q ss_pred eCCccEEEEEeCCCCCHHHHHhhhc-----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCe
Q 045067 129 EVEIPVLVFESAEYGNLHDLLKRSY-----------QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYI 197 (347)
Q Consensus 129 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Ni 197 (347)
.++..+++|||+++|+|.+++.... ......+++..++.++.|++.||+||| +.+|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeE
Confidence 9999999999999999999996531 023456899999999999999999999 99999999999999
Q ss_pred EECCCCceEEecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCC
Q 045067 198 LVSERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG 276 (347)
Q Consensus 198 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~ 276 (347)
+++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++||+++.|..||.....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--- 240 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--- 240 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---
Confidence 99999999999999998765433221 12234567899999998889999999999999999999558888854211
Q ss_pred CCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 277 DESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
.. .......+.... .....+..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 241 -----~~-~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 -----EE-LFKLLKEGYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----HH-HHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 111222111100 01122456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=297.75 Aligned_cols=248 Identities=22% Similarity=0.312 Sum_probs=195.2
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCHH
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLH 146 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 146 (347)
++||+|+||.||+|...++..+++|..... .......+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999855555555555443 3333456889999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeecc
Q 045067 147 DLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG 226 (347)
Q Consensus 147 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 226 (347)
+++... ...+++..+..++.+++.||.|+| +.+++||||+|+||+++.++.++++|||++.............
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 81 SFLRKK----KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 998653 246889999999999999999999 9999999999999999999999999999987654332222222
Q ss_pred ccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCch
Q 045067 227 VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDE 306 (347)
Q Consensus 227 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (347)
..+++.|+|||++.+..++.++||||||+++|++++.|..||..... .. .......... ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------~~-~~~~~~~~~~-----~~~---- 215 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--------QQ-AREQVEKGYR-----MSC---- 215 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------HH-HHHHHHcCCC-----CCC----
Confidence 34567899999999888999999999999999999449999864321 11 1111111110 000
Q ss_pred hhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 307 LLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 307 ~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
....+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 216 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 -PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1123456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=301.07 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=202.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-Cc--eEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DR--TISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~--~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
.++|+..+.||+|+||.||+|.. . ++ .++++|..... .....+.+.+|+.++++++|||++++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 45678889999999999999998 2 22 24555554433 33445678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++++|.+++... ...+++..+..++.+++.||+||| +.+++||||||+||+++.++.++++|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 99999999999999752 256899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceee--ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 216 IPEGETYID--DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 216 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
......... .....++.|+|||++.+..++.++|||||||++||+++.|..||..... ....... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i-~~~~ 227 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAI-NDGF 227 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHH-hcCC
Confidence 643322111 1122356799999998888999999999999999999559999854221 1122221 1111
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
. .+ .....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ~----~~------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 R----LP------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred C----CC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 00 0112345688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=319.35 Aligned_cols=257 Identities=16% Similarity=0.203 Sum_probs=199.4
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
+....++|+..+.||+|+||.||++.. .++..+++|++... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 344557899999999999999999999 55666666665431 12233567899999999999999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.++||||+++|+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 9999999999999999965 45889999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccC----CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTG----YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
+...............||+.|+|||++.+. .++.++||||+||++|+|+ +|.+||..... .......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell-~G~~Pf~~~~~--------~~~~~~i 259 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML-VGDTPFYADSL--------VGTYSKI 259 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHH-hCCCCCCCCCH--------HHHHHHH
Confidence 987654333223456799999999988653 3789999999999999999 99999964321 1222222
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAED--RPTMIDVAKQ 339 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~--RPs~~ell~~ 339 (347)
........ .+. ....+..+.+++.+||+.+|.+ |||+.|+++.
T Consensus 260 ~~~~~~~~-----~p~---~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 260 MDHKNSLN-----FPE---DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HhCCcccC-----CCC---cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 22111000 000 0123456778999999865543 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=299.33 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=204.4
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.++|+..+.||.|+||.||+|...++.+++|+...... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 35688889999999999999998877777777655433 4477999999999999999999999999889999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... ....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 83 AKGSLVDYLRSR---GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999764 2236899999999999999999999 9999999999999999999999999999997763322
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
. ....+..|+|||.+.+..++.++|+||||+++|++++.|..||..... ............ .
T Consensus 157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------~~~~~~~~~~~~-----~ 218 (256)
T cd05039 157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------KDVVPHVEKGYR-----M 218 (256)
T ss_pred c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---------HHHHHHHhcCCC-----C
Confidence 1 234567899999998888999999999999999999559999864321 111111111110 0
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
.. ....++.+.+++.+||..+|++|||+.++++.|+++
T Consensus 219 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EA-----PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CC-----ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00 112245688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=299.26 Aligned_cols=261 Identities=21% Similarity=0.303 Sum_probs=205.7
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccC---CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG---SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||+|.. .++..+++|.... ......+.+.+|+.++++++|+|++++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5788899999999999999999 3555555554432 22233467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ......+++..+..++.+++.||.||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHF-KKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHh-cccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999998753 122356899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... ......+++.|+|||.+.+..++.++|+|||||++|+|+ +|..||.... ......... ...+...
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~------~~~~~~~~~-~~~~~~~-- 226 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA-ALQSPFYGDK------MNLYSLCKK-IEKCDYP-- 226 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH-HCCCCcccCC------ccHHHHHhh-hhcCCCC--
Confidence 3322 122346888999999998888999999999999999999 8899985322 111111111 1111111
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
.. .....+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 227 ---~~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 ---PL----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---CC----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11 01133456889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=317.63 Aligned_cols=253 Identities=15% Similarity=0.184 Sum_probs=193.3
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||+||+|.. .++..+++|++.... ......+.+|+.++.+++||||+++++++.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999998 555666666654321 223356888999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999999764 67999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCc----------------------------------eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhc
Q 045067 218 EGET----------------------------------YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLST 263 (347)
Q Consensus 218 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~ 263 (347)
.... .......||+.|+|||++.+..++.++|||||||++|||+ +
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell-~ 231 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-I 231 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH-h
Confidence 2110 0012357999999999999999999999999999999999 9
Q ss_pred CCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhcc--CCCCCCCCHHHHHHH
Q 045067 264 GEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQS--ASAEDRPTMIDVAKQ 339 (347)
Q Consensus 264 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~--~~P~~RPs~~ell~~ 339 (347)
|..||..... ............ .-.+.+.. ....++.+++.+++. .++..||+++|+++.
T Consensus 232 G~~Pf~~~~~--------~~~~~~i~~~~~-~~~~p~~~-------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 232 GYPPFCSETP--------QETYKKVMNWKE-TLIFPPEV-------PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCCCH--------HHHHHHHHcCcC-cccCCCcC-------CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9999964321 111222211100 00011111 123345677776443 344467999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=301.11 Aligned_cols=256 Identities=21% Similarity=0.316 Sum_probs=201.8
Q ss_pred ccCCCCCeecccCceEEEEEEe--CC--ceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL--PD--RTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~--~~--~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
++|...+.||+|+||.||+|.. .+ ...+++|..... .....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 5678889999999999999987 22 224555554433 333456789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++++|.+++... ...+++.++..++.|++.||.||| +.+++||||||+||+++.++.++++|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999763 256899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCceeec--cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 217 PEGETYIDD--GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 217 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
......... ...++..|+|||++.+..++.++|+||||+++|++++.|..||..... ...... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~-~~~~~- 226 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKA-IEEGY- 226 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHH-HhCCC-
Confidence 543322221 223456899999999888999999999999999998559999864321 111111 11110
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
.. +. ....+..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 227 -~~--~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 -RL--PA------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -cC--CC------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 00 112245678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=322.44 Aligned_cols=252 Identities=18% Similarity=0.203 Sum_probs=199.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|...+.||+|+||+||+|.. .++..+++|.+... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4688889999999999999999 44555555554432 1233467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999999864 67999999999999999999999 9999999999999999999999999999987665
Q ss_pred CCC----------------------------ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccc
Q 045067 218 EGE----------------------------TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFN 269 (347)
Q Consensus 218 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~ 269 (347)
... ........||+.|+|||.+.+..++.++|||||||++|||+ +|+.||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-~g~~Pf~ 231 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML-YGFPPFY 231 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhc-cCCCCCC
Confidence 432 11123456899999999999999999999999999999999 9999996
Q ss_pred cCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 045067 270 MGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-MIDVAKQ 339 (347)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-~~ell~~ 339 (347)
.... ............ ....+.. ...++.+.+++.+||. +|.+||+ +.++++.
T Consensus 232 ~~~~--------~~~~~~i~~~~~--~~~~p~~------~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 232 SDTL--------QETYNKIINWKE--SLRFPPD------PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCH--------HHHHHHHhccCC--cccCCCC------CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4321 111111111000 0000000 0134567899999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=302.90 Aligned_cols=258 Identities=19% Similarity=0.278 Sum_probs=200.7
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCce----EEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRT----ISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|+..+.||+|+||+||+|.+ .++. .+++|... .......+.+.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4577889999999999999997 3332 13445443 3344445678899999999999999999999875 45789
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
++||+++|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 86 VTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999753 256899999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 216 IPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 216 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
....... ......+++.|+|||...+..++.++|||||||++|||++.|.+||..... .........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~~ 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---------REIPDLLEKGER 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---------HHHHHHHHCCCc
Confidence 6533221 112234567899999998889999999999999999999559999864221 111122222111
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.. .....+..+.+++.+||+.||++||++.++++.|+++...
T Consensus 230 ~~----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 230 LP----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 10 0112245678999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=319.81 Aligned_cols=269 Identities=22% Similarity=0.312 Sum_probs=225.7
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV 130 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 130 (347)
-..++|+....+..+.++||-|.||.||.|+| .-...+++|.++.+.. ..++|+.|+.+|+.|.|||+|+++|+|..+
T Consensus 257 Pn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 257 PNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred CCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 34567777777788889999999999999999 5566666676666553 348899999999999999999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
..+||++|||.+|+|.+++... +...++....+.++.||..|+.||. .+++|||||-..|+|+.++..+|++||
T Consensus 336 pPFYIiTEfM~yGNLLdYLRec---nr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLREC---NRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHh---chhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeecc
Confidence 9999999999999999999875 5567888889999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
|+++.+..+......+..-.+.|.|||-+....++.|+|||+|||+|||+.+.|-.||.... +.+ +-..+.
T Consensus 410 GLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lSq-VY~LLE 480 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQ-VYGLLE 480 (1157)
T ss_pred chhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HHH-HHHHHh
Confidence 99999876654433444567899999999999999999999999999999999999986432 122 222222
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.+ -++.++ ..+++.+++|+..||+.+|.+||+++|+-+.|+.++.+
T Consensus 481 kg-------yRM~~P---eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 481 KG-------YRMDGP---EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cc-------ccccCC---CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 21 222222 34577899999999999999999999999999988753
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.01 Aligned_cols=249 Identities=20% Similarity=0.326 Sum_probs=194.1
Q ss_pred eecccCceEEEEEEe---CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCC
Q 045067 69 IITESSIFRLCQGVL---PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGN 144 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~---~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 144 (347)
.||+|+||.||+|.+ +++..+++|+.... .....+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 389999999999987 23444555555443 3333467899999999999999999999885 457899999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceee
Q 045067 145 LHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID 224 (347)
Q Consensus 145 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 224 (347)
|.+++... ...+++..+.+++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSGK----KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 99998652 257899999999999999999999 99999999999999999999999999999876544332211
Q ss_pred --ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 225 --DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 225 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
....+++.|+|||.+.+..++.++|||||||++|++++.|..||..... ..... ....+...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~-~~~~~~~~------- 217 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMS-FIEQGKRL------- 217 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHH-HHHCCCCC-------
Confidence 1223457899999988888999999999999999999559999964321 11221 22211110
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
..+...+.++.+++.+||+.+|++||++.+|.+.|+.+.
T Consensus 218 ---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 218 ---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 011123457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=299.53 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=198.2
Q ss_pred ccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
++|...+.||+|++|.||+|...++..+++|....... ..+.+.+|+.++++++|||++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 45778889999999999999984443344554443322 2367889999999999999999999875 456899999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
+++|.+++... ....+++..+..++.+++.||.||| +.+++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 84 KGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999753 2345889999999999999999999 99999999999999999999999999999976644332
Q ss_pred eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
.......++..|+|||...+..++.++|+||||+++|+|++.|..||..... ..... ....... ..
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~-~~~~~~~-----~~ 223 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLE-QVERGYR-----MP 223 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH-HHHcCCC-----CC
Confidence 2222344677899999998888999999999999999999449999864321 11111 1111110 00
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
.....+..+.+++.+||+.+|++||++.++++.|++
T Consensus 224 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 -----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111235578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=305.88 Aligned_cols=266 Identities=22% Similarity=0.282 Sum_probs=197.2
Q ss_pred CCCCeecccCceEEEEEEe-----CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEEE
Q 045067 65 HYRNIITESSIFRLCQGVL-----PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIPVLV 136 (347)
Q Consensus 65 ~~~~~lg~G~~g~Vy~~~~-----~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 136 (347)
...+.||+|+||+||.+.+ .++..+++|..... .......+.+|+.++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988653 34455555655443 223446788999999999999999999988754 357899
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...
T Consensus 87 ~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 87 MEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999999976 46999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCCce--eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 217 PEGETY--IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 217 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
...... ......++..|+|||.+.+..++.++||||||+++|+|+ +|..||......... ..............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~-tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~ 233 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL-THCDSKQSPPKKFEE---MIGPKQGQMTVVRL 233 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH-hCCCCCCCCcchhhh---hhcccccccchhhh
Confidence 543221 112234566799999998888999999999999999999 898887543210000 00000000000000
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
.+..+..... ......+.++.+++.+||+.+|++|||+.++++.|+++.
T Consensus 234 ~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000000000 011223467889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=303.07 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=201.1
Q ss_pred hccCCCCCeecccCceEEEEEEeCC------ceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPD------RTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
.++|...+.||+|+||.||+|...+ ...+++|... .........+.+|+.++..++||||+++++++..+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4568888999999999999998722 2344444443 33334446788999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEe
Q 045067 134 VLVFESAEYGNLHDLLKRSYQS-----HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLF 208 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 208 (347)
++||||+++|+|.+++...... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 9999999999999999753111 1234788999999999999999999 9999999999999999999999999
Q ss_pred cCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 209 NFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 209 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
|||+++........ ......++..|+|||.+.+..++.++|||||||++||+++.|..||..... .. ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~-~~~ 232 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EE-VLK 232 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--------HH-HHH
Confidence 99998766443221 122345678999999998888999999999999999999449999864321 11 112
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
....+.... .. ...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 233 ~~~~~~~~~-----~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 FVIDGGHLD-----LP-----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHhcCCCCC-----CC-----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 222211111 11 112457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=315.29 Aligned_cols=266 Identities=17% Similarity=0.240 Sum_probs=190.9
Q ss_pred cCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----ccE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE-----IPV 134 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 134 (347)
.|+..+.||+|+||.||+|.. . +..+++|++.... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 367788999999999999998 3 4455555543321 2223356889999999999999999999876432 479
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+||||+. ++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999996 6999998764 56999999999999999999999 9999999999999999999999999999997
Q ss_pred cCCCCCc--eeeccccccCCccccccccc--CCCCCccchHHHHHHHHHHHhcCCCccccCccCCC-------CCchHHH
Q 045067 215 SIPEGET--YIDDGVKGTSGIVAPEYART--GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG-------DESFEMD 283 (347)
Q Consensus 215 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~ 283 (347)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|+ +|++||........ .......
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~-tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHH-cCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6533221 11234578999999998865 67899999999999999999 99999964321000 0000000
Q ss_pred HHHHHHhcc---CcccccCCc-cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 284 FVKKYIENR---GFNGIVDPR-IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 284 ~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
......... ....+.... .......+.....+.+++.+||+.+|++|||++|+++
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000 000000000 0000001122346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=309.50 Aligned_cols=254 Identities=21% Similarity=0.259 Sum_probs=198.0
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCc--------------hhHHHHHHHHHHHHhcCCCcee
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF--------------DAYDCCFNNIVFASQMSHNNVL 121 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv 121 (347)
=.+.-+.|+..+.||+|.||.|-+|.. .++.++++|++.+... ...+...+|+.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 345567899999999999999999999 6777777777665431 1235788999999999999999
Q ss_pred eeeeeeeeC--CccEEEEEeCCCCCHHHHHhhhccCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 045067 122 RLIGCCLEV--EIPVLVFESAEYGNLHDLLKRSYQSHSEP-LLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198 (347)
Q Consensus 122 ~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nil 198 (347)
+|+.+..+. +.+|||+|||..|.+...-.. .+ ++..+++.++.+++.||+||| .+|||||||||+|+|
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d------~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD------KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLL 242 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCC------cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheE
Confidence 999998765 489999999998877554322 34 999999999999999999999 999999999999999
Q ss_pred ECCCCceEEecCCCCccCCCCC----ceeeccccccCCcccccccccC----CCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 199 VSERYVPKLFNFSLSASIPEGE----TYIDDGVKGTSGIVAPEYARTG----YLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 199 l~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
++.+|++||+|||.+.....+. ........|||.|+|||...++ ..+.+.||||+||+||.|+ .|+.||.+
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll-fG~~PF~~ 321 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL-FGQLPFFD 321 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh-hccCCccc
Confidence 9999999999999987653221 1111336799999999988763 2357899999999999999 99999965
Q ss_pred CccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 271 GLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... .....+... ..+.-+.. ++..+.+.+|+.++|++||+.|.+..+|..
T Consensus 322 ~~~--------~~l~~KIvn---------~pL~fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 322 DFE--------LELFDKIVN---------DPLEFPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred chH--------HHHHHHHhc---------CcccCCCc-ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 321 222222221 11111111 134567889999999999999999988754
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=317.24 Aligned_cols=267 Identities=19% Similarity=0.294 Sum_probs=204.5
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEeC------C-ceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeee
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVLP------D-RTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCL 128 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~-~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 128 (347)
++...++|...+.||+|+||.||+|++. . ..+++|++.........+.+.+|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4445566778899999999999999862 2 2455555543333344467899999999997 999999999999
Q ss_pred eCCccEEEEEeCCCCCHHHHHhhhcc------------------------------------------------------
Q 045067 129 EVEIPVLVFESAEYGNLHDLLKRSYQ------------------------------------------------------ 154 (347)
Q Consensus 129 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 154 (347)
..+..++|+||+++|+|.+++.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975311
Q ss_pred ---------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 045067 155 ---------------------------------------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSS 195 (347)
Q Consensus 155 ---------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~ 195 (347)
.....+++..+..++.|++.||+||| +.+++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 01124677888999999999999999 999999999999
Q ss_pred CeEECCCCceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccC
Q 045067 196 YILVSERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL 274 (347)
Q Consensus 196 Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~ 274 (347)
|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++.|..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 999999999999999999765432221 112345678999999998888999999999999999999558888854211
Q ss_pred CCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 275 NGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
..........+.. ... +...+.++.+++.+||+.+|.+||++.||++.|+++.
T Consensus 348 -------~~~~~~~~~~~~~--~~~--------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 -------NEQFYNAIKRGYR--MAK--------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -------hHHHHHHHHcCCC--CCC--------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111121222110 000 1122456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=315.80 Aligned_cols=252 Identities=16% Similarity=0.174 Sum_probs=198.8
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|...+.||+|+||+||++.. .++..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688889999999999999998 455555555554322 223456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 999999999999763 256899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcccccccc------cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYAR------TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
...........||+.|+|||++. +..++.++|||||||++|+|+ +|..||..... ..........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~-~g~~Pf~~~~~--------~~~~~~i~~~ 224 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI-YGRSPFHEGTS--------AKTYNNIMNF 224 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeec-cCCCCCCCCCH--------HHHHHHHHcC
Confidence 54433334457899999999876 456789999999999999999 99999964321 1122222221
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.......+ ....+..+.+++.+||+ +|++|||+.++++
T Consensus 225 ~~~~~~~~--------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 225 QRFLKFPE--------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCccCCCC--------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11110000 01234567899999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=315.97 Aligned_cols=248 Identities=19% Similarity=0.201 Sum_probs=188.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|+..+.||+|+||.||+|.+ .++..+++|... .......+.+.+|+.+++.++|+||+++++++.+++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3455668899999999999998 444444444443 33333446789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+.+|+|.+. ....+..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 154 ~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 154 MDGGSLEGT---------HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred CCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999998643 23556778899999999999999 999999999999999999999999999998765432
Q ss_pred CceeeccccccCCccccccccc-----CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 220 ETYIDDGVKGTSGIVAPEYART-----GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.. ......||..|+|||++.. ...+.++|||||||++|||+ +|+.||..... .. .............
T Consensus 222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~-~g~~pf~~~~~----~~-~~~~~~~~~~~~~- 293 (353)
T PLN00034 222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFY-LGRFPFGVGRQ----GD-WASLMCAICMSQP- 293 (353)
T ss_pred cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHH-hCCCCCCCCCC----cc-HHHHHHHHhccCC-
Confidence 21 1234578999999998743 34457899999999999999 99999973211 11 1111111111000
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+ ........++.+++.+||+.||++|||+.|+++.
T Consensus 294 -----~-----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 -----P-----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -----C-----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111234568899999999999999999999863
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=306.60 Aligned_cols=260 Identities=22% Similarity=0.308 Sum_probs=199.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc-e--EEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR-T--ISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~-~--~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 136 (347)
++|+..+.||+|+||.||+|.+ .++ . +++++............+.+|+.++.++ +||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5678889999999999999998 333 2 3444433333334446788999999999 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 137 FESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
+||+++|+|.+++..... .....+++..+..++.|++.||+||| +.+++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence 999999999999975321 11235889999999999999999999 9999999999999999999999
Q ss_pred EEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 206 KLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
||+|||++....... ......++..|+|||.+.+..++.++|||||||++|||++.|..||..... ....
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~ 233 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELY 233 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HHHH
Confidence 999999986432111 111223467899999998888999999999999999999449999864221 1111
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
.. ...... ... ....+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 234 ~~-~~~~~~-----~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 234 EK-LPQGYR-----LEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HH-HhcCCc-----CCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 111100 000 01124467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=299.68 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=203.4
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
..++|...+.||+|+||.||+|...++..+++|.+..... ..+.+.+|+.++++++|||++++++++.+....+++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 3467888899999999999999985545555565554332 236789999999999999999999999988899999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++... ....+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 83 ~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 83 MSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred cCCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999763 2346899999999999999999999 999999999999999999999999999998776543
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
.........++..|+|||.+.+..++.++|+||+|+++|++++.|+.||..... ............ ...
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~---~~~ 225 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERGYR---MPR 225 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC---CCC
Confidence 222222334567899999999888999999999999999999559999964321 111122111100 000
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
+ ...+.++.+++.+||+.+|++||++.++.+.|++
T Consensus 226 -----~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 -----P---PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----C---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0 1124568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=305.45 Aligned_cols=266 Identities=21% Similarity=0.306 Sum_probs=200.8
Q ss_pred hccCCCCCeecccCceEEEEEEeCC-----------------ceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceee
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPD-----------------RTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLR 122 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~ 122 (347)
.++|+..+.||+|+||.||+|...+ ...+++|.... ......+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568888999999999999998721 12345555443 33345577899999999999999999
Q ss_pred eeeeeeeCCccEEEEEeCCCCCHHHHHhhhccC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 045067 123 LIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQS------HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSY 196 (347)
Q Consensus 123 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~N 196 (347)
+++++..+...++++||+++++|.+++...... ....+++..+..++.|++.||+||| +.+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence 999999999999999999999999999764211 1126899999999999999999999 9999999999999
Q ss_pred eEECCCCceEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhc-CCCccccCccC
Q 045067 197 ILVSERYVPKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLST-GEDLFNMGLRL 274 (347)
Q Consensus 197 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~-g~~p~~~~~~~ 274 (347)
|+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++. +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876543322 122334567899999999888899999999999999999842 6677753211
Q ss_pred CCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 275 NGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
..................... .....+.++.+++.+||+.+|++|||+.||++.|+
T Consensus 240 ----~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 ----QQVIENAGHFFRDDGRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ----HHHHHHHHhccccccccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111111111000000 01122457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=300.08 Aligned_cols=257 Identities=22% Similarity=0.301 Sum_probs=202.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CC---ceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PD---RTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~---~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
++|...+.||+|+||.||+|.+ +. ...+++|...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577888999999999999997 22 2334444444333 4455779999999999999999999998875 557899
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|.+++... ...+++..+..++.+++.||+||| +.+++||||||+||+++.++.++++|||++...
T Consensus 85 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 85 MELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999763 245899999999999999999999 999999999999999999999999999998776
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
............++..|+|||.+.+..++.++||||||+++||+++.|..||..... ...... ...+...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~-~~~~~~~- 227 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--------NDVIGR-IENGERL- 227 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHH-HHcCCcC-
Confidence 544333233344567899999988888999999999999999999669999964322 111111 1111100
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
.. ....+..+.+++.+||..+|++|||+.++++.|+++..
T Consensus 228 ----~~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 ----PM-----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ----CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 11234568899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=305.55 Aligned_cols=251 Identities=19% Similarity=0.232 Sum_probs=195.9
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
+|+..+.||+|+||+||++.. .++..+++|.+.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999998 445444445443321 1222457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++|+|.+++... ....+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999988653 2246899999999999999999999 99999999999999999999999999999877543
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
... .....|++.|+|||++.+..++.++||||+||++|||+ +|+.||..... ...............
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~-~g~~pf~~~~~-----~~~~~~~~~~~~~~~----- 221 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMI-EGKSPFRQRKE-----KVKREEVERRVKEDQ----- 221 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHH-HCCCCCCCCch-----hhHHHHHHHHhhhcc-----
Confidence 322 12356899999999998889999999999999999999 89999974221 111111111111110
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
.......+..+.+++.+||+.||++|| ++.++++
T Consensus 222 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 ------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 001112345678999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=305.68 Aligned_cols=265 Identities=18% Similarity=0.283 Sum_probs=205.5
Q ss_pred HHhccCCCCCeecccCceEEEEEEe--------CCceEEEEEEccC-CCchhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL--------PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCL 128 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 128 (347)
...++|...+.||+|+||.||+|.. ..+..+++|.... ......+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3456788889999999999999975 1123455555443 2334456789999999999 8999999999999
Q ss_pred eCCccEEEEEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCe
Q 045067 129 EVEIPVLVFESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYI 197 (347)
Q Consensus 129 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Ni 197 (347)
.....+++|||+++|+|.+++..... .....+++.++..++.|++.||.||| +.+++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence 99999999999999999999976311 11245788999999999999999999 99999999999999
Q ss_pred EECCCCceEEecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCC
Q 045067 198 LVSERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG 276 (347)
Q Consensus 198 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~ 276 (347)
+++.++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|++++.|..||....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 99999999999999998765432221 2234467789999999888899999999999999999955888885321
Q ss_pred CCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 277 DESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
....... ....... .. ....+..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 245 ----~~~~~~~-~~~~~~~--~~--------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 ----VEELFKL-LKEGHRM--DK--------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ----HHHHHHH-HHcCCcC--CC--------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1122222 2221110 00 11234568899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=302.77 Aligned_cols=261 Identities=21% Similarity=0.268 Sum_probs=204.1
Q ss_pred ccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||+|.. ++..+++|+..... .....+.+.+|+.+++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677888999999999999997 44455555443322 2233467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++... ......+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHF-KKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHh-hccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999998753 112356899999999999999999999 9999999999999999999999999999987664
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
..... .....++..|+|||.+.+..++.++|+||||+++|+|+ +|..||..... ......... ...
T Consensus 158 ~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~------~~~~~~~~~-~~~----- 223 (267)
T cd08229 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA-ALQSPFYGDKM------NLYSLCKKI-EQC----- 223 (267)
T ss_pred cCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHH-hCCCCcccccc------hHHHHhhhh-hcC-----
Confidence 33221 23356889999999998888999999999999999999 89999853211 111111111 111
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
..+.. .....+..+.+++.+||+.+|++|||+.+|.+.++++.
T Consensus 224 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 DYPPL----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCC----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11111 11234557889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.16 Aligned_cols=261 Identities=21% Similarity=0.334 Sum_probs=203.2
Q ss_pred HHhccCCCCCeecccCceEEEEEEe------CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL------PDRTISVVKFID-GSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV 130 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 130 (347)
...++|...+.||+|+||.||+|.. .....+++|... .......+.+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 3446788999999999999999975 122234444443 33334456789999999999 799999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
+..+++|||+++|+|.+++... ....+++.++..++.+++.||.||| +.+++|+||||+||+++.++.++++||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~---~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCC
Confidence 9999999999999999999753 1234899999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 211 SLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 211 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
|++......... ......++..|+|||.+.+..++.++||||+||++|+|++.|.+||..... . .......
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-------~-~~~~~~~ 257 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-------D-SKFYKLI 257 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-------h-HHHHHHH
Confidence 999766543321 122334678899999999889999999999999999999449999864321 1 1111122
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
..+... . .....+.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 258 ~~~~~~-----~-----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEGYRM-----A-----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcCCcC-----C-----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 211100 0 0112245688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=302.69 Aligned_cols=259 Identities=20% Similarity=0.308 Sum_probs=198.5
Q ss_pred ccCCCCCeecccCceEEEEEEe-----CCce-EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-----PDRT-ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~-~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|+..+.||+|+||.||+|.. ..+. +++|+............+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577788999999999999985 1234 444444433333444678899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC
Q 045067 136 VFESAEYGNLHDLLKRSYQ------------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY 203 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~ 203 (347)
||||+++++|.+++..... .....+++.....++.+++.||.||| +.+++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 9999999999999853210 01235788999999999999999999 99999999999999999999
Q ss_pred ceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH
Q 045067 204 VPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282 (347)
Q Consensus 204 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~ 282 (347)
.+||+|||+++........ ......++..|+|||++.+..++.++|+|||||++|||++.|.+||..... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------Q 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 9999999999776433221 122344577899999998888999999999999999999549989853211 1
Q ss_pred HHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 283 DFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
.. ........... .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 234 ~~-~~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EV-IEMVRKRQLLP----------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH-HHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 11111111110 011224567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.49 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=195.6
Q ss_pred CeecccCceEEEEEEe--CC--ceEEEEEEccCCCc-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL--PD--RTISVVKFIDGSVF-DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~--~~--~~~~v~k~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||.||+|.+ .+ ...+++|....... ...+.+.+|+.++++++|||++++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 4699999999999987 22 24555555554432 34467899999999999999999999876 4567999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ..+++..+..++.|++.||+||| ..+++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999864 47899999999999999999999 999999999999999999999999999999876543322
Q ss_pred ee--ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 223 ID--DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 223 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
.. ....++..|+|||.+.+..++.++||||||+++|++++.|.+||..... .... .........
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~-~~~~~~~~~----- 217 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVI-AMLESGERL----- 217 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHH-HHHHcCCcC-----
Confidence 11 1223456899999998889999999999999999999449999964321 1111 122221110
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
......+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 218 -----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 -----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011123456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=298.79 Aligned_cols=258 Identities=22% Similarity=0.356 Sum_probs=198.2
Q ss_pred CCCCCeecccCceEEEEEEe-C-C---ceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc-----
Q 045067 64 YHYRNIITESSIFRLCQGVL-P-D---RTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI----- 132 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~-~---~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 132 (347)
|...+.||+|+||.||+|.. . + ..+++|++.... .....+.+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 45678899999999999998 2 2 234455443322 22334678999999999999999999998876554
Q ss_pred -cEEEEEeCCCCCHHHHHhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 133 -PVLVFESAEYGNLHDLLKRSYQ-SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 133 -~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
.++++||+++|+|.+++..... .....+++..+..++.|++.||.||| +.+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 7999999999999999865321 12346899999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 211 SLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 211 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++.|.+||..... .......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~~~- 228 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYDYL- 228 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-
Confidence 9998765433221 11233567899999998889999999999999999999459999864321 1122221
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
..+.... . +...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 229 ~~~~~~~-----~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHGNRLK-----Q-----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcCCCCC-----C-----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2111111 0 112345788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=314.19 Aligned_cols=241 Identities=15% Similarity=0.153 Sum_probs=191.0
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYG 143 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 143 (347)
+.||+|+||.||++.. .++..+++|++... .......+.+|+.++..++||||+++.+++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999998 45555555555432 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 144 NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 144 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
+|.+++... ..+++..+..++.|++.||.||| + .+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 151 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA- 151 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-
Confidence 999998764 57899999999999999999999 7 7999999999999999999999999999875432221
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++|||||||++|+|+ +|..||..... ....... ..... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-tG~~Pf~~~~~--------~~~~~~i-~~~~~------~~ 215 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDH--------EKLFELI-LMEEI------RF 215 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeec-cCCCCCCCCCH--------HHHHHHH-hcCCC------CC
Confidence 123456999999999999999999999999999999999 99999964221 1111111 11110 00
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
+.....++.+++.+||+.||++|+ ++.++++
T Consensus 216 -----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 -----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 011244678999999999999996 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=310.68 Aligned_cols=240 Identities=20% Similarity=0.244 Sum_probs=187.8
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||.||+|.. .++..+++|.+... .....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999998 45555555554432 122335566777777654 899999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 9999999764 57899999999999999999999 9999999999999999999999999999987643322 2
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++|||||||++|||+ +|..||..... ........... +..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell-~G~~Pf~~~~~--------~~~~~~i~~~~-------~~~ 215 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEML-IGQSPFHGEDE--------DELFDSILNDR-------PHF 215 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHcCC-------CCC
Confidence 233467999999999999989999999999999999999 89999964321 11222211110 000
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTMI-DVA 337 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~-ell 337 (347)
+.....++.+++.+||+.+|++||++. +++
T Consensus 216 -----~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 -----PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 112244677999999999999999875 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=297.42 Aligned_cols=256 Identities=18% Similarity=0.225 Sum_probs=189.7
Q ss_pred CeecccCceEEEEEEeCC----ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCC
Q 045067 68 NIITESSIFRLCQGVLPD----RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYG 143 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~----~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 143 (347)
+.||+|+||.||+|...+ ..+++|++...........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998722 2345555443333333457889999999999999999999999989999999999999
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee
Q 045067 144 NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223 (347)
Q Consensus 144 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 223 (347)
+|.+++...........++..+..++.|++.||+||| +.+++|+||||+||+++.++.++++|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997642222335677888899999999999999 9999999999999999999999999999987554332221
Q ss_pred -eccccccCCcccccccccC-------CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 224 -DDGVKGTSGIVAPEYARTG-------YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 224 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.....++..|+|||++.+. .++.++|+||||+++|||++.|..||..... . ......... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-------~-~~~~~~~~~-~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-------E-QVLTYTVRE-QQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-------H-HHHHHHhhc-ccC
Confidence 2234578889999987642 3578999999999999999559999964321 0 111111111 111
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
...++.+. ......+.+++..|| .+|++|||+.||+..|+
T Consensus 229 ~~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLK-----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccC-----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11122211 112345778999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=300.52 Aligned_cols=264 Identities=19% Similarity=0.313 Sum_probs=205.7
Q ss_pred hccCCCCCeecccCceEEEEEEeCC-----ceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeee-CCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPD-----RTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE-VEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 133 (347)
.++|+..++||+|+||.||+|.+.. +..+++|.... ......+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999833 45555555443 334445778999999999999999999998776 4678
Q ss_pred EEEEEeCCCCCHHHHHhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQS---HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
++++||+++++|.+++...... ....+++..+..++.+++.||+||| +.+++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998753111 1246899999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 211 SLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 211 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
|+++.+....... .....++..|+|||++.+..++.++|||||||++||+++.|++||..... ... ....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~-~~~~ 232 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEM-AAYL 232 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHH-HHHH
Confidence 9998664433221 22344677899999998888999999999999999999449999964321 111 1222
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
..+.. ... ....+..+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 233 ~~~~~--~~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 233 KDGYR--LAQ--------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HcCCC--CCC--------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 22110 000 012245678999999999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=297.76 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=198.0
Q ss_pred ccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeee-eCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCL-EVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 140 (347)
++|...+.||+|+||.||+|...+..+++|...... ..+.+.+|+.++++++|+|++++++++. .++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 467888999999999999998887776666543322 2367899999999999999999999764 456789999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... ....+++..+..++.+++.||+||| +.+++||||||+||+++.++.+|++|||++.......
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 83 AKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999763 2245889999999999999999999 9999999999999999999999999999987543322
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
....++..|+|||++.+..++.++|||||||++|+|++.|+.||.... ....... ...+.. +
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~-~~~~~~-----~ 218 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPR-VEKGYK-----M 218 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHH-HhcCCC-----C
Confidence 123456789999999888899999999999999999955999985321 1111111 111110 0
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
. .....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 219 ~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 D-----APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred C-----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0 1112345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=317.17 Aligned_cols=259 Identities=16% Similarity=0.207 Sum_probs=200.7
Q ss_pred HHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 045067 55 KELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV 130 (347)
Q Consensus 55 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 130 (347)
.++....++|+..+.||+|+||.||++.. .++..+++|++... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34455568899999999999999999999 56666666665432 122335578899999999999999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
+..++||||+++|+|.+++.. ..++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999999975 45888999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccC----CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTG----YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
|++...............||+.|+|||++.+. .++.++|||||||++|||+ +|.+||..... .....
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell-~G~~Pf~~~~~--------~~~~~ 257 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYADSL--------VGTYS 257 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHH-hCCCCCCCCCH--------HHHHH
Confidence 99987654333333456799999999988653 3789999999999999999 89999964321 12222
Q ss_pred HHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 045067 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAED--RPTMIDVAKQ 339 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~--RPs~~ell~~ 339 (347)
..........+.+ ....+..+.+++.+||+.++.+ ||++.++++.
T Consensus 258 ~i~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 258 KIMNHKNSLTFPD--------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHcCCCcccCCC--------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 2222111101100 1123456789999999844433 7889888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=298.35 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=196.1
Q ss_pred CCCCeecccCceEEEEEEe-CCce--EEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC------Ccc
Q 045067 65 HYRNIITESSIFRLCQGVL-PDRT--ISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV------EIP 133 (347)
Q Consensus 65 ~~~~~lg~G~~g~Vy~~~~-~~~~--~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 133 (347)
...+.||+|+||.||+|.+ .++. .+++|..... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999998 3332 3455544432 233457789999999999999999999987532 256
Q ss_pred EEEEEeCCCCCHHHHHhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQ-SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
++++||+++|+|.+++..... .....+++.....++.|++.||+||| +.+|+||||||+|||++.++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999998753211 12245899999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 213 SASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 213 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
++......... .....+++.|++||...+..++.++||||||+++|||++.|..||..... .. .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~-~~~~~~~ 229 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SE-IYDYLRQ 229 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HH-HHHHHHc
Confidence 98765433221 12234677899999999899999999999999999999448999864221 11 1222222
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
+.... . ....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ~~~~~--~--------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNRLK--Q--------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCC--C--------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 21110 0 112244678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=297.06 Aligned_cols=251 Identities=20% Similarity=0.208 Sum_probs=198.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC-----chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV-----FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|...+.||+|++|.||+|.. .++..+++|...... ....+.+.+|+.++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788899999999999999998 444555555443221 1123568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
++||+++++|.+++... ..++...+..++.+++.||.||| +.+++||||+|+||+++.++.++|+|||++..
T Consensus 82 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999999764 56889999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceee--ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 216 IPEGETYID--DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 216 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
......... ....++..|+|||.+.+..++.++||||+|+++|+|+ +|..||..... . ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~-------~-~~~~~~~~~~~ 224 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEML-TEKPPWAEFEA-------M-AAIFKIATQPT 224 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHH-hCCCCccccch-------H-HHHHHHhccCC
Confidence 543221111 2345788999999999988999999999999999999 89999864321 1 11111111111
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
. +.+ .......+.+++.+||+.+|.+|||+.++++.
T Consensus 225 -~----~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -N----PQL-----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -C----CCC-----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0 111 11234567899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=311.86 Aligned_cols=244 Identities=17% Similarity=0.213 Sum_probs=189.9
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHH---HhcCCCceeeeeeeeeeCCccEEE
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFA---SQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
|...+.||+|+||.||+|.. .++..+++|..... .....+.+.+|+.++ +.++||||+++++++.+++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 55678999999999999998 44555555554432 122335677776665 466799999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|...+.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999998865 57999999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..... ......|++.|+|||.+.+..++.++|||||||++|+|+ +|..||..... ............
T Consensus 152 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~G~~pf~~~~~--------~~~~~~i~~~~~--- 218 (324)
T cd05589 152 MGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML-VGESPFPGDDE--------EEVFDSIVNDEV--- 218 (324)
T ss_pred CCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhCCC---
Confidence 32221 223467999999999999999999999999999999999 89999964321 122222222110
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
.. +...+..+.+++.+||+.||++|| ++.++++
T Consensus 219 ----~~-----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ----RY-----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CC-----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00 112245678999999999999999 4666554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=312.22 Aligned_cols=241 Identities=19% Similarity=0.189 Sum_probs=191.2
Q ss_pred CeecccCceEEEEEEe----CCceEEEEEEccCC----CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 68 NIITESSIFRLCQGVL----PDRTISVVKFIDGS----VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~----~~~~~~v~k~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+.||+|+||.||++.. ..+..+++|++... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999986 23455555655432 112235578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999999764 56888899999999999999999 999999999999999999999999999998754332
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
.. ......||+.|+|||++.+..++.++|||||||++|||+ +|..||..... .......... ..
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~G~~pf~~~~~--------~~~~~~~~~~-~~----- 217 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDML-TGAPPFTAENR--------KKTIDKILKG-KL----- 217 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHh-cCCCCCCCCCH--------HHHHHHHHcC-CC-----
Confidence 22 223457999999999999888999999999999999999 99999964321 1122222211 10
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
.+ +...+..+.+++.+||+.+|++|| ++.++++
T Consensus 218 -~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 -NL-----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CC-----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 00 111244678999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=311.51 Aligned_cols=236 Identities=19% Similarity=0.259 Sum_probs=188.4
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||+||+|.. .++..+++|.+... .....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999998 55555555555432 223346678898888876 699999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~- 151 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence 9999999764 57999999999999999999999 99999999999999999999999999999875432221
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++||||+||++|+|+ +|+.||..... .......... .. ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~Pf~~~~~--------~~~~~~i~~~-~~---~~~-- 216 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEML-CGHAPFEAENE--------DDLFEAILND-EV---VYP-- 216 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHh-hCCCCCCCCCH--------HHHHHHHhcC-CC---CCC--
Confidence 223457999999999999999999999999999999999 89999964321 1222222211 10 001
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTM 333 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~ 333 (347)
...+.++.+++.+||+.||++||++
T Consensus 217 ------~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 ------TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1224567899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=306.18 Aligned_cols=249 Identities=17% Similarity=0.214 Sum_probs=197.3
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.+|+..+.||+|+||.||+|.. .++..+++|..........+.+.+|+.+++.++|||++++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4688888999999999999997 444444444444333334477899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++.. ..+++.++..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 99999999965 45889999999999999999999 9999999999999999999999999999987654322
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
.. .....+++.|+|||.+.+..++.++|||||||++|+|+ +|+.||..... .... ....... . +
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~-~g~~pf~~~~~-------~~~~-~~~~~~~-~-----~ 234 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENP-------LRAL-YLIATNG-T-----P 234 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHH-hCCCCCCCCCH-------HHhH-HHHhcCC-C-----C
Confidence 11 22346889999999998888999999999999999999 99999964321 1111 1111111 0 0
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+. ........+.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 235 ELQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCC---CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 010 11223456789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=296.53 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=199.7
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|+..+.||+|++|.||+|+. .++..+++|..... .....+.+.+|+.++++++|||++++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467788999999999999999 44555555544322 234457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++... ....+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQ---RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999764 2357899999999999999999999 999999999999999999999999999998766543
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
... .....|++.|+|||+..+..++.++|+|||||++++|+ +|+.||..... ........ .+....
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~--------~~~~~~~~-~~~~~~--- 220 (256)
T cd08529 155 TNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECC-TGKHPFDANNQ--------GALILKII-RGVFPP--- 220 (256)
T ss_pred cch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHH-cCCCCC---
Confidence 322 23356889999999999989999999999999999999 89999964321 11111211 111111
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ....+..+.+++.+||+.+|++||++.++++
T Consensus 221 --~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 --V-----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred --C-----ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 0 1123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.36 Aligned_cols=263 Identities=27% Similarity=0.388 Sum_probs=205.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
...|...++||+|+||.||+|.. .++..+++|....... ....|+..+++++||||++++++|.+++..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577888999999999999998 4444444444433221 123568899999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++|+|.++++ .++|..+.+++.|++.||+|||+.++.+|+||||||+||+++.++.+++. ||.+.....
T Consensus 765 ~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 765 IEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT- 834 (968)
T ss_pred CCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-
Confidence 99999999994 38899999999999999999997666799999999999999999888876 665433221
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
.....+|+.|+|||++.+..++.++|||||||++|||+ +|+.||.... +.......|.+............|
T Consensus 835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~-tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 906 (968)
T PLN00113 835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL-TGKSPADAEF---GVHGSIVEWARYCYSDCHLDMWID 906 (968)
T ss_pred ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHH-hCCCCCCccc---CCCCcHHHHHHHhcCccchhheeC
Confidence 12236789999999999999999999999999999999 8999985432 222334455544444333444455
Q ss_pred CccCCc-hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 300 PRIIGD-ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 300 ~~~~~~-~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
+.+... ........++.+++.+||+.+|++||||.|+++.|+++.+
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 554322 1223455678899999999999999999999999999865
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=298.71 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=201.6
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
..++|...+.||+|+||.||+|...++..+++|...... ...+.+.+|+.++++++|+||+++++++.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 346788889999999999999988554445555554432 234678899999999999999999999887 778999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++... ....+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 82 MAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred CCCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999763 2356788999999999999999999 999999999999999999999999999998766543
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
.........++..|+|||++.+..++.++|+|||||++|++++.|..||..... .. .......+...
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~-~~~~~~~~~~~---- 222 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PE-VIRALERGYRM---- 222 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--------HH-HHHHHhCCCCC----
Confidence 322223344667899999999888999999999999999999449999964321 11 11111221110
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
+ .....+.++.+++.+||+++|++||++.++.+.|++
T Consensus 223 ~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 223 P------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred C------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 011234568899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=305.48 Aligned_cols=264 Identities=20% Similarity=0.285 Sum_probs=204.5
Q ss_pred hccCCCCCeecccCceEEEEEEeC--------CceEEEEEEccCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLP--------DRTISVVKFIDGS-VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV 130 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 130 (347)
.++|...+.||+|+||.||+|... ....+++|..... .......+.+|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467899999999999999999861 1124555555433 334456788999999999 799999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill 199 (347)
...++||||+++|+|.+++..... .....+++.+++.++.|++.||+||| +.+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 999999999999999999976311 11235889999999999999999999 9999999999999999
Q ss_pred CCCCceEEecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCC
Q 045067 200 SERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278 (347)
Q Consensus 200 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~ 278 (347)
+.++.++|+|||.+.......... .....+++.|+|||.+.+..++.++|+||+||++|+|++.|..||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence 999999999999987654322111 1223345789999999888899999999999999999955888885321
Q ss_pred chHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
... ........... ..+...+.++.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 248 --~~~-~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 --VEE-LFKLLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred --HHH-HHHHHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111 11122221110 01112345788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=311.17 Aligned_cols=241 Identities=17% Similarity=0.243 Sum_probs=190.4
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCC-ceeeeeeeeeeCCccEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHN-NVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 137 (347)
+|+..+.||+|+||.||+|.. .++..+++|++... .....+.+..|..++..++|+ +|+.+++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477889999999999999998 45555555554432 223446788899999999765 6888999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 999999999999764 56899999999999999999999 9999999999999999999999999999986533
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... ......||+.|+|||++.+..++.++||||+||++|+|+ +|+.||..... .......... .
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell-tG~~pf~~~~~--------~~~~~~i~~~-~---- 217 (324)
T cd05587 153 FGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQPPFDGEDE--------DELFQSIMEH-N---- 217 (324)
T ss_pred CCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHcC-C----
Confidence 2221 123457999999999999999999999999999999999 89999964321 1122222111 1
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM 333 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~ 333 (347)
... +...+..+.+++.+||+.+|++|++.
T Consensus 218 --~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 --VSY-----PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCC-----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 000 11224467899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.57 Aligned_cols=258 Identities=20% Similarity=0.290 Sum_probs=201.9
Q ss_pred ccCCCCCeecccCceEEEEEEe------CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL------PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
.+|...+.||+|+||.||++.. ..+..+++|..........+.+.+|+.+++.++||||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 3567788999999999999974 2345666666665555556789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhcc----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 136 VFESAEYGNLHDLLKRSYQ----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
++||+++++|.+++..... .....+++..+..++.|++.||+||| +.+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence 9999999999999975310 01135889999999999999999999 9999999999999999999999
Q ss_pred EEecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 206 KLFNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
+|+|||++.......... .....+++.|+|||.+.+..++.++|||||||++|||++.|.+||..... ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~ 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------TEA 233 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------HHH
Confidence 999999987654332211 12234578899999999899999999999999999999449999864321 111
Q ss_pred HHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 285 VKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
.......... ..+ ...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 234 ~~~~~~~~~~---~~~--------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 IECITQGREL---ERP--------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHcCccC---CCC--------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111111110 001 122456789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=318.03 Aligned_cols=252 Identities=18% Similarity=0.173 Sum_probs=193.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|...+.||+|+||.||++.. .++..+++|.+... .....+.+.+|+.++.+++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688889999999999999998 45555555544322 1233466889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999999764 67899999999999999999999 9999999999999999999999999999986332
Q ss_pred CCCc------------e----------------------------------eeccccccCCcccccccccCCCCCccchH
Q 045067 218 EGET------------Y----------------------------------IDDGVKGTSGIVAPEYARTGYLNEKCDVY 251 (347)
Q Consensus 218 ~~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 251 (347)
.... . ......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 1000 0 00124689999999999988999999999
Q ss_pred HHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCC-
Q 045067 252 SFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDR- 330 (347)
Q Consensus 252 s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~R- 330 (347)
||||++|||+ +|.+||..... ............ .+.-+ . ....+.++.+++.+|+. +|.+|
T Consensus 233 SlGvil~ell-tG~~Pf~~~~~--------~~~~~~i~~~~~--~~~~p---~---~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 233 SLGAIMFECL-IGWPPFCSENS--------HETYRKIINWRE--TLYFP---D---DIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred ecchhhhhhh-cCCCCCCCCCH--------HHHHHHHHccCC--ccCCC---C---CCCCCHHHHHHHHHHhc-CHhhcC
Confidence 9999999999 99999964321 111111111100 00000 0 01224567899999997 66665
Q ss_pred --CCHHHHHHH
Q 045067 331 --PTMIDVAKQ 339 (347)
Q Consensus 331 --Ps~~ell~~ 339 (347)
+|+.|+++.
T Consensus 295 ~r~~~~~~l~h 305 (377)
T cd05629 295 GRGGAHEIKSH 305 (377)
T ss_pred CCCCHHHHhcC
Confidence 599988763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=325.78 Aligned_cols=261 Identities=18% Similarity=0.213 Sum_probs=202.4
Q ss_pred HHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 045067 55 KELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE 131 (347)
Q Consensus 55 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 131 (347)
.+.....++|...+.||+|+||+||+|.. .++..+++|.+... .......+.+|+..+..++|+|++++++.+....
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34455668999999999999999999998 44554555544332 2334466889999999999999999988765432
Q ss_pred --------ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC
Q 045067 132 --------IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY 203 (347)
Q Consensus 132 --------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~ 203 (347)
.+++||||+++|+|.+++... ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~-~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSR-AKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNG 180 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHh-hccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCC
Confidence 368999999999999999753 123356899999999999999999999 99999999999999999999
Q ss_pred ceEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH
Q 045067 204 VPKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282 (347)
Q Consensus 204 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~ 282 (347)
.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+ +|+.||.... ..
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLl-tG~~Pf~~~~--------~~ 251 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL-TLKRPFDGEN--------ME 251 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCCC--------HH
Confidence 999999999876543221 1223467999999999999999999999999999999999 8999996421 11
Q ss_pred HHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 283 DFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
......... ... + .+...++++.+++.+||+.+|.+|||+.++++.
T Consensus 252 ~~~~~~~~~-~~~----~------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 252 EVMHKTLAG-RYD----P------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHhcC-CCC----C------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 222222211 111 0 111234568899999999999999999999763
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=311.06 Aligned_cols=241 Identities=17% Similarity=0.231 Sum_probs=190.9
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
++||+|+||.||+|.. .++..+++|.+... .....+.+..|..++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999998 45555555554432 223345677899998866 799999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 9999998764 57899999999999999999999 99999999999999999999999999999875432222
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++||||+||++|+|+ +|+.||..... ............ ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~-tg~~Pf~~~~~--------~~~~~~i~~~~~----~~p-- 216 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMM-AGQPPFEADNE--------DDLFESILHDDV----LYP-- 216 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHh-cCCCCCCCCCH--------HHHHHHHHcCCC----CCC--
Confidence 223456899999999999889999999999999999999 89999964321 122222222110 001
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCC-------CHHHHHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRP-------TMIDVAK 338 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-------s~~ell~ 338 (347)
...+.++.+++.+||+.+|++|| ++.++++
T Consensus 217 ------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 ------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 11245678999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=298.73 Aligned_cols=255 Identities=19% Similarity=0.249 Sum_probs=189.0
Q ss_pred eecccCceEEEEEEe-C--CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCC
Q 045067 69 IITESSIFRLCQGVL-P--DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGN 144 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~-~--~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 144 (347)
.||+|+||.||+|.. . ....+++|..... .......+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 589999999999976 2 2234455544333 33344668899999999999999999999999999999999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee-
Q 045067 145 LHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI- 223 (347)
Q Consensus 145 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 223 (347)
|.+++...........++.....++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999997642222234567888999999999999999 9999999999999999999999999999986543322111
Q ss_pred eccccccCCcccccccc-------cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 224 DDGVKGTSGIVAPEYAR-------TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 224 ~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.....+++.|+|||+.. ...++.++|||||||++|||++.|..||..... ............ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~~~-~~ 229 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--------EQVLKQVVREQD-IK 229 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhhccC-cc
Confidence 12344677899999864 245688999999999999999558889864321 112222222211 11
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
...+.+ ....+..+.+++..|| .+|++|||+++|++.|.
T Consensus 230 ~~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 1123445678888998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.64 Aligned_cols=263 Identities=20% Similarity=0.287 Sum_probs=201.3
Q ss_pred HHhccCCCCCeecccCceEEEEEEeC------CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVLP------DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE 131 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 131 (347)
...++|+..+.||+|+||.||+|... .+..+++|..... .......+.+|+.+++.++||||+++++++.++.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999752 1234455544433 2333356889999999999999999999999999
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceE
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQS-----HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPK 206 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~k 206 (347)
..++||||+++|+|.+++...... .....++..+..++.|++.||.||| +++++||||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999753110 1234567788999999999999999 99999999999999999999999
Q ss_pred EecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 207 LFNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 207 l~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
++|||+++......... .....++..|+|||.+.++.++.++|+|||||++|||++.+..||..... ....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~~~ 231 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVL 231 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence 99999987654332211 12234567899999998888999999999999999999558889864221 1122
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
......+ ... . ....++.+.+++.+||+.+|++|||+.++++.|++.
T Consensus 232 ~~~~~~~-~~~-----~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 232 KFVMDGG-YLD-----Q-----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHcCC-CCC-----C-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 2221111 110 0 011235688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.81 Aligned_cols=247 Identities=13% Similarity=0.192 Sum_probs=190.3
Q ss_pred ecccCceEEEEEEe-CC-ceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 70 ITESSIFRLCQGVL-PD-RTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 70 lg~G~~g~Vy~~~~-~~-~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
||+|+||+||++.. .+ ..+++|++..... ....+.+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999998 34 4555555443221 22335678899999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeec
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 225 (347)
.+.+... ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......... ..
T Consensus 81 ~~~~~~~-~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 155 (280)
T cd05608 81 RYHIYNV-DEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TK 155 (280)
T ss_pred HHHHHhc-cccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-cc
Confidence 9887542 112356899999999999999999999 999999999999999999999999999998765443221 23
Q ss_pred cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCc
Q 045067 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGD 305 (347)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (347)
...||+.|+|||++.+..++.++|||||||++|+|+ +|+.||...... ............ ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~-~g~~pf~~~~~~----~~~~~~~~~~~~---------~~~--- 218 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMI-AARGPFRARGEK----VENKELKQRILN---------DSV--- 218 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHH-hCCCCCCCCCcc----hhHHHHHHhhcc---------cCC---
Confidence 457899999999999999999999999999999999 899999643210 000111111110 000
Q ss_pred hhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 306 ELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 306 ~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
......+..+.+++.+||+.||++|| +++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 01112345688999999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=317.68 Aligned_cols=250 Identities=16% Similarity=0.181 Sum_probs=191.3
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.|+..+.||+|+||+||+|.. .++..+++|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999998 555555555554321 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++|+|.+++.+. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999999764 56889999999999999999999 99999999999999999999999999999753210
Q ss_pred CC----------------------------------------------ceeeccccccCCcccccccccCCCCCccchHH
Q 045067 219 GE----------------------------------------------TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYS 252 (347)
Q Consensus 219 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 252 (347)
.. ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 00011246899999999999999999999999
Q ss_pred HHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC
Q 045067 253 FGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT 332 (347)
Q Consensus 253 ~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs 332 (347)
+||++|||+ +|++||..... ............ .. .... ....++++.+++.+|+ .+|++|++
T Consensus 234 lGvil~ell-tG~~Pf~~~~~--------~~~~~~i~~~~~--~~---~~p~---~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 234 VGVILYEML-VGQPPFLAQTP--------LETQMKVINWQT--SL---HIPP---QAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred chHHHHHHH-hCCCCCCCCCH--------HHHHHHHHccCC--Cc---CCCC---cccCCHHHHHHHHHHc-cCHhHcCC
Confidence 999999999 89999964321 111111111000 00 0000 0122445677887765 59999997
Q ss_pred ---HHHHHH
Q 045067 333 ---MIDVAK 338 (347)
Q Consensus 333 ---~~ell~ 338 (347)
+.++++
T Consensus 296 ~~~~~ei~~ 304 (382)
T cd05625 296 KNGADEIKA 304 (382)
T ss_pred CCCHHHHhc
Confidence 777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=300.68 Aligned_cols=246 Identities=15% Similarity=0.199 Sum_probs=189.1
Q ss_pred ecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 70 ITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 70 lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
||+|+||.||++.. .++..+++|.+... .......+..|+.++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999998 44554544444321 112234566799999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeec
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 225 (347)
.+++... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~ 152 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--IT 152 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--ee
Confidence 9988653 2345889999999999999999999 99999999999999999999999999999876654322 23
Q ss_pred cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCc
Q 045067 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGD 305 (347)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (347)
...|++.|+|||++.+..++.++||||+||++|||+ +|..||..... ............. ... . .
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~-~g~~p~~~~~~----~~~~~~~~~~~~~-~~~----~--~--- 217 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV-AGRTPFKDHKE----KVAKEELKRRTLE-DEV----K--F--- 217 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHH-hCCCCCCCCcc----hhhHHHHHHHhhc-ccc----c--c---
Confidence 356899999999998888999999999999999999 89999864321 0001111111111 100 0 0
Q ss_pred hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 306 ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 306 ~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.....+.++.+++.+||+.||++||++.|+++.
T Consensus 218 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 218 -EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred -ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 001234567899999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=300.28 Aligned_cols=264 Identities=22% Similarity=0.245 Sum_probs=199.2
Q ss_pred ccCCCCCeecccCceEEEEEEe-----CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--Ccc
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-----PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIP 133 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 133 (347)
..|...+.||+|+||.||.+.+ .++..+++|... .......+.+.+|+.++++++|||++++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467888999999999999984 234445555444 33344456799999999999999999999998875 568
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++||||+++++|.+++... ...+++..+..++.+++.||+||| +.+++||||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccc
Confidence 9999999999999999653 246899999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCce--eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCC------CCCchHHHHH
Q 045067 214 ASIPEGETY--IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN------GDESFEMDFV 285 (347)
Q Consensus 214 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~ 285 (347)
......... ......++..|+|||.+.+..++.++|||||||++|+|+ ++..|+....... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ell-t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL-TYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhh-cCCCCCccccchhhhhcccccccccHHHH
Confidence 876543221 122345677899999998888999999999999999999 6665543221100 0000111111
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
......+.... .....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLP----------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCC----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111111100 0112345788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=300.42 Aligned_cols=259 Identities=19% Similarity=0.284 Sum_probs=200.6
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-----CceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-----DRTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-----~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
+++|...+.||+|+||.||+|.+ . .+..+++|...... ......+.+|+.++++++||||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 46788889999999999999999 3 34566666655433 33345689999999999999999999999998999
Q ss_pred EEEEEeCCCCCHHHHHhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC---ceEEe
Q 045067 134 VLVFESAEYGNLHDLLKRSYQ--SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY---VPKLF 208 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~---~~kl~ 208 (347)
++||||+++++|.+++..... .....+++..+..++.|++.||+||| +.+++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999976421 11235899999999999999999999 99999999999999998654 58999
Q ss_pred cCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 209 NFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 209 Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++.|..||..... ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~~~ 233 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVMEF 233 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH
Confidence 999998764322211 11223356899999999889999999999999999999569999964321 111111
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
....... . .+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 234 ~~~~~~~-~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGRL-D----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCcC-C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111110 0 01122456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=296.36 Aligned_cols=250 Identities=18% Similarity=0.185 Sum_probs=198.7
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
+|+..+.||+|+||.||++.. .++..+++|.+. .......+.+.+|+.++++++||||+++++++.+++.+++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 467788999999999999998 444444555443 333344577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++|+|.+++... ....++......++.+++.||.||| +.+++|+||||+||+++.++.++++|||++.......
T Consensus 81 ~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999999998653 2356889999999999999999999 9999999999999999999999999999987654322
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
. ......+++.|+|||++.+..++.++|+||||+++|+|+ +|..||..... ........ .+.... .
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~-~g~~p~~~~~~--------~~~~~~~~-~~~~~~-~-- 220 (255)
T cd08219 155 A-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELC-TLKHPFQANSW--------KNLILKVC-QGSYKP-L-- 220 (255)
T ss_pred c-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehh-hccCCCCCCCH--------HHHHHHHh-cCCCCC-C--
Confidence 2 123456889999999999888999999999999999999 89999964221 11222221 111111 0
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+...+..+.+++.+||+.+|++|||+.+++..
T Consensus 221 -------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -------PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -------CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=298.66 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=202.2
Q ss_pred ccCCCCCeecccCceEEEEEEeC------CceEEEEEEccCCCch-hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 62 NNYHYRNIITESSIFRLCQGVLP------DRTISVVKFIDGSVFD-AYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~~v~k~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
++|+..+.||+|+||.||+|+.. +...+++|........ ..+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999972 2345666665544333 4567999999999999999999999999989999
Q ss_pred EEEEeCCCCCHHHHHhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 135 LVFESAEYGNLHDLLKRSYQS----HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
+||||+++|+|.+++...... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999764110 0126899999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
|++...............++..|+|||.+.+..++.++||||||+++|++++.|..||..... ...... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~~-~~ 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLNR-LQ 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHHH-HH
Confidence 998655433222223445678899999988888899999999999999999558889854211 111111 11
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
........ ....+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 233 ~~~~~~~~---------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 AGKLELPV---------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred cCCcCCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111000 0122456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=307.94 Aligned_cols=241 Identities=21% Similarity=0.240 Sum_probs=188.7
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||+||+|.. .++..+++|.+.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999998 455555555544321 22335567788888764 899999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 9999999764 57899999999999999999999 99999999999999999999999999999875432221
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++||||+||++|||+ +|..||..... ........... +..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~-~G~~pf~~~~~--------~~~~~~i~~~~-------~~~ 215 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML-IGQSPFHGHDE--------EELFQSIRMDN-------PCY 215 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhCC-------CCC
Confidence 123456899999999999989999999999999999999 89999964321 11111111111 111
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTMI-DVAK 338 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~-ell~ 338 (347)
+.....++.+++.+||+.+|++||++. ++.+
T Consensus 216 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 -----PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -----CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 011234578999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=301.94 Aligned_cols=260 Identities=24% Similarity=0.371 Sum_probs=201.2
Q ss_pred hccCCCCCeecccCceEEEEEEeC------CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLP------DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
.++|+..+.||+|+||.||+|... ++..+++|..... .......+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888899999999999999862 2445555555443 333446789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhcc-----------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQ-----------------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSY 196 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~N 196 (347)
++++||+++|+|.+++..... .....+++..++.++.|++.||+||| +.+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 999999999999999975310 11234788899999999999999999 9999999999999
Q ss_pred eEECCCCceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCC
Q 045067 197 ILVSERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN 275 (347)
Q Consensus 197 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~ 275 (347)
|+++.++.++|+|||++......... .......++.|+|||.+.+..++.++|||||||++|+|++.|..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999998765433211 112234567899999998889999999999999999999558888753211
Q ss_pred CCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 276 GDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
..... ....+.... .....+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 239 ------~~~~~-~~~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ------EEVIY-YVRDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHH-HHhcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 12222 222221110 011234568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.67 Aligned_cols=249 Identities=18% Similarity=0.211 Sum_probs=197.1
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
|+..+.||+|+||.||+|.. .++..+++|..........+.+.+|+.+++.++|||++++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 45567899999999999999 55667777776655545557789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
++|.+++.+. ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 87 ~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 87 GAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 9999988652 257899999999999999999999 99999999999999999999999999999876543221
Q ss_pred eeccccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 223 IDDGVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
......+++.|+|||++. +..++.++|+||+||++|+|+ +|.+||..... ............
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~-~g~~p~~~~~~--------~~~~~~~~~~~~---- 225 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNP--------MRVLLKIAKSEP---- 225 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc-cCCCCccccCH--------HHHHHHHhhcCC----
Confidence 123356899999999874 446788999999999999999 89999864221 111222211111
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+... .....+..+.+++.+||+.+|.+|||+.++++
T Consensus 226 --~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 226 --PTLA---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 01122456889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.36 Aligned_cols=258 Identities=17% Similarity=0.265 Sum_probs=198.5
Q ss_pred cCCCCCeecccCceEEEEEEe-CC-----ceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PD-----RTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~-----~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
+|...+.||+|+||.||+|.. .+ +..+++|...... ....+.+.+|+.++..++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 355567899999999999987 21 3445555554333 3334668899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhc-----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc
Q 045067 136 VFESAEYGNLHDLLKRSY-----------QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV 204 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~ 204 (347)
++||+++++|.+++.... ......+++..+..++.|++.||.||| +.+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence 999999999999985321 011235888899999999999999999 999999999999999999999
Q ss_pred eEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 205 PKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++.|..||..... ..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~ 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------QD 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence 999999998766433221 122344678999999998888999999999999999999558888864211 12
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
...... ...... .....+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 235 ~~~~i~-~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIR-NRQVLP----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHH-cCCcCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222222 111110 011234568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=296.39 Aligned_cols=252 Identities=23% Similarity=0.408 Sum_probs=192.8
Q ss_pred CeecccCceEEEEEEe-C---CceEEEEEEc-cCCCchhHHHHHHHHHHHHhcCCCceeeeeeeee-eCCccEEEEEeCC
Q 045067 68 NIITESSIFRLCQGVL-P---DRTISVVKFI-DGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCL-EVEIPVLVFESAE 141 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~---~~~~~v~k~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 141 (347)
+.||+|+||.||+|.+ + ....+++|.. ........+.+.+|+.+++.++||||+++++++. .+...++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 3689999999999987 2 2334455544 3333344567889999999999999999999776 4556899999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
+|+|.+++.+. ....++..+..++.+++.||+||| +.+++||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999999763 244677888999999999999999 99999999999999999999999999999876543221
Q ss_pred ee---eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 222 YI---DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 222 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
.. .....++..|+|||.+.+..++.++|||||||++|||++.|.+||..... ............
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~----- 220 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVYLLQGRR----- 220 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhcCCC-----
Confidence 11 12334677899999998888999999999999999999557777753211 111222211110
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
...+ ...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 221 ---~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 ---LLQP---EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---CCCC---CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0001 1124568899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=298.31 Aligned_cols=256 Identities=20% Similarity=0.283 Sum_probs=199.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc---eEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR---TISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~---~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
++|...+.||+|+||.||+|.. .++ ..+++|..... .....+.+.+|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 3467788999999999999998 322 23455554433 344457899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++++|.+++... ...+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++++|||++...
T Consensus 84 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 84 TEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999999999753 256899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCcee--eccc--cccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 217 PEGETYI--DDGV--KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 217 ~~~~~~~--~~~~--~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
....... .... ..+..|+|||.+.+..++.++||||+||++||+++.|..||..... ....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------~~~~~~i-~~~ 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVINAI-EQD 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------HHHHHHH-HcC
Confidence 4322211 1111 1245799999999889999999999999999998569999864321 1111111 111
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
. .... ..+.+..+.+++.+||+.+|++||++.+++..|+++
T Consensus 228 ~-------~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 Y-------RLPP---PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C-------cCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0000 112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=309.47 Aligned_cols=241 Identities=17% Similarity=0.242 Sum_probs=190.9
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 137 (347)
+|...+.||+|+||.||+|.. .++..+++|.+.... ....+.+..|..++..+ +||+|+.+++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477889999999999999998 455555555544321 22335577788888877 5899999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+.+... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 999999999998764 56899999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... ......||+.|+|||++.+..++.++|||||||++|||+ +|+.||..... .......... ..
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell-tg~~Pf~~~~~--------~~~~~~i~~~-~~--- 218 (323)
T cd05616 153 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQAPFEGEDE--------DELFQSIMEH-NV--- 218 (323)
T ss_pred CCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhC-CC---
Confidence 2221 223457999999999999999999999999999999999 89999964321 1122222111 10
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM 333 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~ 333 (347)
.. +...+.++.+++.+||+.+|.+|++.
T Consensus 219 ---~~-----p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 ---AY-----PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CC-----CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 11234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=296.78 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=194.1
Q ss_pred CeecccCceEEEEEEe-CCce--EEEEEEccC-CCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRT--ISVVKFIDG-SVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~--~~v~k~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||.||+|.. +++. .+++|.... ......+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 3689999999999998 3332 244454443 3334446788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 143 GNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 143 g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
|+|.+++..... .....+++.++..++.|++.||+||| +.+++||||||+||+++.++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence 999999975321 11235789999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
++....... .......+..|+|||++.+..++.++|||||||++|||++.|..||..... ....... ..
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~-~~ 226 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKL-PQ 226 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHH-hC
Confidence 985322111 111223456799999998888999999999999999999559999854221 1111111 11
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
.... .. ....+.++.+++.+||+.+|.+|||+.+++..|+++.
T Consensus 227 ~~~~-----~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GYRL-----EK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCC-----CC-----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1000 00 1122346789999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=304.89 Aligned_cols=266 Identities=21% Similarity=0.322 Sum_probs=197.4
Q ss_pred ccCCCCCeecccCceEEEEEEeCC---------------ceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeee
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPD---------------RTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIG 125 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~ 125 (347)
++|...+.||+|+||.||++...+ ...+++|..... .....+.+.+|+.++.+++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 468888999999999999987621 123445544433 3344567899999999999999999999
Q ss_pred eeeeCCccEEEEEeCCCCCHHHHHhhhcc-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 045067 126 CCLEVEIPVLVFESAEYGNLHDLLKRSYQ-------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198 (347)
Q Consensus 126 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nil 198 (347)
++...+..++||||+++++|.+++..... .....+++..++.++.+++.||+||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 99999999999999999999999865210 01124788999999999999999999 999999999999999
Q ss_pred ECCCCceEEecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHh-cCCCccccCccCCC
Q 045067 199 VSERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS-TGEDLFNMGLRLNG 276 (347)
Q Consensus 199 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~-~g~~p~~~~~~~~~ 276 (347)
++.++.+||+|||++.......... .....++..|+|||.+.++.++.++|+|||||++|+|++ .+..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 9999999999999987654332211 122345778999999888889999999999999999983 25667754221
Q ss_pred CCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 277 DESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
................ ..... ..+..+..+.+++.+||+.+|++|||+++|++.|++
T Consensus 239 --~~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 --EQVIENTGEFFRNQGR-QIYLS------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHHHhhhhccc-cccCC------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 0011111111111100 00000 011124568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=299.06 Aligned_cols=264 Identities=21% Similarity=0.287 Sum_probs=197.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-----CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-----PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE--VEIPV 134 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 134 (347)
++|...+.||+|+||.||+|.. .++..+++|..........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999984 2344555555554444445788999999999999999999998754 34688
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+|+||+++|+|.+++.+. ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++.
T Consensus 84 lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred EEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 999999999999999753 246899999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCceee--ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccC-----CC--CCchHHHHH
Q 045067 215 SIPEGETYID--DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL-----NG--DESFEMDFV 285 (347)
Q Consensus 215 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~-----~~--~~~~~~~~~ 285 (347)
.......... ....++..|+|||.+.+..++.++|||||||++|||+ ++..++...... .. .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF-TYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHh-hcCCcCCCcchhhhhhcccccccccchHHH
Confidence 7654332211 1223445699999998888999999999999999999 665554332110 00 000000111
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
......... .. .....+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 236 ~~~~~~~~~-------~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGR-------LP---APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCc-------CC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111100 00 0112345688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=315.17 Aligned_cols=262 Identities=19% Similarity=0.193 Sum_probs=193.6
Q ss_pred cCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----ccE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE-----IPV 134 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 134 (347)
+|+..+.||+|+||.||+|.. . +..+|+|++.... .....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999998 4 4455555543321 2233467889999999999999999999998776 789
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+|+||+. ++|.+.+... ..+++..+..++.|++.||.||| +.+++||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999997 5888888653 67999999999999999999999 9999999999999999999999999999997
Q ss_pred cCCCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCC---------CCCchHHHH
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN---------GDESFEMDF 284 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~---------~~~~~~~~~ 284 (347)
..............+++.|+|||.+.+. .++.++||||+||++|||+ +|++||....... +... ...+
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~i~~~~g~~~-~~~~ 229 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL-GRRILFQAQSPIQQLDLITDLLGTPS-LEAM 229 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHH-cCCCCCCCCCHHHHHHHHHHHcCCCC-HHHH
Confidence 6544333223345678999999988764 5799999999999999999 9999997532200 0000 0000
Q ss_pred ------HHHHHhccCcccccCCccCC-chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 285 ------VKKYIENRGFNGIVDPRIIG-DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 285 ------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........... .+.... ........+++.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 230 RSACEGARAHILRGPHK---PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHhhHHHHHHHHhCCCC---CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000000000 000000 0001122456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=309.03 Aligned_cols=241 Identities=20% Similarity=0.248 Sum_probs=190.8
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||+||+|.. .++..+++|.+... .....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999 44555555554432 123345678899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 9999998764 57999999999999999999999 99999999999999999999999999999865332221
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++|||||||++|+|+ +|+.||..... .......... .. ..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~-~G~~pf~~~~~--------~~~~~~i~~~-~~------~~ 215 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEML-AGQSPFEGDDE--------DELFQSILED-EV------RY 215 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHh-hCCCCCCCCCH--------HHHHHHHHcC-CC------CC
Confidence 123356899999999999999999999999999999999 89999964321 1111111111 10 00
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTM-----IDVAK 338 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~-----~ell~ 338 (347)
+...+..+.+++.+||+.||++|||+ .++++
T Consensus 216 -----~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 -----PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -----CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11224567899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=313.60 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=214.1
Q ss_pred cCCCCCeecccCceEEEEEEe-C---Cc--eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-P---DR--TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~---~~--~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.....++||.|-||.||+|++ + +. .||||......+.+..+.|+.|..+|++++||||++++|+|.+ ...|||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 344557899999999999999 2 22 3455555555666667899999999999999999999999976 678999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
||.++.|.|..+++.+ ...++......++.|+..||+||| +..+|||||-..|||+.....+|++|||+++.+
T Consensus 469 mEL~~~GELr~yLq~n----k~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 469 MELAPLGELREYLQQN----KDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EecccchhHHHHHHhc----cccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 9999999999999873 467999999999999999999999 999999999999999999999999999999999
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.....+..+...-++.|||||.+.-+.++.++|||-|||.+||+++.|.-||..-.. .+.. ..+.+
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN--sDVI-------~~iEn----- 607 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN--SDVI-------GHIEN----- 607 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc--cceE-------EEecC-----
Confidence 887776666666788999999999999999999999999999999999999975332 1100 00011
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
..++ ..++.+++.++.|+.+||.++|.+||.+.++...|.++..
T Consensus 608 --GeRl---P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 608 --GERL---PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --CCCC---CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1122 2334567789999999999999999999999999999875
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=321.02 Aligned_cols=261 Identities=16% Similarity=0.239 Sum_probs=189.9
Q ss_pred HhccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-------
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV------- 130 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 130 (347)
..++|...+.||+|+||.||+|.. + +..+|+|++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 346799999999999999999998 4 4556666654332 2345799999999999999998876432
Q ss_pred -CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-ceEEe
Q 045067 131 -EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLF 208 (347)
Q Consensus 131 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~-~~kl~ 208 (347)
..+++||||+++ +|.+++... ......+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHY-ARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence 246799999985 788777542 123367999999999999999999999 99999999999999999665 79999
Q ss_pred cCCCCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 209 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
|||+|+....... .....||+.|+|||++.+ ..++.++||||+||++|||+ +|.+||...... . .......
T Consensus 214 DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell-tG~~pf~~~~~~----~-~~~~i~~ 285 (440)
T PTZ00036 214 DFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI-LGYPIFSGQSSV----D-QLVRIIQ 285 (440)
T ss_pred ccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCChH----H-HHHHHHH
Confidence 9999987654322 223568999999998765 46899999999999999999 999999753220 0 0000000
Q ss_pred HHhc----------cCcccccCCccCCch----hhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 288 YIEN----------RGFNGIVDPRIIGDE----LLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 288 ~~~~----------~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.... ..+..+.-+.+.... .+...+.++.+|+.+||+++|.+|||+.|+++
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000 000011011111000 01123457889999999999999999999984
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=308.35 Aligned_cols=240 Identities=19% Similarity=0.214 Sum_probs=188.2
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||.||+|.. .++..+++|.+.... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999 455555555544321 22335677888888765 899999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++........
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN- 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-
Confidence 9999998764 57899999999999999999999 99999999999999999999999999999865322221
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++||||+||++|||+ +|..||..... ....... .... +..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~-~g~~Pf~~~~~--------~~~~~~~-~~~~------~~~ 215 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML-IGQSPFHGDDE--------DELFESI-RVDT------PHY 215 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHH-hCCCCCCCCCH--------HHHHHHH-HhCC------CCC
Confidence 223467999999999999999999999999999999999 89999964321 1111111 1110 111
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTMI-DVA 337 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~-ell 337 (347)
. .....++.+++.+||+.||++||++. +++
T Consensus 216 ~-----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 P-----RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C-----CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 11244678999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=303.84 Aligned_cols=264 Identities=20% Similarity=0.302 Sum_probs=203.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe--------CCceEEEEEEccCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL--------PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLE 129 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 129 (347)
..++|...+.||+|+||.||+|.. .....+++|..... .......+.+|+.+++++ +||||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 345678889999999999999975 12344555555433 334456788999999999 69999999999999
Q ss_pred CCccEEEEEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 045067 130 VEIPVLVFESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198 (347)
Q Consensus 130 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nil 198 (347)
....+++|||+++|+|.+++..... .....+++..+..++.|++.||.||| +.|++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEE
Confidence 8999999999999999999976311 11245889999999999999999999 999999999999999
Q ss_pred ECCCCceEEecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCC
Q 045067 199 VSERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD 277 (347)
Q Consensus 199 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~ 277 (347)
++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|+|++.|..||.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---- 242 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---- 242 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH----
Confidence 9999999999999997664322211 11223456899999998889999999999999999999558888854211
Q ss_pred CchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 278 ESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
.... .....+.... .....+.++.+++.+||+.+|++|||+.++++.|+++..
T Consensus 243 ----~~~~-~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 243 ----EELF-KLLREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ----HHHH-HHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111 1112211100 011224467899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=297.61 Aligned_cols=251 Identities=18% Similarity=0.243 Sum_probs=195.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|+..+.||+|+||.||+|.. .++..+++|..... .....+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577888999999999999998 55555555555433 333446789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|..+ ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 81 MDGGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred CCCCChHHh---------hcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999998654 24678889999999999999999 999999999999999999999999999998765432
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
. .....+|..|+|||.+.+..++.++|+|||||++|+|+ +|..||.......... .......... ... .
T Consensus 149 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~-~g~~pf~~~~~~~~~~-~~~~~~~~~~-~~~-----~ 217 (279)
T cd06619 149 I---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELA-LGRFPYPQIQKNQGSL-MPLQLLQCIV-DED-----P 217 (279)
T ss_pred c---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHH-hCCCCchhhccccccc-chHHHHHHHh-ccC-----C
Confidence 1 23357899999999999889999999999999999999 8999986532211111 1111111111 111 1
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+.... ...+.++.+++.+||+.+|++||++.|+++.
T Consensus 218 ~~~~~----~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 218 PVLPV----GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCC----CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111 1123467899999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.12 Aligned_cols=240 Identities=20% Similarity=0.310 Sum_probs=187.6
Q ss_pred CeecccCceEEEEEEeCC-------------ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 68 NIITESSIFRLCQGVLPD-------------RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~-------------~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
+.||+|+||.||+|++.. ...+++|............+.+|+.+++.++||||+++++++.++...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998621 1235556555544444567889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc-------eEE
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV-------PKL 207 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~-------~kl 207 (347)
++|||+++|+|..++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +++
T Consensus 81 lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 999999999999988652 256899999999999999999999 999999999999999987664 899
Q ss_pred ecCCCCccCCCCCceeeccccccCCcccccccc-cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 208 FNFSLSASIPEGETYIDDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
+|||++...... ....++..|+|||.+. +..++.++|||||||++|||+++|..||..... ... .
T Consensus 154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~-~ 219 (262)
T cd05077 154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEK-E 219 (262)
T ss_pred CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHH-H
Confidence 999988655322 2245788999999876 567899999999999999998678888864221 000 1
Q ss_pred HHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
... .... . ... .....+.+++.+||+.||++||++.+|++.|
T Consensus 220 ~~~-~~~~-~-----~~~-----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 RFY-EGQC-M-----LVT-----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHH-hcCc-c-----CCC-----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 111 1110 0 000 1134678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=308.48 Aligned_cols=243 Identities=20% Similarity=0.234 Sum_probs=190.0
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||.||+|.. .++..+++|++.... ....+.+.+|+.++.++ +||||+.+++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999998 555666666555432 23345688999999888 699999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|..++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 151 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD- 151 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence 9999998764 57999999999999999999999 99999999999999999999999999999875332211
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++|||||||++|+|+ +|..||...... .................. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell-~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~------~~ 222 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM-AGRSPFDIITDN--PDMNTEDYLFQVILEKPI------RI 222 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHH-hCCCCCCccCCC--cccccHHHHHHHHHhCCC------CC
Confidence 123467999999999999999999999999999999999 899999643221 111112222222222111 00
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTM 333 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~ 333 (347)
+...+..+.+++.+||+.||++||++
T Consensus 223 -----p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 -----PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -----CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 11123457799999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=301.66 Aligned_cols=251 Identities=17% Similarity=0.195 Sum_probs=199.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
+.|+..+.||.|+||.||+|.. .++..+++|..........+.+.+|+.+++.++|||++++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 5678888999999999999999 556677777766655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|..++.+. ...+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++.......
T Consensus 92 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 92 PGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 999999887652 256899999999999999999999 9999999999999999999999999999886543321
Q ss_pred ceeeccccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 221 TYIDDGVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
. ......+++.|+|||++. ...++.++|+|||||++|+|+ +|.+||..... ...........
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~-~g~~p~~~~~~--------~~~~~~~~~~~--- 231 (292)
T cd06644 165 Q-RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNP--------MRVLLKIAKSE--- 231 (292)
T ss_pred c-ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHh-cCCCCCccccH--------HHHHHHHhcCC---
Confidence 1 123356888999999874 345688999999999999999 99999854221 11111111111
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+... .....+.++.+++.+||+.+|++||++.++++
T Consensus 232 ---~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 ---PPTLS---QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---CccCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01111 11123446789999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=295.57 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=197.9
Q ss_pred ccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
.+|+..+.||+|+||.||+|.+.++..+++|....... ....+.+|+.++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 45777889999999999999984333444444443322 23578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
+++|.+++... ...+++..+..++.+++.||+||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999998752 246889999999999999999999 99999999999999999999999999999876543322
Q ss_pred eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
.......++..|+|||.+.++.++.++||||+|+++|||++.|..||..... .......... .....+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~---~~~~~~~ 224 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETINAG---FRLYKPR 224 (256)
T ss_pred cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHhCC---CCCCCCC
Confidence 2222334567899999998888999999999999999999459999864321 1122221111 1111121
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
. .+..+.+++.+||+.+|++|||+.++++.|
T Consensus 225 ~--------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 L--------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred C--------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1 235688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=300.88 Aligned_cols=266 Identities=19% Similarity=0.320 Sum_probs=199.4
Q ss_pred ccCCCCCeecccCceEEEEEEeC-----------------CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeee
Q 045067 62 NNYHYRNIITESSIFRLCQGVLP-----------------DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRL 123 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 123 (347)
++|+..+.||+|+||.||++... +...+++|..... .....+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998541 2334556655543 33345678999999999999999999
Q ss_pred eeeeeeCCccEEEEEeCCCCCHHHHHhhhccC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCe
Q 045067 124 IGCCLEVEIPVLVFESAEYGNLHDLLKRSYQS------HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYI 197 (347)
Q Consensus 124 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Ni 197 (347)
++++..++..+++|||+++|+|.+++...... ....+++.++..++.|++.||+||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 99999999999999999999999999763211 1134778899999999999999999 99999999999999
Q ss_pred EECCCCceEEecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHh-cCCCccccCccCC
Q 045067 198 LVSERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS-TGEDLFNMGLRLN 275 (347)
Q Consensus 198 ll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~-~g~~p~~~~~~~~ 275 (347)
+++.++.++|+|||++.......... .....+++.|++||...++.++.++|+|||||++|||++ .+..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 99999999999999987654332211 122344678999998888889999999999999999993 27788754321
Q ss_pred CCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 276 GDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
................. ...+. ....+..+.+++.+||+.||++|||+.+|++.|++
T Consensus 240 ---~~~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 ---EQVIENTGEFFRDQGRQ-VYLPK------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHHHhhcccc-ccCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00111111111111100 00000 11224568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=302.39 Aligned_cols=240 Identities=21% Similarity=0.283 Sum_probs=186.5
Q ss_pred eecccCceEEEEEEe--CC-----------------------ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeee
Q 045067 69 IITESSIFRLCQGVL--PD-----------------------RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRL 123 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~--~~-----------------------~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 123 (347)
.||+|+||.||+|.+ ++ ...+++|............+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999985 11 12355566555444444678899999999999999999
Q ss_pred eeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC
Q 045067 124 IGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY 203 (347)
Q Consensus 124 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~ 203 (347)
++++.++...++||||+++|+|..++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccC
Confidence 99999999999999999999999998652 256899999999999999999999 99999999999999997643
Q ss_pred -------ceEEecCCCCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCC
Q 045067 204 -------VPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN 275 (347)
Q Consensus 204 -------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~ 275 (347)
.++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||++.+|..||.....
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-- 227 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-- 227 (274)
T ss_pred cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh--
Confidence 3799999987544322 12357788999998765 56899999999999999996589999864322
Q ss_pred CCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 276 GDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
.. ........ ..... .....+.+++.+||+.+|++|||+.++++.|+
T Consensus 228 ----~~---~~~~~~~~-------~~~~~-----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 ----SE---KERFYEKK-------HRLPE-----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ----HH---HHHHHHhc-------cCCCC-----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00 01111110 00111 11235789999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=303.00 Aligned_cols=250 Identities=18% Similarity=0.233 Sum_probs=198.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
.++|+..+.||+|+||.||+|.. .++..+++|..........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35788889999999999999997 44444444444443333446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++.+ ..+++..+..++.+++.||.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 98 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 999999999965 46889999999999999999999 999999999999999999999999999998765433
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
... .....+++.|+|||...+..++.++|+|||||++|+++ +|..||........ .......+ .
T Consensus 169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~-tg~~pf~~~~~~~~--------~~~~~~~~------~ 232 (297)
T cd06656 169 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV-EGEPPYLNENPLRA--------LYLIATNG------T 232 (297)
T ss_pred ccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCcchh--------eeeeccCC------C
Confidence 221 23356888999999999888999999999999999999 89999964322000 00000000 0
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.. ......+..+.+++.+||+.+|++|||+.++++
T Consensus 233 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 PEL---QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 011223456789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=303.10 Aligned_cols=257 Identities=16% Similarity=0.200 Sum_probs=199.3
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|+..+.||+|+||.||++.+ .++.++++|..... .......+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999998 56666777766543 233345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
+++++|.+++... ..+++..+..++.|++.||.||| + .+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 81 MDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999764 67899999999999999999999 6 5899999999999999999999999999865533
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc----
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF---- 294 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 294 (347)
.. .....++..|+|||.+.+..++.++|+||||+++|+|+ +|+.||...... ...............
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~-~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 153 SM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMA-IGRYPIPPPDAK-----ELEAMFGRPVSEGEAKESH 223 (308)
T ss_pred cc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHH-hCCCCCCCcchh-----hHHHhhcCccccccccCCc
Confidence 21 23456889999999988888999999999999999999 999998643210 000000000000000
Q ss_pred -----------------------ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 295 -----------------------NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 295 -----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
..-..+.... .....++.+++.+||+.+|++|||+.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS----GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcC----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000001000 0124468899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=316.04 Aligned_cols=252 Identities=17% Similarity=0.179 Sum_probs=193.2
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||+|.. .++..+++|.+.... ....+.+.+|+.++++++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688899999999999999998 555556666554321 123356889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|....
T Consensus 81 E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 999999999999764 56889999999999999999999 9999999999999999999999999999975321
Q ss_pred CC------------------------------------------CceeeccccccCCcccccccccCCCCCccchHHHHH
Q 045067 218 EG------------------------------------------ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGL 255 (347)
Q Consensus 218 ~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~ 255 (347)
.. .........||+.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 00 000011346999999999999999999999999999
Q ss_pred HHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC---C
Q 045067 256 LLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP---T 332 (347)
Q Consensus 256 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP---s 332 (347)
++|||+ +|+.||..... ................ + . ....+.++.+++.+|+ .+|.+|+ |
T Consensus 233 ilyell-~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~--~---~---~~~~s~~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 233 ILYEML-VGQPPFLADTP--------AETQLKVINWETTLHI--P---S---QAKLSREASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred eeeehh-hCCCCCCCCCH--------HHHHHHHhccCccccC--C---C---CCCCCHHHHHHHHHHh-cCHhhcCCCCC
Confidence 999999 99999965321 1111111110000000 0 0 0112345677888876 5999999 8
Q ss_pred HHHHHHH
Q 045067 333 MIDVAKQ 339 (347)
Q Consensus 333 ~~ell~~ 339 (347)
+.++++.
T Consensus 295 ~~ell~h 301 (376)
T cd05598 295 ADEIKAH 301 (376)
T ss_pred HHHHhCC
Confidence 8888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=292.86 Aligned_cols=252 Identities=28% Similarity=0.395 Sum_probs=199.6
Q ss_pred CeecccCceEEEEEEeC-C---ceEEEEEEccCCCch-hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVLP-D---RTISVVKFIDGSVFD-AYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~-~---~~~~v~k~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||.||+|... . +..+++|........ ..+.+.+|+..++.++|+|++++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999993 2 455555555544322 357899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 143 GNLHDLLKRSYQS----HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 143 g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
++|.+++...... ....+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999763100 1367899999999999999999999 99999999999999999999999999999987764
Q ss_pred CCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 219 GET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 219 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
... .......+++.|+|||.+.+..++.++||||+|+++|+|++.|..||..... ...... ......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~-~~~~~~--- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEY-LRKGYR--- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHH-HHcCCC---
Confidence 432 1123456788999999998888999999999999999999557999975421 111122 211110
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
. ......+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 226 ----~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----L---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----C---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 011122567889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=305.97 Aligned_cols=265 Identities=18% Similarity=0.321 Sum_probs=200.1
Q ss_pred hccCCCCCeecccCceEEEEEEe------CCceEEEEEEccC-CCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC-C
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL------PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV-E 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 131 (347)
.++|...+.||+|+||.||+|.. .++..+++|.+.. ......+.+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35688899999999999999974 2334445555443 3333446788999999999 689999999988654 4
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccC--------------------------------------------------------
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQS-------------------------------------------------------- 155 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 155 (347)
..+++|||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998652100
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee-ecccc
Q 045067 156 ------HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI-DDGVK 228 (347)
Q Consensus 156 ------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~ 228 (347)
....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124678888999999999999999 9999999999999999999999999999987654332211 12234
Q ss_pred ccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhh
Q 045067 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELL 308 (347)
Q Consensus 229 gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (347)
+++.|+|||.+.+..++.++||||||+++|+|++.|..||..... . .........+.... .+.
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~-~~~~~~~~~~~~~~--~~~------- 305 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------D-EEFCRRLKEGTRMR--APD------- 305 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc-------c-HHHHHHHhccCCCC--CCC-------
Confidence 567899999998889999999999999999999669999864321 0 11112222221110 010
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 309 EHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 309 ~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
...+.+.+++.+||+.+|++|||+.||++.|+.+.+.
T Consensus 306 -~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 306 -YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred -CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1234678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.98 Aligned_cols=254 Identities=19% Similarity=0.226 Sum_probs=190.0
Q ss_pred eecccCceEEEEEEe-CCc--eEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCC
Q 045067 69 IITESSIFRLCQGVL-PDR--TISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGN 144 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~-~~~--~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 144 (347)
.||+|+||.||+|.. ++. ..+++|.... ......+.+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999986 332 3344454443 333445789999999999999999999999999999999999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC-cee
Q 045067 145 LHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE-TYI 223 (347)
Q Consensus 145 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~ 223 (347)
|.+++.... ......++..+..++.|++.||+||| +.+++||||||+|||++.++.++|+|||++....... ...
T Consensus 82 L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 82 LKSYLSQEQ-WHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred HHHHHHhhh-cccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999997631 11245677788899999999999999 9999999999999999999999999999876432221 111
Q ss_pred eccccccCCccccccccc-------CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 224 DDGVKGTSGIVAPEYART-------GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 224 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.....++..|+|||++.. ..++.++|||||||++|||++.+.+||..... ........... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~~-~~~ 228 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIKDQ-QVK 228 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhhc-ccc
Confidence 234567889999998743 24578999999999999999667888854221 12222222221 122
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
..++.+... ..+.+.+++..|| .+|.+||++.+|++.|.
T Consensus 229 ~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 233333221 2345778999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=299.93 Aligned_cols=252 Identities=19% Similarity=0.254 Sum_probs=197.3
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
++|...+.||+|+||.||+|.. .++..+++|............+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4566778899999999999998 566667777665554444466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... +.+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 89 GGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 999999999764 57899999999999999999999 9999999999999999999999999999987654322
Q ss_pred ceeeccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 221 TYIDDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
. ......|+..|+|||++. ...++.++|+||+||++|+|+ +|.+||..... . ...... .....
T Consensus 161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~-~~~~p~~~~~~------~--~~~~~~-~~~~~--- 226 (267)
T cd06645 161 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA-ELQPPMFDLHP------M--RALFLM-TKSNF--- 226 (267)
T ss_pred c-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHh-cCCCCcccccc------h--hhHHhh-hccCC---
Confidence 1 123456899999999874 456889999999999999999 88888854321 0 000111 01111
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..+..... ...+..+.+++.+||+.+|++|||++++++
T Consensus 227 ~~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 QPPKLKDK---MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCccccc---CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 01111000 012345789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=292.00 Aligned_cols=252 Identities=19% Similarity=0.244 Sum_probs=202.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++.|+..++||+|.|+.||++.+ +++..++.|+++.. +....+.+.+|+.|-+.|+||||+++...+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 345677778899999999999998 56655555554432 233568899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC---CCCceEEecCCCC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS---ERYVPKLFNFSLS 213 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~a 213 (347)
+|++.|++|..-|-.. ..+++..+..++.||+.+|+|+| .++|||||+||.|+++. ...-+|++|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999998776543 56888889999999999999999 99999999999999996 3457899999999
Q ss_pred ccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
..+.. .....+..|||+|||||++...+|+..+|||+.||+||-|+ .|.+||.+.+. ....... ..+.
T Consensus 161 i~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL-~G~~PF~~~~~--------~rlye~I-~~g~ 228 (355)
T KOG0033|consen 161 IEVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL-VGYPPFWDEDQ--------HRLYEQI-KAGA 228 (355)
T ss_pred EEeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH-hCCCCCCCccH--------HHHHHHH-hccc
Confidence 98873 33456788999999999999999999999999999999999 99999975321 1122222 2221
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+ + +++ ...+...++..+|+.+||..||.+|.|+.|.+.
T Consensus 229 y-d-----~~~-~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 229 Y-D-----YPS-PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred c-C-----CCC-cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1 1 111 122345667889999999999999999998764
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=306.10 Aligned_cols=254 Identities=21% Similarity=0.235 Sum_probs=206.2
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCCc--hhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCc
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSVF--DAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEI 132 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 132 (347)
....+.|+..+.||.|.||.||+++. . +..+|+|.+...... ...+.+.+|+.+|+++. ||||+.+++++.+...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 34556788889999999999999999 4 444555554443332 23467999999999998 9999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC----CceEEe
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER----YVPKLF 208 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~----~~~kl~ 208 (347)
+++|||++.||.|.+.+... .+++..+..++.|++.++.||| +.|++||||||+|+|+... +.+|++
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~ 181 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLI 181 (382)
T ss_pred EEEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEe
Confidence 99999999999999999863 3999999999999999999999 9999999999999999743 579999
Q ss_pred cCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 209 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
|||++..... .......+||+.|+|||++....|+..+||||+||++|.|+ .|.+||..... ...+. .
T Consensus 182 DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL-~G~~PF~~~~~-------~~~~~-~- 249 (382)
T KOG0032|consen 182 DFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILL-SGVPPFWGETE-------FEIFL-A- 249 (382)
T ss_pred eCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHh-hCCCCCcCCCh-------hHHHH-H-
Confidence 9999988776 33456789999999999999999999999999999999999 99999975432 11111 1
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
...+.+ ... .+..+..+..+.+++..|+..||.+|+|+.++++.
T Consensus 250 i~~~~~------~f~-~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 250 ILRGDF------DFT-SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHcCCC------CCC-CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 112221 111 12223446678899999999999999999999873
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=297.56 Aligned_cols=253 Identities=19% Similarity=0.234 Sum_probs=196.0
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC------
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV------ 130 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 130 (347)
.+++.|+..+.||+|+||.||+|.. .++..+++|....... ....+.+|+.++.++ +|||++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4567788889999999999999998 5566666666554432 336788999999998 699999999998753
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
...+++|||+++++|.+++... ....+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccC
Confidence 3578999999999999999763 2346899999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
|++........ ......|++.|+|||++. +..++.++||||+||++|||+ +|..||..... ....
T Consensus 156 g~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~-~g~~p~~~~~~-------~~~~- 225 (272)
T cd06637 156 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA-EGAPPLCDMHP-------MRAL- 225 (272)
T ss_pred CCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHH-hCCCCccccCH-------HHHH-
Confidence 99876543221 223456899999999875 346788999999999999999 89999864221 1111
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.... .... .... ....+..+.+++.+||+.+|.+|||+.+++.
T Consensus 226 ~~~~-~~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 226 FLIP-RNPA-----PRLK----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHh-cCCC-----CCCC----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111 1110 1111 1122446789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=309.15 Aligned_cols=237 Identities=20% Similarity=0.203 Sum_probs=185.3
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHH-HHHhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIV-FASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||+||+|.. .++..+++|.+.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999999 455555555544321 122244555655 45789999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK- 151 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-
Confidence 9999999764 57899999999999999999999 99999999999999999999999999999875432221
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++|||||||++|+|+ +|..||..... .......... .. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~--------~~~~~~i~~~-~~------~~ 215 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRDT--------AEMYDNILNK-PL------RL 215 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhh-cCCCCCCCCCH--------HHHHHHHHcC-CC------CC
Confidence 223457899999999999999999999999999999999 99999964321 1122222111 10 00
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTMI 334 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ 334 (347)
. ...+..+.+++.+||+.+|.+||++.
T Consensus 216 ~-----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 K-----PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C-----CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0 11245678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.19 Aligned_cols=251 Identities=21% Similarity=0.220 Sum_probs=202.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCch---hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFD---AYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
+.|...+.||.|.-|+||++.. +.....++|++.+..-. -..+...|-+||+.++||.++.+++.++.++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 3455667899999999999999 55688888888765422 2356778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|||+||+|..+.+++ .+..+++..+.-++..++.||+||| -.|||.|||||+||||-++|++.|+||.++....
T Consensus 157 eyCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred ecCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999876 6678999999999999999999999 9999999999999999999999999998875431
Q ss_pred CC----------------------------------C---------------------ceeeccccccCCcccccccccC
Q 045067 218 EG----------------------------------E---------------------TYIDDGVKGTSGIVAPEYARTG 242 (347)
Q Consensus 218 ~~----------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~ 242 (347)
.. . ...++...||-+|+|||++.|.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 10 0 0011234589999999999999
Q ss_pred CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHh
Q 045067 243 YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQC 322 (347)
Q Consensus 243 ~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 322 (347)
..+.++|+|+||+++|||+ .|.-||..... . .. +.+++.+.+.-++.. ..+..+.+||.+.
T Consensus 311 GHgsAVDWWtfGIflYEmL-yG~TPFKG~~~----~----~T---------l~NIv~~~l~Fp~~~-~vs~~akDLIr~L 371 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEML-YGTTPFKGSNN----K----ET---------LRNIVGQPLKFPEEP-EVSSAAKDLIRKL 371 (459)
T ss_pred CCCchhhHHHHHHHHHHHH-hCCCCcCCCCc----h----hh---------HHHHhcCCCcCCCCC-cchhHHHHHHHHH
Confidence 9999999999999999999 99999986533 1 11 112222222111111 4466789999999
Q ss_pred ccCCCCCCCC----HHHHH
Q 045067 323 QSASAEDRPT----MIDVA 337 (347)
Q Consensus 323 l~~~P~~RPs----~~ell 337 (347)
|.+||++|.. +.||-
T Consensus 372 LvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 372 LVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred hccChhhhhccccchHHhh
Confidence 9999999988 66654
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=311.08 Aligned_cols=195 Identities=22% Similarity=0.290 Sum_probs=166.1
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
...+|...+.||+|+||.||+|.. .++..+++|+.... ....|+.++++++||||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 345799999999999999999999 45556666654332 23579999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
++. ++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 138 ~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 138 HYS-SDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred ccC-CcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 996 5898888652 367899999999999999999999 99999999999999999999999999999875432
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
.. ......||+.|+|||++.+..++.++|||||||++|||++.+.++|..
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 210 AP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred Cc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 21 123456899999999999999999999999999999999667777654
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=294.53 Aligned_cols=249 Identities=19% Similarity=0.264 Sum_probs=199.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
++|+..+.||+|+||.||+|.. +++..+++|....... .+.+.+|+.++++++||||+++++++.++...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 5788889999999999999999 4455555555544322 578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... ...+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 81 GAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 999999999752 267899999999999999999999 9999999999999999999999999999987765432
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
. ......++..|+|||.+.+..++.++||||||+++|+|+ +|+.||...... ...... ... ..+
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~-~g~~p~~~~~~~--------~~~~~~-~~~-----~~~ 217 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMA-EGKPPYSDIHPM--------RAIFMI-PNK-----PPP 217 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHH-hCCCCCCCcchh--------hhhhhh-ccC-----CCC
Confidence 2 122345788999999998889999999999999999999 899998643220 000000 000 001
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. .........+.+++.+||+.+|++|||+.|+++
T Consensus 218 ~~---~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TL---SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CC---CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11 111223456889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=297.11 Aligned_cols=256 Identities=20% Similarity=0.240 Sum_probs=198.2
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++..++++.....||+|+||.||+|.. +++..+++|..........+.+.+|+.++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 455667777778999999999999998 5555566665555544455789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-CCceEEecCCC
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPL--LLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-RYVPKLFNFSL 212 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~ 212 (347)
++||+++++|.+++... ...+ +...+..++.|++.||+||| +.+|+||||||+||+++. ++.++|+|||+
T Consensus 83 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 83 FMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 99999999999999763 1334 78888999999999999999 999999999999999986 67999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccC--CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTG--YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
+........ ......+++.|+|||++.+. .++.++|+||+|+++|+|+ +|++||..... .....+......
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~-~g~~p~~~~~~-----~~~~~~~~~~~~ 228 (268)
T cd06624 156 SKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMA-TGKPPFIELGE-----PQAAMFKVGMFK 228 (268)
T ss_pred heecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHH-hCCCCCccccC-----hhhhHhhhhhhc
Confidence 876543222 12234588999999987654 3789999999999999999 89999864211 000001000000
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .+. .+.....++.+++.+||+.+|++|||+.|+++
T Consensus 229 ~-------~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 I-------HPE-----IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred c-------CCC-----CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 011 11223456789999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=322.02 Aligned_cols=257 Identities=18% Similarity=0.211 Sum_probs=203.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CC-ceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeee-eeeeC------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PD-RTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIG-CCLEV------ 130 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~------ 130 (347)
..++++.++|.+|||+.||.|.. .+ ..+|+||++.. .....+.+.+|+.+|++|+ |+|||.+++ .....
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 45567789999999999999999 44 78888888777 4455688999999999996 999999999 33221
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
-.++|+||||.||.|-|+++.. ....|.+.++++|+.+++.|+++||.. ..+|||||||-+||||+.++..|||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~R---lq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTR---LQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHH---HhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 2578999999999999999864 224499999999999999999999932 456999999999999999999999999
Q ss_pred CCCccCCCCCceee--------ccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCc
Q 045067 211 SLSASIPEGETYID--------DGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDES 279 (347)
Q Consensus 211 g~a~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~ 279 (347)
|.++.......... -...-|+.|+|||++. +...++|+|||+|||+||-|+ ....||.....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLC-y~t~PFe~sg~------ 263 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLC-YFTTPFEESGK------ 263 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHH-HhCCCcCcCcc------
Confidence 99876543321100 0123588999999764 678999999999999999999 99999975421
Q ss_pred hHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 280 FEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
..+++....-+.. +..+..+.+||..||++||++||++-+|+..+-+|..
T Consensus 264 ---------------laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 ---------------LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ---------------eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 1122222111111 3456788999999999999999999999999988864
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=303.08 Aligned_cols=262 Identities=17% Similarity=0.204 Sum_probs=193.7
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|...+.||+|+||.||+|+. .++..+++|.+. .........+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5688889999999999999998 444444444443 32233335678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++ +|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LDK-DLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCC-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 985 888888653 245889999999999999999999 999999999999999999999999999998764332
Q ss_pred CceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh--------
Q 045067 220 ETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE-------- 290 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 290 (347)
.. ......+|+.|+|||.+.+ ..++.++||||+||++|+|+ +|++||...... ...........
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07872 158 TK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMA-SGRPLFPGSTVE-----DELHLIFRLLGTPTEETWP 230 (309)
T ss_pred cc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHh
Confidence 22 1223467899999998765 56899999999999999999 899999653220 00000000000
Q ss_pred ----ccCcccccCCccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 ----NRGFNGIVDPRIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ----~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.........+..... ......+.++.+++.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000000 001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=303.35 Aligned_cols=249 Identities=17% Similarity=0.215 Sum_probs=197.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.+|+..+.||.|++|.||+|.. .++..+++|..........+.+.+|+.+++.++|||++++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999997 444444444444333334477899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++.. ..+++.++..++.+++.||+||| +.+++||||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 99 AGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred CCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999865 46899999999999999999999 9999999999999999999999999999987654332
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
.. .....++..|+|||.+.+..++.++|+|||||++|+|+ +|..||..... . .......... ...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~ll-tg~~pf~~~~~-------~-~~~~~~~~~~-~~~---- 234 (296)
T cd06655 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV-EGEPPYLNENP-------L-RALYLIATNG-TPE---- 234 (296)
T ss_pred cc-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH-------H-HHHHHHHhcC-Ccc----
Confidence 21 22346888999999998888999999999999999999 89999964321 1 1111111111 100
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+. .....+..+.+++.+||..+|++|||+.+++.
T Consensus 235 -~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 -LQ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred -cC---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00 11123456789999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=299.40 Aligned_cols=251 Identities=18% Similarity=0.250 Sum_probs=194.8
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-C--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-V--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
+|+..+.||+|+||+||++.. .++..+++|.+... . ......+.+|+.++++++|+|++.+++.+.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367778999999999999999 44444444444322 1 1223457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++++|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999998653 2246899999999999999999999 99999999999999999999999999999876543
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
.... ....|+..|+|||++.+..++.++||||+|+++|+|+ +|+.||..... ...............
T Consensus 155 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~-~g~~Pf~~~~~-----~~~~~~~~~~~~~~~----- 221 (285)
T cd05630 155 GQTI--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI-AGQSPFQQRKK-----KIKREEVERLVKEVQ----- 221 (285)
T ss_pred Cccc--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHH-hCCCCCCCCCc-----cchHHHHHhhhhhhh-----
Confidence 3221 2346899999999999889999999999999999999 89999975321 000111111111100
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-----MIDVAK 338 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-----~~ell~ 338 (347)
.. ........+.+++.+||+.||++||| +.|+++
T Consensus 222 -~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 -EE-----YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hh-----cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00 01122445789999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=311.22 Aligned_cols=238 Identities=18% Similarity=0.171 Sum_probs=189.3
Q ss_pred CeecccCceEEEEEEe----CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 68 NIITESSIFRLCQGVL----PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~----~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
+.||+|+||.||++.. .++..+++|++.... ......+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999876 244555555554322 1223557789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
+|+|.+++.+. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 99999999764 57899999999999999999999 99999999999999999999999999999876543322
Q ss_pred eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
......||+.|+|||.+.+..++.++|||||||++|||+ +|+.||..... ........... . .
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~-tg~~p~~~~~~--------~~~~~~i~~~~-~------~ 216 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML-TGSLPFQGKDR--------KETMTMILKAK-L------G 216 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeec-cCCCCCCCCCH--------HHHHHHHHcCC-C------C
Confidence 123457899999999999888999999999999999999 89999964321 11222221111 0 0
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMID 335 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~e 335 (347)
+ +...+..+.+++.+||+.||++|||+.+
T Consensus 217 ~-----p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 M-----PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C-----CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0 1122456789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.21 Aligned_cols=264 Identities=20% Similarity=0.218 Sum_probs=202.3
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeee-
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCL- 128 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~- 128 (347)
+.++++....++|+..+.||+|+||.||+|.. .++..+++|....... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 45577788899999999999999999999998 5555666665544322 235688999999999 6999999999874
Q ss_pred ----eCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc
Q 045067 129 ----EVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV 204 (347)
Q Consensus 129 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~ 204 (347)
+++..++||||+++++|.+++... ......+++..+..++.|++.||.||| +.+++||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGF-LKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHh-hccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCC
Confidence 345789999999999999988643 122356889999999999999999999 999999999999999999999
Q ss_pred eEEecCCCCccCCCCCceeeccccccCCccccccccc-----CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCc
Q 045067 205 PKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART-----GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDES 279 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~ 279 (347)
++|+|||++........ ......|++.|+|||++.. ..++.++||||+||++|+|+ +|+.||.....
T Consensus 163 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~-~g~~p~~~~~~------ 234 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG-DGDPPLADLHP------ 234 (286)
T ss_pred EEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHh-cCCCCCCCCch------
Confidence 99999999876643221 2233468999999998753 45788999999999999999 89999864321
Q ss_pred hHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 280 FEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
......... .......++ ......+.+++.+||+.+|++|||+.|+++.
T Consensus 235 --~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 235 --MRALFKIPR-NPPPTLHQP--------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --hHHHhhccc-cCCCcccCC--------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 011111100 000011111 1123467899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=305.91 Aligned_cols=241 Identities=16% Similarity=0.234 Sum_probs=190.3
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 137 (347)
+|...+.||+|+||+||+|.. .++..+++|++... .....+.+..|..++..+. |++|+++++++.+.+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467788999999999999998 45555555554432 1233456788999998885 577888999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999999999764 57999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... ......||+.|+|||++.+..++.++||||+||++|+|+ +|++||..... .......... ..
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell-tG~~pf~~~~~--------~~~~~~i~~~-~~--- 218 (323)
T cd05615 153 VDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML-AGQPPFDGEDE--------DELFQSIMEH-NV--- 218 (323)
T ss_pred CCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhC-CC---
Confidence 2221 123456899999999999889999999999999999999 89999964321 1122222211 11
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM 333 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~ 333 (347)
.. +...+.++.+++.+||+.+|.+|++.
T Consensus 219 ---~~-----p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ---SY-----PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CC-----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 00 11224467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.10 Aligned_cols=263 Identities=18% Similarity=0.211 Sum_probs=192.3
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
...|...+.||+|+||.||+|.+ ..+..+++|... ...+.+|+.++++++||||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 34688889999999999999999 444444444321 13467899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+. ++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++.....
T Consensus 242 ~~-~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 YR-SDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 96 6999888652 246999999999999999999999 999999999999999999999999999999765433
Q ss_pred Cce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC-----
Q 045067 220 ETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG----- 293 (347)
Q Consensus 220 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 293 (347)
... ......||+.|+|||++.+..++.++|||||||++|||++.+.++|..... ........... ..+....
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~-~~~~~~~~~l~-~~i~~~~~~~~~ 391 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRG-DERRPYDAQIL-RIIRQAQVHVDE 391 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcc-cccCCcHHHHH-HHHHhhcccccc
Confidence 221 122456999999999999999999999999999999999444445543211 11111111111 1111100
Q ss_pred ccccc----------------CCccCCchh--hHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 294 FNGIV----------------DPRIIGDEL--LEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 294 ~~~~~----------------~~~~~~~~~--~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+.... .+....... .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 000000000 00123367899999999999999999999864
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=307.96 Aligned_cols=240 Identities=20% Similarity=0.196 Sum_probs=186.3
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHH-HHHhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIV-FASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||+||+|.. .++..+++|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999999 555556666554321 122234445544 46788999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ..++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 9999999764 56888899999999999999999 99999999999999999999999999999875432221
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++||||+||++|+|+ +|.+||..... .......... .. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~--------~~~~~~i~~~-~~--~~~--- 216 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNT--------AEMYDNILNK-PL--QLK--- 216 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHh-cCCCCCCCCCH--------HHHHHHHHhC-Cc--CCC---
Confidence 223457999999999999999999999999999999999 99999964321 1111221111 10 001
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVA 337 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell 337 (347)
...+..+.+++.+||+.+|.+||++.+.+
T Consensus 217 ------~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 217 ------PNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred ------CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 12244678999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=294.83 Aligned_cols=258 Identities=20% Similarity=0.304 Sum_probs=201.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCce----EEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRT----ISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
.+|...+.||+|+||.||+|.+ .++. .+++|..... .......+.+|+.++++++|||++++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 4567778999999999999997 3222 3455554443 33345678999999999999999999999887 78899
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
|+||+++|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 99999999999999763 246899999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 216 IPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 216 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
........ .....++..|+|||.+....++.++|+||||+++||+++.|..||..... .............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~ 230 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEKGERL 230 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhCCCCC
Confidence 65333221 12223467899999988888999999999999999999449999864321 1222222111110
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
..+ ......+.+++.+||..+|.+|||+.++++.|+++.+.
T Consensus 231 ---~~~--------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 231 ---PQP--------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ---CCC--------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 001 11234577999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=304.90 Aligned_cols=255 Identities=15% Similarity=0.170 Sum_probs=194.3
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||++.. .++..+++|++... .....+.+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999998 55555666655431 1223356889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++.+. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 999999999999752 256899999999999999999999 9999999999999999999999999999987665
Q ss_pred CCCceeeccccccCCccccccccc-----CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYART-----GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
...........||+.|+|||++.. ..++.++||||+||++|+|+ +|+.||..... ...........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~-~g~~Pf~~~~~--------~~~~~~i~~~~ 224 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML-YGETPFYAESL--------VETYGKIMNHK 224 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHh-hCCCCCCCCCH--------HHHHHHHHcCC
Confidence 433322333569999999998863 45788999999999999999 89999964321 12222222111
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCC--CCCCCCHHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSAS--AEDRPTMIDVAKQ 339 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~--P~~RPs~~ell~~ 339 (347)
....+ +......+..+.+++.+|+..+ +..||++.++++.
T Consensus 225 ~~~~~-------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 225 EHFQF-------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CcccC-------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 11110 0011123456778888877553 3347899888764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=300.31 Aligned_cols=253 Identities=19% Similarity=0.221 Sum_probs=200.6
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
.++|+..+.||.|+||.||+|.. .++..+++|..........+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35678888999999999999998 55666777766655555557799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++.+. ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 84 CDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred cCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 9999999999763 256999999999999999999999 999999999999999999999999999988665432
Q ss_pred CceeeccccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 220 ETYIDDGVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.. ......+++.|+|||.+. ...++.++|+||||+++|+|+ +|.+||..... ......... ...
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~-~g~~p~~~~~~--------~~~~~~~~~-~~~ 225 (280)
T cd06611 157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA-QMEPPHHELNP--------MRVLLKILK-SEP 225 (280)
T ss_pred cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH-hCCCCcccCCH--------HHHHHHHhc-CCC
Confidence 22 123356889999999874 345778999999999999999 99999864321 111111111 111
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+.+.. ....+..+.+++.+||+.+|.+|||+.++++.
T Consensus 226 -----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 -----PTLDQ---PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----CCcCC---cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11111 11224467899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=297.57 Aligned_cols=250 Identities=17% Similarity=0.214 Sum_probs=194.4
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
|+..+.||+|+||+||+|.. .++..+++|.+.... ......+.+|+.++++++|+|++.+.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678899999999999999 455555555544322 12234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999988653 2246999999999999999999999 999999999999999999999999999998765433
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
.. .....|+..|+|||.+.+..++.++|+||+||++|+|+ +|..||..... ............... ...
T Consensus 156 ~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~P~~~~~~-----~~~~~~~~~~~~~~~--~~~- 224 (285)
T cd05632 156 ES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMI-EGQSPFRGRKE-----KVKREEVDRRVLETE--EVY- 224 (285)
T ss_pred Cc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHH-hCCCCCCCCCH-----HHHHHHHHHhhhccc--ccc-
Confidence 22 23457899999999998889999999999999999999 89999964321 111111111111110 000
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-----MIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-----~~ell~ 338 (347)
....+..+.+++.+||+.+|++||+ +.+++.
T Consensus 225 --------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 --------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1122345779999999999999999 667765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.48 Aligned_cols=248 Identities=22% Similarity=0.267 Sum_probs=199.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|+..+.||.|++|.||+|.. .++..+++|..... .......+.+|+.+++.++|||++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3577788999999999999998 45555666655433 234456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++.. ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999975 37899999999999999999999 999999999999999999999999999999776543
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
.. ......+++.|+|||.+.+..++.++||||||+++|+|+ +|.+||..... ....... .... .
T Consensus 152 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~-tg~~p~~~~~~--------~~~~~~~-~~~~-----~ 215 (274)
T cd06609 152 MS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELA-KGEPPLSDLHP--------MRVLFLI-PKNN-----P 215 (274)
T ss_pred cc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHH-hCCCCcccCch--------HHHHHHh-hhcC-----C
Confidence 22 223456888999999999888999999999999999999 89999964321 1111111 1111 1
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.+... ..+..+.+++.+||..+|++|||++++++
T Consensus 216 ~~~~~~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 PSLEGN----KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111111 13456889999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=311.68 Aligned_cols=251 Identities=15% Similarity=0.200 Sum_probs=193.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||++.. .++..+++|++... .....+.+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688889999999999999998 55666666655432 1223466888999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++.+. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++....
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999999764 67899999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCc----------------------------------eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhc
Q 045067 218 EGET----------------------------------YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLST 263 (347)
Q Consensus 218 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~ 263 (347)
.... .......||+.|+|||++.+..++.++|||||||++|||+ +
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~-t 231 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML-I 231 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc-c
Confidence 2110 0011346999999999999999999999999999999999 9
Q ss_pred CCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 045067 264 GEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT---MIDVAK 338 (347)
Q Consensus 264 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs---~~ell~ 338 (347)
|.+||..... ............ .-.+.+.. ..+.++.+++.+|+ .+|.+|++ +.++++
T Consensus 232 G~~Pf~~~~~--------~~~~~~i~~~~~-~~~~p~~~-------~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 232 GYPPFCSETP--------QETYRKVMNWKE-TLVFPPEV-------PISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCCCH--------HHHHHHHHcCCC-ceecCCCC-------CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 9999964321 111122211100 00011110 12345678888876 49999986 555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=297.28 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=195.7
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchh--HHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDA--YDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
|+..+.||+|+||+||++.. .++..+++|......... .....+|+.++++++||||+++++++.+....+++||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 45678999999999999999 555555555555443222 123456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... ..+++..+..++.|++.||.+|| +.+++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~- 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN- 151 (260)
T ss_dssp TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-
T ss_pred cccccccccccc-----ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc-
Confidence 999999999844 68999999999999999999999 999999999999999999999999999998764222
Q ss_pred ceeeccccccCCcccccccc-cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 221 TYIDDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
........++..|+|||.+. +..++.++|+||+|+++|+|+ +|..||..... .................
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~---- 221 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELL-TGKLPFEESNS-----DDQLEIIEKILKRPLPS---- 221 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHH-HSSSSSTTSSH-----HHHHHHHHHHHHTHHHH----
T ss_pred cccccccccccccccccccccccccccccccccccccccccc-ccccccccccc-----hhhhhhhhhcccccccc----
Confidence 22334567899999999988 888999999999999999999 89999864310 01111111111110000
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. . ........+.+++.+||+.||++|||+.++++
T Consensus 222 ~~-~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 SS-Q---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HT-T---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cc-c---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 00011267899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=291.74 Aligned_cols=239 Identities=23% Similarity=0.370 Sum_probs=187.8
Q ss_pred CeecccCceEEEEEEe-CCc----------eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 68 NIITESSIFRLCQGVL-PDR----------TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~----------~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
+.||+|+||.||+|.+ +.+ ..+++|........ ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 3699999999999999 333 23444554443322 4778999999999999999999999988 778999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-------ceEEec
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-------VPKLFN 209 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~-------~~kl~D 209 (347)
+||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++ .++|+|
T Consensus 79 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHRE----KNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999999864 136899999999999999999999 99999999999999999887 799999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccC--CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTG--YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
||++...... ....++..|+|||++.+. .++.++||||||+++|+|++.+..||..... ......
T Consensus 152 fg~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--------~~~~~~ 218 (259)
T cd05037 152 PGIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--------SEKERF 218 (259)
T ss_pred CCcccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--------hhHHHH
Confidence 9998765431 224567789999998876 7899999999999999999557888865321 011111
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
. .... ....+. ...+.+++.+||..+|.+|||+.++++.|+
T Consensus 219 ~-~~~~-------~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 Y-QDQH-------RLPMPD-----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred H-hcCC-------CCCCCC-----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 1100 000000 156789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=293.99 Aligned_cols=253 Identities=20% Similarity=0.256 Sum_probs=201.5
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
++|+..+.||.|+||.||+|.. .++..+++|..........+.+.+|+.++++++||||+++++++.+...++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788889999999999999998 555566666665544445578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 83 GGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 999999998763 257899999999999999999999 9999999999999999999999999999987654322
Q ss_pred ceeeccccccCCcccccccccC---CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 221 TYIDDGVKGTSGIVAPEYARTG---YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
. ......++..|+|||.+.+. .++.++|+||||+++|+|+ +|.+||..... .......... . .
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~-tg~~p~~~~~~--------~~~~~~~~~~-~---~ 221 (262)
T cd06613 156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA-ELQPPMFDLHP--------MRALFLISKS-N---F 221 (262)
T ss_pred h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhc-c---C
Confidence 1 12335688899999988776 8899999999999999999 89999864321 0111111111 0 0
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..+.+. .....+.++.+++.+||+.+|.+|||+.+++.
T Consensus 222 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 PPPKLK---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCcccc---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 011111 11233567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=306.45 Aligned_cols=266 Identities=19% Similarity=0.210 Sum_probs=193.8
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC----
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE---- 131 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 131 (347)
...++|+..+.||+|+||.||++.. . +..+++|++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4567899999999999999999998 4 4455555554322 2233467889999999999999999999986543
Q ss_pred --ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 132 --IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 132 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
..++||||+.+ +|.+.+. ..++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEec
Confidence 47999999985 6777664 34788899999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCC----------CCCc
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN----------GDES 279 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~----------~~~~ 279 (347)
||++....... ......||+.|+|||.+.+..++.++||||+||++|+|+ +|+.||....... ....
T Consensus 167 fg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~-tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 167 FGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred CCCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 99987643322 123457899999999999999999999999999999999 9999997532100 0000
Q ss_pred hHHH----HHHHHHhccC-cc-----cccCCcc-CC-chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 280 FEMD----FVKKYIENRG-FN-----GIVDPRI-IG-DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 280 ~~~~----~~~~~~~~~~-~~-----~~~~~~~-~~-~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.... .......... .. +....-. .. ........+.+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0011111100 00 0000000 00 0001112456889999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.66 Aligned_cols=257 Identities=20% Similarity=0.308 Sum_probs=198.9
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCce----EEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRT----ISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|...+.||+|+||.||+|.+ .++. .+++|...... ......+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4566778999999999999998 3332 24555544432 23335688999999999999999999998754 4679
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
++||+++|+|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccc
Confidence 99999999999998763 246899999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 216 IPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 216 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
....... ......++..|+|||.+.+..++.++|||||||++||+++.|..||..... .........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~~ 229 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDLLEKGER 229 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHCCCC
Confidence 6533221 122344677899999999889999999999999999999558888853211 112222222111
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
. ..+ ...+..+.+++.+||..+|++||++.++++.|+++.+
T Consensus 230 ~--~~~--------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 230 L--PQP--------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred C--CCC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 000 1123467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=288.43 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=194.9
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCHH
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLH 146 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 146 (347)
+.||.|+||.||++...++..+++|..... .....+.+.+|+.++++++||||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999943555555554443 3334567999999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceee-c
Q 045067 147 DLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID-D 225 (347)
Q Consensus 147 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~ 225 (347)
+++... ...+++..+..++.+++.||+||| +.+++||||+|+||+++.++.++|+|||++........... .
T Consensus 81 ~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 81 TFLRKK----KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999652 246889999999999999999999 99999999999999999999999999999876543222111 1
Q ss_pred cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCc
Q 045067 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGD 305 (347)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (347)
...++..|+|||.+.++.++.++|+|||||++|+|++.|..||..... ........... .. .
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---------~~~~~~~~~~~--~~-----~-- 215 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---------QQTRERIESGY--RM-----P-- 215 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---------HHHHHHHhcCC--CC-----C--
Confidence 233466799999998889999999999999999999548888864321 11111111110 00 0
Q ss_pred hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 306 ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 306 ~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
.....+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 216 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 -APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11123457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=305.57 Aligned_cols=255 Identities=16% Similarity=0.160 Sum_probs=195.9
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|...+.||+|+||.||++.. .++.++++|+.... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4688889999999999999999 55666666665431 1222345788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++.+. ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999999763 256899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCceeeccccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
...........||+.|+|||++. ...++.++|||||||++|||+ +|+.||..... ...........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell-~g~~Pf~~~~~--------~~~~~~i~~~~ 224 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML-YGETPFYAESL--------VETYGKIMNHK 224 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHh-cCCCCCCCCCH--------HHHHHHHhCCC
Confidence 43333333457999999999876 346789999999999999999 99999964321 12222222111
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCC--CCCCHHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAE--DRPTMIDVAKQ 339 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~--~RPs~~ell~~ 339 (347)
... ..+......+.++.+++.+|+..+|. .|+++.|+++.
T Consensus 225 ~~~-------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 225 ERF-------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccc-------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 00111122355678899998865444 36889988764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=295.36 Aligned_cols=250 Identities=18% Similarity=0.297 Sum_probs=195.1
Q ss_pred cCCCCCeecccCceEEEEEEeCCceEEEEEEccCCC------chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSV------FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
+|...+.||.|+||.||+|...++..+++|...... ....+.+.+|+.++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367788999999999999988555544444443221 12235688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
+||+++++|.+++.+. ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999764 56889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCC-----ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 217 PEGE-----TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 217 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
.... ........++..|+|||++.+..++.++|+||+||++|+|+ +|..||..... ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~-~g~~p~~~~~~-------~~~~~~~~~~~ 224 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMA-TGKPPLASMDR-------LAAMFYIGAHR 224 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHH-hCCCccccCCh-------HHHHHHhhhcc
Confidence 3211 11122356889999999999888999999999999999999 89999964321 11111111010
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... +.+ ....+.++.+++.+||+.+|++||++.++++
T Consensus 225 ~~~-----~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLM-----PRL-----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC-----CCC-----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 111 1123456789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=297.42 Aligned_cols=256 Identities=20% Similarity=0.276 Sum_probs=200.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|+..+.||+|+||+||++.. .++.++++|.... ......+.+.+|+.+++.++||||+++++++.....+++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4566778899999999999998 5555555555443 3334457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
+++++|.+++... +.+++..+..++.+++.||.||| + .+++||||+|+||+++.++.++|+|||++.....
T Consensus 85 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 85 MDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred CCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999998764 57899999999999999999999 5 6899999999999999999999999999865432
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCch---HHHHHHHHHhccCcc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESF---EMDFVKKYIENRGFN 295 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 295 (347)
.. .....|+..|+|||++.+..++.++|+|||||++|+++ +|+.||............ ............
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 229 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA-LGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--- 229 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHH-hCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---
Confidence 21 12356899999999988888999999999999999999 899999754321111011 111122211110
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.+.+. ....+..+.+++.+||+.||++|||+.|+++.
T Consensus 230 ---~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 230 ---PPRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ---CCCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11111 11234568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.93 Aligned_cols=238 Identities=19% Similarity=0.199 Sum_probs=186.1
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHH-HHHhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIV-FASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||.||+|.. .++..+++|+.... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999998 55555555555432 1222345566655 46778999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|..++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 151 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence 9999998764 67999999999999999999999 99999999999999999999999999999875432211
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||++.+..++.++|||||||++|+|+ +|.+||..... ........... . ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~-~G~~pf~~~~~--------~~~~~~~~~~~-~--~~~--- 216 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDV--------AEMYDNILHKP-L--VLR--- 216 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhh-cCCCCCCCCCH--------HHHHHHHHcCC-c--cCC---
Confidence 223457999999999999999999999999999999999 99999964321 11222222111 0 001
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTMID 335 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~e 335 (347)
+..+..+.+++.+||+.+|.+||++.+
T Consensus 217 ------~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 217 ------PGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred ------CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 112345779999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=328.74 Aligned_cols=263 Identities=17% Similarity=0.201 Sum_probs=199.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|...+.||+|+||.||+|.. . +..+|+|++..... ....+++.+|+.++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5688899999999999999998 4 44555555443221 223467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 138 ESAEYGNLHDLLKRSYQS------HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
||++||+|.+++...... ....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998752111 1234567788999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCc-----------------eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccC
Q 045067 212 LSASIPEGET-----------------YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL 274 (347)
Q Consensus 212 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~ 274 (347)
++........ .......||+.|+|||.+.+..++.++||||+||++|||+ +|+.||.....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELL-TG~~PF~~~~~- 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML-TLSFPYRRKKG- 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHH-HCCCCCCCcch-
Confidence 9976521110 0011246899999999999999999999999999999999 99999964221
Q ss_pred CCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q 045067 275 NGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-TMIDVAKQIKKMYK 345 (347)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-s~~ell~~L~~i~~ 345 (347)
. .... ... ..++... ......+..+.+++.+||+.||++|| ++.++++.|+...+
T Consensus 237 ----~---ki~~----~~~---i~~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 237 ----R---KISY----RDV---ILSPIEV--APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ----h---hhhh----hhh---ccChhhc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0000 000 0000000 00113345678999999999999996 57888888877643
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=299.37 Aligned_cols=240 Identities=18% Similarity=0.300 Sum_probs=186.3
Q ss_pred CeecccCceEEEEEEe-CCc-------eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 68 NIITESSIFRLCQGVL-PDR-------TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~-------~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+.||+|+||.||+|.. ..+ ..+++|..........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 3699999999999988 222 12444555444444456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc--------eEEecCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV--------PKLFNFS 211 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~--------~kl~Dfg 211 (347)
+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999999763 246899999999999999999999 999999999999999987765 5999999
Q ss_pred CCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcC-CCccccCccCCCCCchHHHHHHHHH
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTG-EDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
++...... ....+++.|+|||++.+ ..++.++||||||+++|+|+ +| .+|+..... ... ....
T Consensus 154 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~-~g~~~~~~~~~~--------~~~-~~~~ 218 (258)
T cd05078 154 ISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIF-SGGDKPLSALDS--------QKK-LQFY 218 (258)
T ss_pred cccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHH-cCCCCChhhccH--------HHH-HHHH
Confidence 88654322 22467889999998876 46799999999999999999 65 677653221 011 1111
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
... ..++. ....++.+++.+||+.+|++|||++++++.|+
T Consensus 219 ~~~-------~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 219 EDR-------HQLPA-----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred Hcc-------ccCCC-----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 110 01111 11245789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=299.93 Aligned_cols=263 Identities=20% Similarity=0.213 Sum_probs=203.2
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLE 129 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 129 (347)
+.+.++...+++|+..+.||+|+||.||++.. +++..+++|....... ....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 55577788899999999999999999999999 5666666666654322 236678899999999 79999999999875
Q ss_pred C-----CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc
Q 045067 130 V-----EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV 204 (347)
Q Consensus 130 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~ 204 (347)
. ...++|+||+++++|.+++... ......+++..+..++.|++.||.||| +.+++|+||||+||+++.++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~-~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGL-LICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHh-hhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence 4 3589999999999999998643 112356899999999999999999999 999999999999999999999
Q ss_pred eEEecCCCCccCCCCCceeeccccccCCcccccccccC-----CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCc
Q 045067 205 PKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTG-----YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDES 279 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~ 279 (347)
++|+|||++........ ......++..|+|||.+... .++.++|||||||++|+|+ +|++||.....
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~-~g~~p~~~~~~------ 238 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG-DGDPPLFDMHP------ 238 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh-hCCCCCCCCcH------
Confidence 99999999876543221 12334688999999987543 3689999999999999999 89999864321
Q ss_pred hHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 280 FEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
......... .....+.+ .......+.+++.+||+.+|++||++.|+++
T Consensus 239 --~~~~~~~~~-~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 239 --VKTLFKIPR-NPPPTLLH--------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --HHHHHHHhc-CCCCCCCc--------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111111 11111111 1122346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=301.38 Aligned_cols=263 Identities=19% Similarity=0.283 Sum_probs=203.2
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-------CceEEEEEEccCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-------DRTISVVKFIDGS-VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV 130 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-------~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 130 (347)
..+|...+.||+|+||.||+|.. . ....+++|..... .....+.+.+|+.+++++ +||||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 34688889999999999999976 1 1224555555433 333456789999999999 799999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill 199 (347)
...++++||+++|+|.+++..... .....+++.++..++.|++.||+||| +.+++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence 999999999999999999975311 12245888999999999999999999 9999999999999999
Q ss_pred CCCCceEEecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCC
Q 045067 200 SERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278 (347)
Q Consensus 200 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~ 278 (347)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++.|..||....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 241 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------ 241 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------
Confidence 999999999999987664332211 1223345789999999999999999999999999999955888885421
Q ss_pred chHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
....... ........ . ....+.++.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 242 --~~~~~~~-~~~~~~~~-----~-----~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 --VEELFKL-LKEGHRMD-----K-----PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred --HHHHHHH-HHcCCCCC-----C-----CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1122222 12111110 0 11224468899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=294.59 Aligned_cols=248 Identities=22% Similarity=0.260 Sum_probs=199.5
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
..|+..+.||.|+||.||+|.. .++..+++|..... .....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3466778899999999999998 45555566655433 334457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++.. ..+++..+..++.+++.||+||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 84 ~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 84 LGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999865 46889999999999999999999 999999999999999999999999999998766433
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
.. ......++..|+|||++.+..++.++|+|||||++|||+ +|.+||..... ..... ......
T Consensus 155 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~-tg~~p~~~~~~--------~~~~~-~~~~~~------ 217 (277)
T cd06640 155 QI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELA-KGEPPNSDMHP--------MRVLF-LIPKNN------ 217 (277)
T ss_pred cc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHH-HCCCCCCCcCh--------HhHhh-hhhcCC------
Confidence 22 123346788999999998888999999999999999999 89999864322 00100 001100
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.+......+..+.+++.+||+.+|++||++.+++..
T Consensus 218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 ----PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ----CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 011222345678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=305.52 Aligned_cols=237 Identities=20% Similarity=0.216 Sum_probs=185.1
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHH-HHHhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIV-FASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
++||+|+||.||+|.. .++..+++|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999 556666666554321 122344556654 57889999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|...+... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-E 151 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-C
Confidence 9999988754 57889999999999999999999 9999999999999999999999999999987532222 1
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......||+.|+|||.+.+..++.++|||||||++|||+ +|.+||..... .......... .. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~--------~~~~~~i~~~-~~------~~ 215 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML-YGLPPFYSRDV--------SQMYDNILHK-PL------QL 215 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhh-cCCCCCCCCCH--------HHHHHHHhcC-CC------CC
Confidence 223457899999999999889999999999999999999 99999964321 1111121111 10 01
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTMI 334 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ 334 (347)
+......+.+++.+||+.+|.+||++.
T Consensus 216 -----~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 -----PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112244678999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=294.48 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=194.3
Q ss_pred CCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCCCc--------hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGSVF--------DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
|...+.||+|+||.||+|.. .++ .+++|.+...... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 66778999999999999998 444 4444444332211 1225688999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++++||+++++|.+++... ..+++..+..++.+++.||+||| +.+++||||+|+||+++.++.++|+|||++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999764 57889999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCcee-----eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 214 ASIPEGETYI-----DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 214 ~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
+......... .....|+..|+|||.+.+..++.++|+||+||++|+|+ +|..||..... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~--------~~~~~~~ 224 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML-TGKHPFPDCTQ--------LQAIFKI 224 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHh-hCCCCCCCccH--------HHHHHHH
Confidence 7765322111 11245788999999998888999999999999999999 89999964321 1111111
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. . ..+.+ ....+..+.+++.+||+.+|.+||++.++++
T Consensus 225 ~~-~-----~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 225 GE-N-----ASPEI-----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred hc-c-----CCCcC-----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11 1 11111 1123456789999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=305.31 Aligned_cols=254 Identities=16% Similarity=0.178 Sum_probs=195.7
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|...+.||+|+||+||++.. .++..+++|..... .....+.+.+|..++..++|+||+.+++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999998 55666666665432 1223355788999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999763 256899999999999999999999 9999999999999999999999999999997765
Q ss_pred CCCceeeccccccCCccccccccc-----CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYART-----GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
...........||+.|+|||++.+ +.++.++||||+||++|+|+ +|+.||..... ...........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell-~g~~Pf~~~~~--------~~~~~~i~~~~ 224 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML-YGETPFYAESL--------VETYGKIMNHE 224 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhh-hCCCCccCCCH--------HHHHHHHHcCC
Confidence 443333334579999999998875 46789999999999999999 99999964321 11122221111
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAED--RPTMIDVAK 338 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~--RPs~~ell~ 338 (347)
. +...+......+.++.+++.+|+...+++ |+++.++++
T Consensus 225 ~-------~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 225 E-------RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred C-------cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0 00001111123456889999999875544 467887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=301.47 Aligned_cols=197 Identities=17% Similarity=0.168 Sum_probs=160.8
Q ss_pred CCeeccc--CceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 67 RNIITES--SIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 67 ~~~lg~G--~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
.++||+| +|++||++.. .++..+++|.+... .....+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7899999998 55565555555433 22334567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
+|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++++||+.+........
T Consensus 83 ~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 83 YGSAKDLICTH---FMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCcHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999653 2245899999999999999999999 99999999999999999999999999986544322111
Q ss_pred e------eeccccccCCccccccccc--CCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 222 Y------IDDGVKGTSGIVAPEYART--GYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 222 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
. ......++..|+|||++.+ ..++.++|||||||++|||+ +|..||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA-NGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHH-HCCCCCCC
Confidence 0 0112346778999998875 46899999999999999999 89999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.71 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=196.7
Q ss_pred ccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
++|...+.||+|+||.||+|...+..+++|+..... ..+.+.+|+.++++++|||++++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 458888999999999999998777777666654322 236789999999999999999999998764 5799999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
+++|.+++... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 82 KGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 99999999763 2345889999999999999999999 9999999999999999999999999999986543221
Q ss_pred eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
.....+..|+|||.+.+..++.++|+||||+++|+|++.|++||..... ... ......+... +
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~-~~~~~~~~~~---~-- 217 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEV-KECVEKGYRM---E-- 217 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHH-HHHHhCCCCC---C--
Confidence 1233457899999998889999999999999999999559999864321 111 1111111100 0
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
.....+..+.+++.+||+.+|++||++.++++.|++
T Consensus 218 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 -----PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -----CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011234567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=288.78 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=198.3
Q ss_pred CCCCCeecccCceEEEEEEeCC-c----eEEEEEEccCCCc-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 64 YHYRNIITESSIFRLCQGVLPD-R----TISVVKFIDGSVF-DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~~~-~----~~~v~k~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++..+.||.|+||.||++...+ + ..+++|....... ...+.+.+|+..+..++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456789999999999999932 2 5555555544432 24578999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++... ....+++..+..++.|++.||++|| +.+++|+||+|+||+++.++.++++|||++....
T Consensus 81 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhh---hhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 999999999999764 1122899999999999999999999 9999999999999999999999999999997766
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
...........+++.|+|||.+.+..++.++|+||+|+++++|++.|.+||..... ........ .....
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~-~~~~~-- 223 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLK-KGYRL-- 223 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHh-cCCCC--
Confidence 54332222234778999999998888999999999999999999558899864211 11222211 11110
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
. .....+.++.+++.+||..+|++|||+.|+++.|
T Consensus 224 ~--------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 P--------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C--------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 0112355788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=309.06 Aligned_cols=262 Identities=19% Similarity=0.205 Sum_probs=194.5
Q ss_pred hccCCCCCeecccCceEEEEEEeC---CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLP---DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
...|...+.||+|+||.||++... .+..+++|..... ....+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 456999999999999999999862 2344555554432 23568999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|++. ++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++....
T Consensus 166 e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 166 PKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred hhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 9997 5899988543 67999999999999999999999 9999999999999999999999999999997665
Q ss_pred CCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc--
Q 045067 218 EGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF-- 294 (347)
Q Consensus 218 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 294 (347)
..... ......||+.|+|||++.+..++.++|||||||++|||+ +|+.||....... ......... ........
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~-~g~~pf~~~~~~~-~~~~l~~i~-~~~~~~~~~~ 313 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS-VKNVTLFGKQVKS-SSSQLRSII-RCMQVHPLEF 313 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHH-HCCCCCCCCCCCC-cHHHHHHHH-HHhccCcccc
Confidence 43221 123457999999999999999999999999999999999 8888886433211 000000100 00000000
Q ss_pred ---------------ccccCCccCCchhh--HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 295 ---------------NGIVDPRIIGDELL--EHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 295 ---------------~~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.....+....+... .....++.+++.+||+.+|++|||+.|++..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000 0123467889999999999999999999863
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=319.15 Aligned_cols=305 Identities=21% Similarity=0.316 Sum_probs=235.6
Q ss_pred chhhhhcccchhHHHHHHHHHhhchHHHHHHHhhcC-CCCCCccccCHHHHHHHhccCCCCCeecccCceEEEEEEe-CC
Q 045067 8 TSLFMCNSKNREKADRKAFLMRNGKMFLERLISSCN-GNYNPIRSFSAKELERATNNYHYRNIITESSIFRLCQGVL-PD 85 (347)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~ 85 (347)
++++||++.++.+|+-+...++.+..+.+-...+.. .+...++.++-.|+.+ .++||+|+||+||+|.| +.
T Consensus 648 ~~~~~~~r~q~~~k~~~rr~lq~~~el~eplapS~~~~n~~~lrI~kEtelkk-------~kvLGsgAfGtV~kGiw~Pe 720 (1177)
T KOG1025|consen 648 FSLYMCRRMQIIIKRTMRRLLQLERELVEPLAPSGFAANLALLRILKETELKK-------DKVLGSGAFGTVYKGIWIPE 720 (1177)
T ss_pred HHHhhhhhHHhHhHHHHHHHHHhcccccCccccccccchhhheeechhhhhhh-------hceeccccceeEEeeeEecC
Confidence 557788776666665555554555443332322222 2333445444444443 47899999999999999 33
Q ss_pred c-----eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCC
Q 045067 86 R-----TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPL 160 (347)
Q Consensus 86 ~-----~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l 160 (347)
+ +|++|.+.........+++..|+.+|.+++|||+++++|+|..+. +.||++|++.|+|.++++.. ...+
T Consensus 721 ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~h----r~~i 795 (1177)
T KOG1025|consen 721 GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREH----RDNI 795 (1177)
T ss_pred CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHh----hccc
Confidence 2 455555555555556688999999999999999999999998766 88999999999999999873 4789
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce-eeccccccCCccccccc
Q 045067 161 LLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYA 239 (347)
Q Consensus 161 ~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~ 239 (347)
..+..+.|+.|||+|+.||| .++++||||-+.|||+.....+||.|||+++....+... ......-.+.|||-|.+
T Consensus 796 gsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i 872 (1177)
T KOG1025|consen 796 GSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESI 872 (1177)
T ss_pred cHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHh
Confidence 99999999999999999999 999999999999999999999999999999988755433 23344456789999999
Q ss_pred ccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHH
Q 045067 240 RTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELA 319 (347)
Q Consensus 240 ~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 319 (347)
+...|+.++|||||||++||++|.|..|+..... ..+.+.++.+. ++. .++....+++-++
T Consensus 873 ~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~---------~eI~dlle~ge-------RLs---qPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 873 RIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA---------EEIPDLLEKGE-------RLS---QPPICTIDVYMVM 933 (1177)
T ss_pred hccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH---------HHhhHHHhccc-------cCC---CCCCccHHHHHHH
Confidence 9999999999999999999999999999875322 22333333221 121 2234566789999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 320 FQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 320 ~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.+||..|+..||+++++.+.+.++.+.
T Consensus 934 vkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHHhccCcccCccHHHHHHHHHHHhcC
Confidence 999999999999999999999988653
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=295.74 Aligned_cols=261 Identities=18% Similarity=0.196 Sum_probs=190.1
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhc---CCCceeeeeeeeeeC-----C
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQM---SHNNVLRLIGCCLEV-----E 131 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 131 (347)
.|+..+.||+|+||+||+|.. .++..+++|...... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 477788999999999999999 555555555544321 11223466787777665 699999999988652 3
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
..++++||+++ +|.+++... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV---PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccC
Confidence 57999999985 899988763 2345899999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
++........ .....+|..|+|||++.+..++.++||||+||++|+|+ +|.+||..... .............
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~-~g~~~f~~~~~-----~~~~~~~~~~~~~ 225 (288)
T cd07863 154 LARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKPLFCGNSE-----ADQLGKIFDLIGL 225 (288)
T ss_pred ccccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHH-hCCcCcCCCCH-----HHHHHHHHHHhCC
Confidence 9876543221 23356899999999998889999999999999999999 99999964321 0000011110000
Q ss_pred ---cCc-------ccccCCccCC--chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 ---RGF-------NGIVDPRIIG--DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ---~~~-------~~~~~~~~~~--~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..+ .....+.... ....+.....+.+++.+||+.||++|||+.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0000000000 0111223456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=289.33 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=196.6
Q ss_pred CeecccCceEEEEEEe-C-Cce--EEEEEEccCCCc-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-P-DRT--ISVVKFIDGSVF-DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~-~~~--~~v~k~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|++|.||+|.+ . ++. .+++|....... ...+.+.+|+.++++++||||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 3689999999999998 2 332 355565555444 455789999999999999999999999888 889999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
++|.+++.... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 80 GSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999998741 146899999999999999999999 999999999999999999999999999999876543221
Q ss_pred e--eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 223 I--DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 223 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
. .....++..|+|||.+.+..++.++|||||||++|+|++.|..||..... .+........... ...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~--~~~- 222 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKIDKEGER--LER- 222 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhcCCc--CCC-
Confidence 1 12345778999999999889999999999999999999449999854321 1222222211110 000
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
....+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 223 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 -------PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -------CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1123456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.93 Aligned_cols=250 Identities=20% Similarity=0.251 Sum_probs=199.5
Q ss_pred cCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|+..++||.|+||.||.+.. . +..+++|++.... .....+.+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999888 4 4455555443322 233446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++... ....+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQ---KGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999763 2356899999999999999999999 999999999999999999999999999998766543
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
.. ......+++.|+|||...+..++.++|+||||+++|+|+ +|..||..... ......... +....
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~-~g~~~~~~~~~--------~~~~~~~~~-~~~~~--- 220 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL-TLKRTFDATNP--------LNLVVKIVQ-GNYTP--- 220 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHH-HCCCCCCCCCH--------HHHHHHHHc-CCCCC---
Confidence 32 233456899999999998888899999999999999999 88899864221 122222211 11110
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.....+..+.+++.+||+.+|++|||+.++++.
T Consensus 221 -------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 -------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 012234568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=305.87 Aligned_cols=267 Identities=19% Similarity=0.230 Sum_probs=194.7
Q ss_pred HHhccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV----- 130 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 130 (347)
...++|...+.||+|+||.||++.. .+..+++|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4567899999999999999999988 34555555554332 223346788999999999999999999988653
Q ss_pred -CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 131 -EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 131 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEee
Confidence 357999999975 77777743 4888899999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCC----------CCc
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG----------DES 279 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~----------~~~ 279 (347)
||+++...... ......||+.|+|||++.+..++.++|||||||++|+|+ +|+.||........ ...
T Consensus 163 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 163 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_pred CcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99997654322 223457899999999999989999999999999999999 99999964321000 000
Q ss_pred -hHH---HHHHHHHhcc-CcccccCCcc------CC-chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 280 -FEM---DFVKKYIENR-GFNGIVDPRI------IG-DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 280 -~~~---~~~~~~~~~~-~~~~~~~~~~------~~-~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
... .......... .......+.. .. .........++.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 0000111100 0000000000 00 00111124567899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=300.92 Aligned_cols=262 Identities=18% Similarity=0.213 Sum_probs=194.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|...+.||+|+||.||+|.. .++..+++|... .........+.+|+.++++++||||+++++++.+++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4688889999999999999998 344444444443 32233335678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
++ ++|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 86 ~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 98 5999988653 256889999999999999999999 999999999999999999999999999998765432
Q ss_pred CceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH----------
Q 045067 220 ETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY---------- 288 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 288 (347)
... .....+++.|+|||.+.+ ..++.++|||||||++|+|+ +|++||..... ..........
T Consensus 158 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~-tg~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~ 230 (301)
T cd07873 158 TKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS-TGRPLFPGSTV-----EEQLHFIFRILGTPTEETWP 230 (301)
T ss_pred CCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHH-hCCCCCCCCCH-----HHHHHHHHHHcCCCChhhch
Confidence 211 223457889999998765 45789999999999999999 89999975321 0000000000
Q ss_pred --HhccCcccccCCccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 --IENRGFNGIVDPRIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 --~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...........+....+ ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000000111000 001123456789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=296.55 Aligned_cols=245 Identities=24% Similarity=0.283 Sum_probs=196.4
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
|+..+.||+|+||.||+|.. .++..+++|..... .....+.+.+|+.++++++||||+++++++..+...++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 44556799999999999998 55566666665533 23445678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
+++|.+++.. ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||++........
T Consensus 86 ~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 86 GGSALDLLKP------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999865 56899999999999999999999 99999999999999999999999999999876543321
Q ss_pred eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
......++..|+|||.+.+..++.++|+|||||++|||+ +|..||..... ..... ...... .+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~-tg~~p~~~~~~--------~~~~~-~~~~~~-----~~~ 220 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELA-KGEPPNSDLHP--------MRVLF-LIPKNS-----PPT 220 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHH-hCCCCCcccch--------hhHHh-hhhcCC-----CCC
Confidence 122345788999999999889999999999999999999 89999864321 00000 111110 111
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+ ....+..+.+++.+||+.+|++|||+.+++.
T Consensus 221 ~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 221 L-----EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred C-----CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1 1123456889999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=288.74 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=201.9
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|+..+.||.|+||+||+|.. .++..+++|..... .....+.+.+|+..++.++|+|++++++.+..++..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999998 45555555655433 233457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++.... ....+++..+..++.|++.||.+|| +.+++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 99999999997631 1246899999999999999999999 999999999999999999999999999998766543
Q ss_pred Cce---eeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 220 ETY---IDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 220 ~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
... ......|+..|+|||.+... .++.++|+|||||++|+|+ +|..||..... .....+.....
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~-~g~~p~~~~~~--------~~~~~~~~~~~--- 223 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA-TGAAPYSKYPP--------MKVLMLTLQND--- 223 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHH-hCCCCccccCh--------hhhHHHHhcCC---
Confidence 322 12334688999999988766 7899999999999999999 89999964322 01111111111
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+...........+..+.+++.+||+.||++|||+.++++
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 ---PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ---CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111111111234567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=297.56 Aligned_cols=198 Identities=22% Similarity=0.226 Sum_probs=157.2
Q ss_pred CCeecccCceEEEEEEeC---CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccEEEEEeCC
Q 045067 67 RNIITESSIFRLCQGVLP---DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE--VEIPVLVFESAE 141 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~---~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 141 (347)
.++||+|+||+||+|... ++..+++|...... ....+.+|+.++++++||||+++++++.. +...++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999972 33444445444332 12457899999999999999999998864 456899999997
Q ss_pred CCCHHHHHhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE----CCCCceEEecCCCC
Q 045067 142 YGNLHDLLKRSYQ----SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV----SERYVPKLFNFSLS 213 (347)
Q Consensus 142 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~a 213 (347)
+ +|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 89888764211 11235889999999999999999999 9999999999999999 45679999999999
Q ss_pred ccCCCCCce--eeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccC
Q 045067 214 ASIPEGETY--IDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMG 271 (347)
Q Consensus 214 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~ 271 (347)
+........ ......||+.|+|||++.+ ..++.++||||+||++|+|+ +|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHH-hCCCCccCC
Confidence 776433221 1234678999999998876 46899999999999999999 999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=293.90 Aligned_cols=252 Identities=15% Similarity=0.216 Sum_probs=195.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|+..+.||+|+||.||++.. ..+..+++|.+.. ......+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 3577888999999999999999 3444455554433 2333446789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
+++++|.+++... .....+++..+..++.+++.||.||| + .+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 81 MDAGSLDKLYAGG--VATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred cCCCCHHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 9999999998752 11247899999999999999999999 5 5999999999999999999999999999876533
Q ss_pred CCceeeccccccCCcccccccccC------CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTG------YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
.. .....+++.|+|||.+.+. .++.++|+|||||++|+|+ +|..||..... ............ +
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~-----~~~~~~~~~~~~-~ 225 (286)
T cd06622 156 SL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA-LGRYPYPPETY-----ANIFAQLSAIVD-G 225 (286)
T ss_pred Cc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHH-hCCCCCCCcch-----hhHHHHHHHHhh-c
Confidence 22 2234678899999987554 3578999999999999999 99999964211 111111111111 1
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. +.+ ......++.+++.+||+.+|++||++.++++
T Consensus 226 ~~-----~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 226 DP-----PTL-----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CC-----CCC-----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 10 111 1124566889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=289.27 Aligned_cols=255 Identities=19% Similarity=0.253 Sum_probs=197.5
Q ss_pred cCCCCCeecccCceEEEEEEe-C-CceEEEEEEccC----------CCchhHHHHHHHHHHHHh-cCCCceeeeeeeeee
Q 045067 63 NYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDG----------SVFDAYDCCFNNIVFASQ-MSHNNVLRLIGCCLE 129 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~----------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 129 (347)
+|+..+.||+|+||.||+|.. . ++..+++|.... ........+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 477788999999999999999 3 345555544321 112234557789888865 799999999999999
Q ss_pred CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCCceEEe
Q 045067 130 VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERYVPKLF 208 (347)
Q Consensus 130 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~~~kl~ 208 (347)
++..+++|||+++++|.+++... ......+++..+..++.|++.||.||| + .+++|+||+|+||+++.++.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSL-KEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHH-HhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEe
Confidence 99999999999999999988542 122356899999999999999999999 6 689999999999999999999999
Q ss_pred cCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 209 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|+ +|.+||..... .......
T Consensus 157 dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~-~g~~p~~~~~~--------~~~~~~~ 225 (269)
T cd08528 157 DFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC-TLQPPFYSTNM--------LSLATKI 225 (269)
T ss_pred cccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHH-hCCCcccccCH--------HHHHHHH
Confidence 999987654432 223456889999999999888999999999999999999 89999864321 1111111
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
. ........ ....+..+.+++.+||+.||++||++.|+.+.+++
T Consensus 226 ~-~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 226 V-EAVYEPLP---------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred h-hccCCcCC---------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1 11111100 01224568899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=291.08 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=194.4
Q ss_pred CeecccCceEEEEEEeC-Cc------eEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 68 NIITESSIFRLCQGVLP-DR------TISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~-~~------~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+.||+|+||.||+|... .. ..+++|.... ........+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999872 22 3455554433 3233456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-----ceEEecCCC
Q 045067 140 AEYGNLHDLLKRSYQS--HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-----VPKLFNFSL 212 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~ 212 (347)
+++++|.+++...... ....+++..++.++.+++.||.||| +.+++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999753111 2244789999999999999999999 99999999999999999877 899999999
Q ss_pred CccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 213 SASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 213 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
+......... ......++..|+|||.+.+..++.++|||||||++|+|++.|..||..... ... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~~-~~~~~~ 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QEV-LQHVTA 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HHH-HHHHhc
Confidence 8765433221 112334578899999999889999999999999999999559999864221 111 111111
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
+.. . ......+..+.+++.+||+.+|.+||++.++++.|++
T Consensus 229 ~~~-------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GGR-------L---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCc-------c---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 110 0 0111234567899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=295.47 Aligned_cols=260 Identities=18% Similarity=0.242 Sum_probs=202.1
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLE 129 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 129 (347)
.+..++....+.|+..+.||.|+||.||+|.. .++..+++|....... ....+..|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 45667777788999999999999999999999 6666777776655432 336688999999998 79999999999853
Q ss_pred ------CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC
Q 045067 130 ------VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY 203 (347)
Q Consensus 130 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~ 203 (347)
....+++|||+++|+|.+++... ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNT---KGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENA 158 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCC
Confidence 45789999999999999999763 2345888889999999999999999 99999999999999999999
Q ss_pred ceEEecCCCCccCCCCCceeeccccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCC
Q 045067 204 VPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278 (347)
Q Consensus 204 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~ 278 (347)
.++|+|||++........ ......|++.|+|||.+. +..++.++|+|||||++|+|+ +|..||.....
T Consensus 159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~-~g~~p~~~~~~----- 231 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMA-EGAPPLCDMHP----- 231 (282)
T ss_pred CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHH-hCCCCccccCH-----
Confidence 999999999876532211 123356889999999875 346788999999999999999 89999864321
Q ss_pred chHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.......... ..+... ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 232 ---~~~~~~~~~~------~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 232 ---MRALFLIPRN------PPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---HhhhhhHhhC------CCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000000000 011111 1123457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=291.71 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=201.4
Q ss_pred ccCCCCCeecccCceEEEEEEeC-----CceEEEEEEccCCCch-hHHHHHHHHHHHHhcCCCceeeeeeeeee--CCcc
Q 045067 62 NNYHYRNIITESSIFRLCQGVLP-----DRTISVVKFIDGSVFD-AYDCCFNNIVFASQMSHNNVLRLIGCCLE--VEIP 133 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~v~k~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 133 (347)
.+|...+.||+|+||.||+|.++ .+..+++|........ ..+.+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999972 2445555555544332 45779999999999999999999999877 5578
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
+++|||+++++|.+++... ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred EEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 9999999999999999763 235999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCcee--eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCC------CchHHHHH
Q 045067 214 ASIPEGETYI--DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD------ESFEMDFV 285 (347)
Q Consensus 214 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~------~~~~~~~~ 285 (347)
.......... .....++..|+|||...+..++.++||||||++++||+ +|..|+......... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF-TYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheee-ccCCCcccccchhccccccccccccHHHH
Confidence 8765332211 12234566799999998889999999999999999999 888887543221000 00001111
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
........ +... ....+.++.+++.+||+.+|++|||+.||++.|+++.
T Consensus 236 ~~~~~~~~-------~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 236 LELLKEGE-------RLPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHHHcCC-------cCCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 11122111 0000 1122356889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=291.48 Aligned_cols=260 Identities=17% Similarity=0.154 Sum_probs=192.2
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|+..+.||+|++|.||+|+. .++..+++|.+... .......+.+|+.++++++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477788999999999999998 44545555544322 122335688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
++ ++|.+++.... ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 98 58999886531 2356899999999999999999999 999999999999999999999999999998765432
Q ss_pred CceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc-------
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN------- 291 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 291 (347)
.. ......+++.|+|||.+.+. .++.++|||||||++|+|+ +|++||...... .........
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~-tg~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 224 (285)
T cd07861 155 VR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA-TKKPLFHGDSEI--------DQLFRIFRILGTPTED 224 (285)
T ss_pred cc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHH-HCCCCCCCCCHH--------HHHHHHHHHhCCCChh
Confidence 21 12234578899999987654 5789999999999999999 899999643210 000000000
Q ss_pred --------cCcccccCCccC--CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 --------RGFNGIVDPRII--GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 --------~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
............ ........+.++.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 00001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=314.62 Aligned_cols=268 Identities=13% Similarity=0.169 Sum_probs=190.2
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCC------Cceeeeeeeee
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSH------NNVLRLIGCCL 128 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~ 128 (347)
++...+++|...+.||+|+||+||+|.. .++..+++|++.... .....+..|+.+++.++| ++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3444568899999999999999999998 555555666554322 122456678888877754 45888888887
Q ss_pred eC-CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCC---
Q 045067 129 EV-EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERY--- 203 (347)
Q Consensus 129 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~--- 203 (347)
.+ .+.++|||++ +++|.+++.+. ..+++..+..++.|++.||.||| + .+|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccc
Confidence 64 4789999998 56899988764 67999999999999999999999 7 5999999999999998765
Q ss_pred -------------ceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 204 -------------VPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 204 -------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||+ +|++||..
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell-tG~~pf~~ 347 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY-TGKLLYDT 347 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH-hCCCCCCC
Confidence 4999999987543221 23467999999999999999999999999999999999 99999975
Q ss_pred CccCCC-------CCchHHHHHH--------HHHhc-cCcccccCCc----cCCch--hhHHHHHHHHHHHHHhccCCCC
Q 045067 271 GLRLNG-------DESFEMDFVK--------KYIEN-RGFNGIVDPR----IIGDE--LLEHKLQSSFELAFQCQSASAE 328 (347)
Q Consensus 271 ~~~~~~-------~~~~~~~~~~--------~~~~~-~~~~~~~~~~----~~~~~--~~~~~~~~~~~l~~~cl~~~P~ 328 (347)
...... .......|.. ..+.. +......++. +.... ........+.+|+.+||+.||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 322000 0000000100 00000 0000000000 00000 0001134678999999999999
Q ss_pred CCCCHHHHHH
Q 045067 329 DRPTMIDVAK 338 (347)
Q Consensus 329 ~RPs~~ell~ 338 (347)
+|||+.|+++
T Consensus 428 ~R~ta~e~L~ 437 (467)
T PTZ00284 428 KRLNARQMTT 437 (467)
T ss_pred hCCCHHHHhc
Confidence 9999999986
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=293.90 Aligned_cols=262 Identities=18% Similarity=0.222 Sum_probs=195.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++|+..+.||+|+||.||+|.. .++ .+++|+...... ....+.+.+|+.++++++|||++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4688889999999999999998 444 455554433221 2223567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++++|..++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99998888877543 56899999999999999999999 99999999999999999999999999999977654
Q ss_pred CCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh-------
Q 045067 219 GETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE------- 290 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 290 (347)
... ......++..|+|||.+.+ ..++.++|+||||+++|+|+ +|.+||...... ...........
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~-~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL-TGQPLWPGKSDV-----DQLYLIRKTLGDLIPRHQ 225 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHH-hCCCCCCCCChH-----HHHHHHHHHhCCCChHHh
Confidence 332 1223457889999998765 56789999999999999999 899999643220 00000000000
Q ss_pred ----ccCc-ccccCCccCCc----hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 ----NRGF-NGIVDPRIIGD----ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ----~~~~-~~~~~~~~~~~----~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.... .....+..... ...+..+..+.+++.+||+.+|++|||+.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 226 QIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 00000100000 011123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=299.29 Aligned_cols=254 Identities=19% Similarity=0.156 Sum_probs=195.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||++.. ..+..+++|.+.... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4688889999999999999999 444445544444332 223456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++... ..+++..+..++.+++.||.||| +.+++||||||+||+++.++.++++|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 999999999999764 56899999999999999999999 9999999999999999999999999999886421
Q ss_pred CCC--------------ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 218 EGE--------------TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 218 ~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
... ........++..|+|||.+.+..++.++|+|||||++||++ +|..||..... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~-~g~~pf~~~~~--------~~ 223 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL-VGCVPFFGDTP--------EE 223 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------HH
Confidence 110 00111245788999999998888999999999999999999 99999863211 11
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
........ .. ..+.. ....+..+.+++.+||+.+|++||++.++.+.|+
T Consensus 224 ~~~~~~~~-~~---~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 224 LFGQVISD-DI---EWPEG-----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHHHHhc-cc---CCCCc-----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 22221111 10 01110 0123456789999999999999999766665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=294.57 Aligned_cols=251 Identities=18% Similarity=0.236 Sum_probs=198.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
.++|...+.||+|+||.||+|.. .++..+++|..........+.+.+|+.++++++|||++++++++..++..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36788889999999999999987 44444555554443334447789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++.+ ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 98 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred CCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999975 45789999999999999999999 999999999999999999999999999988765433
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
.. ......+++.|+|||.+.+..++.++|+||||+++|+++ +|+.||....... ........+.
T Consensus 169 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll-~g~~pf~~~~~~~--------~~~~~~~~~~------ 232 (293)
T cd06647 169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV-EGEPPYLNENPLR--------ALYLIATNGT------ 232 (293)
T ss_pred cc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCChhh--------heeehhcCCC------
Confidence 22 123346888999999988888999999999999999999 8999996532200 0000000000
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+.. ......+..+.+++.+||+.+|++||++.+++..
T Consensus 233 ~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PEL---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 1112234567899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=327.80 Aligned_cols=260 Identities=18% Similarity=0.216 Sum_probs=197.7
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV-- 130 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 130 (347)
+.....++|...+.||+|+||+||+|.. .++.++++|.+... .......+.+|+.++++++||||+++++++.+.
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3345567899999999999999999999 56666666665532 223346789999999999999999999988653
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----CCCeEeccCCCCCeEECC-----
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF----SRPIVFRDLKSSYILVSE----- 201 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~----~~~ivH~dlkp~Nill~~----- 201 (347)
..++|||||+++|+|.++|.... .....+++..++.|+.||+.||.|||+.. ..+|+||||||+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~-~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCY-KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 56899999999999999997531 12256999999999999999999999321 145999999999999964
Q ss_pred ------------CCceEEecCCCCccCCCCCceeeccccccCCccccccccc--CCCCCccchHHHHHHHHHHHhcCCCc
Q 045067 202 ------------RYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART--GYLNEKCDVYSFGLLLLQLLSTGEDL 267 (347)
Q Consensus 202 ------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~~~g~~p 267 (347)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|+ +|..|
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL-TGk~P 242 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC-SGKTP 242 (1021)
T ss_pred ccccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH-HCCCC
Confidence 23589999999976543321 234578999999998754 46889999999999999999 89999
Q ss_pred cccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 268 FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
|..... ....... +.... .+.. ...+.++.+|+..||+.+|.+||++.|++.
T Consensus 243 F~~~~~-------~~qli~~-lk~~p-------~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 243 FHKANN-------FSQLISE-LKRGP-------DLPI----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcCCc-------HHHHHHH-HhcCC-------CCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 963211 1122221 11111 1110 112456889999999999999999999984
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=301.22 Aligned_cols=257 Identities=19% Similarity=0.262 Sum_probs=190.9
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV----- 130 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 130 (347)
...+.|...+.||+|+||.||+|.. .++ .+|+|++..... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999998 444 455555433221 22335678999999999999999999987643
Q ss_pred -CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 131 -EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 131 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
...++++|++ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcC
Confidence 3568999998 5799988864 56999999999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
||++...... .....||+.|+|||++.+ ..++.++||||+||++|+|+ +|..||..... .......
T Consensus 162 fg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~--------~~~~~~~ 228 (343)
T cd07878 162 FGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-KGKALFPGNDY--------IDQLKRI 228 (343)
T ss_pred CccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHH-HCCCCCCCCCH--------HHHHHHH
Confidence 9999765432 233568999999998876 57899999999999999999 89999964321 0011111
Q ss_pred Hhc--cC------------cccccC--CccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IEN--RG------------FNGIVD--PRIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~--~~------------~~~~~~--~~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... .. ...... +..... .......+.+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 229 MEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00 000000 000000 000011235789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=299.38 Aligned_cols=245 Identities=20% Similarity=0.261 Sum_probs=192.8
Q ss_pred CCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 67 RNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
...||+|+||.||+|.. .++..+++|..........+.+.+|+.++..++|||++++++++..++..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 34699999999999998 44444555554443333446788999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeec
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 225 (347)
.+++.. ..+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++........ ...
T Consensus 106 ~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 106 TDIVSQ------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred HHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 998865 46899999999999999999999 99999999999999999999999999999875543322 123
Q ss_pred cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCc
Q 045067 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGD 305 (347)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (347)
...++..|+|||++.+..++.++|||||||++|||+ +|..||..... ...... ........ .
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~-~g~~p~~~~~~--------~~~~~~-~~~~~~~~-----~--- 237 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV-DGEPPYFSDSP--------VQAMKR-LRDSPPPK-----L--- 237 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHH-HhccCCCC-----c---
Confidence 456899999999999888999999999999999999 89999864221 111111 11111000 0
Q ss_pred hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 306 ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 306 ~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.........+.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0011223457899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=303.86 Aligned_cols=266 Identities=19% Similarity=0.221 Sum_probs=193.6
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV----- 130 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 130 (347)
...++|...+.||+|+||.||++.. . +..+++|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 3467899999999999999999998 3 4455555554322 223346788999999999999999999987643
Q ss_pred -CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 131 -EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 131 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
..+++||||+++ +|.+.+.. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEe
Confidence 357999999985 78877753 4788899999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCC----------CCCc
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN----------GDES 279 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~----------~~~~ 279 (347)
||+++...... ......+|+.|+|||++.+..++.++|||||||++|+|+ +|+.||....... ....
T Consensus 170 fG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 170 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPCP 246 (364)
T ss_pred CCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99997654322 223457899999999999999999999999999999999 9999996532100 0000
Q ss_pred hHHHH----HHHHHhcc-Cccc-----ccCCccCC--chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 280 FEMDF----VKKYIENR-GFNG-----IVDPRIIG--DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 280 ~~~~~----~~~~~~~~-~~~~-----~~~~~~~~--~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... ........ .... ........ ..........+.+++.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 00000000 0000 00000000 0001112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=306.68 Aligned_cols=242 Identities=23% Similarity=0.305 Sum_probs=194.0
Q ss_pred CCCCCeecccCceEEEEEEe--CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 64 YHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
|+..+.||.|+||.||.|+. +...|++||...... ..-.+.+..|+.+|++++|||++.+.|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55667899999999999999 445566666544322 22347799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
|- |+..|++.-. ..++-+..+..|+.+.+.||+||| +.+.||||||..|||+.+.|.+|++|||.|.....
T Consensus 108 Cl-GSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 108 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred Hh-ccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 97 5888888753 378999999999999999999999 99999999999999999999999999998865543
Q ss_pred CceeeccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCcc-ccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 220 ETYIDDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLF-NMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.+...|||.|||||++. .+.|+-++||||+|++..||. .++||. +++. + ..+-...++.
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELA-ERkPPlFnMNA------M---SALYHIAQNe--- 241 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNA------M---SALYHIAQNE--- 241 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhh-hcCCCccCchH------H---HHHHHHHhcC---
Confidence 34468999999999876 568999999999999999999 666664 3211 1 1111111111
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.|.+. .++.+..++.++..||++-|.+|||.++++.
T Consensus 242 ---sPtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 ---SPTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ---CCCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 12222 2355778999999999999999999999875
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=299.17 Aligned_cols=245 Identities=20% Similarity=0.275 Sum_probs=193.5
Q ss_pred CCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 67 RNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
...||+|+||.||++.. .++..+++|..........+.+.+|+.+++.++|||++++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 35699999999999998 44555555555444444456789999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeec
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 225 (347)
.+++.. ..+++..+..++.+++.||+||| +.+++||||||+||+++.++.++|+|||++........ ...
T Consensus 107 ~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 176 (292)
T cd06658 107 TDIVTH------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK 176 (292)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence 999865 46889999999999999999999 99999999999999999999999999999876543222 123
Q ss_pred cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCc
Q 045067 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGD 305 (347)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (347)
...++..|+|||.+.+..++.++|+||||+++|||+ +|..||..... ...... .... ..+.+...
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~-~g~~p~~~~~~--------~~~~~~-~~~~-----~~~~~~~~ 241 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI-DGEPPYFNEPP--------LQAMRR-IRDN-----LPPRVKDS 241 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHH-HHhc-----CCCccccc
Confidence 356889999999998888999999999999999999 89999864221 111111 1110 11111111
Q ss_pred hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 306 ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 306 ~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
......+.+++.+||..+|++|||+.++++.
T Consensus 242 ---~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 ---HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ---cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1223467799999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=286.40 Aligned_cols=249 Identities=18% Similarity=0.218 Sum_probs=195.4
Q ss_pred cCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeee-CCccEEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE-VEIPVLVFE 138 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 138 (347)
+|+..+.||+|++|.||++.. . +..+++|++.... .....+.+.+|+.++++++|||++++++.+.. +...++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 477889999999999999998 3 4455555543322 22334668899999999999999999988764 446789999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++++|.+++... ....+++.++..++.+++.||++|| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999999763 2356899999999999999999999 99999999999999999999999999999876643
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
... ......+++.|+|||+..+..++.++|+||+|+++++|+ +|+.||.... .......... +...
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~-~g~~~~~~~~--------~~~~~~~~~~-~~~~--- 220 (257)
T cd08223 155 QCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA-TLKHAFNAKD--------MNSLVYRIIE-GKLP--- 220 (257)
T ss_pred cCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHH-cCCCCCCCCC--------HHHHHHHHHh-cCCC---
Confidence 222 223456889999999999999999999999999999999 8998986321 1111222111 1110
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .....++.+.+++.+||+.+|++|||+.+++.
T Consensus 221 --~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 --P-----MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --C-----CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 11234557889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=303.44 Aligned_cols=264 Identities=20% Similarity=0.278 Sum_probs=208.5
Q ss_pred ccCCCCCeecccCceEEEEEEeCC-ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPD-RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
+.....+.||+|-||.|..+...+ ..||+|++..........+|.+|+++|.+++||||+.++|+|..++.+++++|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 345567899999999999999966 5666666666666666688999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++|+|.+++.+.. ...+......+++.||+.|++||. +.++|||||.+.|+|+|.++++||+|||+++.+-.+.
T Consensus 618 EnGDLnqFl~ahe---apt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 618 ENGDLNQFLSAHE---LPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred hcCcHHHHHHhcc---CcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999998751 122455677789999999999999 9999999999999999999999999999999887766
Q ss_pred ceeec-cccccCCcccccccccCCCCCccchHHHHHHHHHHHh-cCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 221 TYIDD-GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS-TGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 221 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
.+... ...-+++|||||.+..+.++.++|+|+||+++||+++ ..+-||..... ....+-....+....... +
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven~~~~~~~~~~~~-~ 765 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVENAGEFFRDQGRQV-V 765 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHhhhhhcCCCCcce-e
Confidence 65443 3445789999999999999999999999999999864 45677764322 001111122222111110 0
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
...+..++..+++++.+||..+-++|||++++...|.+.
T Consensus 766 ------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 ------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 011223466788999999999999999999999888764
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=286.83 Aligned_cols=247 Identities=21% Similarity=0.270 Sum_probs=196.1
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC-----chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV-----FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.|+..+.||+|+||.||+|+. .++..+++|...... ....+.+.+|+.+++.++||||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 366778999999999999999 355555555443322 22446789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
+||+++++|.+++.+. ..+++..+..++.+++.||+||| +.+++|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999999764 56889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCceeeccccccCCcccccccccCC-CCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGY-LNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.... ......++..|+|||.+.... ++.++|+||||+++|+|+ +|+.||..... ..............
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~-~g~~pf~~~~~--------~~~~~~~~~~~~~~ 221 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMA-TGKPPWSQLEG--------VAAVFKIGRSKELP 221 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHH-hCCCCcccCcH--------HHHHHHHHhcccCC
Confidence 4332 223456889999999887666 899999999999999999 89999864321 11222211111111
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ........+.+++.+||+.+|.+||++.+++.
T Consensus 222 ~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 P----------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred C----------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0 11122456789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=290.57 Aligned_cols=276 Identities=22% Similarity=0.255 Sum_probs=214.7
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhc--CCCceeeeeeeeee
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQM--SHNNVLRLIGCCLE 129 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~ 129 (347)
+++--...+..+....+.||+|.||.||+|.|.+..||||.+...+. +.+.+|.+|++.+ +|+||+.+++.-..
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE----~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE----RSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeeccccCCceEEEEecccch----hhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 45555566777788889999999999999999999999998876654 5688898888764 99999999887544
Q ss_pred CC----ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-----CCCCCeEeccCCCCCeEEC
Q 045067 130 VE----IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHI-----GFSRPIVFRDLKSSYILVS 200 (347)
Q Consensus 130 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-----~~~~~ivH~dlkp~Nill~ 200 (347)
++ .+|||++|.+.|||+|+|.. ..++....++++..+|.||+|||. +....|.|||||+.|||+.
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 32 68999999999999999987 589999999999999999999995 3356799999999999999
Q ss_pred CCCceEEecCCCCccCCCCCce---eeccccccCCcccccccccCC----C-C-CccchHHHHHHHHHHHhc--------
Q 045067 201 ERYVPKLFNFSLSASIPEGETY---IDDGVKGTSGIVAPEYARTGY----L-N-EKCDVYSFGLLLLQLLST-------- 263 (347)
Q Consensus 201 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~-~-~~~Dv~s~G~~l~el~~~-------- 263 (347)
.++...|+|+|+|......... ..+..+||.+|||||++.... + + ..+||||||.++||+.-.
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e 430 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE 430 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence 9999999999999776554322 235688999999999987542 2 2 458999999999999821
Q ss_pred -CCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 264 -GEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 264 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
-++||.+..+ .++.+. .+....-.+-+.|.++......+.+..+.++++.||..||..|-|+--+-..|.+
T Consensus 431 ey~~Pyyd~Vp--~DPs~e------eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 431 EYQLPYYDVVP--SDPSFE------EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred hhcCCcccCCC--CCCCHH------HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 2466654433 222211 1112222233334444444555667788999999999999999999999999888
Q ss_pred HHH
Q 045067 343 MYK 345 (347)
Q Consensus 343 i~~ 345 (347)
+.+
T Consensus 503 l~~ 505 (513)
T KOG2052|consen 503 LSN 505 (513)
T ss_pred Hhc
Confidence 763
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=286.98 Aligned_cols=249 Identities=20% Similarity=0.229 Sum_probs=190.8
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCC----CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--Ccc
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGS----VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIP 133 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 133 (347)
.+|+..+.||+|+||.||+|.. .++ .+++|++.... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788899999999999999998 444 45554443221 122345688999999999999999999988753 567
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++++||+++++|.+++.+. ..+++.....++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 8999999999999999764 56889999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCc--eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 214 ASIPEGET--YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 214 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
........ .......++..|+|||.+.+..++.++|+||+||++|+|+ +|+.||..... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~-~g~~pf~~~~~--------~~~~~~~~~~ 224 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML-TEKPPWAEYEA--------MAAIFKIATQ 224 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH-HCCCCccccch--------HHHHHHHhcC
Confidence 76543211 1112345788999999999888999999999999999999 89999964321 1111111111
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ..+.+ .....+.+.+++ +||..+|++||+++||++
T Consensus 225 ~-----~~~~~-----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 P-----TNPQL-----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C-----CCCCC-----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 01111 112234456666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=305.06 Aligned_cols=197 Identities=24% Similarity=0.255 Sum_probs=171.9
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-C-----CceeeeeeeeeeCCccEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-H-----NNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 135 (347)
.|.+.++||+|+||.|-+|.. .++..|++|+++....- ..+...|+.+|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 677889999999999999999 67777777777765432 366778999999996 4 389999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC--CCceEEecCCCC
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE--RYVPKLFNFSLS 213 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~a 213 (347)
|+|.+.. +|.++++.+ ...+++...+..++.||+.||.+|| +.+|||+||||+||||.. ...+||+|||.|
T Consensus 266 VfELL~~-NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eehhhhh-hHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999985 999999986 5567999999999999999999999 999999999999999974 348999999999
Q ss_pred ccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCc
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGL 272 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~ 272 (347)
+.....-. ++.-+.-|.|||++.|.+|+.+.||||||||+.||+ +|.+.|....
T Consensus 339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~-tG~PLfpG~n 392 (586)
T KOG0667|consen 339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELF-TGEPLFPGDN 392 (586)
T ss_pred cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHh-cCccccCCCC
Confidence 77543221 567788999999999999999999999999999999 9999998654
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=292.06 Aligned_cols=256 Identities=20% Similarity=0.233 Sum_probs=198.4
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCC-----
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVE----- 131 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 131 (347)
..+++|+..+.||+|++|.||+|.. .++..+++|....... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4568899999999999999999999 4555666666555433 336789999999999 7999999999997654
Q ss_pred -ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 132 -IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 132 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
..++||||+++++|.+++.... .....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999999987531 12357899999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCceeeccccccCCccccccccc-----CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYART-----GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
|++........ ......++..|+|||.+.. ..++.++|||||||++|+|+ +|.+||..... ....
T Consensus 158 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~--------~~~~ 227 (275)
T cd06608 158 GVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA-DGKPPLCDMHP--------MRAL 227 (275)
T ss_pred ccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH-hCCCCccccch--------HHHH
Confidence 99876543222 1233568899999998753 35678999999999999999 99999964211 1111
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... ... +.+. .....+..+.+++.+||..||++|||+.++++
T Consensus 228 ~~~~~-~~~-----~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 228 FKIPR-NPP-----PTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHhhc-cCC-----CCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 111 1111 11123557889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=286.00 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=197.2
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCc--hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF--DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
.|...+.||+|+||.||+|.. .++..+++|....... ...+.+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 367788999999999999998 4555556555554333 3557899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 9999999999763 45889999999999999999999 999999999999999999999999999998776543
Q ss_pred Cceee---ccccccCCcccccccccCC---CCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 220 ETYID---DGVKGTSGIVAPEYARTGY---LNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 220 ~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
..... ....+++.|+|||++.+.. ++.++||||||+++|+++ +|+.||..... . ........ ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~-~g~~pf~~~~~-----~--~~~~~~~~-~~~ 223 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA-TGKRPWSELDN-----E--FQIMFHVG-AGH 223 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHH-hCCCCccCCcc-----h--HHHHHHHh-cCC
Confidence 32211 1356788999999988765 889999999999999999 89999964321 0 11111111 110
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+.+... ......+.+++.+||+.+|.+|||+.+++.
T Consensus 224 -----~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 -----KPPIPDS---LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -----CCCCCcc---cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111110 112456779999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.31 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=195.7
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcC---CCceeeeeeeeeeCCccEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMS---HNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 137 (347)
.|+..+.||+|+||.||+|.. .++..+++|..... .....+.+.+|+.++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778899999999999998 55666666655433 3334467889999999996 999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++.. ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999865 47899999999999999999999 9999999999999999999999999999987765
Q ss_pred CCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..... .....|+..|+|||.+.+ ..++.++|+|||||++|+|+ +|..||..... ..... ....
T Consensus 153 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll-~g~~p~~~~~~--------~~~~~-~~~~----- 216 (277)
T cd06917 153 QNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA-TGNPPYSDVDA--------FRAMM-LIPK----- 216 (277)
T ss_pred CCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHH-hCCCCCCCCCh--------hhhhh-cccc-----
Confidence 44321 233468899999998765 45789999999999999999 89999964321 00000 0000
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...+.+... ..+.++.+++.+||+.+|++||++.+++.
T Consensus 217 ~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 217 SKPPRLEDN----GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 011111111 13456889999999999999999999964
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=291.10 Aligned_cols=249 Identities=17% Similarity=0.239 Sum_probs=205.8
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
-|.....||+|+||.||+|.+ ..+.|+++|..+..+ +.+++..|+.++++...|++|+++|.|.....+|||||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 355667899999999999999 667766666665543 45889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
.|+..+.+... ..++++..+..++..-++||+||| ...-+|||||..|||++.+|.+|++|||.|-.+.+..
T Consensus 112 AGSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM- 183 (502)
T KOG0574|consen 112 AGSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM- 183 (502)
T ss_pred CCcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-
Confidence 99999999763 478999999999999999999999 8999999999999999999999999999997665322
Q ss_pred eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
...++..|||-|||||++..-.|+.++||||+|++..||. .|++||.+-.+.. ..+. +..-..|.
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMA-EG~PPYsDIHPMR--AIFM------------IPT~PPPT 248 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMA-EGRPPYSDIHPMR--AIFM------------IPTKPPPT 248 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhh-cCCCCcccccccc--eeEe------------ccCCCCCC
Confidence 2345688999999999999999999999999999999999 9999997643310 0000 00001111
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.. .++..+.++-+++.+||-.+|+.|.|+.++++.
T Consensus 249 F~---KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FK---KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CC---ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11 223456788999999999999999999998864
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=286.58 Aligned_cols=252 Identities=19% Similarity=0.286 Sum_probs=196.7
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC------chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV------FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
+|+..+.||+|++|.||+|.. .++..+++|.+.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999998 444444444443322 1134678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-ceEEecCCCCc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLFNFSLSA 214 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~ 214 (347)
|+||+++++|.+++... .++++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||++.
T Consensus 81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999999764 57899999999999999999999 99999999999999998776 59999999987
Q ss_pred cCCCCCce---eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 215 SIPEGETY---IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 215 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
........ ......++..|+|||.+.+..++.++|+||+|+++++|+ +|..||..... .............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~-----~~~~~~~~~~~~~ 226 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA-TAKPPWNAEKH-----SNHLALIFKIASA 226 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHH-hCCCCCCCCCC-----cchHHHHHHHhcc
Confidence 76543211 112346788999999998888999999999999999999 89999864322 1111111111111
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. ..........++.+++.+||+.+|++|||+.+++.
T Consensus 227 ~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 TT----------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CC----------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00 01122234567889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=292.97 Aligned_cols=263 Identities=21% Similarity=0.239 Sum_probs=197.5
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++|+..+.||+|+||.||+|.. +++..+++|.+... .....+.+.+|+.++++++|+||+++++++.+++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3678889999999999999999 45555555555432 22234678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|++++.+..+.... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 99987666665442 56899999999999999999999 99999999999999999999999999999887665
Q ss_pred CCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh-------
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE------- 290 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 290 (347)
..........++..|+|||++.+. .++.++|+||||+++|+|+ +|.+||..... ............
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~-~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL-DGEPLFPGDSD-----IDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHH-hCCCCCCCCCH-----HHHHHHHHHHhCCCCHHHh
Confidence 443223345678999999998887 8899999999999999999 89999864321 000000000000
Q ss_pred -----ccCcc-----cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 -----NRGFN-----GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 -----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... +..++...........+.++.+++.+||+.+|++|||+++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0000000000011122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=292.35 Aligned_cols=247 Identities=19% Similarity=0.257 Sum_probs=194.8
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
|...+.||+|++|.||++.. .++..+++|..........+.+.+|+.+++.++|||++++++++..++..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44557899999999999998 44444555544433333446688999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
++|.+++.. ..+++..+..++.+++.||+||| +.+++||||+|+||+++.++.++++|||.+........
T Consensus 101 ~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 101 GALTDIVTH------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 999999875 46899999999999999999999 99999999999999999999999999998865543322
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
......|++.|+|||...+..++.++|+|||||++|+|+ +|..||..... .......... .. +..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell-~g~~p~~~~~~--------~~~~~~~~~~-~~-----~~~ 235 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV-DGEPPYFNEPP--------LQAMKRIRDN-LP-----PKL 235 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHH-hCCCCCcCCCH--------HHHHHHHHhc-CC-----CCC
Confidence 123356889999999998888999999999999999999 89999864221 1111111111 10 111
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. ....+..+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 KN---LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cc---cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 00 1113456889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=294.59 Aligned_cols=262 Identities=24% Similarity=0.272 Sum_probs=195.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++|+..+.||+|+||.||+|.. +++..+++|...... ....+.+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4678889999999999999999 445555555544322 2234568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++++|.++.... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99998888877543 45899999999999999999999 99999999999999999999999999999876544
Q ss_pred CCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH----------
Q 045067 219 GETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK---------- 287 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 287 (347)
... ......++..|+|||++.+ ..++.++||||||+++|||+ +|.+||...... ........
T Consensus 153 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~-~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07846 153 PGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML-TGEPLFPGDSDI-----DQLYHIIKCLGNLIPRHQ 225 (286)
T ss_pred Ccc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHH-cCCCCCCCCchH-----HHHHHHHHHhCCCchhhH
Confidence 332 2233567889999998765 45788999999999999999 899998643210 00000000
Q ss_pred -HHhcc-CcccccCCccCCch----hhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 288 -YIENR-GFNGIVDPRIIGDE----LLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 288 -~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... .......+...... ..+..+..+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 00000011110000 11123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=287.83 Aligned_cols=261 Identities=21% Similarity=0.203 Sum_probs=199.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 137 (347)
++|...+.||.|++|.||++.. .++..+++|..... .......+.+|+.++++++||||+++++++.+. ..+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3677888999999999999999 55666666665543 223456789999999999999999999988654 3689999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++.... .....++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVK-KRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 9999999999876531 13356889999999999999999999 9999999999999999999999999999986554
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... ....++..|+|||.+.+..++.++||||+||++|+|+ +|..||...... ........ ..........+
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~---~~~~~~~~-~~~~~~~~~~~ 228 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVA-QNRFPFPPEGEP---PLGPIELL-SYIVNMPNPEL 228 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCcccCC---CCChHHHH-HHHhcCCchhh
Confidence 3221 2345788999999999889999999999999999999 899999754221 01111111 11111111111
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...... ....++.+.+++.+||+.+|++|||+.|+++
T Consensus 229 -~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 -KDEPGN---GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -ccCCCC---CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111100 0123457889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=290.81 Aligned_cols=262 Identities=19% Similarity=0.195 Sum_probs=195.7
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|+..+.||+|+||.||+|.. .++..+++|...... ....+.+.+|+.++++++|||++++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 467788999999999999998 444444444443322 23346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+ +++|.+++... ...+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 89999998763 256999999999999999999999 999999999999999999999999999998776544
Q ss_pred CceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc------
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR------ 292 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 292 (347)
.........++..|+|||.+.+. .++.++||||+|+++++|+ +|.+||..... ..............
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~-tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELL-NGSPLFPGEND-----IEQLAIVFRTLGTPNEETWP 226 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHH-cCCcCcCCCCH-----HHHHHHHHHHcCCCChHHHh
Confidence 32222345689999999987654 5689999999999999999 88888854321 00000111100000
Q ss_pred ------CcccccCCccC---CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 ------GFNGIVDPRII---GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 ------~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.......+... .....+.....+.+++.+||+.+|++|||++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 00111123467899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=288.59 Aligned_cols=253 Identities=20% Similarity=0.259 Sum_probs=199.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|+..+.||+|+||.||++.. .++..+++|.+... .....+.+.+|+.++++++||||+++++++..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 3577778999999999999999 45555555554433 334456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
+++++|.+++... ...+++..+..++.+++.||+||| + .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 81 MDGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred cCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 9999999999763 157899999999999999999999 8 9999999999999999999999999998866532
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
... ....++..|+|||.+.+..++.++||||+|+++|+|+ +|..||..... .................
T Consensus 154 ~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~---~~~~~~~~~~~~~~~~~----- 221 (265)
T cd06605 154 SLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELA-TGRFPYPPEND---PPDGIFELLQYIVNEPP----- 221 (265)
T ss_pred HHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHH-hCCCCCCcccc---ccccHHHHHHHHhcCCC-----
Confidence 221 1256888999999999889999999999999999999 89999864321 11112222222222110
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.+.. ...+.++.+++.+||..+|++|||+.+++.
T Consensus 222 -~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 -PRLPS----GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -CCCCh----hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11111 114556889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=285.88 Aligned_cols=249 Identities=19% Similarity=0.222 Sum_probs=197.2
Q ss_pred cCCCCCeecccCceEEEEEEe-CC-ceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PD-RTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~-~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|+..+.||+|+||.||.+.. .+ ..+++|++.... .....+.+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999998 44 445555443221 223346789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++... ....+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999998753 2245789999999999999999999 999999999999999999999999999998765433
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
... .....|++.|+|||+..+..++.++|+|||||++++|+ +|..||.... ........... ...
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~-~g~~~~~~~~--------~~~~~~~~~~~-~~~---- 219 (256)
T cd08218 155 VEL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC-TLKHAFEAGN--------MKNLVLKIIRG-SYP---- 219 (256)
T ss_pred hhh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHH-cCCCCccCCC--------HHHHHHHHhcC-CCC----
Confidence 221 22345788999999998888999999999999999999 8999986421 11222222211 110
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ........+.+++.+||+.+|++||++.++++
T Consensus 220 -~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 -P-----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -C-----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 11123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=296.97 Aligned_cols=252 Identities=19% Similarity=0.233 Sum_probs=196.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-Cc--hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VF--DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||+|.. .++..+++|..... .. ...+.+.+|+.+++.++||||+++++++.++...+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3678889999999999999999 44555555544432 22 23456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+.+++|.+++... ....+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999998753 2356899999999999999999999 9999999999999999999999999999886543
Q ss_pred CCCce----------------------------eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccc
Q 045067 218 EGETY----------------------------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFN 269 (347)
Q Consensus 218 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~ 269 (347)
..... ......||..|+|||++.+..++.++||||||+++|+|+ +|..||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~ 233 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML-YGTTPFK 233 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHh-hCCCCCC
Confidence 22110 111245788999999998888999999999999999999 8999996
Q ss_pred cCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 045067 270 MGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT----MIDVAK 338 (347)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs----~~ell~ 338 (347)
.... . .......... . .... ....+..+.+++.+||+.+|++||| +.+++.
T Consensus 234 ~~~~-------~-~~~~~~~~~~-~------~~~~---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 234 GSNR-------D-ETFSNILKKE-V------TFPG---SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCch-------H-HHHHHHhcCC-c------cCCC---ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 4321 1 1111111110 0 0000 1113567889999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=286.75 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=197.1
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
-|+..+.||+|+||.||+|.. .++..+++|..... .....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 466778899999999999988 45555555654432 2334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++.. ..+++..+..++.+++.|+.+|| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 85 GGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999999865 46899999999999999999999 9999999999999999999999999999987654322
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
. ......++..|+|||.+.+..++.++|+|||||++|+|+ +|..||..... ...... ...... +
T Consensus 156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~--------~~~~~~-~~~~~~-----~ 219 (277)
T cd06641 156 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA-KGEPPHSELHP--------MKVLFL-IPKNNP-----P 219 (277)
T ss_pred h-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHH-cCCCCCCccch--------HHHHHH-HhcCCC-----C
Confidence 1 123346788999999998888899999999999999999 99999864221 111111 111110 1
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.+ ....+..+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TL-----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CC-----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11 11234567899999999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=291.40 Aligned_cols=260 Identities=19% Similarity=0.193 Sum_probs=192.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|+..+.||+|++|.||+|.. .++..+++|..... .......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5688889999999999999998 44555555544332 222234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++ +|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~~-~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 85 LDT-DLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred CCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 985 999998763 246899999999999999999999 999999999999999999999999999998654322
Q ss_pred CceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh---c----
Q 045067 220 ETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE---N---- 291 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~---- 291 (347)
... .....++..|+|||++.+ ..++.++||||+|+++|+|+ +|++||..... .......... .
T Consensus 157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~-~g~~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTD-------VEDQLHKIFRVLGTPTEE 227 (291)
T ss_pred Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHH-hCCCCCCCCcc-------HHHHHHHHHHhcCCCChh
Confidence 111 122346889999998765 46889999999999999999 89999964321 0111111110 0
Q ss_pred --------cCcccccCCccCCch---hhHHH--HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 --------RGFNGIVDPRIIGDE---LLEHK--LQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 --------~~~~~~~~~~~~~~~---~~~~~--~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........+...... ..... ...+.+++.+||+.+|++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000000000 00011 256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=285.07 Aligned_cols=249 Identities=20% Similarity=0.203 Sum_probs=191.8
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CC----CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--Ccc
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GS----VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIP 133 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 133 (347)
++|...+.||+|+||.||.|.. +++..+++|... .. .....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688889999999999999998 444444444432 21 122346788999999999999999999988764 467
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
+++|||+++++|.+++.+. ..+++.....++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 8999999999999999764 46888999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCce--eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 214 ASIPEGETY--IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 214 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
......... ......++..|+|||.+.+..++.++|+|||||++|+|+ +|+.||..... ... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~-~g~~p~~~~~~-------~~~-~~~~~~~ 224 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML-TEKPPWAEFEA-------MAA-IFKIATQ 224 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHh-hCCCCCCccch-------HHH-HHHHhcC
Confidence 765422111 112345888999999998888999999999999999999 89999863211 111 1111111
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ..+ ..+......+.+++.+||. +|++||+++|+++
T Consensus 225 ~-----~~~-----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 P-----TNP-----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C-----CCC-----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0 011 1122334567889999995 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.20 Aligned_cols=253 Identities=18% Similarity=0.241 Sum_probs=193.7
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-C---------chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-V---------FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE 131 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~---------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 131 (347)
+|...+.||+|+||.||+|.. .++..+++|..... . ....+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 366778999999999999988 44544555543321 1 011246788999999999999999999999999
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
..++|+||+++++|.+++.+. ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999999764 57899999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCce-eeccccccCCcccccccccCC--CCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 212 LSASIPEGETY-IDDGVKGTSGIVAPEYARTGY--LNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 212 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
++......... ......++..|+|||.+.... ++.++|+||+|+++|+++ +|..||..... .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~--------~~~~~~~ 224 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF-AGRRPWSDEEA--------IAAMFKL 224 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHH-hCCCCCcCcch--------HHHHHHh
Confidence 98765432111 123356889999999887654 789999999999999999 89999853221 1111111
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.... ....+... .....+..+.+++.+||+++|++|||+.++++
T Consensus 225 ~~~~-~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 225 GNKR-SAPPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hccc-cCCcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111 01111111 11223567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=308.06 Aligned_cols=245 Identities=21% Similarity=0.271 Sum_probs=201.1
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCHH
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLH 146 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 146 (347)
-+||+|.||+||-|+. +++.-.++|-++.......+-+..|+.+.++++|.|||+++|++..++++-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3799999999999999 666666677666655555578999999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC-CCCceEEecCCCCccCCCCCcee
Q 045067 147 DLLKRSYQSHSEPL--LLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS-ERYVPKLFNFSLSASIPEGETYI 223 (347)
Q Consensus 147 ~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~ 223 (347)
+++.... +++ .+.+...+..||++||.||| +..|||||||-.|+|++ -.|.+||+|||-++.+..-.+ .
T Consensus 661 sLLrskW----GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~ 732 (1226)
T KOG4279|consen 661 SLLRSKW----GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-C 732 (1226)
T ss_pred HHHHhcc----CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCc-c
Confidence 9998732 566 78899999999999999999 99999999999999998 578999999999888754333 2
Q ss_pred eccccccCCcccccccccC--CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 224 DDGVKGTSGIVAPEYARTG--YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 224 ~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
..+..||..|||||++..+ .|..++|||||||++.||. +|+|||..... + ...+-...+ +..
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMA-TGrPPF~Elgs-----p------qAAMFkVGm---yKv- 796 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMA-TGRPPFVELGS-----P------QAAMFKVGM---YKV- 796 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeec-cCCCCeeecCC-----h------hHhhhhhcc---eec-
Confidence 3567899999999998765 6889999999999999999 99999964321 1 111111111 111
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+..+.+.+.++..++.+|+.++|.+||++.++++
T Consensus 797 --HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 797 --HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 12334567788999999999999999999999975
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=283.15 Aligned_cols=252 Identities=19% Similarity=0.217 Sum_probs=201.8
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|+..+.||+|++|.||+|+. .++..+++|...... ....+.+.+|+..+.+++|||++++++++..++..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 3678889999999999999999 434444445444333 24457799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
+++++|.+++... ..+++..+..++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999764 67899999999999999999999 8 9999999999999999999999999999877654
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
.... .....++..|+|||.+.+..++.++|+||||+++|+|+ +|..||..... ............ ...
T Consensus 153 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~-tg~~p~~~~~~-----~~~~~~~~~~~~-~~~---- 220 (264)
T cd06623 153 TLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECA-LGKFPFLPPGQ-----PSFFELMQAICD-GPP---- 220 (264)
T ss_pred CCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHH-hCCCCCccccc-----cCHHHHHHHHhc-CCC----
Confidence 3322 12456889999999999889999999999999999999 89999865432 011122222211 111
Q ss_pred CCccCCchhhHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 299 DPRIIGDELLEH-KLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 299 ~~~~~~~~~~~~-~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+.. ... .+..+.+++.+||..+|++|||+.++++.
T Consensus 221 -~~~-----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 -PSL-----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCC-----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 111 34578899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=291.86 Aligned_cols=198 Identities=22% Similarity=0.231 Sum_probs=156.7
Q ss_pred CCeecccCceEEEEEEe-C--CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccEEEEEeCC
Q 045067 67 RNIITESSIFRLCQGVL-P--DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE--VEIPVLVFESAE 141 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~-~--~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 141 (347)
.+.||+|+||.||+|.. + .+..+++|...... ....+.+|+.++++++||||+++++++.. +...++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 35799999999999997 2 23444445444332 22457899999999999999999998854 457899999997
Q ss_pred CCCHHHHHhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE----CCCCceEEecCCCC
Q 045067 142 YGNLHDLLKRSYQ----SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV----SERYVPKLFNFSLS 213 (347)
Q Consensus 142 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~a 213 (347)
+ +|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 88888753211 11235889999999999999999999 9999999999999999 56679999999999
Q ss_pred ccCCCCCce--eeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccC
Q 045067 214 ASIPEGETY--IDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMG 271 (347)
Q Consensus 214 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~ 271 (347)
+........ ......+|+.|+|||++.+ ..++.++||||+||++|||+ +|.+||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~-tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHH-hCCCCcccc
Confidence 876443221 1234568999999998876 46899999999999999999 999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=292.54 Aligned_cols=244 Identities=18% Similarity=0.232 Sum_probs=196.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||++.. .++..+++|...... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3688889999999999999999 445555555544321 223466889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++... ..++...+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999999764 67899999999999999999999 9999999999999999999999999999987765
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.. .....+++.|+|||.+.+...+.++|+||||+++|+|+ +|..||..... ........ .+..
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~--------~~~~~~~~-~~~~--- 215 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEML-AGYPPFFDDNP--------IQIYEKIL-EGKV--- 215 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHh-cCCc---
Confidence 43 23356889999999988888899999999999999999 89999864321 11111111 1110
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
.+. ......+.+++.+||+.+|.+|| +++|+++
T Consensus 216 ---~~~-----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 ---RFP-----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---cCC-----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 011 11245678999999999999999 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=313.21 Aligned_cols=270 Identities=16% Similarity=0.117 Sum_probs=190.2
Q ss_pred HHhccCCCCCeecccCceEEEEEEeC--CceEEEEE--------------Ecc---CCCchhHHHHHHHHHHHHhcCCCc
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVLP--DRTISVVK--------------FID---GSVFDAYDCCFNNIVFASQMSHNN 119 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~v~k--------------~~~---~~~~~~~~~~~~E~~~l~~l~h~n 119 (347)
...++|...+.||+|+||+||++... .+...++| ... .........+.+|+.++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998761 22111111 000 011123356889999999999999
Q ss_pred eeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 045067 120 VLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199 (347)
Q Consensus 120 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill 199 (347)
|+++++++.+.+..++++|++. ++|.+++...............+..++.|++.||.||| +.+|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 9999999999999999999996 48888775432111223446677889999999999999 9999999999999999
Q ss_pred CCCCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCc
Q 045067 200 SERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDES 279 (347)
Q Consensus 200 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~ 279 (347)
+.++.+||+|||++...............||+.|+|||++.+..++.++|||||||++|||++.+.+|+.....
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~------ 374 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG------ 374 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC------
Confidence 99999999999999876544333334567999999999999999999999999999999999555556643211
Q ss_pred hHHHHHHHHHhccC--cccccC---------------Ccc-CCchhh--HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 280 FEMDFVKKYIENRG--FNGIVD---------------PRI-IGDELL--EHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 280 ~~~~~~~~~~~~~~--~~~~~~---------------~~~-~~~~~~--~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.......+...... ..++.+ ... ...... ......+.+++.+||+.||.+|||+.|+++
T Consensus 375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 01111111111000 000000 000 000000 011235678899999999999999999986
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=290.69 Aligned_cols=258 Identities=15% Similarity=0.147 Sum_probs=189.1
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|+..+.||+|+||.||+|.. .++..+++|...... ......+.+|+.++++++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 367788999999999999999 445445555443321 12224578899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++ +|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CDQ-DLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CCC-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 984 888887652 256899999999999999999999 999999999999999999999999999998765432
Q ss_pred CceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCc-cccCccCCCCCchHHHHHHHHHh-------
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDL-FNMGLRLNGDESFEMDFVKKYIE------- 290 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~------- 290 (347)
... .....+++.|+|||.+.+. .++.++||||+||++|+|+ +|..| |..... .........
T Consensus 153 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-tg~~p~~~~~~~--------~~~~~~~~~~~~~~~~ 222 (284)
T cd07839 153 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA-NAGRPLFPGNDV--------DDQLKRIFRLLGTPTE 222 (284)
T ss_pred CCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHH-hcCCCCcCCCCH--------HHHHHHHHHHhCCCCh
Confidence 211 2234578899999987664 5789999999999999999 55555 432211 011111100
Q ss_pred -------c-cCcc--cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 -------N-RGFN--GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 -------~-~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .... .............+..+.++.+++.+||+.||.+|||++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 0000 0000000000111223457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=300.94 Aligned_cols=240 Identities=17% Similarity=0.142 Sum_probs=182.9
Q ss_pred ecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhc---CCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 70 ITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQM---SHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 70 lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
||+|+||+||+|.. .++..+++|++.... .........|..++... +||||+++++++.++...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999998 445555555543321 12223455677777655 699999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.++|+|||++........
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 9999998764 67899999999999999999999 99999999999999999999999999999875433222
Q ss_pred eeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 223 IDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
......||+.|+|||++.+. .++.++||||+||++|+|+ +|..||..... ...... ...+.. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ell-tG~~Pf~~~~~--------~~~~~~-i~~~~~------~ 215 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC-CGWSPFYAEDT--------QQMYRN-IAFGKV------R 215 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEec-cCCCCCCCCCH--------HHHHHH-HHcCCC------C
Confidence 12346799999999988654 5799999999999999999 99999864321 111111 111111 1
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPT----MIDVAK 338 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs----~~ell~ 338 (347)
+... .....+.+++.+||+.+|.+||+ +.++++
T Consensus 216 ~~~~----~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 FPKN----VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCc----cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1110 12446779999999999999984 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=297.51 Aligned_cols=246 Identities=21% Similarity=0.257 Sum_probs=201.3
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.+.|..-++||+||||.||-+.. .+++.++.|.+.+.. ........+|-.+|.+++.+.||.+-..|.+.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 45788889999999999999988 666665555443322 22235578999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
+..|.||+|.-+|.+. ....+++..+.-++.+|+.||+||| ..+||.||+||+|||+|++|+++|+|+|+|..+
T Consensus 264 LtlMNGGDLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEeecCCceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 9999999999999875 3467999999999999999999999 999999999999999999999999999999998
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..+... .+..||.+|||||++.+..|+...|.||+||++|||+ .|+.||..... ..-. +
T Consensus 338 ~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi-~G~sPFr~~Ke-----Kvk~-------------e 396 (591)
T KOG0986|consen 338 PEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMI-AGHSPFRQRKE-----KVKR-------------E 396 (591)
T ss_pred CCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHH-cccCchhhhhh-----hhhH-------------H
Confidence 876654 3458999999999999999999999999999999999 99999975322 0000 0
Q ss_pred ccCCccC--CchhhHHHHHHHHHHHHHhccCCCCCCCCH
Q 045067 297 IVDPRII--GDELLEHKLQSSFELAFQCQSASAEDRPTM 333 (347)
Q Consensus 297 ~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~ 333 (347)
-+|.++. ..+.++..++++.++....|+.||++|.-.
T Consensus 397 Evdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 397 EVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1111111 112334556788899999999999999653
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=289.95 Aligned_cols=262 Identities=18% Similarity=0.181 Sum_probs=193.6
Q ss_pred cCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCCc----hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSVF----DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
+|+..+.||+|+||.||+|.. . +..+++|++...... .....+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 367778999999999999998 3 445555554433221 1234577899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+ +|+|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 78999999763 136999999999999999999999 999999999999999999999999999998776
Q ss_pred CCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc----
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN---- 291 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 291 (347)
...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|+ +|.+||...... . ...........
T Consensus 153 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~-~g~~~~~~~~~~----~-~~~~~~~~~~~~~~~ 225 (298)
T cd07841 153 GSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELL-LRVPFLPGDSDI----D-QLGKIFEALGTPTEE 225 (298)
T ss_pred cCCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHH-cCCccccCCccH----H-HHHHHHHHcCCCchh
Confidence 543221 122356788999998754 46789999999999999999 888888643220 0 00000000000
Q ss_pred -----cCcccccC----CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 292 -----RGFNGIVD----PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 292 -----~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
........ +...........+..+.+++.+||+.+|++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000 0000011112335678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=284.13 Aligned_cols=258 Identities=20% Similarity=0.331 Sum_probs=195.6
Q ss_pred CCCCCeecccCceEEEEEEe--C--CceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 045067 64 YHYRNIITESSIFRLCQGVL--P--DRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE------ 131 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~--~--~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 131 (347)
|...+.||+|+||.||+|.+ + ++..+++|..... .....+.+.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 45677899999999999987 1 2345555554432 2234567889999999999999999999886542
Q ss_pred ccEEEEEeCCCCCHHHHHhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSY-QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
..++++||+.+|+|.+++.... ......+++.....++.|++.||+||| +.+|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875431 112235789999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 211 SLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 211 g~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
|+++......... .....+++.|++||.+.+..++.++|||||||++|+|++.|.+||..... ........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNYLI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHHHH
Confidence 9988764433211 12334567899999998888999999999999999999448999864321 11111111
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
...... . ....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ~~~~~~------~-----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRLK------Q-----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcCC------C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111100 0 012345688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=281.99 Aligned_cols=248 Identities=20% Similarity=0.265 Sum_probs=195.5
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|+..+.||+|+||.||++.. .++..+++|..... .....+.+.+|+.++++++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477788999999999999998 44544555544332 223456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC-CceEEecCCCCccCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-YVPKLFNFSLSASIPE 218 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~a~~~~~ 218 (347)
+++++|.+++... ....+++..+..++.+++.||+||| +.+++|+||+|+||+++.+ +.++++|||++.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR---CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999763 2345899999999999999999999 9999999999999999855 4679999999977654
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
... .....++..|+|||.+.+..++.++||||||+++|+|+ +|..||..... .......... ....+
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~-~~~~~~~~~~~--------~~~~~~~~~~-~~~~~- 221 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA-SLKRAFEAANL--------PALVLKIMSG-TFAPI- 221 (256)
T ss_pred Ccc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHH-hCCCCcccCch--------HHHHHHHHhc-CCCCC-
Confidence 322 22356889999999998888999999999999999999 88888854221 1122222111 11110
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
....+..+.+++.+||+.+|++|||+.|+++
T Consensus 222 ---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 ---------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=290.76 Aligned_cols=262 Identities=17% Similarity=0.140 Sum_probs=191.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++++|...+.||+|+||.||+|.. .++..+++|.... ........+.+|+.+++.++|+||+++++++.++...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 356788999999999999999988 4444444454433 22232346789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+. ++|.+.+... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9996 6887777542 245788889999999999999999 9999999999999999999999999999987643
Q ss_pred CCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh------
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE------ 290 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 290 (347)
.... ......+++.|+|||.+.+. .++.++|||||||++|+|+ +|..||..... ........+.
T Consensus 155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~-~g~~~f~~~~~-------~~~~~~~~~~~~~~~~ 225 (291)
T cd07870 155 IPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML-QGQPAFPGVSD-------VFEQLEKIWTVLGVPT 225 (291)
T ss_pred CCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCchh-------HHHHHHHHHHHcCCCC
Confidence 3221 12234578899999988754 5788999999999999999 89999964321 0111111100
Q ss_pred ---------ccCcccccCCccCCch-----hhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 ---------NRGFNGIVDPRIIGDE-----LLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ---------~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.........+...... ........+.+++.+|++.||++|||+.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000 00011346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=303.97 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=203.5
Q ss_pred CCCeecccCceEEEEEEe--CCc--eEEEEEEccCCCch-hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 66 YRNIITESSIFRLCQGVL--PDR--TISVVKFIDGSVFD-AYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 66 ~~~~lg~G~~g~Vy~~~~--~~~--~~~v~k~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
..++||+|+||.|++|.| .++ .-+++|.+...... ....|.+|+.+|.+|+|||++++||+..+ ....+|+|++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 346799999999999999 333 23556666555433 56889999999999999999999999987 7789999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
+.|+|.+.|.+. ....+.....-.++.|||.|+.||. .+++|||||-..|+|+-....+||+|||+.+.+..+.
T Consensus 193 plGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 193 PLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred ccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999872 4467888899999999999999999 9999999999999999999999999999999988765
Q ss_pred ceee--ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 221 TYID--DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 221 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
.... ....-...|+|||.+....++.++|||+|||++|||+|.|+.||..... .+.+. .++.+
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~qIL~-~iD~~------ 331 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------IQILK-NIDAG------ 331 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------HHHHH-hcccc------
Confidence 4332 2344567899999999999999999999999999999999999975432 12222 22221
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
.++.. +..+++.+++++..||..+|.+|||+..|.+.+
T Consensus 332 -erLpR---Pk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 -ERLPR---PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -ccCCC---CCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 11212 234577899999999999999999999997543
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=308.90 Aligned_cols=246 Identities=18% Similarity=0.244 Sum_probs=205.0
Q ss_pred CCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 67 RNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
+..||.|+||.||+|.. +.+..|+-|++...+....+.++-|+.||+.++||+||++++.|...+.+||+.|||+||..
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 34599999999999999 67788888988888777788999999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeec
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 225 (347)
+..+-. -+..+.+.++.-++.+++.||.||| +..|||||||+.|||+.-+|.++|+|||.+....... ....
T Consensus 117 DaimlE----L~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkRD 188 (1187)
T KOG0579|consen 117 DAIMLE----LGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKRD 188 (1187)
T ss_pred hHHHHH----hccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH-hhhc
Confidence 888765 3478999999999999999999999 9999999999999999999999999999875543211 1123
Q ss_pred cccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 226 GVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 226 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
...|||.|||||+.. ..+|+.++||||||++|.||. .+.||-... ....++.+..+... |
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMA-qiEPPHhel--------npMRVllKiaKSeP------P 253 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMA-QIEPPHHEL--------NPMRVLLKIAKSEP------P 253 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHh-ccCCCcccc--------chHHHHHHHhhcCC------C
Confidence 478999999999764 568999999999999999999 999986532 22344444443321 2
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+. .+......+.+++.+||..||.+||+++++++
T Consensus 254 TLl---qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 TLL---QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ccc---CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 222 22345667889999999999999999999986
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=286.07 Aligned_cols=252 Identities=19% Similarity=0.258 Sum_probs=190.5
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHH-HHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVF-ASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++|+..+.||+|+||.||+|.. .++..+++|..... .......+..|+.. ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688889999999999999999 44555555544433 22233456667765 556689999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR-PIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|++ |+|.+++.... .....+++..+..++.|++.||+||| ++ +++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVY-DKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 58988886532 12356899999999999999999999 76 99999999999999999999999999987654
Q ss_pred CCCceeeccccccCCccccccccc----CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 218 EGETYIDDGVKGTSGIVAPEYART----GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|+ +|+.||..... ........... .
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~-------~~~~~~~~~~~-~ 224 (283)
T cd06617 156 DSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELA-TGRFPYDSWKT-------PFQQLKQVVEE-P 224 (283)
T ss_pred cccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHH-hCCCCCCcccc-------CHHHHHHHHhc-C
Confidence 3221 123468889999998765 45688999999999999999 89999853211 11111111111 1
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. +.... ...+.++.+++.+||..+|++|||+.++++
T Consensus 225 ~-----~~~~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 S-----PQLPA----EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred C-----CCCCc----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 11111 123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=282.08 Aligned_cols=254 Identities=19% Similarity=0.238 Sum_probs=198.7
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE--VEIPVLVF 137 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 137 (347)
+|+..+.||.|+||.||++.. .++..+++|..... .....+.+.+|+.++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477788999999999999998 45555555554432 23334678899999999999999999998764 34679999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF--SRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||+++++|.+++... ......+++..+..++.+++.||.|||... +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~-~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKC-KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHH-hhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999763 122367899999999999999999999543 57899999999999999999999999999887
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
....... .....+++.|+|||.+.+..++.++|+||||+++++|+ +|..||..... ... ......+...
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~--------~~~-~~~~~~~~~~ 228 (265)
T cd08217 160 LGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELC-ALSPPFTARNQ--------LQL-ASKIKEGKFR 228 (265)
T ss_pred ccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHH-HCCCcccCcCH--------HHH-HHHHhcCCCC
Confidence 6544321 23456899999999999888999999999999999999 89999864321 111 1222222111
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .....+..+.+++.+||+.+|++|||+.+|++
T Consensus 229 -----~-----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 229 -----R-----IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -----C-----CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1 11123457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=288.51 Aligned_cols=253 Identities=19% Similarity=0.242 Sum_probs=199.4
Q ss_pred HHhccCCCCCeecccCceEEEEEEeC-CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVLP-DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
..++.|+..+.||+|++|.||+|.+. ++..+++|....... ..+.+.+|+..+++++|+|++++++++..+...++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34566777889999999999999993 444455555544332 4467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++... ...+++..+..++.+++.||.||| +.|++|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 95 EYMDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred eccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999999874 137999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... ......++..|+|||.+.+..++.++|+|||||++|+|+ +|..||..... . ......... .....
T Consensus 168 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~-~g~~p~~~~~~-------~-~~~~~~~~~-~~~~~ 236 (286)
T cd06614 168 KEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA-EGEPPYLREPP-------L-RALFLITTK-GIPPL 236 (286)
T ss_pred cchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHH-hCCCCCCCCCH-------H-HHHHHHHhc-CCCCC
Confidence 3221 122345788999999988888999999999999999999 89999864221 1 111111111 11110
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
......+..+.+++.+||+.+|.+|||+.++++
T Consensus 237 --------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 --------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 011123456889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=297.25 Aligned_cols=264 Identities=17% Similarity=0.221 Sum_probs=193.2
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CC-ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----c
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PD-RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE-----I 132 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 132 (347)
.+++|...+.||+|+||.||+|.. .+ ..+++|++...........+.+|+.++++++||||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 356899999999999999999998 44 4455554433333334466889999999999999999998876543 5
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.++++||+.+ +|.+.+.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 83 ~~lv~e~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEEehhccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccc
Confidence 7999999975 88888865 57999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCcee--eccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 213 SASIPEGETYI--DDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 213 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
+.......... .....|++.|+|||.+.+ ..++.++||||+||++|+|+ +|++||..... ...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~-~G~~~f~~~~~-----~~~~~~~~~~~ 226 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML-SNRPLFPGKDY-----LHQLNLILGVL 226 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCH-----HHHHHHHHHHc
Confidence 87654322211 123568899999997654 56899999999999999999 89999964321 00000000000
Q ss_pred hcc-----------C----cccc-cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 290 ENR-----------G----FNGI-VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 290 ~~~-----------~----~~~~-~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
... . .... ..+........+..+.++.+++.+||+.+|++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0 0000 000000000112234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=286.78 Aligned_cols=257 Identities=17% Similarity=0.177 Sum_probs=191.9
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|+..+.||.|++|.||+|+. .++..+++|...... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999999998 444445555444322 22235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+. ++|.+++... ....+++..+..++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 96 5899988653 2356899999999999999999999 999999999999999999999999999998765432
Q ss_pred CceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc-c-----
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN-R----- 292 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~----- 292 (347)
... .....+++.|+|||.+.+. .++.++||||||+++|+|+ +|..||..... . ......... +
T Consensus 154 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~-tg~~p~~~~~~-------~-~~~~~~~~~~~~~~~~ 223 (284)
T cd07860 154 VRT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV-TRRALFPGDSE-------I-DQLFRIFRTLGTPDEV 223 (284)
T ss_pred ccc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCCCH-------H-HHHHHHHHHhCCCChh
Confidence 211 1233568899999987664 4688999999999999999 89999864321 0 011111100 0
Q ss_pred -------------CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 -------------GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 -------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+........ ....+.....+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 224 VWPGVTSLPDYKPSFPKWARQDF--SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhhhHHHHHHhhcccccccCH--HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0001122346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=319.36 Aligned_cols=254 Identities=21% Similarity=0.276 Sum_probs=196.3
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee------
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE------ 129 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 129 (347)
.....+|+..++||+||||.||+++. ++..+|+||+.-..+......+.+|+..+++|+|||||+++..|..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 45677899999999999999999999 8888899998776655556778999999999999999999886643
Q ss_pred --------------------------------------------------------------------------------
Q 045067 130 -------------------------------------------------------------------------------- 129 (347)
Q Consensus 130 -------------------------------------------------------------------------------- 129 (347)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CccEEEEEeCCCCCHHHHHhhhccCCCCCC-CHHHHHHHHHHHHHH
Q 045067 130 -------------------------V--------EIPVLVFESAEYGNLHDLLKRSYQSHSEPL-LLKHRLKIAMEIANV 175 (347)
Q Consensus 130 -------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l-~~~~~~~i~~~i~~~ 175 (347)
. ..+||-||||+..+|.+++..+ ... .....++++++|++|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N-----~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN-----HFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc-----ccchhhHHHHHHHHHHHHH
Confidence 0 1358899999997888888764 222 467888999999999
Q ss_pred HHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC-----------------CCceeeccccccCCcccccc
Q 045067 176 FAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE-----------------GETYIDDGVKGTSGIVAPEY 238 (347)
Q Consensus 176 l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~-----------------~~~~~~~~~~gt~~y~aPE~ 238 (347)
|.|+| +.|||||||||.||++|+++.+||+|||+|+.... ......++..||..|+|||+
T Consensus 710 LaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 99999 99999999999999999999999999999987210 01112345779999999999
Q ss_pred cccC---CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHH
Q 045067 239 ARTG---YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSS 315 (347)
Q Consensus 239 ~~~~---~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (347)
+.+. .|+.|+|+||+|+|++||+ . ||.- .+ ....+...++.+.+... ........+.-
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~-y---PF~T-------sM-ERa~iL~~LR~g~iP~~-------~~f~~~~~~~e 847 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEML-Y---PFGT-------SM-ERASILTNLRKGSIPEP-------ADFFDPEHPEE 847 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHh-c---cCCc-------hH-HHHHHHHhcccCCCCCC-------cccccccchHH
Confidence 8865 4999999999999999999 3 3421 11 12222333334433322 01112233445
Q ss_pred HHHHHHhccCCCCCCCCHHHHHH
Q 045067 316 FELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 316 ~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+++.++++.||.+||||.|++.
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhh
Confidence 68999999999999999999985
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=277.26 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=199.6
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
+|+..+.||+|++|.||++.. .++..+++|..........+.+.+|+..+++++|||++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 477788999999999999999 4555555555554443455789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
+++|.+++... ...+++..+..++.+++.||.+|| ..+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 81 GGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 99999999763 257899999999999999999999 99999999999999999999999999999877655432
Q ss_pred eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
.....++..|+|||.+.+..++.++|+||||+++++|+ +|+.||..... ....... ..........+
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~--------~~~~~~~-~~~~~~~~~~~- 220 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA-EGKPPYSELPP--------MKALFKI-ATNGPPGLRNP- 220 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHH-hCCCCCCCCch--------HHHHHHH-HhcCCCCcCcc-
Confidence 23456889999999998888999999999999999999 89999864321 1111111 11111111110
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...+..+.+++.+||+.+|++|||+.++++
T Consensus 221 -------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 -------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -------cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011456889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=288.52 Aligned_cols=256 Identities=16% Similarity=0.192 Sum_probs=190.7
Q ss_pred cCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|...+.||+|+||.||++.. .++ .+++|++...........+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455567899999999999999 444 445554443333344567889999999996 99999999999998999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
+.. ++.++...........+++..+..++.+++.||+||| + .+++||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 874 6665543211112367999999999999999999999 5 5999999999999999999999999999876543
Q ss_pred CCceeeccccccCCcccccccccC---CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTG---YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
... .....|++.|+|||++.+. .++.++||||+||++|+|+ +|.+||.... ............ .
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~-------~~~~~~~~~~~~-~-- 227 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVA-TGKFPYPKWN-------SVFDQLTQVVKG-D-- 227 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHH-hCCCCchhcc-------hHHHHHhhhcCC-C--
Confidence 222 1234688999999988765 6899999999999999999 8999986421 111111111111 0
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.+.+... .....+.++.+++.+||+.+|++|||+.+|+..
T Consensus 228 ---~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 ---PPILSNS-EEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---CCcCCCc-CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 112345578899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=297.12 Aligned_cols=249 Identities=19% Similarity=0.251 Sum_probs=195.2
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 138 (347)
..|+..+.||+||.+.||++.. +.+.+++||+.... .....+.+.+|+.+|.+| .|.+|+++++|-..++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 4578889999999999999999 56667777765543 344567899999999999 59999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|-+. +|...|+.. ...++...+..+..|++.++.++| +.||||.||||.|+|+ -.|.+||+|||.|..+..
T Consensus 441 ~Gd~-DL~kiL~k~----~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 441 CGDI-DLNKILKKK----KSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQP 511 (677)
T ss_pred cccc-cHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence 9874 999999874 233443488889999999999999 9999999999999998 568999999999999887
Q ss_pred CCcee-eccccccCCcccccccccC-----------CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 219 GETYI-DDGVKGTSGIVAPEYARTG-----------YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 219 ~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
+.+.. ....+||+.||+||.+... ..+.++||||+|||||+|+ .|++||.... .+..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv-YgktPf~~~~----------n~~a 580 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV-YGKTPFGQII----------NQIA 580 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH-hcCCchHHHH----------HHHH
Confidence 76544 3467899999999987532 2468899999999999999 9999995321 1111
Q ss_pred HHHhccCcccccCCccC--CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 287 KYIENRGFNGIVDPRII--GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+ +..+.+|... -++.++ ..++.+++..||..||++|||+.+|++
T Consensus 581 K------l~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 K------LHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred H------HHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1 1122222111 011111 123889999999999999999999986
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=286.37 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=191.3
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
+.|...+.||+|+||+||+|.. .++..+++|... .. .....+.+.+|+.+++.++|||++++++++.+++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4477788999999999999998 444444444433 22 2233456889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+. |+|.+.+... ...+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9998 5888877542 256899999999999999999999 9999999999999999999999999999986553
Q ss_pred CCCceeeccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.. ....+++.|+|||++. ...++.++||||||+++|||+ +|.+||..... .......... ..
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~-tg~~p~~~~~~--------~~~~~~~~~~-~~ 231 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNA--------MSALYHIAQN-DS 231 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHH-cCCCCCCCccH--------HHHHHHHhcC-CC
Confidence 32 2346788999999874 456889999999999999999 89999854221 0111111111 00
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+.. .....+..+.+++.+||+.+|++||++.+++..
T Consensus 232 -----~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 -----PTL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CCC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111 111235578899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=288.20 Aligned_cols=259 Identities=13% Similarity=0.113 Sum_probs=185.7
Q ss_pred hccCCCCCeecccCceEEEEEEe-CC---ceEEEEEEccCCCchh-H----------HHHHHHHHHHHhcCCCceeeeee
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PD---RTISVVKFIDGSVFDA-Y----------DCCFNNIVFASQMSHNNVLRLIG 125 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~---~~~~v~k~~~~~~~~~-~----------~~~~~E~~~l~~l~h~niv~l~~ 125 (347)
.+.|...++||+|+||.||+|.+ ++ ..++++|......... . .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35788999999999999999998 44 4556666543322111 0 11223334455678999999999
Q ss_pred eeeeCC----ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC
Q 045067 126 CCLEVE----IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE 201 (347)
Q Consensus 126 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~ 201 (347)
++.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcC
Confidence 766543 34677887754 777777653 34678889999999999999999 999999999999999999
Q ss_pred CCceEEecCCCCccCCCCCce------eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCC
Q 045067 202 RYVPKLFNFSLSASIPEGETY------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN 275 (347)
Q Consensus 202 ~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~ 275 (347)
++.++|+|||+|+........ ......||+.|+|||++.+..++.++||||+||++|||+ +|..||.....
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~-~g~~P~~~~~~-- 238 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA-GIKLPWKGFGH-- 238 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCcccc--
Confidence 999999999999766432211 112346999999999999999999999999999999999 99999975421
Q ss_pred CCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 276 GDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
............... +..+.. .....+..+.+++..||+.+|++||++.++++.|+
T Consensus 239 -~~~~~~~~~~~~~~~-----~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 -NGNLIHAAKCDFIKR-----LHEGKI----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred -chHHHHHhHHHHHHH-----hhhhhh----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 000000000111110 000111 11122456889999999999999999999998763
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=287.85 Aligned_cols=270 Identities=21% Similarity=0.223 Sum_probs=195.4
Q ss_pred CCCCCeecccCceEEEEEEe-C--CceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEE
Q 045067 64 YHYRNIITESSIFRLCQGVL-P--DRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIPVL 135 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~--~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 135 (347)
|...+.||+|+||.||+|.. . ++..+++|...... ....+.+.+|+.++.+++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 67778899999999999999 4 45666666555422 23336678999999999999999999999988 78999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC----CCceEEecCC
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE----RYVPKLFNFS 211 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~----~~~~kl~Dfg 211 (347)
||||+++ +|.+++..........++...+..++.|++.||+||| +.+++||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999985 7888776542223347899999999999999999999 999999999999999999 9999999999
Q ss_pred CCccCCCCCc--eeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCC-CCchHHHHHHH
Q 045067 212 LSASIPEGET--YIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG-DESFEMDFVKK 287 (347)
Q Consensus 212 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~~ 287 (347)
++........ .......+++.|+|||.+.+ ..++.++|||||||++++|+ +|++||........ ..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH-hcCCCCcCCcccccccchhHHHHHHH
Confidence 9887643322 11234567899999997765 46789999999999999999 99999975433210 00000001111
Q ss_pred HHh---------------ccCccc---cc-CCccCCchhhH------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 288 YIE---------------NRGFNG---IV-DPRIIGDELLE------HKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 288 ~~~---------------~~~~~~---~~-~~~~~~~~~~~------~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... ...... .. ........... .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 000000 00 00000000000 22346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=288.76 Aligned_cols=243 Identities=21% Similarity=0.288 Sum_probs=191.1
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCHH
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLH 146 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 146 (347)
..||+|+||.||++.. .++..+++|..........+.+.+|+.+++.++|||++++++++..++..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5699999999999998 444444444444333344567899999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeecc
Q 045067 147 DLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG 226 (347)
Q Consensus 147 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 226 (347)
+++.. ..+++.....++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++........ ....
T Consensus 106 ~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 106 DIVTH------TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 98854 46899999999999999999999 99999999999999999999999999998876543321 1233
Q ss_pred ccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCch
Q 045067 227 VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDE 306 (347)
Q Consensus 227 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (347)
..+++.|+|||.+.+..++.++|+||+|+++|+|+ +|..||..... ...... .... . .+...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~-tg~~p~~~~~~--------~~~~~~-~~~~-~----~~~~~--- 237 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV-DGEPPYFNEPP--------LKAMKM-IRDN-L----PPKLK--- 237 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHH-HHhh-C----CcccC---
Confidence 56889999999988888899999999999999999 89999864221 111111 1111 0 01110
Q ss_pred hhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 307 LLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 307 ~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.....+..+.+++.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 01122345779999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=299.59 Aligned_cols=243 Identities=20% Similarity=0.294 Sum_probs=195.6
Q ss_pred CCeecccCceEEEEEEe-CCce-EEE--EEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc--cEEEEEe
Q 045067 67 RNIITESSIFRLCQGVL-PDRT-ISV--VKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI--PVLVFES 139 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~-~~~~-~~v--~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 139 (347)
..+||+|+|-+||+|.. ..+. ||. +|+... ......++|..|+.+|+.|+||||++++.+|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 35799999999999999 3443 332 222221 223445889999999999999999999999998765 7899999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-CCceEEecCCCCccCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-RYVPKLFNFSLSASIPE 218 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~ 218 (347)
+..|+|..++++. +.++......|++||++||.|||+. ..+|||||||-+||+|+. .|.+||+|+|+|+....
T Consensus 125 ~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 125 FTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999987 7899999999999999999999975 568999999999999984 58999999999987654
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
.. .....|||.|||||+.. ..|+...||||||+.++||. |+..||.-... .++..++...+.. ...+
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMv-T~eYPYsEC~n-------~AQIYKKV~SGiK-P~sl 265 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMV-TSEYPYSECTN-------PAQIYKKVTSGIK-PAAL 265 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHH-hccCChhhhCC-------HHHHHHHHHcCCC-HHHh
Confidence 32 23378999999999876 78899999999999999999 99999975443 4555555554321 1111
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .-..+++.++|.+|+.. .+.|||+.|++.
T Consensus 266 ~---------kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 S---------KVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred h---------ccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1 11134678999999999 999999999985
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=284.16 Aligned_cols=260 Identities=19% Similarity=0.199 Sum_probs=194.6
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
+|+..+.||.|++|.||+|+. .++..+++|..... .....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 478889999999999999999 45555555544433 3333466789999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++ +|.+++.... ....+++..+..++.|++.||.||| +.+++||||+|+||++++++.++++|||++.......
T Consensus 81 ~~-~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 81 DK-DLKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred Cc-cHHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 85 8999886531 2246899999999999999999999 9999999999999999999999999999987654322
Q ss_pred ceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc---c----
Q 045067 221 TYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN---R---- 292 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---- 292 (347)
. ......++..|++||.+.+ ..++.++|+||+||++|+|+ +|.+||...... +........ .
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~-~g~~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 224 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI-TGRPLFPGTNNE--------DQLLKIFRIMGTPTEST 224 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCcH--------HHHHHHHHHhCCCChhh
Confidence 1 1123457889999998765 45789999999999999999 899999753220 111111000 0
Q ss_pred -----CcccccC--CccC---CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 -----GFNGIVD--PRII---GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 -----~~~~~~~--~~~~---~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
....... +... .....+..+..+.+++.+||+.+|.+||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 225 WPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0000 00111223457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=283.54 Aligned_cols=247 Identities=17% Similarity=0.210 Sum_probs=197.8
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
+|+..+.||.|+||.||+|.. .++..+++|...... ....+.+.+|+.++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 477889999999999999999 455555666554322 2345778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+.+++|.+++... ..+++..+..++.+++.||.||| +.+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999999763 57899999999999999999999 99999999999999999999999999999876654
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
.. ......|+..|+|||.+.+..++.++|+||+|+++|+|+ +|..||..... . ........... ...
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~-----~-~~~~~~~~~~~--~~~-- 219 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECL-RGKRPYRGHSR-----T-IRDQIRAKQET--ADV-- 219 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHH-hCCCCCCCCCc-----c-HHHHHHHHhcc--ccc--
Confidence 32 223456888999999998888999999999999999999 89999875432 1 11111111111 000
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCH--HHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM--IDVA 337 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~--~ell 337 (347)
..+...+..+.+++.+||+.+|.+||++ .|++
T Consensus 220 -------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 -------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111234678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=283.09 Aligned_cols=258 Identities=21% Similarity=0.253 Sum_probs=188.5
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeC--CccEEEEE
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEV--EIPVLVFE 138 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 138 (347)
|+..+.||+|+||.||+|.. .++..+++|..... .........+|+..+.++. |||++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45678899999999999998 44444444444332 2222234568999999885 99999999999987 88999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|++ ++|.+.+... ...+++..+..++.|++.||.||| +.+++||||+|+||+++. +.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 998 5888888652 256899999999999999999999 999999999999999999 9999999999977643
Q ss_pred CCceeeccccccCCcccccccc-cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH----------
Q 045067 219 GETYIDDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK---------- 287 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 287 (347)
.... ....++..|+|||.+. +..++.++||||+||++|||+ +|.+||...... ........
T Consensus 152 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~-~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07831 152 KPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL-SLFPLFPGTNEL-----DQIAKIHDVLGTPDAEVL 223 (282)
T ss_pred CCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHH-cCCcCCCCCCHH-----HHHHHHHHHcCCCCHHHH
Confidence 3221 2345788999999654 456789999999999999999 899999653220 00011100
Q ss_pred -HHhccCcccccCCccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 288 -YIENRGFNGIVDPRIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 288 -~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
............+..... ......+..+.+++.+||+++|++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 110000000001110000 011233568899999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=281.41 Aligned_cols=249 Identities=23% Similarity=0.289 Sum_probs=195.5
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|+..+.||+|+||.||+|.. .++..+++|...... ....+.+.+|+.++++++||||+++++.+.++...++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 467788999999999999999 444555555544321 12335688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-ceEEecCCCCccCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLFNFSLSASIPE 218 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~ 218 (347)
+++++|.+++... ....+++..+..++.+++.||.||| +.+++|+||+|+||++++++ .++++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999999763 2245799999999999999999999 99999999999999999885 469999999876653
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
... ......|++.|+|||+..+..++.++|+||||+++++++ +|..||.... ........... ..
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~--------~~~~~~~~~~~-~~---- 219 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELC-TLKHPFEGNN--------LHQLVLKICQG-YF---- 219 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCcc--------HHHHHHHHhcc-cC----
Confidence 322 122346889999999998888999999999999999999 8999985321 11222222211 11
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+. .+..+..+.+++.+||+.+|++|||+.|++.
T Consensus 220 ~~~------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 API------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCC------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 110 1122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=285.22 Aligned_cols=258 Identities=19% Similarity=0.205 Sum_probs=192.2
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 136 (347)
++|+..+.||.|+||.||+|.. .++..+++|.+.... ......+.+|+.++.+++||||+++++++..+ ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4688889999999999999999 445555555443322 12223567899999999999999999998877 889999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
+||+.+ +|.+++... ...+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 85 ~e~~~~-~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVEH-DLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcCc-CHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 999985 999998763 246899999999999999999999 999999999999999999999999999998776
Q ss_pred CCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc----
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN---- 291 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 291 (347)
...... .....+++.|+|||.+.+. .++.++|+||+|+++|+|+ +|.+||..... .....+....
T Consensus 157 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~~f~~~~~--------~~~~~~~~~~~~~~ 226 (293)
T cd07843 157 GSPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL-TKKPLFPGKSE--------IDQLNKIFKLLGTP 226 (293)
T ss_pred cCCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHH-hCCCCCCCCCh--------HHHHHHHHHHhCCC
Confidence 543211 1234578899999987654 4689999999999999999 89999964321 0111110000
Q ss_pred ----------------cCcccccCCccCCchhhHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 ----------------RGFNGIVDPRIIGDELLEH-KLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ----------------~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..........+. ...... ....+.+++.+||+.+|++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 227 TEKIWPGFSELPGAKKKTFTKYPYNQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chHHHHHhhccchhcccccccccchhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000 000001 2456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=274.51 Aligned_cols=275 Identities=22% Similarity=0.201 Sum_probs=206.7
Q ss_pred HhccCCCCCeecccCceEEEEEEe-C--C---ceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeee-CC
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-P--D---RTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLE-VE 131 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~--~---~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 131 (347)
....|+....||+|.||.||+|+. + + ..+|+||+...+. .+.-....+|+.+++.++|||++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 344578888999999999999976 2 1 2455666554422 2223668899999999999999999999887 78
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC----CceEE
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER----YVPKL 207 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~----~~~kl 207 (347)
.+++++||.+. +|...|+-.+.+....++...+..|++||+.|+.||| ++-|+||||||.|||+..+ |.+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence 99999999997 9999998766666678999999999999999999999 9999999999999999877 99999
Q ss_pred ecCCCCccCCCCCce--eeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCC-CCCchHHH
Q 045067 208 FNFSLSASIPEGETY--IDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN-GDESFEMD 283 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~-~~~~~~~~ 283 (347)
+|||+++.+...-.. .......|++|.|||++.| ..|+++.|||++|||+.||+ +-+|.|....... ...++..+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL-tl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL-TLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHH-ccCccccchhhhcccCCCchHH
Confidence 999999987654322 2345678999999997776 48999999999999999999 8888887543321 12245555
Q ss_pred HHHHHHhccCc------cc---ccCC---------ccCCchhhHH-------HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 284 FVKKYIENRGF------NG---IVDP---------RIIGDELLEH-------KLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 284 ~~~~~~~~~~~------~~---~~~~---------~~~~~~~~~~-------~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+...+.--.. .. +.+. ....+..+.. ..+...+|+.++|++||.+|.|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 55555431110 00 0000 0000000000 1124789999999999999999999876
Q ss_pred H
Q 045067 339 Q 339 (347)
Q Consensus 339 ~ 339 (347)
.
T Consensus 337 h 337 (438)
T KOG0666|consen 337 H 337 (438)
T ss_pred c
Confidence 3
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=281.06 Aligned_cols=249 Identities=20% Similarity=0.254 Sum_probs=191.2
Q ss_pred HHHHHHhccCCCCCee--cccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC
Q 045067 55 KELERATNNYHYRNII--TESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV 130 (347)
Q Consensus 55 ~e~~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 130 (347)
.++....++|...+.+ |+|+||.||++.. .++..+++|......... .|+.....+ +|||++++++++..+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 4455556677776666 9999999999998 566677777665432211 122222222 799999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-ceEEec
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLFN 209 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~-~~kl~D 209 (347)
+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++ .++|+|
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999764 48999999999999999999999 99999999999999999988 999999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
||++....... ...++..|+|||++.+..++.++|+||+|+++|+|+ +|..||..... .......+....
T Consensus 154 fg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~-~g~~p~~~~~~---~~~~~~~~~~~~- 223 (267)
T PHA03390 154 YGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELL-TGKHPFKEDED---EELDLESLLKRQ- 223 (267)
T ss_pred CccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHH-HCCCCCCCCCc---chhhHHHHHHhh-
Confidence 99987654322 246889999999999888999999999999999999 89999974322 111111111111
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-MIDVAK 338 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-~~ell~ 338 (347)
.. .. ......+..+.+++.+||+.+|.+||+ ++++++
T Consensus 224 -~~--------~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 -QK--------KL---PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -cc--------cC---CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00 00 111134557889999999999999996 588874
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=283.42 Aligned_cols=263 Identities=15% Similarity=0.126 Sum_probs=192.3
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCc-----
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEI----- 132 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 132 (347)
++|+..+.||+|+||.||+|.. .++..+++|...... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688889999999999999998 455555555444322 222356889999999995 6999999999887665
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-CCceEEecCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-RYVPKLFNFS 211 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg 211 (347)
.+++|||+++ +|.+++..........+++..+..++.|++.||.||| +.+++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 8999887642222356899999999999999999999 999999999999999998 8999999999
Q ss_pred CCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
++......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|+ +|.+||..... .........
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~~~~~~~~--------~~~~~~~~~ 226 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSE--------LQQLLHIFK 226 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHH-cCCCCCCCCCH--------HHHHHHHHH
Confidence 98765432111 122356889999997764 56799999999999999999 89999864321 111111111
Q ss_pred c-cC-cccccC-----------CccC---CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 N-RG-FNGIVD-----------PRII---GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ~-~~-~~~~~~-----------~~~~---~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. +. ...... +... .....+.....+.+++.+||++||.+|||+.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00 000000 0000 00111223557889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=283.47 Aligned_cols=261 Identities=19% Similarity=0.196 Sum_probs=193.4
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEEEEE
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIPVLVFE 138 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 138 (347)
|+..+.||+|+||.||+|+. +++..+++|..... .....+.+.+|+.++++++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 56678899999999999999 44555555555443 223335688999999999999999999999988 78999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++ +|.+++... ...+++..+..++.+++.||+||| +.+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMDH-DLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cccc-cHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 9985 899988652 247899999999999999999999 99999999999999999999999999999877654
Q ss_pred CCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc---Cc
Q 045067 219 GETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR---GF 294 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 294 (347)
..........++..|+|||.+.+ ..++.++||||||+++|+|+ +|.+||..... .............. .+
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~-t~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF-LGKPIFQGSTE-----LEQLEKIFELCGSPTDENW 226 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH-hCCCCCCCCCh-----HHHHHHHHHHhCCCchhhc
Confidence 43222233457889999997664 46789999999999999999 89999864321 11111111111000 00
Q ss_pred cc--------ccCCccCCc----hhhHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 295 NG--------IVDPRIIGD----ELLEH-KLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 295 ~~--------~~~~~~~~~----~~~~~-~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. ...+..... ..... .+..+.+++.+||+.+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 000000000 00111 1557889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=283.87 Aligned_cols=245 Identities=22% Similarity=0.270 Sum_probs=191.2
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
|...+.||+|+||.||+|.. .++..+++|..... .......+.+|+.++++++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66778899999999999998 45555555554422 223345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++ +|.+.+... ...+++..+..++.+++.||.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 107 CLG-SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 985 888877542 256899999999999999999999 999999999999999999999999999988654322
Q ss_pred CceeeccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 220 ETYIDDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
....+++.|+|||++. ++.++.++|||||||++|+|+ +|..||..... ............
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~-~g~~p~~~~~~--------~~~~~~~~~~~~--- 241 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNA--------MSALYHIAQNES--- 241 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHH-hCCCCCCCccH--------HHHHHHHHhccC---
Confidence 2346888999999873 457889999999999999999 89988853211 111111111111
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
+.. .....+..+.+++.+||+.+|.+||++.++++.+
T Consensus 242 ---~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 ---PTL----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred ---CCC----CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 000 1112345678999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=288.35 Aligned_cols=249 Identities=18% Similarity=0.241 Sum_probs=204.6
Q ss_pred HhccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
+.+-|...+-||+|-|+.|-.|++ .+..||||.+.+..- .-....+.+|+..|+-++|||||+++.+......+||+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 445677778899999999999998 566666655544332 22235689999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC-CCCceEEecCCCCcc
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS-ERYVPKLFNFSLSAS 215 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~a~~ 215 (347)
+|+-.+|+|+++|-+ +...+.+....+++.||+.|+.|+| +..+|||||||+|+++- .-|-+||.|||++..
T Consensus 96 LELGD~GDl~DyImK----He~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMK----HEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEecCCchHHHHHHh----hhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeecccccc
Confidence 999999999999977 4578999999999999999999999 99999999999999875 678999999999977
Q ss_pred CCCCCceeeccccccCCcccccccccCCCC-CccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLN-EKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
+..+... ++.+|+..|-|||.+.|..|+ ++.||||+|||||.|+ +|++||..... .+.+...+
T Consensus 169 f~PG~kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLV-CGq~PFqeAND--------SETLTmIm----- 232 (864)
T KOG4717|consen 169 FQPGKKL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLV-CGQPPFQEAND--------SETLTMIM----- 232 (864)
T ss_pred CCCcchh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHH-hCCCccccccc--------hhhhhhhh-----
Confidence 7665443 567999999999999988776 7899999999999999 99999974321 12222222
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
|-.. ..+.+.+.++.+||.+||..||++|.|.++|+.
T Consensus 233 ----DCKY---tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 ----DCKY---TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ----cccc---cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2111 223467889999999999999999999999875
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=276.60 Aligned_cols=242 Identities=20% Similarity=0.236 Sum_probs=191.5
Q ss_pred ecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 70 ITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 70 lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
||.|+||.||+|+. .++..+++|...... ....+.+.+|+.++++++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999 434455555444322 23346789999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeec
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 225 (347)
.+++.+. ..++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 9999764 56899999999999999999999 9999999999999999999999999999987765432 122
Q ss_pred cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCc
Q 045067 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGD 305 (347)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (347)
...+++.|+|||.+.+..++.++|+||+|+++|+|+ +|..||..... ............... ..
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~------~~~~~~~~~~~~~~~-----~~---- 214 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELL-TGRPPFGEDDE------DPMEIYNDILKGNGK-----LE---- 214 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHH-hCCCCcCCCCC------CHHHHHHHHhccCCC-----CC----
Confidence 346889999999988888999999999999999999 89999965321 011222222211100 00
Q ss_pred hhhHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 045067 306 ELLEHKLQSSFELAFQCQSASAEDRPT-----MIDVAK 338 (347)
Q Consensus 306 ~~~~~~~~~~~~l~~~cl~~~P~~RPs-----~~ell~ 338 (347)
.+...+..+.+++.+||+.+|++||+ +.|+++
T Consensus 215 -~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 -FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred -CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11112457889999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.71 Aligned_cols=266 Identities=24% Similarity=0.282 Sum_probs=197.8
Q ss_pred CCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHh--cCCCceeeeeeeeeeCC----ccEEEE
Q 045067 64 YHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQ--MSHNNVLRLIGCCLEVE----IPVLVF 137 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~ 137 (347)
....++||+|.||.||+|.+.++.||||++.... .+.|.+|-.|++. +.|+||+++++.-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhccCceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 3445679999999999999988888887765433 3678888888875 47999999999866554 789999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------CCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF------SRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~------~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
||.+.|+|.+++.. ..++|....+++..++.||+|||+.. ..+|+|||||++||||.+|++..|+|||
T Consensus 288 ~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999987 58999999999999999999999632 4579999999999999999999999999
Q ss_pred CCccCCCCCcee-eccccccCCcccccccccCC-CC-----CccchHHHHHHHHHHHhcCCCccc-------cCcc-CCC
Q 045067 212 LSASIPEGETYI-DDGVKGTSGIVAPEYARTGY-LN-----EKCDVYSFGLLLLQLLSTGEDLFN-------MGLR-LNG 276 (347)
Q Consensus 212 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~s~G~~l~el~~~g~~p~~-------~~~~-~~~ 276 (347)
+|..+....... .....||.+|||||++.+.. +. .+.||||+|.++||++|.....+. .... .-+
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 998877544322 23478999999999988752 22 468999999999999965433322 1111 001
Q ss_pred CCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 277 DESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
..+.. +..+...-.... .|.++....-...+..+++.+..||+.||+.|.|+.=+-+++.++.
T Consensus 442 ~hPt~-e~mq~~VV~kK~----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 442 NHPTL-EEMQELVVRKKQ----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCCCH-HHHHHHHHhhcc----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 11111 112222111111 1222111111133567899999999999999999999999888775
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=274.82 Aligned_cols=250 Identities=24% Similarity=0.267 Sum_probs=199.9
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIPVLVF 137 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 137 (347)
+|...+.||+|++|.||+|.. .++..+++|...... ....+.+.+|+.++++++||||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 467788999999999999999 355555555544433 23457789999999999999999999999988 8899999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++... ..+++..+..++.+++.||+||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999999874 48999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 218 EGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 218 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..... ......++..|+|||.+.+..++.++||||||+++++|+ +|..||..... ...............
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~-------~~~~~~~~~~~~~~~- 223 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA-TGKPPWSELGN-------PMAALYKIGSSGEPP- 223 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCc-------hHHHHHhccccCCCc-
Confidence 54321 123356889999999998888999999999999999999 89999865321 111111111101110
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..+...+..+.+++.+||+.+|++||++.+++.
T Consensus 224 ---------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 ---------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111122567889999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=282.72 Aligned_cols=256 Identities=17% Similarity=0.155 Sum_probs=191.4
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
|+..+.||.|++|.||+|.. .++..+++|...... ....+.+.+|+.++++++|||++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56678899999999999998 445555555444322 222356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
+ ++|.+++... ....+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSS---PLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 6 6999998764 1236899999999999999999999 9999999999999999999999999999987654322
Q ss_pred ceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc-c------
Q 045067 221 TYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN-R------ 292 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~------ 292 (347)
.. .....+++.|+|||++.+. .++.++|+||||+++|+|+ +|.+||..... . ......... +
T Consensus 154 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~-------~-~~~~~~~~~~~~~~~~~ 223 (283)
T cd07835 154 RT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMV-NRRPLFPGDSE-------I-DQLFRIFRTLGTPDEDV 223 (283)
T ss_pred cc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHH-hCCCCCCCCCH-------H-HHHHHHHHHhCCCChHH
Confidence 11 1223568899999977654 5789999999999999999 89999864321 0 001111000 0
Q ss_pred --------C----cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 --------G----FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 --------~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ........ ........+..+.+++.+||+.+|.+|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 224 WPGVTSLPDYKPTFPKWARQD--LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhchhhhhhcccccccc--hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 00000000 00111122357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=295.05 Aligned_cols=252 Identities=20% Similarity=0.198 Sum_probs=205.2
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCc--hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF--DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
........|.....||+|.|+.|..|++ .++.-+++|++.++.. ...+.+.+|+.+|..++|||||+++.+......
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 3455677899999999999999999999 5555555556655432 223558999999999999999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
+|+||||+.+|.+++++.+. +.+....+..++.|++.|++||| ++.|||||||++|||++.+.++||+|||+
T Consensus 130 lylV~eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgf 201 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGF 201 (596)
T ss_pred eEEEEEeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeecccc
Confidence 99999999999999999886 67777999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
+..+..+. ...+.+|++.|+|||++.+..| .+.+|+||+|+++|.|+ .|..||+....-. .+.
T Consensus 202 S~~~~~~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV-~GsLPFDG~~lk~-------------Lr~ 265 (596)
T KOG0586|consen 202 STFFDYGL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALV-EGSLPFDGQNLKE-------------LRP 265 (596)
T ss_pred ceeecccc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeee-ecccccCCccccc-------------ccc
Confidence 98876433 3467899999999999998765 58999999999999999 9999997532200 000
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+. +...+..+. -...++.++++++|..+|.+|++++++.+
T Consensus 266 rv----l~gk~rIp~---~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 266 RV----LRGKYRIPF---YMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred hh----eeeeecccc---eeechhHHHHHHhhccCccccCCHHHhhh
Confidence 00 001111111 22346779999999999999999999865
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=276.74 Aligned_cols=249 Identities=19% Similarity=0.163 Sum_probs=193.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-----CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--Ccc
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-----VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIP 133 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 133 (347)
.+|...+.||+|+||.||+|.. .++..+++|..... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999998 44444555543321 123346788999999999999999999998764 457
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++++||+++++|.+++... ..+++.....++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 8999999999999999764 56889999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCc--eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 214 ASIPEGET--YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 214 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
+....... .......++..|+|||.+.+..++.++|+|||||++|+|+ +|++||..... . ....+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~-------~-~~~~~~~~~ 224 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML-TEKPPWAEYEA-------M-AAIFKIATQ 224 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHH-hCCCCCCccCH-------H-HHHHHHHcC
Confidence 76532111 1112356889999999998888899999999999999999 89999964211 1 111111111
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .. + ..+....+.+.+++.+||+ +|..||++.+++.
T Consensus 225 ~-~~----~-----~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 P-TK----P-----MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred C-CC----C-----CCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1 00 1 1112334668899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=289.71 Aligned_cols=266 Identities=19% Similarity=0.212 Sum_probs=194.7
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV----- 130 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 130 (347)
...+.|+..+.||+|+||.||+|.. .++..+++|..... .......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3567899999999999999999998 45555555544322 223345678999999999999999999988643
Q ss_pred -CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 131 -EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 131 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
...++||||+.+ +|.+.+.. .++...+..++.|++.||+||| +.+++||||||+||+++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQM-------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence 357999999974 88888854 3888999999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCC----------CCCc
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN----------GDES 279 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~----------~~~~ 279 (347)
||++........ .....++..|+|||.+.+..++.++||||+||++|+|+ +|+.||....... ....
T Consensus 162 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 162 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-RGTVLFPGTDHIDQWNKIIEQLGTPSD 238 (353)
T ss_pred CccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHH-HCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999976543322 23346789999999999999999999999999999999 8999996432100 0000
Q ss_pred hHHHH----HHHHHhccC------cccccCCccCC---chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 280 FEMDF----VKKYIENRG------FNGIVDPRIIG---DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 280 ~~~~~----~~~~~~~~~------~~~~~~~~~~~---~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... ......... +.+........ +......+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 000111000 00111100000 0001123556889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=274.59 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=199.8
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|...+.||+|+||.||++.. .++..+++|...... ....+.+.+|+.+++.++|||++++.+.+..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 477788999999999999999 444455555444332 24456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++.... .....+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQK-KEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhh-ccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999997641 12367999999999999999999999 999999999999999999999999999998776544
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
. .......|++.|+|||...+..++.++|+||+|+++++|+ +|..||..... ......... .....
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~-~g~~p~~~~~~--------~~~~~~~~~-~~~~~--- 222 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELC-TLKHPFEGENL--------LELALKILK-GQYPP--- 222 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHH-cCCCCCCCCcH--------HHHHHHHhc-CCCCC---
Confidence 3 1233456889999999988888999999999999999999 89999864321 112222111 11111
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+ .......+.+++.+||..+|++|||+.++++
T Consensus 223 --~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 --I-----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1 1123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=267.73 Aligned_cols=246 Identities=18% Similarity=0.242 Sum_probs=195.5
Q ss_pred CCeecccCceEEEEEEe-CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEEeCCCC
Q 045067 67 RNIITESSIFRLCQGVL-PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVFESAEYG 143 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 143 (347)
...||+|+.|.|+++++ ..+.+.++|.... ......+++...+.++..-+ +|+||+.+|+|..+..+++.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 34599999999999999 5566655555544 44445577888888877664 99999999999999999999999973
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee
Q 045067 144 NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223 (347)
Q Consensus 144 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 223 (347)
.+..++... .+++++...-++...+++||.||-. .++|+|||+||+|||+|+.|++|+||||.+-.+.++.-+
T Consensus 176 C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 176 CAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred HHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 777777663 3679999999999999999999985 689999999999999999999999999998776654332
Q ss_pred eccccccCCccccccccc---CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 224 DDGVKGTSGIVAPEYART---GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 224 ~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
+...|.+.|||||-+.- ..|+-++||||||++++||. +|+.||..... .-+.+.+...+.. |
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLa-Tg~yPy~~c~t-------dFe~ltkvln~eP------P 313 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELA-TGQYPYKGCKT-------DFEVLTKVLNEEP------P 313 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhh-cccCCCCCCCc-------cHHHHHHHHhcCC------C
Confidence 34568899999997763 46888999999999999999 99999975432 2244445444321 3
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+.... ..++.+++++..||+.|+.+||...++++
T Consensus 314 ~L~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 314 LLPGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCccc---CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 332222 14678999999999999999999998875
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=279.83 Aligned_cols=242 Identities=18% Similarity=0.195 Sum_probs=182.8
Q ss_pred eecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHH---hcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 69 IITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFAS---QMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
.||+|+||.||++.. .++..+++|...... ......+.+|..+++ ..+|||++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999998 555555555443321 111133445544443 3479999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
+|+|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++++|||++........
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 99999998764 57999999999999999999999 99999999999999999999999999999865543221
Q ss_pred eeeccccccCCcccccccc-cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 222 YIDDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
....|++.|+|||.+. +..++.++|+||+||++|+|+ +|..||..... ... ......... ...
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~-----~~~-~~~~~~~~~------~~~ 216 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL-RGHSPFRQHKT-----KDK-HEIDRMTLT------VNV 216 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHH-hCCCCcCCCCC-----cCH-HHHHHHhhc------CCc
Confidence 2346899999999876 456899999999999999999 89999964321 001 111111100 011
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAKQ 339 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~~ 339 (347)
. .+...+.++.+++.+||+.||++|| |+.++++.
T Consensus 217 ~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 E-----LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred C-----CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1 1122345788999999999999999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=282.53 Aligned_cols=244 Identities=18% Similarity=0.208 Sum_probs=188.3
Q ss_pred ecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 70 ITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 70 lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
||+|+||+||++.. .++..+++|...... ....+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999988 455555555544321 22234567899999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeec
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 225 (347)
.+++.+. ....+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 152 (277)
T cd05577 81 KYHIYNV---GEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IK 152 (277)
T ss_pred HHHHHHc---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cc
Confidence 9999764 2246899999999999999999999 99999999999999999999999999999876543221 23
Q ss_pred cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCc
Q 045067 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGD 305 (347)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (347)
...++..|+|||.+.+..++.++|+||+|+++|+|+ +|+.||....... ............ ..
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~-----~~~~~~~~~~~~------~~----- 215 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI-AGRSPFRQRKEKV-----EKEELKRRTLEM------AV----- 215 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHh-hCCCCCCCCcccc-----cHHHHHhccccc------cc-----
Confidence 346788999999988888999999999999999999 8999996533210 001111100000 00
Q ss_pred hhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 306 ELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 306 ~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
......+..+.+++.+||+.+|++|| ++.++++
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 01112245678999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=281.59 Aligned_cols=260 Identities=18% Similarity=0.127 Sum_probs=190.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++|+..+.||+|++|.||+|.. .++..+++|...... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4688889999999999999998 445445555443322 1223568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-CCceEEecCCCCccCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-RYVPKLFNFSLSASIP 217 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~ 217 (347)
|++ ++|.+++... ....+++..+..++.|++.||+||| +.+++|+||+|+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 997 5888887653 2234678888999999999999999 999999999999999985 5679999999997654
Q ss_pred CCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc--cCc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN--RGF 294 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 294 (347)
.... ......+++.|+|||.+.+ ..++.++||||+||++|+|+ +|.+||..... . ......... ...
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~-tg~~pf~~~~~-------~-~~~~~~~~~~~~~~ 224 (294)
T PLN00009 155 IPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV-NQKPLFPGDSE-------I-DELFKIFRILGTPN 224 (294)
T ss_pred CCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCH-------H-HHHHHHHHHhCCCC
Confidence 3221 1123457889999998765 46789999999999999999 89999964321 0 111111100 000
Q ss_pred cccc------------CCccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 295 NGIV------------DPRIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 295 ~~~~------------~~~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.... .+..... ...+..+..+.+++.+||+.+|++||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 225 EETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0000000 011122456889999999999999999999986
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=282.65 Aligned_cols=266 Identities=17% Similarity=0.186 Sum_probs=194.3
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC----
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE---- 131 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 131 (347)
...++|+..+.||+|+||.||+|+. .++..+++|...... ......+.+|+.++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567899999999999999999999 445555555554322 222356778999999999999999999987654
Q ss_pred ------ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 132 ------IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 132 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
..++|+||+++ +|.+.+... ...+++..+..++.|++.||+||| +.+|+|+||+|+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcE
Confidence 78999999986 777777642 246899999999999999999999 9999999999999999999999
Q ss_pred EEecCCCCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 206 KLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
||+|||++...............++..|+|||.+.+ ..++.++||||+||++|+|+ +|++||..... ......
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~-~g~~~~~~~~~-----~~~~~~ 229 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF-TKKPIFQANQE-----LAQLEL 229 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCh-----HHHHHH
Confidence 999999987765433222223346788999997764 45789999999999999999 89999964321 111111
Q ss_pred HHHHHhccC---cccc--------cCCccC----CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 285 VKKYIENRG---FNGI--------VDPRII----GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 285 ~~~~~~~~~---~~~~--------~~~~~~----~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+........ +..+ .++... ........+..+.+++.+||+.+|++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111000 0000 000000 00011122457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=282.43 Aligned_cols=244 Identities=22% Similarity=0.210 Sum_probs=191.9
Q ss_pred ecccCceEEEEEEe-CCceEEEEEEccCCCc---hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 70 ITESSIFRLCQGVL-PDRTISVVKFIDGSVF---DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 70 lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
||.|+||.||++.. .++..+++|....... ...+.+.+|+.++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999 4456666666554332 3446788999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc----
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET---- 221 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~---- 221 (347)
.+++.+. ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9999864 47899999999999999999999 99999999999999999999999999999876543321
Q ss_pred ---eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 222 ---YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 222 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
.......++..|+|||...+...+.++|+||||+++|+++ +|..||..... ......... +...
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~-~g~~p~~~~~~--------~~~~~~~~~-~~~~--- 219 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFL-VGIPPFHGETP--------EEIFQNILN-GKIE--- 219 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHhc-CCcC---
Confidence 1123355788999999988888999999999999999999 89999864321 111111111 1110
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
.+ .. ...+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 220 ~~-----~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 220 WP-----ED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CC-----cc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 00 00 01245678999999999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=274.01 Aligned_cols=247 Identities=22% Similarity=0.340 Sum_probs=197.7
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCc--hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF--DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|+..+.||+|++|.||+|.. .++..+++|....... ...+.+.+|+.++++++|||++++++++.+++..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 467788999999999999998 4444455554444332 3457799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++... ..+++..+..++.+++.||.+|| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999999764 67999999999999999999999 999999999999999999999999999999876544
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
... .....++..|+|||...+..++.++|+||+|+++|+|+ +|..||..... ......... ...
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~-~g~~p~~~~~~--------~~~~~~~~~-~~~----- 216 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELL-TGNPPYYDLNP--------MAALFRIVQ-DDH----- 216 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHH-hCCCCCCCccH--------HHHHHHHhc-cCC-----
Confidence 332 23356888999999988878899999999999999999 89999864221 111111111 111
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.+ ....+..+.+++.+||+.+|++|||+.+++.
T Consensus 217 ~~~-----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPL-----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCC-----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111 1122456789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=279.57 Aligned_cols=260 Identities=19% Similarity=0.173 Sum_probs=195.4
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCc--hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF--DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
|...+.||.|++|.||+|.. .++..+++|....... .....+.+|+.++++++||||+++++++.++...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 55678899999999999998 4555555554443322 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++ +|.+++... ...+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 85 888888662 257899999999999999999999 9999999999999999999999999999987765443
Q ss_pred ceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc---Cccc
Q 045067 221 TYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR---GFNG 296 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 296 (347)
. ......++..|+|||.+.+. .++.++|+||+|+++|+|+ +|+.||....... ............ ....
T Consensus 153 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~-tg~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 153 R-PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELL-SRRPLFPGKSEID-----QLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred c-cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHH-hCCCCCCCCCHHH-----HHHHHHHHcCCCchHhccc
Confidence 1 12234578899999988776 7899999999999999999 8999996532200 000000000000 0000
Q ss_pred -----------ccC-CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 -----------IVD-PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 -----------~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..+ .........+..+.++.+++.+||+++|.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 000011122344668899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=322.36 Aligned_cols=255 Identities=20% Similarity=0.222 Sum_probs=206.0
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccC--CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG--SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
+..++-+++....||.|.||.||.|.. ++|...++|-+.. ........+.+|+.++..++|||+|+++|+=.+.+.+
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 344556677888999999999999999 7777777764432 2344456788999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
+|.||||.+|+|.++++.+ .-.++.....+..|++.|++||| +.|||||||||.||+++.+|.+|++|||.|
T Consensus 1310 ~IFMEyC~~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHhccCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccce
Confidence 9999999999999999874 55677777788999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCcee---eccccccCCcccccccccC---CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 214 ASIPEGETYI---DDGVKGTSGIVAPEYARTG---YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 214 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
..+..+.... .+...||+.|||||++.+. ...-+.||||+|||+.||+ +|+.||...+. +|...
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~-tGkrPW~~~dn---------e~aIM 1451 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMA-TGKRPWAELDN---------EWAIM 1451 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEee-cCCCchhhccc---------hhHHH
Confidence 8887654222 2457899999999999864 3567899999999999999 99999975432 22222
Q ss_pred H-HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 288 Y-IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 288 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+ ...+... ..+...+++-.+++..||+.||++|.++.|+++.
T Consensus 1452 y~V~~gh~P----------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1452 YHVAAGHKP----------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHHhccCCC----------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1 1112211 1222356778899999999999999999988764
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=289.25 Aligned_cols=267 Identities=16% Similarity=0.213 Sum_probs=193.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeee----CCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE----VEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 133 (347)
.++|+..+.||+|+||.||+|.. .++..+++|.+... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 46788899999999999999998 44444444444332 12334667889999999999999999988763 3468
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++|+||+. ++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999996 5999998754 56999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCce---eeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCC-------CCchHH
Q 045067 214 ASIPEGETY---IDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG-------DESFEM 282 (347)
Q Consensus 214 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~-------~~~~~~ 282 (347)
......... ......++..|+|||.+.+ ..++.++||||+||++|+|+ +|++||........ ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~-~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHH-cCCCccCCCChHHHHHHHHHHhCCChh
Confidence 765432211 1123568899999998765 56899999999999999999 99999965321000 000000
Q ss_pred HHHHHHHhccCcccc---cCCc--cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 283 DFVKKYIENRGFNGI---VDPR--IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 283 ~~~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........ ....+. .... .......+..+..+.+++.+||+.+|++|||+++++.
T Consensus 234 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 234 EVLNRIGS-DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred Hhhhhhch-hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000000 000000 0000 0001111233567899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=273.20 Aligned_cols=267 Identities=21% Similarity=0.270 Sum_probs=211.7
Q ss_pred ccCHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 045067 51 SFSAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCL 128 (347)
Q Consensus 51 ~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 128 (347)
+-++.++.+.|+ ++||+|+|+.|..++. .++.-+++|++.+.......++.+|++++.+. .|+||+.++++|.
T Consensus 72 ~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 72 SGKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred cchHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 345778888887 5799999999999998 67777777777776667778899999999998 5999999999999
Q ss_pred eCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC---ce
Q 045067 129 EVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY---VP 205 (347)
Q Consensus 129 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~---~~ 205 (347)
++..+|||||-|.||+|..+|.+. ..+++..+.++..+|+.||.||| .+||.|||+||+|||..... -+
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPv 218 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPV 218 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCce
Confidence 999999999999999999999886 78999999999999999999999 99999999999999997554 57
Q ss_pred EEecCCCCccCCCCCc------eeeccccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccC
Q 045067 206 KLFNFSLSASIPEGET------YIDDGVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL 274 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~ 274 (347)
||+||.+..-+..+.. ....+.+|+..|||||+.. ...|+.++|.||+|||+|-|+ .|.+||......
T Consensus 219 KiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImL-sGYpPFvG~Cg~ 297 (463)
T KOG0607|consen 219 KICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIML-SGYPPFVGHCGA 297 (463)
T ss_pred eeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHH-hCCCCccCccCC
Confidence 9999987655432221 1123578999999999754 347889999999999999999 999999875432
Q ss_pred C----CCCchHH--HHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 275 N----GDESFEM--DFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 275 ~----~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+ ....... +.+-.-++++.+ ++. +....+.+.+..+++...+..+|.+|.++.+++.
T Consensus 298 dCGWdrGe~Cr~CQ~~LFesIQEGkY-eFP------dkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 298 DCGWDRGEVCRVCQNKLFESIQEGKY-EFP------DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCccCCCccHHHHHHHHHHHhccCC-cCC------hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1 1111111 112222333332 222 2334566788899999999999999999998876
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=275.48 Aligned_cols=249 Identities=18% Similarity=0.226 Sum_probs=198.4
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|+..+.||+|+||.||++.. .++..+++|..... .......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477788999999999999988 44444445544432 223346688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++... ......+++..+..++.+++.||+||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKR-KKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999998763 122356899999999999999999999 999999999999999999999999999998776544
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
......+++.|+|||.+.+..++.++|+||+|+++|+|+ +|..||..... ... ......+....
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~-~g~~p~~~~~~--------~~~-~~~~~~~~~~~--- 220 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA-TFAPPFEARSM--------QDL-RYKVQRGKYPP--- 220 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------HHH-HHHHhcCCCCC---
Confidence 223356889999999999889999999999999999999 99999964321 111 11111111111
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.......++.+++.+||+.+|++|||+.++++
T Consensus 221 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 -------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11134566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=284.53 Aligned_cols=265 Identities=16% Similarity=0.191 Sum_probs=189.3
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc----
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI---- 132 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 132 (347)
..++|+..+.||+|+||.||+|.. .++ .+++|++..... ......+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 345688899999999999999998 444 455554433222 2222456789999999999999999999876543
Q ss_pred ----cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEe
Q 045067 133 ----PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLF 208 (347)
Q Consensus 133 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 208 (347)
.++||||+.+ +|.+.+... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEEC
Confidence 4999999975 888888652 246899999999999999999999 9999999999999999999999999
Q ss_pred cCCCCccCCCCCce---eeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 209 NFSLSASIPEGETY---IDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 209 Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
|||++......... ......++..|+|||.+.+. .++.++||||||+++|+|+ +|++||..... ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~-t~~~~~~~~~~-----~~~~~~ 235 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW-TRSPIMQGNTE-----QHQLTL 235 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHH-hCCCCCCCCCH-----HHHHHH
Confidence 99998766433221 11234578899999987654 4789999999999999999 89999864321 111111
Q ss_pred HHHHHhcc---Cccc-----ccCC-ccCCch--hh------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 285 VKKYIENR---GFNG-----IVDP-RIIGDE--LL------EHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 285 ~~~~~~~~---~~~~-----~~~~-~~~~~~--~~------~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.......- .... ..+. ...... .. ......+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 11111000 0000 0000 000000 00 001235679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=274.93 Aligned_cols=243 Identities=19% Similarity=0.142 Sum_probs=185.2
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccCCCc---hhHHHHHHHHHHH-HhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDGSVF---DAYDCCFNNIVFA-SQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||.||+|.. .++..+++|....... .....+..|..++ ...+|||++++++++..++..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999998 4455555565544321 1122344555544 445899999999999999999999999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
++|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 9999999764 57899999999999999999999 99999999999999999999999999998865433
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
.....+++.|+|||.+.+..++.++||||+|+++|+|+ +|..||..... ....... ...... ...
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~--------~~~~~~~-~~~~~~--~~~-- 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFL-FGYPPFHAETP--------DAVFDNI-LSRRIN--WPE-- 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHH-HCCCCCCCCCH--------HHHHHHH-HhcccC--CCC--
Confidence 22346888999999988888899999999999999999 89999964321 1111111 111110 000
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
......+..+.+++.+||+.+|++||++.++.+.|
T Consensus 215 ---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 215 ---EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ---cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 01112355788999999999999999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=282.85 Aligned_cols=260 Identities=17% Similarity=0.166 Sum_probs=191.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 135 (347)
.++|+..+.||+|+||.||+|.. .++..+++|... ... ......+.+|+.++++++|+|++++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46788999999999999999998 444444444443 222 12223467899999999999999999998765 46899
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+.+ +|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++..
T Consensus 86 v~e~~~~-~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCCC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 9999975 899888753 256899999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc--c
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN--R 292 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~ 292 (347)
....... .....+++.|+|||.+.+ ..++.++||||+||++|+|+ +|.+||..... .......... .
T Consensus 158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~-~g~~~f~~~~~--------~~~~~~~~~~~~~ 227 (309)
T cd07845 158 YGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELL-AHKPLLPGKSE--------IEQLDLIIQLLGT 227 (309)
T ss_pred cCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHHhcCC
Confidence 6543211 122345788999998765 56789999999999999999 89999964322 1111111110 0
Q ss_pred ---Ccc---------ccc--C-CccCC-chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 ---GFN---------GIV--D-PRIIG-DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 ---~~~---------~~~--~-~~~~~-~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... ... . ..... ........+.+.+++.+||+.||++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 000 0 00000 0001112556789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=304.89 Aligned_cols=269 Identities=23% Similarity=0.349 Sum_probs=215.0
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEe----C-----CceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeee
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVL----P-----DRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIG 125 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~----~-----~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 125 (347)
.++...++....+.||+|.||.|++|.. . .-.||||...........+.+..|+.+|..+ .||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 3555556666667999999999999986 1 1235555555555555668899999999999 5999999999
Q ss_pred eeeeCCccEEEEEeCCCCCHHHHHhhhc---------cCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 045067 126 CCLEVEIPVLVFESAEYGNLHDLLKRSY---------QSHS--EPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKS 194 (347)
Q Consensus 126 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp 194 (347)
+|...+..++|+||+..|+|.+++...+ .... ..+.....+.++.|||.|++||+ +.++|||||-.
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence 9999999999999999999999998764 1111 13889999999999999999999 99999999999
Q ss_pred CCeEECCCCceEEecCCCCccCCCCCceeecccc--ccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCc
Q 045067 195 SYILVSERYVPKLFNFSLSASIPEGETYIDDGVK--GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGL 272 (347)
Q Consensus 195 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~ 272 (347)
.|||+..+..+||+|||+|+.......+...... -...|||||.+....|+.+|||||||++|||++|.|..||...
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~- 525 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI- 525 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC-
Confidence 9999999999999999999977665555433333 3456999999999999999999999999999999999999641
Q ss_pred cCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 273 RLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
....+. ....+.+.. + +.+..+.+++++++..||+.+|++||++.++++.|+....
T Consensus 526 ------~~~~~l-~~~l~~G~r-------~---~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 526 ------PPTEEL-LEFLKEGNR-------M---EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred ------CcHHHH-HHHHhcCCC-------C---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 112222 224444321 1 2223456788999999999999999999999999998643
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=281.41 Aligned_cols=257 Identities=19% Similarity=0.210 Sum_probs=187.7
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCHH
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLH 146 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 146 (347)
+.+|.|+++.||++..++..+++|++... ......+.+.+|+.+++.++||||+++++++.+.+..+++|||+++|+|.
T Consensus 8 ~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 8 KCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred HhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 34455566666666555666666665443 23344577999999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc-----
Q 045067 147 DLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET----- 221 (347)
Q Consensus 147 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~----- 221 (347)
+++... ....+++.....++.|++.||+||| +.+|+||||||+||+++.++.++++|||.+........
T Consensus 88 ~~l~~~---~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 88 DLLKTH---FPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999864 2245889999999999999999999 99999999999999999999999999998865532211
Q ss_pred -eeeccccccCCccccccccc--CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc-------
Q 045067 222 -YIDDGVKGTSGIVAPEYART--GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN------- 291 (347)
Q Consensus 222 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 291 (347)
.......++..|+|||.+.+ ..++.++|+|||||++|||+ +|..||..... ...........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~-~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~ 233 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELA-NGHVPFKDMPA-------TQMLLEKVRGTVPCLLDK 233 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCH-------HHHHHHHHhccCcccccc
Confidence 11123457788999998865 35789999999999999999 89999975321 00111111000
Q ss_pred -------cCccc----ccCCcc---CCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 -------RGFNG----IVDPRI---IGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 -------~~~~~----~~~~~~---~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... ..++.. ...........++.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 000000 000111233457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=281.29 Aligned_cols=255 Identities=16% Similarity=0.174 Sum_probs=195.8
Q ss_pred cCCCCCeecccCceEEEEEEe----CCceEEEEEEccCCC----chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCcc
Q 045067 63 NYHYRNIITESSIFRLCQGVL----PDRTISVVKFIDGSV----FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~~v~k~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 133 (347)
+|+..+.||+|+||.||++.. .++..+++|...... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367778999999999999986 233444455444321 22335688999999999 599999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 9999999999999998753 56899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCCcccccccccCC--CCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTGY--LNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
...............|+..|+|||.+.+.. .+.++|+||||+++|+|+ +|..||..... ..............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~-tg~~p~~~~~~----~~~~~~~~~~~~~~ 227 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL-TGASPFTVDGE----QNSQSEISRRILKS 227 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHH-hCCCCcccCcc----cchHHHHHHHHHcc
Confidence 766543332233456889999999887654 788999999999999999 89999864211 11111222221111
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
. +.. .......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 228 ~-------~~~-----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 K-------PPF-----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred C-------CCC-----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 000 11123467899999999999999999888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=286.39 Aligned_cols=269 Identities=22% Similarity=0.274 Sum_probs=193.6
Q ss_pred HhccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC--Ccc
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV--EIP 133 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 133 (347)
+.++|+..+.||+|+||.||+|.. . +..+++|++.... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 456788889999999999999998 3 4455556554321 222335678899999999 999999999988653 368
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++||||++ ++|.+++.. ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.+||+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999998 599998865 36889999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCce----eeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCC--------CCch
Q 045067 214 ASIPEGETY----IDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG--------DESF 280 (347)
Q Consensus 214 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~--------~~~~ 280 (347)
......... ......|+..|+|||.+.+ ..++.++|+||||+++|+|+ +|++||........ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~-tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML-LGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 766543221 1233568899999997754 56789999999999999999 99999964322000 0000
Q ss_pred H--HHHHHHHHhccCcccccCCc-cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 281 E--MDFVKKYIENRGFNGIVDPR-IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 281 ~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
. .................... ..........+.++.+++.+||+.+|++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 00000000000000000000 00001111235578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=282.97 Aligned_cols=260 Identities=19% Similarity=0.189 Sum_probs=189.0
Q ss_pred eeccc--CceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCC
Q 045067 69 IITES--SIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYG 143 (347)
Q Consensus 69 ~lg~G--~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 143 (347)
.||+| +||+||++.+ .++..+++|+.... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999998 45555555555432 2334467889999999999999999999999999999999999999
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee
Q 045067 144 NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223 (347)
Q Consensus 144 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 223 (347)
+|.+++... ....+++..+..++.|++.||+||| +.+++||||||+||+++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~---~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 85 SANSLLKTY---FPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999998764 2245899999999999999999999 9999999999999999999999999997543322111100
Q ss_pred ------eccccccCCcccccccccC--CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC--
Q 045067 224 ------DDGVKGTSGIVAPEYARTG--YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG-- 293 (347)
Q Consensus 224 ------~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 293 (347)
.....++..|+|||++.+. .++.++||||+||++|+|+ +|.+||...... ... ........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~-~g~~p~~~~~~~-------~~~-~~~~~~~~~~ 229 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA-TGRVPFQDMLRT-------QML-LQKLKGPPYS 229 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCcChH-------HHH-HHHhcCCCCC
Confidence 0112356679999988764 4789999999999999999 899999653210 000 00000000
Q ss_pred ----------------------------------cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH-
Q 045067 294 ----------------------------------FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK- 338 (347)
Q Consensus 294 ----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~- 338 (347)
.....+..+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred Cccccccchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000000011 11112345668899999999999999999999974
Q ss_pred -HHHHHH
Q 045067 339 -QIKKMY 344 (347)
Q Consensus 339 -~L~~i~ 344 (347)
+++.+.
T Consensus 309 ~~~~~~~ 315 (328)
T cd08226 309 AFFKQVK 315 (328)
T ss_pred HHHHHHH
Confidence 444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=312.67 Aligned_cols=258 Identities=18% Similarity=0.190 Sum_probs=214.3
Q ss_pred HHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccC---CCchhHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 045067 54 AKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG---SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE 129 (347)
Q Consensus 54 ~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 129 (347)
..++....++|.+.++||+|+||.|..+++ .++.|+++|++++ ........|..|-.+|..-+.+.|+.++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 345666678999999999999999999999 7889999998876 223344678899999999999999999999999
Q ss_pred CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 130 VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 130 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
++++|+||||++||+|..++.+. ..+|+..+..++..|+.||+-|| +.|+|||||||+|||+|..|++||+|
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeecc
Confidence 99999999999999999999885 47999999999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccc----c-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYAR----T-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
||.+..+..++...+....|||-|.+||++. + +.|++.+|.||+||++|||+ .|..||.... ++..
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMl-yG~TPFYads--------lveT 289 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEML-YGETPFYADS--------LVET 289 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHH-cCCCcchHHH--------HHHH
Confidence 9999988877777778889999999999886 3 57899999999999999999 9999996432 3444
Q ss_pred HHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC---HHHHH
Q 045067 285 VKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT---MIDVA 337 (347)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs---~~ell 337 (347)
..+.+.....-.+. .....++++.+||.+.+. +|+.|.. ++++-
T Consensus 290 Y~KIm~hk~~l~FP--------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 290 YGKIMNHKESLSFP--------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred HHHHhchhhhcCCC--------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 45554432211111 111245677788887665 5888877 66553
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=275.46 Aligned_cols=257 Identities=19% Similarity=0.202 Sum_probs=191.4
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-C-chhHHHHHHHHHHHHhc---CCCceeeeeeeeeeCCc-----
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-V-FDAYDCCFNNIVFASQM---SHNNVLRLIGCCLEVEI----- 132 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~-~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 132 (347)
|+..+.||+|+||.||+|.. .++..+++|..... . ......+.+|+.++.++ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 55678899999999999999 44555555544422 2 12234566788887766 59999999999988776
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.+++|||+++ +|.+++... ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~---~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC---PKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhccc-CHHHHHHHc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 9999999985 899988764 2235899999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
+........ .....++..|+|||.+.+..++.++|+|||||++|+|+ +|.+||..... ..........-
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~-~~~~~~~~~~~--------~~~~~~~~~~~ 222 (287)
T cd07838 154 ARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSE--------ADQLDKIFDVI 222 (287)
T ss_pred ceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHH-hCCCcccCCCh--------HHHHHHHHHHc
Confidence 877643322 12335788999999999889999999999999999999 88999865322 11111111110
Q ss_pred Cc-------------ccccCCccC--CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 GF-------------NGIVDPRII--GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 ~~-------------~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. ......... ...........+.+++.+||+.+|++||++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 000000000 01112234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=287.61 Aligned_cols=263 Identities=18% Similarity=0.222 Sum_probs=193.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CC-ceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----Cc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PD-RTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV-----EI 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 132 (347)
.+.|...+.||+|+||+||+|.. .+ ..+++|++.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688889999999999999998 44 455555544321 222335678899999999999999999987654 35
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 799999997 6899988764 67999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh-
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE- 290 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 290 (347)
+....... .......++..|+|||.+.+ ..++.++|+|||||++|+|+ +|++||..... ............
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~-----~~~~~~~~~~~~~ 227 (337)
T cd07858 155 ARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDY-----VHQLKLITELLGS 227 (337)
T ss_pred ccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHH-cCCCCCCCCCh-----HHHHHHHHHHhCC
Confidence 97664432 12234567889999997764 56899999999999999999 99999964321 000000000000
Q ss_pred ----------ccCccccc---C--CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 291 ----------NRGFNGIV---D--PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 291 ----------~~~~~~~~---~--~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
........ . +........+..+.++.+++.+||+.+|++|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 0 0000001112345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=278.23 Aligned_cols=244 Identities=22% Similarity=0.271 Sum_probs=188.5
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
|...+.||+|+||+||+|+. .++..+++|..... .....+.+.+|+.+++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567799999999999998 45555555544332 223345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+. |+|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 97 5888887652 256899999999999999999999 99999999999999999999999999998854322
Q ss_pred CceeeccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 220 ETYIDDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.....|+..|+|||++. +..++.++|||||||++|+|+ +|.+||..... .......... ...
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~-~g~~p~~~~~~--------~~~~~~~~~~-~~~- 238 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNA--------MSALYHIAQN-DSP- 238 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCh--------HHHHHHHHhc-CCC-
Confidence 22356889999999874 456889999999999999999 89998854321 1111111111 111
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
... ....+..+.+++.+||+.+|.+||++.+++..
T Consensus 239 ----~~~----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 ----TLQ----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----CCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 11123457899999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=277.36 Aligned_cols=265 Identities=18% Similarity=0.195 Sum_probs=191.6
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEEeC
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
|+..+.||+|++|+||+|+. +++..+++|..... .........+|+..+.+++ |||++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 56678899999999999999 44444444444332 2222234567999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
+|+|.+.+... ....+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDR---KGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 67999988764 2246899999999999999999999 9999999999999999999999999999987664432
Q ss_pred ceeeccccccCCcccccccc-cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCC--------CCchHHHHHHHHHhc
Q 045067 221 TYIDDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG--------DESFEMDFVKKYIEN 291 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~~~ 291 (347)
. .....++..|+|||.+. +..++.++|+||||+++++|+ +|.+||........ +......|.......
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 154 P--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELY-TLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred C--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHH-hCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 2 12356788999999774 456789999999999999999 89999865422000 000000011111000
Q ss_pred cCcccccCCccCC--chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGFNGIVDPRIIG--DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
......+...... ..........+.+++.+||+.+|++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0110000000000 0001112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.80 Aligned_cols=252 Identities=17% Similarity=0.236 Sum_probs=191.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 137 (347)
.++|+..+.||+|+||.||+|.+ .++..+++|.... ........+.+|+.++.+.. ||||+++++++.++...+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 35678889999999999999999 4355555555443 33333456777887777774 999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
||++ ++|.+++... ...+++..+..++.+++.||+||| + .+++||||+|+||+++.++.++|+|||++...
T Consensus 94 e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 94 ELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9986 4888887653 257899999999999999999999 6 59999999999999999999999999998765
Q ss_pred CCCCceeeccccccCCcccccccccCC----CCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGY----LNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
...... ....++..|+|||.+.+.. ++.++|+||||+++|+|+ +|..||..... ............
T Consensus 166 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~-------~~~~~~~~~~~~ 235 (296)
T cd06618 166 VDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA-TGQFPYKNCKT-------EFEVLTKILQEE 235 (296)
T ss_pred cCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHH-hCCCCCCcchh-------HHHHHHHHhcCC
Confidence 432221 2235788999999887553 788999999999999999 89999853211 112222222221
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
. . ...... ..+.++.+++.+||+.+|++||++.++++.
T Consensus 236 ~-~-----~~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 P-P-----SLPPNE---GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-C-----CCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 0 110000 124568899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=286.09 Aligned_cols=269 Identities=19% Similarity=0.220 Sum_probs=194.8
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeee-CC
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE-VE 131 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 131 (347)
++..++++|+..+.||.|+||.||+|.. .++ .+++|++.... .....+.+.+|+.++++++||||+++.+++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 3455788999999999999999999998 344 45555544322 22234678899999999999999999998865 55
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
..++++||+. ++|.+++.. ..++......++.|++.||.||| +.+++||||+|+||+++.++.++|+|||
T Consensus 84 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg 153 (328)
T cd07856 84 DIYFVTELLG-TDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFG 153 (328)
T ss_pred cEEEEeehhc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccc
Confidence 7899999995 589988865 46888888999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCC-------CchHHH
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD-------ESFEMD 283 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~ 283 (347)
.+....... ....++..|+|||.+.+ ..++.++|+|||||++|+|+ +|.+||......... ......
T Consensus 154 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~-tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd07856 154 LARIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML-EGKPLFPGKDHVNQFSIITDLLGTPPDD 228 (328)
T ss_pred cccccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 987543221 23457889999998765 57899999999999999999 899999653220000 000000
Q ss_pred HHHHHHhccCc---ccccC-CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 284 FVKKYIENRGF---NGIVD-PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 284 ~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+.......... ..... .........+.....+.+++.+||+.+|++|||+.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11110000000 00000 0000001111234578899999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=278.37 Aligned_cols=251 Identities=17% Similarity=0.199 Sum_probs=192.8
Q ss_pred cCCCCCeecccCceEEEEEEe----CCceEEEEEEccCCC----chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCcc
Q 045067 63 NYHYRNIITESSIFRLCQGVL----PDRTISVVKFIDGSV----FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~~v~k~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 133 (347)
+|+..+.||.|+||.||.+.. .++..+++|...... ....+.+.+|+.++.++ +||||+.+++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477788999999999999987 245555566554322 22336688999999999 599999999999998999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++|+||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 9999999999999999764 56889999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCCcccccccccC--CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTG--YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
...............|+..|+|||.+.+. .++.++||||||+++|+|+ +|..||..... ..............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll-~g~~p~~~~~~----~~~~~~~~~~~~~~ 227 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL-TGASPFTVDGE----KNSQAEISRRILKS 227 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHh-cCCCCCCcCCc----cccHHHHHHHhhcc
Confidence 76644332222345688999999987653 4678999999999999999 89999863211 11111222222111
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
. +.. .......+.+++.+||+.+|++|| ++.+++.
T Consensus 228 ~-------~~~-----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 E-------PPY-----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred C-------CCC-----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1 000 112244678999999999999997 6676654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=278.18 Aligned_cols=248 Identities=19% Similarity=0.229 Sum_probs=198.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 136 (347)
++|...+.||+|+||.||+|.. .++..+++|+.... .....+.+.+|+.++++++ ||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688889999999999999999 45666666665542 2233466889999999998 99999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
||++++++|.+++.+. ..+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 9999999999999864 57999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCc-------------------eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCC
Q 045067 217 PEGET-------------------YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD 277 (347)
Q Consensus 217 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~ 277 (347)
..... .......++..|+|||...+..++.++|+||+|+++++++ +|+.||.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~---- 227 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML-TGKPPFRGSNE---- 227 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHH-hCCCCCCCccH----
Confidence 43221 1112345788999999988888999999999999999999 89999974321
Q ss_pred CchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCH----HHHHH
Q 045067 278 ESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM----IDVAK 338 (347)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~----~ell~ 338 (347)
............ .. +...++.+.+++.+||+.+|++|||+ .++++
T Consensus 228 ----~~~~~~~~~~~~-------~~-----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 ----YLTFQKILKLEY-------SF-----PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ----HHHHHHHHhcCC-------CC-----CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111112111100 00 11224567899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=278.63 Aligned_cols=244 Identities=23% Similarity=0.278 Sum_probs=188.2
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccC---CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG---SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
|+..+.||+|+||.||+|.. .++..+++|.... ......+.+.+|+.+++.++|||++++.+++......++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 55667899999999999998 4444444444332 2223345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+. |+|.+.+... ...+++..+..++.+++.||.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 97 CL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred cC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 97 5888877542 256899999999999999999999 999999999999999999999999999998665332
Q ss_pred CceeeccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 220 ETYIDDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
....+++.|+|||.+. ...++.++|||||||++|+|+ +|..||..... .......... ..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~--------~~~~~~~~~~-~~-- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNA--------MSALYHIAQN-ES-- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHH-cCCCCCccccH--------HHHHHHHhhc-CC--
Confidence 2346788999999874 356789999999999999999 89988753211 1111111111 11
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+.. ........+.+++.+||+.+|++||++.+++..
T Consensus 232 ---~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 ---PAL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ---CCc----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 111 011234567899999999999999999998865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=287.09 Aligned_cols=263 Identities=21% Similarity=0.236 Sum_probs=197.9
Q ss_pred cCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----ccE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE-----IPV 134 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 134 (347)
+|...+.||.|+||.||+|.. . +..+++|++..... ....+.+.+|+.+++.++||||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 477788999999999999998 4 44555555443322 334467899999999999999999999988775 789
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
++|||++ ++|.+++... ..+++..+..++.+++.||+||| +.+++||||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999998 4899998764 47999999999999999999999 9999999999999999999999999999988
Q ss_pred cCCCCCc--eeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 215 SIPEGET--YIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 215 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
....... .......++..|+|||.+.+. .++.++|+||+|+++|+|+ +|.+||..... ..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~-~g~~pf~~~~~--------~~~~~~i~~~ 222 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFPGRDY--------IDQLNLIVEV 222 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHH-cCCCCcCCCCH--------HHHHHHHHHh
Confidence 7654321 112335678899999998877 8899999999999999999 99999965421 0111111100
Q ss_pred c--------------CcccccC---C--ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHH
Q 045067 292 R--------------GFNGIVD---P--RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ--IKKM 343 (347)
Q Consensus 292 ~--------------~~~~~~~---~--~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~--L~~i 343 (347)
. .....+. . ........+..+..+.+++.+||+.+|++|||+.+++.. ++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred cCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0 0000000 0 000000111235578899999999999999999999873 5443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=275.72 Aligned_cols=241 Identities=18% Similarity=0.204 Sum_probs=182.0
Q ss_pred eecccCceEEEEEEe-CCceEEEEEEccCCC-c--hhHHHHHHHHH---HHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 69 IITESSIFRLCQGVL-PDRTISVVKFIDGSV-F--DAYDCCFNNIV---FASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~-~--~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
+||+|+||.||+|.. .++..+++|...... . .....+..|.. .++...||||+.+.+++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999998 445444555443321 1 11122344443 3444579999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
+|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 99999998754 57999999999999999999999 99999999999999999999999999999876543221
Q ss_pred eeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 222 YIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
....|+..|+|||.+.++ .++.++||||+||++|+|+ +|..||...... . ... ........ ..
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~-~g~~p~~~~~~~--~---~~~-~~~~~~~~------~~ 216 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL-RGHSPFRQHKTK--D---KHE-IDRMTLTM------AV 216 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHH-hCCCCCCCCCcc--c---hHH-HHHHhhcc------CC
Confidence 235689999999988744 6899999999999999999 899999753220 0 011 11111100 11
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
.+. ...+..+.+++.+||..+|++|| ++.++++
T Consensus 217 ~~~-----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 ELP-----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCC-----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111 11245688999999999999999 9999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=285.84 Aligned_cols=259 Identities=18% Similarity=0.183 Sum_probs=188.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC---------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--------- 130 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 130 (347)
..+|...+.||.|+||.||+|.. .++..+++|..........+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36788899999999999999998 44444444444333334447788999999999999999999876543
Q ss_pred -----CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC-CCCc
Q 045067 131 -----EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS-ERYV 204 (347)
Q Consensus 131 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~-~~~~ 204 (347)
...++|+||++ ++|.+++.. ..+++..+..++.|++.||.||| +.+++||||||+||+++ .++.
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCce
Confidence 35789999998 599988864 46899999999999999999999 99999999999999998 4567
Q ss_pred eEEecCCCCccCCCCCce--eeccccccCCcccccccc-cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchH
Q 045067 205 PKLFNFSLSASIPEGETY--IDDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFE 281 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~ 281 (347)
++++|||++......... ......++..|+|||.+. +..++.++|||||||++|+|+ +|+.||.....
T Consensus 154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~-~g~~pf~~~~~-------- 224 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKPLFAGAHE-------- 224 (342)
T ss_pred EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------
Confidence 899999998765322111 112245788999999764 457889999999999999999 99999964321
Q ss_pred HHHHHHHHhccCc--------------c----cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 282 MDFVKKYIENRGF--------------N----GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 282 ~~~~~~~~~~~~~--------------~----~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
............. . ....+.............++.+++.+||+.+|++|||+.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 225 LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000 0 0000000000111123456889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=283.92 Aligned_cols=258 Identities=19% Similarity=0.232 Sum_probs=192.1
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC--
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE-- 131 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 131 (347)
+....++|+..+.||+|+||.||+|.. .++ .+++|+..... .....+.+.+|+.++++++||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 444677899999999999999999998 444 45555443322 2223356889999999999999999999987654
Q ss_pred ----ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEE
Q 045067 132 ----IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207 (347)
Q Consensus 132 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl 207 (347)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+++
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEE
Confidence 358999999 5799988864 56899999999999999999999 999999999999999999999999
Q ss_pred ecCCCCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 208 FNFSLSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
+|||++....... ....+++.|+|||.+.+ ..++.++|+||+|+++|+++ +|.+||..... .....
T Consensus 160 ~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~pf~~~~~--------~~~~~ 226 (343)
T cd07880 160 LDFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML-TGKPLFKGHDH--------LDQLM 226 (343)
T ss_pred eecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHH
Confidence 9999987654322 23467889999998775 46889999999999999999 89999964321 00111
Q ss_pred HHHhc--------------cCcccccC--CccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 045067 287 KYIEN--------------RGFNGIVD--PRIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVA 337 (347)
Q Consensus 287 ~~~~~--------------~~~~~~~~--~~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell 337 (347)
..... ........ +..... ........++.+++.+|++.||++|||+.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 227 EIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 11000 00000000 000000 00112344688999999999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=284.54 Aligned_cols=259 Identities=18% Similarity=0.263 Sum_probs=189.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE------ 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 131 (347)
.++|...+.||+|+||.||+|.. . +..+++|++.... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37888899999999999999998 4 4455555544322 2222356889999999999999999999987543
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
..++|+||+.. +|...+. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence 45899999974 7777653 36889999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||..... .........
T Consensus 163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~-~g~~pf~~~~~--------~~~~~~~~~ 229 (342)
T cd07879 163 LARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML-TGKTLFKGKDY--------LDQLTQILK 229 (342)
T ss_pred CCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHH
Confidence 98765332 123467889999998765 46889999999999999999 89999974321 011111110
Q ss_pred c--------------cCcccccC--CccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHH
Q 045067 291 N--------------RGFNGIVD--PRIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ--IKKM 343 (347)
Q Consensus 291 ~--------------~~~~~~~~--~~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~--L~~i 343 (347)
. ........ +..... ...+.....+.+++.+||+.||++||++.+++.. ++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred hcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0 00000000 000000 0001223467899999999999999999999843 5544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=280.14 Aligned_cols=264 Identities=16% Similarity=0.178 Sum_probs=189.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCCc-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSVF-DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE------ 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 131 (347)
.++|+..+.||+|+||.||+|.. . +..+++|++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999999999999998 3 445555554433221 12245778999999999999999999875433
Q ss_pred --ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 132 --IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 132 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
.+++|+||+.+ +|...+... ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECc
Confidence 46999999975 787777542 257999999999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCcee----------eccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCC
Q 045067 210 FSLSASIPEGETYI----------DDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278 (347)
Q Consensus 210 fg~a~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~ 278 (347)
||++.......... .....+++.|+|||.+.+ ..++.++|||||||++|+|+ +|.+||......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~-~g~~~~~~~~~~---- 233 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF-TRRPILQGKSDI---- 233 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHH-hCCCCCCCCCHH----
Confidence 99987654322111 122356788999997765 45789999999999999999 899999643220
Q ss_pred chHHHHHHHHHhcc---------Cccc----ccCCccCCc--hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 279 SFEMDFVKKYIENR---------GFNG----IVDPRIIGD--ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 279 ~~~~~~~~~~~~~~---------~~~~----~~~~~~~~~--~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
............. .... ......... .......+.+.+++.+||+.+|++|||+.|++.
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 234 -DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred -HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0001111100000 0000 000000000 001112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=281.27 Aligned_cols=267 Identities=18% Similarity=0.211 Sum_probs=194.6
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeee
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCL 128 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 128 (347)
....++..++++|...+.||+|+||.||+|.. .++ .+++|++.... .....+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34456777889999999999999999999987 444 44455443322 2223466889999999999999999999886
Q ss_pred eC------CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC
Q 045067 129 EV------EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER 202 (347)
Q Consensus 129 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~ 202 (347)
.. ...+++++++ +++|.+++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNED 156 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCC
Confidence 43 3467888887 5799988865 46899999999999999999999 9999999999999999999
Q ss_pred CceEEecCCCCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchH
Q 045067 203 YVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFE 281 (347)
Q Consensus 203 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~ 281 (347)
+.++|+|||++...... .....++..|+|||.+.+ ..++.++||||+||++|+|+ +|++||...... ...
T Consensus 157 ~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~-~g~~pf~~~~~~----~~~ 227 (345)
T cd07877 157 CELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHI----DQL 227 (345)
T ss_pred CCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHH----HHH
Confidence 99999999998765332 223567889999998766 56889999999999999999 899999643210 000
Q ss_pred HHHHHHHHhccCccccc----C----------CccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 282 MDFVKKYIENRGFNGIV----D----------PRIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 282 ~~~~~~~~~~~~~~~~~----~----------~~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.. ..... ......+. + +..... .........+.+++.+||+.+|.+|||+.+++..
T Consensus 228 ~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 228 KL-ILRLV-GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HH-HHHHh-CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 00000 00000000 0 000000 0000124467899999999999999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=271.45 Aligned_cols=250 Identities=16% Similarity=0.185 Sum_probs=191.1
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEc---cCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFI---DGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~---~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.|...+.||+|+||.||++.. ..+....+|+. ... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 367778999999999999988 33222222222 211 122234577899999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
+||+++++|.+++... ......+++..+..++.|++.||.||| +.+++|+||+|+||+++. +.++|+|||.+...
T Consensus 81 ~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEEL-KHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHH-hhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999998653 123357999999999999999999999 999999999999999975 56999999998765
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..... ......+++.|+|||...+..++.++|+||||+++|+|+ +|..||.... ......... .+.
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~-~~~~~~~~~~--------~~~~~~~~~-~~~--- 221 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC-CLAHAFEGQN--------FLSVVLRIV-EGP--- 221 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHH-hCCCCCCCcc--------HHHHHHHHH-cCC---
Confidence 43322 223456888999999988888899999999999999999 8999985321 111111111 111
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+. .....+.++.+++.+||+.+|++||++.++++
T Consensus 222 --~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 --TPS-----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCC-----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111 11234557889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=280.29 Aligned_cols=266 Identities=17% Similarity=0.199 Sum_probs=186.9
Q ss_pred cCCCCCeecccCceEEEEEEe-CC--c-eEEEEEEccCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC----Cc
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PD--R-TISVVKFIDGS-VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV----EI 132 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~--~-~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 132 (347)
+|...+.||+|+||.||++.. .. + .+++|++.... .....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 367778999999999999998 33 4 44554443221 222346688999999999 599999999875432 45
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.++++||+. ++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 788999987 5999998654 67899999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCce---eeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCC-------CchH
Q 045067 213 SASIPEGETY---IDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD-------ESFE 281 (347)
Q Consensus 213 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~-------~~~~ 281 (347)
+......... ......||..|+|||++.+ ..++.++|+||+||++|+++ +|.+||......... ....
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQILQVLGTPD 230 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHH-hCCcCCCCCCHHHHHHHHHHHhCCCC
Confidence 9765433211 1123568999999997765 56899999999999999999 899998653210000 0000
Q ss_pred HHHHHHHHhcc--Cccccc--CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 282 MDFVKKYIENR--GFNGIV--DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 282 ~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........... ...... .+........+.....+.+++.+||+.+|++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 000000 0000000000112457889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=279.80 Aligned_cols=262 Identities=16% Similarity=0.179 Sum_probs=189.5
Q ss_pred ccCC-CCCeecccCceEEEEEEe-C-CceEEEEEEccCCCch-------------hHHHHHHHHHHHHhcCCCceeeeee
Q 045067 62 NNYH-YRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSVFD-------------AYDCCFNNIVFASQMSHNNVLRLIG 125 (347)
Q Consensus 62 ~~~~-~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~~ 125 (347)
+.|. ..+.||.|+||+||+|.. . +..+++|+........ ....+.+|+.++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 346799999999999998 3 4455555543322111 0124779999999999999999999
Q ss_pred eeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 126 CCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 126 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
++..++..++||||+. |+|.+++... ..+++.....++.|++.||.||| +.+++|+||+|+||+++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCE
Confidence 9999999999999997 5999998753 56899999999999999999999 9999999999999999999999
Q ss_pred EEecCCCCccCCCCC-------------ceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccC
Q 045067 206 KLFNFSLSASIPEGE-------------TYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMG 271 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~ 271 (347)
+|+|||++....... ........+++.|+|||.+.+. .++.++|+||+||++|+|+ +|.+||...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~-tg~~p~~~~ 237 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL-TGKPLFPGE 237 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCC
Confidence 999999987654111 0111223467889999988764 5789999999999999999 799999753
Q ss_pred ccCCCCCchHHHHHHHHHhccC---ccc--------ccCCccCC--chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 272 LRLNGDESFEMDFVKKYIENRG---FNG--------IVDPRIIG--DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~---~~~--------~~~~~~~~--~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. ............... +.. ...+.... .......+..+.+++.+||+.+|++|||++|++.
T Consensus 238 ~~-----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 238 NE-----IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CH-----HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 22 000111111110000 000 00000000 0001122456889999999999999999999985
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=288.69 Aligned_cols=273 Identities=17% Similarity=0.205 Sum_probs=199.8
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC------CccEE
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV------EIPVL 135 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 135 (347)
+...+.||+|+||.||+|++ ..|..+++|..+. ......+.+.+|+++|++++|||||+++++=.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999998 5555555555444 4455568899999999999999999999975543 35789
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC--CCC--ceEEecCC
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS--ERY--VPKLFNFS 211 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~--~~~--~~kl~Dfg 211 (347)
|||||+||||...+++. .+...+++...+.+..++..||.||| +++|+||||||.||++- .+| .-||+|||
T Consensus 95 vmEyC~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEeecCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999873 45678999999999999999999999 99999999999999985 223 46999999
Q ss_pred CCccCCCCCceeeccccccCCcccccccc-cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
.|+.+..+. ......||..|++||+.. .+.|+..+|.|||||++|+.+ ||..||..................+..+
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~ca-TG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECA-TGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHh-ccCCCCCcCCCccccchhhhhhhccCCC
Confidence 999987765 345678999999999888 588999999999999999999 9999996533211111111111111111
Q ss_pred ccCc---ccccC-----CccCCc-hhhHHHHHHHHHHHHHhccCCCCCCC--CHHHHHHHHHHHH
Q 045067 291 NRGF---NGIVD-----PRIIGD-ELLEHKLQSSFELAFQCQSASAEDRP--TMIDVAKQIKKMY 344 (347)
Q Consensus 291 ~~~~---~~~~~-----~~~~~~-~~~~~~~~~~~~l~~~cl~~~P~~RP--s~~ell~~L~~i~ 344 (347)
...+ .+..+ ..++.+ .........+-.++..+|..+|++|- ...+....+.+|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 0000 00000 011111 11122234566788888899999998 6777766666664
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=272.38 Aligned_cols=259 Identities=19% Similarity=0.205 Sum_probs=193.8
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
|+..+.||+|++|.||+|.. .++..+++|...... ....+.+.+|+.++++++|||++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 45667899999999999999 445555555554432 223366889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
+ ++|.+++... ...+++..+..++.+++.||.||| +.+++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 8 5999999863 146999999999999999999999 9999999999999999999999999999987664432
Q ss_pred ceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh---------
Q 045067 221 TYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE--------- 290 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 290 (347)
. ......++..|+|||.+.+. .++.++|+|||||++||++ +|.+||..... ............
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 153 R-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI-TGKPLFPGDSE-----IDQLFKIFQILGTPTEESWPG 225 (282)
T ss_pred c-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHH-hCCCCCCCccH-----HHHHHHHHHHhCCCcHHHHHh
Confidence 2 12234467889999988766 8899999999999999999 88999965321 000000000000
Q ss_pred ccC---cccccCCccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 NRG---FNGIVDPRIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ~~~---~~~~~~~~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... ..... +..... ...+.....+.+++.+||+.+|++||++.+++.
T Consensus 226 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 226 VTKLPDYKPTF-PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hcccccccccc-cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 00000 000000 111122457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=263.85 Aligned_cols=254 Identities=19% Similarity=0.221 Sum_probs=202.0
Q ss_pred HHhccCCCC-CeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC----C
Q 045067 59 RATNNYHYR-NIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV----E 131 (347)
Q Consensus 59 ~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~ 131 (347)
.++++|+.. ++||-|-.|.|-.+.+ .++.-+++|++..+ ....+|+++.-.. .|||||.++++|.+. .
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 357777654 5899999999999998 66777777776654 4567888876555 699999999998753 4
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC---CCCceEEe
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS---ERYVPKLF 208 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~---~~~~~kl~ 208 (347)
.+.+|||.|.||.|++.++.. ....+.+.++..|+.||..|+.||| +.+|.||||||+|+|.. .|..+||+
T Consensus 133 cLLiVmE~meGGeLfsriq~~---g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR---GDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eeEeeeecccchHHHHHHHHc---ccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence 678999999999999999876 4467999999999999999999999 99999999999999997 45679999
Q ss_pred cCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 209 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
|||+|+....... ..+.+.||.|.|||++....|+..+|+||+||++|-|+ .|.+||.+.....-. .-.+..
T Consensus 207 DfGFAK~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlL-CGyPPFYS~hg~ais-----pgMk~r 278 (400)
T KOG0604|consen 207 DFGFAKETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLAIS-----PGMKRR 278 (400)
T ss_pred ccccccccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhh-cCCCcccccCCccCC-----hhHHhH
Confidence 9999987654332 35678999999999999999999999999999999999 999999865431111 111111
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+..+.+ ++. ++.....+++..++++.+|..+|.+|.|+.++++
T Consensus 279 I~~gqy-~FP------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 279 IRTGQY-EFP------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hhccCc-cCC------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 222211 111 2233466788999999999999999999999875
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=282.84 Aligned_cols=257 Identities=20% Similarity=0.259 Sum_probs=192.7
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc---
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI--- 132 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 132 (347)
...++|+..+.||+|++|.||+|.. .++..+++|..... .....+.+.+|+.++++++|||++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3467899999999999999999999 44544555544332 22233567889999999999999999988776554
Q ss_pred ---cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 133 ---PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 133 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
.++|+||+. ++|.+++.. ..+++..+..++.|++.||+||| +.+++||||+|+||+++.++.++|+|
T Consensus 92 ~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLMG-ADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecCC-CCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcc
Confidence 899999995 699999865 56999999999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
||++...... .....++..|+|||.+.+ ..++.++||||+||++|+++ +|+.||..... .......
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ell-tg~~pf~~~~~--------~~~~~~i 228 (343)
T cd07851 162 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGKTLFPGSDH--------IDQLKRI 228 (343)
T ss_pred cccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCCh--------HHHHHHH
Confidence 9998765433 233467889999998765 46789999999999999999 89999964321 1111111
Q ss_pred Hhcc-C-ccc------------ccCC--ccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IENR-G-FNG------------IVDP--RIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~~-~-~~~------------~~~~--~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.... . ... .... ..... ......+.++.+++.+||+.+|++|||+.+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 229 MNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 1100 0 000 0000 00000 000112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=266.24 Aligned_cols=242 Identities=18% Similarity=0.195 Sum_probs=200.4
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCc---hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF---DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...++||+|.||.|-.++- ..++.+++|++++..- +....-..|-.+|+..+||.+..+...|+..+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46788999999999999999998 7888888888876542 3334556788999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+.||.|+-++++. ..+++....-+-..|+.||.||| +++||.||||.+|.|+|.+|++||+|||+++.-
T Consensus 247 MeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999875 67899988999999999999999 999999999999999999999999999999765
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.... ...++.||||.|+|||++....|..+.|.|.+||++|||+ +|+.||..... ...+-.-...+-.
T Consensus 319 I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMm-CGRLPFyn~dh-------~kLFeLIl~ed~k--- 386 (516)
T KOG0690|consen 319 IKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMM-CGRLPFYNKDH-------EKLFELILMEDLK--- 386 (516)
T ss_pred cccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHH-hccCcccccch-------hHHHHHHHhhhcc---
Confidence 4332 2346789999999999999999999999999999999999 99999965332 1111111111111
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT 332 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs 332 (347)
-| ...++++..|+...|..||.+|..
T Consensus 387 --FP--------r~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 387 --FP--------RTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred --CC--------ccCCHHHHHHHHHHhhcChHhhcC
Confidence 11 223456778999999999999953
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=266.61 Aligned_cols=236 Identities=22% Similarity=0.226 Sum_probs=188.4
Q ss_pred ecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 70 ITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 70 lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
||.|+||.||++.. .++..+++|...... ....+.+.+|+.++++++|||++++++.+.++...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999 445555555544332 12346789999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeec
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 225 (347)
.+++... ..+++.....++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTN 151 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-ccc
Confidence 9999764 46899999999999999999999 99999999999999999999999999999876644321 123
Q ss_pred cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCc
Q 045067 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGD 305 (347)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (347)
...++..|+|||...+...+.++|+||||+++|+++ +|..||..... .......... . ..+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~-~g~~p~~~~~~--------~~~~~~~~~~-~------~~~--- 212 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEML-TGKPPFYAEDR--------KEIYEKILKD-P------LRF--- 212 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHH-HCCCCCCCCCH--------HHHHHHHhcC-C------CCC---
Confidence 456888999999998888899999999999999999 89999964321 1111221110 0 000
Q ss_pred hhhHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 045067 306 ELLEHKLQSSFELAFQCQSASAEDRPTMID 335 (347)
Q Consensus 306 ~~~~~~~~~~~~l~~~cl~~~P~~RPs~~e 335 (347)
....+..+.+++.+||..+|++||++.+
T Consensus 213 --~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 213 --PEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred --CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1111456789999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=239.92 Aligned_cols=259 Identities=16% Similarity=0.155 Sum_probs=198.6
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
+|...++||+|.||+||+|+. ++..++++|...-.. .+-.....+|+-+++.+.|.|||+++++...++.+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 355567799999999999999 667766666554332 22335688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
|.. +|..+.... .+.++...+..++.|++.||.|+| ++++.|||+||+|.||+.+|.+|++|||+++.....
T Consensus 83 cdq-dlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hhH-HHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 985 898888663 378999999999999999999999 999999999999999999999999999999887654
Q ss_pred CceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh-ccC----
Q 045067 220 ETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE-NRG---- 293 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~---- 293 (347)
.... +....|.+|.+|.++.+ ..|+.+.|+||.||++.|+...|++.|...+. .+.+...+. -+.
T Consensus 155 vrcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--------ddqlkrif~~lg~p~ed 225 (292)
T KOG0662|consen 155 VRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--------DDQLKRIFRLLGTPTED 225 (292)
T ss_pred eEee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--------HHHHHHHHHHhCCCccc
Confidence 4322 33467999999997776 47899999999999999999999999975432 222222222 111
Q ss_pred ----cccccCCcc----CCchh----hHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 ----FNGIVDPRI----IGDEL----LEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 ----~~~~~~~~~----~~~~~----~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+..+.|... ..... .+.....-.+++...+.-+|..|.++++.++
T Consensus 226 ~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 226 QWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111112111 11111 1112224468888889999999999998765
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=286.39 Aligned_cols=261 Identities=19% Similarity=0.241 Sum_probs=214.2
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLE 129 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 129 (347)
+.++.+..-++.|++.++||.|.+|.||+++. +++..+++|+.......+ +++..|..++... .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 44555666778899999999999999999999 788888888888776555 7788999999888 69999999999874
Q ss_pred -----CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc
Q 045067 130 -----VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV 204 (347)
Q Consensus 130 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~ 204 (347)
++.+|||||||.+||..|++++. .+..+.|..+..|++.++.||.||| ...++|||+|-.|||++.++.
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~---~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNT---KGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhh---cccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCc
Confidence 46899999999999999999986 3688999999999999999999999 999999999999999999999
Q ss_pred eEEecCCCCccCCCCCceeeccccccCCccccccccc-----CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCc
Q 045067 205 PKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART-----GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDES 279 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~ 279 (347)
+|++|||.+..+.... ...++..||+.|||||++.. ..|+..+|+||+|++..||- -|.+|+.+..+
T Consensus 162 VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEla-dG~PPl~DmHP------ 233 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMA-EGAPPLCDMHP------ 233 (953)
T ss_pred EEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhc-CCCCCccCcch------
Confidence 9999999988765432 23456789999999998864 35678899999999999999 99999876543
Q ss_pred hHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 280 FEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. +..+.. .+-..|.+.. +....+++.++|..||..|.++||++.++++
T Consensus 234 --m---raLF~I---pRNPPPkLkr---p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 234 --M---RALFLI---PRNPPPKLKR---PKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --h---hhhccC---CCCCCccccc---hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1 111111 1111122221 2344678999999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=297.78 Aligned_cols=145 Identities=20% Similarity=0.182 Sum_probs=126.3
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|...+.||+|+||.||+|.. .++..+++|++... .......+.+|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 5788889999999999999999 44555555544432 1223466889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
||+.+++|.+++... ..+++..+..++.||+.||.||| ..+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999764 56889999999999999999999 8999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=260.16 Aligned_cols=220 Identities=22% Similarity=0.181 Sum_probs=172.2
Q ss_pred cCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhh
Q 045067 73 SSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKR 151 (347)
Q Consensus 73 G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 151 (347)
|.+|.||++.. .++..+++|.+.... ...+|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999999 455555555554432 233455555566799999999999999999999999999999999976
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeeccccccC
Q 045067 152 SYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231 (347)
Q Consensus 152 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~ 231 (347)
. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||.+....... ....++.
T Consensus 79 ~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~ 146 (237)
T cd05576 79 F-----LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVEN 146 (237)
T ss_pred h-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCc
Confidence 4 56899999999999999999999 9999999999999999999999999999876554321 2234677
Q ss_pred CcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHH
Q 045067 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHK 311 (347)
Q Consensus 232 ~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (347)
.|+|||...+..++.++|+||+|+++|||+ +|..|+...... ... .....+ +...
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~-~g~~~~~~~~~~--------------~~~-----~~~~~~-----~~~~ 201 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELL-TGKTLVECHPSG--------------INT-----HTTLNI-----PEWV 201 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHH-HCcchhhcCchh--------------ccc-----ccccCC-----cccC
Confidence 899999988888899999999999999999 888877532110 000 000001 1123
Q ss_pred HHHHHHHHHHhccCCCCCCCCHH
Q 045067 312 LQSSFELAFQCQSASAEDRPTMI 334 (347)
Q Consensus 312 ~~~~~~l~~~cl~~~P~~RPs~~ 334 (347)
...+.+++.+||+.||++||++.
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCCC
Confidence 45678999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=281.41 Aligned_cols=239 Identities=23% Similarity=0.266 Sum_probs=192.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++.|.....+|.|+|+.|-.+.. .+.....+|++.... ....+|+.++... +||||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 66788888899999999999998 555555555555442 2234677666665 79999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE-CCCCceEEecCCCCccCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV-SERYVPKLFNFSLSASIP 217 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill-~~~~~~kl~Dfg~a~~~~ 217 (347)
.+.|+.|.+.+... +.....+..|+.+|+.|+.||| ++|+|||||||+|||+ +..++++|+|||.++...
T Consensus 397 ~l~g~ell~ri~~~------~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK------PEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hccccHHHHHHHhc------chhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999988888663 3334777789999999999999 9999999999999999 589999999999998766
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.. ..+.+-|..|.|||+.....|++++|+||||++||+|+ +|+.||..... . ..+...+..+.
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML-~G~tp~~~~P~-------~-~ei~~~i~~~~---- 530 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEML-TGRTLFAAHPA-------G-IEIHTRIQMPK---- 530 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHH-hCCCccccCCc-------h-HHHHHhhcCCc----
Confidence 54 23457789999999999999999999999999999999 99999975432 1 11222222211
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.....+..+.+|+.+||+.||.+||+|.++..
T Consensus 531 ---------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 ---------FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---------cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11345667889999999999999999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=268.98 Aligned_cols=249 Identities=16% Similarity=0.240 Sum_probs=200.7
Q ss_pred CHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 045067 53 SAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQM-SHNNVLRLIGCC 127 (347)
Q Consensus 53 ~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 127 (347)
+..+... ..+|....+||+|+||.|-+|.. .+...+++|++.++. .++.+.-+.|-.+|+.- +-|.+++++.++
T Consensus 341 ~~~d~i~-~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 341 SKRDRIK-ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred Cccccee-ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence 3344333 34688899999999999999998 566777777776653 23345566787788766 578999999999
Q ss_pred eeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEE
Q 045067 128 LEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207 (347)
Q Consensus 128 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl 207 (347)
++-+.+|+||||+.||+|-.+|+.- +.+.++.+.-++..|+-||-+|| ++||+.||||..|||+|.+|++||
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi 491 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKI 491 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEe
Confidence 9999999999999999999999875 77889999999999999999999 999999999999999999999999
Q ss_pred ecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 208 FNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
+|||+++.-..+.. ...+.+|||.|+|||.+..++|+.++|.|||||+||||+ .|++||+..+. ....+.
T Consensus 492 ~DFGmcKEni~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEml-aGQpPFdGeDE--------~elF~a 561 (683)
T KOG0696|consen 492 ADFGMCKENIFDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQPPFDGEDE--------DELFQA 561 (683)
T ss_pred eecccccccccCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHH-cCCCCCCCCCH--------HHHHHH
Confidence 99999976443322 345689999999999999999999999999999999999 99999975432 122222
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT 332 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs 332 (347)
.... .+ ..+...+.++.+++...|...|.+|..
T Consensus 562 I~eh---------nv---syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 562 IMEH---------NV---SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHc---------cC---cCcccccHHHHHHHHHHhhcCCccccC
Confidence 2221 11 122344667888999999999999954
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=258.84 Aligned_cols=265 Identities=18% Similarity=0.223 Sum_probs=201.2
Q ss_pred CccccCHHHHHHHhccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeee
Q 045067 48 PIRSFSAKELERATNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLI 124 (347)
Q Consensus 48 ~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 124 (347)
.+..|+.+.++.. ..||.|+||+|++-.+ + +...|||++.........+++..|.....+- ++||||+++
T Consensus 57 ~~~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 57 HLHTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred cccccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 4556766666654 4599999999999999 4 5556666665555555667888888876544 799999999
Q ss_pred eeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc
Q 045067 125 GCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV 204 (347)
Q Consensus 125 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~ 204 (347)
|.+..++..|+-||+|. .||..+...-+......+++...-.|....+.||+||-. ...|||||+||+|||+|..|.
T Consensus 130 Ga~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCC
Confidence 99999999999999997 488776543332234679999999999999999999985 679999999999999999999
Q ss_pred eEEecCCCCccCCCCCceeeccccccCCccccccccc--CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH
Q 045067 205 PKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART--GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~ 282 (347)
+||||||.+-.+..+ ...+...|...|||||-+.. ..|+-+|||||+|++|||+. +|..||..... ..
T Consensus 207 vKLCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvA-tG~fPyr~w~s-------vf 276 (361)
T KOG1006|consen 207 VKLCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVA-TGNFPYRKWDS-------VF 276 (361)
T ss_pred EeeecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeee-cCCCCcchHHH-------HH
Confidence 999999998665432 11233568889999997764 35889999999999999999 99999864321 22
Q ss_pred HHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 283 DFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.+....... . |.+..+...-+....+..++.-||.+|.++||+..++..
T Consensus 277 eql~~Vv~gd-p-----p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 277 EQLCQVVIGD-P-----PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HHHHHHHcCC-C-----CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 3333333322 1 222222222345667899999999999999999998865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=261.01 Aligned_cols=262 Identities=16% Similarity=0.226 Sum_probs=195.0
Q ss_pred ccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--------
Q 045067 62 NNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV-------- 130 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 130 (347)
+.|....+||+|.||.||+|+. .++.|+++|++-... .+--....+|+.+|..+.|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4466677899999999999999 455667777665332 22224578999999999999999999988642
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
..+|+|+++|+. +|..++.+. ...++..++.+++.++..||.|+| ...|+|||+||+|+||+.+|.+||+||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecc
Confidence 258999999986 999999763 367999999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCcee---eccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 211 SLSASIPEGETYI---DDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 211 g~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
|+++.+....... .+....|.+|.+||.+.| ..|+++.|||..||++.||+ ++.+.+..... ......+.
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMw-trspimqgnte-----qqql~~Is 242 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMW-TRSPIMQGNTE-----QQQLHLIS 242 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHH-ccCccccCChH-----HHHHHHHH
Confidence 9997765433222 233556999999997665 58999999999999999999 99988875432 11111222
Q ss_pred HHHhccCcccccCCcc-------------CCch---hhHHHH------HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 287 KYIENRGFNGIVDPRI-------------IGDE---LLEHKL------QSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~-------------~~~~---~~~~~~------~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.... ++..-+.|.+ .+.. ..++.. ++.++|+.+++..||.+|+++++++..
T Consensus 243 ~LcG--s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 243 QLCG--SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHhc--cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 2211 1111111100 0000 011112 267899999999999999999998753
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=288.57 Aligned_cols=248 Identities=25% Similarity=0.327 Sum_probs=193.1
Q ss_pred cCCCCCeecccCceE-EEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeC
Q 045067 63 NYHYRNIITESSIFR-LCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~-Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
-|...+++|.|+.|+ ||+|+++++.||||++..... +...+|+..|+.- +|||||++++.-.+....||+.|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~----~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFF----DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhH----HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 345567889999985 999999999999999887643 5678999999887 5999999999988899999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC---C--CceEEecCCCCcc
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE---R--YVPKLFNFSLSAS 215 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~---~--~~~kl~Dfg~a~~ 215 (347)
.. +|.++++... .......-.....+..|+++||+||| +.+||||||||+||||+. + .+++|+|||+++.
T Consensus 586 ~~-sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 586 AC-SLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hh-hHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 86 9999998730 01011111345677899999999999 999999999999999985 2 4789999999999
Q ss_pred CCCCCcee--eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 216 IPEGETYI--DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 216 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
...+.+.. ..+..||-+|+|||++.....+.++||||+||++|+.++.|..||.+.... .... ..+.
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R------~~NI-----l~~~ 729 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER------QANI-----LTGN 729 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh------hhhh-----hcCc
Confidence 87665433 346789999999999999888899999999999999998899999754320 0000 0110
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .+..-....+. ++.+||.+|+.++|..||++.+|+.
T Consensus 730 ~------~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 730 Y------TLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred c------ceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 00000111111 6789999999999999999999974
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=268.56 Aligned_cols=244 Identities=20% Similarity=0.219 Sum_probs=195.3
Q ss_pred CCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCC
Q 045067 67 RNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYG 143 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 143 (347)
.++||+|.||+||-|.+ .++.-+++|++.+.. ......+.+|+.||++++||.||.+...|++.+.+++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 36899999999999999 555544455544332 12226789999999999999999999999999999999999974
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC---CceEEecCCCCccCCCCC
Q 045067 144 NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER---YVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 144 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~ 220 (347)
++.+.|-.. ..+.+++..-..++.||+.||.||| .++|+|+||||+|||+... ..+||||||+|+.+++..
T Consensus 648 DMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILSS---EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 777776543 4578999999999999999999999 9999999999999999743 479999999999987654
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
. .....|||.|+|||++++..|+..-|+||+||++|--+ .|..||+.... +...+++..+ +.
T Consensus 722 F--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsL-SGTFPFNEdEd-----------IndQIQNAaF--My-- 783 (888)
T KOG4236|consen 722 F--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSL-SGTFPFNEDED-----------INDQIQNAAF--MY-- 783 (888)
T ss_pred h--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEe-cccccCCCccc-----------hhHHhhcccc--cc--
Confidence 3 35678999999999999999999999999999999999 99999974322 1112222111 11
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
++....+..+.+++||...|+..-++|-|...-++
T Consensus 784 ---Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 784 ---PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ---CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 12233466778899999999999999999887654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=284.02 Aligned_cols=261 Identities=20% Similarity=0.202 Sum_probs=165.8
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CC-----ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeee------e
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PD-----RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGC------C 127 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~-----~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~ 127 (347)
..++|...+.||+|+||.||+|++ ++ ..+++|++..... .+.+.+|. +....+.++..+... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~--l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNER--VRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHH--HHhhchhhHHHHHHhhhccccc
Confidence 567899999999999999999999 43 4566665433221 12222221 122222222222211 2
Q ss_pred eeCCccEEEEEeCCCCCHHHHHhhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 045067 128 LEVEIPVLVFESAEYGNLHDLLKRSYQS---------------HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDL 192 (347)
Q Consensus 128 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dl 192 (347)
..+...++|+||+++++|.+++...... .........+..++.|++.||.||| +.+|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcC
Confidence 3556789999999999999998752100 0001123345679999999999999 999999999
Q ss_pred CCCCeEECC-CCceEEecCCCCccCCCCCceeeccccccCCcccccccccC----------------------CCCCccc
Q 045067 193 KSSYILVSE-RYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTG----------------------YLNEKCD 249 (347)
Q Consensus 193 kp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 249 (347)
||+|||++. ++.+||+|||+|+..............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 57999999999987654444444556789999999965322 1334669
Q ss_pred hHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc----CcccccCCccCCc-----hhhHHHHHHHHHHHH
Q 045067 250 VYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR----GFNGIVDPRIIGD-----ELLEHKLQSSFELAF 320 (347)
Q Consensus 250 v~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~ 320 (347)
|||+||++|||+ ++..+++.. ...+.......+ .+.....+....+ ...+.......+|+.
T Consensus 362 VwSlGviL~el~-~~~~~~~~~---------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 362 IYSAGLIFLQMA-FPNLRSDSN---------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred cHHHHHHHHHHH-hCcCCCchH---------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 999999999999 665554321 111111110000 0000111110000 000111224568999
Q ss_pred HhccCCCCCCCCHHHHHH
Q 045067 321 QCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 321 ~cl~~~P~~RPs~~ell~ 338 (347)
+||+.||++|||+.|+++
T Consensus 432 ~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 432 SMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHccCCcccCCCHHHHhC
Confidence 999999999999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=251.39 Aligned_cols=238 Identities=24% Similarity=0.250 Sum_probs=188.1
Q ss_pred CceEEEEEEe-CCceEEEEEEccCCCchh-HHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhh
Q 045067 74 SIFRLCQGVL-PDRTISVVKFIDGSVFDA-YDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKR 151 (347)
Q Consensus 74 ~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 151 (347)
+||.||+|+. .++..+++|......... .+.+.+|+..+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5899999999 445555555554433222 57899999999999999999999999999999999999999999999976
Q ss_pred hccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeeccccccC
Q 045067 152 SYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231 (347)
Q Consensus 152 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~ 231 (347)
. ..+++..+..++.+++.++.+|| +.+++|+||+|+||+++.++.++++|||.+....... ......++.
T Consensus 81 ~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~ 150 (244)
T smart00220 81 R-----GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP 150 (244)
T ss_pred c-----cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence 4 33899999999999999999999 8999999999999999999999999999987765432 223456888
Q ss_pred CcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHH
Q 045067 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHK 311 (347)
Q Consensus 232 ~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (347)
.|++||.+.+..++.++|+||+|+++++++ +|..||..... . ............. . .......
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~-~~~~p~~~~~~-------~-~~~~~~~~~~~~~----~----~~~~~~~ 213 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELL-TGKPPFPGDDQ-------L-LELFKKIGKPKPP----F----PPPEWKI 213 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCc-------H-HHHHHHHhccCCC----C----ccccccC
Confidence 999999998888899999999999999999 89999864211 1 1111122211111 0 0000003
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 312 LQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 312 ~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.++.+++.+||..+|++||++.++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhh
Confidence 456889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=253.83 Aligned_cols=270 Identities=17% Similarity=0.260 Sum_probs=215.0
Q ss_pred HHHHHHhccCCCCCeecccCceEEEEEEe-C------CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeee
Q 045067 55 KELERATNNYHYRNIITESSIFRLCQGVL-P------DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCC 127 (347)
Q Consensus 55 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~------~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 127 (347)
.|+......+....++-+|.||.||+|.| + .+.+.+|.+.+..+.-....+..|...+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 35555566777788899999999999976 1 2345555555666666667889999999999999999999988
Q ss_pred eeC-CccEEEEEeCCCCCHHHHHhhhc---cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC
Q 045067 128 LEV-EIPVLVFESAEYGNLHDLLKRSY---QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY 203 (347)
Q Consensus 128 ~~~-~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~ 203 (347)
..+ ..++..+.++.-|+|..++.-.+ ....+.+...+...++.|++.|++||| .+++||.||...|.+||+.-
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence 764 57888899999999999998321 223456778888899999999999999 99999999999999999999
Q ss_pred ceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH
Q 045067 204 VPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282 (347)
Q Consensus 204 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~ 282 (347)
.+||+|-.+++.+....-+ .....-.+..||+||.+.+..|+.++|+|||||++|||+|.|+.|+..-++
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--------- 504 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--------- 504 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---------
Confidence 9999999999887644322 122334577899999999999999999999999999999999999864332
Q ss_pred HHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 283 DFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.....+++++. ++. .+.+++.++..++.-||...|++||+++|++.-|.++..+
T Consensus 505 fEm~~ylkdGy-------Rla---QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 505 FEMEHYLKDGY-------RLA---QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HHHHHHHhccc-------eec---CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 22233334331 222 2235677899999999999999999999999999998764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=259.82 Aligned_cols=257 Identities=19% Similarity=0.227 Sum_probs=195.2
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC-------chhHHHHHHHHHHHHhcCCCceeeeeeeee-eC
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV-------FDAYDCCFNNIVFASQMSHNNVLRLIGCCL-EV 130 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~ 130 (347)
..+.|-...+||+|||+.||+|.. ....++++|+..... ..-.+...+|..|...|+||.||++++++. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 345566678899999999999999 667777777654322 112355789999999999999999999987 45
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC---CCceEE
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE---RYVPKL 207 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~---~~~~kl 207 (347)
+.+|-|+|||+|.+|+-+++.. ..+++..+..|+.||+.||.||... ..+|||-||||.|||+.+ -|.+||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 6789999999999999999876 7799999999999999999999854 678999999999999964 478999
Q ss_pred ecCCCCccCCCCCce------eeccccccCCcccccccc-c---CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCC
Q 045067 208 FNFSLSASIPEGETY------IDDGVKGTSGIVAPEYAR-T---GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD 277 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~-~---~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~ 277 (347)
.|||+++.+..+... ..+...||.+|++||.+. + ...+.|+||||+||++|..+ .|+-||.....
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQCl-YGrKPFGhnqs---- 689 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCL-YGRKPFGHNQS---- 689 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhh-ccCCCCCCchh----
Confidence 999999987654321 234577999999999654 3 25688999999999999999 99999965322
Q ss_pred CchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 045067 278 ESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVA 337 (347)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell 337 (347)
..+ .+....+-....-..+ .-+....++..+|.+||++.-++|...-++.
T Consensus 690 ---QQd----ILqeNTIlkAtEVqFP---~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 690 ---QQD----ILQENTILKATEVQFP---PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ---HHH----HHhhhchhcceeccCC---CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111 1111111111000011 1123355678999999999999998776654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=247.52 Aligned_cols=250 Identities=18% Similarity=0.219 Sum_probs=201.4
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 135 (347)
.++|...++||+|+|+.|-.+.+ .+..++++|++++.. ..+.+-...|-.+..+- +||.+|.++.+|+++..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46788999999999999999999 778888888776532 23345566777777666 79999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
|.||++||+|--+++.+ ..+++..+..+...|..||.||| ++||+.||||..|+|+|..|++|+.|+|+++.
T Consensus 329 vieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999998876 68999999999999999999999 99999999999999999999999999999976
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
-.... ...++.+|||.|.|||.+++..|..+.|.|++||+++||+ .|+.||+--.. ........+.+-..+-+..+.
T Consensus 401 ~l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemm-agrspfdivgm-~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 401 GLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM-AGRSPFDIVGM-DNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred CCCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHH-cCCCCcceecC-CCcccchhHHHHHHHhhhccc
Confidence 54333 2346789999999999999999999999999999999999 99999985432 222333334444333322111
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT 332 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs 332 (347)
++ ...+..+..++...|.+||..|..
T Consensus 478 ------ip-----rslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 ------IP-----RSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ------cc-----ceeehhhHHHHHHhhcCCcHHhcC
Confidence 10 112234568888999999999853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=267.10 Aligned_cols=265 Identities=14% Similarity=0.170 Sum_probs=175.8
Q ss_pred HhccCCCCCeecccCceEEEEEEe------------------CCceEEEEEEccCCCchhH--------------HHHHH
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL------------------PDRTISVVKFIDGSVFDAY--------------DCCFN 107 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~------------------~~~~~~v~k~~~~~~~~~~--------------~~~~~ 107 (347)
..++|...++||+|+||+||+|.. .+..|++|++... ..... +....
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~-~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMD-RQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEeccc-chhhHHHHHhhhhhhhcccchhHH
Confidence 467899999999999999999974 1234566655332 22111 22345
Q ss_pred HHHHHHhcCCCce-----eeeeeeeee--------CCccEEEEEeCCCCCHHHHHhhhccC-------------------
Q 045067 108 NIVFASQMSHNNV-----LRLIGCCLE--------VEIPVLVFESAEYGNLHDLLKRSYQS------------------- 155 (347)
Q Consensus 108 E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~------------------- 155 (347)
|+..+.+++|.++ ++++++|.. ....++|+||+++++|.+++......
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777876654 667777653 34679999999999999998742100
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeeccccccCCccc
Q 045067 156 HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVA 235 (347)
Q Consensus 156 ~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~a 235 (347)
....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...............+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence 1123467788899999999999999 9999999999999999999999999999997654332222222345889999
Q ss_pred ccccccCC--------------------C--CCccchHHHHHHHHHHHhcCC-CccccCccCCCCCchHHHHHHHH--Hh
Q 045067 236 PEYARTGY--------------------L--NEKCDVYSFGLLLLQLLSTGE-DLFNMGLRLNGDESFEMDFVKKY--IE 290 (347)
Q Consensus 236 PE~~~~~~--------------------~--~~~~Dv~s~G~~l~el~~~g~-~p~~~~~~~~~~~~~~~~~~~~~--~~ 290 (347)
||.+.... + ..+.||||+||++++|+ ++. .|+...................+ ..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~-~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMC-VPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHH-hCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 99765322 1 13479999999999999 655 36643211000000000000000 11
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCC---CCCCCHHHHHH
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASA---EDRPTMIDVAK 338 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P---~~RPs~~ell~ 338 (347)
.... + . ...+.......+++.++|..+| .+|+|+.|+++
T Consensus 458 ~~~~----~--~---~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQKY----D--F---SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccCC----C--c---ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1100 0 0 0112335567899999999766 78999999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=264.98 Aligned_cols=203 Identities=19% Similarity=0.235 Sum_probs=175.3
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
.-|..++-||-|+||.|.++.. ++..+++.|.+.+.. .........|-.||..-+.+.||+|+..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4577888999999999999998 888888888877643 223355778999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||++||++-++|-+. +-+.+..+..++..+.+|+++.| ..|+|||||||+|||||.+|++||.|||+++-+.
T Consensus 709 dYIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccce
Confidence 999999999998765 67889999999999999999999 9999999999999999999999999999986431
Q ss_pred ---------CCC-----------------c---------------eeeccccccCCcccccccccCCCCCccchHHHHHH
Q 045067 218 ---------EGE-----------------T---------------YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLL 256 (347)
Q Consensus 218 ---------~~~-----------------~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~ 256 (347)
.+. . .......||+.|+|||++....|+..+|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 000 0 00123569999999999999999999999999999
Q ss_pred HHHHHhcCCCccccCcc
Q 045067 257 LLQLLSTGEDLFNMGLR 273 (347)
Q Consensus 257 l~el~~~g~~p~~~~~~ 273 (347)
||||+ .|++||-+..+
T Consensus 861 l~em~-~g~~pf~~~tp 876 (1034)
T KOG0608|consen 861 LYEML-VGQPPFLADTP 876 (1034)
T ss_pred HHHHh-hCCCCccCCCC
Confidence 99999 99999987655
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=265.77 Aligned_cols=241 Identities=18% Similarity=0.226 Sum_probs=197.2
Q ss_pred cCCCCCeecccCceEEEEEEeCCce-EEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVLPDRT-ISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++..+.-||-||||.|-.+..++.. ..++|++++. .....+++..|-.+|...+.|.||+++-.|.+++.+|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3445566999999999999885444 3555554432 23334778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
-|-||.|+..+.+. +.++..+...++.++++|++||| .++||.|||||+|.++|.+|-+||.|||+|+.+..
T Consensus 501 aClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 501 ACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred hhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999875 88999999999999999999999 99999999999999999999999999999999876
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
+.. .-+.+|||.|.|||.+.+...+.++|.||+|+++|||+ +|.+||....+ +...+.+.+-+..-
T Consensus 573 g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL-~G~pPFs~~dp-----mktYn~ILkGid~i------ 638 (732)
T KOG0614|consen 573 GRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELL-TGSPPFSGVDP-----MKTYNLILKGIDKI------ 638 (732)
T ss_pred CCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHH-cCCCCCCCCch-----HHHHHHHHhhhhhh------
Confidence 644 34689999999999999999999999999999999999 99999986433 32333333222211
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT 332 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs 332 (347)
+.+........+++.+....+|..|.-
T Consensus 639 -------~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 -------EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -------hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 112233445678999999999999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=253.58 Aligned_cols=265 Identities=19% Similarity=0.221 Sum_probs=199.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-C-C----ceeeeeeeeeeCCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-H-N----NVLRLIGCCLEVEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~ 133 (347)
++.|.....+|+|.||.|-.+.. ..+..+++|+++... ...+...-|+.+|++|. + | -++.+.+++.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 77899999999999999999988 556777777776543 33466788999999993 2 2 367788889889999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC------------
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE------------ 201 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~------------ 201 (347)
+||+|.+. -|+.+++.++ +..+++..++..++.|++.++++|| +.+++|-||||+|||+.+
T Consensus 167 CivfellG-~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 167 CIVFELLG-LSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred EEEEeccC-hhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCc
Confidence 99999994 5999999875 5678999999999999999999999 999999999999999942
Q ss_pred --------CCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCcc
Q 045067 202 --------RYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLR 273 (347)
Q Consensus 202 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~ 273 (347)
+..++++|||.|+...... +....|..|.|||++.+-.++..+||||+||||+|+. +|...|.....
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely-tG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY-TGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEee-ccceecccCCc
Confidence 3468999999997765443 3456889999999999999999999999999999999 99988875432
Q ss_pred CCC-------CCchHHHH-----HHHHHhccCcc-----------cccCCccCC---chhhHHHHHHHHHHHHHhccCCC
Q 045067 274 LNG-------DESFEMDF-----VKKYIENRGFN-----------GIVDPRIIG---DELLEHKLQSSFELAFQCQSASA 327 (347)
Q Consensus 274 ~~~-------~~~~~~~~-----~~~~~~~~~~~-----------~~~~~~~~~---~~~~~~~~~~~~~l~~~cl~~~P 327 (347)
.+. -++..... ..+.+..+.+. ...++..+. ....+....++.+|+.+||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 110 00111111 22222222111 000000000 01112334579999999999999
Q ss_pred CCCCCHHHHHH
Q 045067 328 EDRPTMIDVAK 338 (347)
Q Consensus 328 ~~RPs~~ell~ 338 (347)
.+|+|+.|+++
T Consensus 395 ~~RiTl~EAL~ 405 (415)
T KOG0671|consen 395 ARRITLREALS 405 (415)
T ss_pred cccccHHHHhc
Confidence 99999999885
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=232.56 Aligned_cols=261 Identities=16% Similarity=0.236 Sum_probs=190.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeC--CccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEV--EIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 136 (347)
.++|+..+.+|+|.|+.||.|.. .+..-+|+|++++... +.+.+|+.||+.|. ||||+++++...++ ..+.|+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46788889999999999999998 6666666666655432 56899999999996 99999999998875 478899
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-CCceEEecCCCCcc
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-RYVPKLFNFSLSAS 215 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~ 215 (347)
+||..+.+...+. ..+....+..++.+++.||.|+| +.||.|||+||.|+++|. ...++|+|+|+|..
T Consensus 114 FE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 9999998877766 45778888999999999999999 999999999999999994 56899999999988
Q ss_pred CCCCCceeeccccccCCcccccccc-cCCCCCccchHHHHHHHHHHHhcCCCcccc-CccCCC--------CCchHHHHH
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNM-GLRLNG--------DESFEMDFV 285 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~-~~~~~~--------~~~~~~~~~ 285 (347)
...+... +-...+..|-.||.+- .+.|+.+-|+|||||++..|+ ..+.||-. .+..+. +...+...+
T Consensus 183 YHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~mi-FrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 183 YHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI-FRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred cCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHH-hccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 8766554 3356677889999654 578899999999999999999 66655533 221000 000011111
Q ss_pred HHHHh--ccCcccccCC-------ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 286 KKYIE--NRGFNGIVDP-------RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 286 ~~~~~--~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+.-- +..+..+++. +...++...-..+++.+++.+.|..|-.+|||+.|...
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11100 0011111111 11111111122368899999999999999999999764
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=223.96 Aligned_cols=207 Identities=15% Similarity=0.154 Sum_probs=165.4
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEc-cCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccE
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFI-DGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~-~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 134 (347)
+...++......||+|++|.|-+-++ .++.+.++|.+ ..-..+...+..+|+.+..+- .+|.+|.++|...+...++
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 33344455556799999999998888 55555555544 333445557788999887655 7999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
|.||.|. .||..+-.+- ...++.+++...-+|+..++.||.|||+ ...++|||+||+|||++.+|.+|+||||.+-
T Consensus 122 IcME~M~-tSldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EeHHHhh-hhHHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999997 4888765443 2345789999999999999999999996 6799999999999999999999999999986
Q ss_pred cCCCCCceeeccccccCCccccccccc----CCCCCccchHHHHHHHHHHHhcCCCccccC
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYART----GYLNEKCDVYSFGLLLLQLLSTGEDLFNMG 271 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~ 271 (347)
.+.++-- .+...|...|||||.+.. ..|+-++||||+|+++.||. +++.||...
T Consensus 198 ~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA-~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA-ILRFPYESW 255 (282)
T ss_pred eehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhh-hcccccccc
Confidence 6543321 122568889999997753 37899999999999999999 999999753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=236.34 Aligned_cols=267 Identities=17% Similarity=0.207 Sum_probs=196.5
Q ss_pred cCCCCCeecccCceEEEEEEe--CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-----ccE
Q 045067 63 NYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE-----IPV 134 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 134 (347)
+.+..+-||-|+||.||.++. +++.++.+|+.+.- .-...+.+.+|+.+|..++|.|++..++...-.. .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 445668899999999999999 56777788876542 2233477899999999999999999888765432 578
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+++|.|. .+|...|-.. +.++...+.-+..||+.||.||| +.+|.||||||.|.|++.|..+||+|||+++
T Consensus 134 V~TELmQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccccc
Confidence 8999997 4888887653 78999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCC----------CCchHHH
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG----------DESFEMD 283 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~----------~~~~~~~ 283 (347)
.-..+.....+...-|..|.|||.+.| +.|+.+.||||+||++.||+ .++..|....+... .......
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELL-gRrILFQAq~PiqQL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELL-QRKILFQAAGPIEQLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHH-hhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence 766555544555667899999997766 58999999999999999999 89988876443110 0001111
Q ss_pred HHHHHHhccCcccccC-Cc---cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 284 FVKKYIENRGFNGIVD-PR---IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.+....+...+..-.. |. +-.-....+.-.+..++..+++..+|++|.+.++.+..
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 1111111111111000 10 00001111233466788889999999999998887654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-31 Score=223.43 Aligned_cols=210 Identities=26% Similarity=0.373 Sum_probs=178.2
Q ss_pred ecccCceEEEEEEeC-CceEEEEEEccCCCch-hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCHHH
Q 045067 70 ITESSIFRLCQGVLP-DRTISVVKFIDGSVFD-AYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD 147 (347)
Q Consensus 70 lg~G~~g~Vy~~~~~-~~~~~v~k~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 147 (347)
||+|++|.||++... ++..+++|........ ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999994 3555555555444322 34679999999999999999999999999899999999999999999
Q ss_pred HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-CCceEEecCCCCccCCCCCceeecc
Q 045067 148 LLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-RYVPKLFNFSLSASIPEGETYIDDG 226 (347)
Q Consensus 148 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 226 (347)
++... ...+++..+..++.+++.++.+|| +.+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~ 152 (215)
T cd00180 81 LLKEN----EGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT 152 (215)
T ss_pred HHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence 99763 146899999999999999999999 899999999999999999 89999999999876654321 1223
Q ss_pred ccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCc
Q 045067 227 VKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGD 305 (347)
Q Consensus 227 ~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (347)
..+...|++||..... .++.++|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 5578899999988877 888999999999999998
Q ss_pred hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 306 ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 306 ~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 235689999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-33 Score=250.02 Aligned_cols=195 Identities=21% Similarity=0.257 Sum_probs=167.9
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHH---------HHHHHHHHHhcC---CCceeeeeeeee
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDC---------CFNNIVFASQMS---HNNVLRLIGCCL 128 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~l~~~~~ 128 (347)
.+|+..+.+|+|+||.|+.|++ .+...+|+|.+.+..-- .+. +-.|+.||..++ |+||++++++|+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL-~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERIL-VDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhh-hhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 4588889999999999999999 56667777776654311 122 336999999997 999999999999
Q ss_pred eCCccEEEEEeC-CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEE
Q 045067 129 EVEIPVLVFESA-EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207 (347)
Q Consensus 129 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl 207 (347)
+++.+||+||-. ++-+|+++|+.. ..+++..+..|+.|++.|++||| +.||||||||-+|+.++.+|-+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEE
Confidence 999999999986 566999999875 67999999999999999999999 999999999999999999999999
Q ss_pred ecCCCCccCCCCCceeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccc
Q 045067 208 FNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFN 269 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~ 269 (347)
+|||.|.....+.. ....||..|+|||++.|..| ....|||++|++||.++ ....||.
T Consensus 712 idfgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytiv-ykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIV-YKENPYY 770 (772)
T ss_pred eeccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEE-eccCCCc
Confidence 99999877665543 23679999999999998866 46689999999999999 8888874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=228.57 Aligned_cols=263 Identities=19% Similarity=0.207 Sum_probs=196.5
Q ss_pred hccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE------ 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 131 (347)
...|...+-+|.|.- .|-.+.. .+.++++||...+- .....++..+|...+..++|+||++++.++.-.+
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 345666777888888 6767766 68889999876652 1233477899999999999999999999987543
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
.+|+|||+|.. +|...+.- .++-.+...+..|+++|+.||| +.||+||||||+||++..+..+||.|||
T Consensus 95 e~y~v~e~m~~-nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM-------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccch
Confidence 67999999985 99998863 4777888899999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCC----------CCchH
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG----------DESFE 281 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~----------~~~~~ 281 (347)
+|+.-... ...+.+..|..|.|||++.+..+.+.+||||+||++.||+ +|...|......+. .....
T Consensus 164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli-~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 164 LARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELI-LGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred hhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHh-hceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 99765433 3456788999999999999888999999999999999999 99999975433110 01111
Q ss_pred HHH----HHHHHhc------cCcccccCCccCCc--hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 282 MDF----VKKYIEN------RGFNGIVDPRIIGD--ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 282 ~~~----~~~~~~~------~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... +..+... ..+.+.+....-.. +...-....+.+++.+||..||++|.|+.+++.
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 111 0111110 11111111111111 111122457789999999999999999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=229.95 Aligned_cols=131 Identities=20% Similarity=0.266 Sum_probs=112.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-----C---Cceeeeeeeeee---
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-----H---NNVLRLIGCCLE--- 129 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--- 129 (347)
+.|...++||.|-|++||++-. .+...+++|+.+... .-.+..+.|+.+|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788889999999999999988 677888888776542 33477889999999983 3 379999999875
Q ss_pred -CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 045067 130 -VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199 (347)
Q Consensus 130 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill 199 (347)
+.++++|+|++. -+|..+|... .-+.++...+..|+.||+.||.|||. ..||||-||||+|||+
T Consensus 157 NG~HVCMVfEvLG-dnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLG-DNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhh-hHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 458999999996 4999999875 55789999999999999999999996 6799999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=221.00 Aligned_cols=198 Identities=27% Similarity=0.336 Sum_probs=168.8
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCch-hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFD-AYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
|...+.||+|++|.||++.. +++..+++|........ ..+.+.+|+..+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 45667899999999999999 43555666666554433 55789999999999999999999999999899999999999
Q ss_pred CCCHHHHHhhhccCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 142 YGNLHDLLKRSYQSHSEP-LLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~-l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
+++|.+++... .. +++.....++.+++.++.+|| +.+++|+|++|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 81 GGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999999874 23 889999999999999999999 8999999999999999999999999999988765543
Q ss_pred ceeeccccccCCccccccc-ccCCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 221 TYIDDGVKGTSGIVAPEYA-RTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
........++..|++||.+ ....++.++|+|+||+++++|+ +|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~-~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELL-WGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHH-HCCCCccc
Confidence 1122335678899999988 6677888999999999999999 79999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=221.75 Aligned_cols=265 Identities=18% Similarity=0.225 Sum_probs=196.3
Q ss_pred cCHHHHHH--HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeee-
Q 045067 52 FSAKELER--ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGC- 126 (347)
Q Consensus 52 ~~~~e~~~--~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~- 126 (347)
++..|+++ ..+.|.+.+.+|+|.||.+-++.+ ..+..+|+|..+.... ...+|.+|...--.|. |.||+.-+++
T Consensus 12 I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~va 90 (378)
T KOG1345|consen 12 IPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVA 90 (378)
T ss_pred cccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHH
Confidence 34444443 456788889999999999999999 6777788887776543 3478999998877774 8899987664
Q ss_pred eeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC--CCCc
Q 045067 127 CLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS--ERYV 204 (347)
Q Consensus 127 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~--~~~~ 204 (347)
|+..+...+++||+|.|+|.+.+.. ..+.+....+++.|+++|+.|+| ++++||||||.+||||- +..+
T Consensus 91 Fqt~d~YvF~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~r 161 (378)
T KOG1345|consen 91 FQTSDAYVFVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYR 161 (378)
T ss_pred hhcCceEEEeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccE
Confidence 5667788899999999999999976 56888999999999999999999 99999999999999995 4458
Q ss_pred eEEecCCCCccCCCCCceeeccccccCCcccccccccC-----CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCc
Q 045067 205 PKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTG-----YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDES 279 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~ 279 (347)
+|++|||+.+..+.- ......+..|.+||..... ...+.+|+|.||+++|..+ +|.+||......+
T Consensus 162 vKlcDFG~t~k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cl-tG~~PWQka~~~d---- 232 (378)
T KOG1345|consen 162 VKLCDFGLTRKVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCL-TGKFPWQKASIMD---- 232 (378)
T ss_pred EEeeecccccccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeee-cCCCcchhhhccC----
Confidence 999999998665332 1223456678999966432 3468899999999999999 9999998543211
Q ss_pred hHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 280 FEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
...|-...+..+... ++ +......++.+..+..+-|..+|++|--..++.....+.
T Consensus 233 -~~Y~~~~~w~~rk~~-----~~--P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 233 -KPYWEWEQWLKRKNP-----AL--PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred -chHHHHHHHhcccCc-----cC--chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 122222223322211 11 122233456678899999999999996666655544443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=249.43 Aligned_cols=254 Identities=19% Similarity=0.234 Sum_probs=201.9
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
-.++|....++|+|+||.||+++. ..+..+++|+++....+...-+..|+.+++..+||||+.++|.+.....+++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 346788889999999999999999 6777777777776666666778899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
||.+|+|.+.-... +++++.++...++..+.||+||| +.+=+|||||-.|||+.+.|.+|++|||.+..+..
T Consensus 93 ycgggslQdiy~~T-----gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred ecCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999988765 88999999999999999999999 99999999999999999999999999999876643
Q ss_pred CCceeeccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 219 GETYIDDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.- .......||+.|||||+.. .+.|...+|||+.|+...|+- .-++|--+..+ ..+...+....+
T Consensus 165 ti-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~-eLqpplfdlhp---------mr~l~LmTkS~~- 232 (829)
T KOG0576|consen 165 TI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELG-ELQPPLFDLHP---------MRALFLMTKSGF- 232 (829)
T ss_pred hh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhh-hcCCcccccch---------HHHHHHhhccCC-
Confidence 22 1234578999999999653 567899999999999999998 66655432111 111111111111
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
-.+.+... ....+.+.++++.|+..+|++|||++.+++
T Consensus 233 --qpp~lkDk---~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 --QPPTLKDK---TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --CCCcccCC---ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11122111 122456779999999999999999988765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=230.80 Aligned_cols=199 Identities=24% Similarity=0.297 Sum_probs=161.8
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe-C---Cc-eEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL-P---DR-TISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV 130 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~---~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 130 (347)
+....+.|..+++||+|.|++||+++. . .+ .+++|++...+.. .++.+|++.|..+ .+.||+++.+++..+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 445566788899999999999999998 3 33 4555555555443 5689999999999 599999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-CCceEEec
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-RYVPKLFN 209 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-~~~~kl~D 209 (347)
+.+.+|+||++..+..++.. .++...+..+++.++.||.++| .+|||||||||+|+|.+. .+.-.|+|
T Consensus 108 d~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred CeeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEe
Confidence 99999999999999999884 4778999999999999999999 999999999999999984 56789999
Q ss_pred CCCCccCCC---------------------------------CCce----------eeccccccCCcccccccc-cCCCC
Q 045067 210 FSLSASIPE---------------------------------GETY----------IDDGVKGTSGIVAPEYAR-TGYLN 245 (347)
Q Consensus 210 fg~a~~~~~---------------------------------~~~~----------~~~~~~gt~~y~aPE~~~-~~~~~ 245 (347)
||+|..... .... ..-...||++|.|||++. ....+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 999872100 0000 001256999999999655 56779
Q ss_pred CccchHHHHHHHHHHHhcCCCcccc
Q 045067 246 EKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 246 ~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
+++||||.|||+..++ +++.||-.
T Consensus 257 taiDiws~GVI~Lsll-s~~~PFf~ 280 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLL-SRRYPFFK 280 (418)
T ss_pred Cccceeeccceeehhh-cccccccc
Confidence 9999999999999999 66666643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=231.35 Aligned_cols=201 Identities=20% Similarity=0.197 Sum_probs=165.3
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC------CCceeeeeeeeeeCCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS------HNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~~ 133 (347)
-+.|......|+|-|++|-+|.. ..+..+++|++...... .+.=..|+.+|.+|+ --|+++++-.|...+++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 35677777889999999999998 33445555555544322 245578999999995 24889999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC-CceEEecCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-YVPKLFNFSL 212 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~ 212 (347)
|||+|.+. -+|.+++++.. ..-.|....+..++.|+..||.+|- ..+|+|.||||.|||+++. ..+||||||.
T Consensus 510 ClVFE~Ls-lNLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 510 CLVFEPLS-LNLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred EEEehhhh-chHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCcc
Confidence 99999997 49999998852 2355788899999999999999999 9999999999999999865 5789999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGL 272 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~ 272 (347)
|-....+.. +.+..+.-|.|||.+.|-.|+...|+||+||+||||. +|...|....
T Consensus 584 A~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElY-tGkIlFpG~T 639 (752)
T KOG0670|consen 584 ASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELY-TGKILFPGRT 639 (752)
T ss_pred ccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEee-ccceecCCCC
Confidence 977665433 2355667899999999999999999999999999999 9999997643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=253.67 Aligned_cols=195 Identities=18% Similarity=0.201 Sum_probs=139.1
Q ss_pred hcCC-Cceeeeeeee-------eeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 045067 114 QMSH-NNVLRLIGCC-------LEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR 185 (347)
Q Consensus 114 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 185 (347)
.++| +||.++++++ .....++.++|++. ++|.+++... ...+++.++..++.||+.||+||| ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAH---SQ 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHH---hC
Confidence 4455 5787888876 23346778899885 5999999752 356999999999999999999999 99
Q ss_pred CeEeccCCCCCeEECC-------------------CCceEEecCCCCccCCCCC---------------ceeeccccccC
Q 045067 186 PIVFRDLKSSYILVSE-------------------RYVPKLFNFSLSASIPEGE---------------TYIDDGVKGTS 231 (347)
Q Consensus 186 ~ivH~dlkp~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~---------------~~~~~~~~gt~ 231 (347)
+|+||||||+|||++. ++.+|++|||+++...... ........||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999954 4456666666665321100 00001245788
Q ss_pred CcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHH
Q 045067 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHK 311 (347)
Q Consensus 232 ~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (347)
.|+|||++.+..++.++|||||||++|||+ ++.+|+.... ....... .. ...+.. ...
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl-~~~~~~~~~~----------~~~~~~~-~~----~~~~~~------~~~ 237 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELF-CPVSSREEKS----------RTMSSLR-HR----VLPPQI------LLN 237 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHh-hCCCchhhHH----------HHHHHHH-Hh----hcChhh------hhc
Confidence 999999999999999999999999999999 7887764211 0111111 00 011110 111
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 312 LQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 312 ~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
......++.+||+++|.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 238 WPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 234568889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-28 Score=199.14 Aligned_cols=169 Identities=21% Similarity=0.228 Sum_probs=127.9
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ...+++.++..++.|++.||.||| +.+ ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc--
Confidence 6899999763 256999999999999999999999 666 999999999999999 99887654322
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
..||+.|+|||++.+..++.++|||||||++|||+ +|+.||..... ............. .. ++..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-tg~~p~~~~~~-------~~~~~~~~~~~~~-~~--~~~~ 128 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEAL-DYELPYNEERE-------LSAILEILLNGMP-AD--DPRD 128 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHH-hCCCCccccch-------hcHHHHHHHHHhc-cC--Cccc
Confidence 25889999999999999999999999999999999 99999864321 1111222211110 00 0000
Q ss_pred CCchhhHHHHH--HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 303 IGDELLEHKLQ--SSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 303 ~~~~~~~~~~~--~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
......... .+.+++.+||+.+|++|||+.|+++.+..+..
T Consensus 129 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 129 --RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred --cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 011122222 58999999999999999999999999887754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=208.37 Aligned_cols=171 Identities=13% Similarity=0.060 Sum_probs=129.7
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-----CchhHHHHHHHHHHHHhcCCCceee-e
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-----VFDAYDCCFNNIVFASQMSHNNVLR-L 123 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l 123 (347)
++-+.+....++|...+.||+|+||+||+|.+ . ++.++++|..... .....+.+.+|+.+|++++|+|++. +
T Consensus 8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l 87 (365)
T PRK09188 8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL 87 (365)
T ss_pred CcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence 44456667788899999999999999999988 2 5555444443222 1223466899999999999999985 4
Q ss_pred eeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC-CCCCeEECCC
Q 045067 124 IGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDL-KSSYILVSER 202 (347)
Q Consensus 124 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dl-kp~Nill~~~ 202 (347)
+++ ...++||||++|++|.. +.. .. ...++.+++.||.||| +.||+|||| ||+|||++.+
T Consensus 88 ~~~----~~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~ 148 (365)
T PRK09188 88 LAT----GKDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPD 148 (365)
T ss_pred EEc----CCcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCC
Confidence 432 45799999999999963 211 11 1467889999999999 999999999 9999999999
Q ss_pred CceEEecCCCCccCCCCCceee-------ccccccCCccccccccc
Q 045067 203 YVPKLFNFSLSASIPEGETYID-------DGVKGTSGIVAPEYART 241 (347)
Q Consensus 203 ~~~kl~Dfg~a~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~ 241 (347)
+.++|+|||+|+.......... ....+++.|.|||.+..
T Consensus 149 ~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 149 GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999999987654321111 24567888999998764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-25 Score=201.75 Aligned_cols=260 Identities=17% Similarity=0.127 Sum_probs=193.4
Q ss_pred cCCCCCeecccCceEEEEEEeCC--ceEEEEEEccCCCchhHHHHHHHHHHHHhcCC----Cceeeeeeee-eeCCccEE
Q 045067 63 NYHYRNIITESSIFRLCQGVLPD--RTISVVKFIDGSVFDAYDCCFNNIVFASQMSH----NNVLRLIGCC-LEVEIPVL 135 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 135 (347)
.|...+.||+|+||.||.+.... ...+++|+...........+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999999833 35677776665432222368889999988863 5888998888 47778899
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC-----CceEEecC
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-----YVPKLFNF 210 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~-----~~~kl~Df 210 (347)
||+.+. .+|.++.... ..+.++..++++++.|++.+|.+|| +.|++||||||+|+++... ..+.+.||
T Consensus 99 VM~l~G-~sL~dl~~~~---~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 99 VMSLLG-PSLEDLRKRN---PPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred EEeccC-ccHHHHHHhC---CCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 999995 6999988664 2478999999999999999999999 9999999999999999855 46899999
Q ss_pred CCCc--cCCCCCc-----e-e-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchH
Q 045067 211 SLSA--SIPEGET-----Y-I-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFE 281 (347)
Q Consensus 211 g~a~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~ 281 (347)
|+++ ....... . . .....||..|+++....+...+.+.|+||++.++.+++ .|..||........
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~-~g~LPW~~~~~~~~----- 245 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELL-KGSLPWEALEMTDL----- 245 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHh-cCCCCCccccccch-----
Confidence 9998 3221111 1 0 12345999999999999999999999999999999999 99999965432111
Q ss_pred HHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 282 MDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
............. .. .....+.++.++...+-..+...+|....+...|++...
T Consensus 246 ~~~~~~~~~~~~~----~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 246 KSKFEKDPRKLLT----DR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHHHHHHhhhhcc----cc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 1111111111111 00 011123345566666666899999999999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-23 Score=187.10 Aligned_cols=262 Identities=22% Similarity=0.277 Sum_probs=192.8
Q ss_pred CCCCCeecccCceEEEEEEeCCceEEEEEEccCCCch--hHHHHHHHHHHHHhcCCC-ceeeeeeeeeeCCccEEEEEeC
Q 045067 64 YHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFD--AYDCCFNNIVFASQMSHN-NVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~ 140 (347)
|...+.||.|+||.||++... ..++++.+....... ....+.+|+.+++.+.|+ +++++.+++......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 566778999999999999987 444444444433322 357899999999999988 7999999997777789999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-ceEEecCCCCccCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLFNFSLSASIPEG 219 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~ 219 (347)
.++++.+++...... ..+.......++.+++.++.|+| ..+++|||+||+||+++..+ .++++|||.+......
T Consensus 81 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 81 DGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999777653100 26889999999999999999999 99999999999999999988 7999999998755543
Q ss_pred Cce-----eeccccccCCccccccccc---CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 220 ETY-----IDDGVKGTSGIVAPEYART---GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 220 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
... ......||..|++||.+.+ ..++...|+||+|+++++++ .+..||...... ............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~-~~~~p~~~~~~~-----~~~~~~~~~~~~ 229 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL-TGLPPFEGEKNS-----SATSQTLKIILE 229 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCCcc-----ccHHHHHHHHHh
Confidence 321 2356789999999998887 68889999999999999999 899886543211 011111222211
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.... ........... ......+.+++..|+..+|..|.++.+....
T Consensus 230 ~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 230 LPTP-SLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cCCc-ccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111 00000000000 1223467799999999999999998876653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-24 Score=180.67 Aligned_cols=264 Identities=14% Similarity=0.126 Sum_probs=199.6
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 137 (347)
+.-+|.++++||.|+||.++.|+. -++..+++|+-+..+ ...++..|....+.| ..++|...+.+...+.+-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 345789999999999999999999 444444455444333 225678899888888 5889999999988899999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC-----CceEEecCCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-----YVPKLFNFSL 212 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~-----~~~kl~Dfg~ 212 (347)
|++. .+|.|+..-. +..++..++..++.|++.-++++| ++.+|.|||||+|+||... ..+.++|||+
T Consensus 104 dLLG-PSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 104 DLLG-PSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhC-cCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 9994 6888888654 367999999999999999999999 9999999999999999844 3688999999
Q ss_pred CccCCCCCcee------eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 213 SASIPEGETYI------DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 213 a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
|+...+..+.. .....||.+||+-....|...|.+-|+-|+|=++++++ .|..||...... .. -.
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFL-RGsLPWQGLKA~-----tn---K~ 246 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL-RGSLPWQGLKAD-----TN---KE 246 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhc-cCCCccccccCc-----ch---HH
Confidence 99887654321 24577999999999999999999999999999999999 999999864321 11 11
Q ss_pred HHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
++.+-+...+.. +........+.++..-+.-.-..+-..-|..+-+...+.++.+.
T Consensus 247 kYeKIGe~Kr~T----~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 247 KYEKIGETKRST----PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred HHHHhccccccC----CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 222222211111 11222333455666666666667778888888888777776543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=214.42 Aligned_cols=252 Identities=18% Similarity=0.193 Sum_probs=184.4
Q ss_pred CCCCeecccCceEEEEEEe-CCceEEEEEEc-----cCCCch-hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 65 HYRNIITESSIFRLCQGVL-PDRTISVVKFI-----DGSVFD-AYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 65 ~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~-----~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
....++|.|++|.|+.... ........+.. ...... ....+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999998877776 33322222211 111111 1122566777778889999988777776665555559
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|||++ +|+.++... ..+....+-.++.|++.|++|+| ..|+.|||+||+|+++..+|.+||+|||.+....
T Consensus 401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 999999863 47888899999999999999999 9999999999999999999999999999887665
Q ss_pred CCCc---eeeccccccCCcccccccccCCCCCc-cchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 218 EGET---YIDDGVKGTSGIVAPEYARTGYLNEK-CDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 218 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.... ....+.+|+-.|+|||++.+..|.+. .||||.|+++..|. +|+.||...... +..+ ........
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~-~~~~~Wk~a~~~--~~~~-----~~~~~~~~ 543 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMI-LGRFPWKVAKKS--DNSF-----KTNNYSDQ 543 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEe-cCCCcccccccc--ccch-----hhhccccc
Confidence 3322 44567889999999999999888765 89999999999999 889999876542 1111 00000000
Q ss_pred cccccCCccCCc-hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 FNGIVDPRIIGD-ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 ~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. ...+. ......+.....++.++|+++|.+|.|+++|++
T Consensus 544 ~~-----~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 RN-----IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cc-----cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00 00111 122334557789999999999999999999985
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=187.77 Aligned_cols=248 Identities=19% Similarity=0.226 Sum_probs=185.0
Q ss_pred CCeecccCceEEEEEEeCCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 67 RNIITESSIFRLCQGVLPDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
..+|.+.-.|..|+|+|.+..++++.+.- ..+....+.|..|.-.|+-+.||||+.++|.|..+.++.++..||+.|+|
T Consensus 195 ~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 34588889999999999777766654332 22222336688899889888999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec-cCCCCCeEECCCCceEEecCCCCccCCCCCceee
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFR-DLKSSYILVSERYVPKLFNFSLSASIPEGETYID 224 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~-dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 224 (347)
...++.. .+-..+-.++.+++.+++.|++|||+ -.+++-| -|.+..+++|++.+++|+- +-++. +...
T Consensus 275 ynvlhe~---t~vvvd~sqav~faldiargmaflhs--lep~ipr~~lns~hvmidedltarism-ad~kf-----sfqe 343 (448)
T KOG0195|consen 275 YNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHS--LEPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQE 343 (448)
T ss_pred HHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhh--cchhhhhhhcccceEEecchhhhheec-cccee-----eeec
Confidence 9999875 44557888999999999999999995 2345544 5888999999998887751 11111 1122
Q ss_pred ccccccCCcccccccccCCCC---CccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 225 DGVKGTSGIVAPEYARTGYLN---EKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 225 ~~~~gt~~y~aPE~~~~~~~~---~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
.+....|.||+||.++..+-+ .++|+|||++++|||. ++..||.+..+.+.. ...+. ++ +...
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~-trevpfadlspmecg----mkial----eg-----lrv~ 409 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELN-TREVPFADLSPMECG----MKIAL----EG-----LRVH 409 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhh-ccccccccCCchhhh----hhhhh----cc-----cccc
Confidence 344567899999988865433 5799999999999999 999999876542111 11110 11 0111
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
+ ++..+..+.+|+.-|+..||.+||.+..++-.|++++
T Consensus 410 i-----ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 I-----PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred C-----CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1 1233456789999999999999999999999999875
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.6e-24 Score=173.61 Aligned_cols=263 Identities=15% Similarity=0.144 Sum_probs=194.5
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 137 (347)
..+.|...+.||+|+||.+|.|.. .++.-+++|+-...... ..+..|..+...|+ ...|..+..+..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 356789999999999999999999 55555555544333211 45788999999986 457777777888888899999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC---CCceEEecCCCCc
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE---RYVPKLFNFSLSA 214 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~a~ 214 (347)
|... .+|.++.+-. +..++..+++-++-|++.-++|+| .++++||||||+|+|..- ...+.++|||+|+
T Consensus 91 dLLG-PsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 91 DLLG-PSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eccC-ccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchh
Confidence 9994 6999988653 267899999999999999999999 999999999999999974 3578999999998
Q ss_pred cCCCCCce------eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 215 SIPEGETY------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 215 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
...+..+. ......||.+|++-....+...+.+.|+-|+|.+|.++. .|..||..... .....--..
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfn-rG~LPWQglka------~tk~QKyEk 235 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFN-RGSLPWQGLKA------ATKKQKYEK 235 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeee-cCCCcccccch------hhHHHHHHH
Confidence 87543321 124567999999998888888899999999999999999 99999975432 111111111
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
+.+..+. .+.+......+.++.-.+.-|-..--++-|...-+.+.+.-+..
T Consensus 236 I~EkK~s------~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 236 ISEKKMS------TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHHhhcC------CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 1111110 11111223345677888888888888888887777766655543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=208.89 Aligned_cols=247 Identities=20% Similarity=0.237 Sum_probs=182.8
Q ss_pred cCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHH---HHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 63 NYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCC---FNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++...+.||++.|=.|.+|.++.|.+++|...+....-..+.+ ..|++ ....+|||.+++.-+-..++..|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777889999999999999998888887777766533322333 34444 4455899999998887788888999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc--CC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS--IP 217 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~--~~ 217 (347)
... +|.|.+.-. .-+...+..-|+.|++.||..+| ..||+|||||.+||||..-.-+.|+||..-+. ++
T Consensus 103 vkh-nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred Hhh-hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 986 999999753 45677788889999999999999 99999999999999999999999999986443 22
Q ss_pred CCCce----eeccccccCCcccccccccC-----------CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH
Q 045067 218 EGETY----IDDGVKGTSGIVAPEYARTG-----------YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282 (347)
Q Consensus 218 ~~~~~----~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~ 282 (347)
.+.+. .-.+...-..|.|||-+... ..+++.||||+||++.||++.|+|||...+.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL--------- 244 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL--------- 244 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH---------
Confidence 32221 11223344579999966431 1578999999999999999889999974321
Q ss_pred HHHHHHHhccCcccccCCccCCchhhHHH--HHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 283 DFVKKYIENRGFNGIVDPRIIGDELLEHK--LQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
.++...+. .++ +...+. ...+..++..|++.||++|.|+++.++.-
T Consensus 245 ---~aYr~~~~----~~~-----e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 245 ---LAYRSGNA----DDP-----EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ---HhHhccCc----cCH-----HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 11111110 000 000000 11467999999999999999999999863
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=190.30 Aligned_cols=217 Identities=25% Similarity=0.381 Sum_probs=164.6
Q ss_pred HHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe-Eec
Q 045067 112 ASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPI-VFR 190 (347)
Q Consensus 112 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i-vH~ 190 (347)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.. ....+++.....++.+++.||+||| ..+| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHh---cCcceeee
Confidence 3568899999999999999999999999999999999987 3477999999999999999999999 5554 999
Q ss_pred cCCCCCeEECCCCceEEecCCCCccCCCC-CceeeccccccCCcccccccccC-------CCCCccchHHHHHHHHHHHh
Q 045067 191 DLKSSYILVSERYVPKLFNFSLSASIPEG-ETYIDDGVKGTSGIVAPEYARTG-------YLNEKCDVYSFGLLLLQLLS 262 (347)
Q Consensus 191 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~G~~l~el~~ 262 (347)
.+++.|.++|..+.+|++|||+....... .........-...|.|||.+.+. ..+.+.|+||||++++|++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~- 152 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL- 152 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH-
Confidence 99999999999999999999998665421 11111112245578999988764 1467799999999999999
Q ss_pred cCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 263 TGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 263 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
+...||......... .+.+....+ .....+.|.+... .+..+++..++.+||..+|.+||++.++-..++.
T Consensus 153 ~r~~~~~~~~~~~~~----~eii~~~~~--~~~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDP----DEIILRVKK--GGSNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred hccCccccccccCCh----HHHHHHHHh--cCCCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 999999764432221 222222222 1112222332211 1334478899999999999999999999998887
Q ss_pred HHH
Q 045067 343 MYK 345 (347)
Q Consensus 343 i~~ 345 (347)
+.+
T Consensus 224 ~~~ 226 (484)
T KOG1023|consen 224 INK 226 (484)
T ss_pred hcc
Confidence 654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=170.25 Aligned_cols=139 Identities=11% Similarity=0.071 Sum_probs=102.7
Q ss_pred CCeecccCceEEEEEEeC-CceEEEEEEccCCCc-hh------------------------HHHHHHHHHHHHhcCCCce
Q 045067 67 RNIITESSIFRLCQGVLP-DRTISVVKFIDGSVF-DA------------------------YDCCFNNIVFASQMSHNNV 120 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~-~~~~~v~k~~~~~~~-~~------------------------~~~~~~E~~~l~~l~h~ni 120 (347)
...||+|+||.||+|... +..+|+|........ .. .....+|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999985 445555544332110 00 0122359999999988776
Q ss_pred eeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEeccCCCCCeEE
Q 045067 121 LRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYL-HIGFSRPIVFRDLKSSYILV 199 (347)
Q Consensus 121 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~ivH~dlkp~Nill 199 (347)
.....+.. ...+|||||++++++....... ..++......++.|++.+|.++ | +.||+||||||+||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence 44333222 2238999999988776553322 5788999999999999999999 7 8899999999999999
Q ss_pred CCCCceEEecCCCCccC
Q 045067 200 SERYVPKLFNFSLSASI 216 (347)
Q Consensus 200 ~~~~~~kl~Dfg~a~~~ 216 (347)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 578999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=172.77 Aligned_cols=171 Identities=14% Similarity=0.111 Sum_probs=129.1
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchh---HHH------HHHHHHHHHhcCCCceeeeeeeeeeC
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDA---YDC------CFNNIVFASQMSHNNVLRLIGCCLEV 130 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~---~~~------~~~E~~~l~~l~h~niv~l~~~~~~~ 130 (347)
..++|...+++|.|+||.||.+..+++.+ |+|+........ .+. +.+|+..+.++.||+|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~-iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKY-ILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcE-EEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 46789999999999999999976655554 445554332222 122 57999999999999999998886643
Q ss_pred --------CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC
Q 045067 131 --------EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER 202 (347)
Q Consensus 131 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~ 202 (347)
...+|+|||++|.+|.++.. ++. ....+++.+|..+| ..|++|||++|+||+++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCC
Confidence 35789999999999988742 222 24568999999999 9999999999999999998
Q ss_pred CceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHH
Q 045067 203 YVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLL 261 (347)
Q Consensus 203 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~ 261 (347)
+ ++++|||........... ..++....+..++|+||||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999987554321110 11344556678999999999887665
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-21 Score=163.51 Aligned_cols=140 Identities=16% Similarity=0.107 Sum_probs=105.9
Q ss_pred CCeecccCceEEEEEEeCCceEEEEEEccCCCch--------------------------hHHHHHHHHHHHHhcCCCce
Q 045067 67 RNIITESSIFRLCQGVLPDRTISVVKFIDGSVFD--------------------------AYDCCFNNIVFASQMSHNNV 120 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 120 (347)
...||+|++|.||+|...++..+++|+....... ....+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3679999999999999854444445544432210 01224578999999999987
Q ss_pred eeeeeeeeeCCccEEEEEeCCCCCHHHH-HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeE
Q 045067 121 LRLIGCCLEVEIPVLVFESAEYGNLHDL-LKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYIL 198 (347)
Q Consensus 121 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nil 198 (347)
.....+... ..++||||++|+++... +.. ..++......++.+++.++.++| + .||+||||||+||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEE
Confidence 544443332 24899999998755443 432 46788899999999999999999 8 99999999999999
Q ss_pred ECCCCceEEecCCCCccCCC
Q 045067 199 VSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 199 l~~~~~~kl~Dfg~a~~~~~ 218 (347)
++ ++.++|+|||++.....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 98 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-23 Score=192.35 Aligned_cols=225 Identities=19% Similarity=0.148 Sum_probs=180.5
Q ss_pred eecccCceEEEEEEe----CCceEEEEEEccCCCc--hhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEEeCC
Q 045067 69 IITESSIFRLCQGVL----PDRTISVVKFIDGSVF--DAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~----~~~~~~v~k~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
++|.|+||.|+.+.- +.+..+++|+..+.+. ........|..++..++ ||.+++++..+..+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999997655 5566777776665432 11235567888899996 9999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 221 (347)
||+|...+.+. ..+.+.....+...++-+++++| +.+++|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99999998764 56777788888899999999999 99999999999999999999999999999876544322
Q ss_pred eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
.+||..|||||.+. ....++|.||||++.+||+ +|..||.. +......+..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~fell-tg~~pf~~------------~~~~~Il~~~--------- 203 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELL-TGTLPFGG------------DTMKRILKAE--------- 203 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHh-hCCCCCch------------HHHHHHhhhc---------
Confidence 28999999999887 5678899999999999999 99999852 2222222211
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTM 333 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~ 333 (347)
...+......+.+++..++..+|.+|.-.
T Consensus 204 ---~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 ---LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ---cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 12234556677899999999999999765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=160.99 Aligned_cols=184 Identities=14% Similarity=0.052 Sum_probs=133.7
Q ss_pred CCCCeecccCceEEEEEEeCCceEEEEEEccCCC---chhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEEeC
Q 045067 65 HYRNIITESSIFRLCQGVLPDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 65 ~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.....|++|+||+||.+..++.+++...+....- ......+.+|+.+|++|+ |+++++++++ +..+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 3557899999999997777555555544433322 111235789999999995 5789998886 3459999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC-CCCCeEECCCCceEEecCCCCccCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDL-KSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dl-kp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
.|.+|...+.. . ...++.+++.+|.++| ..||+|||| ||+|||++.++.++|+|||+|......
T Consensus 81 ~G~~L~~~~~~------~------~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 81 AGAAMYQRPPR------G------DLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred cCccHHhhhhh------h------hHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 99888654321 1 1346788999999999 999999999 799999999999999999999865433
Q ss_pred Cce----e--------eccccccCCccccccccc-CCCC-CccchHHHHHHHHHHHhcCCCcc
Q 045067 220 ETY----I--------DDGVKGTSGIVAPEYART-GYLN-EKCDVYSFGLLLLQLLSTGEDLF 268 (347)
Q Consensus 220 ~~~----~--------~~~~~gt~~y~aPE~~~~-~~~~-~~~Dv~s~G~~l~el~~~g~~p~ 268 (347)
... . ..-...++.|++|+...- ...+ ...+.++-|.-+|.++ |++.|.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~-~~~~~~ 207 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFV-TRRVLH 207 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHH-hccCCc
Confidence 210 0 011236788888874332 2334 6789999999999999 555544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.5e-23 Score=187.46 Aligned_cols=174 Identities=29% Similarity=0.372 Sum_probs=128.4
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
.+||.|++|.-.+|.++|...+ .....++...+.++.|++.|+.| ++.+|+|+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 3578999999999999997532 34567788899999999999987 689999999999999999999999999
Q ss_pred CCccCCCCC-----ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 212 LSASIPEGE-----TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 212 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
+.+...... ....+...||..||+||.+.+..|+.++||||||++|+|++..-.-.+.- .. ..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-----------~~-t~ 469 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-----------IA-TL 469 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------HH-hh
Confidence 988776554 12234577999999999999999999999999999999999412222210 00 00
Q ss_pred HHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 045067 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMID 335 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~e 335 (347)
.-++.+. +++....+ .++-..|+.+++.+.|.+||++.+
T Consensus 470 ~d~r~g~----ip~~~~~d------~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 470 TDIRDGI----IPPEFLQD------YPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhhcCC----CChHHhhc------CcHHHHHHHHhcCCCcccCchHHH
Confidence 1111111 11111111 223458999999999999994443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-21 Score=162.14 Aligned_cols=136 Identities=10% Similarity=0.033 Sum_probs=104.3
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-----CCCceeeeeeeeeeCC---c-c
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-----SHNNVLRLIGCCLEVE---I-P 133 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~ 133 (347)
+.....||+|+||.||. + .+...++|+... ......+.+.+|+.+++.+ .||||++++|++.++. . +
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~-~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYH-RGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEec-cccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 44567899999999996 5 444445544433 3233447799999999999 5799999999999874 3 3
Q ss_pred EEEEEe--CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCeEeccCCCCCeEECC----CCceE
Q 045067 134 VLVFES--AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVF-AYLHIGFSRPIVFRDLKSSYILVSE----RYVPK 206 (347)
Q Consensus 134 ~lv~e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~lH~~~~~~ivH~dlkp~Nill~~----~~~~k 206 (347)
.+|+|| +.+|+|.+++.+ ..+++. ..++.+++.++ +||| +.+|+||||||+|||++. ++.++
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEE
Confidence 378999 557999999965 235554 35677888777 9999 999999999999999974 34899
Q ss_pred EecCCCC
Q 045067 207 LFNFSLS 213 (347)
Q Consensus 207 l~Dfg~a 213 (347)
|+||+.+
T Consensus 150 LiDg~G~ 156 (210)
T PRK10345 150 VCDNIGE 156 (210)
T ss_pred EEECCCC
Confidence 9995433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=190.62 Aligned_cols=255 Identities=13% Similarity=0.095 Sum_probs=183.0
Q ss_pred HHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcC---CCceeeeeeeeeeC
Q 045067 54 AKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS---HNNVLRLIGCCLEV 130 (347)
Q Consensus 54 ~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 130 (347)
..+++...+.|.+.+.||+|+||.||.|+..++..+|+|+-..... -+|.=-.+++.+|+ -+.|..+..++.-.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3456667788999999999999999999996677777776554431 12333334455555 23555555666666
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC-------CCC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS-------ERY 203 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~-------~~~ 203 (347)
+..+||+||.+.|+|.++++.+ +.+++..+..++.+++.-+++|| ..+||||||||+|+||. ...
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred CcceeeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCccc
Confidence 7789999999999999999854 78999999999999999999999 99999999999999995 345
Q ss_pred ceEEecCCCCccCCCCC-ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH
Q 045067 204 VPKLFNFSLSASIPEGE-TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282 (347)
Q Consensus 204 ~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~ 282 (347)
.++|+|||.+..+.--. ...-+..++|-.+-.+|+..|..+++.+|.|.++.+++-|+ .|+..-
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mL-FG~y~q-------------- 903 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVML-FGKYME-------------- 903 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHH-HHHHHH--------------
Confidence 78999999987664211 12335577889999999999999999999999999999999 655332
Q ss_pred HHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 283 DFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
..++..+. ++..+. .... .....++...+|..+-..=|...++...|++...
T Consensus 904 ------~~~g~~~~-~~~~~~-Ry~~---~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 904 ------VKNGSSWM-VKTNFP-RYWK---RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred ------hcCCccee-ccccch-hhhh---HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 11111111 111000 0001 1123356666667666666777777777776643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=169.44 Aligned_cols=235 Identities=17% Similarity=0.163 Sum_probs=143.4
Q ss_pred cCCCCCeecccCceEEEEEEe-CCce-EEEEEEccCC--CchhHHHHHHHHHHHHhcCC----------Cceeeeeeeee
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRT-ISVVKFIDGS--VFDAYDCCFNNIVFASQMSH----------NNVLRLIGCCL 128 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~-~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 128 (347)
++...+.||.|+++.||.+++ .++. .+++...-.. .....+.+.+|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 345667899999999999999 4444 4444433322 23345666666654444322 12222222211
Q ss_pred ---------eC---C-----ccEEEEEeCCCCCHHHHHhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 045067 129 ---------EV---E-----IPVLVFESAEYGNLHDLLKRSY--QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVF 189 (347)
Q Consensus 129 ---------~~---~-----~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH 189 (347)
.. + +.+++|+-+. ++|.+++..-. ......+....++.+..|++..+++|| ..|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence 11 1 3367888886 49988865311 111123445566778899999999999 999999
Q ss_pred ccCCCCCeEECCCCceEEecCCCCccCCCCCceeeccccccCCccccccccc--------CCCCCccchHHHHHHHHHHH
Q 045067 190 RDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART--------GYLNEKCDVYSFGLLLLQLL 261 (347)
Q Consensus 190 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~G~~l~el~ 261 (347)
+||+|+|++++.+|.++|+||+........ . .. ...+..|.|||.... -.++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~--~-~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR--Y-RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE--E-EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce--e-ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999876554321 1 11 345578999996643 25788999999999999999
Q ss_pred hcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCC
Q 045067 262 STGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDR 330 (347)
Q Consensus 262 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~R 330 (347)
+++.||........... .+ .... +.++.+..||..+|+.||.+|
T Consensus 245 -C~~lPf~~~~~~~~~~~-----------------~f------~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 -CGRLPFGLSSPEADPEW-----------------DF------SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -HSS-STCCCGGGSTSGG-----------------GG------TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred -HccCCCCCCCccccccc-----------------cc------hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 89999976543111110 00 1111 567788999999999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-20 Score=156.33 Aligned_cols=135 Identities=19% Similarity=0.172 Sum_probs=113.0
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCCCc-------hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGSVF-------DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
+.||+|++|.||+|.+.+..+++|+....... .....+.+|+.++..+.|+++.....++.+.+..+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 57999999999999997777777765543221 11245788999999999999887777777778889999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
+|++|.+++... . . .+..++.+++.+|.++| +.+++|||++|.||+++ ++.++++|||.+..
T Consensus 82 ~G~~L~~~~~~~-----~---~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN-----G---M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc-----c---H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999998652 1 1 78889999999999999 99999999999999999 78999999998754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.9e-20 Score=162.04 Aligned_cols=196 Identities=18% Similarity=0.205 Sum_probs=140.2
Q ss_pred CCCceeeeeeeeee---------------------------CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHH
Q 045067 116 SHNNVLRLIGCCLE---------------------------VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168 (347)
Q Consensus 116 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i 168 (347)
.|||||+++++|.+ +..+|+||...+. +|..++-. ...+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc------CCCchHHHHHH
Confidence 49999999998765 3467999998886 99999965 56777788889
Q ss_pred HHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC--CCC--ceEEecCCCCccCCCCC---ce--eeccccccCCccccccc
Q 045067 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVS--ERY--VPKLFNFSLSASIPEGE---TY--IDDGVKGTSGIVAPEYA 239 (347)
Q Consensus 169 ~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~--~~~--~~kl~Dfg~a~~~~~~~---~~--~~~~~~gt~~y~aPE~~ 239 (347)
+.|+++|+.||| .+||.|||+|++|||+. +|+ .+.|+|||.+..-.... .+ ..-...|....||||..
T Consensus 347 laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 999999999999 99999999999999995 333 56889999764332211 11 11234577888999987
Q ss_pred ccCC------CCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHH
Q 045067 240 RTGY------LNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQ 313 (347)
Q Consensus 240 ~~~~------~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (347)
...+ --.|+|.|+.|.+.||++ +...||..... ..+. . +. +++..+ +..++.+++
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIf-g~~NPFY~rGe-----m~L~-~-r~-Yqe~qL----------Palp~~vpp 484 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIF-GRSNPFYKRGE-----MLLD-T-RT-YQESQL----------PALPSRVPP 484 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHh-ccCCcccccch-----heec-h-hh-hhhhhC----------CCCcccCCh
Confidence 6432 136899999999999999 88999865211 1000 0 00 111111 122234455
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 314 SSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 314 ~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
.+.+++...|+.||++|||..-....|
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHH
Confidence 678999999999999999976555444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=152.89 Aligned_cols=131 Identities=19% Similarity=0.179 Sum_probs=107.0
Q ss_pred eecccCceEEEEEEeCCceEEEEEEccCCCc-------hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 69 IITESSIFRLCQGVLPDRTISVVKFIDGSVF-------DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
.||+|+||.||+|.+++..+++|........ ....++.+|+.++..++|+++.....++...+..+++|||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3899999999999987777777775543211 112557789999999998876655555566677899999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
|++|.+++... .. .++.+++.+|.+|| +.+++|||++|.||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEG-----ND-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhc-----HH-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988642 11 78899999999999 99999999999999999 89999999998855
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=172.66 Aligned_cols=139 Identities=17% Similarity=0.153 Sum_probs=114.2
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCC-c------hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSV-F------DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~-~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
....|...+.||+|+||+||+|.+.+..+++++...... . ...+++.+|+.++..++|++++....++.+...
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344456678999999999999999666666655433221 1 123568899999999999999888777777778
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.++||||+++++|.+++. ....++.+++.+|.+|| +.+++||||||+||++ .++.++|+|||+
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 899999999999999874 24578999999999999 9999999999999999 678999999999
Q ss_pred Ccc
Q 045067 213 SAS 215 (347)
Q Consensus 213 a~~ 215 (347)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=153.16 Aligned_cols=141 Identities=14% Similarity=0.078 Sum_probs=105.1
Q ss_pred cCCCCCeecccCceEEEEEE-e--CCceEEEEEEccCCCc-------------------h----hHHHHHHHHHHHHhcC
Q 045067 63 NYHYRNIITESSIFRLCQGV-L--PDRTISVVKFIDGSVF-------------------D----AYDCCFNNIVFASQMS 116 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~-~--~~~~~~v~k~~~~~~~-------------------~----~~~~~~~E~~~l~~l~ 116 (347)
.|...+.||+|++|.||+|+ . ++..+++|........ . ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778899999999999998 3 4455555544332110 0 1123568999999997
Q ss_pred CCc--eeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEeccCC
Q 045067 117 HNN--VLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP-IVFRDLK 193 (347)
Q Consensus 117 h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-ivH~dlk 193 (347)
+.+ +.+++++ ...++||||+++++|....... ..+.......++.+++.++.+|| ..+ ++|||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dik 176 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLS 176 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCC
Confidence 533 3444442 2348999999998887654321 34566677899999999999999 999 9999999
Q ss_pred CCCeEECCCCceEEecCCCCccC
Q 045067 194 SSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 194 p~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|+||+++ ++.++++|||.+...
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999 889999999988654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.9e-20 Score=176.43 Aligned_cols=211 Identities=22% Similarity=0.208 Sum_probs=145.0
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
...++|..++.|..|+||.||...+ ..++-.+.|+-+..- +.+- ++.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee----------------
Confidence 3457899999999999999999998 444444445433221 1111 22222333333
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|+=...++.. ++++.. ++.+++||| +.||+|||+||+|.+|..-|++|+.|||+++...
T Consensus 136 -----gDc~tllk~~-----g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -----GDCATLLKNI-----GPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -----chhhhhcccC-----CCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 4545555442 445532 277999999 9999999999999999999999999999986543
Q ss_pred CCC--------------ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 218 EGE--------------TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 218 ~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
... .......+||+.|.|||++....|...+|+|++|+++||.+ .|..||....+ ..
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFL-VgcvpffGdtp--------ee 265 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL-VGCVPFFGDTP--------EE 265 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHh-eeeeeccCCCH--------HH
Confidence 211 11234578999999999999999999999999999999999 99999864322 11
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT 332 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs 332 (347)
.+...+..... .++..+...+++.+++.+.|+.+|..|--
T Consensus 266 lfg~visd~i~---------wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 266 LFGQVISDDIE---------WPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred HHhhhhhhhcc---------ccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 11222221110 11112233557889999999999999953
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-18 Score=144.02 Aligned_cols=145 Identities=14% Similarity=0.039 Sum_probs=106.9
Q ss_pred HHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCc----------------------hhHHHHHHHHHHH
Q 045067 55 KELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVF----------------------DAYDCCFNNIVFA 112 (347)
Q Consensus 55 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~----------------------~~~~~~~~E~~~l 112 (347)
.++......|...+.||+|+||.||++...++..+++|+...... .......+|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444445777889999999999999985454455554332210 0112356789999
Q ss_pred HhcCCCc--eeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 045067 113 SQMSHNN--VLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFR 190 (347)
Q Consensus 113 ~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~ 190 (347)
..+.|++ +...++ ....++||||++|++|...... .....++.+++.++.++| +.+++||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh---~~gi~H~ 149 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY---KHGIIHG 149 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH---HCCCCcC
Confidence 9998774 444433 2455899999999988765421 234578889999999999 9999999
Q ss_pred cCCCCCeEECCCCceEEecCCCCccCC
Q 045067 191 DLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 191 dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+|+||+++.++.++|+|||++....
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.1e-19 Score=171.00 Aligned_cols=256 Identities=19% Similarity=0.229 Sum_probs=189.6
Q ss_pred hccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 135 (347)
...|...+-||+|+|+.|-.... +....++.+...... .....+...|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 34566777799999999988887 333344444333322 223345556888877886 9999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-ceEEecCCCCc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLFNFSLSA 214 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~ 214 (347)
.++|..++++.+-+... .....+......+..|+..++.|+|. ..++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999988321 11256777888899999999999995 67899999999999999999 99999999998
Q ss_pred cCCC--CCceeeccccc-cCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 215 SIPE--GETYIDDGVKG-TSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 215 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
.... +........+| ++.|+|||...+ ....+..|+||.|+++.-++ +|..|+........... .+..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~-~g~~p~~~~~~~~~~~~-------~~~~ 245 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAML-TGELPWDFPSRKDGRYS-------SWKS 245 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccc-cCCCCccccccccccce-------eecc
Confidence 8766 33444456778 999999998887 46678899999999999999 99999976544221110 0111
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVA 337 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell 337 (347)
... .. .............+++.+++..+|..|.+.+++.
T Consensus 246 ~~~---~~-----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 246 NKG---RF-----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccc---cc-----ccCccccCChhhhhcccccccCCchhcccccccc
Confidence 100 00 0111122334567888999999999999988764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-16 Score=137.45 Aligned_cols=136 Identities=16% Similarity=0.130 Sum_probs=104.6
Q ss_pred CCeec-ccCceEEEEEEeCCceEEEEEEccCC------------CchhHHHHHHHHHHHHhcCCCce--eeeeeeeeeCC
Q 045067 67 RNIIT-ESSIFRLCQGVLPDRTISVVKFIDGS------------VFDAYDCCFNNIVFASQMSHNNV--LRLIGCCLEVE 131 (347)
Q Consensus 67 ~~~lg-~G~~g~Vy~~~~~~~~~~v~k~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~ 131 (347)
..+|| .||.|+||.+..+++.++++...... .......+.+|+.++.+++|+++ +..+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 35788 89999999998887777776553211 01223567899999999998875 66666644322
Q ss_pred ----ccEEEEEeCCC-CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceE
Q 045067 132 ----IPVLVFESAEY-GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPK 206 (347)
Q Consensus 132 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~k 206 (347)
..++|+|+++| .+|.+++.. ..++.. .+.+++.+|.+|| +.||+||||||.|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEE
Confidence 23599999997 689998865 345543 3568899999999 99999999999999999999999
Q ss_pred EecCCCCcc
Q 045067 207 LFNFSLSAS 215 (347)
Q Consensus 207 l~Dfg~a~~ 215 (347)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998755
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.2e-16 Score=126.34 Aligned_cols=135 Identities=14% Similarity=0.084 Sum_probs=108.2
Q ss_pred CCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCC--CceeeeeeeeeeCCccEEEEEeCCCC
Q 045067 66 YRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSH--NNVLRLIGCCLEVEIPVLVFESAEYG 143 (347)
Q Consensus 66 ~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 143 (347)
..+.||.|.++.||++..++..+++ |....... ...+.+|+.++..++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~i-K~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVL-KINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecCCeEEE-EecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3467999999999999996655544 44444322 3678899999999976 58889988888778899999999986
Q ss_pred CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 144 NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 144 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
++..+ +......++.+++.+++.+|.....+++|+|++|.||+++.++.++++|||.+..
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 65432 4456677889999999999943335799999999999999999999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=132.33 Aligned_cols=136 Identities=17% Similarity=0.081 Sum_probs=93.1
Q ss_pred CCeecccCceEEEEEEeCCceEEEEEEccCCCch--hHHH----------------------HHHHHHHHHhcCCCc--e
Q 045067 67 RNIITESSIFRLCQGVLPDRTISVVKFIDGSVFD--AYDC----------------------CFNNIVFASQMSHNN--V 120 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 120 (347)
.+.||+|+||+||+|...++..+++|+....... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999854444455544432111 1011 135666666664432 3
Q ss_pred eeeeeeeeeCCccEEEEEeCCCCCHHH-HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeE
Q 045067 121 LRLIGCCLEVEIPVLVFESAEYGNLHD-LLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYIL 198 (347)
Q Consensus 121 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nil 198 (347)
.+.+++ ...++||||++++++.. .+... ... .....++.+++.++.++| . .+++|+||||+||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNIL 147 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEE
Confidence 444443 24589999999855432 22211 111 567789999999999999 7 99999999999999
Q ss_pred ECCCCceEEecCCCCccCC
Q 045067 199 VSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 199 l~~~~~~kl~Dfg~a~~~~ 217 (347)
++ ++.++++|||.+....
T Consensus 148 i~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EE-CCcEEEEECccccccc
Confidence 99 9999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.7e-14 Score=132.05 Aligned_cols=140 Identities=17% Similarity=0.115 Sum_probs=92.9
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCCCchhH----------------------------------------HHHHH
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAY----------------------------------------DCCFN 107 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~----------------------------------------~~~~~ 107 (347)
+-||+|++|.||+|+..++..+|+|+..+...... -.+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999994444444444443211000 02444
Q ss_pred HHHHHHhcC-----CCceeeeeeee-eeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHH-HHHHhh
Q 045067 108 NIVFASQMS-----HNNVLRLIGCC-LEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN-VFAYLH 180 (347)
Q Consensus 108 E~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~l~~lH 180 (347)
|+..+.++. ++++ .+-.++ ...+..+|||||++|++|.+...... ...+ ...++..++. .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCCC---HHHHHHHHHHHHHHHHH
Confidence 555555552 3333 322222 22345689999999999998765320 1222 3345555555 467889
Q ss_pred cCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 181 IGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 181 ~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
..|++|+|++|.||+++.++.++++|||++..+..
T Consensus 275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 89999999999999999999999999999877653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.9e-14 Score=133.30 Aligned_cols=247 Identities=18% Similarity=0.113 Sum_probs=179.9
Q ss_pred cCCCCCeecc--cCceEEEEEEe----CCceEEEEEEccCCC-chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccE
Q 045067 63 NYHYRNIITE--SSIFRLCQGVL----PDRTISVVKFIDGSV-FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 63 ~~~~~~~lg~--G~~g~Vy~~~~----~~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 134 (347)
.|...+.+|+ |.+|.||.+.. +...+++++.....+ ......-.+|+.....+ .|+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556678999 99999999988 344566666433322 22223445777777777 4999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCCeEeccCCCCCeEECCC-CceEEec
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN----VFAYLHIGFSRPIVFRDLKSSYILVSER-YVPKLFN 209 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~lH~~~~~~ivH~dlkp~Nill~~~-~~~kl~D 209 (347)
+-+|+|. .+|.++.... ...++....+....+... ||.++| ..+++|-|+||.||+...+ ...+++|
T Consensus 195 iqtE~~~-~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeecccc-chhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCC
Confidence 9999997 5888888763 244666677777777777 999999 9999999999999999999 8899999
Q ss_pred CCCCccCCCCCcee----eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 210 FSLSASIPEGETYI----DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 210 fg~a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
||+...+....... .....|...|++||... +.++...|+|++|.+..+.. .+..+......
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~-l~~~~~~~g~~------------ 332 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAI-LGSHLPSVGKN------------ 332 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhH-hhcccccCCCC------------
Confidence 99988877654221 12235788999999765 56689999999999999988 55544332100
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.-+..+++....++........+...+.++++.+|..|++...+..
T Consensus 333 -------~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 333 -------SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -------CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0011122333344444444556667999999999999999887653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.9e-14 Score=123.85 Aligned_cols=203 Identities=22% Similarity=0.277 Sum_probs=138.8
Q ss_pred HHHhcCCCceeeeeeeeeeCC-----ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 045067 111 FASQMSHNNVLRLIGCCLEVE-----IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR 185 (347)
Q Consensus 111 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~ 185 (347)
-+-++.|.||++++.|+.+.+ ...+++|||..|+|..+|++. +.....+......+|+-||..||.|||+. +.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt-~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRT-KKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHH-HHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 344567999999999987643 578999999999999999876 33446688888889999999999999954 67
Q ss_pred CeEeccCCCCCeEECCCCceEEecCCCCccCC---CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHh
Q 045067 186 PIVFRDLKSSYILVSERYVPKLFNFSLSASIP---EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS 262 (347)
Q Consensus 186 ~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~ 262 (347)
+|+|+++.-.-|++..+|-+|++--.-...-. ...........+.++|.+||.-.....+..+|||+||+...+|.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema- 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA- 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH-
Confidence 89999999999999999988886432111100 00111112345678999999776667788999999999999987
Q ss_pred cCCC-ccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 263 TGED-LFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 263 ~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
-+.. |-...+. ... .....+ .+.+.+.. .-..++..|++..|..||+|++++-.
T Consensus 277 ilEiq~tnseS~------~~~---ee~ia~---------~i~~len~-----lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESK------VEV---EENIAN---------VIIGLENG-----LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcce------eeh---hhhhhh---------heeeccCc-----cccCcCcccccCCCCCCcchhhhhcC
Confidence 3332 1111110 000 000000 00000000 11367889999999999999988643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.5e-12 Score=122.20 Aligned_cols=164 Identities=16% Similarity=0.144 Sum_probs=123.9
Q ss_pred CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHH
Q 045067 84 PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLK 163 (347)
Q Consensus 84 ~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~ 163 (347)
+++++.|........ ...+...+.++.|+.++||||++++..+..++..|||+|-+. .|..+++.. ...
T Consensus 36 ~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~~~ 104 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------GKE 104 (690)
T ss_pred cCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------HHH
Confidence 566666666665554 444667889999999999999999999999999999999986 788888652 255
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeeccccccCCcccccccccCC
Q 045067 164 HRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGY 243 (347)
Q Consensus 164 ~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 243 (347)
.+...+.||+.||-|||+ ..+++|++|.-+.|+++..|..||++|.++........ ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 566678999999999985 67999999999999999999999999987644322111 111111222355665443222
Q ss_pred CCCccchHHHHHHHHHHHhcC
Q 045067 244 LNEKCDVYSFGLLLLQLLSTG 264 (347)
Q Consensus 244 ~~~~~Dv~s~G~~l~el~~~g 264 (347)
...|.|-|||+++|++ .|
T Consensus 182 --~s~D~~~Lg~li~el~-ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELF-NG 199 (690)
T ss_pred --cchhhhhHHHHHHHHh-Cc
Confidence 4579999999999999 66
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.8e-13 Score=107.94 Aligned_cols=126 Identities=15% Similarity=0.046 Sum_probs=90.9
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCcee-eeeeeeeeCCccEEEEEeCCCCCHH
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVL-RLIGCCLEVEIPVLVFESAEYGNLH 146 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L~ 146 (347)
+.|+.|.++.||++..+++.+++|. ...... ....+.+|+.+++.+.+.+++ +++.+. ....++|||+++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~-~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRI-PGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEe-CCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 5688999999999998766655554 433321 123467899999988655544 444443 33458999999998765
Q ss_pred HHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 147 DLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP-----IVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 147 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+. . . ....++.+++.+|+.|| ..+ ++|||++|.||+++ ++.++++|||.+.
T Consensus 80 ~~--~--------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TE--D--------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cc--c--------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 43 0 0 11235678999999999 666 59999999999998 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.8e-12 Score=101.97 Aligned_cols=131 Identities=18% Similarity=0.146 Sum_probs=100.8
Q ss_pred eecccCceEEEEEEeCCceEEEEEEccCCCch-------hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 69 IITESSIFRLCQGVLPDRTISVVKFIDGSVFD-------AYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
.+++|+-+.+|.+.+-+.++++|..+++.-.. ...+-.+|+.+++++.--.|....-+..+.....|+|||.+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 57899999999998866666666665554311 12446689999998865555544445567777889999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
|..|.+.+... ...++..+-.-+.-|| ..||+||||.++||.+..+. +.++|||++..
T Consensus 83 G~~lkd~l~~~------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 98999898752 2456777777888999 99999999999999996654 99999999853
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-11 Score=102.50 Aligned_cols=136 Identities=13% Similarity=0.042 Sum_probs=95.7
Q ss_pred CeecccCceEEEEEEeCC-------ceEEEEEEccCCC----------------------chhHHHHH----HHHHHHHh
Q 045067 68 NIITESSIFRLCQGVLPD-------RTISVVKFIDGSV----------------------FDAYDCCF----NNIVFASQ 114 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~-------~~~~v~k~~~~~~----------------------~~~~~~~~----~E~~~l~~ 114 (347)
..||.|--+.||.|...+ +..+++|+...+. ....+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 469999999999998732 3455566543221 01122233 89999998
Q ss_pred cCC--CceeeeeeeeeeCCccEEEEEeCCCCCHHH-HHhhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEec
Q 045067 115 MSH--NNVLRLIGCCLEVEIPVLVFESAEYGNLHD-LLKRSYQSHSEPLLLKHRLKIAMEIANVFAYL-HIGFSRPIVFR 190 (347)
Q Consensus 115 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l-H~~~~~~ivH~ 190 (347)
+.. -++..++++ ..-+|||||+.++.+.. .+.+ ..++......+..+++.+|..| | ..+++||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 853 355555554 34589999998654422 2322 2345556677889999999998 8 8999999
Q ss_pred cCCCCCeEECCCCceEEecCCCCccCC
Q 045067 191 DLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 191 dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||++.||+++ ++.+.++|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999996 5789999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.1e-11 Score=99.02 Aligned_cols=144 Identities=14% Similarity=0.129 Sum_probs=108.1
Q ss_pred CCCeecccCceEEEEEEeCCceEEEEEEccCCCc-------hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 66 YRNIITESSIFRLCQGVLPDRTISVVKFIDGSVF-------DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 66 ~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
....+-+|+-+.|+++.+.+...++|....+.-. -...+..+|+.+|.++.--.|.-..-++.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4567899999999999999888888877665431 123567789999998865455444445566677789999
Q ss_pred eCCC-CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC---ceEEecCCCCc
Q 045067 139 SAEY-GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY---VPKLFNFSLSA 214 (347)
Q Consensus 139 ~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~a~ 214 (347)
|.+| .++.+++.... . ..........++..+-..+.-|| ..+|+||||..+||++..++ .+.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~--~-~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTM--E-DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHc--c-CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 9986 47888887642 1 11222223678888989999999 99999999999999997655 45799999874
Q ss_pred c
Q 045067 215 S 215 (347)
Q Consensus 215 ~ 215 (347)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.5e-12 Score=123.59 Aligned_cols=147 Identities=16% Similarity=0.148 Sum_probs=88.7
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCch----------------------------------hHHH-
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFD----------------------------------AYDC- 104 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~----------------------------------~~~~- 104 (347)
...|+. +-||+|++|.||+|+. +++..+++|+..+.... -.+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 6899999999999999 42555555555433100 0111
Q ss_pred -----HHHHHHHHHhcC----CCceeeeeeeeee-CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHH
Q 045067 105 -----CFNNIVFASQMS----HNNVLRLIGCCLE-VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174 (347)
Q Consensus 105 -----~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~ 174 (347)
+.+|+..+.+++ +.+.+.+-.++.+ .+..+|||||+.|+.+.+.-.-. ....+.... +...+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~----~~g~d~~~l---a~~~v~ 270 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALR----AAGTDMKLL---AERGVE 270 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHH----hcCCCHHHH---HHHHHH
Confidence 334444444442 3333333333322 34568999999999998753211 012222211 111111
Q ss_pred -HHHHhhcCCCCCeEeccCCCCCeEECCCC----ceEEecCCCCccCCC
Q 045067 175 -VFAYLHIGFSRPIVFRDLKSSYILVSERY----VPKLFNFSLSASIPE 218 (347)
Q Consensus 175 -~l~~lH~~~~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~a~~~~~ 218 (347)
-+..+. ..|++|+|++|.||+++.++ .+++.|||+...+..
T Consensus 271 ~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 123344 78999999999999999888 999999999877654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.5e-13 Score=134.22 Aligned_cols=250 Identities=18% Similarity=0.106 Sum_probs=173.9
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCc---eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDR---TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~---~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
...+.+...+-+-+|+++.++.+.- ..+ ..-+.+..++-.....+...++-.++-..++|.++....-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 3456667777788999999998776 222 222233333222222344444554444456788887766666677889
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
|+++|..+++|...+++. +..+..-.......+..++++|| ...+.|+|++|.|.+...++..++.|||...
T Consensus 881 L~~~~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred hhhHHhccCCchhhhhcC-----CCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccc
Confidence 999999999999999874 34555555566777888999999 8889999999999999999999999998432
Q ss_pred cCCC---------------------CC-----c----eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcC
Q 045067 215 SIPE---------------------GE-----T----YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264 (347)
Q Consensus 215 ~~~~---------------------~~-----~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g 264 (347)
.... .. . .......+|+.|.+||...+......+|+|++|++++|.+ +|
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l-~g 1031 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL-TG 1031 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh-cC
Confidence 2210 00 0 0012355899999999999999999999999999999999 99
Q ss_pred CCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHH
Q 045067 265 EDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMI 334 (347)
Q Consensus 265 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ 334 (347)
.+||++..+ .+.+ ..+....+..+...........+++...+..+|.+|-.+.
T Consensus 1032 ~pp~na~tp------------q~~f-----~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETP------------QQIF-----ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCcch------------hhhh-----hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999987544 1111 1222222222233334455677888899999999997765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=9.6e-13 Score=122.14 Aligned_cols=248 Identities=16% Similarity=0.138 Sum_probs=171.6
Q ss_pred HHhccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCCchhH--HHHHHHHHHHHhc-CCCceeeeeeeeeeCCcc
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSVFDAY--DCCFNNIVFASQM-SHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~~~~~--~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 133 (347)
.-+.+|..+..||.|.|+.|+.... .++.+++.|-......... ..-..|+.+...+ .|.++++.+..+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788899999999999998776 3555555544333222211 2235677777666 599999988888888888
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC-CceEEecCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-YVPKLFNFSL 212 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~ 212 (347)
++-.|||.++++...+.-. ..++....+++..+++.++.++| +..++|+|+||+||++..+ +..++.|||.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccc
Confidence 8999999998877766322 56788889999999999999999 9999999999999999886 7889999998
Q ss_pred CccCCCCCceeeccccccCCcc--cccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 213 SASIPEGETYIDDGVKGTSGIV--APEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
++.+..... ...+.-++. +++......+..+.|++|||..+.+.+ ++.+.-..... | ..+.
T Consensus 414 ~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~-~~~~ls~~~~~----------~--~~i~ 476 (524)
T KOG0601|consen 414 WTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAI-TGSPLSESGVQ----------S--LTIR 476 (524)
T ss_pred ccccceecc----cccccccccccchhhccccccccccccccccccccccc-cCcccCccccc----------c--eeee
Confidence 865322111 112223333 455556667889999999999999998 55443221100 0 0000
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
.+.. +. . +....++..+...+..+++..||++.++....+.
T Consensus 477 ~~~~-----p~--~----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 477 SGDT-----PN--L----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cccc-----cC--C----CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1100 01 1 1112556778888999999999999887655443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.7e-10 Score=103.14 Aligned_cols=272 Identities=13% Similarity=0.046 Sum_probs=163.7
Q ss_pred CCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceee--------eeeeeeeCCccEE
Q 045067 65 HYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLR--------LIGCCLEVEIPVL 135 (347)
Q Consensus 65 ~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------l~~~~~~~~~~~l 135 (347)
...+-||+|+.+.+|..-.-.+.| +|. .......... .-+..|... .||-+-. ++|- ..+...-+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~V-AKI-Yh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGf 87 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQV-AKI-YHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGF 87 (637)
T ss_pred CCCccccCCccceeeecchhhchh-hee-ecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEE
Confidence 345679999999999754323333 333 2222222211 223333333 4554322 1111 11223567
Q ss_pred EEEeCCCC-CHHHHHhh-hccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 136 VFESAEYG-NLHDLLKR-SYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 136 v~e~~~~g-~L~~~l~~-~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
+|..+++- -+..+.+. .+..+-....|+..++.++.++.+-+-|| ..|.+-||+.++|+|+++++.+.+.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccce
Confidence 88887753 23333321 11223345789999999999999999999 999999999999999999999999985432
Q ss_pred ccCCCCCceeeccccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCC-CchHHHHHHH
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD-ESFEMDFVKK 287 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~ 287 (347)
.. ..+ ........|...|.+||... +-.-+..+|-|.+|+++++++-.|+.||..-...... .+........
T Consensus 165 qi-~~n-g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 165 QI-NAN-GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ee-ccC-CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 11 111 12223467899999999654 3345678999999999999986779999865432111 1111111111
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccC--CCCCCCCHHHHHHHHHHHHHhC
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSA--SAEDRPTMIDVAKQIKKMYKSF 347 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~--~P~~RPs~~ell~~L~~i~~~~ 347 (347)
.+-...-...--...+......-.++.+..+..+|+.. ++.-|||+...+..|..+.++|
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 11000000000000111222333456778888899865 4678999999999999887764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.8e-11 Score=102.62 Aligned_cols=142 Identities=15% Similarity=0.133 Sum_probs=103.7
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCCCc-hhHHHHHHHHHHHHhcCCC--ceeeeeeeeeeC---CccEEEEEeCC
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGSVF-DAYDCCFNNIVFASQMSHN--NVLRLIGCCLEV---EIPVLVFESAE 141 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~ 141 (347)
+.|+.|..+.||++...++..+++|....... .....+.+|+.+++.+.+. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999986544455555443321 1335688999999999753 456677776553 25689999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF-------------------------------------- 183 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-------------------------------------- 183 (347)
|.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9887765431 34666777777888888888887421
Q ss_pred ---------------CCCeEeccCCCCCeEECC--CCceEEecCCCCcc
Q 045067 184 ---------------SRPIVFRDLKSSYILVSE--RYVPKLFNFSLSAS 215 (347)
Q Consensus 184 ---------------~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~a~~ 215 (347)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 56689999997743
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.4e-10 Score=99.84 Aligned_cols=141 Identities=10% Similarity=0.024 Sum_probs=100.4
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCCCchhH----------HHHHHHHHHHHhcCCCce--eeeeeeeee-----C
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAY----------DCCFNNIVFASQMSHNNV--LRLIGCCLE-----V 130 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~----------~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~ 130 (347)
+++-......|++..+++..+++|+.......... ..+.+|...+.++...+| ..++++... .
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 45555555567788778887777765433311111 137789998888843333 333444432 2
Q ss_pred CccEEEEEeCCCC-CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-------C
Q 045067 131 EIPVLVFESAEYG-NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-------R 202 (347)
Q Consensus 131 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-------~ 202 (347)
...+||||++++. +|.+++... ...+.+...+..++.+++..+..|| ..||+|+|++++|||++. +
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~---~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADW---ATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCC
Confidence 3468999999975 799998642 1134566777889999999999999 999999999999999975 4
Q ss_pred CceEEecCCCCc
Q 045067 203 YVPKLFNFSLSA 214 (347)
Q Consensus 203 ~~~kl~Dfg~a~ 214 (347)
+.+.++||+.+.
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 688999999774
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.8e-09 Score=96.89 Aligned_cols=169 Identities=20% Similarity=0.175 Sum_probs=123.7
Q ss_pred CceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee----CCccEEEEEeCCC-CCHHH
Q 045067 74 SIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE----VEIPVLVFESAEY-GNLHD 147 (347)
Q Consensus 74 ~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L~~ 147 (347)
.-.+.|+++. -+|..+|+|.+.............-++.++++.|+|+|++..++.. +..+++|++|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3468999998 5666666666643332222234466888999999999999998873 4478999999876 57777
Q ss_pred HHhhhc----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 148 LLKRSY----------QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 148 ~l~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
+--.+. ...+..+++...+.++.|+..||.++| +.|...+-|.|.+|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 643221 122345778899999999999999999 9999999999999999999999999888764443
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcC
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g 264 (347)
.+.. |.+.+ -.+-|.=.||.++..|. +|
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLA-t~ 472 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALA-TG 472 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHh-hc
Confidence 3220 11111 23468889999999999 54
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-09 Score=89.70 Aligned_cols=126 Identities=18% Similarity=0.140 Sum_probs=78.4
Q ss_pred EEEEEEeCCceEEEEEEccCCC--------------------------chhHHHHHHHHHHHHhcCCC--ceeeeeeeee
Q 045067 77 RLCQGVLPDRTISVVKFIDGSV--------------------------FDAYDCCFNNIVFASQMSHN--NVLRLIGCCL 128 (347)
Q Consensus 77 ~Vy~~~~~~~~~~v~k~~~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 128 (347)
.||.|...++..+++|+..... ........+|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998655555555543221 00123466899999999755 455665542
Q ss_pred eCCccEEEEEeCC--CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 129 EVEIPVLVFESAE--YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAY-LHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 129 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
.-+|||||++ |..+..+... .++......++.+++..+.. +| ..|++||||.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-------~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-------DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-------GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-------cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eE
Confidence 3479999998 6555554432 22233445566777775544 58 9999999999999999887 99
Q ss_pred EEecCCCCccCC
Q 045067 206 KLFNFSLSASIP 217 (347)
Q Consensus 206 kl~Dfg~a~~~~ 217 (347)
.++|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999875543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.9e-08 Score=83.65 Aligned_cols=141 Identities=11% Similarity=-0.010 Sum_probs=104.0
Q ss_pred eecccCceEEEEEEeCCceEEEEEEccCCC-----chhHHHHHHHHHHHHhcCCC--ceeeeeeeeeeC----CccEEEE
Q 045067 69 IITESSIFRLCQGVLPDRTISVVKFIDGSV-----FDAYDCCFNNIVFASQMSHN--NVLRLIGCCLEV----EIPVLVF 137 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~-----~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~ 137 (347)
--|+||.+-|++-.+++..+++|+.-+.-. +-....|.+|+..+.++..- .+.+...+.... -.-+||+
T Consensus 25 N~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 25 NYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 357899999999888777888887652211 22346799999999988532 244444221111 1357999
Q ss_pred EeCCC-CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc--eEEecCCCCc
Q 045067 138 ESAEY-GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV--PKLFNFSLSA 214 (347)
Q Consensus 138 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~a~ 214 (347)
|-+++ -+|.+++.+. .-.+.+...+..+..+++..+.-|| ..|+.|+|+-+.||+++.++. +.++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97763 5899988653 1235677788899999999999999 999999999999999986667 9999998664
Q ss_pred c
Q 045067 215 S 215 (347)
Q Consensus 215 ~ 215 (347)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.2e-09 Score=88.23 Aligned_cols=135 Identities=18% Similarity=0.071 Sum_probs=94.7
Q ss_pred CCCCCeecccCceEEEEEEeCCceEEEEEEccCCC----------------------chhHHHHHHHHHHHHhcCCC--c
Q 045067 64 YHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSV----------------------FDAYDCCFNNIVFASQMSHN--N 119 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n 119 (347)
...+..||-|--+.||.|..+.+..+++|+..... .-......+|..+|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 44567899999999999999655555555443211 01234467899999999655 6
Q ss_pred eeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 045067 120 VLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199 (347)
Q Consensus 120 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill 199 (347)
+.+.+++ +.-.+|||+..|-.|...- ++......++..|+.-+..+- ..|+||||+++=||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEE
Confidence 6666655 3447999999986554432 123333345555666555555 7889999999999999
Q ss_pred CCCCceEEecCCCCcc
Q 045067 200 SERYVPKLFNFSLSAS 215 (347)
Q Consensus 200 ~~~~~~kl~Dfg~a~~ 215 (347)
+++|.+.++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999976543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=9.4e-09 Score=86.81 Aligned_cols=105 Identities=20% Similarity=0.144 Sum_probs=82.2
Q ss_pred HHHHHHHHHHHhcCCC--ceeeeeeeeeeCC----ccEEEEEeCCCC-CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHH
Q 045067 103 DCCFNNIVFASQMSHN--NVLRLIGCCLEVE----IPVLVFESAEYG-NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANV 175 (347)
Q Consensus 103 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~ 175 (347)
....+|...+..+..- .+...+++..... ..+||+|++++. +|.+++... ...+......++.+++..
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-----~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-----EQLDPSQRRELLRALARL 130 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-----cccchhhHHHHHHHHHHH
Confidence 4577888888777433 2344555554422 358999999874 799999764 236667788899999999
Q ss_pred HHHhhcCCCCCeEeccCCCCCeEECCCC---ceEEecCCCCcc
Q 045067 176 FAYLHIGFSRPIVFRDLKSSYILVSERY---VPKLFNFSLSAS 215 (347)
Q Consensus 176 l~~lH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~a~~ 215 (347)
+.-|| ..||+|+|+++.|||++.++ .+.++||+.++.
T Consensus 131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999 99999999999999999887 899999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.1e-10 Score=106.44 Aligned_cols=150 Identities=19% Similarity=0.230 Sum_probs=104.6
Q ss_pred HHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeec--------cccccCCcccccccccC
Q 045067 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD--------GVKGTSGIVAPEYARTG 242 (347)
Q Consensus 171 ~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~~ 242 (347)
+++.|+.|+|. +.++||++|.|++|.++.++..||+.|+++.....+...... -......|.|||++.+.
T Consensus 107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44489999996 789999999999999999999999999987655442221111 12245689999999998
Q ss_pred CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHh
Q 045067 243 YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQC 322 (347)
Q Consensus 243 ~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 322 (347)
..++++|+||+||++|-+..+|...+..... .....+..... +.. ........++++.+=+.++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-----~~~~~~~~~~~---------~~~--~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGG-----LLSYSFSRNLL---------NAG--AFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCC-----cchhhhhhccc---------ccc--cccccccCcHHHHHHHHHH
Confidence 8899999999999999998777777654321 00000000000 000 0011134566788888999
Q ss_pred ccCCCCCCCCHHHHHH
Q 045067 323 QSASAEDRPTMIDVAK 338 (347)
Q Consensus 323 l~~~P~~RPs~~ell~ 338 (347)
+..++.-||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999997776543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.65 E-value=7e-07 Score=76.43 Aligned_cols=141 Identities=6% Similarity=-0.028 Sum_probs=82.7
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCc--eeeeeeeeeeCCccEEEEEeCCCCC-
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNN--VLRLIGCCLEVEIPVLVFESAEYGN- 144 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~- 144 (347)
..||+|..+.||+. .++. .|+|+..... ......+|.++++.+..-. +.+.+++..+++...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~-~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGK-WMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe--cCCC-EEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999984 2344 4566655433 2245789999999886433 4667777777777889999999853
Q ss_pred HHHHH--------------hh----hccCCCCCCCHHHHH-HHHHH----------HHH-HHHHhhc-CCCCCeEeccCC
Q 045067 145 LHDLL--------------KR----SYQSHSEPLLLKHRL-KIAME----------IAN-VFAYLHI-GFSRPIVFRDLK 193 (347)
Q Consensus 145 L~~~l--------------~~----~~~~~~~~l~~~~~~-~i~~~----------i~~-~l~~lH~-~~~~~ivH~dlk 193 (347)
+...+ .. -........+..... .+..+ +.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 10 000000011111111 01000 001 1112211 124467899999
Q ss_pred CCCeEECCCCceEEecCCCCc
Q 045067 194 SSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 194 p~Nill~~~~~~kl~Dfg~a~ 214 (347)
|.||++++++ +.++||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.7e-06 Score=69.06 Aligned_cols=101 Identities=19% Similarity=0.199 Sum_probs=82.1
Q ss_pred HHHHHHHHhcCC-CceeeeeeeeeeCCccEEEEEeCCCCCHHHH---HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 045067 106 FNNIVFASQMSH-NNVLRLIGCCLEVEIPVLVFESAEYGNLHDL---LKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHI 181 (347)
Q Consensus 106 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 181 (347)
..|.-+++.+++ +++.+++|+|-+ ++|.||.+.+++... +.. -...+|..+.+++.+++..+.++++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-----~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-----FLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-----ccccCHHHHHHHHHHHHHHHHHHhc
Confidence 358888888875 699999999944 789999987766432 111 1357899999999999999999997
Q ss_pred CCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 182 GFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 182 ~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
.....+.-.|++|+|+-+++++++|++|......
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 6556788899999999999999999999986543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.4e-06 Score=72.34 Aligned_cols=153 Identities=18% Similarity=0.097 Sum_probs=95.6
Q ss_pred cCHHHHHHHhccCCCCC---eecccCceEEEEEEeCCceEEEEEEccCCCchh------------------------HHH
Q 045067 52 FSAKELERATNNYHYRN---IITESSIFRLCQGVLPDRTISVVKFIDGSVFDA------------------------YDC 104 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~---~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~------------------------~~~ 104 (347)
.+.+.+....+...... .|.+|--+.||+|...++..+++|+...++..- ..-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 44455555555544443 456788889999998655555555554332110 011
Q ss_pred HHHHHHHHHhcC--CCceeeeeeeeeeCCccEEEEEeCCCC-CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 045067 105 CFNNIVFASQMS--HNNVLRLIGCCLEVEIPVLVFESAEYG-NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHI 181 (347)
Q Consensus 105 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 181 (347)
...|+.-|.++. +=.+.+.+++. ...|||||++.. .-.-.|+ .-++.......+..+++..+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHHH
Confidence 235777777663 33344444443 347999998653 1111111 1233333566777888888877771
Q ss_pred CCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 182 GFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 182 ~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
..++||+||+.=|||+. ++.+.|+|||-|....
T Consensus 185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 38999999999999998 8899999999875543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.1e-06 Score=70.79 Aligned_cols=137 Identities=13% Similarity=0.053 Sum_probs=84.2
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHH---------HHHHHHHHHhcC---CCceeeeeeee
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDC---------CFNNIVFASQMS---HNNVLRLIGCC 127 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~l~~~~ 127 (347)
..++|...+++-......|.+-..+++..+.|- .........+. ..+++..+.+++ -.....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~-pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKE-PREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEec-cchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 345666777777777777777666665555444 33322222122 223444444442 22222322222
Q ss_pred ee-----CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC
Q 045067 128 LE-----VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER 202 (347)
Q Consensus 128 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~ 202 (347)
.. ....+++|||++|..|.+... ++. .+...+..++.-|| ..|+.|||..|.|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC
Confidence 21 234568999999987766532 222 24456778899999 9999999999999999854
Q ss_pred CceEEecCCCCc
Q 045067 203 YVPKLFNFSLSA 214 (347)
Q Consensus 203 ~~~kl~Dfg~a~ 214 (347)
.++++||+..+
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 59999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.1e-06 Score=72.66 Aligned_cols=143 Identities=16% Similarity=0.105 Sum_probs=79.8
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCC--ceeeeeeeeee---CCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHN--NVLRLIGCCLE---VEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~ 142 (347)
+.|+.|..+.||+...+++.+++|. .... .....+.+|..+++.+... .+.+++.+... ....+++|++++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~-~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKF-YRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEE-ESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEE-eCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 5689999999999999776555554 4333 3446788999998888533 34566654433 2356899999998
Q ss_pred CCHHH----------------HHhhhccC--CCCCCCHHH---------HHHH------------HHHHHH-HHHHhhc-
Q 045067 143 GNLHD----------------LLKRSYQS--HSEPLLLKH---------RLKI------------AMEIAN-VFAYLHI- 181 (347)
Q Consensus 143 g~L~~----------------~l~~~~~~--~~~~l~~~~---------~~~i------------~~~i~~-~l~~lH~- 181 (347)
.++.. .+..-... ...+..... .... ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87777 11111000 111111110 0000 001111 2222221
Q ss_pred ---CCCCCeEeccCCCCCeEEC-CCCceEEecCCCC
Q 045067 182 ---GFSRPIVFRDLKSSYILVS-ERYVPKLFNFSLS 213 (347)
Q Consensus 182 ---~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~a 213 (347)
.....++|+|+.|.||+++ .++.+.|+||+.+
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 1257799999999999999 6666689999865
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.5e-06 Score=86.76 Aligned_cols=78 Identities=8% Similarity=0.020 Sum_probs=54.1
Q ss_pred CCeecccCceEEEEEEeCCc---eEEEEEEccC-CCchhHHHHHHHHHHHHhcC-CCce--eeeeeeeeeC---CccEEE
Q 045067 67 RNIITESSIFRLCQGVLPDR---TISVVKFIDG-SVFDAYDCCFNNIVFASQMS-HNNV--LRLIGCCLEV---EIPVLV 136 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~~---~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 136 (347)
.+.++.|.++.+|+....++ .-+|+|..+. ........+.+|+.+++.+. |+++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999887432 2344444433 22222356889999999995 6665 7778887764 467899
Q ss_pred EEeCCCCC
Q 045067 137 FESAEYGN 144 (347)
Q Consensus 137 ~e~~~~g~ 144 (347)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.9e-06 Score=81.82 Aligned_cols=142 Identities=16% Similarity=0.087 Sum_probs=87.9
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCCCchh------------------------------HH----------HHHH
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGSVFDA------------------------------YD----------CCFN 107 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~------------------------------~~----------~~~~ 107 (347)
.-|+.++-|.||+|++.+|.-|++|+..+.-... .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 4688999999999999655555555544322100 00 1224
Q ss_pred HHHHHHhcC-----CCceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 045067 108 NIVFASQMS-----HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIG 182 (347)
Q Consensus 108 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~ 182 (347)
|...+.+++ .|++.-..-++.-.+.-.|+|||++|..+.+..... ....+.........++. +..+-
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~----~~g~d~k~ia~~~~~~f--~~q~~-- 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK----SAGIDRKELAELLVRAF--LRQLL-- 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH----hcCCCHHHHHHHHHHHH--HHHHH--
Confidence 444444442 333322222223345668999999998888875331 13455333332222221 23333
Q ss_pred CCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 183 FSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 183 ~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
..|+.|+|..|.||+++.+|.+.+.|||+...+..
T Consensus 283 -~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 -RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 67999999999999999999999999999877654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=3.9e-08 Score=92.53 Aligned_cols=183 Identities=16% Similarity=0.087 Sum_probs=133.1
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCc-eeeeeeeeeeCCccEEEEEeCCCC-CH
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNN-VLRLIGCCLEVEIPVLVFESAEYG-NL 145 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-~L 145 (347)
+.+++|+++.++|.+.........+++... ....-++++|.+++||| .+..++-+..+...+++++++.++ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 457899999999998743333334444333 33556888999999999 777777777778899999999876 22
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeec
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 225 (347)
...+.. ....+...+...+...-+.+++++| +..=+|+| ||+..+ +..+..||+.+..+.... ..+
T Consensus 323 ~~~~~~----se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 323 ALEMTV----SEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred cccCCh----hhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 222211 1123444555566777788999999 65568888 776544 788999999887665443 234
Q ss_pred cccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 226 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
...+++.++|||+...+.+....|+|+.|+-..++. -|.+|-..
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~a-p~~pPr~~ 432 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMA-PGLPPRSS 432 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcC-CCCCCCCC
Confidence 567999999999999999999999999998777777 77777654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.43 E-value=5e-06 Score=72.15 Aligned_cols=140 Identities=11% Similarity=-0.051 Sum_probs=82.0
Q ss_pred ecccCc-eEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEEeCCCCCHHH
Q 045067 70 ITESSI-FRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVFESAEYGNLHD 147 (347)
Q Consensus 70 lg~G~~-g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 147 (347)
|..|.. +.||+...+++ .+++|...... ...+.+|+.++..+. +--+.+++++...++..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~~~-~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGKNP-GLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCCCC-cEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 78999987654 55555554432 245678999988884 4445577777766667899999999877664
Q ss_pred HH----------------hhhccCC--CCCCCHH--HHHHH-----------------------HHHHHHHHHHhh-cCC
Q 045067 148 LL----------------KRSYQSH--SEPLLLK--HRLKI-----------------------AMEIANVFAYLH-IGF 183 (347)
Q Consensus 148 ~l----------------~~~~~~~--~~~l~~~--~~~~i-----------------------~~~i~~~l~~lH-~~~ 183 (347)
.. ..-.... ..+.... ..... ...+...|.... ...
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 1110000 0111100 00000 111111111111 111
Q ss_pred CCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 184 SRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 184 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
...++|+|+.|.||++++++.+.|+||+.+
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a 191 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRL 191 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence 456999999999999999877889999876
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.43 E-value=7.6e-06 Score=68.15 Aligned_cols=130 Identities=23% Similarity=0.204 Sum_probs=91.9
Q ss_pred CCCCeecccCceEEEEEEeCCceEEEEEEccCCC----------------chhHHHHHHHHHHHHhcC------CCceee
Q 045067 65 HYRNIITESSIFRLCQGVLPDRTISVVKFIDGSV----------------FDAYDCCFNNIVFASQMS------HNNVLR 122 (347)
Q Consensus 65 ~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~ 122 (347)
+....||+|+.-.||. +++.+-.++|+..... .....+..+|+.....+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3456799999998886 4555555566555443 223466777887777666 889999
Q ss_pred eeeeeeeCCccEEEEEeCCC------CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 045067 123 LIGCCLEVEIPVLVFESAEY------GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSY 196 (347)
Q Consensus 123 l~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~N 196 (347)
++|+..++.-+.+|+|...+ -||.+++.+ ..++. ...+.+.++. .+|- +.+|+.+|++|.|
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~------~~~~~-~~~~~L~~f~---~~l~---~~~Iv~~dl~~~N 148 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE------GGLTE-ELRQALDEFK---RYLL---DHHIVIRDLNPHN 148 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc------CCccH-HHHHHHHHHH---HHHH---HcCCeecCCCccc
Confidence 99999999999999998632 378888865 45665 4444444444 4555 7789999999999
Q ss_pred eEECCCC----ceEEec
Q 045067 197 ILVSERY----VPKLFN 209 (347)
Q Consensus 197 ill~~~~----~~kl~D 209 (347)
|++.... .+.|+|
T Consensus 149 Iv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEEecCCCceEEEEEe
Confidence 9997332 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.6e-06 Score=66.86 Aligned_cols=127 Identities=10% Similarity=-0.030 Sum_probs=89.2
Q ss_pred CCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceee-eeeeeeeCCccEEEEEeCCCCC
Q 045067 66 YRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLR-LIGCCLEVEIPVLVFESAEYGN 144 (347)
Q Consensus 66 ~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g~ 144 (347)
..+.|++|.+|.||+|.+.+..+++|.....+. ...+..|+++|..+.--++.+ ++.+- .-.+.|||..|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 446799999999999999888888887665543 366889999999998776654 33332 2245699999878
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC-CCCeEECCCCceEEecCCCCc
Q 045067 145 LHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLK-SSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 145 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlk-p~Nill~~~~~~kl~Dfg~a~ 214 (347)
|.++-.. .+..+..+ +++.-.-|- ..||-|+.|. |...++-+++.+.|+||..|+
T Consensus 99 L~~~~~~--------~~rk~l~~----vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 99 LGKLEIG--------GDRKHLLR----VLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhc--------ccHHHHHH----HHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 8776542 13334333 334433344 7789999886 444444455599999999886
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.2e-05 Score=65.96 Aligned_cols=73 Identities=8% Similarity=-0.066 Sum_probs=44.4
Q ss_pred CeecccCce-EEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCC---ceeeeeeeeeeC---CccEEEEEeC
Q 045067 68 NIITESSIF-RLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHN---NVLRLIGCCLEV---EIPVLVFESA 140 (347)
Q Consensus 68 ~~lg~G~~g-~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~ 140 (347)
+.|+.|+.. .||+. +. -.|+|+..... ....+.+|..++..+... .+..+++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~---~~-~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL---GD-DMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc---CC-ceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777776 58875 22 35556654422 235788999999887532 233444443332 2358899999
Q ss_pred CCCCHH
Q 045067 141 EYGNLH 146 (347)
Q Consensus 141 ~~g~L~ 146 (347)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 986663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.3e-05 Score=80.71 Aligned_cols=194 Identities=21% Similarity=0.203 Sum_probs=130.6
Q ss_pred HHHHHHHHhcCCCceeeeeeeeeeCCc----cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 045067 106 FNNIVFASQMSHNNVLRLIGCCLEVEI----PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHI 181 (347)
Q Consensus 106 ~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~ 181 (347)
.-|...+.++.|+|++.+++|...... ..+..|+++.-++.+.++.- ..++..+.+.+..++.+||.++|
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-----~~i~~~~~r~~~~~~~~GL~~~h- 303 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-----GSIPLETLRILHQKLLEGLAYLH- 303 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-----cccCHHHHHHHHHHHhhhHHHHH-
Confidence 345666778899999999998765433 23456889888999988764 78999999999999999999999
Q ss_pred CCCCCeEeccCCCC---CeEECCCCceEEe--cCCCCccCCCCCceeeccccccCCcccccccccCCCCC--ccchHHHH
Q 045067 182 GFSRPIVFRDLKSS---YILVSERYVPKLF--NFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNE--KCDVYSFG 254 (347)
Q Consensus 182 ~~~~~ivH~dlkp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dv~s~G 254 (347)
+....|.-+..+ +--.+..+...++ ||+.+......... .....+..+.+||......... ..|+|.+|
T Consensus 304 --~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 304 --SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred --HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 555555444443 3344556666666 88887766544322 1223455677888666555444 47999999
Q ss_pred HHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHH
Q 045067 255 LLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMI 334 (347)
Q Consensus 255 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ 334 (347)
.....+. .+..+-..... . ..+.+.. ......+...+|+..++++|+++.
T Consensus 380 ll~~~~~-~~~~i~~~~~~-----------~---------~~~l~~~---------~~~~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 380 LLLLQLS-QGEDISEKSAV-----------P---------VSLLDVL---------STSELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHhhhh-hcCcccccccc-----------h---------hhhhccc---------cchhhhhhhhhhcchhhhhccchh
Confidence 9999998 44433211100 0 0000100 011456788899999999999999
Q ss_pred HHHHH
Q 045067 335 DVAKQ 339 (347)
Q Consensus 335 ell~~ 339 (347)
+++..
T Consensus 430 ~ll~~ 434 (1351)
T KOG1035|consen 430 ELLTH 434 (1351)
T ss_pred hhhhc
Confidence 98864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.7e-05 Score=71.74 Aligned_cols=142 Identities=15% Similarity=0.065 Sum_probs=84.7
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCCCch-------------------------------hHHH------HHHHHH
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGSVFD-------------------------------AYDC------CFNNIV 110 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~-------------------------------~~~~------~~~E~~ 110 (347)
+-||..+.|.|++|+..++..+++|+..+.-.. ..+. |.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 568999999999999966665555554433210 0011 223333
Q ss_pred HHHhc----CCCce---eeeeeeee-eCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 045067 111 FASQM----SHNNV---LRLIGCCL-EVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIG 182 (347)
Q Consensus 111 ~l~~l----~h~ni---v~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~ 182 (347)
-..++ .|-+. |.+=.++. -.....|+||||+|..+.|.-.- ....++...+..-+.+...-+-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i----~~~gi~~~~i~~~l~~~~~~qI----- 317 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI----DKRGISPHDILNKLVEAYLEQI----- 317 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH----HHcCCCHHHHHHHHHHHHHHHH-----
Confidence 33332 34441 11212222 23456899999999876665321 1145665544443333322111
Q ss_pred CCCCeEeccCCCCCeEECC----CCceEEecCCCCccCCC
Q 045067 183 FSRPIVFRDLKSSYILVSE----RYVPKLFNFSLSASIPE 218 (347)
Q Consensus 183 ~~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~a~~~~~ 218 (347)
...|++|+|=.|.||++.. ++.+.+-|||+...+..
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2568999999999999983 67899999999876654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00013 Score=60.54 Aligned_cols=135 Identities=18% Similarity=0.160 Sum_probs=92.8
Q ss_pred CccccCHHHHHHHhccCCCCCeecccCc-eEEEEEEeCCceEEEEEE--ccCCC--------c----------hhHHHHH
Q 045067 48 PIRSFSAKELERATNNYHYRNIITESSI-FRLCQGVLPDRTISVVKF--IDGSV--------F----------DAYDCCF 106 (347)
Q Consensus 48 ~~~~~~~~e~~~~~~~~~~~~~lg~G~~-g~Vy~~~~~~~~~~v~k~--~~~~~--------~----------~~~~~~~ 106 (347)
.+..|+. .+.+++..+.||.|.. |.||++..++..+|+|-. ..... . ...+-|.
T Consensus 28 KL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~ 102 (207)
T PF13095_consen 28 KLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN 102 (207)
T ss_pred CcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence 3555665 3378899999999999 999999998876655551 11000 0 1123577
Q ss_pred HHHHHHHhcC---CCce--eeeeeeeeeC------------------CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHH
Q 045067 107 NNIVFASQMS---HNNV--LRLIGCCLEV------------------EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLK 163 (347)
Q Consensus 107 ~E~~~l~~l~---h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~ 163 (347)
.|.+...+|+ +.++ ++++||..=. ....||.||.+... .+...
T Consensus 103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~ 168 (207)
T PF13095_consen 103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIR 168 (207)
T ss_pred HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchh
Confidence 8988888774 4455 8999987322 13467888876532 12222
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 164 HRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 164 ~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
-+.++..-+..+| ..||+-+|+++.|.. .-+|+|||.+
T Consensus 169 ----~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 169 ----DIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ----HHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 2456677788999 999999999999975 5689999854
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.0002 Score=64.02 Aligned_cols=77 Identities=10% Similarity=-0.055 Sum_probs=54.7
Q ss_pred CCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCC---CceeeeeeeeeeC---CccEEEEEe
Q 045067 66 YRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSH---NNVLRLIGCCLEV---EIPVLVFES 139 (347)
Q Consensus 66 ~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~---~~~~lv~e~ 139 (347)
..+-||.|..+.||.....++.++ +|+..... ....+.+|...|+.+.- -.+.++++++.++ +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~~~-~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGNPM-PLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCCCEE-EEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 345699999999999987556544 44433311 12568899999988842 3577788877543 568999999
Q ss_pred CCCCCH
Q 045067 140 AEYGNL 145 (347)
Q Consensus 140 ~~~g~L 145 (347)
++++++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00017 Score=62.18 Aligned_cols=73 Identities=11% Similarity=0.015 Sum_probs=45.8
Q ss_pred CeecccCceEEEEEEeCC--ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEeCCCCC
Q 045067 68 NIITESSIFRLCQGVLPD--RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV-LRLIGCCLEVEIPVLVFESAEYGN 144 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~--~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 144 (347)
+.|..|-...+|+....+ +.-+++|+........ -...+|+.++..+...++ .++++... -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457788888999998753 4556666665433221 223478888888853333 34444332 248999999866
Q ss_pred H
Q 045067 145 L 145 (347)
Q Consensus 145 L 145 (347)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.96 E-value=9e-05 Score=66.25 Aligned_cols=144 Identities=13% Similarity=0.066 Sum_probs=80.7
Q ss_pred CCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCc--eeeeeee------eeeCCccEEEEE
Q 045067 67 RNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNN--VLRLIGC------CLEVEIPVLVFE 138 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e 138 (347)
.+.|..|....+|+...+++..++ |+.... ..+.+..|+.++..+.+.. +.+++.. ...++..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vL-r~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVL-TLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCCCcEEE-EEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 345777877899998776665444 554432 2255677888888774322 3444332 122345689999
Q ss_pred eCCCCCHHH-----------H---HhhhccCCC------CCCCHHHHH----------HHHHHHHHHHHHhhc----CCC
Q 045067 139 SAEYGNLHD-----------L---LKRSYQSHS------EPLLLKHRL----------KIAMEIANVFAYLHI----GFS 184 (347)
Q Consensus 139 ~~~~g~L~~-----------~---l~~~~~~~~------~~l~~~~~~----------~i~~~i~~~l~~lH~----~~~ 184 (347)
+++|..+.. . ++.....-. ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999865421 0 111100000 011111110 011112233334331 124
Q ss_pred CCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 185 RPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 185 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 579999999999999988777899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.92 E-value=9.5e-05 Score=64.66 Aligned_cols=140 Identities=14% Similarity=0.034 Sum_probs=75.1
Q ss_pred ecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEeCCCCCHHH-
Q 045067 70 ITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV-LRLIGCCLEVEIPVLVFESAEYGNLHD- 147 (347)
Q Consensus 70 lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~- 147 (347)
+..|-.+.+|+...+++. +++|..........-...+|..+++.+....+ .++++.. . -++|+||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~-~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGIS-FVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEeCCcc-EEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 556777899988765554 44565443321110135788889988854333 3334332 2 378999999865432
Q ss_pred -------------HHhhhccC--CCCCCCHHH-HHHHHHHH---------HHHHHHhhc-----CCCCCeEeccCCCCCe
Q 045067 148 -------------LLKRSYQS--HSEPLLLKH-RLKIAMEI---------ANVFAYLHI-----GFSRPIVFRDLKSSYI 197 (347)
Q Consensus 148 -------------~l~~~~~~--~~~~l~~~~-~~~i~~~i---------~~~l~~lH~-----~~~~~ivH~dlkp~Ni 197 (347)
.+.+-... ...+++... ...+..++ ...+..+-. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 11111111 111222211 11111111 111111110 1134689999999999
Q ss_pred EECCCCceEEecCCCCcc
Q 045067 198 LVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 198 ll~~~~~~kl~Dfg~a~~ 215 (347)
++++++ +.++||+.+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999987743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00062 Score=62.93 Aligned_cols=75 Identities=11% Similarity=-0.010 Sum_probs=50.1
Q ss_pred CeecccCceEEEEEEeCCc--eEEEEEEccC-----CC-chhHHHHHHHHHHHHhcC---CCceeeeeeeeeeCCccEEE
Q 045067 68 NIITESSIFRLCQGVLPDR--TISVVKFIDG-----SV-FDAYDCCFNNIVFASQMS---HNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~--~~~v~k~~~~-----~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 136 (347)
+.||.|.++.||++...++ .+++|...+. .. ....++...|...|..+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5689999999999999554 5555543321 11 123466778888888763 2456667666 44567899
Q ss_pred EEeCCCCC
Q 045067 137 FESAEYGN 144 (347)
Q Consensus 137 ~e~~~~g~ 144 (347)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00047 Score=62.04 Aligned_cols=159 Identities=11% Similarity=0.095 Sum_probs=84.8
Q ss_pred CHHHHHHHhccCCC-----CCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCc--eeeeee
Q 045067 53 SAKELERATNNYHY-----RNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNN--VLRLIG 125 (347)
Q Consensus 53 ~~~e~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~ 125 (347)
+.+++....+.|.. .+.++.|....+|+...+++..++ |+...... .+.+..|+.++..|.... +.+++.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~~~vL-K~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVGRYIL-TLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCCcEEE-EEecCCCC--HHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 33455544444433 345677777899998776665554 44433211 244566777777774222 334433
Q ss_pred ee------eeCCccEEEEEeCCCCCHH-----------HH---HhhhccC---CCC---C-CCHHHHHH-----------
Q 045067 126 CC------LEVEIPVLVFESAEYGNLH-----------DL---LKRSYQS---HSE---P-LLLKHRLK----------- 167 (347)
Q Consensus 126 ~~------~~~~~~~lv~e~~~~g~L~-----------~~---l~~~~~~---~~~---~-l~~~~~~~----------- 167 (347)
.. ..++..++++||++|.++. .. ++..... ... . -.|.....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 21 1234578999999875431 11 1111000 000 0 01111000
Q ss_pred -HHHHHHHHHHHhhc----CCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 168 -IAMEIANVFAYLHI----GFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 168 -i~~~i~~~l~~lH~----~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
....+...++++.. ....+++|+|+.+.|++++.++...|+||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 01112234444431 125789999999999999988777899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.0016 Score=58.81 Aligned_cols=159 Identities=13% Similarity=0.085 Sum_probs=80.9
Q ss_pred cCHHHHHHHhccCCC-----CCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCc--eeeee
Q 045067 52 FSAKELERATNNYHY-----RNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNN--VLRLI 124 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 124 (347)
++.+++......|.. .+.|+.|....+|+...+++..++ |+..... .+.+..|+.++..|...+ +.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vL-K~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVL-TLFERLT---AEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEE-EEeccCC---hHHhHHHHHHHHHHHHCCCCCCcce
Confidence 444555554455533 245667777899998876665544 4443211 133445556665553111 22322
Q ss_pred e------eeeeCCccEEEEEeCCCCCHH-----------HHHhhhc---cC------CCCCCCH-HHHHH----------
Q 045067 125 G------CCLEVEIPVLVFESAEYGNLH-----------DLLKRSY---QS------HSEPLLL-KHRLK---------- 167 (347)
Q Consensus 125 ~------~~~~~~~~~lv~e~~~~g~L~-----------~~l~~~~---~~------~~~~l~~-~~~~~---------- 167 (347)
. +....+..++++||++|..+. ..+.+.. .. ....+.+ .....
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 112245678999999986431 1111100 00 0011111 11111
Q ss_pred --HHHH-HHHHHHHhhc----CCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 168 --IAME-IANVFAYLHI----GFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 168 --i~~~-i~~~l~~lH~----~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
...+ +...++.+.. ....+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 1111222221 025689999999999999876556899999763
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.74 E-value=4.6e-05 Score=67.06 Aligned_cols=134 Identities=11% Similarity=-0.008 Sum_probs=90.9
Q ss_pred cCCCCCeecccCceEEEEEEeCCceEEEEEEccCCC------------------chh----HHHHHHHHHHHHhcC-CC-
Q 045067 63 NYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSV------------------FDA----YDCCFNNIVFASQMS-HN- 118 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~------------------~~~----~~~~~~E~~~l~~l~-h~- 118 (347)
-++.++.||-|--+.||.+....+...++|+..-.. ..+ .-...+|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456778999999999999999767767766543211 001 123457888888884 32
Q ss_pred ceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 045067 119 NVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198 (347)
Q Consensus 119 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nil 198 (347)
-+.+.+++. .-++|||++.|-.|...- ...+.+++..-+.++ +--|. .+|+||||+.-=||+
T Consensus 173 pVPkpiD~~----RH~Vvmelv~g~Pl~~v~--------~v~d~~~ly~~lm~~---Iv~la---~~GlIHgDFNEFNim 234 (465)
T KOG2268|consen 173 PVPKPIDHN----RHCVVMELVDGYPLRQVR--------HVEDPPTLYDDLMGL---IVRLA---NHGLIHGDFNEFNIM 234 (465)
T ss_pred CCCCccccc----ceeeHHHhhcccceeeee--------ecCChHHHHHHHHHH---HHHHH---HcCceecccchheeE
Confidence 344455543 347899999886665543 223344444433333 34445 899999999999999
Q ss_pred ECCCCceEEecCCCCc
Q 045067 199 VSERYVPKLFNFSLSA 214 (347)
Q Consensus 199 l~~~~~~kl~Dfg~a~ 214 (347)
+++++.++++||--..
T Consensus 235 v~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMV 250 (465)
T ss_pred EecCCCEEEeechHhh
Confidence 9999999999997543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0005 Score=61.66 Aligned_cols=74 Identities=18% Similarity=0.084 Sum_probs=46.8
Q ss_pred CeecccCceEEEEEEeCC-------ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEe
Q 045067 68 NIITESSIFRLCQGVLPD-------RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV-LRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~-------~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 139 (347)
+.+..|-...+|+....+ +..+|+|+....... .....+|..++..+....+ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL-LIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc-eechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 346667777999988744 456677776554322 2446788888888853333 345555432 368999
Q ss_pred CCCCCHH
Q 045067 140 AEYGNLH 146 (347)
Q Consensus 140 ~~~g~L~ 146 (347)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 8886654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0011 Score=59.26 Aligned_cols=136 Identities=16% Similarity=0.083 Sum_probs=81.5
Q ss_pred eecccCceEEEEEEeCCceEEEEEEccC--CCchhHHHHHHHHHHHHhcCC--CceeeeeeeeeeCC--ccEEEEEeCCC
Q 045067 69 IITESSIFRLCQGVLPDRTISVVKFIDG--SVFDAYDCCFNNIVFASQMSH--NNVLRLIGCCLEVE--IPVLVFESAEY 142 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~~~~~~~v~k~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~~ 142 (347)
.+..|....+|....+ +...+++ .+. ..........+|..+++.+.- --+...+++|.++. ..+.||+|+.|
T Consensus 32 ~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 32 EISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 3433433445555444 5555666 332 222333556788888887742 24445677777666 77999999997
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHH-HHHHHHHHHhhc----------------------------------------
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIA-MEIANVFAYLHI---------------------------------------- 181 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~-~~i~~~l~~lH~---------------------------------------- 181 (347)
..+.+.... ...+ .+++ ..++..|+-||+
T Consensus 110 e~~~~~~~~------~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 110 EVVWSALPP------ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred eeccCcCCc------ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 433322211 0011 1122 244445555553
Q ss_pred ---------------CCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 182 ---------------GFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 182 ---------------~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
.....++|||+.+.|++++.++-+=|.||+++..-
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 11446899999999999999988999999998654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.51 E-value=3.1e-05 Score=80.19 Aligned_cols=164 Identities=12% Similarity=-0.086 Sum_probs=116.5
Q ss_pred HHHHHHHHHHHhcCCCceeeeeeeeee--CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 045067 103 DCCFNNIVFASQMSHNNVLRLIGCCLE--VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLH 180 (347)
Q Consensus 103 ~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH 180 (347)
+....|..-++...|+++.....=... +...+.+++|+.+|.+++.|-++ .....+++..-+.....+.+.+..-+|
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg-~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKG-LEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhc-cccCCcchhchHHHHHHHHHhccchhh
Confidence 444556666666789988765544332 34678999999999999999775 223344554444444444455555555
Q ss_pred cCC--CCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHH
Q 045067 181 IGF--SRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLL 258 (347)
Q Consensus 181 ~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ 258 (347)
+.. ..-.+|+++|+.|.+|..+.+++++++|+.+..... ........+++.|+.|+....-.++.++|+|..|+.+|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 322 345789999999999999999999999999832222 22223456788899999888888898999999999999
Q ss_pred HHHhcCCCccc
Q 045067 259 QLLSTGEDLFN 269 (347)
Q Consensus 259 el~~~g~~p~~ 269 (347)
+.- .+..+|.
T Consensus 1432 ~rs-~~n~~fi 1441 (2724)
T KOG1826|consen 1432 LRS-DGNAYFI 1441 (2724)
T ss_pred HHh-cccHHHH
Confidence 887 7766653
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0018 Score=57.26 Aligned_cols=32 Identities=22% Similarity=0.311 Sum_probs=25.8
Q ss_pred CCCeEeccCCCCCeEECCCCc-eEEecCCCCcc
Q 045067 184 SRPIVFRDLKSSYILVSERYV-PKLFNFSLSAS 215 (347)
Q Consensus 184 ~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~a~~ 215 (347)
...++|+|+.|.||++++++. .-|+||+.+..
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 345899999999999997555 46999997743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0025 Score=58.30 Aligned_cols=142 Identities=17% Similarity=0.100 Sum_probs=79.9
Q ss_pred CeecccCceEEEEEEeCC-----ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEeCC
Q 045067 68 NIITESSIFRLCQGVLPD-----RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV-LRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~-----~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~ 141 (347)
..|..|-...+|+....+ +..+++|+....+....+ -.+|..++..+...++ .++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 455567778999987622 246777777665433323 3678888888854333 3455655332 5899988
Q ss_pred CCCHHHH--------------HhhhccCC---CC-CCCHHHHHHHHHHH-----------------H---HHHH-Hhhc-
Q 045067 142 YGNLHDL--------------LKRSYQSH---SE-PLLLKHRLKIAMEI-----------------A---NVFA-YLHI- 181 (347)
Q Consensus 142 ~g~L~~~--------------l~~~~~~~---~~-~l~~~~~~~i~~~i-----------------~---~~l~-~lH~- 181 (347)
+.+|... +.+..... .. ...+....++..++ . ..|. .+..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 11110100 01 11233333332211 1 1111 1111
Q ss_pred CCCCCeEeccCCCCCeEECC-CCceEEecCCCCc
Q 045067 182 GFSRPIVFRDLKSSYILVSE-RYVPKLFNFSLSA 214 (347)
Q Consensus 182 ~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~ 214 (347)
.....++|+|+++.||++++ ++.+.++||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11457899999999999986 4689999998774
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0051 Score=56.85 Aligned_cols=74 Identities=4% Similarity=-0.068 Sum_probs=48.8
Q ss_pred CCeecccCceEEEEEEeCCceEEEEEEccCCC---c---hhHHHHHHHHHHHHhcC---CCceeeeeeeeeeCCccEEEE
Q 045067 67 RNIITESSIFRLCQGVLPDRTISVVKFIDGSV---F---DAYDCCFNNIVFASQMS---HNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~---~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 137 (347)
.+.||.|....||+...+++.+++|.-..... . ...++-..|...|+.+. ..++.+++.++. +.-+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEE
Confidence 45789999999999887666655555432111 1 12345556677776653 247778888876 4457899
Q ss_pred EeCCC
Q 045067 138 ESAEY 142 (347)
Q Consensus 138 e~~~~ 142 (347)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99976
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0027 Score=53.12 Aligned_cols=117 Identities=13% Similarity=-0.013 Sum_probs=77.9
Q ss_pred cCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhh
Q 045067 73 SSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS 152 (347)
Q Consensus 73 G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 152 (347)
|+-++.-.+...-|+..+||+....-.-....+.++..+++++. .|+++..= ++-.+-++.|+|-..
T Consensus 73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~--------- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI--------- 139 (308)
T ss_pred CCceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc---------
Confidence 45566666666557788888766544323356788888888775 46666531 333567888988531
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 153 YQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 153 ~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.-... .++.--+.+|.-.|+. +.+.+|||..|+||+-|..|.+||.|-+.
T Consensus 140 -----~i~~~----N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 140 -----KINFS----NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -----ccchh----HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 11111 1111124677778853 67899999999999999999999999763
|
The function of this family is unknown. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0046 Score=54.82 Aligned_cols=74 Identities=12% Similarity=-0.051 Sum_probs=45.6
Q ss_pred CCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcC---CCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 66 YRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS---HNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 66 ~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
..+.++.|....+|+...+++.+++|.-. . .....|..|..-|+.|. .-.+.+.+++....+..+|++||++.
T Consensus 21 ~~~~v~GG~i~~a~~~~~~~~~~FvK~~~-~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLDTDGGSYFVKVNS-E---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEEE--SSSSEEEEEETTS-EEEEEEEE-G---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eeEecCCCChhheEEEECCCccEEEEecC-h---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 34568889999999988666666666544 2 12256888988888883 33577888888777777999999876
Q ss_pred C
Q 045067 143 G 143 (347)
Q Consensus 143 g 143 (347)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 5
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0075 Score=54.45 Aligned_cols=140 Identities=14% Similarity=0.081 Sum_probs=90.1
Q ss_pred CCCeecccCceEEEEEEeCCceEEEEEEccCCC--c-----------------------h-hHHHHHHHHHHHHhcCCCc
Q 045067 66 YRNIITESSIFRLCQGVLPDRTISVVKFIDGSV--F-----------------------D-AYDCCFNNIVFASQMSHNN 119 (347)
Q Consensus 66 ~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~--~-----------------------~-~~~~~~~E~~~l~~l~h~n 119 (347)
....|..|--+.||.|+-.+|.-+++|+...+- . . ..--...|+.-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345788999999999999555445555544321 0 0 0111345777777775444
Q ss_pred eeeeeeeeeeCCccEEEEEeCCCCC-HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 045067 120 VLRLIGCCLEVEIPVLVFESAEYGN-LHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198 (347)
Q Consensus 120 iv~l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nil 198 (347)
|.-.--... ..-.|||+++..-. -.-.|+ ...++...+..+-.+++.-+.-|-+ ..++||.||+-=|+|
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLK------d~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~L 297 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLK------DASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLL 297 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcccc------cccCChHHHHHHHHHHHHHHHHHHH--Hhceeccchhhhhhe
Confidence 322111111 12269999986421 222232 2567777777788888888877764 568999999999998
Q ss_pred ECCCCceEEecCCCCccC
Q 045067 199 VSERYVPKLFNFSLSASI 216 (347)
Q Consensus 199 l~~~~~~kl~Dfg~a~~~ 216 (347)
+ .+|.+.|+|.+-+...
T Consensus 298 y-hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 298 Y-HDGKLYIIDVSQSVEH 314 (520)
T ss_pred E-ECCEEEEEEccccccC
Confidence 8 6789999999876543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.02 Score=51.43 Aligned_cols=29 Identities=17% Similarity=0.260 Sum_probs=25.5
Q ss_pred CCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 184 SRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 184 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
..+++|||+.+.||+++. +.+.|+||+.+
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 468999999999999987 67899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.014 Score=53.02 Aligned_cols=143 Identities=13% Similarity=0.067 Sum_probs=77.7
Q ss_pred CeecccCceEEEEEEeCC----ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVLPD----RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV-LRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~----~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.|..|-...+|+....+ ...+++|+....+... -.-.+|..+++.+..-++ .++++++.. . ++.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 455567778899987632 2356677766544322 223578888888864444 345555432 2 58888877
Q ss_pred CCHHH--------------HHhhhccCC---CC-CCCHHHHHHHHHHH-------------------------HHHHHHh
Q 045067 143 GNLHD--------------LLKRSYQSH---SE-PLLLKHRLKIAMEI-------------------------ANVFAYL 179 (347)
Q Consensus 143 g~L~~--------------~l~~~~~~~---~~-~l~~~~~~~i~~~i-------------------------~~~l~~l 179 (347)
.+|.. .+.+-.... .. +-.+.....+..++ +..+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 55421 111110100 01 11233322222221 1111111
Q ss_pred hc--CCCCCeEeccCCCCCeEECC-CCceEEecCCCCcc
Q 045067 180 HI--GFSRPIVFRDLKSSYILVSE-RYVPKLFNFSLSAS 215 (347)
Q Consensus 180 H~--~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~ 215 (347)
.. ....-.+|+|+.+.||++++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 11234799999999999974 57899999988743
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.028 Score=51.19 Aligned_cols=72 Identities=13% Similarity=-0.007 Sum_probs=44.7
Q ss_pred eecccCceEEEEEEeCCc--eEEEEEEcc------CCCchhHHHHHHHHHHHHhcC--CC-ceeeeeeeeeeCCccEEEE
Q 045067 69 IITESSIFRLCQGVLPDR--TISVVKFID------GSVFDAYDCCFNNIVFASQMS--HN-NVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~~~~--~~~v~k~~~------~~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 137 (347)
.||.|....||++..+++ .++||.-.+ .+-+-..++..-|...|.... .| .+.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998543 455544321 111233456667888886663 34 34444443 445567999
Q ss_pred EeCCC
Q 045067 138 ESAEY 142 (347)
Q Consensus 138 e~~~~ 142 (347)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.007 Score=56.84 Aligned_cols=48 Identities=19% Similarity=0.280 Sum_probs=38.0
Q ss_pred HHHHHHHHHHHhcCCCceeeeeeeeeeC-CccEEEEEeCCCCCHHHHHhh
Q 045067 103 DCCFNNIVFASQMSHNNVLRLIGCCLEV-EIPVLVFESAEYGNLHDLLKR 151 (347)
Q Consensus 103 ~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~ 151 (347)
..+.--..+++.+.|+|....+.+.... ....+|+|++. .+|.+.+..
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~ 75 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKT 75 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHh
Confidence 4566778889999999999988876543 35788999996 599998865
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.33 Score=44.01 Aligned_cols=95 Identities=14% Similarity=0.081 Sum_probs=53.1
Q ss_pred ccccCHHHHHHHhccCCC---CC-eecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCC--ceee
Q 045067 49 IRSFSAKELERATNNYHY---RN-IITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHN--NVLR 122 (347)
Q Consensus 49 ~~~~~~~e~~~~~~~~~~---~~-~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~ 122 (347)
...++-+.+..+...+.. .+ ..-.+.-..||+...+++..+++|+...... ....+..|+..+..|... .++.
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~-~~~~i~~E~~~l~~L~~~gipv~~ 86 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERW-SDAQILEEHAFALELAEAEIPVVA 86 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccC-CHHHHHHHHHHHHHHHHCCCCCCC
Confidence 334555665555554422 11 1123445679999887676788887764432 235677788888777321 1222
Q ss_pred ---eee--eeeeCCccEEEEEeCCCCC
Q 045067 123 ---LIG--CCLEVEIPVLVFESAEYGN 144 (347)
Q Consensus 123 ---l~~--~~~~~~~~~lv~e~~~~g~ 144 (347)
.-| ....++..+.++++++|..
T Consensus 87 p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 87 PLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 111 1222456778899988753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.05 Score=48.94 Aligned_cols=31 Identities=23% Similarity=0.201 Sum_probs=27.9
Q ss_pred CCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 184 SRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 184 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
..+++|+|+.+.|+++++++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4589999999999999999999999998763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.085 Score=47.73 Aligned_cols=140 Identities=11% Similarity=0.054 Sum_probs=77.8
Q ss_pred ecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcC---CCc---eeeeee----eeeeCCccEEEEEe
Q 045067 70 ITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS---HNN---VLRLIG----CCLEVEIPVLVFES 139 (347)
Q Consensus 70 lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~---h~n---iv~l~~----~~~~~~~~~lv~e~ 139 (347)
|.+ .-..+|+....++.. |+|+.... . ...++.-|...+..|. .+- +...-| ....+...+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~-~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-W-TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-C-CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 556799998877776 88887775 2 2256777888887773 111 222211 11112367788999
Q ss_pred CCCCCHHH-H--------------Hh----hhc---cCCCCCCCHHH-------------HHHHHHHHHHHHHHhhc---
Q 045067 140 AEYGNLHD-L--------------LK----RSY---QSHSEPLLLKH-------------RLKIAMEIANVFAYLHI--- 181 (347)
Q Consensus 140 ~~~g~L~~-~--------------l~----~~~---~~~~~~l~~~~-------------~~~i~~~i~~~l~~lH~--- 181 (347)
++|..+.. . ++ ... ........|.. ......++...+..+..
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99877662 0 11 110 00001122320 00012222222333321
Q ss_pred -CC-CCC--eEeccCCCCCeEECCCCc-eEEecCCCC
Q 045067 182 -GF-SRP--IVFRDLKSSYILVSERYV-PKLFNFSLS 213 (347)
Q Consensus 182 -~~-~~~--ivH~dlkp~Nill~~~~~-~kl~Dfg~a 213 (347)
.. ..+ +||+|+.|.||+++.+.. .-++||+.+
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccc
Confidence 11 233 999999999999998875 889999976
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.023 Score=51.36 Aligned_cols=103 Identities=15% Similarity=0.145 Sum_probs=70.0
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
...|++|++.. ++|.. + ..-.+.+...++++.+.-++-+.. ....-|||+.-.||||+ +|++.|+||
T Consensus 299 ~y~yl~~kdhg-t~is~-i--------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 299 LYLYLHFKDHG-TPISI-I--------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred eEEEEEEecCC-ceeee-e--------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEe
Confidence 35567777763 34322 2 345688899999999988888874 56889999999999999 999999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHH
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSF 253 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~ 253 (347)
-+++....+... ...+.--|-.+.|.. +..-+||-+
T Consensus 366 klsRl~~~q~~i------sy~rldhp~lF~G~d-d~QFeIYrl 401 (488)
T COG5072 366 KLSRLSYSQGII------SYNRLDHPDLFNGVD-DYQFEIYRL 401 (488)
T ss_pred eeeecccCCcee------eccccCchhhhcCcc-ceeeeHHHH
Confidence 999854332211 112223455555433 667777753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.12 Score=47.82 Aligned_cols=74 Identities=15% Similarity=0.010 Sum_probs=44.9
Q ss_pred CeecccCceEEEEEEeCCc---e----EEEEEEccCCCchhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEe
Q 045067 68 NIITESSIFRLCQGVLPDR---T----ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV-LRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~---~----~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 139 (347)
+.|..|-...+|++...++ . .++.+.....+... -.-.+|+.+++.+...++ .++++.+.. +++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-IDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-eccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 4566688889999986322 2 23444433322211 123568999999865544 455665542 699999
Q ss_pred CCCCCHH
Q 045067 140 AEYGNLH 146 (347)
Q Consensus 140 ~~~g~L~ 146 (347)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9986654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.12 Score=54.07 Aligned_cols=32 Identities=19% Similarity=0.245 Sum_probs=26.7
Q ss_pred CCCeEeccCCCCCeEECCCC--ceE-EecCCCCcc
Q 045067 184 SRPIVFRDLKSSYILVSERY--VPK-LFNFSLSAS 215 (347)
Q Consensus 184 ~~~ivH~dlkp~Nill~~~~--~~k-l~Dfg~a~~ 215 (347)
..++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 56799999999999999775 555 999997744
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.25 Score=42.02 Aligned_cols=74 Identities=12% Similarity=-0.024 Sum_probs=47.6
Q ss_pred eecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcC---CCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 69 IITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS---HNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
.+..|.--..|.......++.+|. .... ....|..|+.-|..+. .-.+.+++.+-.+..+.|+|+||.+-+.+
T Consensus 23 ~v~gG~inea~~v~dg~~~~FvK~-n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLRDGTDPFFVKC-NQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEeecCCcceEEEe-cchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 344454455555555555555554 3222 1255778888777774 34566777887888899999999987655
Q ss_pred H
Q 045067 146 H 146 (347)
Q Consensus 146 ~ 146 (347)
.
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 5
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.13 Score=47.48 Aligned_cols=74 Identities=8% Similarity=-0.125 Sum_probs=47.4
Q ss_pred CCeecccCceEEEEEEeC--CceEEEEEEccCC----C-chhHHHHHHHHHHHHhcC--CC-ceeeeeeeeeeCCccEEE
Q 045067 67 RNIITESSIFRLCQGVLP--DRTISVVKFIDGS----V-FDAYDCCFNNIVFASQMS--HN-NVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~--~~~~~v~k~~~~~----~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 136 (347)
.+.||.|.-..||++... ++.++||.-.+.. + +-..++..-|...|+... .| ++.+++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 357899999999999974 4556665433211 1 223466777888887763 44 44555543 44556788
Q ss_pred EEeCCC
Q 045067 137 FESAEY 142 (347)
Q Consensus 137 ~e~~~~ 142 (347)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.17 E-value=0.11 Score=45.02 Aligned_cols=75 Identities=16% Similarity=0.025 Sum_probs=53.2
Q ss_pred CeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHH---HHHHhcCCCceeeeeeeeeeCCccEEEEEeC-CCC
Q 045067 68 NIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNI---VFASQMSHNNVLRLIGCCLEVEIPVLVFESA-EYG 143 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~-~~g 143 (347)
..+..|..+.|+.++..++..+|+|+...... ...|. ..|+..+-...|++++.- ...-.+++|.+ ++.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~ 80 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGR 80 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCC
Confidence 44677899999999997888888888775432 12333 457777878889998864 34557888888 555
Q ss_pred CHHHHH
Q 045067 144 NLHDLL 149 (347)
Q Consensus 144 ~L~~~l 149 (347)
+|.+..
T Consensus 81 ~L~~~~ 86 (253)
T PF04655_consen 81 SLASLP 86 (253)
T ss_pred chhhcc
Confidence 776554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.096 Score=48.17 Aligned_cols=62 Identities=19% Similarity=0.051 Sum_probs=46.7
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE 201 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~ 201 (347)
...++-+|..|.++..+++. ...++..+.+++.-.+.|+.-+-. -.+++|.|+.|.||++-.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~------~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW------KSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhc------ccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence 34677889999999999975 455666677777777777654432 568999999999999953
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 347 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-29 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-27 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-24 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-05 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-05 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-04 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-04 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-04 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-04 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-04 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-04 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-04 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-04 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-04 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-04 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-04 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-04 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-04 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-04 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-04 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-04 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-04 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-04 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-04 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-04 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-04 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 9e-60
Identities = 89/303 (29%), Positives = 140/303 (46%), Gaps = 9/303 (2%)
Query: 40 SSCNGNYNPIRSFSAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVF 99
SS +LE ATNN+ ++ +I ++ +GVL D +K
Sbjct: 17 SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS 76
Query: 100 DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEP 159
+ I S H +++ LIG C E +L+++ E GNL L S +
Sbjct: 77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-DLPTMS 135
Query: 160 LLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219
+ + RL+I + A YLH I+ RD+KS IL+ E +VPK+ +F +S E
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 220 -ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278
+T++ VKGT G + PEY G L EK DVYSFG++L ++L L +
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL-CARSAIVQ--SLPREM 249
Query: 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338
++ + N IVDP + E L+ + A +C + S+EDRP+M DV
Sbjct: 250 VNLAEWAVESHNNGQLEQIVDPNLADKIRPE-SLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 339 QIK 341
+++
Sbjct: 309 KLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 1e-59
Identities = 84/292 (28%), Positives = 149/292 (51%), Gaps = 10/292 (3%)
Query: 49 IRSFSAKELERATNNYHYRNIITE---SSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCC 105
++ FS +EL+ A++N+ +NI+ +++ G L D T+ VK + +
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYK---GRLADGTLVAVKRLKEERTQGGELQ 73
Query: 106 FNNIVFA-SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKH 164
F V S H N+LRL G C+ +LV+ G++ L R PL
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL-RERPESQPPLDWPK 132
Query: 165 RLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID 224
R +IA+ A AYLH I+ RD+K++ IL+ E + + +F L+ + +T++
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192
Query: 225 DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284
V+GT G +APEY TG +EK DV+ +G++LL+L+ TG+ F++ N D+ +D+
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI-TGQRAFDLARLANDDDVMLLDW 251
Query: 285 VKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
VK ++ + +VD + + +++ ++A C +S +RP M +V
Sbjct: 252 VKGLLKEKKLEALVDVD-LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-48
Identities = 75/311 (24%), Positives = 138/311 (44%), Gaps = 30/311 (9%)
Query: 50 RSFSAKELERATNNYHYRNIITESSI-----F-RLCQGVLPDRTISVVKFIDGSVFDAY- 102
SFS EL+ TNN+ R I + F + +G + + T++V K
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72
Query: 103 -DCCFNN-IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPL 160
F+ I ++ H N++ L+G + + LV+ G+L D L + PL
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPL 130
Query: 161 LLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220
R KIA AN +LH + RD+KS+ IL+ E + K+ +F L+ + +
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 221 -TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLR---LNG 276
T + + GT+ +APE G + K D+YSFG++LL++++ GL +
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIIT--------GLPAVDEHR 238
Query: 277 DESFEMDFVKKYI-ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMID 335
+ +D ++ E + +D ++ + +++ + +A QC RP +
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS--VEAMYSVASQCLHEKKNKRPDIKK 296
Query: 336 VAKQIKKMYKS 346
V + +++M S
Sbjct: 297 VQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-39
Identities = 59/320 (18%), Positives = 107/320 (33%), Gaps = 39/320 (12%)
Query: 52 FSAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVF 111
+ L + + + + L + ++V F +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD--KQSWQNEYEVYS 71
Query: 112 ASQMSHNNVLRLIGCCLEVEIPV----LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLK 167
M H N+L+ IG L+ E G+L D L + +
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KANVVSWNELCH 125
Query: 168 IAMEIANVFAYLH------IGFSRP-IVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220
IA +A AYLH +P I RD+KS +L+ + +F L+ G+
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 221 TYID-DGVKGTSGIVAPEYARTGYLNE-----KCDVYSFGLLLLQLLS--------TGED 266
+ D G GT +APE + + D+Y+ GL+L +L S E
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 267 LFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSAS 326
+ + S E +++ + ++ P + + E +C
Sbjct: 246 MLPFEEEIGQHPSLED--MQEVVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHD 299
Query: 327 AEDRPTMIDVAKQIKKMYKS 346
AE R + V ++I +M +
Sbjct: 300 AEARLSAGCVGERITQMQRL 319
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 45/245 (18%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
S+++H N+++L G CL PV LV E AE G+L+++L H + ++
Sbjct: 56 SRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQ 110
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLFNFSLSASIPEGETYIDDGVKGT 230
+ AYLH + ++ RDLK +L+ V K+ +F + I T KG+
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT----NNKGS 166
Query: 231 SGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289
+ +APE + + Y +EKCDV+S+G++L +++ T F+ E+ I
Sbjct: 167 AAWMAPEVFEGSNY-SEKCDVFSWGIILWEVI-TRRKPFD-----------EIGGPAFRI 213
Query: 290 ENRGFNGI-------VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342
NG + I L+ +C S RP+M ++ K +
Sbjct: 214 MWAVHNGTRPPLIKNLPKPIE--SLMT-----------RCWSKDPSQRPSMEEIVKIMTH 260
Query: 343 MYKSF 347
+ + F
Sbjct: 261 LMRYF 265
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 59/242 (24%), Positives = 102/242 (42%), Gaps = 37/242 (15%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
++ H N++ +G + +V E G+L+ LL + E L + RL +A ++
Sbjct: 89 KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYDV 146
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
A YLH + PIV R+LKS +LV ++Y K+ +F LS GT
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPE 204
Query: 233 IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292
+APE R NEK DVYSFG++L +L T + + ++ + +
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELA-TLQQPWG-----------NLNPA-QVVAAV 251
Query: 293 GFNGI-------VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345
GF ++P++ ++E C + RP+ + ++ + K
Sbjct: 252 GFKCKRLEIPRNLNPQVA--AIIE-----------GCWTNEPWKRPSFATIMDLLRPLIK 298
Query: 346 SF 347
S
Sbjct: 299 SA 300
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 51/246 (20%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
S ++H N+++L G P +V E G+L+ L + P+ +L++ ++I
Sbjct: 78 SNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDI 131
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSER-----YVPKLFNFSLSASIPEGETYIDDGV 227
A Y+ + PIV RDL+S I + K+ +F LS + G+
Sbjct: 132 ALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS----GL 186
Query: 228 KGTSGIVAPE--YARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285
G +APE A EK D YSF ++L +L TGE F+ E +
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL-TGEGPFD-----------EYSYG 234
Query: 286 K-KYIENRGFNGI-------VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVA 337
K K+I G+ PR+ ++E C S + RP +
Sbjct: 235 KIKFINMIREEGLRPTIPEDCPPRLR--NVIE-----------LCWSGDPKKRPHFSYIV 281
Query: 338 KQIKKM 343
K++ ++
Sbjct: 282 KELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 46/247 (18%), Positives = 85/247 (34%), Gaps = 52/247 (21%)
Query: 113 SQMSHNNVLRLIGCCLE--VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM 170
SH NVL ++G C P L+ YG+L+++L + + +K A+
Sbjct: 62 RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG---TNFVVDQSQAVKFAL 118
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL--FNFSLSASIPEGETYIDDGVK 228
++A A+LH I L S +++ E ++ + S G
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--------SPGRM 169
Query: 229 GTSGIVAPE---YARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285
VAPE D++SF +LL +L+ T E F ++ +
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV-TREVPFA-----------DLSNM 217
Query: 286 KKYIENRGFNGI-------VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338
+ G+ + P + +L++ C + RP +
Sbjct: 218 -EIGMKVALEGLRPTIPPGISPHVS--KLMK-----------ICMNEDPAKRPKFDMIVP 263
Query: 339 QIKKMYK 345
++KM
Sbjct: 264 ILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-28
Identities = 57/246 (23%), Positives = 94/246 (38%), Gaps = 50/246 (20%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
+ + H N++ L G CL+ LV E A G L+ +L + + + A++I
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL------SGKRIPPDILVNWAVQI 114
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP--------KLFNFSLSASIPEGETYID 224
A YLH PI+ RDLKSS IL+ ++ K+ +F L+
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM-- 172
Query: 225 DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284
G +APE R ++ DV+S+G+LL +LL TGE F +D
Sbjct: 173 -SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL-TGEVPFR-----------GIDG 219
Query: 285 VKKYIENRGFNGI-------VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVA 337
+ N + +L+E C + RP+ ++
Sbjct: 220 L-AVAYGVAMNKLALPIPSTCPEPFA--KLME-----------DCWNPDPHSRPSFTNIL 265
Query: 338 KQIKKM 343
Q+ +
Sbjct: 266 DQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-28
Identities = 50/252 (19%), Positives = 85/252 (33%), Gaps = 48/252 (19%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
+ H NVL+ IG + + + E + G L ++K R+ A +I
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS----MDSQYPWSQRVSFAKDI 117
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
A+ AYLH S I+ RDL S LV E + +F L+ + + +T +
Sbjct: 118 ASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 233 IV-------------APEYARTGYLNEKCDVYSFGLLLLQLLSTGE-----DLFNMGLRL 274
APE +EK DV+SFG++L +++ M L
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL 234
Query: 275 NGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMI 334
N + P F + +C E RP+ +
Sbjct: 235 NVRGFLDRYCPPN----------CPPSF-------------FPITVRCCDLDPEKRPSFV 271
Query: 335 DVAKQIKKMYKS 346
+ ++ +
Sbjct: 272 KLEHWLETLRMH 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 53/260 (20%), Positives = 91/260 (35%), Gaps = 39/260 (15%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPV----LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
M H N+L I ++ L+ + E G+L+D L S L K LK+
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKL 139
Query: 169 AMEIANVFAYLH-----IGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223
A + +LH I RDLKS ILV + + + L+ +
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
Query: 224 DD---GVKGTSGIVAPE------YARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL 274
D GT + PE D+YSFGL+L ++ +
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA-RRCVSGGIV--- 255
Query: 275 NGDESFEMDFVKKYIENRGFNGIVD--------PRIIGDELLEHKLQSSFELAFQCQSAS 326
E +++ + + + + + P + L+ +L +C + +
Sbjct: 256 ---EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312
Query: 327 AEDRPTMIDVAKQIKKMYKS 346
R T + V K + KM +S
Sbjct: 313 PASRLTALRVKKTLAKMSES 332
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 61/330 (18%), Positives = 101/330 (30%), Gaps = 46/330 (13%)
Query: 52 FSAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVF 111
+A E +N +I + +G L +R ++V F + NI
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN--RQNFINEKNIYR 60
Query: 112 ASQMSHNNVLRLIGCCLEVEIPV-----LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRL 166
M H+N+ R I V LV E G+L L
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSSC 114
Query: 167 KIAMEIANVFAYLH------IGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220
++A + AYLH + I RDL S +LV + +F LS +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 221 TYIDD-------GVKGTSGIVAPEYAR-------TGYLNEKCDVYSFGLLLLQLLSTGED 266
GT +APE ++ D+Y+ GL+ ++ D
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 267 LFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD--------PRIIGDELLEHKLQSSF-E 317
LF ++M F + + F + P+ S E
Sbjct: 235 LFPGE----SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290
Query: 318 LAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347
C AE R T +++ ++ +
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 50/239 (20%), Positives = 100/239 (41%), Gaps = 31/239 (12%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
+ H N+L +G ++ +V + E +L+ L +K + IA +
Sbjct: 75 RKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQT 129
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
A YLH ++ I+ RDLKS+ I + E K+ +F L+ + + SG
Sbjct: 130 ARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE--KSRWSGSHQFEQLSG 184
Query: 233 IV---APEYARTGYLN---EKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286
+ APE R N + DVY+FG++L +L+ TG+ ++ ++
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM-TGQLPYS-----------NINNRD 232
Query: 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345
+ IE G + ++ + + L +C ++RP+ + +I+++ +
Sbjct: 233 QIIEMVGRGSL---SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-26
Identities = 47/261 (18%), Positives = 91/261 (34%), Gaps = 41/261 (15%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPV----LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
+ H N+L I + LV + E+G+L D L + + ++ +K+
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKL 144
Query: 169 AMEIANVFAYLH-----IGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223
A+ A+ A+LH I RDLKS ILV + + + L+ I
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 224 DD---GVKGTSGIVAPE-------YARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLR 273
D GT +APE ++ D+Y+ GL+ ++
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFES-FKRADIYAMGLVFWEIARRCSIGGIH--- 260
Query: 274 LNGDESFEMDFVKKYIENRGFNGIVD--------PRIIGDELLEHKLQSSFELAFQCQSA 325
E +++ + + + P I L+ ++ +C A
Sbjct: 261 ----EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316
Query: 326 SAEDRPTMIDVAKQIKKMYKS 346
+ R T + + K + ++ +
Sbjct: 317 NGAARLTALRIKKTLSQLSQQ 337
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 53/257 (20%), Positives = 91/257 (35%), Gaps = 39/257 (15%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPV----LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
+ H N+L I + L+ E G+L+D L L L+I
Sbjct: 57 VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRI 110
Query: 169 AMEIANVFAYLH-----IGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223
+ IA+ A+LH I RDLKS ILV + + + L+ + +
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQL 170
Query: 224 DDGVK---GTSGIVAPE------YARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL 274
D G GT +APE ++ D+++FGL+L ++ +
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA-RRMVSNGIV--- 226
Query: 275 NGDESFEMDFVKKYIENRGFNGIVD--------PRIIGDELLEHKLQSSFELAFQCQSAS 326
E ++ F + F + P I + L S +L +C +
Sbjct: 227 ---EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283
Query: 327 AEDRPTMIDVAKQIKKM 343
R T + + K + K+
Sbjct: 284 PSARLTALRIKKTLTKI 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 44/246 (17%), Positives = 83/246 (33%), Gaps = 40/246 (16%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
Q H NV+ +G C+ ++ + L+ +++ L + +IA EI
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEI 139
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS----ASIPEGETYIDDGVK 228
YLH ++ I+ +DLKS + V + +F L
Sbjct: 140 VKGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQN 195
Query: 229 GTSGIVAPEYARTGYL---------NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDES 279
G +APE R ++ DV++ G + +L E F +
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH-AREWPFK---TQPAEAI 251
Query: 280 FEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339
+ G + +G E+ ++ C + E+RPT +
Sbjct: 252 IWQ--M-----GTGMKPNLSQIGMGKEIS--------DILLFCWAFEQEERPTFTKLMDM 296
Query: 340 IKKMYK 345
++K+ K
Sbjct: 297 LEKLPK 302
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 7e-21
Identities = 61/240 (25%), Positives = 107/240 (44%), Gaps = 39/240 (16%)
Query: 114 QMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
Q SH N++RLIG C + + P+ +V E + G+ L+ + L +K L++ +
Sbjct: 168 QYSHPNIVRLIGVCTQKQ-PIYIVMELVQGGDFLTFLR----TEGARLRVKTLLQMVGDA 222
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG-----V 227
A YL S+ + RDL + LV+E+ V K+ +F +S +G G V
Sbjct: 223 AAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279
Query: 228 KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287
K T APE G + + DV+SFG+LL + S G + L+ + ++
Sbjct: 280 KWT----APEALNYGRYSSESDVWSFGILLWETFSLGASPYP---NLSNQQ------TRE 326
Query: 288 YIENRGFNGIVD-PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
++E G + P + D + F L QC + RP+ + ++++ + K
Sbjct: 327 FVEK---GGRLPCPELCPDAV--------FRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 41/163 (25%), Positives = 79/163 (48%), Gaps = 17/163 (10%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS-----YQSHSEPLLLKHRLK 167
+ + ++V+RL+G + + +++ E G+L L+ P L ++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 168 IAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGV 227
+A EIA+ AYL+ + V RDL + +V+E + K+ +F ++ I E + Y
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----R 195
Query: 228 KGTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
KG G++ +PE + G DV+SFG++L ++ + E
Sbjct: 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 57/247 (23%), Positives = 103/247 (41%), Gaps = 46/247 (18%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVL-VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
SH NVL L+G CL E L V ++G+L + + ++ + +K + ++
Sbjct: 81 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQ 136
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG----- 226
+A YL S+ V RDL + ++ E++ K+ +F L+ + + E Y
Sbjct: 137 VAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 227 --VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE----DLFNMGLRLNGDESF 280
VK A E +T K DV+SFG+LL +L++ G D+
Sbjct: 194 LPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------- 240
Query: 281 EMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340
+ Y+ ++ P D L +E+ +C AE RP+ ++ +I
Sbjct: 241 ----ITVYLLQGRR--LLQPEYCPDPL--------YEVMLKCWHPKAEMRPSFSELVSRI 286
Query: 341 KKMYKSF 347
++ +F
Sbjct: 287 SAIFSTF 293
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 58/258 (22%), Positives = 104/258 (40%), Gaps = 61/258 (23%)
Query: 113 SQMSHNNVLRLIGCCLEVE-----IPVLVFESAEYGNLHD-LLKRSYQSHSEPLLLKHRL 166
SH NV+RL+G C+E+ P+++ +YG+LH LL ++ + + L+ L
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 167 KIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG 226
K ++IA YL +R + RDL + ++ + + +F LS I G+ Y
Sbjct: 151 KFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY---- 203
Query: 227 VKGTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTG---------EDLFNM-- 270
+G + A E K DV++FG+ + ++ + G ++++
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263
Query: 271 -GLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAED 329
G RL P DEL +E+ + C D
Sbjct: 264 HGHRLK-----------------------QPEDCLDEL--------YEIMYSCWRTDPLD 292
Query: 330 RPTMIDVAKQIKKMYKSF 347
RPT + Q++K+ +S
Sbjct: 293 RPTFSVLRLQLEKLLESL 310
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-19
Identities = 38/165 (23%), Positives = 74/165 (44%), Gaps = 19/165 (11%)
Query: 113 SQMSHNNVLRLIGCCLEVE------IPVLVFESAEYGNLHD-LLKRSYQSHSEPLLLKHR 165
+ H +V +L+G L IP+++ ++G+LH LL + L L+
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
++ ++IA YL SR + RDL + +++E + +F LS I G+ Y
Sbjct: 140 VRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY--- 193
Query: 226 GVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
+G + + A E DV++FG+ + ++++ G+
Sbjct: 194 -RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 5e-19
Identities = 54/245 (22%), Positives = 102/245 (41%), Gaps = 42/245 (17%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVL-VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
SH NVL L+G CL E L V ++G+L + + ++ + +K + ++
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDLIGFGLQ 200
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
+A +L S+ V RDL + ++ E++ K+ +F L+ + + E T
Sbjct: 201 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS--VHNKTG 255
Query: 232 GIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGE----DLFNMGLRLNGDESFEM 282
+ A E +T K DV+SFG+LL +L++ G D+
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----------- 304
Query: 283 DFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342
+ Y+ ++ P D L +E+ +C AE RP+ ++ +I
Sbjct: 305 --ITVYLLQGRR--LLQPEYCPDPL--------YEVMLKCWHPKAEMRPSFSELVSRISA 352
Query: 343 MYKSF 347
++ +F
Sbjct: 353 IFSTF 357
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-18
Identities = 53/245 (21%), Positives = 97/245 (39%), Gaps = 44/245 (17%)
Query: 113 SQMSHNNVLRLIGCCLEVE-IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
++H NVL LIG L E +P ++ +G+L ++ S +K + ++
Sbjct: 77 RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR----SPQRNPTVKDLISFGLQ 132
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
+A YL + V RDL + ++ E + K+ +F L+ I + E Y +
Sbjct: 133 VARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ--QHRH 187
Query: 232 GIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGE----DLFNMGLRLNGDESFEM 282
+ A E +T K DV+SFG+LL +LL+ G + L
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL---------T 238
Query: 283 DFVKK-YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341
F+ + + P D L +++ QC A RPT + +++
Sbjct: 239 HFLAQGRRLPQ-------PEYCPDSL--------YQVMQQCWEADPAVRPTFRVLVGEVE 283
Query: 342 KMYKS 346
++ +
Sbjct: 284 QIVSA 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 52/251 (20%), Positives = 97/251 (38%), Gaps = 39/251 (15%)
Query: 113 SQMSHNNVLRLIGCCLE-VEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM 170
+ H+N+++ G C + L+ E YG+L D L++ H E + L+
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTS 152
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
+I YL ++ + RDL + ILV K+ +F L+ +P+ + Y G
Sbjct: 153 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209
Query: 231 SGI--VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288
S I APE + DV+SFG++L +L + E +
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS----------------PPA 253
Query: 289 IENRGFNGIVDPRIIGDELLE-----HKL-------QSSFELAFQCQSASAEDRPTMIDV 336
R ++I L+E +L + + +C + + RP+ D+
Sbjct: 254 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313
Query: 337 AKQIKKMYKSF 347
A ++ ++
Sbjct: 314 ALRVDQIRDQM 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 51/251 (20%), Positives = 98/251 (39%), Gaps = 39/251 (15%)
Query: 113 SQMSHNNVLRLIGCCLE-VEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM 170
+ H+N+++ G C + L+ E YG+L D L++ H E + L+
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK----HKERIDHIKLLQYTS 121
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
+I YL ++ + RDL + ILV K+ +F L+ +P+ + + G
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 231 SGI--VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288
S I APE + DV+SFG++L +L + E +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS----------------PPA 222
Query: 289 IENRGFNGIVDPRIIGDELLE-----HKL-------QSSFELAFQCQSASAEDRPTMIDV 336
R ++I L+E +L + + +C + + RP+ D+
Sbjct: 223 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282
Query: 337 AKQIKKMYKSF 347
A ++ ++ +
Sbjct: 283 ALRVDQIRDNM 293
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 57/248 (22%), Positives = 99/248 (39%), Gaps = 36/248 (14%)
Query: 113 SQMSHNNVLRLIGCCLE-VEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM 170
+ H ++++ GCC + + LV E G+L D L R + L L A
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQ 141
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
+I AYLH ++ + RDL + +L+ + K+ +F L+ ++PEG Y G
Sbjct: 142 QICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 231 SGI--VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288
S + APE + DV+SFG+ L +LL+ + + +
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA------- 251
Query: 289 IENRGFNGIVDPRIIGDELLE--HKL-------QSSFELAFQCQSASAEDRPTMIDVAKQ 339
+ R+ ELLE +L + L C A RPT ++
Sbjct: 252 -----QGQMTVLRLT--ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPI 304
Query: 340 IKKMYKSF 347
+K +++ +
Sbjct: 305 LKTVHEKY 312
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 51/246 (20%), Positives = 95/246 (38%), Gaps = 34/246 (13%)
Query: 113 SQMSHNNVLRLIGCCLEVEI-PV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM 170
+ H N+++ G C E + L+ E G+L + L + + LK +LK A+
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAV 133
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
+I YL SR V RDL + +LV + K+ +F L+ +I + Y
Sbjct: 134 QICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 231 SGI--VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288
S + APE DV+SFG+ L +LL+ + + F +
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDS------DSSPMALFLKMIGPTH 244
Query: 289 IENRGFNGIVDPRIIGDELLE--HKL-------QSSFELAFQCQSASAEDRPTMIDVAKQ 339
+ R++ L+ +L ++L +C +R + ++ +
Sbjct: 245 ------GQMTVTRLV--NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296
Query: 340 IKKMYK 345
+ + K
Sbjct: 297 FEALLK 302
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 51/234 (21%), Positives = 105/234 (44%), Gaps = 27/234 (11%)
Query: 114 QMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
++ H N+++L+G C E P ++ E YGNL D L+ + + + + L +A +I
Sbjct: 272 EIKHPNLVQLLGVCTR-EPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMATQI 327
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
++ YL + + R+L + LV E ++ K+ +F LS + G K
Sbjct: 328 SSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
Query: 233 IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292
APE + K DV++FG+LL ++ + G + ++ + V + +E +
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP---GIDLSQ------VYELLE-K 434
Query: 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+ + P +++ +EL C + DRP+ ++ + + M++
Sbjct: 435 DYR-MERPEGCPEKV--------YELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 53/250 (21%), Positives = 92/250 (36%), Gaps = 48/250 (19%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK--RSYQSHSEPLLLKHRLKIAM 170
S+ +H N++R IG L+ ++ E G+L L+ R S L + L +A
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVS---ERYVPKLFNFSLSASIPEGETYIDDGV 227
+IA YL + RD+ + L++ V K+ +F ++ I Y
Sbjct: 148 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----R 200
Query: 228 KGTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGE----DLFNMGLRLNGDE 278
KG ++ PE G K D +SFG+LL ++ S G N +
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV------ 254
Query: 279 SFEMDFVKKYIENRGFNGIVDPRIIG--DELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
++FV +G + + + QC EDRP +
Sbjct: 255 ---LEFVT--------SGGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAII 295
Query: 337 AKQIKKMYKS 346
++I+ +
Sbjct: 296 LERIEYCTQD 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 53/250 (21%), Positives = 92/250 (36%), Gaps = 48/250 (19%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK--RSYQSHSEPLLLKHRLKIAM 170
S+ +H N++R IG L+ ++ E G+L L+ R S L + L +A
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVS---ERYVPKLFNFSLSASIPEGETYIDDGV 227
+IA YL + RD+ + L++ V K+ +F ++ I Y
Sbjct: 189 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----R 241
Query: 228 KGTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGE----DLFNMGLRLNGDE 278
KG ++ PE G K D +SFG+LL ++ S G N +
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV------ 295
Query: 279 SFEMDFVKKYIENRGFNGIVDPRIIG--DELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
++FV +G + + + QC EDRP +
Sbjct: 296 ---LEFVT--------SGGRMDPPKNCPGPV--------YRIMTQCWQHQPEDRPNFAII 336
Query: 337 AKQIKKMYKS 346
++I+ +
Sbjct: 337 LERIEYCTQD 346
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 53/248 (21%), Positives = 103/248 (41%), Gaps = 42/248 (16%)
Query: 116 SHNNVLRLIGCCLEVEIPVLV-FESAEYGNLHDLLKRS-----------YQSHSEPLLLK 163
H NV+ L+G C + P++V E ++GNL L+ + + L L+
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 164 HRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI 223
H + + ++A +L SR + RDL + IL+SE+ V K+ +F L+ I + Y
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY- 204
Query: 224 DDGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278
V+ + APE + DV+SFG+LL ++ S G + G++++ +
Sbjct: 205 ---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDEE- 259
Query: 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338
+ ++ P E+ ++ C RPT ++ +
Sbjct: 260 ------FCRRLKEGTRMRA--PDYTTPEM--------YQTMLDCWHGEPSQRPTFSELVE 303
Query: 339 QIKKMYKS 346
+ + ++
Sbjct: 304 HLGNLLQA 311
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 22/168 (13%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS----------YQSHSEPLLL 162
+ + H +++R G C E ++VFE +G+L+ L+ PL L
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 163 KHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222
L +A ++A YL V RDL + LV + V K+ +F +S I + Y
Sbjct: 158 GQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 223 IDDGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
G ++ PE + DV+SFG++L ++ + G+
Sbjct: 215 ----RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 28/234 (11%)
Query: 114 QMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
++ H +++L E P+ +V E G+L D LK + L + +A +I
Sbjct: 318 KLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL---VDMAAQI 372
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
A+ AY+ V RDL+++ ILV E V K+ +F L+ I + E G K
Sbjct: 373 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 429
Query: 233 IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292
APE A G K DV+SFG+LL +L + G + + E V +E R
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP---GMVNRE------VLDQVE-R 479
Query: 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
G+ + P + L +L QC E+RPT + ++ + S
Sbjct: 480 GYR-MPCPPECPESL--------HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 28/234 (11%)
Query: 114 QMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
++ H +++L E P+ +V E G+L D LK + L + +A +I
Sbjct: 235 KLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL---VDMAAQI 289
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
A+ AY+ V RDL+++ ILV E V K+ +F L+ I + E G K
Sbjct: 290 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 233 IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292
APE A G K DV+SFG+LL +L + G + + E V +E R
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP---GMVNRE------VLDQVE-R 396
Query: 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
G+ + P + L +L QC E+RPT + ++ + S
Sbjct: 397 GYR-MPCPPECPESL--------HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 58/246 (23%), Positives = 93/246 (37%), Gaps = 34/246 (13%)
Query: 114 QMSHNNVLRLIGCCLE-VEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
+ + +++ G + LV E G L D L+R H L L + +
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR----HRARLDASRLLLYSSQ 135
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
I YL SR V RDL + ILV K+ +F L+ +P + Y G S
Sbjct: 136 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 232 GI--VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289
I APE + + DV+SFG++L +L + D+S +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT------------YCDKSCSPSAEFLRM 240
Query: 290 ENRGFNGIVDPRIIGDELLE--HKL-------QSSFELAFQCQSASAEDRPTMIDVAKQI 340
+ R++ ELLE +L EL C + S +DRP+ + Q+
Sbjct: 241 MGCERDVPALSRLL--ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298
Query: 341 KKMYKS 346
++
Sbjct: 299 DMLWSG 304
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 114 QMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
+ H+ +++L + P+ ++ E G+L D LK L + + +I
Sbjct: 239 TLQHDKLVKLHAVVTKE--PIYIITEFMAKGSLLDFLK---SDEGSKQPLPKLIDFSAQI 293
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG----VK 228
A A++ R + RDL+++ ILVS V K+ +F L+ I + E +G +K
Sbjct: 294 AEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
T APE G K DV+SFG+LL+++++ G
Sbjct: 351 WT----APEAINFGSFTIKSDVWSFGILLMEIVTYGR 383
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 23/158 (14%)
Query: 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS-----------YQSHSEPLLLKH 164
H N++ L+G C + ++ E A GNL + L+ + E + K
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 165 RLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID 224
+ ++A YL S+ + RDL + +LV+E V K+ +F L+ I + Y
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-- 213
Query: 225 DGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLL 257
K T+G + APE + DV+SFG+L+
Sbjct: 214 --KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
++SH +++L G CLE P+ LV E E+G L D L ++ + L + ++
Sbjct: 58 MKLSHPKLVQLYGVCLEQA-PICLVTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLD 112
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG----V 227
+ AYL ++ RDL + LV E V K+ +F ++ + + + G V
Sbjct: 113 VCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 228 KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
K +PE + K DV+SFG+L+ ++ S G+
Sbjct: 170 KWA----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 203
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-17
Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 23/158 (14%)
Query: 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS-----------YQSHSEPLLLKH 164
H N++ L+G C + ++ E A GNL + L+ + E L K
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 165 RLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID 224
+ A ++A YL S+ + RDL + +LV+E V K+ +F L+ I + Y
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-- 247
Query: 225 DGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLL 257
K T+G + APE + DV+SFG+LL
Sbjct: 248 --KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 283
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-17
Identities = 34/156 (21%), Positives = 68/156 (43%), Gaps = 21/156 (13%)
Query: 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS---------YQSHSEPLLLKHRL 166
H N++ L+G C +++ E YG+L + L+R + + + L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 167 KIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG 226
+ ++A A+L S+ + RD+ + +L++ +V K+ +F L+ I Y
Sbjct: 168 HFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY---- 220
Query: 227 VKGTSGIV-----APEYARTGYLNEKCDVYSFGLLL 257
+ + + APE + DV+S+G+LL
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 35/157 (22%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
+SH +++L G C + ++ E G L + L + + L++ ++
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDV 129
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG----VK 228
YL S+ + RDL + LV+++ V K+ +F LS + + E G V+
Sbjct: 130 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
+ PE + K D+++FG+L+ ++ S G+
Sbjct: 187 WS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-17
Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 114 QMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
Q+ H+N+++L+G +E + + +V E G+L D L+ L LK ++++
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDV 298
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
YL V RDL + +LVSE V K+ +F L+ + VK T
Sbjct: 299 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT-- 353
Query: 233 IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
APE R + K DV+SFG+LL ++ S G
Sbjct: 354 --APEALREKKFSTKSDVWSFGILLWEIYSFGR 384
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-17
Identities = 37/157 (23%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
++SH +++ G C + +V E G L + L +SH + L L++ ++
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDV 113
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG----VK 228
A+L S + RDL + LV K+ +F ++ + + + G VK
Sbjct: 114 CEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK 170
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
+ APE + K DV++FG+L+ ++ S G+
Sbjct: 171 WS----APEVFHYFKYSSKSDVWAFGILMWEVFSLGK 203
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 37/160 (23%), Positives = 68/160 (42%), Gaps = 25/160 (15%)
Query: 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS-------------YQSHSEPLLL 162
+H N++ L+G C +++ E YG+L + L+R + L L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 163 KHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222
+ L + ++A A+L S+ + RDL + IL++ + K+ +F L+ I Y
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 223 IDDGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLL 257
V + + APE + DV+S+G+ L
Sbjct: 202 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 38/161 (23%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS-----------YQSHSEPLL 161
+ + H ++++ G C + + ++VFE ++G+L+ L+ + L
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 162 LKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221
L L IA +IA+ YL S+ V RDL + LV + K+ +F +S + +
Sbjct: 132 LSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 222 YIDDGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLL 257
Y G ++ PE + DV+SFG++L
Sbjct: 189 Y----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 41/158 (25%), Positives = 69/158 (43%), Gaps = 23/158 (14%)
Query: 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS-----------YQSHSEPLLLKH 164
H N++ L+G C + ++ E A GNL + L+ + E + K
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 165 RLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID 224
+ ++A YL S+ + RDL + +LV+E V K+ +F L+ I + Y
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-- 259
Query: 225 DGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLL 257
K T+G + APE + DV+SFG+L+
Sbjct: 260 --KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 295
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 14/156 (8%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
++ H N+++L+G C ++ E YGNL D L+ + + + + L +A +I+
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR---ECNRQEVSAVVLLYMATQIS 121
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG----VKG 229
+ YL + + RDL + LV E ++ K+ +F LS + G +K
Sbjct: 122 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 230 TSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
T APE + K DV++FG+LL ++ + G
Sbjct: 179 T----APESLAYNKFSIKSDVWAFGVLLWEIATYGM 210
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 40/157 (25%), Positives = 63/157 (40%), Gaps = 16/157 (10%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
Q H ++++LIG E ++ E G L L Q L L + A ++
Sbjct: 446 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQL 500
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG----VK 228
+ AYL S+ V RD+ + +LVS KL +F LS + + Y +K
Sbjct: 501 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
APE DV+ FG+ + ++L G
Sbjct: 558 WM----APESINFRRFTSASDVWMFGVCMWEILMHGV 590
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 31/169 (18%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS-------------------Y 153
++ + N+++L+G C + L+FE YG+L++ L+
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 154 QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213
PL +L IA ++A AYL R V RDL + LV E V K+ +F LS
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 214 ASIPEGETYIDDGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLL 257
+I + Y + + PE + DV+++G++L
Sbjct: 222 RNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 266
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-16
Identities = 36/157 (22%), Positives = 67/157 (42%), Gaps = 17/157 (10%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
+ + +V RL+G CL L+ + +G L D + + H + + ++ L ++IA
Sbjct: 73 SVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIA 127
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG-----VK 228
YL R +V RDL + +LV K+ +F L+ + E +K
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
A E + DV+S+G+ + +L++ G
Sbjct: 185 WM----ALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 34/169 (20%), Positives = 72/169 (42%), Gaps = 23/169 (13%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKR-----------SYQSHSEPLL 161
+++ H NV+ L+G + + ++F +G+LH+ L ++ L
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 162 LKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET 221
+ + +IA YL S +V +DL + +LV ++ K+ + L + +
Sbjct: 127 PPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183
Query: 222 YIDDGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
Y + ++ APE G + D++S+G++L ++ S G
Sbjct: 184 Y----KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-16
Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 31/169 (18%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS-------------------Y 153
Q++H +V++L G C + +L+ E A+YG+L L+ S
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 154 QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213
L + + A +I+ YL +V RDL + ILV+E K+ +F LS
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 214 ASIPEGETYIDDGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLL 257
+ E ++Y VK + G + A E + DV+SFG+LL
Sbjct: 198 RDVYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-16
Identities = 52/240 (21%), Positives = 89/240 (37%), Gaps = 39/240 (16%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
+ H ++++LIG E E ++ E YG L L + + L + + +++I
Sbjct: 68 KNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQI 122
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG----VK 228
AYL S V RD+ ILV+ KL +F LS I + + Y +K
Sbjct: 123 CKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288
+PE DV+ F + + ++LS G+ F L + V
Sbjct: 180 WM----SPESINFRRFTTASDVWMFAVCMWEILSFGKQPF---FWLENKD------VIGV 226
Query: 289 IENRGFNGIVDPRIIG--DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+E G P+ L + L +C DRP ++ + +Y+
Sbjct: 227 LE----KGDRLPKPDLCPPVL--------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-16
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVL-VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
Q+ H ++RL + P+ + E E G+L D LK L + L +A +I
Sbjct: 64 QLQHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLK---TPSGIKLTINKLLDMAAQI 118
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG----VK 228
A A++ R + RDL+++ ILVS+ K+ +F L+ I + E +G +K
Sbjct: 119 AEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
T APE G K DV+SFG+LL ++++ G
Sbjct: 176 WT----APEAINYGTFTIKSDVWSFGILLTEIVTHGR 208
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-16
Identities = 40/157 (25%), Positives = 63/157 (40%), Gaps = 16/157 (10%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
Q H ++++LIG E ++ E G L L Q L L + A ++
Sbjct: 71 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQL 125
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG----VK 228
+ AYL S+ V RD+ + +LVS KL +F LS + + Y +K
Sbjct: 126 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
APE DV+ FG+ + ++L G
Sbjct: 183 WM----APESINFRRFTSASDVWMFGVCMWEILMHGV 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 32/157 (20%), Positives = 66/157 (42%), Gaps = 17/157 (10%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
+ H +++RL+G C LV + G+L D ++ H L + L ++IA
Sbjct: 71 SLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVR----QHRGALGPQLLLNWGVQIA 125
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
YL +V R+L + +L+ ++ +F ++ +P + + +
Sbjct: 126 KGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ----LLYSEAK 178
Query: 234 V-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
A E G + DV+S+G+ + +L++ G
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 215
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 21/158 (13%)
Query: 114 QMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
Q+ H+N+++L+G +E + + +V E G+L D L+ L LK ++++
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR---SRGRSVLGGDCLLKFSLDV 126
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG-----V 227
YL V RDL + +LVSE V K+ +F L+ E V
Sbjct: 127 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPV 178
Query: 228 KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
K T APE R + K DV+SFG+LL ++ S G
Sbjct: 179 KWT----APEALREKKFSTKSDVWSFGILLWEIYSFGR 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 36/157 (22%), Positives = 67/157 (42%), Gaps = 17/157 (10%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
+ + +V RL+G CL L+ + +G L D + + H + + ++ L ++IA
Sbjct: 73 SVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIA 127
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDG-----VK 228
YL R +V RDL + +LV K+ +F L+ + E +K
Sbjct: 128 KGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
A E + DV+S+G+ + +L++ G
Sbjct: 185 WM----ALESILHRIYTHQSDVWSYGVTVWELMTFGS 217
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 57/235 (24%), Positives = 103/235 (43%), Gaps = 29/235 (12%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q+ + ++RLIG C E +LV E A G LH L E + + + ++ +++
Sbjct: 392 QLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVS 446
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
YL + V R+L + +L+ R+ K+ +F LS ++ ++Y G +
Sbjct: 447 MGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 503
Query: 234 --VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291
APE + + DV+S+G+ + + LS G+ + ++ G E V +IE
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK---KMKGPE------VMAFIE- 553
Query: 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+G + P EL + L C EDRP + V ++++ Y S
Sbjct: 554 QGKR-MECPPECPPEL--------YALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 48/157 (30%), Positives = 67/157 (42%), Gaps = 26/157 (16%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS-----------YQSHSEPLLLKHR 165
H N++ L+G C L E A +GNL D L++S S + L +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
L A ++A YL + + RDL + ILV E YV K+ +F LS E Y
Sbjct: 145 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--- 195
Query: 226 GVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLL 257
VK T G + A E DV+S+G+LL
Sbjct: 196 -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 231
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 29/236 (12%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
Q+ + ++RLIG C E +LV E A G LH L E + + + ++ ++
Sbjct: 65 HQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQV 119
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
+ YL + V RDL + +L+ R+ K+ +F LS ++ ++Y G
Sbjct: 120 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176
Query: 233 I--VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290
+ APE + + DV+S+G+ + + LS G+ + ++ G E V +IE
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK---KMKGPE------VMAFIE 227
Query: 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+G + P EL + L C EDRP + V ++++ Y S
Sbjct: 228 -QGKR-MECPPECPPEL--------YALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 42/165 (25%), Positives = 66/165 (40%), Gaps = 30/165 (18%)
Query: 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRS------------------YQSHS 157
SH N++ L+G C L+FE YG+L + L+ +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 158 EPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217
L + L A ++A +L + V RDL + +LV+ V K+ +F L+ I
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 218 EGETYIDDGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLL 257
Y V + + APE G K DV+S+G+LL
Sbjct: 224 SDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 54/238 (22%), Positives = 88/238 (36%), Gaps = 34/238 (14%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q H N++RL G + ++V E E G+L L ++H + + + +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVG 161
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
YL V RDL + +LV V K+ +F LS + + G I
Sbjct: 162 AGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 234 --VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLF-NMGLRLNGDESFEMDFVKKYIE 290
APE + DV+SFG+++ ++L+ GE + NM N D V +E
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT---NRD-------VISSVE 268
Query: 291 NRGFNGIVDPRIIG--DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
G P +G L +L C RP + + + +S
Sbjct: 269 ----EGYRLPAPMGCPHAL--------HQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 55/235 (23%), Positives = 102/235 (43%), Gaps = 30/235 (12%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q+ + ++R+IG C E +LV E AE G L+ L++ + + K+ +++ +++
Sbjct: 74 QLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVS 127
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI 233
YL V RDL + +L+ ++ K+ +F LS ++ E Y G +
Sbjct: 128 MGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 234 --VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291
APE + K DV+SFG+L+ + S G+ + + G E V +E
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY---RGMKGSE------VTAMLE- 234
Query: 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+G + P E+ ++L C + E+RP V +++ Y
Sbjct: 235 KGER-MGCPAGCPREM--------YDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 9/155 (5%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
Q H N++RL G + + ++V E E G+L L + H + + + I
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGI 156
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
A+ YL V RDL + IL++ V K+ +F L + + G
Sbjct: 157 ASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 233 I--VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
I +PE DV+S+G++L +++S GE
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 55/243 (22%), Positives = 97/243 (39%), Gaps = 42/243 (17%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
Q SH+N++RL G + + +++ E E G L L + + + + I
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQLVGMLRGI 156
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE--TYIDDG---- 226
A YL + V RDL + ILV+ V K+ +F LS + + TY G
Sbjct: 157 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 227 VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLF-NMGLRLNGDESFEMDFV 285
++ T APE DV+SFG+++ ++++ GE + + N + V
Sbjct: 214 IRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHE-------V 259
Query: 286 KKYIENRGFNGIVDPRIIG--DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
K I +G P + + ++L QC RP D+ + K+
Sbjct: 260 MKAIN----DGFRLPTPMDCPSAI--------YQLMMQCWQQERARRPKFADIVSILDKL 307
Query: 344 YKS 346
++
Sbjct: 308 IRA 310
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-14
Identities = 55/238 (23%), Positives = 102/238 (42%), Gaps = 38/238 (15%)
Query: 114 QMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
+ H N++RL G L P+ +V E A G+L D L + H LL + A+++
Sbjct: 77 SLDHRNLIRLYGVVLTP--PMKMVTELAPLGSLLDRL----RKHQGHFLLGTLSRYAVQV 130
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
A YL S+ + RDL + +L++ R + K+ +F L ++P+ DD
Sbjct: 131 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEH 183
Query: 233 I------VAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286
APE +T + D + FG+ L ++ + G++ + + LNG + +
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW---IGLNGSQ------IL 234
Query: 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344
I+ G + P ++ + + QC + EDRPT + + + +
Sbjct: 235 HKIDKEGER-LPRPEDCPQDI--------YNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 44/216 (20%), Positives = 70/216 (32%), Gaps = 32/216 (14%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
H +RL E I L E +L + S E +
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWG----Y 162
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
+ A+LH S+ +V D+K + I + R KL +F L + + +
Sbjct: 163 LRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQE 217
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLL------STGEDLFNMG-----LRLNGD 277
G +APE + Y DV+S GL +L++ GE +
Sbjct: 218 GDPRYMAPELLQGSY-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAG 276
Query: 278 ESFEM-DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
S E+ + +E DP R + LL
Sbjct: 277 LSSELRSVLVMMLE-------PDPKLRATAEALLAL 305
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 48/222 (21%), Positives = 78/222 (35%), Gaps = 42/222 (18%)
Query: 113 SQMSHNNVLRLIGCCLEVEIP----VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
+ H N++R VLV E G L LKR ++ +L
Sbjct: 80 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRS----W 134
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLFNFSLSASIPEGETYIDDGV 227
+I +LH + PI+ RDLK I ++ K+ + L+ V
Sbjct: 135 CRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AV 190
Query: 228 KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE----DLFNMG------------ 271
GT +APE Y +E DVY+FG+ +L++ T E + N
Sbjct: 191 IGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMA-TSEYPYSECQNAAQIYRRVTSGVKP 248
Query: 272 LRLNGDESFEM-DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
+ E+ + ++ I + R +LL H
Sbjct: 249 ASFDKVAIPEVKEIIEGCIR-------QNKDERYSIKDLLNH 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 46/224 (20%), Positives = 79/224 (35%), Gaps = 46/224 (20%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVF 176
H NV+R + + + E L + +++ +H + + + +
Sbjct: 77 HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG----LEPITLLQQTTSGL 131
Query: 177 AYLHIGFSRPIVFRDLKSSYILVSE-----RYVPKLFNFSLSASIPEGETYID--DGVKG 229
A+LH S IV RDLK IL+S + + +F L + G GV G
Sbjct: 132 AHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 230 TSGIVAPEY----ARTGYLNEKCDVYSFGLLLLQLLSTGE----DLFNMGLR-LNGDESF 280
T G +APE + D++S G + ++S G L G S
Sbjct: 189 TEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL 247
Query: 281 EM------------DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
+ + ++K I +DP R +L+H
Sbjct: 248 DCLHPEKHEDVIARELIEKMIA-------MDPQKRPSAKHVLKH 284
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 34/233 (14%), Positives = 73/233 (31%), Gaps = 33/233 (14%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
+ ++ L VLV E YG L + + + + + + AM +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVP-----------KLFNFSLSA---SIPEG 219
+ +H I+ D+K ++ ++ L + S P+G
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 220 ETYIDDGVKGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278
+ TSG E + + N + D + + +L G + ++ G E
Sbjct: 240 TIFT--AKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCML-FGTYMK---VKNEGGE 292
Query: 279 SFEMDFVKKYIENRGFNGIVD--------PRIIGDELLEHKLQSSFELAFQCQ 323
++ +N + +LL KL+ F+ + +
Sbjct: 293 CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNK 345
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 54/254 (21%), Positives = 96/254 (37%), Gaps = 51/254 (20%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
+ H N+++L + + LV E E G L + + + E I +I
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII-NRHKFDE----CDAANIMKQIL 156
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
+ YLH IV RD+K IL+ + K+ +F LS+ + D GT
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGT 211
Query: 231 SGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESFEM 282
+ +APE + Y NEKCDV+S G+++ LL +D+ + G F+
Sbjct: 212 AYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK--GKYYFDF 268
Query: 283 -----------DFVKKYIENRGFNGIVDP--RIIGDELLEHK-LQSSFELAFQCQSASAE 328
+ +K + D R +E L + ++ + +
Sbjct: 269 NDWKNISDEAKELIKLMLT-------YDYNKRCTAEEALNSRWIKK------YANNINKS 315
Query: 329 DRPTMIDVAKQIKK 342
D+ T+ ++K
Sbjct: 316 DQKTLCGALSNMRK 329
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 67.8 bits (165), Expect = 9e-13
Identities = 23/144 (15%), Positives = 49/144 (34%), Gaps = 22/144 (15%)
Query: 134 VLVFESAEYGNLHDLLK--RSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRD 191
++ NL + S+ S + L+ RL++ +++ + A LH +V
Sbjct: 181 FFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTY 236
Query: 192 LKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEY----------ART 241
L+ I++ +R L F +G + + G PE
Sbjct: 237 LRPVDIVLDQRGGVFLTGFEHLV--RDGASAV---SPIGRGFAPPETTAERMLPFGQHHP 291
Query: 242 GYLNEKCDVYSFGLLLLQLLSTGE 265
+ D ++ GL + + +
Sbjct: 292 TLMTFAFDTWTLGLAIYWIW-CAD 314
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 60/254 (23%), Positives = 104/254 (40%), Gaps = 51/254 (20%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q+ H N+++L + LV E G L D + S + SE +I ++
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSE----VDAARIIRQVL 136
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
+ Y+H IV RDLK +L+ S+ ++ +F LS + D GT
Sbjct: 137 SGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGT 191
Query: 231 SGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESFEM 282
+ +APE Y +EKCDV+S G++L LLS D+ + G +FE+
Sbjct: 192 AYYIAPEVLHGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFEL 248
Query: 283 -----------DFVKKYIENRGFNGIVDP--RIIGDELLEHK-LQSSFELAFQCQSASAE 328
D ++K + P RI + L+H+ +Q+ + +
Sbjct: 249 PQWKKVSESAKDLIRKMLT-------YVPSMRISARDALDHEWIQT------YTKEQISV 295
Query: 329 DRPTMIDVAKQIKK 342
D P++ + I++
Sbjct: 296 DVPSLDNAILNIRQ 309
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 41/246 (16%), Positives = 92/246 (37%), Gaps = 48/246 (19%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
S++SH +++ G C+ + +LV E ++G+L LK + + + +L++A ++
Sbjct: 67 SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK----KNKNCINILWKLEVAKQL 122
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP--------KLFNFSLSASIPEGETYID 224
A +L ++ ++ + IL+ KL + +S ++ + +
Sbjct: 123 AAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQ 178
Query: 225 DGVKGTSGIVAPE---YARTGYLNEKCDVYSFGLLLLQLLSTGED-LFNMGLRLNGDESF 280
+ + PE + LN D +SFG L ++ S G+ L + +
Sbjct: 179 ERIPWV----PPECIENPKN--LNLATDKWSFGTTLWEICSGGDKPLSAL----DSQR-- 226
Query: 281 EMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340
++ E + P EL L C + RP+ + + +
Sbjct: 227 ----KLQFYE----DRHQLPAPKAAEL--------ANLINNCMDYEPDHRPSFRAIIRDL 270
Query: 341 KKMYKS 346
++
Sbjct: 271 NSLFTP 276
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 57/254 (22%), Positives = 104/254 (40%), Gaps = 50/254 (19%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
+ H N+++L + LV E + G L D + +E I ++
Sbjct: 92 LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII-HRMKFNE----VDAAVIIKQVL 146
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
+ YLH IV RDLK +L+ + + K+ +F LSA + + GT
Sbjct: 147 SGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RLGT 201
Query: 231 SGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESFEM 282
+ +APE R Y +EKCDV+S G++L LL+ T +++ + G +F+
Sbjct: 202 AYYIAPEVLRKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK--GKYTFDS 258
Query: 283 -----------DFVKKYIENRGFNGIVDP--RIIGDELLEHK-LQSSFELAFQCQSASAE 328
D +K+ ++ D RI + LEH ++ + S
Sbjct: 259 PEWKNVSEGAKDLIKQMLQ-------FDSQRRISAQQALEHPWIKEMCS-----KKESGI 306
Query: 329 DRPTMIDVAKQIKK 342
+ P++ + + ++K
Sbjct: 307 ELPSLANAIENMRK 320
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 26/165 (15%), Positives = 58/165 (35%), Gaps = 23/165 (13%)
Query: 115 MSHNNVLRLIGCCLEVEIPVLVF-ESAEYGNLHDLLK--RSYQSHSEPLLLKHRLKIAME 171
++R+ ++ + F NL + S+ S + L+ RL++ ++
Sbjct: 155 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQ 214
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
+ + A LH +V L+ I++ +R L F + +G + +
Sbjct: 215 VIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL--VRDGARVVSSV---SR 266
Query: 232 GIVAPEY-----------ARTGYLNEKCDVYSFGLLLLQLLSTGE 265
G PE R + D ++ GL++ + +
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW-CAD 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 17/139 (12%), Positives = 37/139 (26%), Gaps = 13/139 (9%)
Query: 134 VLVFESAEYGNLHDLLKR--SYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRD 191
+L+ +A +L L + + ++ + A L S+ +V
Sbjct: 164 LLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGH 219
Query: 192 LKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEY--ARTGYLNEKCD 249
+ + L + S G E+ A T +
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASS--VPVTYAPREFLNASTATFTHALN 275
Query: 250 VYSFGLLLLQLLSTGEDLF 268
+ GL + ++ F
Sbjct: 276 AWQLGLSIYRVW-CLFLPF 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 54/237 (22%), Positives = 92/237 (38%), Gaps = 48/237 (20%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESA----------EY---GNLHDLLKRSYQSHSEP 159
+ ++H V+R LE V + EY G L+DL+ +
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR- 115
Query: 160 LLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219
++ +I +Y+H S+ I+ RDLK I + E K+ +F L+ ++
Sbjct: 116 ---DEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 220 ETYIDDGVK-------------GTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLL---S 262
+ + GT+ VA E TG+ NEK D+YS G++ +++ S
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFS 229
Query: 263 TGEDLFNMGLRL-NGDESFEMDFVKKYIENRGFNGIV------DP--RIIGDELLEH 310
TG + N+ +L + F DF ++ I+ DP R LL
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKV--EKKIIRLLIDHDPNKRPGARTLLNS 284
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 47/257 (18%), Positives = 90/257 (35%), Gaps = 50/257 (19%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
+ H ++ L + V+++E G L + + + SE ++ ++
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE----DEAVEYMRQVC 265
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVP--KLFNFSLSASIPEGETYIDDGVKGTS 231
++H V DLK I+ + + KL +F L+A + ++ GT+
Sbjct: 266 KGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTA 320
Query: 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESFE-- 281
APE A + D++S G+L LLS ++ D + +
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS--CDWNMDDS 378
Query: 282 ---------MDFVKKYIENRGFNGIVDP--RIIGDELLEHK-LQSSFELAFQCQSASAED 329
DF++K + + DP R+ + LEH L +A D
Sbjct: 379 AFSGISEDGKDFIRKLL-------LADPNTRMTIHQALEHPWLTP--------GNAPGRD 423
Query: 330 RPTMIDVAKQIKKMYKS 346
+I+ K+
Sbjct: 424 SQIPSSRYTKIRDSIKT 440
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 59/254 (23%), Positives = 101/254 (39%), Gaps = 50/254 (19%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
++ H N+++L + +V E G L D + + SE +I ++
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII-KRKRFSE----HDAARIIKQVF 131
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
+ Y+H IV RDLK IL+ + K+ +F LS + D GT
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGT 186
Query: 231 SGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESFEM 282
+ +APE R Y +EKCDV+S G++L LLS D+ G +F++
Sbjct: 187 AYYIAPEVLRGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDL 243
Query: 283 -----------DFVKKYIENRGFNGIVDP--RIIGDELLEHK-LQSSFELAFQCQSASAE 328
D ++K + P RI + LEH +Q + ++ +
Sbjct: 244 PQWRTISDDAKDLIRKMLT-------FHPSLRITATQCLEHPWIQK-----YSSETPTIS 291
Query: 329 DRPTMIDVAKQIKK 342
D P++ I++
Sbjct: 292 DLPSLESAMTNIRQ 305
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 36/164 (21%), Positives = 63/164 (38%), Gaps = 23/164 (14%)
Query: 111 FASQMSHNNVLRLI-----GCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
F +++ H +++++ + +V E +L + L +
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEA 184
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
+ +EI +YLH S +V+ DLK I+++E + KL + + I
Sbjct: 185 IAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRI--NSF---G 235
Query: 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFN 269
+ GT G APE RTG D+Y+ G L L N
Sbjct: 236 YLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALT-LDLPTRN 277
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-11
Identities = 53/256 (20%), Positives = 94/256 (36%), Gaps = 53/256 (20%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD-LLKRSYQSH--SEPLLLKHRLKIAM 170
+ H +++ L+ + +VFE + +L ++KR+ SE
Sbjct: 82 MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE----AVASHYMR 137
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP---KLFNFSLSASIPEGETYIDDGV 227
+I Y H I+ RD+K +L++ + KL F ++ + E V
Sbjct: 138 QILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 228 KGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLS-------TGEDLFNMGLRLNGDES 279
GT +APE R Y + DV+ G++L LLS T E LF ++ G
Sbjct: 195 -GTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK--GKYK 250
Query: 280 FEM-----------DFVKKYIENRGFNGIVDP--RIIGDELLEHKLQSSFELAFQCQSAS 326
D V++ + +DP RI E L H + +
Sbjct: 251 MNPRQWSHISESAKDLVRRMLM-------LDPAERITVYEALNHP--------WLKERDR 295
Query: 327 AEDRPTMIDVAKQIKK 342
+ + + +Q++K
Sbjct: 296 YAYKIHLPETVEQLRK 311
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 8e-11
Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 44/221 (19%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
++ H N+++L + +V E G L D + + SE +I ++
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII-KRKRFSE----HDAARIIKQVF 131
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
+ Y+H IV RDLK IL+ + K+ +F LS + D GT
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGT 186
Query: 231 SGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESFEM 282
+ +APE R Y +EKCDV+S G++L LLS D+ G +F++
Sbjct: 187 AYYIAPEVLRGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDL 243
Query: 283 -----------DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
D ++K + P RI + LEH
Sbjct: 244 PQWRTISDDAKDLIRKMLT-------FHPSLRITATQCLEH 277
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 39/186 (20%), Positives = 76/186 (40%), Gaps = 21/186 (11%)
Query: 85 DRTISVVKFIDGSVFDAYD--CCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142
D V+K I+ S + + + + M H N+++ E +V + E
Sbjct: 48 DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 143 GNLHDLLKRSYQSH-SEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE 201
G+L + E + L ++I ++H R I+ RD+KS I +++
Sbjct: 108 GDLFKRINAQKGVLFQEDQI----LDWFVQICLALKHVH---DRKILHRDIKSQNIFLTK 160
Query: 202 RYVPKL--FNFS--LSASIPEGETYIDDGVKGTSGIVAPE-YARTGYLNEKCDVYSFGLL 256
+L F + L++++ I GT ++PE Y N K D+++ G +
Sbjct: 161 DGTVQLGDFGIARVLNSTVELARACI-----GTPYYLSPEICENKPY-NNKSDIWALGCV 214
Query: 257 LLQLLS 262
L +L +
Sbjct: 215 LYELCT 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 53/249 (21%), Positives = 82/249 (32%), Gaps = 75/249 (30%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEY---------GNLHDLLKRSYQSHSEPLLLKHR-- 165
H NV+R + + NL DL++ S L K
Sbjct: 68 HPNVIRYYC----------SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP-------------KLFNFSL 212
+ + +IA+ A+LH S I+ RDLK ILVS + +F L
Sbjct: 118 ISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 213 SASIPEGETYIDDGVK---GTSGIVAPE-------YARTGYLNEKCDVYSFGLLLLQLLS 262
+ G++ + GTSG APE L D++S G + +LS
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 263 TGEDLFNMGLR-----LNGDESFEM--------------DFVKKYIENRGFNGIVDP--R 301
G+ F + G S + D + + I+ DP R
Sbjct: 235 KGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMID-------HDPLKR 287
Query: 302 IIGDELLEH 310
++L H
Sbjct: 288 PTAMKVLRH 296
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 40/189 (21%), Positives = 65/189 (34%), Gaps = 21/189 (11%)
Query: 85 DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV----LVFESA 140
D +K I + +H N+LRL+ CL L+
Sbjct: 53 DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112
Query: 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS 200
+ G L + ++R L L + + I +H ++ RDLK + IL+
Sbjct: 113 KRGTLWNEIERLKDKG-NFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLG 168
Query: 201 ERYVPKL--FNFSLSASIP-----EGETYIDDGVK-GTSGIVAPE----YARTGYLNEKC 248
+ P L A I + T D + T APE + +E+
Sbjct: 169 DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI-DERT 227
Query: 249 DVYSFGLLL 257
DV+S G +L
Sbjct: 228 DVWSLGCVL 236
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 3e-10
Identities = 46/221 (20%), Positives = 76/221 (34%), Gaps = 44/221 (19%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
+ H N++RL + LV E G L + + + E +I ++
Sbjct: 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV-HKRVFRE----SDAARIMKDVL 116
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
+ AY H + RDLK L S KL +F L+A G+ GT
Sbjct: 117 SAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGT 171
Query: 231 SGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESFEM 282
V+P+ Y +CD +S G+++ LL T ++ G +F
Sbjct: 172 PYYVSPQVLEGLY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE--GTFTFPE 228
Query: 283 -----------DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
+++ + P RI + LEH
Sbjct: 229 KDWLNVSPQAESLIRRLLT-------KSPKQRITSLQALEH 262
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 5e-10
Identities = 60/413 (14%), Positives = 135/413 (32%), Gaps = 103/413 (24%)
Query: 1 MALCTGQTSLFM--CNSKNREKA-DRKAFLMRNGK--------MFLERLISSCNGNYN-- 47
+ G+T + + C S + D K F + L++L+ + N+
Sbjct: 158 VLGS-GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 48 -------PIRSFSAK-ELERATNNYHYRN--II----TESSIFRL----CQGVLPDRTIS 89
+R S + EL R + Y N ++ + + C+ +L R
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 90 VVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLL 149
V F+ + +++ + + V L+ L+ L
Sbjct: 277 VTDFLSAATTTHISLDHHSMTL----TPDEVKSLLLKYLDCRP--------------QDL 318
Query: 150 KRSYQSHSEPLLLKHRLKIAMEIANVFA----YLHIGFSRPIVFRDLKSSY-----ILVS 200
R + + P L IA I + A + H+ + + ++SS
Sbjct: 319 PREVLTTN-PRRLS---IIAESIRDGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYR 372
Query: 201 ERYVPKLFNFSLSASIPEG--ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLL 258
+ + +L F SA IP D +K +V + + + ++ + + +
Sbjct: 373 KMFD-RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI 431
Query: 259 QLLSTGEDLFNMGLRLNGDESFEM--DFVKKYIENRGF--NGIVDPRI-------IG--- 304
L L++ + + + V Y + F + ++ P + IG
Sbjct: 432 YLE----------LKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHL 481
Query: 305 DELLEHKLQSSFELAFQ---------CQSASAEDRP-TMIDVAKQIKKMYKSF 347
+ + + F + F ++A + ++++ +Q+K YK +
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF-YKPY 533
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 8e-04
Identities = 49/300 (16%), Positives = 103/300 (34%), Gaps = 72/300 (24%)
Query: 56 ELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQM 115
+ E + Y Y++I+ S+F + + V+ + S+ + + + S+
Sbjct: 8 DFETGEHQYQYKDIL---SVFE--DAFVDNFDCKDVQDMPKSILSKEEI---DHIIMSKD 59
Query: 116 SHNNVLRLIGCCLE-----VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLL----KHRL 166
+ + LRL L V+ V Y L +K + S + + RL
Sbjct: 60 AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRL 119
Query: 167 KIAMEIANVFAYLHIGFSRPIVFRDLKSS-YILVSERYVPKLFNFSLSASIPEGETYIDD 225
VFA ++ SR + L+ + L + V + D
Sbjct: 120 ---YNDNQVFAKYNV--SRLQPYLKLRQALLELRPAKNV------------------LID 156
Query: 226 GVKGTSG--IVAPEYARTGYLNEKCD--VY--SFG--------LLLLQLLSTGEDLFNMG 271
GV G SG VA + + + K D ++ + L +LQ L D N
Sbjct: 157 GVLG-SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP-NWT 214
Query: 272 LRLNGDESFEM------DFVKKYIENRGFNGIVDPR--IIGDELLEHKLQSSFELAFQCQ 323
R + + ++ +++ ++++ + ++ + K ++F C+
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKPY-----ENCLLVLLNVQNAKAWNAFN--LSCK 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 5e-10
Identities = 45/223 (20%), Positives = 90/223 (40%), Gaps = 45/223 (20%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD--LLKRSYQSH-SEPLLLKHRLKIAM 170
+ H N++++ + +V E+ E G L + + ++ SE + ++
Sbjct: 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE----GYVAELMK 131
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSASIPEGETYIDDGV 227
++ N AY H S+ +V +DLK IL S K+ +F L+ E +
Sbjct: 132 QMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--A 186
Query: 228 KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDES 279
GT+ +APE + KCD++S G+++ LL+ + E++ + +
Sbjct: 187 AGTALYMAPEVFKRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY--KEPN 243
Query: 280 FE----------MDFVKKYIENRGFNGIVDP--RIIGDELLEH 310
+ +D +K+ + DP R ++L H
Sbjct: 244 YAVECRPLTPQAVDLLKQMLT-------KDPERRPSAAQVLHH 279
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 6e-10
Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 9/154 (5%)
Query: 112 ASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
+SQ+SH N++ +I E + LV E E L + ++ PL + + +
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQ 119
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
I + + H IV RD+K IL+ K+F+F ++ ++ E + V GT
Sbjct: 120 ILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176
Query: 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
+PE A+ +E D+YS G++L ++L GE
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEML-VGE 209
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 46/265 (17%), Positives = 91/265 (34%), Gaps = 60/265 (22%)
Query: 115 MSHNNVLRLIGCCLEVEIPV----LVFESAEYGNLHD-LLKRSYQSHSEPLLLKHRLKIA 169
+++ ++ + ++ E E G L + +R Q+ +E + +I
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE----REAAEIM 134
Query: 170 MEIANVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSASIPEGETYIDDG 226
+I +LH S I RD+K +L + V KL +F + +
Sbjct: 135 RDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ---T 188
Query: 227 VKGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLR--LN 275
T VAPE Y ++ CD++S G+++ LL TG+ + R
Sbjct: 189 PCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247
Query: 276 GDESFEM-----------DFVKKYIENRGFNGIVDP--RIIGDELLEHKLQSSFELAFQC 322
G F ++ ++ DP R+ + + H +
Sbjct: 248 GQYGFPNPEWSEVSEDAKQLIRLLLK-------TDPTERLTITQFMNHP--------WIN 292
Query: 323 QSASAEDRPTMIDVAKQIKKMYKSF 347
QS P + A+ +++ +
Sbjct: 293 QSMVVPQTP--LHTARVLQEDKDHW 315
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 8e-10
Identities = 56/222 (25%), Positives = 84/222 (37%), Gaps = 48/222 (21%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVF 176
H N+++L LVF+ + G L D L + SE K KI + V
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSE----KETRKIMRALLEVI 137
Query: 177 AYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAP 236
LH IV RDLK IL+ + KL +F S + GE + V GT +AP
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--VCGTPSYLAP 192
Query: 237 E-------YARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESFE 281
E GY ++ D++S G+++ LL+ + M + G+ F
Sbjct: 193 EIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--GNYQFG 249
Query: 282 M-----------DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
D V +++ V P R +E L H
Sbjct: 250 SPEWDDYSDTVKDLVSRFLV-------VQPQKRYTAEEALAH 284
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 35/155 (22%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
Q++H NV++ +E +V E A+ G+L ++K ++ + + K +++
Sbjct: 87 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH-FKKQKRLIPERTVWKYFVQL 145
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL--FNFS--LSASIPEGETYIDDGVK 228
+ ++H SR ++ RD+K + + ++ V KL S+ + +
Sbjct: 146 CSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----- 197
Query: 229 GTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLS 262
GT ++PE GY N K D++S G LL ++ +
Sbjct: 198 GTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAA 231
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 37/176 (21%), Positives = 71/176 (40%), Gaps = 28/176 (15%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPV----------------LVFESAEYGNLHDLLKRSYQSH 156
+++ H N++ GC + + E + G L +++
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 157 -SEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215
+ L L+ + +I Y+H S+ ++ RDLK S I + + K+ +F L S
Sbjct: 119 LDKVLALE----LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 216 IPEGETYIDDGVKGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270
+ KGT ++PE + Y ++ D+Y+ GL+L +LL + F
Sbjct: 172 LKNDGKR--TRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET 224
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 41/192 (21%), Positives = 78/192 (40%), Gaps = 24/192 (12%)
Query: 85 DRTISVVKFIDGSVFDAYDC--CFNNIVFASQMSHNNVLRLIGCCLEVEIPVL--VFESA 140
D I V K +D + + + ++ H N++R ++ L V E
Sbjct: 30 DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 141 EYGNLHDLLKRSYQSH---SEPLLLKHRLKIAMEIANVFAYLH--IGFSRPIVFRDLKSS 195
E G+L ++ + + E +L+ + ++ H ++ RDLK +
Sbjct: 90 EGGDLASVITKGTKERQYLDEEFVLR----VMTQLTLALKECHRRSDGGHTVLHRDLKPA 145
Query: 196 YILVSERYVPKL--FNFS--LSASIPEGETYIDDGVKGTSGIVAPE-YARTGYLNEKCDV 250
+ + + KL F + L+ +T++ GT ++PE R Y NEK D+
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-----GTPYYMSPEQMNRMSY-NEKSDI 199
Query: 251 YSFGLLLLQLLS 262
+S G LL +L +
Sbjct: 200 WSLGCLLYELCA 211
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 57/258 (22%), Positives = 98/258 (37%), Gaps = 52/258 (20%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q+ H+NV+ L VL+ E G L D L + +S SE + +I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSE----EEATSFIKQIL 125
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVP----KLFNFSLSASIPEGETYIDDGVKG 229
+ YLH ++ I DLK I++ ++ +P KL +F L+ I +G + + + G
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFG 180
Query: 230 TSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESFE 281
T VAPE L + D++S G++ LLS T ++ F+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS--VSYDFD 238
Query: 282 -----------MDFVKKYIENRGFNGIVDP--RIIGDELLEHK-LQSSFELAFQCQSASA 327
DF++K + + + R+ E L H + + A
Sbjct: 239 EEFFSHTSELAKDFIRKLL-------VKETRKRLTIQEALRHPWIT-------PVDNQQA 284
Query: 328 EDRPTMIDVAKQIKKMYK 345
R + + +K Y
Sbjct: 285 MVRRESVVNLENFRKQYV 302
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 50/223 (22%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHD-LLKRSYQSHSEPLLLKHRLKIAMEIANV 175
H +++ LI LVF+ G L D L ++ + SE K I +
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSE----KETRSIMRSLLEA 212
Query: 176 FAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVA 235
++LH + IV RDLK IL+ + +L +F S + GE + + GT G +A
Sbjct: 213 VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGYLA 267
Query: 236 PE-------YARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESF 280
PE GY ++ D+++ G++L LL+ + M + G F
Sbjct: 268 PEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME--GQYQF 324
Query: 281 EM-----------DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
D + + ++ VDP R+ ++ L+H
Sbjct: 325 SSPEWDDRSSTVKDLISRLLQ-------VDPEARLTAEQALQH 360
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 37/160 (23%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 112 ASQMSHNNVLRL--IGC--CLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLK 167
A+ ++H ++ + G +P +V E + L D++ P+ K ++
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIE 120
Query: 168 IAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI--DD 225
+ + + H I+ RD+K + I++S K+ +F ++ +I + +
Sbjct: 121 VIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
V GT+ ++PE AR ++ + DVYS G +L ++L TGE
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL-TGE 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 57/258 (22%), Positives = 97/258 (37%), Gaps = 52/258 (20%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
Q+ H N++ L VL+ E G L D L + +S SE + +I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSE----EEATSFIKQIL 125
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVP----KLFNFSLSASIPEGETYIDDGVKG 229
+ YLH ++ I DLK I++ ++ +P KL +F L+ I +G + + + G
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFG 180
Query: 230 TSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESFE 281
T VAPE L + D++S G++ LLS T ++ F+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA--VSYDFD 238
Query: 282 -----------MDFVKKYIENRGFNGIVDP--RIIGDELLEHK-LQSSFELAFQCQSASA 327
DF++K + + + R+ E L H + + A
Sbjct: 239 EEFFSQTSELAKDFIRKLL-------VKETRKRLTIQEALRHPWIT-------PVDTQQA 284
Query: 328 EDRPTMIDVAKQIKKMYK 345
R + + KK Y
Sbjct: 285 MVRRESVVNLENFKKQYV 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 40/173 (23%), Positives = 67/173 (38%), Gaps = 30/173 (17%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPV------------LVFESAEYGNLHDLLKRSYQSHSEPL 160
+++ H ++R LE + + NL D + + E
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEER 115
Query: 161 LLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI---- 216
L I ++IA +LH S+ ++ RDLK S I + V K+ +F L ++
Sbjct: 116 ERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 217 -------PEGETYIDDGVKGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLL 261
P G GT ++PE Y + K D++S GL+L +LL
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELL 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 7e-09
Identities = 38/150 (25%), Positives = 64/150 (42%), Gaps = 13/150 (8%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
S + H N+LRL G + L+ E A G ++ L++ E E+
Sbjct: 64 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQ----RTATYITEL 118
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
AN +Y H S+ ++ RD+K +L+ K+ +F S P + GT
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLD 172
Query: 233 IVAPE-YARTGYLNEKCDVYSFGLLLLQLL 261
+ PE + +EK D++S G+L + L
Sbjct: 173 YLPPEMIEGRMH-DEKVDLWSLGVLCYEFL 201
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 32/155 (20%), Positives = 66/155 (42%), Gaps = 12/155 (7%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLL---KRSYQSHSEPLLLKHRLKI 168
+ + + L G + V +++E E ++ ++++ + ++ I
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
+ N F+Y+H + I RD+K S IL+ + KL +F S + + + G +
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK---GSR 211
Query: 229 GTSGIVAPE--YARTGYLNEKCDVYSFGLLLLQLL 261
GT + PE + Y K D++S G+ L +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 20/167 (11%)
Query: 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSS 195
+ NL D + R + E L I ++IA +LH S+ ++ RDLK S
Sbjct: 139 QMQLCRKENLKDWMNR--RCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPS 193
Query: 196 YILVSERYVPKLFNFSLSASIPEGE------TYIDDGVKGTSGI-----VAPE-YARTGY 243
I + V K+ +F L ++ + E T + T + ++PE Y
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253
Query: 244 LNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG--DESFEMDFVKKY 288
+ K D++S GL+L +LL + + + F + F +KY
Sbjct: 254 -SHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKY 299
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 12/118 (10%)
Query: 153 YQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212
+ + L L+H + + ++A +L SR + RDL + IL+SE+ V K+ +F L
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGL 239
Query: 213 SASIPEGETYIDDGVKGTSGIV-----APEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
+ I + Y V+ + APE + DV+SFG+LL ++ S G
Sbjct: 240 ARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 14/60 (23%), Positives = 24/60 (40%), Gaps = 1/60 (1%)
Query: 116 SHNNVLRLIGCCLEVEIPVLV-FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174
H NV+ L+G C + P++V E ++GNL L+ R + +
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 34/182 (18%), Positives = 63/182 (34%), Gaps = 28/182 (15%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSH---SEPLLLKHR 165
A H++V+R E + ++ E G+L D + +Y+ E L
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD-- 119
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI-- 223
+ +++ Y+H S +V D+K S I +S +P + +
Sbjct: 120 --LLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 224 --DDGV----------KGTSGIVAPE--YARTGYLNEKCDVYSFGLLLLQLLSTGEDLFN 269
D G +G S +A E + K D+++ L ++ E L
Sbjct: 175 IGDLGHVTRISSPQVEEGDSRFLANEVLQENYTH-LPKADIFALALTVVCAA-GAEPLPR 232
Query: 270 MG 271
G
Sbjct: 233 NG 234
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 40/228 (17%), Positives = 74/228 (32%), Gaps = 53/228 (23%)
Query: 117 HNNVLRLIGCCLEVEIPV----LVFESAEYGNLHD-LLKRSYQSHSEPLLLKHRLKIAME 171
+++R++ + +V E + G L + R Q+ +E + +I
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE----REASEIMKS 169
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSASIPEGETYIDDGVK 228
I YLH S I RD+K +L + KL +F + +
Sbjct: 170 IGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PC 224
Query: 229 GTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLS------------TGEDLFNMGLRLN 275
T VAPE Y ++ CD++S G+++ LL +
Sbjct: 225 YTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-- 281
Query: 276 GDESFEM-----------DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
G F ++ ++ +P R+ E + H
Sbjct: 282 GQYEFPNPEWSEVSEEVKMLIRNLLK-------TEPTQRMTITEFMNH 322
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 31/159 (19%), Positives = 53/159 (33%), Gaps = 24/159 (15%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSH-SEPLLLKHRLK 167
+ + +H N++ + +V YG+ DL+ + +E
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA------- 129
Query: 168 IAM---EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID 224
IA + Y+H V R +K+S+IL+S L + S+
Sbjct: 130 IAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186
Query: 225 DGVKGTSGIV------APE---YARTGYLNEKCDVYSFG 254
V +PE GY + K D+YS G
Sbjct: 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVG 224
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 44/231 (19%), Positives = 83/231 (35%), Gaps = 51/231 (22%)
Query: 113 SQMSHNN--VLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM 170
+++ ++ ++RL + + +V E +L+ LK+ +S
Sbjct: 81 NKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-KKSIDPWERKS----YWK 134
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI-DDGVKG 229
+ +H IV DLK + L+ + + KL +F ++ + T + D G
Sbjct: 135 NMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVG 190
Query: 230 TSGIVAPE-----------YARTGYLNEKCDVYSFGLLLLQLLSTG----EDLFNMGLRL 274
T + PE ++ K DV+S G +L + G + + N +L
Sbjct: 191 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIINQISKL 249
Query: 275 ----NGDESFEM---------DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
+ + E D +K ++ DP RI ELL H
Sbjct: 250 HAIIDPNHEIEFPDIPEKDLQDVLKCCLK-------RDPKQRISIPELLAH 293
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 28/128 (21%), Positives = 50/128 (39%), Gaps = 12/128 (9%)
Query: 141 EY---GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYI 197
+L +L+R PL + I +I + H + RD+K I
Sbjct: 114 RLINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENI 165
Query: 198 LVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLL 257
LVS L +F ++++ + + GT +APE + + D+Y+ +L
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVL 225
Query: 258 LQLLSTGE 265
+ L TG
Sbjct: 226 YECL-TGS 232
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 36/162 (22%), Positives = 68/162 (41%), Gaps = 24/162 (14%)
Query: 114 QMSHNNVLRLI------GCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLK 167
+++H NV+ ++P+L E E G+L L + + L
Sbjct: 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ--FENCCGLKEGPIRT 125
Query: 168 IAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS---ERYVPKLFNFSLSASIPEGE---T 221
+ +I++ YLH I+ RDLK I++ +R + K+ + + + +GE
Sbjct: 126 LLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182
Query: 222 YIDDGVKGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLS 262
++ GT +APE + Y D +SFG L + ++
Sbjct: 183 FV-----GTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECIT 218
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 51/243 (20%), Positives = 83/243 (34%), Gaps = 41/243 (16%)
Query: 91 VKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK 150
K I + N I +Q+ H N+++L VLV E + G L D +
Sbjct: 119 AKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178
Query: 151 RSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP--KLF 208
+ +E + +I ++H I+ DLK IL R K+
Sbjct: 179 DESYNLTE----LDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKII 231
Query: 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS------ 262
+F L+ E GT +APE +++ D++S G++ LLS
Sbjct: 232 DFGLARRYKPREKLKV--NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289
Query: 263 --TGEDLFNMGLRLNGDESFE-----------MDFVKKYIENRGFNGIVDP--RIIGDEL 307
+ N L E +F+ K + I + RI E
Sbjct: 290 GDNDAETLNNILA--CRWDLEDEEFQDISEEAKEFISKLL-------IKEKSWRISASEA 340
Query: 308 LEH 310
L+H
Sbjct: 341 LKH 343
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 58/256 (22%), Positives = 98/256 (38%), Gaps = 52/256 (20%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
++ H NV+ L +L+ E G L D L +S +E + + +I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTE----EEATEFLKQIL 124
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVP----KLFNFSLSASIPEGETYIDDGVKG 229
N YLH S I DLK I++ +R VP K+ +F L+ I G + + + G
Sbjct: 125 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFG 179
Query: 230 TSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESFE 281
T VAPE L + D++S G++ LLS T ++ + FE
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA--VNYEFE 237
Query: 282 -----------MDFVKKYIENRGFNGIVDP--RIIGDELLEHK-LQSSFELAFQCQSASA 327
DF+++ + + DP R+ + L+H ++ + A
Sbjct: 238 DEYFSNTSALAKDFIRRLL-------VKDPKKRMTIQDSLQHPWIKPK-------DTQQA 283
Query: 328 EDRPTMIDVAKQIKKM 343
R ++ KK
Sbjct: 284 LSRKASAVNMEKFKKF 299
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 35/159 (22%), Positives = 61/159 (38%), Gaps = 16/159 (10%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
+ +S ++ L G E + E E G+L L+K+ E L +
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ-MGCLPEDRALY----YLGQA 159
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP-KLFNFSLSASIPE----GETYIDDGV 227
YLH +R I+ D+K+ +L+S L +F + + D +
Sbjct: 160 LEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 228 KGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLSTGE 265
GT +APE + K D++S ++L +L G
Sbjct: 217 PGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHML-NGC 253
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 52/226 (23%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEP---LLLKHRLKIAM 170
++ H N++ L VL+ E G L D L +S +E LK
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQ------ 116
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP----KLFNFSLSASIPEGETYIDDG 226
I + YLH S+ I DLK I++ ++ VP KL +F ++ I G + +
Sbjct: 117 -ILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-- 170
Query: 227 VKGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGD 277
+ GT VAPE + D++S G++ LLS T ++ +
Sbjct: 171 IFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISA--VN 227
Query: 278 ESFEM-----------DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
F+ DF+++ + + DP R+ + LEH
Sbjct: 228 YDFDEEYFSNTSELAKDFIRRLL-------VKDPKRRMTIAQSLEH 266
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 6e-08
Identities = 42/175 (24%), Positives = 81/175 (46%), Gaps = 20/175 (11%)
Query: 91 VKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK 150
VK +D + FN +V H NV+ + L E ++ E + G L D++
Sbjct: 75 VKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS 134
Query: 151 RSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL--F 208
+ L + + + AYLH ++ ++ RD+KS IL++ KL F
Sbjct: 135 QV------RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDF 185
Query: 209 NFS--LSASIPEGETYIDDGVKGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQL 260
F +S +P+ ++ + GT +APE +R+ Y + D++S G++++++
Sbjct: 186 GFCAQISKDVPKRKSLV-----GTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEM 234
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 44/225 (19%), Positives = 79/225 (35%), Gaps = 49/225 (21%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVF 176
+ ++RL + + +V E +L+ LK+ +S +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-KKSIDPWERKS----YWKNMLEAV 121
Query: 177 AYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGIVA 235
+H IV DLK + L+ + + KL +F ++ + T + D GT +
Sbjct: 122 HTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 236 PE-----------YARTGYLNEKCDVYSFGLLLLQLLSTG----EDLFNMGLRL----NG 276
PE ++ K DV+S G +L + G + + N +L +
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIINQISKLHAIIDP 236
Query: 277 DESFEM---------DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
+ E D +K ++ DP RI ELL H
Sbjct: 237 NHEIEFPDIPEKDLQDVLKCCLK-------RDPKQRISIPELLAH 274
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 50/280 (17%), Positives = 86/280 (30%), Gaps = 49/280 (17%)
Query: 91 VKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK 150
KFI+ N I +Q+ H ++ L + VL+ E G L D +
Sbjct: 81 AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140
Query: 151 RSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP--KLF 208
SE + + ++H IV D+K I+ + K+
Sbjct: 141 AEDYKMSE----AEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 193
Query: 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS------ 262
+F L+ + E T+ APE + D+++ G+L LLS
Sbjct: 194 DFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251
Query: 263 --TGEDLFNMGLRLNGDESFE-----------MDFVKKYIENRGFNGIVDP--RIIGDEL 307
+ R D F+ DF+K + +P R+ +
Sbjct: 252 GEDDLETLQNVKR--CDWEFDEDAFSSVSPEAKDFIKNLL-------QKEPRKRLTVHDA 302
Query: 308 LEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347
LEH + S +I++ K
Sbjct: 303 LEHP--------WLKGDHSNLTSRIPSSRYNKIRQKIKEK 334
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 52/225 (23%), Positives = 85/225 (37%), Gaps = 48/225 (21%)
Query: 114 QMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIA 173
+++H ++++ + +V E E G L D + + + E ++
Sbjct: 196 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN-KRLKE----ATCKLYFYQML 249
Query: 174 NVFAYLHIGFSRPIVFRDLKSSYILVSERYVP---KLFNFSLSASIPEGETYIDDGVKGT 230
YLH I+ RDLK +L+S + K+ +F S + E + GT
Sbjct: 250 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGT 304
Query: 231 SGIVAPE----YARTGYLNEKCDVYSFGLLLLQLLSTG-----EDLFNMGLR---LNGDE 278
+APE GY N D +S G++L LS G E + L+ +G
Sbjct: 305 PTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLS-GYPPFSEHRTQVSLKDQITSGKY 362
Query: 279 SFE-----------MDFVKKYIENRGFNGIVDP--RIIGDELLEH 310
+F +D VKK + VDP R +E L H
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLV-------VDPKARFTTEEALRH 400
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 8e-08
Identities = 66/280 (23%), Positives = 96/280 (34%), Gaps = 61/280 (21%)
Query: 91 VKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD--L 148
+K I S N I ++ H N++ L LV + G L D L
Sbjct: 39 LKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL 98
Query: 149 LKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV---SERYVP 205
+ Y +E K + ++ + YLH IV RDLK +L E
Sbjct: 99 ERGVY---TE----KDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKI 148
Query: 206 KLFNFSLSASIPEGETYIDDGVKGTSGIVAPEY-ARTGYLNEKCDVYSFGLLLLQLLS-- 262
+ +F LS G GT G VAPE A+ Y ++ D +S G++ LL
Sbjct: 149 MITDFGLSKMEQNGIMS---TACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGY 204
Query: 263 ------TGEDLFNMGLRLNGDESFEM-----------DFVKKYIENRGFNGIVDP--RII 303
T LF G FE DF+ +E DP R
Sbjct: 205 PPFYEETESKLFEKIKE--GYYEFESPFWDDISESAKDFICHLLE-------KDPNERYT 255
Query: 304 GDELLEHK-LQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342
++ L H + + +A R V+ QI+K
Sbjct: 256 CEKALSHPWIDGN----------TALHRDIYPSVSLQIQK 285
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 8e-08
Identities = 35/175 (20%), Positives = 71/175 (40%), Gaps = 20/175 (11%)
Query: 91 VKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK 150
++ ++ + N I+ + + N++ + L + +V E G+L D++
Sbjct: 50 IRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109
Query: 151 RSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL--F 208
+ + + E +LH S ++ RD+KS IL+ KL F
Sbjct: 110 ET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 160
Query: 209 NFS--LSASIPEGETYIDDGVKGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQL 260
F ++ + T + GT +APE R Y K D++S G++ +++
Sbjct: 161 GFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEM 209
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 54/257 (21%), Positives = 89/257 (34%), Gaps = 60/257 (23%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHD--LLKRSYQSHSEPLLLKHRLKIAMEIAN 174
H N++ L + + +V E + G L D L ++ + SE + + I
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF---SE----REASAVLFTITK 127
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILVSER----YVPKLFNFSLSASIPEGETYIDDGVKGT 230
YLH ++ +V RDLK S IL + ++ +F + + + T
Sbjct: 128 TVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YT 183
Query: 231 SGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLS-----------TGEDLFNMGLRLNGDE 278
+ VAPE R GY + CD++S G+LL +L+ T E++ G
Sbjct: 184 ANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS--GKF 240
Query: 279 SFEM-----------DFVKKYIENRGFNGIVDP--RIIGDELLEHKLQSSFELAFQCQSA 325
S D V K + VDP R+ +L H +
Sbjct: 241 SLSGGYWNSVSDTAKDLVSKMLH-------VDPHQRLTAALVLRHP--------WIVHWD 285
Query: 326 SAEDRPTMIDVAKQIKK 342
A + K
Sbjct: 286 QLPQYQLNRQDAPHLVK 302
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 47/255 (18%), Positives = 91/255 (35%), Gaps = 53/255 (20%)
Query: 91 VKFIDGSVFDAYDC--CFNNIVFASQMSHNN--VLRLIGCCLEVEIPVLVFESAEYGNLH 146
+K+++ D N I + +++ ++ ++RL + + +V E +L+
Sbjct: 85 IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLN 143
Query: 147 DLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPK 206
LK+ +S + +H IV DLK + L+ + + K
Sbjct: 144 SWLKK-KKSIDPWERKS----YWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-K 194
Query: 207 LFNFSLSASIPEGETYI-DDGVKGTSGIVAPE-----------YARTGYLNEKCDVYSFG 254
L +F ++ + T + D G + PE ++ K DV+S G
Sbjct: 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254
Query: 255 LLLLQLLSTG----EDLFNMGLRL----NGDESFEM---------DFVKKYIENRGFNGI 297
+L + G + + N +L + + E D +K ++
Sbjct: 255 CILYYMT-YGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLK------- 306
Query: 298 VDP--RIIGDELLEH 310
DP RI ELL H
Sbjct: 307 RDPKQRISIPELLAH 321
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 53/266 (19%), Positives = 97/266 (36%), Gaps = 56/266 (21%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHD--LLKRSYQSHSEPLLLKHRLKIAMEIAN 174
H N+++L + LV E G L + K+ + SE I ++ +
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHF---SE----TEASYIMRKLVS 117
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
+++H +V RDLK +L ++ K+ +F + P + T
Sbjct: 118 AVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173
Query: 232 GIVAPE-YARTGYLNEKCDVYSFGLLLLQLLS---------------TGEDLFNMGLRLN 275
APE + GY +E CD++S G++L +LS + ++ +
Sbjct: 174 HYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK-- 230
Query: 276 GDESFEM-----------DFVKKYIENRGFNGIVDP--RIIGDELLEHK-LQSSFELAFQ 321
GD SFE D ++ + VDP R+ L ++ LQ +L+
Sbjct: 231 GDFSFEGEAWKNVSQEAKDLIQGLLT-------VDPNKRLKMSGLRYNEWLQDGSQLSSN 283
Query: 322 CQSASAEDRPTMIDVAKQIKKMYKSF 347
+ V +K + +F
Sbjct: 284 PLMTPDILGSSGAAVHTCVKATFHAF 309
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 35/159 (22%), Positives = 63/159 (39%), Gaps = 30/159 (18%)
Query: 107 NNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRL 166
I Q +V++ G + +V E G++ D+++ ++ +E
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED------- 125
Query: 167 KIAMEIANV-------FAYLHIGFSRPIVFRDLKSSYILVSERYVPKL--FNFS--LSAS 215
EIA + YLH + RD+K+ IL++ KL F + L+ +
Sbjct: 126 ----EIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178
Query: 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFG 254
+ + T I GT +APE + N D++S G
Sbjct: 179 MAKRNTVI-----GTPFWMAPEVIQEIGYNCVADIWSLG 212
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 37/200 (18%), Positives = 68/200 (34%), Gaps = 27/200 (13%)
Query: 85 DRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIP-------VLV 136
+K + + + + F ++S H N+++ + L+
Sbjct: 52 SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111
Query: 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSY 196
G L + LK+ PL LKI + ++H PI+ RDLK
Sbjct: 112 LTELCKGQLVEFLKK--MESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVEN 168
Query: 197 ILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGI------------VAPE---YART 241
+L+S + KL +F SA+ + + + PE
Sbjct: 169 LLLSNQGTIKLCDFG-SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 242 GYLNEKCDVYSFGLLLLQLL 261
+ EK D+++ G +L L
Sbjct: 228 FPIGEKQDIWALGCILYLLC 247
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 7e-07
Identities = 35/150 (23%), Positives = 64/150 (42%), Gaps = 13/150 (8%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
S + H N+LR+ + + L+ E A G L+ L++ E + + E+
Sbjct: 69 SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQ---RSATFME-EL 123
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
A+ Y H R ++ RD+K +L+ + K+ +F S P + GT
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT---MCGTLD 177
Query: 233 IVAPE-YARTGYLNEKCDVYSFGLLLLQLL 261
+ PE + +EK D++ G+L + L
Sbjct: 178 YLPPEMIEGKTH-DEKVDLWCAGVLCYEFL 206
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 8e-07
Identities = 40/155 (25%), Positives = 63/155 (40%), Gaps = 20/155 (12%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
Q+ H ++L L E V LV E G ++ LK + SE + R +
Sbjct: 66 CQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN---EAR-HFMHQ 120
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK--- 228
I YLH S I+ RDL S +L++ K+ +F L+ +
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM-----PHEKHYTL 172
Query: 229 -GTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLL 261
GT ++PE R+ + + DV+S G + LL
Sbjct: 173 CGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLL 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 44/223 (19%), Positives = 76/223 (34%), Gaps = 49/223 (21%)
Query: 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD-LLKRSYQSHSEP---LLLKHRLKIAME 171
S V+ L +L+ E A G + L + SE L+K
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ------- 139
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP---KLFNFSLSASIPEGETYIDDGVK 228
I YLH IV DLK IL+S Y K+ +F +S I + +
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IM 194
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESF 280
GT +APE + D+++ G++ LL+ ++ + + + +
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ--VNVDY 252
Query: 281 EM-----------DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
DF++ + + +P R + L H
Sbjct: 253 SEETFSSVSQLATDFIQSLL-------VKNPEKRPTAEICLSH 288
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 40/168 (23%), Positives = 56/168 (33%), Gaps = 42/168 (25%)
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVS--ERYVPKLFNFSLSASIPEGETYIDDGVK- 228
I + YLH ++ I RD+K L S + + KL +F LS + G+
Sbjct: 177 IFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233
Query: 229 --GTSGIVAPE---YARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLN 275
GT VAPE Y KCD +S G+LL LL D + L
Sbjct: 234 KAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-- 290
Query: 276 GDESFEM-----------DFVKKYIENRGFNGIVDP--RIIGDELLEH 310
FE D + + + R L+H
Sbjct: 291 KKLCFENPNYNVLSPLARDLLSNLLN-------RNVDERFDAMRALQH 331
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 39/150 (26%), Positives = 63/150 (42%), Gaps = 18/150 (12%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
I SQ V + G L+ ++ E G+ DLL+ PL I
Sbjct: 71 ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------PGPLDETQIATI 124
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG----ETYID 224
EI YLH S + RD+K++ +L+SE KL +F ++ + + T++
Sbjct: 125 LREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV- 180
Query: 225 DGVKGTSGIVAPEYARTGYLNEKCDVYSFG 254
GT +APE + + K D++S G
Sbjct: 181 ----GTPFWMAPEVIKQSAYDSKADIWSLG 206
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 45/178 (25%), Positives = 73/178 (41%), Gaps = 32/178 (17%)
Query: 88 ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD 147
I + + + + + F ++ H N ++ GC L LV E G+ D
Sbjct: 84 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD 142
Query: 148 LLKRSYQSHSEPLLLKHRLKIAMEIANV-------FAYLHIGFSRPIVFRDLKSSYILVS 200
LL+ + E EIA V AYLH S ++ RD+K+ IL+S
Sbjct: 143 LLEVHKKPLQEV-----------EIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLS 188
Query: 201 ERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPE----YARTGYLNEKCDVYSFG 254
E + KL +F ++ + +++ GT +APE Y + K DV+S G
Sbjct: 189 EPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQY-DGKVDVWSLG 240
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 38/183 (20%), Positives = 74/183 (40%), Gaps = 18/183 (9%)
Query: 141 EY---GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYI 197
E+ G+L +LK++ E +L K +++ + YL I+ RD+K S I
Sbjct: 111 EHMDGGSLDQVLKKA-GRIPEQILGK----VSIAVIKGLTYLR--EKHKIMHRDVKPSNI 163
Query: 198 LVSERYVPKLFNFSLSASIPEG--ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGL 255
LV+ R KL +F +S + + +++ GT ++PE + + + + D++S GL
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYSVQSDIWSMGL 218
Query: 256 LLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSS 315
L++ ++ G + F E + + +
Sbjct: 219 SLVE-MAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277
Query: 316 FEL 318
FEL
Sbjct: 278 FEL 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 18/168 (10%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
I SQ H N++ + + LV + G++ D++K + I
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 169 AM---EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
A E+ YLH + RD+K+ IL+ E ++ +F +SA + G +
Sbjct: 124 ATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 226 GVKGTSGIV------APE--YARTGYLNEKCDVYSFGLLLLQLLSTGE 265
V+ T V APE GY + K D++SFG+ ++L TG
Sbjct: 181 KVRKT--FVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELA-TGA 224
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 38/162 (23%), Positives = 66/162 (40%), Gaps = 35/162 (21%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRL----- 166
++H +V+ G E V +V E +L +L KR + L
Sbjct: 96 RSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-----------RKALTEPEA 143
Query: 167 -KIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
+I YLH ++ RDLK + ++E K+ +F L+ + D
Sbjct: 144 RYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY------D 194
Query: 226 GVK-----GTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLL 261
G + GT +APE ++ G+ + + DV+S G ++ LL
Sbjct: 195 GERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLL 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 31/163 (19%), Positives = 65/163 (39%), Gaps = 21/163 (12%)
Query: 114 QMSHNNVLRLIGC--CLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
+++H N+++L VL+ E G+L+ +L+ S++ L L + +
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAYGLPESEFLIVLRD 120
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVS----ERYVPKLFNFSLSASIPEGETYIDDGV 227
+ +L IV R++K I+ + V KL +F + + + E ++ +
Sbjct: 121 VVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--L 175
Query: 228 KGTSGIVAPE-YARTGYL-------NEKCDVYSFGLLLLQLLS 262
GT + P+ Y R D++S G+ +
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 31/163 (19%), Positives = 65/163 (39%), Gaps = 21/163 (12%)
Query: 114 QMSHNNVLRLIGC--CLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
+++H N+++L VL+ E G+L+ +L+ S++ L L + +
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE--PSNAYGLPESEFLIVLRD 120
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVS----ERYVPKLFNFSLSASIPEGETYIDDGV 227
+ +L IV R++K I+ + V KL +F + + + E ++ +
Sbjct: 121 VVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--L 175
Query: 228 KGTSGIVAPE-YARTGYL-------NEKCDVYSFGLLLLQLLS 262
GT + P+ Y R D++S G+ +
Sbjct: 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 28/163 (17%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHD--LLKRSYQSHSEPLLLKHRLKIAMEIAN 174
H NVL LI E + LVFE G++ +R + +E + ++A+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHF---NE----LEASVVVQDVAS 122
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSASIPEGETYIDDGVK--- 228
+LH ++ I RDLK IL ++ K+ +F L + I
Sbjct: 123 ALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 229 ---GTSGIVAPE------YARTGYLNEKCDVYSFGLLLLQLLS 262
G++ +APE + Y +++CD++S G++L LLS
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLS 221
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 36/181 (19%), Positives = 70/181 (38%), Gaps = 37/181 (20%)
Query: 91 VKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK 150
K I+ + + I + H +++L+G ++ E G + ++
Sbjct: 49 AKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML 108
Query: 151 RSYQSHSEPLLLKHRLKIAMEIANV-------FAYLHIGFSRPIVFRDLKSSYILVSERY 203
+ +EP +I V +LH S+ I+ RDLK+ +L++
Sbjct: 109 ELDRGLTEP-----------QIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEG 154
Query: 204 VPKL--FNFS--LSASIPEGETYIDDGVKGTSGIVAPE------YARTGYLNEKCDVYSF 253
+L F S ++ + +++I GT +APE T Y + K D++S
Sbjct: 155 DIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETMKDTPY-DYKADIWSL 208
Query: 254 G 254
G
Sbjct: 209 G 209
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 7e-06
Identities = 38/162 (23%), Positives = 66/162 (40%), Gaps = 35/162 (21%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRL----- 166
++H +V+ G E V +V E +L +L KR + L
Sbjct: 70 RSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-----------RKALTEPEA 117
Query: 167 -KIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
+I YLH ++ RDLK + ++E K+ +F L+ + D
Sbjct: 118 RYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY------D 168
Query: 226 GVK-----GTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLL 261
G + GT +APE ++ G+ + + DV+S G ++ LL
Sbjct: 169 GERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLL 209
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 9e-06
Identities = 19/155 (12%), Positives = 36/155 (23%), Gaps = 41/155 (26%)
Query: 112 ASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAME 171
S++ V R++ ++V E G+L ++ ++
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-------TSPSPVGAIRAMQS 137
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK-GT 230
+A H + S + VS D V
Sbjct: 138 LAAAADAAH---RAGVALSIDHPSRVRVSI----------------------DGDVVLAY 172
Query: 231 SGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
+ + D+ G L LL
Sbjct: 173 PATMPDANPQD-------DIRGIGASLYALL-VNR 199
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 17/128 (13%)
Query: 141 EY--GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198
E L KR E +L K + + I YL ++ RD+K S IL
Sbjct: 104 ELMGTCAEKLKKRMQGPIPERILGK----MTVAIVKALYYLK--EKHGVIHRDVKPSNIL 157
Query: 199 VSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPE------YARTGYLNEKCDVYS 252
+ ER KL +F +S + + D G + +APE + Y + + DV+S
Sbjct: 158 LDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWS 214
Query: 253 FGLLLLQL 260
G+ L++L
Sbjct: 215 LGISLVEL 222
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 32/131 (24%), Positives = 53/131 (40%), Gaps = 20/131 (15%)
Query: 141 EY--GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198
E + K Y + + + KI + +L + I+ RD+K S IL
Sbjct: 101 ELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNIL 158
Query: 199 VSERYVPKLFNFSLSASIPEGETYIDDGVK----GTSGIVAPE-----YARTGYLNEKCD 249
+ KL +F +S + +D K G +APE +R GY + + D
Sbjct: 159 LDRSGNIKLCDFGISGQL------VDSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSD 211
Query: 250 VYSFGLLLLQL 260
V+S G+ L +L
Sbjct: 212 VWSLGITLYEL 222
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 31/139 (22%), Positives = 55/139 (39%), Gaps = 28/139 (20%)
Query: 141 EY--GNLHDLLKRSYQSH---SEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSS 195
E +L K+ E +L K IA+ I +LH ++ RD+K S
Sbjct: 86 ELMDTSLDKFYKQVIDKGQTIPEDILGK----IAVSIVKALEHLHS--KLSVIHRDVKPS 139
Query: 196 YILVSERYVPKL--FNFS--LSASIPEGETYIDDGVKGTSGIVAPE-----YARTGYLNE 246
+L++ K+ F S L + + G +APE + GY +
Sbjct: 140 NVLINALGQVKMCDFGISGYLVDDV-AKDIDA-----GCKPYMAPERINPELNQKGY-SV 192
Query: 247 KCDVYSFGLLLLQLLSTGE 265
K D++S G+ +++ L+
Sbjct: 193 KSDIWSLGITMIE-LAILR 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 46/261 (17%), Positives = 81/261 (31%), Gaps = 75/261 (28%)
Query: 117 HNNVLRLIGCCLEVEIPV----LVFESAEYGNLHD-LLKRSYQSHSEPLLLKHRLKIAME 171
+++R++ + +V E + G L + R Q+ +E + +I
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE----REASEIMKS 125
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
I YLH S I RD+K +L Y K N L D G
Sbjct: 126 IGEAIQYLH---SINIAHRDVKPENLL----YTSKRPNAILKL--------TDFGF---- 166
Query: 232 GIVAPEYARTGYLNEKCDVYSFGLLLLQLLS------------TGEDLFNMGLRLNGDES 279
A E Y ++ CD++S G+++ LL + G
Sbjct: 167 ---AKETTGEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--GQYE 220
Query: 280 FEM-----------DFVKKYIENRGFNGIVDP--RIIGDELLEHKLQSSFELAFQCQSAS 326
F ++ ++ +P R+ E + H + QS
Sbjct: 221 FPNPEWSEVSEEVKMLIRNLLK-------TEPTQRMTITEFMNHP--------WIMQSTK 265
Query: 327 AEDRPTMI-DVAKQIKKMYKS 346
P V K+ K+ ++
Sbjct: 266 VPQTPLHTSRVLKEDKERWED 286
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 38/156 (24%), Positives = 67/156 (42%), Gaps = 23/156 (14%)
Query: 115 MSHNNVLRLIGCCLEV-EIPV-----LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
+ H NV++L+ EV + P +VFE G + ++ +PL
Sbjct: 93 LDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFY 142
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
++ YLH + I+ RD+K S +LV E K+ +F +S + + + V
Sbjct: 143 FQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV- 198
Query: 229 GTSGIVAPE---YARTGYLNEKCDVYSFGLLLLQLL 261
GT +APE R + + DV++ G+ L +
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 42/187 (22%), Positives = 69/187 (36%), Gaps = 39/187 (20%)
Query: 91 VKFIDGSVFDAYDC--CFNNIVFASQMSHNNVLRLIGCCLEV-EIP---VLVFESAEYGN 144
+K ID + + F + ++H N+++L EV E L+ E A G
Sbjct: 45 IKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL----FEVIETEKTLYLIMEYASGGE 100
Query: 145 LHDLLKRSYQSHSEPLLLKHRL------KIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198
+ D L R+ +I + Y H + IV RDLK+ +L
Sbjct: 101 VFDYLVA-----------HGRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLL 146
Query: 199 VSERYVPKLFNFSLSASIPEGE---TYIDDGVKGTSGIVAPE-YARTGYLNEKCDVYSFG 254
+ K+ +F S G + G APE + Y + DV+S G
Sbjct: 147 LDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPYAAPELFQGKKYDGPEVDVWSLG 201
Query: 255 LLLLQLL 261
++L L+
Sbjct: 202 VILYTLV 208
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 41/165 (24%), Positives = 66/165 (40%), Gaps = 29/165 (17%)
Query: 107 NNIVFASQMS-HNNVLRLIGCCLEVEIPV------LVFESAEYGNLHDLLKRSYQSHSEP 159
I + S H N+ G ++ P LV E G++ DL+K +
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK---NTKGNT 125
Query: 160 LLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219
L + I EI ++LH ++ RD+K +L++E KL +F +SA +
Sbjct: 126 LKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182
Query: 220 ----ETYIDDGVKGTSGIVAPE------YARTGYLNEKCDVYSFG 254
T+I GT +APE Y + K D++S G
Sbjct: 183 VGRRNTFI-----GTPYWMAPEVIACDENPDATY-DFKSDLWSLG 221
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 6/92 (6%)
Query: 172 IANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTS 231
+ + YL + I+ RD+K I+++E + KL +F +A + G+ + GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTFCGTI 193
Query: 232 GIVAPE-YARTGYLNEKCDVYSFGLLLLQLLS 262
APE Y + +++S G+ L L+
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 31/117 (26%), Positives = 52/117 (44%), Gaps = 12/117 (10%)
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILV-SERYVPKLFNFSLSASIPEGETYIDDGV 227
A EI ++H +R +V+RDLK + IL+ +V ++ + L+ + + +
Sbjct: 298 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHV-RISDLGLACDFSKKKPH---AS 350
Query: 228 KGTSGIVAPE--YARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282
GT G +APE Y + D +S G +L +LL G F + E M
Sbjct: 351 VGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLL-RGHSPFRQHKTKDKHEIDRM 405
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 9e-04
Identities = 28/107 (26%), Positives = 44/107 (41%), Gaps = 16/107 (14%)
Query: 114 QMSHNNVLRLIGCCLEVEIPV--------LVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
+ H NV+ LI C P LVF+ E HDL + L
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDL-AGLLSNVLVKFTLSEI 126
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212
++ + N Y+H I+ RD+K++ +L++ V KL +F L
Sbjct: 127 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL 170
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 347 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.31 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.07 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.89 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.65 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.54 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.45 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.2 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.99 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.95 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.85 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.78 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.62 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.56 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.43 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.39 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.37 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.35 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.2 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.04 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.02 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.45 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.28 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 86.88 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.72 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.99 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-60 Score=420.78 Aligned_cols=263 Identities=19% Similarity=0.284 Sum_probs=211.4
Q ss_pred ccCCCCCeecccCceEEEEEEeC------CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVLP------DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|...+.||+|+||+||+|.+. ++..+++|.+........++|.+|+.+|++++|||||+++|+|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999872 244555555555555566889999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEE
Q 045067 136 VFESAEYGNLHDLLKRSY--------QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl 207 (347)
|||||++|+|.+++.... ......+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997531 112356999999999999999999999 999999999999999999999999
Q ss_pred ecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 208 FNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
+|||+|+......... .....||+.|||||++.+..|+.++|||||||++|||+|.|+.||..... .+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~~ 241 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVIE 241 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence 9999998765433222 23456999999999999999999999999999999999559999975321 22333
Q ss_pred HHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
..... .... .+...++++.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 242 ~i~~~-~~~~----------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 CITQG-RVLQ----------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHT-CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcC-CCCC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 33222 1111 0112355788999999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=421.39 Aligned_cols=263 Identities=19% Similarity=0.270 Sum_probs=205.8
Q ss_pred ccCCCCCeecccCceEEEEEEeC------CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVLP------DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|...+.||+|+||+||+|.+. ++..+++|.+........+.|.+|+.+|++++|||||+++|+|.+++.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777789999999999999862 345555666665555666889999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhcc----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 136 VFESAEYGNLHDLLKRSYQ----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
|||||++|+|.+++..... ....++++.+++.++.|++.||+||| +.+||||||||+|||++.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence 9999999999999976321 12346999999999999999999999 9999999999999999999999
Q ss_pred EEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 206 KLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+|.|+.||..... .+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~ 269 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TEA 269 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence 9999999987654332 2234567999999999999999999999999999999999449999964321 222
Q ss_pred HHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 285 VKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.......... .. +...++++.+|+.+||+.||++|||+.||++.|+.+.++
T Consensus 270 ~~~i~~g~~~--------~~---p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 270 IDCITQGREL--------ER---PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHTCCC--------CC---CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHcCCCC--------CC---cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 2332222111 01 112345788999999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-59 Score=413.02 Aligned_cols=264 Identities=20% Similarity=0.272 Sum_probs=204.7
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
..+++...+.||+|+||+||+|++.+ .+|||.+... ......+.|.+|+.++++++|||||+++|++.+ +.++||||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 34567788999999999999999854 4665554322 233445789999999999999999999999865 56899999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
||++|+|.+++... ...+++.++..++.|++.||+||| +++||||||||+|||++.++.+||+|||+|+....
T Consensus 112 y~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 112 WCEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CCSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred cCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999763 357999999999999999999999 89999999999999999999999999999987653
Q ss_pred CC-ceeeccccccCCccccccccc---CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 219 GE-TYIDDGVKGTSGIVAPEYART---GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 219 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.. ........||+.|||||++.+ +.|+.++|||||||++|||+ +|+.||..... ...+......+..
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ell-tg~~Pf~~~~~--------~~~~~~~~~~~~~ 255 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM-TGELPYSHINN--------RDQIIFMVGRGYA 255 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHH-HSSCTTTTCCC--------HHHHHHHHHTTCC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHH-HCCCCCCCCCh--------HHHHHHHHhcCCC
Confidence 32 222345689999999998864 46899999999999999999 89999964321 1222222222211
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhC
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~~ 347 (347)
.+.+. ......++++.+|+.+||+.||++||||.||++.|+.++.++
T Consensus 256 ----~p~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 256 ----SPDLS--KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp ----CCCST--TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ----CCCcc--cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 11111 111234567889999999999999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=418.48 Aligned_cols=259 Identities=18% Similarity=0.269 Sum_probs=206.0
Q ss_pred cCCCCCeecccCceEEEEEEeC------C-ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 63 NYHYRNIITESSIFRLCQGVLP------D-RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~~------~-~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++...+.||+|+||+||+|.+. + ..||||++.........+.|.+|+.++++++|||||+++|+|.+++.++|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4556778999999999999972 2 34555554444444445789999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc
Q 045067 136 VFESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV 204 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~ 204 (347)
|||||++|+|.++|..... .....+++..+..++.|++.||+||| +++||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence 9999999999999965311 11246899999999999999999999 999999999999999999999
Q ss_pred eEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 205 PKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
+||+|||+|+....... .......||+.|||||++.++.|+.++|||||||++|||+|.|+.||..... .+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~--------~~ 255 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------QD 255 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--------HH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence 99999999987643322 2234567999999999999999999999999999999999559999964321 22
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
.... ...+.... .+..++..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 256 ~~~~-i~~~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVEM-IRNRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHH-HHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHH-HHcCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2222 22222111 1123356788999999999999999999999999854
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-59 Score=419.44 Aligned_cols=249 Identities=20% Similarity=0.268 Sum_probs=205.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
+.|+..+.||+|+||+||+|++ .++..+++|.+........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4588899999999999999999 455544444444333344477899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
+||+|.+++.+ ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 154 ~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 154 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 99999999976 56999999999999999999999 9999999999999999999999999999998775433
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
. ...+.+||+.|||||++.+..|+.++||||+||++|||+ +|++||.... ............ .+
T Consensus 225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml-~G~~PF~~~~--------~~~~~~~i~~~~------~~ 288 (346)
T 4fih_A 225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV-DGEPPYFNEP--------PLKAMKMIRDNL------PP 288 (346)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCTTTTSC--------HHHHHHHHHHSS------CC
T ss_pred C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCcC--------HHHHHHHHHcCC------CC
Confidence 2 234578999999999999999999999999999999999 9999996432 122222222211 11
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+. .....++++.+|+.+||+.||++|||+.|+++
T Consensus 289 ~~~---~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 289 RLK---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCS---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 11234567889999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-58 Score=415.73 Aligned_cols=255 Identities=18% Similarity=0.163 Sum_probs=203.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
.+.|...++||+|+||+||+|++ .++..+++|.+.... ...+|+.++++++|||||++++++.+++.+||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 35677788999999999999998 445444444444332 124799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-ceEEecCCCCccCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLFNFSLSASIPE 218 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~~~ 218 (347)
|+||+|.+++.+. +.+++..+..++.|++.||+||| +++|+||||||+|||++.+| .+||+|||+|+....
T Consensus 132 ~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 132 LEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999875 67999999999999999999999 99999999999999999987 699999999987754
Q ss_pred CCce----eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 219 GETY----IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 219 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.... .....+||+.|||||++.+..|+.++||||+||++|||+ +|++||..... .... .........
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyeml-tG~~Pf~~~~~----~~~~----~~i~~~~~~ 274 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML-NGCHPWTQYFR----GPLC----LKIASEPPP 274 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSSTTTCC----SCCH----HHHHHSCCG
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH-HCcCCCCCCCH----HHHH----HHHHcCCCC
Confidence 3221 123457999999999999999999999999999999999 99999975332 1111 111111110
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
. ...++..++.+.+++.+||+.||++|||+.|+++.|.+..+.
T Consensus 275 ~---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 275 I---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp G---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 0 011123356788999999999999999999999999887653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=415.52 Aligned_cols=250 Identities=21% Similarity=0.236 Sum_probs=198.7
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++|+..+.||+|+||+||+|.+ .++..+++|.+... .....+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999998 44444444444332 23345779999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
||+||+|.++|... ....+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999753 2356789999999999999999999 99999999999999999999999999999987643
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
.. ......+||+.|||||++.+..|+.++||||+||++|||+ +|++||.... ........... ....
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyeml-tG~~PF~~~~--------~~~~~~~i~~~-~~~~-- 244 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC-TLKHAFEAGS--------MKNLVLKIISG-SFPP-- 244 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCSCCCSS--------HHHHHHHHHHT-CCCC--
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCcC--------HHHHHHHHHcC-CCCC--
Confidence 21 1224567999999999999999999999999999999999 9999996432 22333333332 1111
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 245 ---~-----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 ---V-----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---C-----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1123456889999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-58 Score=409.93 Aligned_cols=272 Identities=19% Similarity=0.222 Sum_probs=202.6
Q ss_pred ccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC----ccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE----IPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 137 (347)
.+|...+.||+|+||+||+|++++..||||++.... .....+..|+..+.+++|||||++++++.+++ .++|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 456777899999999999999987777777654322 11122345666667889999999999998754 579999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF-----SRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
|||++|+|.++++. ..+++..+.+++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+
T Consensus 81 Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999976 57999999999999999999999320 12999999999999999999999999999
Q ss_pred CccCCCCCcee---eccccccCCcccccccccC------CCCCccchHHHHHHHHHHHhcCCCccccCccCCCC------
Q 045067 213 SASIPEGETYI---DDGVKGTSGIVAPEYARTG------YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD------ 277 (347)
Q Consensus 213 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~------ 277 (347)
|+......... .....||+.|||||++.+. .++.++|||||||++|||+ +|.+||.........
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~-tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA-RRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH-HTBCBTTBCCCCCCTTTTTSC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH-HCCCCCCccccccccchhccc
Confidence 98765443221 2346799999999998764 4678999999999999999 888877543221110
Q ss_pred CchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 278 ESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
............... ..++.++......+.+..+.+|+.+||+.||++||||.||++.|++|.++
T Consensus 234 ~~~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SSCCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccchHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 011112222222221 22333333233335567889999999999999999999999999998753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=414.25 Aligned_cols=274 Identities=19% Similarity=0.324 Sum_probs=218.3
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEe-CC------ceEEEEEEccCCCchhHHHHHHHHHHHHhcCC-Cceeee
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVL-PD------RTISVVKFIDGSVFDAYDCCFNNIVFASQMSH-NNVLRL 123 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~------~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l 123 (347)
+...+++...++|+..+.||+|+||+||+|.+ .. ..||+|++.........+.+.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 45567777788999999999999999999997 21 23455555444444555779999999999965 899999
Q ss_pred eeeeeeC-CccEEEEEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 045067 124 IGCCLEV-EIPVLVFESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRD 191 (347)
Q Consensus 124 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~d 191 (347)
+|+|.++ +.++||||||++|+|.++|.+... .....+++..+..++.|++.||+||| +++|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence 9998764 578999999999999999976321 11245899999999999999999999 99999999
Q ss_pred CCCCCeEECCCCceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 192 LKSSYILVSERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 192 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
|||+|||++.++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+|.|+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999877654433 334567999999999999999999999999999999999559999964
Q ss_pred CccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 271 GLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
... . ..+......+.... . +...++++.+++.+||+.||++|||+.||++.|+++.++
T Consensus 291 ~~~-------~-~~~~~~i~~g~~~~-------~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKI-------D-EEFCRRLKEGTRMR-------A---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCC-------S-HHHHHHHHHTCCCC-------C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCH-------H-HHHHHHHHcCCCCC-------C---CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 321 1 12222233322111 1 112345688999999999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-57 Score=401.85 Aligned_cols=244 Identities=20% Similarity=0.264 Sum_probs=194.0
Q ss_pred CCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeee----CCccEEEE
Q 045067 65 HYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE----VEIPVLVF 137 (347)
Q Consensus 65 ~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 137 (347)
...+.||+|+||+||+|.+ . +..+|+|++.... .....+.+.+|+.++++++|||||++++++.+ ++.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4456799999999999999 4 4456666654432 33345779999999999999999999999875 34689999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEEC-CCCceEEecCCCCc
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP--IVFRDLKSSYILVS-ERYVPKLFNFSLSA 214 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~a~ 214 (347)
|||+||+|.+++.+. ..+++..+..++.|++.||+||| +++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 999999999999875 68999999999999999999999 877 99999999999998 47999999999997
Q ss_pred cCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
..... ...+.+||+.|||||++.+ .|+.++|||||||++|||+ +|++||..... ..... .....+..
T Consensus 181 ~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyell-tg~~Pf~~~~~-------~~~~~-~~i~~~~~ 247 (290)
T 3fpq_A 181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA-TSEYPYSECQN-------AAQIY-RRVTSGVK 247 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHH-HSSCTTTTCSS-------HHHHH-HHHTTTCC
T ss_pred eCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHH-HCCCCCCCCCc-------HHHHH-HHHHcCCC
Confidence 64432 2345689999999998875 5899999999999999999 99999964321 11222 22222211
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. ......++++.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~---------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 PA---------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CG---------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 111122446889999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=420.21 Aligned_cols=249 Identities=20% Similarity=0.266 Sum_probs=205.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
+.|+..+.||+|+||.||+|.+ .++..+++|.+........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5688999999999999999999 455555555444444444577999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
+||+|.+++.. ..+++..+..++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 231 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 99999999976 56999999999999999999999 9999999999999999999999999999998775443
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
. ...+.+||+.|||||++.+..|+.++|||||||++|||+ +|++||..... ............ +
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml-~G~~PF~~~~~--------~~~~~~i~~~~~------~ 365 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV-DGEPPYFNEPP--------LKAMKMIRDNLP------P 365 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCH--------HHHHHHHHHSCC------C
T ss_pred c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCcCH--------HHHHHHHHcCCC------C
Confidence 2 234578999999999999999999999999999999999 99999964321 222222222211 1
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+. .....++++.+|+.+||+.||++|||+.|+++
T Consensus 366 ~~~---~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 366 RLK---NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCS---CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCc---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 11123457889999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-58 Score=406.21 Aligned_cols=248 Identities=18% Similarity=0.226 Sum_probs=205.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|+..+.||+|+||+||+|.+ .++..+++|++.+. .....+.+.+|+.+|++++|||||++++++.+++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999999 55555555555432 123346799999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
||||+||+|.+++.+. +.+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+..
T Consensus 111 mEy~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 9999999999999875 68999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCC-ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 217 PEGE-TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 217 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.... .....+.+||+.|||||++.+..|+.++||||+||++|||+ +|++||.... ........... ..
T Consensus 183 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml-~G~~PF~~~~--------~~~~~~~i~~~-~~- 251 (311)
T 4aw0_A 183 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV-AGLPPFRAGN--------EGLIFAKIIKL-EY- 251 (311)
T ss_dssp CTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHH-HSSCSSCCSS--------HHHHHHHHHHT-CC-
T ss_pred CCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCC--------HHHHHHHHHcC-CC-
Confidence 5433 22345678999999999999999999999999999999999 9999996432 12233333322 11
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVA 337 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell 337 (347)
.++ ...++++.+|+.+||+.||++|||+.|++
T Consensus 252 -----~~p-----~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -----DFP-----EKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -----CCC-----TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -----CCC-----cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 011 12245678999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-56 Score=391.87 Aligned_cols=245 Identities=19% Similarity=0.248 Sum_probs=187.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||+||+|.. .++..+++|++.... ....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999998 445555555444321 233467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||| +|+|.+++.+. +.+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 57999999764 67999999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCceeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
... ...+.+||+.|||||++.+..+ +.++||||+||++|+|+ +|++||.... .......... +...
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~ll-tg~~PF~~~~--------~~~~~~~i~~-~~~~- 230 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML-CRRLPFDDES--------IPVLFKNISN-GVYT- 230 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHH-HSSCSSCCSS--------HHHHHHHHHH-TCCC-
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHH-HCCCCCCCCC--------HHHHHHHHHc-CCCC-
Confidence 432 2345789999999999988775 58999999999999999 9999996432 1222222222 2110
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+ +...++++.+++.+||+.||++|||+.|+++
T Consensus 231 -----~-----p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 231 -----L-----PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----C-----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----C-----CCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 0122456789999999999999999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=390.60 Aligned_cols=250 Identities=20% Similarity=0.292 Sum_probs=188.1
Q ss_pred ccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC--------
Q 045067 62 NNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE-------- 131 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 131 (347)
++|+..+.||+|+||+||+|.+ ++..+|+|++.........+.+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4688999999999999999998 455666666554444455578999999999999999999999987644
Q ss_pred ----ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEE
Q 045067 132 ----IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207 (347)
Q Consensus 132 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl 207 (347)
.+|+|||||++|+|.+++... ......++..+..++.|++.||+||| +++|+||||||+|||++.++.+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR--CTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC--CSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc--CCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEE
Confidence 369999999999999999863 12234567788999999999999999 999999999999999999999999
Q ss_pred ecCCCCccCCCCCce-----------eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCC
Q 045067 208 FNFSLSASIPEGETY-----------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG 276 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~ 276 (347)
+|||+|+........ ...+.+||+.|||||++.+..|+.++|||||||++|||+ + ||....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell-~---Pf~~~~---- 231 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-Y---PFSTQM---- 231 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH-S---CCSSHH----
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHc-c---CCCCcc----
Confidence 999999876543211 123457999999999999999999999999999999999 5 664211
Q ss_pred CCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 277 DESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........ ...... +.......+.+.+++.+||+.||++|||+.|+++
T Consensus 232 ---~~~~~~~~-~~~~~~----------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 ---ERVRTLTD-VRNLKF----------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---HHHHHHHH-HHTTCC----------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHH-HhcCCC----------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01111111 111111 1223344556789999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=397.27 Aligned_cols=247 Identities=18% Similarity=0.184 Sum_probs=194.7
Q ss_pred ccCCCCCeecccCceEEEEEEe----CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL----PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|+..+.||+|+||+||+|.. .++..+++|++.... ......+.+|+.+|++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999987 234555555554332 2223568899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
|||||+||+|.+++.+. +.+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999876 68999999999999999999999 99999999999999999999999999999986
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
...... ...+.+||+.|||||++.+..|+.++||||+||++|||+ +|++||.... ............ .
T Consensus 176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyeml-tG~~PF~~~~--------~~~~~~~i~~~~-~- 243 (304)
T 3ubd_A 176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML-TGTLPFQGKD--------RKETMTMILKAK-L- 243 (304)
T ss_dssp -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH-HSSCSSCCSS--------HHHHHHHHHHCC-C-
T ss_pred ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHH-hCCCCCCCcC--------HHHHHHHHHcCC-C-
Confidence 543322 234578999999999999999999999999999999999 9999996432 122233332221 1
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM-----IDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~-----~ell~ 338 (347)
.. +...++++.+|+.+||+.||++|||+ +|+++
T Consensus 244 -----~~-----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 -----GM-----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----CC-----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----CC-----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 00 11234568899999999999999995 56653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=379.67 Aligned_cols=259 Identities=17% Similarity=0.228 Sum_probs=196.9
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeee------CCc
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE------VEI 132 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 132 (347)
++|+..+.||+|+||+||+|.+ .++ .||+|++.... .....+.+.+|+.+|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999998 444 45555543332 23344678899999999999999999998764 357
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
+|||||||+ |+|.+++.+. +.+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecce
Confidence 899999997 6899999764 68999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCC---ceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 213 SASIPEGE---TYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 213 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
|+.+.... .....+.+||+.|+|||++.+. .++.++||||+||++|||+ +|++||..... .......
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell-~G~~pF~g~~~--------~~~l~~I 275 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML-ARRQLFPGKNY--------VHQLQLI 275 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH-HTSCSSCCSSH--------HHHHHHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH-HCCCCCCCCCH--------HHHHHHH
Confidence 98764332 1223457899999999988765 6799999999999999999 99999974321 1222222
Q ss_pred Hhc-cCcc-cc---------------cCCccCC--chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IEN-RGFN-GI---------------VDPRIIG--DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~-~~~~-~~---------------~~~~~~~--~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... +... .. +.+.... ....+..++++.+|+.+||+.||++|||+.|+++
T Consensus 276 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 276 MMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111 0000 00 0000000 0011123457889999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=375.47 Aligned_cols=198 Identities=20% Similarity=0.257 Sum_probs=166.0
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe----CCc-eEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCC
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL----PDR-TISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVE 131 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 131 (347)
....+.|...+.||+|+||+||+|+. ..+ .+|+|++.... ....+.+|+.+|..+ +||||+++++++.+.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 34567899999999999999999986 233 45555554432 225688999999998 6999999999999999
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC-CceEEecC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-YVPKLFNF 210 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Df 210 (347)
.+|+||||+++|+|.+++. .+++.++..++.|++.||+||| ++||+||||||+|||++.+ +.+||+||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 9999999999999999983 4899999999999999999999 9999999999999999876 79999999
Q ss_pred CCCccCCCCCc---------------------------eeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHh
Q 045067 211 SLSASIPEGET---------------------------YIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLS 262 (347)
Q Consensus 211 g~a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~ 262 (347)
|+|+....... ......+||+.|+|||++.+. .++.++||||+||++|||+
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell- 241 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL- 241 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH-
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH-
Confidence 99976543211 112345799999999988765 5899999999999999999
Q ss_pred cCCCcccc
Q 045067 263 TGEDLFNM 270 (347)
Q Consensus 263 ~g~~p~~~ 270 (347)
+|++||..
T Consensus 242 ~G~~Pf~~ 249 (361)
T 4f9c_A 242 SGRYPFYK 249 (361)
T ss_dssp HTCSSSSC
T ss_pred HCCCCCCC
Confidence 99999853
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=372.83 Aligned_cols=291 Identities=27% Similarity=0.498 Sum_probs=238.9
Q ss_pred CCCccccCHHHHHHHhccCCCCCeecccCceEEEEEEeC-CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeee
Q 045067 46 YNPIRSFSAKELERATNNYHYRNIITESSIFRLCQGVLP-DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLI 124 (347)
Q Consensus 46 ~~~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 124 (347)
...++.|+..++...+++|...+.||+|+||.||+|... +..+|+|++...........+.+|+.+++.++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 345778999999999999999999999999999999984 4455555544433333334689999999999999999999
Q ss_pred eeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---CeEeccCCCCCeEECC
Q 045067 125 GCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR---PIVFRDLKSSYILVSE 201 (347)
Q Consensus 125 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~---~ivH~dlkp~Nill~~ 201 (347)
+++.+++..++||||+++|+|.+++... ......+++..+..++.|++.||.||| +. +|+||||||+|||++.
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRER-PESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCC-STTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECT
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhc-cccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECC
Confidence 9999999999999999999999999864 223345999999999999999999999 77 9999999999999999
Q ss_pred CCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchH
Q 045067 202 RYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFE 281 (347)
Q Consensus 202 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~ 281 (347)
++.+||+|||++...............||+.|+|||.+.+..++.++|||||||++|+|+ +|+.||.............
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~~~ 248 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI-TGQRAFDLARLANDDDVML 248 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHH-HCCCSBCHHHHTTTSCSBH
T ss_pred CCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHH-hCCCcccccccccccchhH
Confidence 999999999999877655544455567999999999998889999999999999999999 9999997543333444445
Q ss_pred HHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 282 MDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
..+..............+...... .....+..+.+++.+||+.||++|||+.||++.|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 249 LDWVKGLLKEKKLEALVDVDLQGN-YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHHTTTTSSCCSTTSSCTTCTTS-CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHhhchhhhhhcChhhccc-cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 556555555555556666555433 345667889999999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=364.95 Aligned_cols=287 Identities=30% Similarity=0.433 Sum_probs=231.7
Q ss_pred ccCHHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 045067 51 SFSAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV 130 (347)
Q Consensus 51 ~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 130 (347)
.++..++...+++|...+.||+|+||.||+|.+.++..+++|..........+.+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 45566777789999999999999999999999854444444444444445557899999999999999999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
+..++||||+++|+|.+++... ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGS-DLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSS-CCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CeEEEEEEcCCCCcHHHHHhcc-CCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999764 122346899999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCC-ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 211 SLSASIPEGE-TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 211 g~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
|++....... ........||+.|+|||++.+..++.++|||||||++|+|+ +|+.||..... ........+.....
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell-~g~~p~~~~~~--~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL-CARSAIVQSLP--REMVNLAEWAVESH 260 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHH-HCCTTCSCSSS--SSCCCHHHHTHHHH
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHH-hCCCcccccCc--HHHHHHHHHhhhcc
Confidence 9997654322 22223456899999999998899999999999999999999 89999976543 22223344444444
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
..+.+....++.... ......+..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 261 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 261 NNGQLEQIVDPNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp TTTCCCSSSSSSCTT-CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccHHHhcChhhcc-ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 455555666655433 2335667889999999999999999999999999998865
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=390.95 Aligned_cols=252 Identities=16% Similarity=0.192 Sum_probs=206.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
.++|+..+.||+|+||.||+|.. .++..+++|.+........+.+.+|+.+|+.++|||||++++++.+++.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999999 55555555555555545557899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC--CceEEecCCCCccCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER--YVPKLFNFSLSASIP 217 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~a~~~~ 217 (347)
|+||+|.+++... ...+++..+..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|||+|+.+.
T Consensus 236 ~~gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 236 MSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred cCCCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999652 257999999999999999999999 9999999999999999854 899999999998876
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... ....+||+.|||||++.+..|+.++||||+||++|||+ +|.+||..... .......... ...
T Consensus 309 ~~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml-~G~~Pf~~~~~--------~~~~~~i~~~-~~~-- 374 (573)
T 3uto_A 309 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL-SGLSPFGGEND--------DETLRNVKSC-DWN-- 374 (573)
T ss_dssp TTSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH-HSCCSSCCSSH--------HHHHHHHHTT-CCC--
T ss_pred CCCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCcCH--------HHHHHHHHhC-CCC--
Confidence 5433 24468999999999999999999999999999999999 99999964321 2222222221 110
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ........++++.+|+.+||+.||++|||+.|+++
T Consensus 375 ----~-~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 ----M-DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp ----C-CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----C-CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 01111233567889999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=388.92 Aligned_cols=249 Identities=16% Similarity=0.172 Sum_probs=197.7
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHH---HHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCF---NNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
-++|+..++||+|+||.||+|.. .++..+++|++.+.. ......+. +++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 36799999999999999999999 566666666554321 11112333 346667778999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
|||||||+||+|.++|.+. +.+++..+..++.||+.||+||| +++||||||||+|||++.+|.+||+|||+|
T Consensus 268 ylVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEeccccee
Confidence 9999999999999999875 67999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCceeeccccccCCcccccccc-cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
+...... ..+.+||+.|||||++. +..|+.++||||+||++|||+ +|++||..... ..............
T Consensus 340 ~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmL-tG~~PF~~~~~-----~~~~~i~~~i~~~~ 410 (689)
T 3v5w_A 340 CDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL-RGHSPFRQHKT-----KDKHEIDRMTLTMA 410 (689)
T ss_dssp EECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH-HSSCTTCGGGC-----CCHHHHHHHHHHCC
T ss_pred eecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCh-----HHHHHHHHhhcCCC
Confidence 8765433 23568999999999986 457999999999999999999 99999975322 11112222222211
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-----MIDVAK 338 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-----~~ell~ 338 (347)
. .. +...++++.+|+.+||+.||.+|++ +.||++
T Consensus 411 -~------~~-----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 -V------EL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -C------CC-----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -C------CC-----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0 01 1123456889999999999999998 577653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=352.18 Aligned_cols=261 Identities=20% Similarity=0.272 Sum_probs=209.6
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
.++|...+.||+|+||+||+|.+ .++..+++|..........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35788889999999999999999 55555555555554555668899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 89 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999863 367999999999999999999999 999999999999999999999999999999876543
Q ss_pred Cceee-------------ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 220 ETYID-------------DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 220 ~~~~~-------------~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
..... ....||+.|+|||++.+..++.++||||||+++|+|+ +|..|+...............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~-~g~~~~~~~~~~~~~~~~~~~--- 237 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGLNVR--- 237 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HTCCSSTTTSCBCTTSSBCHH---
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHh-cCCCCCcchhhhHHHHhhhhh---
Confidence 22111 1457999999999999999999999999999999999 888888654332221111111
Q ss_pred HHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
...... .. ...++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus 238 ~~~~~~-----~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 238 GFLDRY-----CP---------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp HHHHHT-----CC---------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccccc-----CC---------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000000 00 11233577999999999999999999999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=347.08 Aligned_cols=287 Identities=25% Similarity=0.373 Sum_probs=229.4
Q ss_pred CCccccCHHHHHHHhccCCCC------CeecccCceEEEEEEeCCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCC
Q 045067 47 NPIRSFSAKELERATNNYHYR------NIITESSIFRLCQGVLPDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSH 117 (347)
Q Consensus 47 ~~~~~~~~~e~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h 117 (347)
.....|++.++..++++|... +.||+|+||.||+|..++..+++|++.... .....+.+.+|+.++++++|
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 346789999999999999888 899999999999999987888888776532 23345779999999999999
Q ss_pred CceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCe
Q 045067 118 NNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYI 197 (347)
Q Consensus 118 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Ni 197 (347)
|||+++++++.+.+..++||||+++++|.+++.... ....+++..+..++.|++.||.||| +.+++||||||+||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Ni 164 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANI 164 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHE
Confidence 999999999999999999999999999999997531 2356999999999999999999999 99999999999999
Q ss_pred EECCCCceEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCC
Q 045067 198 LVSERYVPKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG 276 (347)
Q Consensus 198 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~ 276 (347)
+++.++.+||+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|+|+ +|.+||......
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~~-- 240 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEII-TGLPAVDEHREP-- 240 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHH-HCCCSBCTTBSS--
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHH-HCCCCcccCcch--
Confidence 999999999999999987654322 22334579999999998765 5789999999999999999 899999754321
Q ss_pred CCchHHHHHHHHHhc-cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 277 DESFEMDFVKKYIEN-RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.....+....... ..+...+++.+. ......+..+.+++.+||+.+|.+|||+.++++.|+++..|
T Consensus 241 --~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 241 --QLLLDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp --SBTTHHHHHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred --HHHHHHHHHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 1111222222111 122233333332 22345677899999999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=351.94 Aligned_cols=270 Identities=20% Similarity=0.184 Sum_probs=208.7
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC----ccEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE----IPVL 135 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 135 (347)
..++|+..+.||+|+||+||+|.+.+..+|+|++... . .......+|+.++++++||||+++++++.+.. .+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ-D-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG-G-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEECCCEEEEEEeecC-c-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3467899999999999999999988766666665332 2 22345667999999999999999999998754 3699
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC----------CeEeccCCCCCeEECCCCce
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR----------PIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~----------~ivH~dlkp~Nill~~~~~~ 205 (347)
||||+++|+|.+++.. ..+++..+..++.|++.||+||| +. +|+||||||+|||++.++.+
T Consensus 100 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred EEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 9999999999999976 46999999999999999999999 88 99999999999999999999
Q ss_pred EEecCCCCccCCCCCce-eeccccccCCcccccccccC-----CCCCccchHHHHHHHHHHHhcCCCccccCccCCCC--
Q 045067 206 KLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTG-----YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD-- 277 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~-- 277 (347)
||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+ +|+.||.........
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~-tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA-SRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTBTTSSSCCCCCCCTT
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHH-hCCCCCCCCcchhccch
Confidence 99999999776543322 22346799999999988763 5567899999999999999 999999754331110
Q ss_pred ------CchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 278 ------ESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 278 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
......... ...... ..+.+.........+.++.+++.+||+.||++|||+.|+++.|++|.+.
T Consensus 250 ~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 250 EEEIGQHPSLEDMQE-VVVHKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHCSSCCHHHHHH-HHTTSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhh-hhhccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 011111111 111111 1122221122234566799999999999999999999999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=349.45 Aligned_cols=250 Identities=17% Similarity=0.209 Sum_probs=202.8
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
.+.|...+.||+|+||+||+|.. .++..+++|..........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999998 44444444444333333447789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++|+|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 99 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999999976 46999999999999999999999 999999999999999999999999999999876543
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
.. ......||+.|+|||.+.+..++.++||||+||++|+|+ +|..||..... ............ .
T Consensus 170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~--------~~~~~~~~~~~~-~---- 234 (297)
T 3fxz_A 170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENP--------LRALYLIATNGT-P---- 234 (297)
T ss_dssp TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCH--------HHHHHHHHHHCS-C----
T ss_pred cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhCCC-C----
Confidence 32 234467999999999999999999999999999999999 89999964321 111112221111 0
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 235 -~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 -ELQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -CCS---CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCC---CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 110 11223456889999999999999999999976
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=346.03 Aligned_cols=268 Identities=23% Similarity=0.297 Sum_probs=204.5
Q ss_pred HHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 54 AKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 54 ~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
..++....++|...+.||+|+||+||+|...+..+++|.+..... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 344445567899999999999999999998777777776655432 3344678999999999999999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEECCCCceEEecC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP--IVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+||
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred eEEEEecCCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence 999999999999999997631 1123999999999999999999999 888 999999999999999999999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
|+++...... .......||+.|+|||.+.+..++.++|||||||++|+|+ +|+.||..... .........
T Consensus 184 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-tg~~Pf~~~~~--------~~~~~~~~~ 253 (309)
T 3p86_A 184 GLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA-TLQQPWGNLNP--------AQVVAAVGF 253 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHH-HCCCTTTTSCH--------HHHHHHHHH
T ss_pred CCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHh
Confidence 9997544322 1233467999999999999999999999999999999999 99999964321 112121111
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
..... .. +...++++.+++.+||+.+|++|||+.++++.|+.+.++
T Consensus 254 ~~~~~-----~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 254 KCKRL-----EI-----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp SCCCC-----CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred cCCCC-----CC-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11100 01 112345688999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=340.31 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=208.8
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
.++|...+.||+|+||.||+|.+ +++.+++ |........ .+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vav-K~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAI-KTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEE-EEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEE-EEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 45788889999999999999999 4455544 444443322 36799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++++|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 87 MEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999763 356899999999999999999999 999999999999999999999999999999876544
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
.........+|+.|+|||.+.+..++.++||||+|+++|+|++.|..||..... ........... ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~~---~~~~ 228 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGF---RLYK 228 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTC---CCCC
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcCc---cCCC
Confidence 333334456788999999999899999999999999999999449999964321 12222222111 1111
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
+. ..+..+.+++.+||+.+|++|||+.++++.|+++.++
T Consensus 229 ~~--------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 PR--------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CT--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC--------cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11 1244678999999999999999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=347.04 Aligned_cols=260 Identities=20% Similarity=0.303 Sum_probs=206.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CC---ce-EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PD---RT-ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~---~~-~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
.++|...+.||+|+||+||+|.+ .+ +. +++|++.........+.+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 35677889999999999999998 22 22 555555444444555779999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 128 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999652 357999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCc--eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 216 IPEGET--YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 216 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++.|..||..... ............
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~~~~ 272 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISSVEEGYR 272 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTTCC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcCCC
Confidence 654322 2223345678899999999899999999999999999999449999964321 122222221111
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.. .....+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 273 ~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 273 LP-----------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CC-----------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 00 0112345688999999999999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=358.50 Aligned_cols=266 Identities=23% Similarity=0.317 Sum_probs=212.0
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
.+....++|...+.||+|+||.||+|.+ .++..+++|..... .....+.+.+|+.++++++||||+++++++.+++..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 4444567888899999999999999999 45555555555433 333446788999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 188 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp EEEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 9999999999999999764 246999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCceee-ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 214 ASIPEGETYID-DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 214 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
+.......... ....+++.|+|||.+.+..++.++|||||||++|||++.|..||..... .........+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---------~~~~~~~~~~ 331 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------QQTREFVEKG 331 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---------HHHHHHHHTT
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHcC
Confidence 76543322111 1234577899999999889999999999999999999559999964321 1122222222
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhC
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~~ 347 (347)
.. ...+ ...+..+.+++.+||+.||++|||+.++++.|+++.+.+
T Consensus 332 ~~-------~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 332 GR-------LPCP---ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp CC-------CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CC-------CCCC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 11 0011 122456889999999999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=346.99 Aligned_cols=261 Identities=19% Similarity=0.251 Sum_probs=210.3
Q ss_pred cccCHHHHHHHhcc----------CCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCC
Q 045067 50 RSFSAKELERATNN----------YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHN 118 (347)
Q Consensus 50 ~~~~~~e~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ 118 (347)
..++.+++..+++. |...+.||+|+||.||+|.. .++..+++|..........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34888898888765 66677999999999999998 34555555555444444457799999999999999
Q ss_pred ceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 045067 119 NVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198 (347)
Q Consensus 119 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nil 198 (347)
||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIl 173 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSIL 173 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEE
Confidence 999999999999999999999999999999865 56999999999999999999999 899999999999999
Q ss_pred ECCCCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCC
Q 045067 199 VSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278 (347)
Q Consensus 199 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~ 278 (347)
++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|+ +|+.||.....
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~-~g~~pf~~~~~----- 246 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV-DGEPPYFSDSP----- 246 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCH-----
T ss_pred ECCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH-----
Confidence 999999999999999876543222 23467999999999999999999999999999999999 89999964321
Q ss_pred chHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
......... ... +.... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 247 ---~~~~~~~~~-~~~-----~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 247 ---VQAMKRLRD-SPP-----PKLKN---SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ---HHHHHHHHH-SSC-----CCCTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHhc-CCC-----CCcCc---cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122222211 111 11111 1123456889999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=337.48 Aligned_cols=259 Identities=19% Similarity=0.287 Sum_probs=210.1
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.++|...+.||+|+||.||+|.+.++..+++|........ .+.+.+|+.++.+++||||+++++++.++...++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 4678889999999999999999865544555555443322 367899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999774 246999999999999999999999 9999999999999999999999999999998776655
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
........+|+.|+|||.+.+..++.++||||+|+++|+|++.|..||..... ........... ....+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~---~~~~~ 227 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--------SEVVLKVSQGH---RLYRP 227 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHHTTC---CCCCC
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--------HHHHHHHHcCC---CCCCC
Confidence 44444566788899999999889999999999999999999339999964321 12222222111 11111
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
. ..++.+.+++.+||+.+|++|||+.++++.|+.+.+.
T Consensus 228 ~--------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 228 H--------LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp T--------TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred C--------cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1 1234678999999999999999999999999988653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=347.11 Aligned_cols=248 Identities=19% Similarity=0.234 Sum_probs=202.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
..++|...+.||+|+||.||+|.+ .++ .+|+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 456799999999999999999998 444 45555443322 233456788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp ECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999999875 67999999999999999999999 999999999999999999999999999999766
Q ss_pred CCCCceeeccccccCCcccccccccCCCC-CccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLN-EKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
..... ....+||+.|+|||++.+..++ +++||||+||++|+|+ +|+.||.... ........... ...
T Consensus 165 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~--------~~~~~~~i~~~-~~~ 232 (328)
T 3fe3_A 165 TVGGK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV-SGSLPFDGQN--------LKELRERVLRG-KYR 232 (328)
T ss_dssp SSSCG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHH-HSSCSSCCSS--------HHHHHHHHHHC-CCC
T ss_pred CCCCc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHH-hCCCCCCCCC--------HHHHHHHHHhC-CCC
Confidence 54332 3456799999999999887765 7999999999999999 8999996432 12222222221 111
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. + ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 233 ------~--p---~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 233 ------I--P---FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ------C--C---TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ------C--C---CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0 112456789999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=350.33 Aligned_cols=263 Identities=18% Similarity=0.290 Sum_probs=208.6
Q ss_pred hccCCCCCeecccCceEEEEEEe--------CCceEEEEEEccCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL--------PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV 130 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 130 (347)
.++|...+.||+|+||.||+|.+ .++..+++|..... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46788889999999999999986 12344555555443 444557799999999999 899999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill 199 (347)
+..++||||+++|+|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 999999999999999999986421 11245899999999999999999999 9999999999999999
Q ss_pred CCCCceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCC
Q 045067 200 SERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278 (347)
Q Consensus 200 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~ 278 (347)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++.|..||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~----- 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 99999999999999876543321 123356788999999999999999999999999999999449999964321
Q ss_pred chHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
. .. ......+... .. +...+.++.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 312 ~---~~-~~~~~~~~~~-----~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 312 E---EL-FKLLKEGHRM-----DK-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp G---GH-HHHHHTTCCC-----CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---HH-HHHHhcCCCC-----CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 11 1112221111 00 11234568899999999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=341.05 Aligned_cols=269 Identities=18% Similarity=0.275 Sum_probs=205.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-----CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--Ccc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-----PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 133 (347)
.++|+..+.||+|+||+||+|.+ .++..+++|..........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36788899999999999999984 34556666666555555567899999999999999999999998653 568
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred EEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 9999999999999999763 245999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCce--eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCcc-------CCCCCchHHHH
Q 045067 214 ASIPEGETY--IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLR-------LNGDESFEMDF 284 (347)
Q Consensus 214 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~ 284 (347)
......... ......+++.|+|||.+.+..++.++||||||+++|+|+ +|..|+..... ...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF-TYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH-HTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHH-hcccccCCChHHHHhhhcCccccchhHHH
Confidence 876543321 123345778899999999999999999999999999999 88888754211 00011111111
Q ss_pred HHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhC
Q 045067 285 VKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347 (347)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~~ 347 (347)
........... . .+...+.++.+++.+||+.||++|||+.|+++.|+++.+.+
T Consensus 241 ~~~~~~~~~~~-------~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 241 LIELLKNNGRL-------P---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHTTCCC-------C---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHhccCcC-------C---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 11222211110 0 01123457889999999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=339.90 Aligned_cols=260 Identities=20% Similarity=0.282 Sum_probs=202.7
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...+.||+|+||.||+|.. . +..+++|++.... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 45788899999999999999998 3 4455555553332 233456789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999875 67999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
............||+.|+|||.+.+..++.++||||+|+++|+|+ +|+.||..... ............ ..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll-~g~~pf~~~~~--------~~~~~~~~~~~~-~~ 231 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML-VGEPPFNGETA--------VSIAIKHIQDSV-PN 231 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHH-HSSCSSCSSCH--------HHHHHHHHSSCC-CC
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCCh--------HHHHHHHhhccC-CC
Confidence 544333344567999999999999999999999999999999999 89999964321 111122221110 00
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-TMIDVAKQIKKMY 344 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-s~~ell~~L~~i~ 344 (347)
. . .......+..+.+++.+||+.||++|| ++.++.+.|+.+.
T Consensus 232 ~-~-----~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 232 V-T-----TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp H-H-----HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred c-c-----hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0 0 001112345688999999999999998 8999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=350.54 Aligned_cols=260 Identities=19% Similarity=0.306 Sum_probs=195.9
Q ss_pred hccCCCCCeecccCceEEEEEEeC----Cce-EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLP----DRT-ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~-~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
.++|...+.||+|+||.||+|.+. ++. +++|++.........+.+.+|+.++++++||||+++++++.+++..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457899999999999999999873 344 444444333344455779999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 124 v~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 99999999999999763 357999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCcee--eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 216 IPEGETYI--DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 216 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
........ .....+++.|+|||++.+..++.++|||||||++|||++.|+.||..... ...... ...+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~-i~~~~ 267 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKA-VDEGY 267 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHH-HHTTE
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH-HHcCC
Confidence 65432211 12334678899999999999999999999999999999559999964321 122222 22111
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
. ... ....+..+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 268 ~-------~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 268 R-------LPP---PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp E-------CCC---CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C-------CCC---CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 0 000 112345688999999999999999999999999998653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=337.75 Aligned_cols=261 Identities=20% Similarity=0.276 Sum_probs=196.5
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-C---CceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-P---DRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~---~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
...++|...+.||+|+||.||+|.+ . .+..+++|.... ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 3456788899999999999999998 2 223455555443 34445577999999999999999999999974 5678
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++||||+++++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccc
Confidence 9999999999999999763 256999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
...............+|+.|+|||.+.+..++.++||||||+++|+|+++|..||..... . ...... ..+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----~---~~~~~i-~~~~ 234 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----N---DVIGRI-ENGE 234 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----G---GHHHHH-HTTC
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----H---HHHHHH-HcCC
Confidence 876554333334456788999999999899999999999999999999559999975322 1 111111 1111
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
... . ....++.+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 235 ~~~-----~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 235 RLP-----M-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC-----C-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 100 0 112345688999999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=350.28 Aligned_cols=275 Identities=18% Similarity=0.303 Sum_probs=215.2
Q ss_pred ccCHHHHHHHhccCCCCCeecccCceEEEEEEe------CCceEEEEEEccC-CCchhHHHHHHHHHHHHhc-CCCceee
Q 045067 51 SFSAKELERATNNYHYRNIITESSIFRLCQGVL------PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQM-SHNNVLR 122 (347)
Q Consensus 51 ~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~ 122 (347)
.+...+++...++|...+.||+|+||.||+|.+ .++..+++|.+.. ......+.+.+|+.++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 466777888889999999999999999999984 3334455554443 4444457799999999999 7999999
Q ss_pred eeeeeeeCC-ccEEEEEeCCCCCHHHHHhhhccC----------------------------------------------
Q 045067 123 LIGCCLEVE-IPVLVFESAEYGNLHDLLKRSYQS---------------------------------------------- 155 (347)
Q Consensus 123 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------------------------------------- 155 (347)
+++++.+.+ ..++||||+++|+|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999988755 489999999999999999764210
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 156 ---------------HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 156 ---------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 0122899999999999999999999 9999999999999999999999999999998765433
Q ss_pred c-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 221 T-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 221 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
. .......||+.|+|||++.+..++.++|||||||++|||++.|..||..... . .........+.....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~-~~~~~~~~~~~~~~~-- 317 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-------D-EEFCRRLKEGTRMRA-- 317 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-------S-HHHHHHHHHTCCCCC--
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch-------h-HHHHHHHHcCCCCCC--
Confidence 2 2234567899999999999999999999999999999999339999964321 1 112222222211110
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
+...++++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 318 --------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 318 --------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 011245688999999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=337.73 Aligned_cols=265 Identities=21% Similarity=0.271 Sum_probs=203.7
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHh--cCCCceeeeeeeeeeC----Ccc
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQ--MSHNNVLRLIGCCLEV----EIP 133 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~ 133 (347)
..++|...+.||+|+||+||+|.+++..+|+|++... ....+.+|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 3568999999999999999999997767666665332 22556677777766 7999999999987653 458
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeEeccCCCCCeEECCCCceEEe
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF-----SRPIVFRDLKSSYILVSERYVPKLF 208 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivH~dlkp~Nill~~~~~~kl~ 208 (347)
++||||+++|+|.++++. ..+++..+..++.|++.||+|||+.. +.+|+||||||+|||++.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999965 57999999999999999999999422 5789999999999999999999999
Q ss_pred cCCCCccCCCCCcee---eccccccCCcccccccccC------CCCCccchHHHHHHHHHHHhcC----------CCccc
Q 045067 209 NFSLSASIPEGETYI---DDGVKGTSGIVAPEYARTG------YLNEKCDVYSFGLLLLQLLSTG----------EDLFN 269 (347)
Q Consensus 209 Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~el~~~g----------~~p~~ 269 (347)
|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+ +| ..||.
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~-tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA-RRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH-TTBCBTTBCCCCCCTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHH-hhhcCcccccccccccc
Confidence 999997655433322 2335799999999998876 4557999999999999999 88 77775
Q ss_pred cCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 270 MGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
..... .. ............. ..+...........+..+.+++.+||+.||++|||+.++++.|++|
T Consensus 235 ~~~~~--~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPN--DP--SFEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCS--SC--CHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCC--Cc--chhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 43221 11 1112222221111 1122222223345677899999999999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=342.00 Aligned_cols=251 Identities=15% Similarity=0.196 Sum_probs=205.8
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
.++|...+.||+|+||.||+|.. .++..+++|...... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 46788999999999999999999 566666666665443 3346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC--CCceEEecCCCCccCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE--RYVPKLFNFSLSASIP 217 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~a~~~~ 217 (347)
+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||++....
T Consensus 83 ~~g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 83 ISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999999999752 246999999999999999999999 999999999999999997 7899999999998775
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... .....||+.|+|||++.+..++.++||||+||++|+|+ +|.+||..... ............ .
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~--------~~~~~~i~~~~~-~-- 221 (321)
T 1tki_A 156 PGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL-SGINPFLAETN--------QQIIENIMNAEY-T-- 221 (321)
T ss_dssp TTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH-HSSCTTCCSSH--------HHHHHHHHHTCC-C--
T ss_pred CCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH-hCCCCCcCCCH--------HHHHHHHHcCCC-C--
Confidence 4432 23467899999999999888999999999999999999 99999964321 222222222211 0
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.........+.++.+++.+||+.||.+|||+.|+++
T Consensus 222 -----~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 -----FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001111233567889999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=345.73 Aligned_cols=252 Identities=19% Similarity=0.256 Sum_probs=202.6
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCc------hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF------DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
..+.|...+.||+|+||.||+|.. .++..+++|++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 456789999999999999999999 4455455554433221 124678999999999999999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC----ceEEe
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY----VPKLF 208 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~----~~kl~ 208 (347)
.++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 99999999999999999764 67999999999999999999999 99999999999999998777 79999
Q ss_pred cCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 209 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
|||++........ .....||+.|+|||++.+..++.++||||+||++|+|+ +|.+||..... .......
T Consensus 162 DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll-~g~~Pf~~~~~--------~~~~~~i 230 (361)
T 2yab_A 162 DFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL-SGASPFLGDTK--------QETLANI 230 (361)
T ss_dssp CCSSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSCCSSCCSSH--------HHHHHHH
T ss_pred ecCCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHH
Confidence 9999987654332 23467999999999999999999999999999999999 89999964321 1222222
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. .... + ........+..+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~-~~~~--~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 231 TA-VSYD--F-----DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HT-TCCC--C-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Hh-cCCC--C-----CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11 1110 0 01111233457889999999999999999999985
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=334.81 Aligned_cols=262 Identities=18% Similarity=0.291 Sum_probs=208.1
Q ss_pred HHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
....++|...+.||+|+||.||+|.+.++..+++|........ .+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 3445678889999999999999999966655555555544333 367899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 99 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 99 EYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp CCCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred eccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 999999999999763 256999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
...........+|+.|+|||.+.+..++.++||||+|+++|+|++.|+.||..... ............ .
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~---~ 240 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQGLR---L 240 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHHTTCC---C
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHHHHHHhcccC---C
Confidence 43332233455788899999999889999999999999999999339999964321 122222211110 0
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
..+. ..++.+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 241 ~~~~--------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 241 YRPH--------LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCT--------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCC--------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1111 1134678999999999999999999999999998763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=349.71 Aligned_cols=252 Identities=18% Similarity=0.230 Sum_probs=198.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 135 (347)
.++|...++||+|+||.||+|.. .++..+++|++... .....+.+.+|..++.++ +||||+++++++.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 46799999999999999999999 56666666655432 222335688999999887 89999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999999875 67999999999999999999999 99999999999999999999999999999976
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
..... ......+||+.|+|||++.+..++.++|||||||++|||+ +|++||..........................
T Consensus 203 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell-~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~- 279 (396)
T 4dc2_A 203 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM-AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 279 (396)
T ss_dssp CCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSTTTTC------CCHHHHHHHHHHCCC-
T ss_pred cccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH-hCCCCCcccccccccchhhHHHHHHHHhcccc-
Confidence 33222 2234578999999999999999999999999999999999 89999964322111111112222222222111
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM 333 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~ 333 (347)
.. +...+.++.+++.+||+.||++||++
T Consensus 280 -----~~-----p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -----RI-----PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CC-----CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----CC-----CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 01 11234567899999999999999996
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=341.89 Aligned_cols=248 Identities=16% Similarity=0.180 Sum_probs=202.4
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...+.||+|+||.||+|.. .++..+++|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 36788999999999999999999 55555666655432 122346788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999999875 67999999999999999999999 999999999999999999999999999999764
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..... .....+||+.|+|||++.+..++.++||||+||++|||+ +|.+||..... .......... ..
T Consensus 156 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~--------~~~~~~i~~~-~~-- 222 (337)
T 1o6l_A 156 ISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDH--------ERLFELILME-EI-- 222 (337)
T ss_dssp CCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHC-CC--
T ss_pred ccCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHh-cCCCCCCCCCH--------HHHHHHHHcC-CC--
Confidence 33222 234567999999999999999999999999999999999 89999964321 1222222221 11
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
..+ ...++++.+++.+||+.||++|| ++.|+++
T Consensus 223 ----~~p-----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 ----RFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CCC-----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCC-----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 010 12245678999999999999999 8998875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=350.77 Aligned_cols=254 Identities=18% Similarity=0.195 Sum_probs=202.3
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
...++|...+.||+|+||+||+|.. .++..+++|.+.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3567899999999999999999998 455555555444332 2334678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC---CCCceEEecCCC
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS---ERYVPKLFNFSL 212 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~ 212 (347)
||||+++|+|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999874 67999999999999999999999 99999999999999998 568899999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
+........ ......||+.|+|||++.+..++.++||||+||++|+|+ +|.+||..... ........ .+
T Consensus 160 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell-~G~~Pf~~~~~--------~~~~~~i~-~~ 228 (444)
T 3soa_A 160 AIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL-VGYPPFWDEDQ--------HRLYQQIK-AG 228 (444)
T ss_dssp CBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHHHHH-HT
T ss_pred eEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHH-hCCCCCCCccH--------HHHHHHHH-hC
Confidence 977654332 224467999999999999999999999999999999999 99999964321 12222222 22
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... ...+ .....++++.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~-~~~~------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 229 AYD-FPSP------EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCC-CCTT------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-CCcc------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111 1111 11123456889999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=362.76 Aligned_cols=266 Identities=20% Similarity=0.303 Sum_probs=211.0
Q ss_pred CHHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 53 SAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 53 ~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
..++++...++|...+.||+|+||.||+|.+.++..+++|.+..... ..+.+.+|+.++++++||||+++++++. .+.
T Consensus 179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp CTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence 34556666788999999999999999999995444444444444332 3478999999999999999999999986 567
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.++||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSH---HHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred cEEEEeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 89999999999999999753 1236889999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
++..............+|+.|+|||++.+..++.++|||||||++|||++.|+.||..... ...........
T Consensus 331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~ 402 (454)
T 1qcf_A 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALERGY 402 (454)
T ss_dssp GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHHHTC
T ss_pred ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCC
Confidence 9876543222223345678999999999899999999999999999999449999964321 22222222211
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
.. .. +...+.++.+++.+||+.||++|||+.+|++.|+++..
T Consensus 403 ~~--------~~---~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 403 RM--------PR---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CC--------CC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CC--------CC---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11 01 11234568899999999999999999999999998864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.97 Aligned_cols=273 Identities=21% Similarity=0.249 Sum_probs=208.9
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhc--CCCceeeeeeeeee
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQM--SHNNVLRLIGCCLE 129 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~ 129 (347)
.+...-....++|...+.||+|+||.||+|.+.+..+|+|.+... ....+.+|..++..+ +||||+++++++..
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 344455566789999999999999999999998777777665432 224456666666554 89999999999988
Q ss_pred C----CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--------CeEeccCCCCCe
Q 045067 130 V----EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR--------PIVFRDLKSSYI 197 (347)
Q Consensus 130 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~--------~ivH~dlkp~Ni 197 (347)
. ...++||||+++|+|.+++.. ..+++..+..++.|++.||.||| +. +|+||||||+||
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Ni 173 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNI 173 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGE
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHE
Confidence 7 688999999999999999976 46999999999999999999999 77 999999999999
Q ss_pred EECCCCceEEecCCCCccCCCCCcee---eccccccCCcccccccccCCCCCc------cchHHHHHHHHHHHhcC----
Q 045067 198 LVSERYVPKLFNFSLSASIPEGETYI---DDGVKGTSGIVAPEYARTGYLNEK------CDVYSFGLLLLQLLSTG---- 264 (347)
Q Consensus 198 ll~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~G~~l~el~~~g---- 264 (347)
|++.++.+||+|||++.......... .....||+.|+|||++.+...+.. +|||||||++|||+ +|
T Consensus 174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~-tg~~~~ 252 (337)
T 3mdy_A 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA-RRCVSG 252 (337)
T ss_dssp EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHH-TTBCBT
T ss_pred EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHH-hccCcc
Confidence 99999999999999997765433221 134579999999999987766655 99999999999999 88
Q ss_pred ------CCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 265 ------EDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 265 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.||...... . . ............. ..+...........+.++.+++.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~p~~~~~~~--~-~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPS--D-P-SYEDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324 (337)
T ss_dssp TBCCCCCCTTTTTSCS--S-C-CHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cccccccccHhhhcCC--C-C-chhhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence 5555432221 1 1 1122222222111 12222222223466778999999999999999999999999
Q ss_pred HHHHHHHh
Q 045067 339 QIKKMYKS 346 (347)
Q Consensus 339 ~L~~i~~~ 346 (347)
.|+++.++
T Consensus 325 ~L~~l~~~ 332 (337)
T 3mdy_A 325 TLAKMSES 332 (337)
T ss_dssp HHHHHHHT
T ss_pred HHHHHHhh
Confidence 99999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=332.54 Aligned_cols=263 Identities=14% Similarity=0.102 Sum_probs=207.6
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.++|...+.||+|+||.||+|.. .++..+++|+..... ..+.+.+|+.++..+ +|+|++++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45788999999999999999997 555555555544332 225688999999999 79999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc-----eEEecCCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV-----PKLFNFSLS 213 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~a 213 (347)
|+ +++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||++
T Consensus 87 ~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 87 LL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99 88999999863 256999999999999999999999 999999999999999987776 999999999
Q ss_pred ccCCCCCce------eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 214 ASIPEGETY------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 214 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
......... ......||+.|+|||.+.+..++.++|||||||++|+|+ +|+.||..... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~-----~~~~~~~~~ 232 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL-RGSLPWQGLKA-----ATNKQKYER 232 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTSSCCS-----CCHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH-cCCCCcchhhc-----cccHHHHHH
Confidence 876543221 124467999999999999999999999999999999999 99999975322 111111111
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
........ .........++.+.+++.+||+.||++|||+.+|++.|+++.++
T Consensus 233 ~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 233 IGEKKQST-------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHHHHHHS-------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHhhccCc-------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 11110000 00011112345788999999999999999999999999999765
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=358.01 Aligned_cols=263 Identities=16% Similarity=0.177 Sum_probs=209.8
Q ss_pred CHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeee
Q 045067 53 SAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCL 128 (347)
Q Consensus 53 ~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 128 (347)
+..++....++|...++||+|+||+||+|.. .++.++++|++.... ....+.+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 4456666788999999999999999999999 556666666654321 112244889999999999999999999999
Q ss_pred eCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEe
Q 045067 129 EVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLF 208 (347)
Q Consensus 129 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 208 (347)
+++.+++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEc
Confidence 999999999999999999999762 267999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCccCCCCCceeeccccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 209 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
|||+++.............+||+.|+|||++. ...++.++|||||||++|||+ +|++||..... ..
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ell-tG~~Pf~~~~~--------~~ 288 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML-YGETPFYAESL--------VE 288 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHH-HSSCTTCCSSH--------HH
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHH-hCCCCCCCCCh--------hH
Confidence 99999877655554445578999999999886 567899999999999999999 99999964321 22
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAED--RPTMIDVAK 338 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~--RPs~~ell~ 338 (347)
........... ...+.. ....++++.+|+.+||..+|++ ||++.|+++
T Consensus 289 ~~~~i~~~~~~--~~~p~~-----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 289 TYGKIMNHKER--FQFPTQ-----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHHHTHHHH--CCCCSS-----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred HHHhhhhcccc--ccCCcc-----cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 22222221100 000110 0112456789999999888888 999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=362.01 Aligned_cols=264 Identities=21% Similarity=0.311 Sum_probs=212.3
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
+++...++|...+.||+|+||.||+|.+ .++..+++|.+..... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 3444566788889999999999999999 4455555555554432 3478999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 293 lv~E~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 366 (495)
T 1opk_A 293 IITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSR 366 (495)
T ss_dssp EEEECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEE
T ss_pred EEEEccCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccce
Confidence 999999999999999763 3356899999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
..............+++.|+|||++.+..++.++|||||||++|||++.|..||..... . .. ......+.
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----~---~~-~~~~~~~~- 436 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----S---QV-YELLEKDY- 436 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----G---GH-HHHHHTTC-
T ss_pred eccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----H---HH-HHHHHcCC-
Confidence 77554433334455778999999999999999999999999999999449999975321 1 11 11122111
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
+... +...+..+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 437 ------~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 437 ------RMER---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ------CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ------CCCC---CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 0000 11234568899999999999999999999999988743
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=352.96 Aligned_cols=255 Identities=22% Similarity=0.303 Sum_probs=206.1
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC-ccEEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE-IPVLVFE 138 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 138 (347)
..++|...+.||+|+||.||+|.+.+..+|+|.+.... ..+.+.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 45678888999999999999999987776666655432 3477999999999999999999999987765 7899999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 268 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp CCTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999999999875 2234799999999999999999999 99999999999999999999999999999975433
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
.. ....+++.|+|||.+.+..++.++|||||||++|||++.|+.||..... . ...... ..+..
T Consensus 342 ~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~---~~~~~i-~~~~~---- 404 (450)
T 1k9a_A 342 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----K---DVVPRV-EKGYK---- 404 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----T---THHHHH-HTTCC----
T ss_pred cc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----H---HHHHHH-HcCCC----
Confidence 21 2236788999999999999999999999999999999549999975322 1 111111 11110
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.. .+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 405 ---~~---~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 405 ---MD---APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CC---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 00 1112345788999999999999999999999999998763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=338.39 Aligned_cols=252 Identities=21% Similarity=0.247 Sum_probs=201.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCc-----hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVF-----DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
..+.|...+.||+|+||.||+|.. .++..+++|.+. .... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 345688899999999999999999 445444444443 2211 134679999999999999999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC----ceEEe
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY----VPKLF 208 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~----~~kl~ 208 (347)
.++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 99999999999999999764 67999999999999999999999 99999999999999999887 89999
Q ss_pred cCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 209 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
|||++........ .....||+.|+|||++.+..++.++|||||||++|+|+ +|..||..... .......
T Consensus 161 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~--------~~~~~~~ 229 (326)
T 2y0a_A 161 DFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL-SGASPFLGDTK--------QETLANV 229 (326)
T ss_dssp CCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSCCSSCCSSH--------HHHHHHH
T ss_pred ECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHH-HCcCCCCCCCH--------HHHHHHH
Confidence 9999987654322 23457999999999999899999999999999999999 89999964321 1122221
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... .. .. ........+..+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~-~~------~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 230 SAV-NY------EF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHT-CC------CC-CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Hhc-CC------Cc-CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 10 00 01111223456889999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=344.04 Aligned_cols=267 Identities=19% Similarity=0.260 Sum_probs=211.8
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe-C-------C-ceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL-P-------D-RTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCC 127 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~-------~-~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 127 (347)
....++|...+.||+|+||+||+|.. . . ..+++|++.........+.+.+|+.+++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 33457888899999999999999986 1 1 235555554444445557799999999999 899999999999
Q ss_pred eeCCccEEEEEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 045067 128 LEVEIPVLVFESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSY 196 (347)
Q Consensus 128 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~N 196 (347)
.+++..++||||+++|+|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcce
Confidence 999999999999999999999987421 11245999999999999999999999 9999999999999
Q ss_pred eEECCCCceEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCC
Q 045067 197 ILVSERYVPKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN 275 (347)
Q Consensus 197 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~ 275 (347)
||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|+|++.|..||.....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-- 299 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 299 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999987654322 2233456788999999999999999999999999999999439999964321
Q ss_pred CCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 276 GDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.. .......+..... ....+.++.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 300 ------~~-~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 300 ------EE-LFKLLKEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp ------HH-HHHHHHTTCCCCC----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HH-HHHHHHcCCCCCC----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 12 2222222211110 012245688999999999999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=344.32 Aligned_cols=269 Identities=25% Similarity=0.360 Sum_probs=211.2
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEeCC------ceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeee
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVLPD------RTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCL 128 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 128 (347)
++....++|...+.||+|+||.||+|...+ +..+++|.... ......+.+.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 344557889999999999999999999832 25555555544 34444577999999999999999999999999
Q ss_pred eCCccEEEEEeCCCCCHHHHHhhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 045067 129 EVEIPVLVFESAEYGNLHDLLKRSYQS-------------------HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVF 189 (347)
Q Consensus 129 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH 189 (347)
+++..++||||+++|+|.+++...... ....+++..+..++.|++.||.||| +.+|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence 999999999999999999999763110 1256899999999999999999999 999999
Q ss_pred ccCCCCCeEECCCCceEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCcc
Q 045067 190 RDLKSSYILVSERYVPKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLF 268 (347)
Q Consensus 190 ~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~ 268 (347)
|||||+|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++.|..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999876543221 12234568899999999998899999999999999999994399999
Q ss_pred ccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 269 NMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
..... .... .....+..... +...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 278 ~~~~~--------~~~~-~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 278 YGMAH--------EEVI-YYVRDGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTSCH--------HHHH-HHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCCh--------HHHH-HHHhCCCcCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 64321 1222 22222221110 112245688999999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=334.20 Aligned_cols=271 Identities=16% Similarity=0.176 Sum_probs=208.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC--ccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE--IPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 136 (347)
.+.|...+.||+|+||+||+|.. .++..+++|++. .......+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 35688899999999999999999 444445555444 333334577889999999999999999999988765 77999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE----CCCCceEEecCCC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV----SERYVPKLFNFSL 212 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~ 212 (347)
|||+++++|.+++.... ....+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EECCTTCBHHHHHHSGG--GTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EeCCCCCCHHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 99999999999998642 1234999999999999999999999 9999999999999999 7888899999999
Q ss_pred CccCCCCCceeeccccccCCcccccccc--------cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYAR--------TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
++....... .....||+.|+|||++. +..++.++|||||||++|||+ +|+.||..... .......
T Consensus 163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~----~~~~~~~ 235 (319)
T 4euu_A 163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA-TGSLPFRPFEG----PRRNKEV 235 (319)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHH-HSSCSEECTTC----GGGCHHH
T ss_pred ceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCc----cchhHHH
Confidence 987654432 23457999999999876 578899999999999999999 89999974322 1112223
Q ss_pred HHHHHhccCcc---cc---------cCCccC-CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 285 VKKYIENRGFN---GI---------VDPRII-GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 285 ~~~~~~~~~~~---~~---------~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
........... .. +...+. ...........+.+++.+||+.||++|||+.|+++...+.
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 33333221100 00 000111 1123346677889999999999999999999999988764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=330.96 Aligned_cols=259 Identities=21% Similarity=0.316 Sum_probs=208.1
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
.++|...+.||+|+||.||+|.+.++..+++|........ .+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 3578888999999999999999954444455554443322 367999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++++|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 86 EHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp TTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999763 256899999999999999999999 9999999999999999999999999999997765432
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
........+++.|+|||.+.+..++.++||||+|+++|+|++.|.+||..... ......... +.. ...+
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~~-~~~--~~~~ 227 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDIST-GFR--LYKP 227 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHT-TCC--CCCC
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHhc-CCc--CCCC
Confidence 22223456788999999999889999999999999999999449999964321 122222211 110 0111
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
. ..+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 228 ~--------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 228 R--------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp T--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred c--------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1 1244678999999999999999999999999999764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=334.49 Aligned_cols=264 Identities=21% Similarity=0.286 Sum_probs=214.6
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++...++|...+.||+|+||+||+|.+ .++..+++|...... ...+.+.+|+.++++++||||+++++++.+++..++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 334567889999999999999999999 445555555555443 334779999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++++|.+++... ....+++..+..++.+++.||.||| +.+|+||||||+||+++.++.++|+|||++..
T Consensus 87 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEECCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEcCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999764 3356999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.............+|+.|+|||.+.+..++.++||||+|+++|+|++.|.+||..... ... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~----~~~~~~~~~- 230 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQV----YELLEKDYR- 230 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGH----HHHHHTTCC-
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHH----HHHHhccCC-
Confidence 7655544445566788999999999899999999999999999999339999965322 111 111111110
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.. .....++.+.+++.+||+.||.+|||+.++++.|+++..+
T Consensus 231 ----~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 ----ME-----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ----CC-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CC-----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 00 0112245688999999999999999999999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=336.86 Aligned_cols=266 Identities=21% Similarity=0.315 Sum_probs=211.0
Q ss_pred HHhccCCCCCeecccCceEEEEEEe------CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL------PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE 131 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 131 (347)
...++|...+.||+|+||.||+|.. .++..+++|.... ......+.+.+|+.++++++||||+++++++.+++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3457788999999999999999986 2335555555544 34445577999999999999999999999999999
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQS-------------------HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDL 192 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dl 192 (347)
..++||||+++|+|.+++...... ....+++..+..++.|++.||.||| +.+|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccccc
Confidence 999999999999999999864210 1134899999999999999999999 999999999
Q ss_pred CCCCeEECCCCceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccC
Q 045067 193 KSSYILVSERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMG 271 (347)
Q Consensus 193 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~ 271 (347)
||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||+||++|+|++.|..||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 2234567889999999999999999999999999999993399999643
Q ss_pred ccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 272 LRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.. .. .......+.... .....++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus 257 ~~-----~~----~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PP-----ER----LFNLLKTGHRME----------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CG-----GG----HHHHHHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CH-----HH----HHHHhhcCCcCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 22 11 111222211110 0112345688999999999999999999999999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=333.25 Aligned_cols=264 Identities=23% Similarity=0.331 Sum_probs=209.9
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
+++...++|...+.||+|+||.||+|...++..+++|....... ..+.+.+|+.++++++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 34445678899999999999999999996554445554444332 3477999999999999999999999986 456899
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++++|.+++... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 85 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp EEECCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 99999999999999753 1136999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.............+++.|+|||.+.+..++.++||||||+++|+|++.|+.||..... ....... ..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~-~~~~~- 228 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNL-ERGYR- 228 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHH-HTTCC-
T ss_pred ccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHHHH-hcccC-
Confidence 7654433334456788999999999889999999999999999999449999964321 1222222 11110
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
... ....+..+.+++.+||+.+|++|||+.++++.|+++..+
T Consensus 229 -~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 229 -MVR--------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCC--------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 000 112245688999999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=342.57 Aligned_cols=254 Identities=19% Similarity=0.249 Sum_probs=203.2
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
...++|...+.||+|+||.||+|.. .++..+++|++... .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4567899999999999999999998 44554555544332 23345678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC---CceEEecCCC
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER---YVPKLFNFSL 212 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~ 212 (347)
||||+++|+|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999999764 67999999999999999999999 9999999999999999865 4599999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
+........ .....||+.|+|||++.+..++.++|||||||++|+|+ +|.+||..... ....... ..+
T Consensus 178 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~Pf~~~~~--------~~~~~~i-~~~ 245 (362)
T 2bdw_A 178 AIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL-VGYPPFWDEDQ--------HRLYAQI-KAG 245 (362)
T ss_dssp CBCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHH-HHT
T ss_pred ceEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHH-HCCCCCCCCCH--------HHHHHHH-HhC
Confidence 987654322 23467999999999999989999999999999999999 99999964321 1222222 222
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
... .. .......+.++.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~-~~------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 246 AYD-YP------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCC-CC------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCC-CC------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 00 01112335578899999999999999999998753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=335.24 Aligned_cols=252 Identities=20% Similarity=0.233 Sum_probs=196.8
Q ss_pred HhccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE------ 131 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 131 (347)
..++|+..+.||+|+||.||+|.+ . +..+|+|++.........+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 346788999999999999999999 3 44555555544444445578999999999999999999999986643
Q ss_pred ---------------------------------------------------ccEEEEEeCCCCCHHHHHhhhccCCCCCC
Q 045067 132 ---------------------------------------------------IPVLVFESAEYGNLHDLLKRSYQSHSEPL 160 (347)
Q Consensus 132 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l 160 (347)
..++||||+++|+|.+++.... .....
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~ 161 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDR 161 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGS
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccch
Confidence 2799999999999999998742 22446
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCc-----------eeeccccc
Q 045067 161 LLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGET-----------YIDDGVKG 229 (347)
Q Consensus 161 ~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-----------~~~~~~~g 229 (347)
++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....... .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 77789999999999999999 99999999999999999999999999999987754421 11234579
Q ss_pred cCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhH
Q 045067 230 TSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLE 309 (347)
Q Consensus 230 t~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (347)
|+.|+|||.+.+..++.++|||||||++|+|+ +|..|+... ........... .+....
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~~~~~~~~~-----------~~~~~~~~~~~----------~~~~~~ 296 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELL-YSFSTQMER-----------VRIITDVRNLK----------FPLLFT 296 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHH-SCCCCHHHH-----------HHHHHHHHTTC----------CCHHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHH-HcCCChhHH-----------HHHHHHhhccC----------CCcccc
Confidence 99999999999999999999999999999999 777665321 11111111111 112233
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 310 HKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 310 ~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...+.+.+++.+||+.||++|||+.|+++
T Consensus 297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 297 QKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred cCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 44567789999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=343.69 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=197.8
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.++|...+.||+|+||+||+|.. .++..+++|+.. .......+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 46789999999999999999998 455555555443 3333334678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999764 67999999999999999999999 99999999999999999999999999999976543
Q ss_pred CCc-eeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 219 GET-YIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 219 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
... .......||+.|+|||++.+..+ +.++||||+||++|+|+ +|+.||..... . .............
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~----~---~~~~~~~~~~~~~-- 227 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML-AGELPWDQPSD----S---CQEYSDWKEKKTY-- 227 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHH-HSSCSCSSSCT----T---SHHHHHHHTTCTT--
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCch----H---HHHHHHHhccccc--
Confidence 322 22235679999999999887765 78999999999999999 89999975332 0 0111111111110
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 228 -~~-------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 228 -LN-------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp -ST-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 01123456789999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=338.26 Aligned_cols=262 Identities=15% Similarity=0.131 Sum_probs=206.6
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.++|...+.||+|+||+||+|.. .++..+++|+...... .+.+.+|+.+++++ +||||+++++++.+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46788999999999999999998 5555555555543322 25688999999999 99999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc-----eEEecCCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV-----PKLFNFSLS 213 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~a 213 (347)
|+ +++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||++
T Consensus 86 ~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 86 LL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred eC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 99 88999999863 367999999999999999999999 999999999999999998887 999999999
Q ss_pred ccCCCCCce------eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 214 ASIPEGETY------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 214 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
+........ ......||+.|+|||++.+..++.++|||||||++|||+ +|+.||..... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell-~g~~Pf~~~~~-----~~~~~~~~~ 231 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFL-RGSLPWQGLKA-----DTLKERYQK 231 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTTTCCC-----SSHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHh-cCCCCcccccc-----ccHHHHHHH
Confidence 876443221 123567999999999999999999999999999999999 89999975321 111122222
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
...... . ..........+ ++.+++.+||+.+|.+||++.+|.+.|+++.+.
T Consensus 232 i~~~~~-~------~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 232 IGDTKR-A------TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HHHHHH-H------SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHhhhc-c------CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 111100 0 00000001123 788999999999999999999999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=340.31 Aligned_cols=251 Identities=19% Similarity=0.237 Sum_probs=198.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 136 (347)
++|...+.||+|+||.||+|.. .++..+++|++... .....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5788999999999999999999 55565555555432 233446688999999988 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999875 67999999999999999999999 999999999999999999999999999999764
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..... .....+||+.|+|||++.+..++.++||||+||++|||+ +|++||..........................
T Consensus 161 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-- 236 (345)
T 3a8x_A 161 LRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM-AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-- 236 (345)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCTTTTTTC-------CHHHHHHHHHHCCC--
T ss_pred cCCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHH-hCCCCcCCcccccccccccHHHHHHHHHcCCC--
Confidence 33221 234568999999999999999999999999999999999 89999965322111111111222222222111
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM 333 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~ 333 (347)
.++ ...+..+.+++.+||+.||++||++
T Consensus 237 ----~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ----RIP-----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCC-----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCC-----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 010 1224567899999999999999996
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=327.74 Aligned_cols=254 Identities=20% Similarity=0.216 Sum_probs=204.7
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIPVLVF 137 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 137 (347)
.++|...+.||+|+||+||+|.+++..+++|.+.... .....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 3578889999999999999999987777776665443 234456799999999999999999999999887 7889999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP--IVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||+++|+|.+++... ....+++..+..++.|++.||.||| +.+ ++||||||+||+++.++.++++|||++..
T Consensus 89 e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp ECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred cccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999864 2235899999999999999999999 888 99999999999999999999999987754
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCC---ccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNE---KCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
... ....||+.|+|||.+.+..++. ++|||||||++|+|+ +|+.||..... ...........
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~--------~~~~~~~~~~~ 227 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV-TREVPFADLSN--------MEIGMKVALEG 227 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHH-HCSCTTTTSCH--------HHHHHHHHHSC
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHH-hCCCCccccCh--------HHHHHHHHhcC
Confidence 322 2346899999999988765544 799999999999999 89999964321 12222222222
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
... .. +...+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 228 ~~~-----~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 LRP-----TI-----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCC-----CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCC-----CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111 11 11234568899999999999999999999999999865
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=341.58 Aligned_cols=257 Identities=18% Similarity=0.291 Sum_probs=198.3
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc-e----EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR-T----ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~-~----~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|...+.||+|+||+||+|.+ .++ . +++|++.........+.+.+|+.++++++||||+++++++.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 5688889999999999999998 333 2 34444333333344578999999999999999999999998754 789
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
++||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 94 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999763 367999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 216 IPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 216 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
....... ......+|+.|+|||.+.+..++.++|||||||++|||++.|+.||..... .. .......+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~----~~~~~~~~~~ 237 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SE----ISSILEKGER 237 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GG----HHHHHHTTCC
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HH----HHHHHHcCCC
Confidence 6543322 223455788999999999999999999999999999999339999974322 11 1122221111
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
. .. ....+..+.+++.+||+.+|++|||+.++++.|+++.+
T Consensus 238 ~--~~--------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 L--PQ--------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp C--CC--------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred C--CC--------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 00 11224468899999999999999999999999998864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=347.05 Aligned_cols=263 Identities=18% Similarity=0.245 Sum_probs=205.5
Q ss_pred hccCCCCCeecccCceEEEEEEeC------Cce-EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLP------DRT-ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~-~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
.++|...+.||+|+||+||+|.+. ++. +|+|++...........+.+|+.++++++||||+++++++.++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888899999999999999952 333 4444444333444556789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC---ceEEe
Q 045067 134 VLVFESAEYGNLHDLLKRSYQ--SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY---VPKLF 208 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~---~~kl~ 208 (347)
++||||+++|+|.+++..... .....+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999987521 12245899999999999999999999 99999999999999999555 59999
Q ss_pred cCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 209 NFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 209 Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++.|.+||..... ......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH
Confidence 9999875422111 1123356789999999999999999999999999999999449999964321 122222
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
....... . .....+..+.+++.+||+.+|++|||+.+|++.|+.+.+
T Consensus 299 i~~~~~~-~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 299 VTSGGRM-D----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHTTCCC-C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCC-C----------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 2221111 0 011224467899999999999999999999999998865
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=357.74 Aligned_cols=265 Identities=23% Similarity=0.298 Sum_probs=204.9
Q ss_pred HHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 54 AKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 54 ~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
...++...++|...+.||+|+||.||+|.+.++..+++|....... ..+.+.+|+.++++++||||+++++++.+ +..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 4445556678888999999999999999995544455555554332 23779999999999999999999999876 678
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 254 ~iv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp EEEECCCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEEehhhcCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence 9999999999999999753 1245899999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
+..............+++.|+|||.+.+..++.++|||||||++|||++.|+.||..... ....... ..+.
T Consensus 328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i-~~~~ 398 (452)
T 1fmk_A 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQV-ERGY 398 (452)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHH-HTTC
T ss_pred eecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-HcCC
Confidence 876543332233455788999999999899999999999999999999449999964321 1222222 2211
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
. ... +...+..+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 399 ~-------~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 399 R-------MPC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp C-------CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred C-------CCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 0 000 11234568899999999999999999999999998864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=342.23 Aligned_cols=253 Identities=17% Similarity=0.182 Sum_probs=206.6
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
..+.|...+.||+|+||.||+|.. .++.++++|+...........+.+|+.++++++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 356799999999999999999999 5667777777766555555678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC--CCceEEecCCCCccC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE--RYVPKLFNFSLSASI 216 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~a~~~ 216 (347)
|+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||++...
T Consensus 129 ~~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 129 FLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp CCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99999999999753 256999999999999999999999 999999999999999974 578999999999876
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..... .....||+.|+|||++.+..++.++|||||||++|+|+ +|..||..... ........... ..
T Consensus 202 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-tg~~Pf~~~~~--------~~~~~~i~~~~-~~- 268 (387)
T 1kob_A 202 NPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL-SGLSPFAGEDD--------LETLQNVKRCD-WE- 268 (387)
T ss_dssp CTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH-HSCCSSCCSSH--------HHHHHHHHHCC-CC-
T ss_pred CCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhCC-CC-
Confidence 54432 23357999999999999999999999999999999999 89999964321 12222222211 10
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.++ ......+.++.+++.+||+.||++|||+.|+++
T Consensus 269 -~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 -FDE-----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -CCS-----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -CCc-----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 011 111123456889999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=344.11 Aligned_cols=249 Identities=18% Similarity=0.251 Sum_probs=197.6
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 134 (347)
..++|...+.||+|+||.||+|.. .++..+++|++... .....+.+.+|..++..+ +||||+++++++.+.+.++
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 357899999999999999999998 55555555555432 122346688999999988 7999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 101 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEcccccee
Confidence 999999999999999875 67999999999999999999999 9999999999999999999999999999997
Q ss_pred cCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
...... ......+||+.|+|||++.+..++.++||||+||++|||+ +|++||..... ............
T Consensus 173 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~G~~Pf~~~~~--------~~~~~~i~~~~~- 241 (353)
T 3txo_A 173 EGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEML-CGHAPFEAENE--------DDLFEAILNDEV- 241 (353)
T ss_dssp CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHCCC-
T ss_pred ecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHH-hCCCCCCCCCH--------HHHHHHHHcCCC-
Confidence 643322 2234567999999999999889999999999999999999 89999964321 222333322211
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCH------HHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM------IDVAK 338 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~------~ell~ 338 (347)
..+ ...+..+.+++.+||+.||++||++ .|+++
T Consensus 242 ---~~p--------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ---VYP--------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CCC--------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCC--------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 001 1124467899999999999999998 66654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=332.59 Aligned_cols=264 Identities=17% Similarity=0.153 Sum_probs=198.7
Q ss_pred HHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
...++|...+.||+|+||+||+|...++..+++|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 3457899999999999999999999445444444443322 22346788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++ +|.+.+... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 98 ~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 98 FEFMEK-DLKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EECCSE-EHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EcCCCC-CHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 999985 888888653 356999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
..... ......||+.|+|||++.+ ..++.++||||+||++|+|+ +|++||..... .................
T Consensus 170 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~ 242 (311)
T 3niz_A 170 GIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI-TGKPLFPGVTD-----DDQLPKIFSILGTPNPR 242 (311)
T ss_dssp TSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH-HSSCSCCCSST-----TTHHHHHHHHHCCCCTT
T ss_pred CCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHH-hCCCCCCCCCh-----HHHHHHHHHHHCCCChH
Confidence 53322 2234578999999998876 57899999999999999999 89999975332 11111111111111000
Q ss_pred ---c-------------ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 ---G-------------IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ---~-------------~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ..... ......+....++.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 243 EWPQVQELPLWKQRTFQVFEKK-PWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSGGGTTSHHHHSCCCCCCCCC-CHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhhhhhccchhhhcccccccCC-cHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 00000 000111123457889999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=340.78 Aligned_cols=256 Identities=17% Similarity=0.199 Sum_probs=201.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-----CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-----VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
..+.|...+.||+|+||+||+|.. .++..+++|++... .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346799999999999999999998 45555555544321 112347789999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc---eEEecC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV---PKLFNF 210 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Df 210 (347)
++||||+++|+|.+.+.... .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999998886531 12245899999999999999999999 999999999999999986654 999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
|++........ ......||+.|+|||++.+..++.++||||+||++|+|+ +|..||.... .........
T Consensus 178 g~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~---------~~~~~~i~~ 246 (351)
T 3c0i_A 178 GVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILL-SGCLPFYGTK---------ERLFEGIIK 246 (351)
T ss_dssp TTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCSSH---------HHHHHHHHH
T ss_pred cceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHH-HCCCCCCCcH---------HHHHHHHHc
Confidence 99987654332 234467999999999999999999999999999999999 8999996421 112222222
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ... . ........+..+.+++.+||+.||++|||+.|+++
T Consensus 247 ~-~~~--~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 G-KYK--M-----NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp T-CCC--C-----CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-CCC--C-----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 110 0 01111223557889999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=328.12 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=192.7
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
.++|...+.||+|+||.||+|.+.+..+++|....... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 35788889999999999999999866666665543322 223467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC---eEeccCCCCCeEECC--------CCceE
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP---IVFRDLKSSYILVSE--------RYVPK 206 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~dlkp~Nill~~--------~~~~k 206 (347)
||+++++|.+++.. ..+++..+..++.|++.||.||| +.+ |+||||||+||+++. ++.+|
T Consensus 86 e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 86 EFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp ECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 99999999999965 57999999999999999999999 777 999999999999986 77899
Q ss_pred EecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 207 LFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 207 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
|+|||++........ ....||+.|+|||.+.+..++.++||||+|+++|+|+ +|+.||..... .....
T Consensus 157 l~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~--------~~~~~ 224 (271)
T 3dtc_A 157 ITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL-TGEVPFRGIDG--------LAVAY 224 (271)
T ss_dssp ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHH-HCCCTTTTSCH--------HHHHH
T ss_pred EccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHH
Confidence 999999976543322 2357899999999999999999999999999999999 89999964321 11111
Q ss_pred HHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
...... ... .. ....+..+.+++.+||+.||++|||+.|+++.|++|
T Consensus 225 ~~~~~~-~~~----~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 225 GVAMNK-LAL----PI-----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHTSC-CCC----CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hhhcCC-CCC----CC-----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111111 110 00 112245688999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=339.56 Aligned_cols=246 Identities=21% Similarity=0.270 Sum_probs=197.6
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...+.||+|+||.||+|.+ .++..+++|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35788999999999999999998 555555555443221 12235788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+ +|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 88 ~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp ECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999 57999998765 67999999999999999999999 999999999999999999999999999999776
Q ss_pred CCCCceeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
..... ....+||+.|+|||++.+..+ ++++||||+||++|+|+ +|+.||....... ...
T Consensus 159 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~Pf~~~~~~~-----------------~~~ 218 (336)
T 3h4j_B 159 TDGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVML-VGRLPFDDEFIPN-----------------LFK 218 (336)
T ss_dssp TTSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHH-HSSCSSBCSSSTT-----------------CBC
T ss_pred cCCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHH-hCCCCCCCccHHH-----------------HHH
Confidence 54322 234679999999999988765 78999999999999999 9999997532210 000
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+...... .+...++.+.+++.+||+.||.+|||+.|+++
T Consensus 219 ~i~~~~~~---~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 219 KVNSCVYV---MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCSSCCC---CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHcCCCC---CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111110 11123456789999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=349.18 Aligned_cols=258 Identities=16% Similarity=0.196 Sum_probs=206.9
Q ss_pred HHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 045067 55 KELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV 130 (347)
Q Consensus 55 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 130 (347)
.++....++|...+.||+|+||+||+|.. .++.++++|++.... ....+.+.+|+.+++.++||||+++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 34555678999999999999999999999 556666666654311 11224588999999999999999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
+.+++||||++||+|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999999976 46899999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccCC----CCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGY----LNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
|+++.............+||+.|+|||++.+.. ++.++|||||||++|||+ +|++||..... .....
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell-~G~~Pf~~~~~--------~~~~~ 283 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML-VGDTPFYADSL--------VGTYS 283 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHH-HSSCTTCCSSH--------HHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHH-hCCCCCCCCCh--------hhHHH
Confidence 999877655444445678999999999887654 789999999999999999 89999964321 22222
Q ss_pred HHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 045067 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAED--RPTMIDVAK 338 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~--RPs~~ell~ 338 (347)
........... +. ....+.++.+|+.+||+.+|.+ ||++.|+++
T Consensus 284 ~i~~~~~~~~~--p~------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 284 KIMNHKNSLTF--PD------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHTHHHHCCC--CT------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHhccccccC--CC------cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 22221100000 00 0112456789999999999988 999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=334.68 Aligned_cols=245 Identities=21% Similarity=0.296 Sum_probs=201.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...+.||+|+||.||+|.. .++..+++|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 36788999999999999999999 556666666554321 12346688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp ECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 9999999999999874 67999999999999999999999 999999999999999999999999999999875
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
... ....+||+.|+|||++.+..++.++||||+||++|||+ +|.+||.... ............ .
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~--------~~~~~~~i~~~~-~-- 220 (318)
T 1fot_A 157 PDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML-AGYTPFYDSN--------TMKTYEKILNAE-L-- 220 (318)
T ss_dssp SSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHH-HSSCTTCCSS--------HHHHHHHHHHCC-C--
T ss_pred CCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHH-hCCCCCCCCC--------HHHHHHHHHhCC-C--
Confidence 432 23467999999999999999999999999999999999 8999996432 122222332221 1
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
... ...+.++.+++.+||+.||++|| ++.|+++
T Consensus 221 ----~~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ----RFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----CCC-----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCC-----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 010 12245678999999999999999 8888874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=330.44 Aligned_cols=259 Identities=22% Similarity=0.313 Sum_probs=202.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-C---CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-P---DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~---~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
..++|...+.||+|+||+||+|.+ . .+..+++|..... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 356788999999999999999987 2 2234555555443 44455789999999999999999999999865 4578
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+||||+++++|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.
T Consensus 89 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 999999999999999764 256899999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
..............+|+.|+|||.+.+..++.++||||||+++|+|++.|+.||..... ... ... ...+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----~~~---~~~-~~~~~~ 232 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----KDV---IGV-LEKGDR 232 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----GGH---HHH-HHHTCC
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----HHH---HHH-HhcCCC
Confidence 76554433334456788999999999899999999999999999999339999964322 111 111 111111
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
.. .+ ...++.+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 233 ~~--~~--------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 233 LP--KP--------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CC--CC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC--CC--------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 00 00 1124568899999999999999999999999999865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=332.18 Aligned_cols=256 Identities=20% Similarity=0.339 Sum_probs=196.3
Q ss_pred ccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
++|...+.||+|+||+||+|.+.+..+++|++... ...+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 56888899999999999999998777766665432 33477999999999999999999999887 45899999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc-eEEecCCCCccCCCCC
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV-PKLFNFSLSASIPEGE 220 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~a~~~~~~~ 220 (347)
+|+|.+++.... ....+++..+..++.|++.||+|||+....+|+||||||+||+++.++. +||+|||++.......
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~ 160 (307)
T 2eva_A 83 GGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM 160 (307)
T ss_dssp TCBHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence 999999997631 1134789999999999999999999211189999999999999998886 7999999987654322
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
....||+.|+|||.+.+..++.++||||||+++|+|+ +|+.||..... . ........ ..+....
T Consensus 161 ----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~----~--~~~~~~~~-~~~~~~~---- 224 (307)
T 2eva_A 161 ----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVI-TRRKPFDEIGG----P--AFRIMWAV-HNGTRPP---- 224 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHH-HTCCTTTTTCS----S--HHHHHHHH-HTTCCCC----
T ss_pred ----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHH-HCCCCchhhCc----c--HHHHHHHH-hcCCCCC----
Confidence 2346899999999999999999999999999999999 89999964321 1 11111111 1111111
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
. ....+..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 225 -~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 225 -L-----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp -C-----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred -c-----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1 112245678999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=332.45 Aligned_cols=268 Identities=21% Similarity=0.337 Sum_probs=211.4
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe------CCceEEEEEEccC-CCchhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL------PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLE 129 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 129 (347)
....++|...+.||+|+||.||+|.+ .++..+++|.... ......+.+.+|+.+++++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 33456788999999999999999984 3445555555544 3334557799999999999 89999999999999
Q ss_pred CCccEEEEEeCCCCCHHHHHhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 045067 130 VEIPVLVFESAEYGNLHDLLKRSYQ-------------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSY 196 (347)
Q Consensus 130 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~N 196 (347)
++..++||||+++|+|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccce
Confidence 9999999999999999999986421 01225899999999999999999999 9999999999999
Q ss_pred eEECCCCceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCC
Q 045067 197 ILVSERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN 275 (347)
Q Consensus 197 ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~ 275 (347)
|+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++.|..||.....
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-- 253 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-- 253 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc--
Confidence 99999999999999999877654332 223456788999999999999999999999999999999449999965321
Q ss_pred CCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 276 GDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
. ........... .... ....+..+.+++.+||+.||.+|||+.|+++.|+++.++
T Consensus 254 -----~-~~~~~~~~~~~-~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 254 -----D-SKFYKMIKEGF-RMLS---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -----S-HHHHHHHHHTC-CCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----h-hHHHHHhccCC-CCCC---------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1 11111222111 1000 012245688999999999999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=329.75 Aligned_cols=259 Identities=20% Similarity=0.269 Sum_probs=203.1
Q ss_pred cCCCCCeecccCceEEEEEEe-CCc----eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc-EEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDR----TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP-VLV 136 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~----~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 136 (347)
.|...+.||+|+||+||+|.+ +++ .+++|+..........+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 344568899999999999997 322 34444444444445567899999999999999999999999876655 999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
+||+.+|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 102 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp ECCCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EecccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999762 367899999999999999999999 999999999999999999999999999999765
Q ss_pred CCCCc---eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 217 PEGET---YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 217 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++.+.+||..... . .. ........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-----~---~~-~~~~~~~~ 245 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-----F---DL-THFLAQGR 245 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-----G---GH-HHHHHTTC
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-----H---HH-HHHhhcCC
Confidence 43321 1123456789999999999999999999999999999999557777754322 1 11 11111111
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhC
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~~ 347 (347)
... . ....+..+.+++.+||+.||.+|||+.++++.|+++.+++
T Consensus 246 ~~~-------~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 246 RLP-------Q---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CCC-------C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCC-------C---CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 000 0 1122456889999999999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=332.35 Aligned_cols=266 Identities=20% Similarity=0.226 Sum_probs=204.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-----CCce-EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--Ccc
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-----PDRT-ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIP 133 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~-~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 133 (347)
+.|...+.||+|+||.||+|.+ .++. +++|++.........+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999983 3444 4555444344444457799999999999999999999999876 678
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccc
Confidence 9999999999999999653 256999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCce--eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCcc------CCCCCchHHHHH
Q 045067 214 ASIPEGETY--IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLR------LNGDESFEMDFV 285 (347)
Q Consensus 214 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~ 285 (347)
......... ......+|..|+|||.+.+..++.++||||+|+++|+|+ +|..|+..... ............
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL-TYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH-TTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHH-HccCCCcchhhHHhhccCCcccccCHHHH
Confidence 877654432 233466888999999999999999999999999999999 88888753211 001111111222
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
......+.... .....++.+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 253 ~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 253 VNTLKEGKRLP----------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHTTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHhccCCCC----------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 22222211100 111234568899999999999999999999999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=332.30 Aligned_cols=261 Identities=23% Similarity=0.393 Sum_probs=203.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-Cc--e-EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeee-eCCccE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DR--T-ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCL-EVEIPV 134 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~--~-~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 134 (347)
...|...+.||+|+||+||+|.+ + ++ . +++|+..........+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 34577889999999999999997 2 21 2 44444444444455678999999999999999999999865 456889
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 104 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccc
Confidence 999999999999999752 356899999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCc---eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 215 SIPEGET---YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 215 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
....... .......+|+.|+|||.+.+..++.++||||+|+++|+|++.+.+||..... . .........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~----~~~~~~~~~ 248 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----F----DITVYLLQG 248 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT----T----THHHHHHTT
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH----H----HHHHHHhcC
Confidence 7654322 1123456788999999999999999999999999999999548888864322 1 111111111
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhC
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~~ 347 (347)
.. ...+ ...+..+.+++.+||+.+|++|||+.|+++.|+++.+++
T Consensus 249 ~~---~~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 249 RR---LLQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CC---CCCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CC---CCCC--------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 10 0111 112346889999999999999999999999999998764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=339.39 Aligned_cols=269 Identities=20% Similarity=0.290 Sum_probs=207.2
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe------CCceEEEEEEccC-CCchhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL------PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCL 128 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 128 (347)
++...++|...+.||+|+||.||+|.+ .++..+++|.... ......+.+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 344567899999999999999999996 2334455554443 3334457799999999999 8999999999999
Q ss_pred eCCccEEEEEeCCCCCHHHHHhhhccC------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 045067 129 EVEIPVLVFESAEYGNLHDLLKRSYQS------------------HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFR 190 (347)
Q Consensus 129 ~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~ 190 (347)
+++..++||||+++|+|.+++...... ....+++..+..++.|++.||.||| +.+|+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 999999999999999999999764110 0134799999999999999999999 9999999
Q ss_pred cCCCCCeEECCCCceEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccc
Q 045067 191 DLKSSYILVSERYVPKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFN 269 (347)
Q Consensus 191 dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~ 269 (347)
||||+|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++|||||||++|+|++.|..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999976654332 223445678899999999989999999999999999999944999996
Q ss_pred cCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 270 MGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.... . .........+... .. +...+..+.+++.+||+.||.+|||+.++++.|+.+..+
T Consensus 277 ~~~~-------~-~~~~~~~~~~~~~-----~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPV-------D-ANFYKLIQNGFKM-----DQ-----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCC-------S-HHHHHHHHTTCCC-----CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCc-------H-HHHHHHHhcCCCC-----CC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 5321 1 1112222221110 00 112245688999999999999999999999999988653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=335.61 Aligned_cols=257 Identities=18% Similarity=0.311 Sum_probs=200.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc-e----EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR-T----ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~-~----~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|...+.||+|+||+||+|.+ .++ . +++|...........+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 4678889999999999999998 333 2 44444433333334466789999999999999999999986 466899
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999763 257899999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 216 IPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 216 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
....... ......+|+.|+|||.+.+..++.++|||||||++|+|++.|..||..... . . .......+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~---~-~~~~~~~~~~ 235 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----A---E-VPDLLEKGER 235 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----T---H-HHHHHHTTCB
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----H---H-HHHHHHcCCC
Confidence 7544322 234456788999999999999999999999999999999339999975322 1 1 1111221111
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
...+. ..+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 236 --~~~~~--------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 236 --LAQPQ--------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp --CCCCT--------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred --CCCCC--------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01111 112346789999999999999999999999998854
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=342.45 Aligned_cols=250 Identities=17% Similarity=0.234 Sum_probs=200.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...+.||+|+||.||+|.. .++..+++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 36788999999999999999999 556666666554321 22346788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+.+|+|.+++... ..+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+|||++...
T Consensus 94 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp ECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999864 67999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCccccccccc---CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYART---GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
..... ....+||+.|+|||++.+ ..++.++|||||||++|+|+ +|+.||..... ............. .
T Consensus 166 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ell-tG~~Pf~~~~~-----~~~~~~~~~~~~~-~ 236 (384)
T 4fr4_A 166 PRETQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL-RGRRPYHIRSS-----TSSKEIVHTFETT-V 236 (384)
T ss_dssp CTTCC--BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHH-HSSCSSCCCTT-----SCHHHHHHHHHHC-C
T ss_pred cCCCc--eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHH-hCCCCCCCCCC-----ccHHHHHHHHhhc-c
Confidence 54322 345689999999998864 46899999999999999999 89999964322 1112222222111 1
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-MIDVAK 338 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-~~ell~ 338 (347)
. . .+...+..+.+++.+||+.||.+||+ +.++.+
T Consensus 237 ~------~-----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 V------T-----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp C------C-----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred c------C-----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 0 01122456889999999999999998 666653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=330.20 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=192.8
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCc--------------------------hhHHHHHHHHHHHH
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF--------------------------DAYDCCFNNIVFAS 113 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~--------------------------~~~~~~~~E~~~l~ 113 (347)
.++|...+.||+|+||.||+|.. .++..+++|++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46788999999999999999998 5555555555433211 12356889999999
Q ss_pred hcCCCceeeeeeeeee--CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 045067 114 QMSHNNVLRLIGCCLE--VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRD 191 (347)
Q Consensus 114 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~d 191 (347)
+++||||+++++++.+ ....++||||+++++|.+++.. ..+++..+..++.|++.||.||| +.+|+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccC
Confidence 9999999999999986 5688999999999999886543 57999999999999999999999 99999999
Q ss_pred CCCCCeEECCCCceEEecCCCCccCCCCCceeeccccccCCcccccccccCC---CCCccchHHHHHHHHHHHhcCCCcc
Q 045067 192 LKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGY---LNEKCDVYSFGLLLLQLLSTGEDLF 268 (347)
Q Consensus 192 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~el~~~g~~p~ 268 (347)
|||+|||++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++|||||||++|+|+ +|+.||
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf 240 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV-FGQCPF 240 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH-HSSCSS
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH-HCCCCC
Confidence 999999999999999999999987654332 234467999999999887654 478899999999999999 899999
Q ss_pred ccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 269 NMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... ....... ...... . +. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~--------~~~~~~~-~~~~~~-~--~~------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 241 MDERI--------MCLHSKI-KSQALE-F--PD------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CCSSH--------HHHHHHH-HHCCCC-C--CS------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccH--------HHHHHHH-hcccCC-C--CC------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 64221 1122222 111111 0 00 0122456789999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=331.97 Aligned_cols=264 Identities=21% Similarity=0.287 Sum_probs=205.0
Q ss_pred CCCCCeecccCceEEEEEEe-----CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--CccEE
Q 045067 64 YHYRNIITESSIFRLCQGVL-----PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV--EIPVL 135 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 135 (347)
|...+.||+|+||+||++.+ .++..+++|... .......+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48889999999999998865 244445555444 43444557799999999999999999999999884 57899
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++|+|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 113 v~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 9999999999999976 45999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCce--eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccC------CCCCchHHHHHHH
Q 045067 216 IPEGETY--IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL------NGDESFEMDFVKK 287 (347)
Q Consensus 216 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~ 287 (347)
....... ......+|+.|+|||.+.+..++.++||||||+++|+|+ +|..||...... .............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELL-THCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH-TTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHH-hCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 7654332 223456888999999999989999999999999999999 999998643210 0000001111112
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhC
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~~ 347 (347)
........ ......+..+.+++.+||+.||++|||+.|+++.|+++.++|
T Consensus 263 ~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 263 LLERGERL----------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhcccCC----------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 22211110 011123457889999999999999999999999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=340.66 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=201.3
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCc
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 132 (347)
....++|...+.||+|+||.||+|.. .++..+++|.+.... ....+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 44567899999999999999999999 556666666554321 22346688999999887 89999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChh
Confidence 99999999999999999875 67999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
++....... .....+||+.|+|||++.+..++.++||||+||++|||+ +|.+||..... ...........
T Consensus 165 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~--------~~~~~~i~~~~ 234 (345)
T 1xjd_A 165 CKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML-IGQSPFHGQDE--------EELFHSIRMDN 234 (345)
T ss_dssp CBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHCC
T ss_pred hhhcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHh-cCCCCCCCCCH--------HHHHHHHHhCC
Confidence 976433222 234568999999999999999999999999999999999 89999964321 12222222211
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMI-DVA 337 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~-ell 337 (347)
+.. +...+.++.+++.+||+.||++||++. +++
T Consensus 235 -------~~~-----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -------PFY-----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------CCC-----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------CCC-----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011 012245678999999999999999987 554
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=326.36 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=197.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC-chh------HHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV-FDA------YDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~-~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
.++|...+.||+|+||+||+|.+ .++..+++|...... ... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36788899999999999999999 455555555543322 111 167899999999999999999999986544
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEECCCCc-----e
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP--IVFRDLKSSYILVSERYV-----P 205 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~dlkp~Nill~~~~~-----~ 205 (347)
++||||+++|+|.+.+... ...+++..+..++.|++.||+||| +.+ |+||||||+||+++.++. +
T Consensus 97 -~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -eEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 7999999999999988653 357999999999999999999999 888 999999999999988776 9
Q ss_pred EEecCCCCccCCCCCceeeccccccCCccccccc--ccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 206 KLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYA--RTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
||+|||++...... .....||+.|+|||.+ ....++.++||||+||++|+|+ +|+.||..... ....
T Consensus 169 kl~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~------~~~~ 237 (287)
T 4f0f_A 169 KVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL-TGEGPFDEYSY------GKIK 237 (287)
T ss_dssp EECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH-HSSCTTTTCCC------CHHH
T ss_pred EeCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH-cCCCCCccccc------cHHH
Confidence 99999999754332 2346799999999988 3456789999999999999999 89999964321 1112
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
.......... . +.. ....++.+.+++.+||+.||++|||+.|+++.|+++
T Consensus 238 ~~~~~~~~~~-~----~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 238 FINMIREEGL-R----PTI-----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHSCC-C----CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHhccCC-C----CCC-----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 2222222211 1 111 112345688999999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=343.09 Aligned_cols=269 Identities=13% Similarity=0.123 Sum_probs=200.6
Q ss_pred HhccCCCCCeecccCceEEEEEEeC-C-----ceEEEEEEccCCCchh-----------HHHHHHHHHHHHhcCCCceee
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLP-D-----RTISVVKFIDGSVFDA-----------YDCCFNNIVFASQMSHNNVLR 122 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~-----~~~~v~k~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 122 (347)
..++|...+.||+|+||+||+|.+. + +..+++|+........ ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4568999999999999999999983 2 2444555544432111 122344556667778999999
Q ss_pred eeeeeeeC----CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 045067 123 LIGCCLEV----EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198 (347)
Q Consensus 123 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nil 198 (347)
+++++... ...++||||+ +++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEE
Confidence 99998875 4589999999 89999999763 367999999999999999999999 999999999999999
Q ss_pred EC--CCCceEEecCCCCccCCCCCce------eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 199 VS--ERYVPKLFNFSLSASIPEGETY------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 199 l~--~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
++ .++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+ +|+.||..
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~-~g~~Pf~~ 263 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL-TGHLPWED 263 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSCCTTGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHH-hCCCCccc
Confidence 99 8899999999999776432211 112345999999999999999999999999999999999 89999975
Q ss_pred CccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 271 GLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
... ............. .....+.++.+.. ...+.++.+++..||+.+|.+||++.+|++.|+++.++
T Consensus 264 ~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 264 NLK----DPKYVRDSKIRYR-ENIASLMDKCFPA----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp GTT----CHHHHHHHHHHHH-HCHHHHHHHHSCT----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccc----CHHHHHHHHHHhh-hhHHHHHHHhccc----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 321 1111111111111 1111222211111 11245688999999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=330.79 Aligned_cols=252 Identities=18% Similarity=0.304 Sum_probs=200.7
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCc-------eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDR-------TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~-------~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
.++|...+.||+|+||+||+|.. .++ ..+++|..........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 35788889999999999999998 322 3455555555444555789999999999999999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc--------
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV-------- 204 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~-------- 204 (347)
.++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred CEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999874 245999999999999999999999 999999999999999998887
Q ss_pred eEEecCCCCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 205 PKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
+||+|||++...... ....+|+.|+|||.+.+ ..++.++|||||||++|+|++.+.+||..... ..
T Consensus 160 ~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--------~~ 226 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--------QR 226 (289)
T ss_dssp EEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HH
T ss_pred eeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--------HH
Confidence 999999998654322 23468899999998887 77899999999999999999446666643211 11
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
............ .. .+.++.+++.+||+.||++|||+.++++.|+++..
T Consensus 227 ~~~~~~~~~~~~----~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 227 KLQFYEDRHQLP----AP---------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHHHTTCCCC----CC---------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHHHhhccCCCC----CC---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111111111 11 12346799999999999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=337.99 Aligned_cols=254 Identities=18% Similarity=0.189 Sum_probs=191.1
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
..++|...+.||+|+||+||++.. .++..+++|.+...... .+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 356799999999999999999999 45555555554443222 2678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc--eEEecCCCCccC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV--PKLFNFSLSASI 216 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~a~~~ 216 (347)
|+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+++..
T Consensus 97 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 97 YASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred eCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999999765 67999999999999999999999 999999999999999987765 999999998754
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCc-cchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEK-CDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.... ......||+.|+|||++.+..++.+ +||||+||++|+|+ +|+.||..... ............... ..
T Consensus 169 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~----~~~~~~~~~~~~~~~-~~ 240 (361)
T 3uc3_A 169 VLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVML-VGAYPFEDPEE----PRDYRKTIQRILSVK-YS 240 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHH-HSSCSCC--------CCCHHHHHHHHHTTC-CC
T ss_pred cccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHH-hCCCCCCCCcc----HHHHHHHHHHHhcCC-CC
Confidence 3222 1234579999999999888777655 89999999999999 89999975322 111222222222211 10
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.... ...++.+.+++.+||+.||++|||+.|+++.
T Consensus 241 ------~~~~---~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 ------IPDD---IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ------CCTT---SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ------CCCc---CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0000 0123567899999999999999999999863
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=327.36 Aligned_cols=260 Identities=17% Similarity=0.168 Sum_probs=194.5
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++|+..+.||+|+||+||+|.. .++..+++|... .. .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4688889999999999999999 445544444443 32 23334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++ +|.+.+... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9986 666666542 267999999999999999999999 99999999999999999999999999999987643
Q ss_pred CCceeeccccccCCcccccccccCC-CCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc---cC-
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGY-LNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN---RG- 293 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~- 293 (347)
... ......||+.|+|||++.+.. ++.++||||+||++|+|++++.++|.... ........... ..
T Consensus 154 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--------~~~~~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--------VDDQLKRIFRLLGTPTE 224 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--------HHHHHHHHHHHHCCCCT
T ss_pred ccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--------HHHHHHHHHHHhCCCCh
Confidence 322 223457899999999887665 89999999999999999944444454221 11222222211 00
Q ss_pred --cccc---cC--------CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 --FNGI---VD--------PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 --~~~~---~~--------~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+... .+ ............+..+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 00 000000111233557889999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=333.36 Aligned_cols=259 Identities=20% Similarity=0.281 Sum_probs=198.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-CC-c----eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PD-R----TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~-~----~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|...+.||+|+||+||+|.. .+ + .+++|.+...........+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 4566678999999999999988 22 1 2555554443344445678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 124 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999763 357999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCce--eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 216 IPEGETY--IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 216 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
....... ......+|+.|+|||.+.+..++.++|||||||++|+|++.|..||..... ...... ...+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~-~~~~~ 267 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKA-INDGF 267 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHH-HHTTC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHH-HHCCC
Confidence 6543221 122345678999999999999999999999999999999449999964321 122222 22211
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.. .. ....+..+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 268 ~~-------~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 268 RL-------PT---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CC-------CC---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cC-------CC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 00 112245688999999999999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=325.90 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=204.4
Q ss_pred ccCCCCC-eecccCceEEEEEEe---CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRN-IITESSIFRLCQGVL---PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
++|.... .||+|+||.||+|.+ +++..+++|.... ......+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 899999999999986 2444455555444 3444567899999999999999999999999 55678999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++++|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999652 356999999999999999999999 999999999999999999999999999999877
Q ss_pred CCCCcee--eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 217 PEGETYI--DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 217 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
....... .....+|+.|+|||.+.+..++.++||||||+++|+|++.|+.||..... .... .....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~-~~i~~~~~ 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVM-AFIEQGKR 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHH-HHHHTTCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HHHH-HHHhcCCc
Confidence 5443322 22345688999999999889999999999999999999339999964321 1111 12222111
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
. .. +...+..+.+++.+||+.+|++|||+.++++.|+++..+
T Consensus 232 ~-----~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 232 M-----EC-----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp C-----CC-----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-----CC-----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 01 112345788999999999999999999999999999765
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=334.54 Aligned_cols=267 Identities=18% Similarity=0.300 Sum_probs=194.7
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe-CCce---EEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL-PDRT---ISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE 131 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~---~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 131 (347)
....++|...+.||+|+||+||+|.+ .++. .+++|..... .....+.+.+|+.++++++||||+++++++....
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 34456799999999999999999998 3331 4445544432 3344578999999999999999999999998776
Q ss_pred cc------EEEEEeCCCCCHHHHHhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc
Q 045067 132 IP------VLVFESAEYGNLHDLLKRSYQ-SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV 204 (347)
Q Consensus 132 ~~------~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~ 204 (347)
.. ++||||+++|+|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence 55 999999999999999976421 12236899999999999999999999 999999999999999999999
Q ss_pred eEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 205 PKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++.|.+||..... . .
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~---~ 247 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----A---E 247 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----G---G
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----H---H
Confidence 999999999876543322 123345788999999999999999999999999999999449999975322 1 1
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
............ .....+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 248 ~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 248 IYNYLIGGNRLK-----------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HHHHHHTTCCCC-----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcCCCCC-----------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111111100 0112345688999999999999999999999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=343.40 Aligned_cols=259 Identities=22% Similarity=0.373 Sum_probs=194.4
Q ss_pred cCCCCCeecccCceEEEEEEe--CCc--eEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee-CCccEEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL--PDR--TISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE-VEIPVLV 136 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~--~~~--~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv 136 (347)
.|...+.||+|+||+||+|.+ +++ ..+++|... .......+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 355567899999999999997 332 234455444 3344556789999999999999999999998754 5678999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 170 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EECCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999763 356889999999999999999999 999999999999999999999999999999866
Q ss_pred CCCCce---eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 217 PEGETY---IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 217 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
...... ......+|+.|+|||.+.+..++.++|||||||++|||++.|.+||..... .. .. ... ..+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~----~~-~~---~~~-~~~~ 313 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FD-IT---VYL-LQGR 313 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS----SC-HH---HHH-HTTC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH----HH-HH---HHH-HcCC
Confidence 433211 123355788999999999999999999999999999999558899865322 11 11 111 1111
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhC
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~~ 347 (347)
....+ ...+..+.+++.+||+.+|++|||+.|+++.|+++..++
T Consensus 314 --~~~~p--------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 314 --RLLQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp --CCCCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --CCCCC--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 01111 122456889999999999999999999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=339.61 Aligned_cols=270 Identities=19% Similarity=0.187 Sum_probs=196.5
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHH--HhcCCCceeeeeeeeee-----CCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFA--SQMSHNNVLRLIGCCLE-----VEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l--~~l~h~niv~l~~~~~~-----~~~~ 133 (347)
.++|...+.||+|+||.||+|..++..+|+|.+.... .+.+..|..++ ..++||||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 4678889999999999999998877766666654322 24445555554 45899999999985543 2367
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---------CeEeccCCCCCeEECCCCc
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR---------PIVFRDLKSSYILVSERYV 204 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~---------~ivH~dlkp~Nill~~~~~ 204 (347)
++||||+++|+|.+++.. ...++..+..++.|++.||.||| +. +|+||||||+|||++.++.
T Consensus 88 ~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred EEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCc
Confidence 899999999999999976 45689999999999999999999 88 9999999999999999999
Q ss_pred eEEecCCCCccCCCCCc-------eeeccccccCCccccccccc-------CCCCCccchHHHHHHHHHHHhcCCCcc-c
Q 045067 205 PKLFNFSLSASIPEGET-------YIDDGVKGTSGIVAPEYART-------GYLNEKCDVYSFGLLLLQLLSTGEDLF-N 269 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~el~~~g~~p~-~ 269 (347)
+||+|||++........ .......||+.|+|||++.+ ..++.++|||||||++|||+ +|..|| .
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell-~g~~p~~~ 237 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF-MRCTDLFP 237 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHH-TTBGGGST
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHH-hcCCcCCC
Confidence 99999999987653221 11234569999999998876 45678899999999999999 665554 3
Q ss_pred cCccCCCCCch--------HHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 270 MGLRLNGDESF--------EMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 270 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
........... .................+..... .....+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK---ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC---CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc---cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 32211111000 01111111111111111111111 11235667999999999999999999999999999
Q ss_pred HHHHhC
Q 045067 342 KMYKSF 347 (347)
Q Consensus 342 ~i~~~~ 347 (347)
++...+
T Consensus 315 ~ll~~~ 320 (336)
T 3g2f_A 315 ELMMIW 320 (336)
T ss_dssp HHHHCC
T ss_pred HHHHHH
Confidence 998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=339.75 Aligned_cols=246 Identities=20% Similarity=0.188 Sum_probs=195.8
Q ss_pred CCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 67 RNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
.+.||+|+||.||+|.. .++..+++|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999998 55666666666655545567899999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE--CCCCceEEecCCCCccCCCCCcee
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV--SERYVPKLFNFSLSASIPEGETYI 223 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~~ 223 (347)
.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 174 ~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 174 FDRIIDE----SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp HHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 9998753 256999999999999999999999 9999999999999999 5778999999999987654432
Q ss_pred eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccC
Q 045067 224 DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRII 303 (347)
Q Consensus 224 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (347)
.....||+.|+|||++.+..++.++|||||||++|||+ +|..||.... .............. .
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~--------~~~~~~~i~~~~~~--~------ 307 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL-SGLSPFLGDN--------DAETLNNILACRWD--L------ 307 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHH-HSSCTTCCSS--------HHHHHHHHHHTCCC--S------
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHH-hCCCCCCCCC--------HHHHHHHHHhccCC--C------
Confidence 23456999999999999999999999999999999999 8999996432 12222333222110 0
Q ss_pred CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 304 GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........++++.+++.+||+.||++|||+.|+++
T Consensus 308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01111233567889999999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=324.14 Aligned_cols=250 Identities=21% Similarity=0.233 Sum_probs=201.3
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
..+.|...+.||+|+||.||+|.. .++ .+++|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY-FVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG-GCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhh-ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 456789999999999999999999 444 4555555443 2334578999999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE---CCCCceEEecCCCCc
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSA 214 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a~ 214 (347)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.++|+|||++.
T Consensus 86 e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 86 ELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp ECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999999875 67999999999999999999999 9999999999999999 788999999999997
Q ss_pred cCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
....... .....||+.|+|||.+.+. ++.++||||+|+++|+|+ +|..||..... .......... ..
T Consensus 158 ~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~-~g~~p~~~~~~--------~~~~~~~~~~-~~ 224 (277)
T 3f3z_A 158 RFKPGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLL-CGYPPFSAPTD--------SEVMLKIREG-TF 224 (277)
T ss_dssp ECCTTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHC-CC
T ss_pred eccCccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHH-HCCCCCCCCCH--------HHHHHHHHhC-CC
Confidence 7654332 2345799999999988654 899999999999999999 89999964321 1222222221 11
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .........++.+.+++.+||+.||++|||+.++++
T Consensus 225 ~-------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 T-------FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp C-------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred C-------CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 001111123457889999999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=337.63 Aligned_cols=245 Identities=17% Similarity=0.215 Sum_probs=201.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...+.||+|+||.||+|.. .++..+++|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 36789999999999999999999 455555555554321 12346788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceec
Confidence 9999999999999875 57999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
... ....+||+.|+|||++.+..++.++|||||||++|||+ +|.+||.... ........... ..
T Consensus 192 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~--------~~~~~~~i~~~-~~-- 255 (350)
T 1rdq_E 192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA-AGYPPFFADQ--------PIQIYEKIVSG-KV-- 255 (350)
T ss_dssp SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSS--------HHHHHHHHHHC-CC--
T ss_pred cCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHh-hCCCCCCCCC--------HHHHHHHHHcC-CC--
Confidence 432 23467999999999999999999999999999999999 8999996432 12222232222 11
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-----MIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-----~~ell~ 338 (347)
.. +...+..+.+++.+||+.||.+||+ +.|+++
T Consensus 256 ----~~-----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ----RF-----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CC-----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CC-----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 01 0122456889999999999999998 787764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=326.85 Aligned_cols=262 Identities=20% Similarity=0.270 Sum_probs=195.5
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
..++|...+.||+|+||+||+|.+.+ .+++|.+.... .....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 35678999999999999999998744 35555554332 234457799999999999999999999965 5567899999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 100 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999652 367999999999999999999999 99999999999999999999999999999876543
Q ss_pred CC-ceeeccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 219 GE-TYIDDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 219 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.. ........||+.|+|||.+. +..++.++||||||+++|+|+ +|+.||..... ..........+..
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~--------~~~~~~~~~~~~~ 243 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM-TGQLPYSNINN--------RDQIIEMVGRGSL 243 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHH-HSSCTTSSCCC--------HHHHHHHHHHTSC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHH-HCCCCccccch--------HHHHHHHhccccc
Confidence 22 22223457999999999886 567889999999999999999 89999964322 1222222222222
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
...... .....+..+.+++.+||+.+|++|||+.++++.|+++.+
T Consensus 244 ~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 SPDLSK------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCTTS------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred Ccchhh------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111110 111234578899999999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=335.80 Aligned_cols=269 Identities=18% Similarity=0.314 Sum_probs=210.6
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe-CCc------eEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL-PDR------TISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCL 128 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~------~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 128 (347)
++...++|...+.||+|+||.||+|.. ..+ .+++|.+.........+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 444567899999999999999999998 222 35555554444444557799999999999 8999999999999
Q ss_pred eCCccEEEEEeCCCCCHHHHHhhhcc---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 045067 129 EVEIPVLVFESAEYGNLHDLLKRSYQ---------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199 (347)
Q Consensus 129 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill 199 (347)
+++..++||||+++|+|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence 99999999999999999999975311 01245899999999999999999999 9999999999999999
Q ss_pred CCCCceEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCC
Q 045067 200 SERYVPKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278 (347)
Q Consensus 200 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~ 278 (347)
+.++.+||+|||++........ .......+|+.|+|||.+.+..++.++|||||||++|+|++.|.+||..... .
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~ 273 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV----N 273 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS----S
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch----h
Confidence 9999999999999976543322 2223456788999999999899999999999999999999449999964321 1
Q ss_pred chHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
............ ...+ ...+..+.+++.+||+.||.+|||+.|+++.|+++.++
T Consensus 274 ----~~~~~~~~~~~~--~~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 274 ----SKFYKLVKDGYQ--MAQP--------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ----HHHHHHHHHTCC--CCCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHhcCCC--CCCC--------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 111122222110 0001 11235678999999999999999999999999998653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=326.79 Aligned_cols=265 Identities=17% Similarity=0.169 Sum_probs=201.2
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeee-eeCCccEEE
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCC-LEVEIPVLV 136 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv 136 (347)
...++|...+.||+|+||+||+|.. .++..+++|+...... .+.+.+|+.+++.++|++++..++.+ .+++..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999998 5555555555433321 24588999999999988776665554 667788999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE---CCCCceEEecCCCC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLS 213 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a 213 (347)
|||+ +++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EECC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEcc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 9999 88999999752 257999999999999999999999 9999999999999999 78899999999999
Q ss_pred ccCCCCCce------eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 214 ASIPEGETY------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 214 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
......... ......||+.|+|||.+.+..++.++|||||||++|+|+ +|+.||......... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~-~~~~~~~~~ 233 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN-LGSLPWQGLKAATKR-QKYERISEK 233 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTSSCCCSSSS-SHHHHHHHH
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHh-cCCCCCcccchhhhh-hhhhhhhcc
Confidence 876543321 123467999999999999999999999999999999999 999999764331111 111111111
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.... .. .......+..+.+++.+||+.+|++|||+.++++.|+++.++
T Consensus 234 ~~~~-~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 234 KMST-PI----------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHS-CH----------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccc-hh----------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 1111 00 000112245788999999999999999999999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=351.40 Aligned_cols=263 Identities=16% Similarity=0.174 Sum_probs=207.1
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeee
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCC 127 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 127 (347)
+.+.++....++|...+.||+|+||.||+|.. .++..+++|++.+.. ....+.+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34456666778999999999999999999999 556666666554321 12235588999999999999999999999
Q ss_pred eeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEE
Q 045067 128 LEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207 (347)
Q Consensus 128 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl 207 (347)
.+.+.+|+||||+++|+|.+++.+. +..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL 203 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRL 203 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEE
Confidence 9999999999999999999999864 247999999999999999999999 999999999999999999999999
Q ss_pred ecCCCCccCCCCCceeeccccccCCcccccccc-------cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCch
Q 045067 208 FNFSLSASIPEGETYIDDGVKGTSGIVAPEYAR-------TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESF 280 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~ 280 (347)
+|||+++.............+||+.|+|||++. +..++.++|||||||++|||+ +|++||.....
T Consensus 204 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell-tG~~Pf~~~~~------- 275 (412)
T 2vd5_A 204 ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF-YGQTPFYADST------- 275 (412)
T ss_dssp CCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH-HSSCTTCCSSH-------
T ss_pred eechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH-hCCCCCCCCCH-------
Confidence 999999887655444344568999999999887 357899999999999999999 99999964321
Q ss_pred HHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCC---CCHHHHHH
Q 045067 281 EMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDR---PTMIDVAK 338 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~R---Ps~~ell~ 338 (347)
............. ...+. .....+.++.+++.+||. +|.+| |+++|+++
T Consensus 276 -~~~~~~i~~~~~~--~~~p~-----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 276 -AETYGKIVHYKEH--LSLPL-----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -HHHHHHHHTHHHH--CCCC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -HHHHHHHHhcccC--cCCCc-----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1222222211000 00010 011234578899999999 99998 58888864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=332.67 Aligned_cols=264 Identities=18% Similarity=0.294 Sum_probs=208.0
Q ss_pred HhccCCCCCeecccCceEEEEEEeC--------CceEEEEEEccC-CCchhHHHHHHHHHHHHhc-CCCceeeeeeeeee
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLP--------DRTISVVKFIDG-SVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLE 129 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 129 (347)
..++|...+.||+|+||.||+|.+. ++..+++|.... ......+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999872 234455555543 3444557799999999999 89999999999999
Q ss_pred CCccEEEEEeCCCCCHHHHHhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 045067 130 VEIPVLVFESAEYGNLHDLLKRSYQS-----------HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198 (347)
Q Consensus 130 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nil 198 (347)
.+..++||||+++|+|.+++...... ....+++..+..++.|++.||.||| +.+|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence 99999999999999999999864210 1234899999999999999999999 999999999999999
Q ss_pred ECCCCceEEecCCCCccCCCCCcee-eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCC
Q 045067 199 VSERYVPKLFNFSLSASIPEGETYI-DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD 277 (347)
Q Consensus 199 l~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~ 277 (347)
++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++||||||+++|+|++.|..||.....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---- 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence 9999999999999998765443222 23355788999999998889999999999999999999449999964321
Q ss_pred CchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 278 ESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
..... ....+.... . ....+..+.+++.+||+.+|.+|||+.|+++.|+++.+
T Consensus 266 ----~~~~~-~~~~~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 266 ----EELFK-LLKEGHRMD-----K-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp ----HHHHH-HHHHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHH-HHhcCCCCC-----C-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12222 222221110 0 11224568899999999999999999999999999865
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=330.12 Aligned_cols=264 Identities=17% Similarity=0.185 Sum_probs=186.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCce-EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRT-ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~-~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.++|...+.||+|+||.||+|.. .++. +++|++.........+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46788999999999999999998 4444 555544433333344678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 139 SAEYGNLHDLLKRSYQ-SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|++ |+|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 599999876421 12245899999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc-cCcc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN-RGFN 295 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 295 (347)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|+ +|++||..... .......... +...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~--------~~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-TGKPLFPGTND--------EEQLKLIFDIMGTPN 229 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHHHHHHHHCSCC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCh--------HHHHHHHHHHhCCCC
Confidence 3322 1234578999999998876 46899999999999999999 89999964321 1111111110 0000
Q ss_pred c-c---------cCCccC----C-------chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 G-I---------VDPRII----G-------DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~-~---------~~~~~~----~-------~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. . ..+.+. . .......+.++.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0 000000 0 0000122457889999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=334.77 Aligned_cols=258 Identities=19% Similarity=0.296 Sum_probs=198.3
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-Cce----EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DRT----ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~----~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
.++|...+.||+|+||+||+|.+ . +.. +++|++.........+.+.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 35688899999999999999998 3 333 34444444444445578999999999999999999999998754 78
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+++||+.+|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 999999999999999763 357999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 215 SIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 215 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
....... .......+|+.|+|||.+.+..++.++|||||||++|+|++.|..||..... .. .........
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~----~~~~~~~~~ 236 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SE----ISSILEKGE 236 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GG----HHHHHHTTC
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HH----HHHHHHcCC
Confidence 7644322 1223455788999999999999999999999999999999339999975322 11 111122111
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
... . ....+..+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus 237 ~~~-------~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 RLP-------Q---PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCC-------C---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCC-------C---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 100 0 11224468899999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=329.56 Aligned_cols=261 Identities=16% Similarity=0.140 Sum_probs=198.1
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
...++|...+.||+|+||.||+|.. .++..+++|+..... ....+.+.+|+.++.+++||||+++++++.+++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 3457899999999999999999998 556666666655432 223467899999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 111 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~ 182 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIAS 182 (309)
T ss_dssp EEEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred EEEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCc
Confidence 999999999999999875 67999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
..............||+.|+|||.+.+..++.++||||||+++|+|+ +|+.||..... ............
T Consensus 183 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~---------~~~~~~~~~~~~ 252 (309)
T 2h34_A 183 ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL-TGSPPYQGDQL---------SVMGAHINQAIP 252 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHH-HSSCSSCSCHH---------HHHHHHHHSCCC
T ss_pred cccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHH-HCCCCCCCchH---------HHHHHHhccCCC
Confidence 76544333334567999999999999999999999999999999999 89999964321 122222221110
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-TMIDVAKQIKKMYK 345 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-s~~ell~~L~~i~~ 345 (347)
. + .......+..+.+++.+||+.||++|| |+.++++.|+++..
T Consensus 253 ~----~----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 253 R----P----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp C----G----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred C----c----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 0 0 011112344678999999999999999 99999999987643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=333.03 Aligned_cols=274 Identities=19% Similarity=0.318 Sum_probs=214.3
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEe------CCceEEEEEEccC-CCchhHHHHHHHHHHHHhc-CCCceeee
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVL------PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQM-SHNNVLRL 123 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l 123 (347)
+...++....++|...+.||+|+||+||+|.+ .++..+++|.... ......+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 55666777788999999999999999999984 2345555555544 3344456789999999999 79999999
Q ss_pred eeeeeeCC-ccEEEEEeCCCCCHHHHHhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 045067 124 IGCCLEVE-IPVLVFESAEYGNLHDLLKRSYQS-----------HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRD 191 (347)
Q Consensus 124 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~d 191 (347)
++++...+ ..++||||+++|+|.+++...... ....+++..+..++.|++.||.||| +.+|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 99988754 589999999999999999864110 0122889999999999999999999 99999999
Q ss_pred CCCCCeEECCCCceEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 192 LKSSYILVSERYVPKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 192 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
|||+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++.|..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987654433 2234466889999999999999999999999999999999449999964
Q ss_pred CccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 271 GLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
... ..... .....+.... . ....++.+.+++.+||+.||.+|||+.|+++.|+++.++
T Consensus 254 ~~~-------~~~~~-~~~~~~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 254 VKI-------DEEFC-RRLKEGTRMR-----A-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCC-------SHHHH-HHHHHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cch-------hHHHH-HHhccCccCC-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 321 11111 2222211110 0 011244688999999999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=330.87 Aligned_cols=276 Identities=18% Similarity=0.228 Sum_probs=213.0
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHh--cCCCceeeeeeeeee
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQ--MSHNNVLRLIGCCLE 129 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~ 129 (347)
.+..--....++|...+.||+|+||.||+|.+.+..+|+|.+... ..+.+.+|+.++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 455555667789999999999999999999997666666655322 23667889999987 789999999999988
Q ss_pred CC----ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeEeccCCCCCeEEC
Q 045067 130 VE----IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF-----SRPIVFRDLKSSYILVS 200 (347)
Q Consensus 130 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivH~dlkp~Nill~ 200 (347)
.. ..++||||+++|+|.+++.+ ..+++..+..++.|++.||.|||+.. +.+|+||||||+|||++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 76 78999999999999999976 46999999999999999999999321 46899999999999999
Q ss_pred CCCceEEecCCCCccCCCCCce---eeccccccCCcccccccccC------CCCCccchHHHHHHHHHHHhcC-------
Q 045067 201 ERYVPKLFNFSLSASIPEGETY---IDDGVKGTSGIVAPEYARTG------YLNEKCDVYSFGLLLLQLLSTG------- 264 (347)
Q Consensus 201 ~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~G~~l~el~~~g------- 264 (347)
.++.+||+|||++......... ......||+.|+|||.+.+. .++.++|||||||++|||+ +|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~-tg~~~~~~~ 260 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA-RRCSIGGIH 260 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH-TTBCBTTBC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH-hccCcCCcc
Confidence 9999999999999776544322 12345799999999988765 2347899999999999999 77
Q ss_pred ---CCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 045067 265 ---EDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIK 341 (347)
Q Consensus 265 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~ 341 (347)
..||...... ......+ ........ ..+.+.........+..+.+++.+||+.||++|||+.++++.|+
T Consensus 261 ~~~~~p~~~~~~~---~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 261 EDYQLPYYDLVPS---DPSVEEM-RKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CCCCCTTTTTSCS---SCCHHHH-HHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred cccccCccccCcC---cccHHHH-HHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 6676543221 1111122 22221111 12222221223356778999999999999999999999999999
Q ss_pred HHHHh
Q 045067 342 KMYKS 346 (347)
Q Consensus 342 ~i~~~ 346 (347)
++.++
T Consensus 333 ~i~~~ 337 (342)
T 1b6c_B 333 QLSQQ 337 (342)
T ss_dssp HHHHT
T ss_pred HHHHH
Confidence 99875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=327.33 Aligned_cols=265 Identities=20% Similarity=0.259 Sum_probs=197.3
Q ss_pred HhccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccC--CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDG--SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
..++|...+.||+|+||.||+|.. . +..+++|++... ......+.+.+|+.++++++||||+++++++.+++..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346789999999999999999998 4 445555554432 223445678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++++|.+++.... .....+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 110 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEECCCSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred EEecCCCCCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 999999999999997531 12356899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
...... ......|++.|+|||.+.+..++.++||||||+++|+|+ +|..||..... ....... ........
T Consensus 186 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~-~g~~p~~~~~~------~~~~~~~-~~~~~~~~ 256 (310)
T 2wqm_A 186 FSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA-ALQSPFYGDKM------NLYSLCK-KIEQCDYP 256 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTC---C------CHHHHHH-HHHTTCSC
T ss_pred ecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHH-hCCCCCcccch------hHHHHHH-HhhcccCC
Confidence 543322 123456899999999999999999999999999999999 89999853211 1112222 22222211
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.... ...+.++.+++.+||+.||++|||+.++++.|+++...
T Consensus 257 ~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 257 PLPS---------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp CCCT---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcc---------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1110 12245688999999999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=336.85 Aligned_cols=249 Identities=17% Similarity=0.236 Sum_probs=201.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 134 (347)
..++|...+.||+|+||.||+|.. .++..+++|++.... ....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 356799999999999999999999 556666666654321 22346688999999988 7999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+||||++||+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 98 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999999875 67999999999999999999999 9999999999999999999999999999997
Q ss_pred cCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
....... .....+||+.|+|||++.+..++.++|||||||++|||+ +|++||.... ............ .
T Consensus 170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~G~~Pf~~~~--------~~~~~~~i~~~~-~ 238 (353)
T 2i0e_A 170 ENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQAPFEGED--------EDELFQSIMEHN-V 238 (353)
T ss_dssp CCCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHH-HSSCSSCCSS--------HHHHHHHHHHCC-C
T ss_pred ccccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHH-cCCCCCCCCC--------HHHHHHHHHhCC-C
Confidence 6433222 234568999999999999999999999999999999999 8999996432 122223332221 1
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-----MIDVAK 338 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-----~~ell~ 338 (347)
.. +...+.++.+++.+||+.||.+||+ +.++++
T Consensus 239 ------~~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ------AY-----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------CC-----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------CC-----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 01 1123456889999999999999996 466653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=327.76 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=205.0
Q ss_pred HHHhccCCCCC-eecccCceEEEEEEe---CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 045067 58 ERATNNYHYRN-IITESSIFRLCQGVL---PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE 131 (347)
Q Consensus 58 ~~~~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 131 (347)
....++|...+ .||+|+||+||+|.+ .++..+++|...... ....+.+.+|+.+++.++||||+++++++ ..+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 33456677777 999999999999965 334555555554332 23357799999999999999999999998 567
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CcEEEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCC
Confidence 789999999999999999874 56999999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceee--ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 212 LSASIPEGETYID--DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 212 ~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
++........... ....+++.|+|||.+.+..++.++||||||+++|+|++.|..||..... .. .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~-~~~~~ 233 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SE-VTAML 233 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HH-HHHHH
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HH-HHHHH
Confidence 9987755443222 2345678999999999888999999999999999999339999964321 11 22222
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
..+.... . ....+..+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 234 ~~~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 234 EKGERMG-----C-----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp HTTCCCC-----C-----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCC-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 2221110 1 112345688999999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=336.45 Aligned_cols=252 Identities=19% Similarity=0.216 Sum_probs=187.1
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
...+.|...+.||+|+||.||+|.. .++..+++|++.... ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 4567799999999999999999999 455555555554432 2366889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC---CCceEEecCCCCc
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE---RYVPKLFNFSLSA 214 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~a~ 214 (347)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||+++
T Consensus 128 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 128 ELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp CCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 999999999999764 56999999999999999999999 999999999999999975 8899999999997
Q ss_pred cCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
...... ......||+.|+|||++.+..++.++|||||||++|||+ +|..||..... .......... ...
T Consensus 200 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~-------~~~~~~~i~~-~~~ 268 (349)
T 2w4o_A 200 IVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL-CGFEPFYDERG-------DQFMFRRILN-CEY 268 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCTTCCTTC-------HHHHHHHHHT-TCC
T ss_pred ccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHH-hCCCCCCCCcc-------cHHHHHHHHh-CCC
Confidence 654322 123467999999999999999999999999999999999 89999864321 1111222222 111
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 269 ~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 Y-FIS------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp C-CCT------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-cCC------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 000 111223456889999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=337.72 Aligned_cols=211 Identities=20% Similarity=0.240 Sum_probs=181.5
Q ss_pred CCccccCHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-----CCce
Q 045067 47 NPIRSFSAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-----HNNV 120 (347)
Q Consensus 47 ~~~~~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni 120 (347)
..+..+++.+.....++|...+.||+|+||+||+|.. .++..+++|++.... ...+.+..|+.+++.++ ||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 3455577777777889999999999999999999999 556666666655432 33466788999999996 9999
Q ss_pred eeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC
Q 045067 121 LRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS 200 (347)
Q Consensus 121 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~ 200 (347)
+++++++...+..++||||+ +++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~ 171 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN---NYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLD 171 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEES
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEc
Confidence 99999999999999999999 78999999874 2245999999999999999999999 99999999999999997
Q ss_pred C-------------------------CCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHH
Q 045067 201 E-------------------------RYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGL 255 (347)
Q Consensus 201 ~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~ 255 (347)
. ++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 5 7899999999997654322 3457899999999999999999999999999
Q ss_pred HHHHHHhcCCCcccc
Q 045067 256 LLLQLLSTGEDLFNM 270 (347)
Q Consensus 256 ~l~el~~~g~~p~~~ 270 (347)
++|+|+ +|+.||..
T Consensus 248 il~ell-~g~~pf~~ 261 (360)
T 3llt_A 248 VLAELY-TGSLLFRT 261 (360)
T ss_dssp HHHHHH-HSSCSCCC
T ss_pred HHHHHH-HCCCCCCC
Confidence 999999 99999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=340.45 Aligned_cols=268 Identities=15% Similarity=0.155 Sum_probs=198.6
Q ss_pred HhccCCCCCeeccc--CceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 60 ATNNYHYRNIITES--SIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 60 ~~~~~~~~~~lg~G--~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
..++|+..+.||+| +||+||+|.. .++..+++|.+... .....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35679999999999 9999999999 44544444444322 2334567889999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||.+.
T Consensus 103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH---FMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEECCTTCBHHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEccCCCCHHHHHhhh---cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 999999999999999764 2356999999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCCc------eeeccccccCCccccccccc--CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 215 SIPEGET------YIDDGVKGTSGIVAPEYART--GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 215 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|+ +|++||...... ........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~~----~~~~~~~~ 251 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA-NGHVPFKDMPAT----QMLLEKLN 251 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHH-HSSCTTTTCCST----THHHHC--
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHH-HCCCCCCCCCHH----HHHHHHhc
Confidence 5432211 11123478999999999887 57899999999999999999 899999753221 00000000
Q ss_pred HHHh----------------------ccCccccc--------CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 045067 287 KYIE----------------------NRGFNGIV--------DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336 (347)
Q Consensus 287 ~~~~----------------------~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~el 336 (347)
.... ........ .............++.+.+|+.+||+.||++|||+.|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 0000 00000000 00000001112234578999999999999999999999
Q ss_pred HH
Q 045067 337 AK 338 (347)
Q Consensus 337 l~ 338 (347)
++
T Consensus 332 l~ 333 (389)
T 3gni_B 332 LN 333 (389)
T ss_dssp TT
T ss_pred hc
Confidence 85
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=331.16 Aligned_cols=268 Identities=18% Similarity=0.270 Sum_probs=208.4
Q ss_pred hccCCCCCeecccCceEEEEEEe-----CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC--cc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-----PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE--IP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 133 (347)
.++|...+.||+|+||.||+|.+ .++..+++|..........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688889999999999999984 345555666555555555678999999999999999999999987654 78
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++||||+++++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 120 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred EEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 9999999999999999863 256999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCcee--eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCcc-------CCCCCchHHHH
Q 045067 214 ASIPEGETYI--DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLR-------LNGDESFEMDF 284 (347)
Q Consensus 214 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~ 284 (347)
.......... .....++..|+|||.+.+..++.++||||||+++|+|+ +|..|+..... ...........
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~-tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF-TYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH-HTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHH-hcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 8776543322 22345778899999999888999999999999999999 88888763210 00000111111
Q ss_pred HHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 285 VKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
........... . .....+.++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 272 ~~~~~~~~~~~-------~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 272 LIELLKNNGRL-------P---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHTTCCC-------C---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCC-------C---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 12222221110 0 0112345688999999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=323.93 Aligned_cols=264 Identities=17% Similarity=0.164 Sum_probs=204.0
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeee-eeCCccEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCC-LEVEIPVLVF 137 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 137 (347)
..++|...+.||+|+||.||+|.. .++..+++|+...... .+.+.+|+.+++.++|++++..+.++ ..++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 356799999999999999999998 5555555555443322 25688999999999988766655554 5667889999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE---CCCCceEEecCCCCc
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSA 214 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a~ 214 (347)
||+ +++|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||++.
T Consensus 85 e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp ECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 999 78999999752 257999999999999999999999 9999999999999999 488999999999998
Q ss_pred cCCCCCce------eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 215 SIPEGETY------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 215 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
........ ......||+.|+|||.+.+..++.++|||||||++|+|+ +|+.||......... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~-~~~~~~~~~~ 234 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN-LGSLPWQGLKAATKR-QKYERISEKK 234 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTSSCCCSSSS-SHHHHHHHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHH-hCCCCCCCcCchhhh-hhhhhhcccc
Confidence 76544321 123467999999999999999999999999999999999 899999764331111 1111111111
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
... .. +......++.+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 235 ~~~-~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 235 MST-PI----------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHS-CH----------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCC-ch----------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 111 00 001112245688999999999999999999999999998764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=329.20 Aligned_cols=252 Identities=19% Similarity=0.247 Sum_probs=201.6
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCce-EEEEEEccCCCc-----hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRT-ISVVKFIDGSVF-----DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~-~~v~k~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
..+.|...+.||+|+||.||+|.. .++. +++|.+...... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 356788999999999999999998 4444 555444433221 134679999999999999999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC----ceEEe
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY----VPKLF 208 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~----~~kl~ 208 (347)
.++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 99999999999999999764 67899999999999999999999 99999999999999999887 79999
Q ss_pred cCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 209 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
|||++........ .....||+.|+|||.+.+..++.++|||||||++|+|+ +|..||..... .......
T Consensus 162 Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~--------~~~~~~i 230 (321)
T 2a2a_A 162 DFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL-SGASPFLGDTK--------QETLANI 230 (321)
T ss_dssp CCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSCCSSCCSSH--------HHHHHHH
T ss_pred cCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHH-HCCCCCCCCCH--------HHHHHHH
Confidence 9999987654332 23456999999999999999999999999999999999 89999964321 1122221
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. .... . ........+..+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~-~~~~--~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 231 TS-VSYD--F-----DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HT-TCCC--C-----CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred Hh-cccc--c-----ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 1100 0 01111223456889999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=330.97 Aligned_cols=248 Identities=19% Similarity=0.202 Sum_probs=191.8
Q ss_pred hccCCCCCeecccCceEEEEEEe----CCceEEEEEEccCCC----chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL----PDRTISVVKFIDGSV----FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~v~k~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
.++|...+.||+|+||.||+|.. .++..+++|++.... ......+.+|+.++++++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999987 355566666554432 2233567899999999999999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999999875 67899999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
++....... ......||+.|+|||++.+..++.++|||||||++|+|+ +|+.||..... ...........
T Consensus 168 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~--------~~~~~~i~~~~ 237 (327)
T 3a62_A 168 CKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML-TGAPPFTGENR--------KKTIDKILKCK 237 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHHHHHHTC
T ss_pred ccccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHH-HCCCCCCCCCH--------HHHHHHHHhCC
Confidence 876433222 233467999999999999889999999999999999999 89999964321 22222222211
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
. .+ +...+..+.+++.+||+.||++|| ++.|+++
T Consensus 238 -~------~~-----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 -L------NL-----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -C------CC-----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -C------CC-----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 00 012245678999999999999999 6777765
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=324.21 Aligned_cols=253 Identities=19% Similarity=0.234 Sum_probs=194.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.+.|...+.||+|+||.||+|.. . +..+++|++.........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 45788899999999999999998 4 445555555444333445789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE---CCCCceEEecCCCCcc
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSAS 215 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a~~ 215 (347)
|+++|+|.+++.... .....+++..+..++.|++.||+||| +.+|+||||||+||++ +.++.+||+|||++..
T Consensus 101 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 101 TCEGGELLERIVSAQ-ARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCSCCBHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred eCCCCcHHHHHHhhh-hcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999986531 12256999999999999999999999 9999999999999999 4568899999999976
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
...... .....||+.|+|||.+. ..++.++||||+|+++|+|+ +|..||..... ..............
T Consensus 177 ~~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll-~g~~pf~~~~~--------~~~~~~~~~~~~~~ 244 (285)
T 3is5_A 177 FKSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLL-TGCLPFTGTSL--------EEVQQKATYKEPNY 244 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHCCCCC
T ss_pred cCCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHH-hCCCCCCCCCH--------HHHHhhhccCCccc
Confidence 544322 23467899999999876 56799999999999999999 89999964321 11111111111100
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .. ....++.+.+++.+||+.||++|||+.|+++
T Consensus 245 ~-~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 A-VE--------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C-C----------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c-cc--------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 0012346789999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=336.15 Aligned_cols=271 Identities=21% Similarity=0.308 Sum_probs=212.7
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEeC------CceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeee
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVLP------DRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLI 124 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 124 (347)
+..++++...++|...+.||+|+||.||+|.+. ++..+++|... .........+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 455566777889999999999999999999873 23444555444 33344456789999999999999999999
Q ss_pred eeeeeCCccEEEEEeCCCCCHHHHHhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 045067 125 GCCLEVEIPVLVFESAEYGNLHDLLKRSYQ-----SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199 (347)
Q Consensus 125 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill 199 (347)
+++.+++..++||||+++|+|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence 999999999999999999999999975310 11145789999999999999999999 9999999999999999
Q ss_pred CCCCceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCC
Q 045067 200 SERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278 (347)
Q Consensus 200 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~ 278 (347)
+.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++.|..||.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 246 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----- 246 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-----
Confidence 99999999999999765433221 123345788999999999999999999999999999999448999864321
Q ss_pred chHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 045067 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344 (347)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~ 344 (347)
...... ...+..... ....+..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 247 ---~~~~~~-~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 247 ---EQVLRF-VMEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp ---HHHHHH-HHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred ---HHHHHH-HHcCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 122222 222211110 1123456889999999999999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=359.56 Aligned_cols=266 Identities=23% Similarity=0.298 Sum_probs=210.1
Q ss_pred CHHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 53 SAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 53 ~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
..+.++...++|...+.||+|+||.||+|.+.++..+++|.+..... ..+.+.+|+.+|++++||||+++++++.+ +.
T Consensus 258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 34455566778888999999999999999995544444454444332 23779999999999999999999999876 67
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.+|||||+.+|+|.+++... ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred ceEeeehhcCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 89999999999999999753 1245899999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
++..............+++.|+|||.+.+..++.++|||||||++|||++.|+.||..... ....... ..+
T Consensus 410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i-~~~ 480 (535)
T 2h8h_A 410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQV-ERG 480 (535)
T ss_dssp TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHH-HTT
T ss_pred ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-HcC
Confidence 9876533222223345778999999999899999999999999999999449999964321 1222222 221
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
.. +.. ....+..+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 481 ~~-------~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 481 YR-------MPC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CC-------CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CC-------CCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 10 000 11234568899999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=332.43 Aligned_cols=266 Identities=21% Similarity=0.228 Sum_probs=207.5
Q ss_pred ccCCCCCeecccCceEEEEEEe-----CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeee--eCCccE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-----PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCL--EVEIPV 134 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 134 (347)
++|...+.||+|+||.||+|.+ .++..+++|.+........+.+.+|+.++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688889999999999999984 355666666666555555677999999999999999999999887 445689
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+||||+++++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 103 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999999863 246999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCce--eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccC-------CCCCchHHHHH
Q 045067 215 SIPEGETY--IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL-------NGDESFEMDFV 285 (347)
Q Consensus 215 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~ 285 (347)
........ ......+|+.|+|||.+.+..++.++||||||+++|+|+ +|..||...... ....... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll-~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF-TYCDKSCSPSAEFLRMMGCERDVPAL-SRL 253 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH-TTTCGGGSHHHHHHHHCC----CCHH-HHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHH-hCCCCCccccchhhhhcccccccccH-HHH
Confidence 77544332 223456888899999999999999999999999999999 899888643210 0011111 111
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
......+... ......++.+.+++.+||+.||++|||+.|+++.|+.+..+
T Consensus 254 ~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 254 LELLEEGQRL----------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHHhhcccCC----------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1111111100 01112345688999999999999999999999999988653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=335.32 Aligned_cols=263 Identities=22% Similarity=0.229 Sum_probs=200.1
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-----CchhHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-----VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE 129 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 129 (347)
++....++|...+.||+|+||.||+|.. .++..+++|+.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4566778899999999999999999999 55555555554321 23445789999999999999999999999999
Q ss_pred CCccEEEEEeCCCCCHHHHHhhhccC-----------------------------------CCCCCCHHHHHHHHHHHHH
Q 045067 130 VEIPVLVFESAEYGNLHDLLKRSYQS-----------------------------------HSEPLLLKHRLKIAMEIAN 174 (347)
Q Consensus 130 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~i~~ 174 (347)
.+..++||||+++|+|.+++...... ....+++..+..++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998531100 0123467788899999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCC--ceEEecCCCCccCCCC---CceeeccccccCCccccccccc--CCCCCc
Q 045067 175 VFAYLHIGFSRPIVFRDLKSSYILVSERY--VPKLFNFSLSASIPEG---ETYIDDGVKGTSGIVAPEYART--GYLNEK 247 (347)
Q Consensus 175 ~l~~lH~~~~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 247 (347)
||+||| +.+|+||||||+||+++.++ .+||+|||++...... .........||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999 99999999999999998776 8999999999765322 1112345679999999998865 678999
Q ss_pred cchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCC
Q 045067 248 CDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASA 327 (347)
Q Consensus 248 ~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P 327 (347)
+|||||||++|+|+ +|+.||..... .............. ........+..+.+++.+||+.||
T Consensus 257 ~DiwslG~il~el~-~g~~pf~~~~~--------~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 257 CDAWSAGVLLHLLL-MGAVPFPGVND--------ADTISQVLNKKLCF--------ENPNYNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHCCCCT--------TSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHHHHHHHHH-HCCCCCCCCCh--------HHHHHHHHhccccc--------CCcccccCCHHHHHHHHHHcCCCh
Confidence 99999999999999 99999964321 22233333221110 011112235578899999999999
Q ss_pred CCCCCHHHHHH
Q 045067 328 EDRPTMIDVAK 338 (347)
Q Consensus 328 ~~RPs~~ell~ 338 (347)
.+|||+.|+++
T Consensus 320 ~~Rps~~~~l~ 330 (345)
T 3hko_A 320 DERFDAMRALQ 330 (345)
T ss_dssp TTSCCHHHHHH
T ss_pred hHCCCHHHHhc
Confidence 99999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=331.18 Aligned_cols=250 Identities=20% Similarity=0.229 Sum_probs=177.8
Q ss_pred CCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEEeCCCCC
Q 045067 67 RNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVFESAEYGN 144 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~ 144 (347)
.+.||+|+||+||+|.. .++..+++|.+... ....+.+|+.++..+. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999999 45555555554432 2366789999999997 9999999999999999999999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC---ceEEecCCCCccCCCCCc
Q 045067 145 LHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY---VPKLFNFSLSASIPEGET 221 (347)
Q Consensus 145 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~~ 221 (347)
|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 93 LFERIKKK-----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp HHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 99999874 67999999999999999999999 99999999999999998665 899999999986554322
Q ss_pred eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCc
Q 045067 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301 (347)
Q Consensus 222 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (347)
......||+.|+|||++.+..++.++||||+||++|+|+ +|+.||........ .......... ...+...
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~-~~~~~~~~~~-i~~~~~~------ 234 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTML-SGQVPFQSHDRSLT-CTSAVEIMKK-IKKGDFS------ 234 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHH-HSSCTTC--------CCCHHHHHHH-HTTTCCC------
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHH-hCCCCCCCCccccc-cccHHHHHHH-HHcCCCC------
Confidence 223467899999999999999999999999999999999 89999975432111 1111122222 2221110
Q ss_pred cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ........++++.+++.+||+.||++|||+.|+++
T Consensus 235 ~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 235 F-EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp C-CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred C-CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0 11122234567899999999999999999998863
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=326.02 Aligned_cols=259 Identities=19% Similarity=0.209 Sum_probs=195.2
Q ss_pred ccCCCCCeecccCceEEEEEEeC-CceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVLP-DRTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|...+.||+|+||+||+|... +..+|+|++..... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888899999999999999994 55566665543322 22236788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++ +|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 985 999998753 357999999999999999999999 999999999999999999999999999998765432
Q ss_pred CceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh---ccC--
Q 045067 220 ETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE---NRG-- 293 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 293 (347)
.. ......||+.|+|||++.+ ..++.++||||+||++|+|+ +|.+||..... ......... ...
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~ 223 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSE--------ADQLMRIFRILGTPNSK 223 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHHHHHHHHCCCCTT
T ss_pred cc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHHHHCCCChh
Confidence 21 1234568999999998875 46899999999999999999 89999964321 111111111 000
Q ss_pred -ccc-----ccCCccC------CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 -FNG-----IVDPRII------GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 -~~~-----~~~~~~~------~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.. ..++... ........++++.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0000000 00111223557889999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=331.40 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=201.9
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc-eE--EEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR-TI--SVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~--~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 136 (347)
++|...+.||+|+||.||+|.. .++ .+ ++|.+.........+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5788899999999999999998 333 32 455444433344456789999999999 899999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhc-----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 137 FESAEYGNLHDLLKRSY-----------QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
|||+++|+|.+++.... ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 99999999999997641 012347999999999999999999999 9999999999999999999999
Q ss_pred EEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 206 KLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
||+|||++....... ......+++.|+|||.+.+..++.++|||||||++|+|++.|..||..... ....
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELY 251 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHH
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HHHH
Confidence 999999987443211 122345788999999999889999999999999999999339999964321 1111
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.....+.. ... ....+..+.+++.+||+.+|.+|||+.++++.|+++.++
T Consensus 252 -~~~~~~~~-----~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 252 -EKLPQGYR-----LEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp -HHGGGTCC-----CCC-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -HHhhcCCC-----CCC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11111110 000 112245688999999999999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=319.97 Aligned_cols=252 Identities=20% Similarity=0.258 Sum_probs=201.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccC-C-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG-S-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
..++|...+.||+|+||.||+|.. .++..+++|.... . .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 357889999999999999999998 4444444444432 2 233456788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc---eEEecCCCC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV---PKLFNFSLS 213 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~a 213 (347)
|||+++++|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||++
T Consensus 84 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999998875 67999999999999999999999 999999999999999986655 999999999
Q ss_pred ccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
........ .....||+.|+|||.+.+..++.++||||+|+++|+|+ +|+.||..... ....... ..+.
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~--------~~~~~~~-~~~~ 223 (284)
T 3kk8_A 156 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL-VGYPPFWDEDQ--------HRLYAQI-KAGA 223 (284)
T ss_dssp EECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHH-HHTC
T ss_pred EEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHH-HCCCCCCCCch--------hHHHHHH-Hhcc
Confidence 77654332 23467999999999999999999999999999999999 99999964321 1222222 2211
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. ...+ .....++.+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~-~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 224 YD-YPSP------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CC-CCTT------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cc-CCch------hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11 0000 01123456889999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=329.96 Aligned_cols=243 Identities=16% Similarity=0.079 Sum_probs=188.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCce-EEEEEEccCC-CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRT-ISVVKFIDGS-VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~-~~v~k~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||+||+|.. .++. +|+|++.... ..........|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 6799999999999999999999 4454 5555443332 223334566677666666 8999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+ +++|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 137 e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp ECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred ecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 999 56999998764 256999999999999999999999 8999999999999999999999999999987764
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCC-CccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE-DLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.... .....||+.|+|||++.+ .++.++|||||||++|||+ +|. +|+... .. .....+..
T Consensus 209 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~-~g~~~~~~~~------------~~-~~~~~~~~-- 269 (311)
T 3p1a_A 209 TAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVA-CNMELPHGGE------------GW-QQLRQGYL-- 269 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHH-HTCCCCSSHH------------HH-HHHTTTCC--
T ss_pred cCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHH-hCCCCCCCcc------------HH-HHHhccCC--
Confidence 4322 234569999999998876 6899999999999999999 664 444211 01 11111111
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........++++.+++.+||+.||++|||+.|+++
T Consensus 270 -------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 -------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11122233567889999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=341.73 Aligned_cols=273 Identities=15% Similarity=0.166 Sum_probs=209.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC--ccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE--IPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 136 (347)
.+.|...+.||+|+||+||+|.+ .++..+++|++. .......+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 35688899999999999999999 445445555444 333334577889999999999999999999988765 77999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE----CCCCceEEecCCC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV----SERYVPKLFNFSL 212 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~ 212 (347)
|||+++|+|.+++.... ....+++..+..++.|++.||+||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 88 ~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp ECCCTTEEHHHHTTSGG--GTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EecCCCCCHHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 99999999999997641 1234999999999999999999999 9999999999999999 7888899999999
Q ss_pred CccCCCCCceeeccccccCCccccccccc--------CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYART--------GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
++....... .....||+.|+|||++.+ ..++.++|||||||++|||+ +|+.||...... ......
T Consensus 163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~-tg~~Pf~~~~~~----~~~~~~ 235 (396)
T 4eut_A 163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA-TGSLPFRPFEGP----RRNKEV 235 (396)
T ss_dssp CEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHH-HSSCSEECTTCT----TTCHHH
T ss_pred ceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHH-HCCCCCCCCCcc----cchHHH
Confidence 987654322 234679999999998765 56788999999999999999 899999753321 112233
Q ss_pred HHHHHhccCccc---c---------cCCccC-CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 285 VKKYIENRGFNG---I---------VDPRII-GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 285 ~~~~~~~~~~~~---~---------~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
............ . +...+. ...........+.+++.+||+.||++|||+.|+++.++++.+
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 333332211100 0 000111 112234567788999999999999999999999999999865
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=330.53 Aligned_cols=258 Identities=17% Similarity=0.268 Sum_probs=194.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc---
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP--- 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 133 (347)
.++|...+.||+|+||.||+|.. .++..+++|++.... ....+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46788999999999999999998 555555555554432 23345788999999999999999999998876544
Q ss_pred -EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 134 -VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 134 -~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 9999999999999999875 67999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCce--eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 213 SASIPEGETY--IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 213 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
+......... ......||+.|+|||.+.+..++.++|||||||++|+|+ +|+.||..... .........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll-~g~~pf~~~~~--------~~~~~~~~~ 233 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL-TGEPPFTGDSP--------VSVAYQHVR 233 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHHHHHH
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCCh--------HHHHHHHhc
Confidence 9876543221 223456899999999999999999999999999999999 89999964321 122222222
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHH-HHHHHHHH
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMID-VAKQIKKM 343 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~e-ll~~L~~i 343 (347)
..... ........+.++.+++.+||+.||++||++.+ +...+.++
T Consensus 234 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 234 EDPIP--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCCCC--------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCC--------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 21110 00111123456889999999999999997555 44555444
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=330.21 Aligned_cols=262 Identities=21% Similarity=0.256 Sum_probs=195.0
Q ss_pred hccCCC-CCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEE
Q 045067 61 TNNYHY-RNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 61 ~~~~~~-~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 137 (347)
.+.|.. .+.||+|+||+||+|.. .++..+++|.+........+.+.+|+.++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 345666 37899999999999998 44555555555444444457899999999985 7999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc---eEEecCCCCc
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV---PKLFNFSLSA 214 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~a~ 214 (347)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+|||++.
T Consensus 91 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999875 67999999999999999999999 999999999999999998776 9999999987
Q ss_pred cCCCCCc------eeeccccccCCccccccccc-----CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCc----
Q 045067 215 SIPEGET------YIDDGVKGTSGIVAPEYART-----GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDES---- 279 (347)
Q Consensus 215 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~---- 279 (347)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|+ +|+.||...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL-SGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH-HSSCSCCCCCCSCSCC----C
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHH-HCCCCCccccccccccccccc
Confidence 6543211 11123569999999998875 56889999999999999999 89999976433111000
Q ss_pred --hHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 280 --FEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 280 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
............+... . ........+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~i~~~~~~------~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYE------F-PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CHHHHHHHHHHHHHCCCC------C-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred chhHHHHHHHHHhccCcc------c-CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0011111122221110 0 00111123457889999999999999999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=335.60 Aligned_cols=243 Identities=20% Similarity=0.224 Sum_probs=198.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--------chhHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--------FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV 130 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 130 (347)
..++|...+.||+|+||+||+|.. .++..+++|.+.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 467899999999999999999998 555555555444332 11234677899999999999999999999999
Q ss_pred CccEEEEEeCCCC-CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 131 EIPVLVFESAEYG-NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 131 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
+..++||||+.+| +|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEee
Confidence 9999999999776 999999864 57999999999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|+ +|..||.....
T Consensus 174 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~--------------- 235 (335)
T 3dls_A 174 FGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV-FEENPFCELEE--------------- 235 (335)
T ss_dssp CTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHH-HSSCSCSSGGG---------------
T ss_pred cccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHH-hCCCchhhHHH---------------
Confidence 999987654432 234579999999999888776 88999999999999999 99999964221
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
........+. ..+.++.+++.+||+.||++|||+.++++.
T Consensus 236 --------~~~~~~~~~~---~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 --------TVEAAIHPPY---LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --------GTTTCCCCSS---CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --------HHhhccCCCc---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000011111 124467899999999999999999999873
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=334.94 Aligned_cols=253 Identities=21% Similarity=0.246 Sum_probs=199.3
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEE
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 136 (347)
...++|...+.||+|+||.||+|.. .++..+++|++..... ...+|+.++.++ +||||+++++++.+++..++|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3467899999999999999999999 5566666666554432 245788888888 799999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC----CceEEecCCC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER----YVPKLFNFSL 212 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~ 212 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+..+ +.+||+|||+
T Consensus 95 ~E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 95 TELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp ECCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999999764 67999999999999999999999 9999999999999998533 3599999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
+........ .....+||+.|+|||++.+..++.++||||+||++|+|+ +|.+||..... .......... ..+
T Consensus 167 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~-----~~~~~~~~~i-~~~ 238 (342)
T 2qr7_A 167 AKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML-TGYTPFANGPD-----DTPEEILARI-GSG 238 (342)
T ss_dssp CEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHH-HSSCSSCSSTT-----SCHHHHHHHH-HHC
T ss_pred cccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHh-cCCCCCCCCCc-----CCHHHHHHHH-ccC
Confidence 987654322 233467899999999998888899999999999999999 89999964211 1122222222 222
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... . . .......+.++.+++.+||+.||++|||+.++++
T Consensus 239 ~~~-~-~-----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 239 KFS-L-S-----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCC-C-C-----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Ccc-c-C-----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 211 0 0 0111223456889999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=327.85 Aligned_cols=263 Identities=19% Similarity=0.220 Sum_probs=194.8
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
.++|...+.||+|+||+||+|.. . +..+++|++..... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 35788899999999999999999 4 44455555544332 223466889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 82 e~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999999988754 67999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH--------
Q 045067 218 EGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY-------- 288 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 288 (347)
.... ......||+.|+|||.+.+ ..++.++||||+|+++|+|+ +|.+||..... ..........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~ 226 (311)
T 4agu_A 154 GPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSD-----VDQLYLIRKTLGDLIPRH 226 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH-----HHHHHHHHHHHCSCCHHH
T ss_pred Cccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCH-----HHHHHHHHHHhccccccc
Confidence 3322 2234578999999998876 67899999999999999999 89999965322 0011111111
Q ss_pred ---Hhcc-Ccc--cccCCccCCc--hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 ---IENR-GFN--GIVDPRIIGD--ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ---~~~~-~~~--~~~~~~~~~~--~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+... ... ...++..... ...+..+..+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 000 0111110000 011223456889999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=321.51 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=201.1
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee---------
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE--------- 129 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 129 (347)
..++|...+.||+|+||.||+|.+ .++..+++|...... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 456788999999999999999999 345555555444432 457799999999999999999998864
Q ss_pred -------CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC
Q 045067 130 -------VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER 202 (347)
Q Consensus 130 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~ 202 (347)
....++||||+++|+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG---GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCC
Confidence 44589999999999999999764 2357999999999999999999999 9999999999999999999
Q ss_pred CceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH
Q 045067 203 YVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282 (347)
Q Consensus 203 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~ 282 (347)
+.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|+ +|..|+... .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~~~~~~~~~----------~ 225 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL-HVCDTAFET----------S 225 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHH-SCCSSHHHH----------H
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHH-hcCCcchhH----------H
Confidence 9999999999987654332 23456999999999999999999999999999999999 777776421 1
Q ss_pred HHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 283 DFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
... ......... . ..+..+.+++.+||+.||++|||+.|+++.|+.+.++
T Consensus 226 ~~~-~~~~~~~~~----~---------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 226 KFF-TDLRDGIIS----D---------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHH-HHHHTTCCC----T---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHH-HHhhccccc----c---------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111 111111111 1 1234577999999999999999999999999988654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=347.91 Aligned_cols=248 Identities=16% Similarity=0.176 Sum_probs=192.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...+.||+|+||.||+|.. .++..+++|++... .......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999998 45555555544321 223346678999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
|||+++|+|.+++... ..+++..+..++.|++.||+||| + .+|+||||||+|||++.++.+||+|||+++.
T Consensus 227 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999875 67999999999999999999999 7 8999999999999999999999999999976
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
...... ......||+.|+|||++.+..++.++|||||||++|||+ +|+.||..... ........... .
T Consensus 299 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~Pf~~~~~--------~~~~~~i~~~~-~- 366 (446)
T 4ejn_A 299 GIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDH--------EKLFELILMEE-I- 366 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHCC-C-
T ss_pred ccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHh-hCCCCCCCCCH--------HHHHHHHHhCC-C-
Confidence 443322 234568999999999999999999999999999999999 89999964321 12222222211 1
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
.. +...++++.+++.+||+.||.+|| |+.|+++
T Consensus 367 -----~~-----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -----RF-----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----CC-----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CC-----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 00 011245678999999999999999 9999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=345.21 Aligned_cols=246 Identities=20% Similarity=0.240 Sum_probs=199.9
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|...+.||+|+||.||+|.+ .++..+++|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5688899999999999999999 445545555443221 123467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 96 E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999764 67999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.... ....+||+.|+|||++.+..+ +.++||||+||++|+|+ +|..||..... ........ .+...
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell-tG~~Pf~~~~~--------~~~~~~i~-~~~~~- 234 (476)
T 2y94_A 168 DGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALL-CGTLPFDDDHV--------PTLFKKIC-DGIFY- 234 (476)
T ss_dssp TTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHH-HSSCSSCCSSS--------HHHHHHHH-TTCCC-
T ss_pred cccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHh-hCCCCCCCCCH--------HHHHHHHh-cCCcC-
Confidence 4332 244679999999999888765 68999999999999999 89999964321 12222222 21110
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+ ...++.+.+++.+||+.||++|||+.|+++
T Consensus 235 -------~p---~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 -------TP---QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -------CC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------CC---ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 00 112346789999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=336.46 Aligned_cols=202 Identities=23% Similarity=0.311 Sum_probs=160.8
Q ss_pred HHhccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCC--c
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVE--I 132 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 132 (347)
...++|...+.||+|+||.||+|.. .+..+|+|++.... .....+.+.+|+.++.++. ||||+++++++..++ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3567899999999999999999998 34556666554332 2344567889999999997 999999999997544 7
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
+++||||++ |+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 899999998 599999976 57999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCC--------------------ceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccC
Q 045067 213 SASIPEGE--------------------TYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMG 271 (347)
Q Consensus 213 a~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~ 271 (347)
++...... ........||+.|+|||++.+ ..++.++||||+||++|||+ +|++||...
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~ 234 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPIFPGS 234 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-HSSCSCCCS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH-hCCCCCCCC
Confidence 97653211 111234679999999998876 67899999999999999999 999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=337.17 Aligned_cols=253 Identities=16% Similarity=0.220 Sum_probs=189.0
Q ss_pred hccCCCC-CeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHh-cCCCceeeeeeeeee----CCcc
Q 045067 61 TNNYHYR-NIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQ-MSHNNVLRLIGCCLE----VEIP 133 (347)
Q Consensus 61 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 133 (347)
.++|... ++||+|+||+||+|.. .++..+++|++... ..+.+|+.++.+ .+||||+++++++.. ...+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456554 6899999999999999 55555555555432 457789988755 489999999999876 5678
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC---CCceEEecC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE---RYVPKLFNF 210 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Df 210 (347)
++||||+++|+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEec
Confidence 9999999999999999763 2246999999999999999999999 999999999999999997 789999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
|+++....... ....+||+.|+|||++.+..++.++|||||||++|+|+ +|+.||............. ....
T Consensus 209 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~~-----~~i~ 280 (400)
T 1nxk_A 209 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLAISPGMK-----TRIR 280 (400)
T ss_dssp TTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHH-HSSCSCCCCTTCSSCCSHH-----HHHH
T ss_pred ccccccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHH-hCCCCCCCCccccccHHHH-----HHHH
Confidence 99987653322 23567899999999999999999999999999999999 9999997543311111111 1111
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.+... ...+ .....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 281 ~~~~~-~~~~------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 281 MGQYE-FPNP------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HTCCC-CCTT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCccc-CCCc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11110 0000 111234568899999999999999999999873
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=325.50 Aligned_cols=270 Identities=22% Similarity=0.333 Sum_probs=200.3
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEe-C---CceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVL-P---DRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE 129 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~---~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 129 (347)
++....++|...+.||+|+||.||+|.. . .+..+++|.+... .....+.+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 3444567788889999999999999987 2 3334555555433 23345678999999999999999999999887
Q ss_pred CC-----ccEEEEEeCCCCCHHHHHhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC
Q 045067 130 VE-----IPVLVFESAEYGNLHDLLKRSYQ-SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY 203 (347)
Q Consensus 130 ~~-----~~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~ 203 (347)
.. ..++||||+++|+|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCC
Confidence 55 35999999999999999854211 23356999999999999999999999 99999999999999999999
Q ss_pred ceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH
Q 045067 204 VPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282 (347)
Q Consensus 204 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~ 282 (347)
.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++.|.+||..... .
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~--- 256 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----H--- 256 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----G---
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----H---
Confidence 9999999999776543221 123345788999999999999999999999999999999449999965322 1
Q ss_pred HHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhC
Q 045067 283 DFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347 (347)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~~ 347 (347)
......... ... . .....+..+.+++.+||+.||.+|||+.++++.|+++.+++
T Consensus 257 ~~~~~~~~~-~~~-----~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 257 EMYDYLLHG-HRL-----K-----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp GHHHHHHTT-CCC-----C-----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHcC-CCC-----C-----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111111 110 0 01123456889999999999999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=353.67 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=197.2
Q ss_pred eecccCceEEEEEEe---CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCCCC
Q 045067 69 IITESSIFRLCQGVL---PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGN 144 (347)
Q Consensus 69 ~lg~G~~g~Vy~~~~---~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 144 (347)
.||+|+||.||+|.+ .++..+++|.+... .....+.+.+|+.++++++||||+++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 799999999999987 24444555555443 33455789999999999999999999999876 56899999999999
Q ss_pred HHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCcee-
Q 045067 145 LHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYI- 223 (347)
Q Consensus 145 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 223 (347)
|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 422 L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 422 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 99999652 356999999999999999999999 9999999999999999999999999999998765433221
Q ss_pred -eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCcc
Q 045067 224 -DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRI 302 (347)
Q Consensus 224 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (347)
.....+|+.|+|||++.+..++.++|||||||++|||++.|+.||..... ..... ....+.. +
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~-~i~~~~~-------~ 558 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMA-FIEQGKR-------M 558 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------HHHHH-HHHTTCC-------C
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHH-HHHcCCC-------C
Confidence 12344678999999999999999999999999999999449999975322 11222 2222211 0
Q ss_pred CCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 303 IGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
. .+...+.++.+++.+||+.+|++|||+.+|++.|+.+..+
T Consensus 559 ~---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 559 E---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp C---CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred C---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 0 1112345788999999999999999999999999998654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=319.15 Aligned_cols=257 Identities=18% Similarity=0.236 Sum_probs=201.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCCC-----chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGSV-----FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
.++|...+.||+|+||.||+|.. .++ .+++|.+..... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 45688899999999999999999 344 455444433221 11347799999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC----ceEEec
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY----VPKLFN 209 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~----~~kl~D 209 (347)
++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++ .+||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999999765 67999999999999999999999 99999999999999999877 899999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
||++........ .....||+.|+|||.+.+..++.++||||||+++|+|+ +|..||..... .......
T Consensus 156 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~--------~~~~~~~- 223 (283)
T 3bhy_A 156 FGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL-SGASPFLGETK--------QETLTNI- 223 (283)
T ss_dssp CTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCTTCCSSH--------HHHHHHH-
T ss_pred cccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHH-HCCCCCCCcch--------HHHHHHh-
Confidence 999987654322 23456899999999999899999999999999999999 89999964321 1111111
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHHHHH
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK--QIKKMY 344 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~--~L~~i~ 344 (347)
..... .. ........+..+.+++.+||+.||++|||+.|+++ .++.+.
T Consensus 224 ~~~~~------~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 224 SAVNY------DF-DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HTTCC------CC-CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred Hhccc------CC-cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 11110 00 01111223456889999999999999999999997 566554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=330.93 Aligned_cols=247 Identities=23% Similarity=0.283 Sum_probs=196.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-C--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-V--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.+.|...+.||+|+||+||+|.. .++..+++|.+... . ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35588889999999999999998 45554444444332 2 23346789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+. |+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 133 ~e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99998 5888888653 267999999999999999999999 999999999999999999999999999999765
Q ss_pred CCCCceeeccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
... ....||+.|+|||++. +..++.++|||||||++|||+ +|++||..... ............
T Consensus 205 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell-~g~~p~~~~~~--------~~~~~~~~~~~~ 270 (348)
T 1u5q_A 205 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNA--------MSALYHIAQNES 270 (348)
T ss_dssp SSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCH--------HHHHHHHHHSCC
T ss_pred CCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCh--------HHHHHHHHhcCC
Confidence 432 2357999999999874 567899999999999999999 89999864221 122222222211
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+.... ...+..+.+++.+||+.||++|||+.++++.
T Consensus 271 ------~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 ------PALQS----GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ------CCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCC----CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111 1124467899999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=321.56 Aligned_cols=247 Identities=19% Similarity=0.287 Sum_probs=197.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...+.||+|+||+||+|.. .++..+++|+..... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 46788999999999999999998 555555555443221 12235688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999999875 67999999999999999999999 999999999999999999999999999988654
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.... .....||+.|+|||.+.+..++.++||||+|+++|+|+ +|..||..... ....... .....
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~--------~~~~~~~-~~~~~-- 224 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPFEANTY--------QETYKRI-SRVEF-- 224 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH-HSSCTTCCSSH--------HHHHHHH-HHTCC--
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHH-HCCCCCCCCcH--------HHHHHHH-HhCCC--
Confidence 4322 23457899999999999999999999999999999999 89999964321 1111111 11110
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.. +...+..+.+++.+||+.||++|||+.|+++.
T Consensus 225 ----~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 ----TF-----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----CC-----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CC-----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 01123467899999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=322.63 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=197.4
Q ss_pred HhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-CccEEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV-EIPVLVFE 138 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 138 (347)
..++|...+.||+|+||+||+|...+..+++|.+. ... ..+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~-~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK-NDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECC-CCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEcCCEEEEEEec-chh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 35678999999999999999999876666655543 322 347789999999999999999999987654 47899999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++++|.+++... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 96 YMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCTTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred cCCCCCHHHHHHhc---ccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999764 1123889999999999999999999 99999999999999999999999999999876543
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
.. ....+++.|+|||.+.+..++.++||||||+++|+|++.|+.||..... . ..... ...+..
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~---~~~~~-~~~~~~---- 232 (278)
T 1byg_A 170 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----K---DVVPR-VEKGYK---- 232 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----G---GHHHH-HTTTCC----
T ss_pred cc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----H---HHHHH-HhcCCC----
Confidence 22 2345788999999999899999999999999999999449999964321 1 11111 111110
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
... ....++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus 233 -~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 -MDA-----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCC-----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 011 112345688999999999999999999999999999763
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=322.74 Aligned_cols=261 Identities=19% Similarity=0.194 Sum_probs=195.0
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCce-EEEEEEccCC----CchhHHHHHHHHHHHHhcC---CCceeeeeeeeeeC
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRT-ISVVKFIDGS----VFDAYDCCFNNIVFASQMS---HNNVLRLIGCCLEV 130 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~-~~v~k~~~~~----~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 130 (347)
..++|...+.||+|+||+||+|.. .++. +|+|.+.... .......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999998 4444 5555443221 1112245778888887764 99999999999876
Q ss_pred C-----ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 131 E-----IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 131 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
. ..++||||+. ++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCE
Confidence 5 5799999998 5999999864 2244999999999999999999999 9999999999999999999999
Q ss_pred EEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 206 KLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|+ +|++||..... ....
T Consensus 160 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~--------~~~~ 228 (308)
T 3g33_A 160 KLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKPLFCGNSE--------ADQL 228 (308)
T ss_dssp EECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTT-TSSCSCCCSSH--------HHHH
T ss_pred EEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHH-hCCCCCCCCCH--------HHHH
Confidence 9999999976643322 24567899999999999999999999999999999999 99999964321 1222
Q ss_pred HHHHhc---cC---ccc-------ccCCccCC--chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 286 KKYIEN---RG---FNG-------IVDPRIIG--DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 286 ~~~~~~---~~---~~~-------~~~~~~~~--~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...... .. +.. .+.+.... ....+..+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 222211 00 000 00000000 0011123457889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=329.65 Aligned_cols=251 Identities=18% Similarity=0.268 Sum_probs=191.0
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCC--CceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSH--NNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 136 (347)
.+.|...+.||+|+||.||+|...++..+++|.+... .....+.+.+|+.++.+++| |||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4568889999999999999999955554555544332 23344678999999999976 9999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
||+ .+++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e~-~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp ECC-CSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EeC-CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 995 567999999874 67999999999999999999999 99999999999999997 678999999999876
Q ss_pred CCCCce-eeccccccCCccccccccc-----------CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 217 PEGETY-IDDGVKGTSGIVAPEYART-----------GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 217 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|+ +|+.||..... ....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~-------~~~~ 229 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIIN-------QISK 229 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHH-HSSCTTTTCCS-------HHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHH-hCCCcchhhhh-------HHHH
Confidence 543322 2235679999999998865 67899999999999999999 99999964221 1122
Q ss_pred HHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 285 VKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
............ . + ...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~-~-~--------~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 LHAIIDPNHEIE-F-P--------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHCTTSCCC-C-C--------CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhcCCcccC-C-c--------ccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 222221111000 0 0 0113457899999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=322.97 Aligned_cols=253 Identities=20% Similarity=0.249 Sum_probs=200.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
..++|+..+.||+|+||.||+|.. .++ .+++|.+.........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 456789999999999999999998 344 455544433333344577899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++....
T Consensus 85 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 85 EYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp ECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 999999999998753 57999999999999999999999 9999999999999999999999999999997654
Q ss_pred CCCc-eeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 218 EGET-YIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 218 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.... .......||+.|+|||.+.+..+ +.++||||||+++|+|+ +|..||..... .. ............
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~---~~----~~~~~~~~~~~~- 227 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML-AGELPWDQPSD---SC----QEYSDWKEKKTY- 227 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHH-HSSCCCSCSCT---TS----HHHHHHHTTCTT-
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHH-hCCCCCCCCch---HH----HHHHHhhhcccc-
Confidence 3322 12234678999999999887665 78999999999999999 89999975322 00 111111111110
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 228 --~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 --LN-------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --ST-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cC-------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00 01123456789999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=337.92 Aligned_cols=246 Identities=20% Similarity=0.223 Sum_probs=190.7
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHH-HHhcCCCceeeeeeeeeeCCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVF-ASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
.++|...+.||+|+||.||+|.. .++..+++|++.... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 46799999999999999999999 556666666554322 2233556777776 467899999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 99999999999999875 67999999999999999999999 99999999999999999999999999999976
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
...... .....+||+.|+|||++.+..++.++|||||||++|||+ +|.+||..... ........... ..
T Consensus 189 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-~G~~Pf~~~~~--------~~~~~~i~~~~-~~ 257 (373)
T 2r5t_A 189 NIEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNT--------AEMYDNILNKP-LQ 257 (373)
T ss_dssp GBCCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCTTCCSBH--------HHHHHHHHHSC-CC
T ss_pred cccCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHH-cCCCCCCCCCH--------HHHHHHHHhcc-cC
Confidence 432221 234568999999999999999999999999999999999 99999964321 22222322221 10
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~el 336 (347)
+. ...+..+.+++.+||+.||.+||++.+.
T Consensus 258 --~~---------~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 258 --LK---------PNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp --CC---------SSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred --CC---------CCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 01 1124467899999999999999998643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=339.19 Aligned_cols=264 Identities=15% Similarity=0.167 Sum_probs=194.9
Q ss_pred hccCCCCCeecccCceEEEEEEeC----CceEEEEEEccCCCch-----------hHHHHHHHHHHHHhcCCCceeeeee
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLP----DRTISVVKFIDGSVFD-----------AYDCCFNNIVFASQMSHNNVLRLIG 125 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~~v~k~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 125 (347)
.++|...+.||+|+||.||+|... ++..+++|........ ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367889999999999999999983 4445555554443211 1134667888899999999999999
Q ss_pred eeee----CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC
Q 045067 126 CCLE----VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE 201 (347)
Q Consensus 126 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~ 201 (347)
++.+ ....++||||+ +++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEcc
Confidence 9988 67899999999 88999999875 47999999999999999999999 899999999999999998
Q ss_pred CC--ceEEecCCCCccCCCCCc------eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCcc
Q 045067 202 RY--VPKLFNFSLSASIPEGET------YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLR 273 (347)
Q Consensus 202 ~~--~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~ 273 (347)
++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+ +|+.||.....
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell-~g~~pf~~~~~ 265 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL-CGKLPWEQNLK 265 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHH-HSSCTTGGGTT
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHH-hCCCCcccccc
Confidence 77 999999999977643211 1113457999999999999999999999999999999999 89999964211
Q ss_pred CCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 274 LNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
.............. ........... ....+.++.+++.+||+.||++|||+.+|++.|+++
T Consensus 266 ----~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 266 ----DPVAVQTAKTNLLD-ELPQSVLKWAP----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp ----CHHHHHHHHHHHHH-TTTHHHHHHSC----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred ----ccHHHHHHHHhhcc-cccHHHHhhcc----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 11111111111111 01000000000 002345788999999999999999999999999865
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=330.87 Aligned_cols=261 Identities=16% Similarity=0.185 Sum_probs=190.5
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|...+.||+|+||+||+|.. .++..+++|.+.. ........+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5688889999999999999999 4555555554443 2222223466899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
++ |+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 98 4999998763 356999999999999999999999 999999999999999999999999999998765433
Q ss_pred CceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 220 ETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
.. ......||+.|+|||.+.+ ..++.++||||+||++|+|+ +|++||..... ............. ......
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~-----~~~~~~i~~~~~~-~~~~~~ 225 (324)
T 3mtl_A 154 TK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMA-TGRPLFPGSTV-----EEQLHFIFRILGT-PTEETW 225 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH-----HHHHHHHHHHHCC-CCTTTS
T ss_pred cc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCH-----HHHHHHHHHHhCC-CChHhc
Confidence 22 2234578999999998876 57899999999999999999 89999965321 1111111111111 000000
Q ss_pred CC-------------ccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 299 DP-------------RIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 299 ~~-------------~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. ..... ......+.++.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00 00000 011123457889999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=323.26 Aligned_cols=251 Identities=19% Similarity=0.209 Sum_probs=199.5
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
..++|...+.||+|+||.||+|.. .++..+++|..........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 456788999999999999999998 4555555555544433334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE---CCCCceEEecCCCCcc
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSAS 215 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a~~ 215 (347)
|+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||++ +.++.+||+|||++..
T Consensus 87 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 87 LVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred cCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999999765 67999999999999999999999 9999999999999999 7889999999999865
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
..... .....||+.|+|||.+.+..++.++||||+|+++|+|+ +|..||..... ........ .+...
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~--------~~~~~~i~-~~~~~ 225 (304)
T 2jam_A 159 EQNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL-CGYPPFYEETE--------SKLFEKIK-EGYYE 225 (304)
T ss_dssp CCCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHH-HSSCTTTTSCH--------HHHHHHHH-HCCCC
T ss_pred cCCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHH-HCCCCCCCCCH--------HHHHHHHH-cCCCC
Confidence 43321 23356899999999999999999999999999999999 89999964321 12222222 21110
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .. ......+..+.+++.+||+.||++|||+.|+++
T Consensus 226 -~-~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 -F-ES-----PFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -C-CT-----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -C-Cc-----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00 111123456889999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=329.50 Aligned_cols=259 Identities=14% Similarity=0.149 Sum_probs=203.4
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEE-----e-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC---CCceeeeeee
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGV-----L-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS---HNNVLRLIGC 126 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~-----~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~ 126 (347)
++....++|...+.||+|+||+||+|. . .++..+++|...... ...+.+|+.++.+++ |+||+.++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 334456778899999999999999994 2 334444455444432 256788888888886 9999999999
Q ss_pred eeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-----
Q 045067 127 CLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE----- 201 (347)
Q Consensus 127 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~----- 201 (347)
+...+..++||||+++|+|.+++..........+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCc
Confidence 999999999999999999999997643333467999999999999999999999 999999999999999998
Q ss_pred ------CCceEEecCCCCccCCC-CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccC
Q 045067 202 ------RYVPKLFNFSLSASIPE-GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL 274 (347)
Q Consensus 202 ------~~~~kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~ 274 (347)
++.+||+|||+|+.... ..........||+.|+|||++.+..++.++|||||||++|||+ +|+.||.....
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~- 290 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML-FGTYMKVKNEG- 290 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHH-HSSCCCEEEET-
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHH-hCCCccccCCC-
Confidence 89999999999976432 2223345577999999999999999999999999999999999 89988864322
Q ss_pred CCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHHHHHHH
Q 045067 275 NGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDR-PTMIDVAKQIKKMYK 345 (347)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~R-Ps~~ell~~L~~i~~ 345 (347)
+. ......+ +.. ...+.+.+++..|++.+|.+| |++.++.+.|+++..
T Consensus 291 -~~--------------~~~~~~~-~~~-------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 291 -GE--------------CKPEGLF-RRL-------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -TE--------------EEECSCC-TTC-------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -Cc--------------eeechhc-ccc-------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 00 0000111 111 113456689999999999999 678899998888764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=320.73 Aligned_cols=250 Identities=20% Similarity=0.268 Sum_probs=179.1
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
..++|...+.||+|+||.||+|.. .++..+++|...... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346788999999999999999998 445545555443221 1223678999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++++|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++..
T Consensus 89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp EEECCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 99999999999999763 357899999999999999999999 99999999999999999999999999999977
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
...... ......||+.|+|||.+.+..++.++||||+|+++|+|+ +|+.||....... .. ..
T Consensus 162 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~~~--------~~----~~---- 223 (278)
T 3cok_A 162 LKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL-IGRPPFDTDTVKN--------TL----NK---- 223 (278)
T ss_dssp CC-----------------------------CTHHHHHHHHHHHHH-HSSCSSCCCSCC---------------------
T ss_pred ccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHH-hCCCCCCChhHHH--------HH----HH----
Confidence 653322 123456899999999999889999999999999999999 8999997532210 00 00
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........ +...+.++.+++.+||+.||++|||+.++++
T Consensus 224 -~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 224 -VVLADYEM---PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCSSCCCC---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -HhhcccCC---ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00000000 1122456789999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=344.20 Aligned_cols=268 Identities=19% Similarity=0.230 Sum_probs=183.8
Q ss_pred hccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----Cc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV-----EI 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 132 (347)
.++|...+.||+|+||+||+|.. .+..+|+|++.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46799999999999999999998 34455566554432 233457789999999999999999999998543 56
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
+|+||||+. |+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 899999986 6999999764 67999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCc--------------------------eeeccccccCCccccccc-ccCCCCCccchHHHHHHHHHHHhc--
Q 045067 213 SASIPEGET--------------------------YIDDGVKGTSGIVAPEYA-RTGYLNEKCDVYSFGLLLLQLLST-- 263 (347)
Q Consensus 213 a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~el~~~-- 263 (347)
++....... .......||+.|+|||++ .+..++.++|||||||++|||+ +
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell-tg~ 281 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL-NMI 281 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-TTS
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH-Hhc
Confidence 987643211 112346789999999975 5667999999999999999999 6
Q ss_pred ---------CCCccccCccCCCCCc------------hHHHHHHHHHh---ccC--------------cccccCCc--cC
Q 045067 264 ---------GEDLFNMGLRLNGDES------------FEMDFVKKYIE---NRG--------------FNGIVDPR--II 303 (347)
Q Consensus 264 ---------g~~p~~~~~~~~~~~~------------~~~~~~~~~~~---~~~--------------~~~~~~~~--~~ 303 (347)
++++|........... .....+..... ... ....+... ..
T Consensus 282 ~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (458)
T 3rp9_A 282 KENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD 361 (458)
T ss_dssp TTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCC
T ss_pred cccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCC
Confidence 6677654321000000 00011111110 000 00000000 00
Q ss_pred CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 304 GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.....+..+.++.+|+.+||+.||++|||+.|+++
T Consensus 362 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 362 LAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp GGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00111223567889999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=332.61 Aligned_cols=249 Identities=17% Similarity=0.256 Sum_probs=191.7
Q ss_pred ccCCCCCeecccCceEEEEEEeCCceEEEEEEccCC--CchhHHHHHHHHHHHHhcC--CCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMS--HNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 137 (347)
..|...+.||+|+||.||+|...++..+++|.+... .....+.+.+|+.++.+++ ||||+++++++..++.+++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458999999999999999999954555555544332 2344577999999999996 599999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
| +.+++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++...
T Consensus 136 E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 5668999999874 57899999999999999999999 99999999999999995 5899999999998765
Q ss_pred CCCce-eeccccccCCccccccccc-----------CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 218 EGETY-IDDGVKGTSGIVAPEYART-----------GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 218 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
..... ......||+.|+|||++.+ ..++.++|||||||++|||+ +|++||..... .....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell-~G~~Pf~~~~~-------~~~~~ 277 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIIN-------QISKL 277 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH-HSSCTTTTCCC-------HHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH-HCCCcchhhhH-------HHHHH
Confidence 43322 2345679999999998865 46889999999999999999 99999964221 11222
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........... .+. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 278 ~~~~~~~~~~~--~~~--------~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 278 HAIIDPNHEIE--FPD--------IPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHCTTSCCC--CCC--------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCccccCC--CCc--------cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 22222111000 010 11346789999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=332.36 Aligned_cols=198 Identities=18% Similarity=0.254 Sum_probs=171.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.++|...+.||+|+||+||+|.+ .++..+++|+.... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 35788899999999999999999 45565666655443 34445779999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR-PIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|+++++|.+++... ..+++..+..++.+++.||.||| +. +|+||||||+||+++.++.+||+|||++....
T Consensus 112 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999875 67999999999999999999999 75 99999999999999999999999999986543
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
.. ......||+.|+|||++.+..++.++|||||||++|+|+ +|+.||..
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~ 232 (360)
T 3eqc_A 184 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA-VGRYPIPP 232 (360)
T ss_dssp HH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHH-HTSCCSSC
T ss_pred cc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHH-hCCCCCCC
Confidence 21 123457899999999999999999999999999999999 99999964
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=321.55 Aligned_cols=246 Identities=19% Similarity=0.235 Sum_probs=193.3
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccC-C-CchhHHHHHHHHHHHHhcCCCceeeeeeeeee----CCccEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG-S-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE----VEIPVL 135 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 135 (347)
.|...+.||+|+||+||+|.. .++..+++|.... . .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 356677899999999999999 4554444444332 2 23445778999999999999999999999875 356899
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEEC-CCCceEEecCCC
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP--IVFRDLKSSYILVS-ERYVPKLFNFSL 212 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~ 212 (347)
||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+ |+||||||+||+++ .++.+||+|||+
T Consensus 107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999875 67999999999999999999999 888 99999999999998 789999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
+........ ....||+.|+|||.+.+ .++.++||||+|+++|+|+ +|+.||..... ........ ..+
T Consensus 179 ~~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~-------~~~~~~~~-~~~ 245 (290)
T 1t4h_A 179 ATLKRASFA---KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA-TSEYPYSECQN-------AAQIYRRV-TSG 245 (290)
T ss_dssp GGGCCTTSB---EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHH-HSSCTTTTCSS-------HHHHHHHH-TTT
T ss_pred ccccccccc---ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHH-hCCCCCCCcCc-------HHHHHHHH-hcc
Confidence 976543322 34568999999998764 5899999999999999999 89999964321 12222221 111
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.... ......++.+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VKPA---------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCG---------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcc---------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111 111122346889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=338.74 Aligned_cols=250 Identities=12% Similarity=0.115 Sum_probs=187.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccC--CCchhHHHHHHHH---HHHHhcCCCceeeee-------ee
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDG--SVFDAYDCCFNNI---VFASQMSHNNVLRLI-------GC 126 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~--~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 126 (347)
.++|...+.||+|+||+||+|.. .++ .+|+|.+... ......+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46688889999999999999998 444 4555544322 2233457789999 455566899999998 55
Q ss_pred eeeCC-----------------ccEEEEEeCCCCCHHHHHhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 045067 127 CLEVE-----------------IPVLVFESAEYGNLHDLLKRSYQS--HSEPLLLKHRLKIAMEIANVFAYLHIGFSRPI 187 (347)
Q Consensus 127 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 187 (347)
+.+.+ ..++||||+ +|+|.+++...... ....+++..+..++.|++.||+||| +.+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 55443 378999999 57999999864111 1123445888899999999999999 9999
Q ss_pred EeccCCCCCeEECCCCceEEecCCCCccCCCCCceeeccccccCCcccccccccC-----------CCCCccchHHHHHH
Q 045067 188 VFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTG-----------YLNEKCDVYSFGLL 256 (347)
Q Consensus 188 vH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~G~~ 256 (347)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2234567 999999998877 89999999999999
Q ss_pred HHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 045067 257 LLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336 (347)
Q Consensus 257 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~el 336 (347)
+|||+ +|+.||....... ....+... . ...++.+.+++.+||+.||++|||+.|+
T Consensus 303 l~ell-tg~~Pf~~~~~~~-----------------~~~~~~~~-~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 303 IYWIW-CADLPITKDAALG-----------------GSEWIFRS-C------KNIPQPVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHH-HSSCCC------C-----------------CSGGGGSS-C------CCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred HHHHH-HCCCCCccccccc-----------------chhhhhhh-c------cCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 99999 8999996432210 00111110 0 1224568899999999999999999999
Q ss_pred HH--HHHHHH
Q 045067 337 AK--QIKKMY 344 (347)
Q Consensus 337 l~--~L~~i~ 344 (347)
++ .++++.
T Consensus 358 l~hp~f~~~~ 367 (377)
T 3byv_A 358 METPEYEQLR 367 (377)
T ss_dssp HTSHHHHHHH
T ss_pred hhChHHHHHH
Confidence 86 555554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=333.47 Aligned_cols=264 Identities=14% Similarity=0.144 Sum_probs=203.0
Q ss_pred hccCCCCCeecccCceEEEEEEeC---------CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceee---------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLP---------DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLR--------- 122 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 122 (347)
.++|...+.||+|+||.||+|... .+..+++|..... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 367999999999999999999983 2455555555433 45889999999999999987
Q ss_pred ------eeeeeee-CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 045067 123 ------LIGCCLE-VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSS 195 (347)
Q Consensus 123 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~ 195 (347)
+++++.. +...++||||+ +++|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~ 188 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS---PKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAE 188 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC---CcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHH
Confidence 5667666 67889999999 89999999863 2357999999999999999999999 999999999999
Q ss_pred CeEECCCC--ceEEecCCCCccCCCCCce------eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCc
Q 045067 196 YILVSERY--VPKLFNFSLSASIPEGETY------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDL 267 (347)
Q Consensus 196 Nill~~~~--~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p 267 (347)
|||++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|+|+ +|+.|
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~p 267 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL-YGFLP 267 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSCCT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHH-hCCCC
Confidence 99999998 9999999999776532211 113357999999999999999999999999999999999 89999
Q ss_pred cccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 268 FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
|..... .............. ....+.+..... ...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 268 f~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 268 WTNCLP---NTEDIMKQKQKFVD--KPGPFVGPCGHW----IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TGGGTT---CHHHHHHHHHHHHH--SCCCEECTTSCE----ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccCCc---CHHHHHHHHHhccC--Chhhhhhhcccc----CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 975431 11111111111111 111111111100 11245688999999999999999999999999999765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.07 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=196.6
Q ss_pred CeecccCceEEEEEEe---CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL---PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~---~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||.||+|.+ ..+..+++|++.... ....+.+.+|+.++.+++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999976 334445555544322 2335779999999999999999999999864 568899999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 9999999764 67999999999999999999999 999999999999999999999999999999876544321
Q ss_pred --eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 223 --IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 223 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
......+|+.|+|||++.+..++.++|||||||++|||++.|+.||..... .. +......+....
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~-~~~~i~~~~~~~---- 592 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SE-VTAMLEKGERMG---- 592 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HH-HHHHHHTTCCCC----
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHHcCCCCC----
Confidence 123345788999999999999999999999999999999449999964322 11 222222221110
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.+...+.++.+++.+||+.||++|||+.+|++.|+++..+
T Consensus 593 ------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 593 ------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0112345788999999999999999999999999998764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=321.55 Aligned_cols=249 Identities=22% Similarity=0.278 Sum_probs=201.7
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.+.|...+.||+|+||.||+|.. .++..+++|+.. .......+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35688889999999999999998 445555555444 3334455789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++++|.+++.. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 101 ~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 101 YLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp CCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred eCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999999965 57999999999999999999999 99999999999999999999999999999977644
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
... ......||+.|+|||.+.+..++.++||||||+++|+|+ +|..||..... ....... .....
T Consensus 172 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~--------~~~~~~~-~~~~~---- 236 (303)
T 3a7i_A 172 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA-RGEPPHSELHP--------MKVLFLI-PKNNP---- 236 (303)
T ss_dssp TBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCH--------HHHHHHH-HHSCC----
T ss_pred ccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHc-cCCCCCCCcCH--------HHHHHHh-hcCCC----
Confidence 321 223457899999999999999999999999999999999 89999864321 1111111 11111
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
+... ...+..+.+++.+||+.||++|||+.++++.
T Consensus 237 -~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 -PTLE-----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -CCCC-----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -CCCc-----cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111 1123467899999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=353.93 Aligned_cols=264 Identities=19% Similarity=0.268 Sum_probs=205.4
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEe-C---CceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVL-P---DRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV 130 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~---~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 130 (347)
+.....++|...+.||+|+||.||+|.+ . .+..+++|... .......+.+.+|+.++++++||||+++++++. +
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 3344457788889999999999999998 2 22344445444 334444577999999999999999999999985 4
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
+..++||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred CceEEEEEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEec
Confidence 6789999999999999999763 256899999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
|+++..............+|+.|+|||.+.+..++.++|||||||++|||++.|.+||..... .........
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~~~~~i~~ 607 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIEN 607 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHH
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHc
Confidence 999877554433334456788999999999899999999999999999999559999964321 122222222
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
... .. . +...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 608 ~~~-~~-----~-----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 608 GER-LP-----M-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TCC-CC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC-CC-----C-----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 111 10 0 112345688999999999999999999999999998653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=330.52 Aligned_cols=263 Identities=19% Similarity=0.234 Sum_probs=201.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee----CCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE----VEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 135 (347)
.++|...+.||+|+||.||++.. .++..+++|.+........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999998 4555555554444444556789999999999999999999999873 347899
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++|+|.+++... ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 108 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERL-KDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEECCTTCBHHHHHHHH-HTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEeCCCCcHHHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999763 223367999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCcee--------eccccccCCcccccccccCC---CCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 216 IPEGETYI--------DDGVKGTSGIVAPEYARTGY---LNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 216 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
........ .....||+.|+|||.+.+.. ++.++||||||+++|+|+ +|+.||...... ... ..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~~--~~~-~~-- 257 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM-FGEGPYDMVFQK--GDS-VA-- 257 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH-HSSCTTHHHHHT--TSC-HH--
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH-hCCCChhhhhcc--cch-hh--
Confidence 54211100 12245799999999887553 689999999999999999 999998642210 000 00
Q ss_pred HHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 285 VKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
...... .. . + . ....+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 258 --~~~~~~-~~-~--~---~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 258 --LAVQNQ-LS-I--P---Q---SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --HHHHCC----C--C---C---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred --HHhhcc-CC-C--C---c---cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 111110 00 0 0 0 01224568899999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=348.16 Aligned_cols=253 Identities=19% Similarity=0.241 Sum_probs=202.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...+.||+|+||.||+|.. .++..+++|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46788999999999999999999 45555555544322 112335688999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||++||+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 263 mEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999764 2245999999999999999999999 999999999999999999999999999999877
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..... .....||+.|+|||++.+..++.++|||||||++|||+ +|++||..... .. ....+.........
T Consensus 337 ~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLl-tG~~PF~~~~~----~~-~~~~i~~~i~~~~~-- 406 (576)
T 2acx_A 337 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI-AGQSPFQQRKK----KI-KREEVERLVKEVPE-- 406 (576)
T ss_dssp CTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHH-HSSCSSSCSSS----CC-CHHHHHHHHHHCCC--
T ss_pred ccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHH-hCCCCCccccc----ch-hHHHHHHHhhcccc--
Confidence 54432 23458999999999999999999999999999999999 89999975322 11 11112222221110
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
.. ....+.++.+++.+||+.||.+|| ++.|+++
T Consensus 407 ----~~-----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 407 ----EY-----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----CC-----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----cC-----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00 112345688999999999999999 7788864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=338.08 Aligned_cols=256 Identities=20% Similarity=0.207 Sum_probs=191.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE------ 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 131 (347)
.++|...+.||+|+||+||+|.. . +..+|+|++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 56788999999999999999998 4 4455555554332 2334567889999999999999999999987653
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
.+++||||+++ +|.+.+. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 56999999986 6777774 34899999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh-
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE- 290 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 290 (347)
+++...... ......||+.|+|||++.+..++.++||||+||++|||+ +|++||..... .........
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-~g~~pF~g~~~--------~~~~~~i~~~ 278 (464)
T 3ttj_A 210 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFPGRDY--------IDQWNKVIEQ 278 (464)
T ss_dssp CC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHH
T ss_pred eeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHHh
Confidence 998765432 234568999999999999999999999999999999999 99999965321 111111111
Q ss_pred ---------------------ccC-cc-----cccCCcc-C-CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 ---------------------NRG-FN-----GIVDPRI-I-GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ---------------------~~~-~~-----~~~~~~~-~-~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... .. ..+.... . ..........++.+|+.+||+.||++|||+.|+++
T Consensus 279 lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00 0000000 0 01112223567899999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=342.61 Aligned_cols=251 Identities=20% Similarity=0.250 Sum_probs=196.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
..+.|...+.||+|+||+||+|.. .++..+++|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 455789999999999999999999 455545555444322 22346789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC---CceEEecCCCC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER---YVPKLFNFSLS 213 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~a 213 (347)
|||+++|+|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.. +.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999998775 67999999999999999999999 9999999999999999764 55999999999
Q ss_pred ccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
........ .....||+.|+|||++. ..++.++||||+||++|+|+ +|.+||..... .......... .
T Consensus 187 ~~~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~--------~~~~~~i~~~-~ 253 (494)
T 3lij_A 187 AVFENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILL-AGYPPFGGQTD--------QEILRKVEKG-K 253 (494)
T ss_dssp EECBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHT-C
T ss_pred eECCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhC-C
Confidence 77654322 24467999999999876 46899999999999999999 99999964321 2222222222 1
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. .. .......++.+.+++.+||+.+|.+|||+.|+++
T Consensus 254 ~~-~~------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 254 YT-FD------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CC-CC------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC-CC------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 11 00 0111223456889999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=342.16 Aligned_cols=252 Identities=22% Similarity=0.232 Sum_probs=199.5
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC-c------------hhHHHHHHHHHHHHhcCCCceeeee
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV-F------------DAYDCCFNNIVFASQMSHNNVLRLI 124 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~-~------------~~~~~~~~E~~~l~~l~h~niv~l~ 124 (347)
...+.|...+.||+|+||+||+|.. .++..+++|++.... . ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3567899999999999999999999 455555555443321 1 2346789999999999999999999
Q ss_pred eeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-
Q 045067 125 GCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY- 203 (347)
Q Consensus 125 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~- 203 (347)
+++.++...++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCC
Confidence 9999999999999999999999999775 67999999999999999999999 99999999999999999776
Q ss_pred --ceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchH
Q 045067 204 --VPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFE 281 (347)
Q Consensus 204 --~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~ 281 (347)
.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|+ +|.+||.....
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~-------- 252 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILL-CGYPPFGGQND-------- 252 (504)
T ss_dssp CSSEEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------
T ss_pred CccEEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHH-hCCCCCCCCCH--------
Confidence 699999999987654322 24467999999999877 46899999999999999999 89999964321
Q ss_pred HHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 282 MDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.......... .... ........+.++.+++.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~~i~~~-~~~~-------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 253 QDIIKKVEKG-KYYF-------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHHHC-CCCC-------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHcC-CCCC-------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2222222221 1100 00111223567889999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=327.17 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=202.0
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--------chhHHHHHHHHHHHHhc-CCCceeeeeee
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--------FDAYDCCFNNIVFASQM-SHNNVLRLIGC 126 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 126 (347)
.....++|...+.||+|+||.||+|.. .++..+++|+..... ....+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 345567899999999999999999998 455555555544322 11235678999999999 79999999999
Q ss_pred eeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceE
Q 045067 127 CLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPK 206 (347)
Q Consensus 127 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~k 206 (347)
+...+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.||+||||||+||+++.++.+|
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999865 67999999999999999999999 99999999999999999999999
Q ss_pred EecCCCCccCCCCCceeeccccccCCccccccccc------CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCch
Q 045067 207 LFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART------GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESF 280 (347)
Q Consensus 207 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~ 280 (347)
|+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|+ +|..||.....
T Consensus 241 l~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell-~g~~pf~~~~~------- 310 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL-AGSPPFWHRRQ------- 310 (365)
T ss_dssp ECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHH-HSSCSSCCSSH-------
T ss_pred EEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHH-HCCCCCCCCCH-------
Confidence 999999987654332 234679999999998863 35889999999999999999 89999964221
Q ss_pred HHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 281 EMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
......... +... . ........+..+.+++.+||+.||++|||+.|+++
T Consensus 311 -~~~~~~i~~-~~~~-~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 311 -ILMLRMIME-GQYQ-F------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HHHHHHHHH-TCCC-C------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHHHHHHh-CCCC-C------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112222211 1110 0 00011122456889999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=321.19 Aligned_cols=248 Identities=19% Similarity=0.227 Sum_probs=202.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...+.||+|+||.||+|.. .++..+++|+.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 46788899999999999999999 55666666655432 233456789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 94 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999999875 67999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..... ......||+.|+|||.+.+..++.++||||+|+++|+|+ +|+.||..... .......... ..
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~--------~~~~~~~~~~-~~-- 232 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPFETSCL--------KETYLRIKKN-EY-- 232 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHH-HSSCTTCCSSH--------HHHHHHHHTT-CC--
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHhhc-cC--
Confidence 53322 223457899999999999888999999999999999999 89999964321 1111111111 10
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... ...+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ----~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 ----SIP-----KHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ----CCC-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCc-----cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 000 112346789999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=341.90 Aligned_cols=251 Identities=20% Similarity=0.241 Sum_probs=199.2
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
..+.|...+.||+|+||+||+|.. .++..+++|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 456799999999999999999999 44554555544321 122346789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC---CCCceEEecCCCC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS---ERYVPKLFNFSLS 213 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~a 213 (347)
|||+++|+|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999999775 67999999999999999999999 99999999999999995 4567999999999
Q ss_pred ccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
+....... .....||+.|+|||++.+ .++.++||||+||++|+|+ +|.+||..... .......... .
T Consensus 172 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll-~g~~pf~~~~~--------~~~~~~i~~~-~ 238 (486)
T 3mwu_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL-SGTPPFYGKNE--------YDILKRVETG-K 238 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHT-C
T ss_pred eECCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhC-C
Confidence 76654322 234679999999999876 5899999999999999999 99999964321 2222222221 1
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... ........+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~-------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 239 YAF-------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CCS-------CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCC-------CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 110 00111233557889999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=328.86 Aligned_cols=253 Identities=19% Similarity=0.225 Sum_probs=191.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE------ 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 131 (347)
.+.|...+.||+|+||.||+|.. . +..+|+|++.... .....+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46788999999999999999998 4 4555555554332 2334567899999999999999999999988653
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 459999999 6799999976 56999999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||+ +|++||..... .........
T Consensus 174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~--------~~~l~~i~~ 240 (367)
T 1cm8_A 174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGSDH--------LDQLKEIMK 240 (367)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHH
T ss_pred cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHH
Confidence 99875432 234678999999998877 68999999999999999999 99999974321 111111111
Q ss_pred c-cC--------------------cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 N-RG--------------------FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ~-~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. +. ......... .......++.+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCH--HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 00 000000000 0111223457889999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=332.77 Aligned_cols=254 Identities=16% Similarity=0.187 Sum_probs=200.2
Q ss_pred hccCCCCCeecccCceEEEEEEe----CCceEEEEEEccCCC----chhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL----PDRTISVVKFIDGSV----FDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVE 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~v~k~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 131 (347)
.++|...+.||+|+||.||+|.. .++..+++|++.... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999998 245555555544321 22335678899999999 6999999999999999
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCC
Confidence 999999999999999999875 67999999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceeeccccccCCccccccccc--CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYART--GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
+++..............||+.|+|||++.+ ..++.++|||||||++|||+ +|+.||..... ............
T Consensus 205 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell-~g~~pf~~~~~----~~~~~~~~~~~~ 279 (355)
T 1vzo_A 205 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL-TGASPFTVDGE----KNSQAEISRRIL 279 (355)
T ss_dssp EEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH-HSSCTTSCTTS----CCCHHHHHHHHH
T ss_pred CCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHH-HCCCCCccCCc----cchHHHHHHHHh
Confidence 998765443333345679999999998875 35789999999999999999 89999964322 111222222222
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAKQ 339 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~~ 339 (347)
... +.. ....+..+.+++.+||+.||.+|| |+.|+++.
T Consensus 280 ~~~-------~~~-----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 280 KSE-------PPY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HCC-------CCC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccC-------CCC-----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 211 011 112245678999999999999999 89998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=318.35 Aligned_cols=246 Identities=18% Similarity=0.229 Sum_probs=200.4
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...+.||+|+||.||+|.. .++..+++|...... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 36788999999999999999999 455555555543221 12236788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999875 57999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.... .....|++.|+|||.+.+..++.++||||||+++|+|+ +|..||..... ......... ...
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~--------~~~~~~~~~-~~~-- 229 (284)
T 2vgo_A 165 PSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL-VGMPPFDSPSH--------TETHRRIVN-VDL-- 229 (284)
T ss_dssp SSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHH-HSSCTTCCSSH--------HHHHHHHHT-TCC--
T ss_pred cccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHH-HCCCCCCCCCH--------hHHHHHHhc-ccc--
Confidence 4322 23457899999999999999999999999999999999 89999964321 111222211 110
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... ...+..+.+++.+||+.||.+|||+.++++
T Consensus 230 ----~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 ----KFP-----PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----CCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCC-----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 010 112446789999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=329.03 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=195.6
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCCc-hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSVF-DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
.++|...+.||+|+||.||+|.. . +..+++|++...... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 35688889999999999999999 4 445555555443332 23456789999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++....
T Consensus 104 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 999998898887653 57999999999999999999999 9999999999999999999999999999997654
Q ss_pred CCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH----------H
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV----------K 286 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------~ 286 (347)
.... ......||+.|+|||.+.+. .++.++||||+||++|+|+ +|++||...... ....... .
T Consensus 176 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 176 APGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF-MGEPLFPGDSDI----DQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHH-HSSCSCCCSSHH----HHHHHHHHHHCSCCHHHH
T ss_pred CCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHH-hCCCCCCCCCcH----HHHHHHHHHhCCCChhhh
Confidence 4322 22345789999999988775 7899999999999999999 899999653220 0000000 0
Q ss_pred HHH-hccCcccccCCccCCch----hhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 287 KYI-ENRGFNGIVDPRIIGDE----LLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 287 ~~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..+ ..........+...... ..+..+..+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 11111111111111111 11123567899999999999999999999885
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=343.78 Aligned_cols=250 Identities=14% Similarity=0.188 Sum_probs=199.3
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|...++||+|+||.||+|.. .++..+++|.+.... ....+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 6788889999999999999999 455555555544321 123467889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||++||+|.+++... ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 265 E~~~gg~L~~~l~~~-~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNV-DEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTS-STTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHh-hcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999763 112356999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
..... ....+||+.|+|||++.+..++.++|||||||++|||+ +|++||..... ................
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyell-tG~~PF~~~~~----~~~~~~~~~~i~~~~~---- 410 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI-AARGPFRARGE----KVENKELKQRVLEQAV---- 410 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCTTC----CCCHHHHHHHHHHCCC----
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHH-hCCCCCCCCcc----chhHHHHHHHHhhccc----
Confidence 44322 23458999999999999999999999999999999999 89999975321 1111222222222110
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM 333 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~ 333 (347)
.. +...+..+.+++.+||+.||++||++
T Consensus 411 ---~~-----p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 ---TY-----PDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ---CC-----CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ---CC-----CcccCHHHHHHHHHhccCCHhHCCCC
Confidence 00 11234567899999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=326.26 Aligned_cols=264 Identities=19% Similarity=0.275 Sum_probs=202.2
Q ss_pred HhccCCCCCeecccCceEEEEEEe------CCc-eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL------PDR-TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
..++|...+.||+|+||.||+|.+ .++ .+++|.+...........+.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 346799999999999999999984 223 4555544434344455678999999999999999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC---CCceEE
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQ--SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE---RYVPKL 207 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~---~~~~kl 207 (347)
.++||||+++++|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999987421 11245899999999999999999999 999999999999999994 456999
Q ss_pred ecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 208 FNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++.|..||..... .....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~ 256 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLE 256 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHHH
Confidence 99999875433221 1123456789999999998889999999999999999999449999964321 11222
Q ss_pred HHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 287 KYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
....+.... . ....+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 257 -~~~~~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 257 -FVTSGGRMD-----P-----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -HHHTTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHhcCCCCC-----C-----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 222211110 0 11224568899999999999999999999999998864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=326.31 Aligned_cols=264 Identities=20% Similarity=0.201 Sum_probs=194.1
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC-----chhHHHHHHHHHHHHhcCCCceeeeeeeeeeC
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV-----FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV 130 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 130 (347)
+....++|...+.||+|+||.||+|.. .++..+++|.+.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 344567899999999999999999999 445555555544321 11124688999999999999999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
+..++||||+++ +|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEEcCCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEec
Confidence 999999999986 899988763 356889999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
|+++....... ......||+.|+|||.+.+. .++.++|||||||++|+|+ +|.+||..... ........
T Consensus 157 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~~~~~~~~--------~~~~~~i~ 226 (346)
T 1ua2_A 157 GLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL-LRVPFLPGDSD--------LDQLTRIF 226 (346)
T ss_dssp GGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHH
T ss_pred ccceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHH-HCCCCCCCCCH--------HHHHHHHH
Confidence 99987643322 22346789999999988654 5899999999999999999 89999864321 12222222
Q ss_pred hc-cC-----cccc---cCC----ccCC---chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 290 EN-RG-----FNGI---VDP----RIIG---DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 290 ~~-~~-----~~~~---~~~----~~~~---~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. +. +... .+. .... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 227 ETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 21 10 0000 000 0000 0011223467899999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=338.38 Aligned_cols=198 Identities=19% Similarity=0.207 Sum_probs=162.8
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCce-EEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----Cc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRT-ISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV-----EI 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~-~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 132 (347)
.++|...+.||+|+||.||+|.. .++. +|+|++.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 56899999999999999999998 4444 5555554332 233456789999999999999999999999876 56
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.|+||||+. |+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 899999997 5999999764 67999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCce---------------------eeccccccCCccccccc-ccCCCCCccchHHHHHHHHHHHhcCCCcc
Q 045067 213 SASIPEGETY---------------------IDDGVKGTSGIVAPEYA-RTGYLNEKCDVYSFGLLLLQLLSTGEDLF 268 (347)
Q Consensus 213 a~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~el~~~g~~p~ 268 (347)
++........ ......||+.|+|||++ .+..++.++||||+||++|||+ +|..||
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell-~g~~p~ 252 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL-NMLQSH 252 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH-TTCTTT
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH-hccccc
Confidence 9876543211 12457799999999975 5667999999999999999999 644444
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=315.41 Aligned_cols=252 Identities=19% Similarity=0.225 Sum_probs=194.0
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
.|....+||+|+||.||+|.. .++..+++|..........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 355556999999999999998 5555555555544444445779999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-CCceEEecCCCCccCCCCC
Q 045067 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-RYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~ 220 (347)
+++|.+++.... ....+++..+..++.|++.||.||| +.+++||||||+||+++. ++.+||+|||++.......
T Consensus 103 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 103 GGSLSALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EEEHHHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCHHHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999997631 2245678999999999999999999 999999999999999987 8999999999998765432
Q ss_pred ceeeccccccCCcccccccccC--CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 221 TYIDDGVKGTSGIVAPEYARTG--YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
. ......||+.|+|||.+.+. .++.++||||||+++|+|+ +|+.||..... ............ .
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~------~~~~~~~~~~~~-~----- 243 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA-TGKPPFYELGE------PQAAMFKVGMFK-V----- 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHH-HTSCTTGGGSS------HHHHHHHHHHHC-C-----
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHH-HCCCCccCCCc------hhHHHHhhcccc-c-----
Confidence 2 12345789999999988764 3789999999999999999 89999964321 111111111110 0
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+.+. ...+.++.+++.+||+.||++|||+.++++
T Consensus 244 ~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIP-----ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCC-----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccc-----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 122456789999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=324.69 Aligned_cols=249 Identities=18% Similarity=0.228 Sum_probs=203.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
..++|...+.||+|+||.||++.. .++..+++|+.... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 346788999999999999999999 55666666655432 23345778999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 119 v~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 99999999999999875 67999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
...... ......||+.|+|||++.+..++.++||||||+++|+|+ +|+.||..... .......... ..
T Consensus 191 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~--------~~~~~~~~~~-~~- 258 (335)
T 2owb_A 191 VEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL-VGKPPFETSCL--------KETYLRIKKN-EY- 258 (335)
T ss_dssp CCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHH-HSSCTTCCSSH--------HHHHHHHHHT-CC-
T ss_pred cccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHH-HCcCCCCCCCH--------HHHHHHHhcC-CC-
Confidence 653322 223467999999999999989999999999999999999 89999964321 1111222111 11
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+. ......+.+++.+||+.||++|||+.|+++
T Consensus 259 -----~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -----SIP-----KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----CCC-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CCC-----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 112345789999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=332.10 Aligned_cols=268 Identities=16% Similarity=0.168 Sum_probs=200.3
Q ss_pred HHHHHHhccCCCCCeecccCceEEEEEEe-CCce-EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC--
Q 045067 55 KELERATNNYHYRNIITESSIFRLCQGVL-PDRT-ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV-- 130 (347)
Q Consensus 55 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~-~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 130 (347)
.++....++|...+.||+|+||.||+|.. .++. +|+|++.........+.+.+|+.++.+++||||+++++++...
T Consensus 20 g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 20 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp -CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred cEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 34444567899999999999999999998 4444 5555554444444457789999999999999999999998765
Q ss_pred ---CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEE
Q 045067 131 ---EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207 (347)
Q Consensus 131 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl 207 (347)
...++||||+.+ +|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||
T Consensus 100 ~~~~~~~iv~e~~~~-~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl 169 (364)
T 3qyz_A 100 EQMKDVYIVQDLMET-DLYKLLKT------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKI 169 (364)
T ss_dssp TTCCCEEEEEECCSE-EHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred cccceEEEEEcccCc-CHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEE
Confidence 368999999984 99999976 56999999999999999999999 999999999999999999999999
Q ss_pred ecCCCCccCCCCCcee--eccccccCCcccccccc-cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH
Q 045067 208 FNFSLSASIPEGETYI--DDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 284 (347)
+|||++.......... .....||+.|+|||++. +..++.++||||+||++|+|+ +|++||..... ......
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~-----~~~~~~ 243 (364)
T 3qyz_A 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHY-----LDQLNH 243 (364)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHH-HSSCSSCCSSG-----GGHHHH
T ss_pred EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHH-HCCCCCCCCCh-----HHHHHH
Confidence 9999998765332211 23457999999999765 456899999999999999999 89999975332 111111
Q ss_pred HHHHHhccCc---------------ccccC-CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 285 VKKYIENRGF---------------NGIVD-PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 285 ~~~~~~~~~~---------------~~~~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.......... ..... ............+.++.+++.+||+.||++|||+.|+++
T Consensus 244 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 244 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111100000 00000 000000111123457889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=343.42 Aligned_cols=251 Identities=22% Similarity=0.248 Sum_probs=201.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
..+.|...+.||+|+||.||+|.. .++..+++|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 456789999999999999999999 45544555544322 12345779999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE---CCCCceEEecCCC
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSL 212 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~ 212 (347)
||||+.+|+|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999999764 67999999999999999999999 9999999999999999 4678999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
+........ .....||+.|+|||++.+ .++.++||||+||++|+|+ +|.+||..... ..........
T Consensus 176 a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll-~g~~pf~~~~~--------~~~~~~i~~~- 242 (484)
T 3nyv_A 176 STHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILL-SGCPPFNGANE--------YDILKKVEKG- 242 (484)
T ss_dssp HHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHC-
T ss_pred eEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHH-HCCCCCCCCCH--------HHHHHHHHcC-
Confidence 987654332 234579999999998876 6899999999999999999 99999964321 2222222222
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.... . .......++.+.+++.+||+.+|++|||+.|+++
T Consensus 243 ~~~~----~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 243 KYTF----E---LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCC----C---SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC----C---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1110 0 0111233567889999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=326.29 Aligned_cols=264 Identities=17% Similarity=0.154 Sum_probs=191.5
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
.-....++|...+.||+|+||+||+|.. .++..+++|.+.... ....+.+.+|+.++++++||||+++++++.+++.
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 3345667899999999999999999998 555656666554332 2223567899999999999999999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC-----CCCceEE
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS-----ERYVPKL 207 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~-----~~~~~kl 207 (347)
.++||||+++ +|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred EEEEEecCCC-CHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEE
Confidence 9999999985 999999875 56999999999999999999999 99999999999999994 5556999
Q ss_pred ecCCCCccCCCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 208 FNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
+|||++........ ......||+.|+|||++.+. .++.++|||||||++|+|+ +|.+||..... .....
T Consensus 179 ~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~--------~~~~~ 248 (329)
T 3gbz_A 179 GDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSE--------IDQLF 248 (329)
T ss_dssp CCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHH
T ss_pred CcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHH-HCCCCcCCCCH--------HHHHH
Confidence 99999976543322 22345689999999988764 5899999999999999999 89999964321 11122
Q ss_pred HHHhc-cCcccc-------------cCCccCCch----hhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 287 KYIEN-RGFNGI-------------VDPRIIGDE----LLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 287 ~~~~~-~~~~~~-------------~~~~~~~~~----~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... +..... ..+...... .......++.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 249 KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 22111 000000 000000000 01112457889999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=318.12 Aligned_cols=259 Identities=22% Similarity=0.307 Sum_probs=196.9
Q ss_pred hccCCCCCeecccCceEEEEEEe--CCce--EEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL--PDRT--ISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~--~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
.++|...+.||+|+||+||+|.+ .++. .+++|..... .....+.+.+|+.++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 45788999999999999999986 2322 3555555432 2344577899999999999999999999988755 8
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
++|+||+++++|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccc
Confidence 9999999999999999763 256999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCcee--eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 214 ASIPEGETYI--DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 214 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++.|+.||..... ..........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~ 240 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKE 240 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTS
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHHcc
Confidence 8775443321 23356788999999999888999999999999999999339999964321 2222222222
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
.... . .....+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 241 ~~~~-------~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 GERL-------P---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCC-------C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCC-------C---CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1110 0 011234568899999999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=326.43 Aligned_cols=262 Identities=18% Similarity=0.223 Sum_probs=196.8
Q ss_pred cccCHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeee
Q 045067 50 RSFSAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCC 127 (347)
Q Consensus 50 ~~~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 127 (347)
..++..++....+.|...+.||+|+||.||+|.+ .++..+++|+...... ..+.+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 3455556666788899999999999999999999 4555555555544332 337789999999999 799999999999
Q ss_pred ee------CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC
Q 045067 128 LE------VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE 201 (347)
Q Consensus 128 ~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~ 201 (347)
.. ....++||||+++|+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||+++.
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~ 164 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTE 164 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECT
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcC
Confidence 87 46789999999999999999863 2356899999999999999999999 999999999999999999
Q ss_pred CCceEEecCCCCccCCCCCceeeccccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCC
Q 045067 202 RYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG 276 (347)
Q Consensus 202 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~ 276 (347)
++.+||+|||++........ ......||+.|+|||.+. +..++.++|||||||++|+|+ +|..||.....
T Consensus 165 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~--- 239 (326)
T 2x7f_A 165 NAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA-EGAPPLCDMHP--- 239 (326)
T ss_dssp TCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHH-HSSCTTTTSCH---
T ss_pred CCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHH-hCCCCCCCCcH---
Confidence 99999999999876543221 123457899999999886 567899999999999999999 89999864321
Q ss_pred CCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 277 DESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.......... ........ ..+..+.+++.+||+.||.+|||+.++++
T Consensus 240 -----~~~~~~~~~~-~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 240 -----MRALFLIPRN-PAPRLKSK---------KWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -----HHHHHHHHHS-CCCCCSCS---------CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHhhcC-ccccCCcc---------ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111111 11111111 12346789999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=327.22 Aligned_cols=261 Identities=19% Similarity=0.265 Sum_probs=186.1
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeee------
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCL------ 128 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~------ 128 (347)
+.....+|...+.||+|+||.||+|.+ .++..+++|.+........+.+.+|+.++.++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 334456789999999999999999998 444444444443334444577899999999996 999999999984
Q ss_pred --eCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEECCCCc
Q 045067 129 --EVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP--IVFRDLKSSYILVSERYV 204 (347)
Q Consensus 129 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~dlkp~Nill~~~~~ 204 (347)
.....++||||+. |+|.+++.... ....+++..+..++.|++.||.||| +.+ |+||||||+|||++.++.
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCC
Confidence 3345799999997 69999987531 2356999999999999999999999 888 999999999999999999
Q ss_pred eEEecCCCCccCCCCCcee-----------eccccccCCccccccc---ccCCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 205 PKLFNFSLSASIPEGETYI-----------DDGVKGTSGIVAPEYA---RTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
+||+|||++.......... .....||+.|+|||++ .+..++.++|||||||++|+|+ +|..||..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~-~g~~p~~~ 255 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC-FRQHPFED 255 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHH-HSSCCC--
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHH-hCCCCCcc
Confidence 9999999998765432211 1135689999999988 5667899999999999999999 99999964
Q ss_pred CccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 271 GLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.... . .... ... ...+ ...+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 256 ~~~~--------~----~~~~-~~~-~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 256 GAKL--------R----IVNG-KYS-IPPH--------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -----------------------CC-CCTT--------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHH--------H----hhcC-ccc-CCcc--------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3210 0 0000 000 0000 01123467899999999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=337.56 Aligned_cols=254 Identities=19% Similarity=0.202 Sum_probs=189.2
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--------chhHHHHHHHHHHHHhcCCCceeeeeeeee
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--------FDAYDCCFNNIVFASQMSHNNVLRLIGCCL 128 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 128 (347)
....++|...+.||+|+||+||+|.. .++..+++|++.... ......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34578899999999999999999998 444444454443211 112235889999999999999999999975
Q ss_pred eCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC---ce
Q 045067 129 EVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY---VP 205 (347)
Q Consensus 129 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~---~~ 205 (347)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCE
T ss_pred -cCceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceE
Confidence 45679999999999999988754 67999999999999999999999 99999999999999997544 59
Q ss_pred EEecCCCCccCCCCCceeeccccccCCccccccccc---CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH
Q 045067 206 KLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART---GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~ 282 (347)
||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|+ +|.+||..... ....
T Consensus 282 kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~----~~~~- 353 (419)
T 3i6u_A 282 KITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL-SGYPPFSEHRT----QVSL- 353 (419)
T ss_dssp EECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHH-HSSCSSCCCSS----SCCH-
T ss_pred EEeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHH-HCCCCCCCCcc----hHHH-
Confidence 999999998765332 2345679999999998753 57789999999999999999 89999964322 1111
Q ss_pred HHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 283 DFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
......+... ..+......+..+.+++.+||+.||++|||+.|+++
T Consensus 354 ---~~~i~~~~~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 354 ---KDQITSGKYN-------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ---HHHHHTTCCC-------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHhcCCCC-------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1111111110 001111223567889999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=320.69 Aligned_cols=255 Identities=19% Similarity=0.226 Sum_probs=199.0
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE--VEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 135 (347)
.++|...+.||+|+||.||+|.. .++..+++|..... .....+.+.+|+.++++++||||+++++++.+ +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 56788999999999999999999 45555555554432 23345678999999999999999999998854 567899
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eEeccCCCCCeEECCCCceEEecC
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP-----IVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~-----ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
||||+++++|.+++.... .....+++..+..++.|++.||.||| +.+ ++||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 999999999999997641 12345999999999999999999999 777 999999999999999999999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
|++........ ......||+.|+|||.+.+..++.++||||||+++|+|+ +|..||..... .... ....
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~--------~~~~-~~i~ 229 (279)
T 2w5a_A 161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC-ALMPPFTAFSQ--------KELA-GKIR 229 (279)
T ss_dssp CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHH-HHHH
T ss_pred chheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHH-HCCCCCcccCH--------HHHH-HHHh
Confidence 99877654322 123456899999999999889999999999999999999 89999964321 1222 2222
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQI 340 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L 340 (347)
.+....+ . ...+.++.+++.+||+.||++|||+.|+++.+
T Consensus 230 ~~~~~~~-----~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 230 EGKFRRI-----P-----YRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HTCCCCC-----C-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred hcccccC-----C-----cccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 2221111 0 12245688999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=327.49 Aligned_cols=253 Identities=15% Similarity=0.194 Sum_probs=196.8
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
..+.|+..+.||+|+||.||+|.. .++..+++|..........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 456788999999999999999999 5566666666655544555789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++++|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp CCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred eCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999998763 256999999999999999999999 99999999999999999999999999998753221
Q ss_pred CCceeeccccccCCccccccc-----ccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 219 GETYIDDGVKGTSGIVAPEYA-----RTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
.. .......||+.|+|||.+ .+..++.++||||||+++|+|+ +|..||..... ............
T Consensus 170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~--------~~~~~~~~~~~~ 239 (302)
T 2j7t_A 170 TL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNP--------MRVLLKIAKSDP 239 (302)
T ss_dssp HH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHH-HSSCTTTTSCH--------HHHHHHHHHSCC
T ss_pred cc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHh-cCCCCCccCCH--------HHHHHHHhccCC
Confidence 10 111235689999999987 3667899999999999999999 99999864321 122222222211
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... . .....+..+.+++.+||+.||++|||+.++++
T Consensus 240 -~~~-----~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 -PTL-----L---TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CCC-----S---SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -ccc-----C---CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111 0 11122456889999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=315.48 Aligned_cols=247 Identities=19% Similarity=0.197 Sum_probs=193.9
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 135 (347)
..++|...+.||+|+||+||+|.. .++..+++|..... .......+.+|+..+..+ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 456799999999999999999999 34554555544432 233446788999999999 89999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC-------------
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER------------- 202 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~------------- 202 (347)
||||+++++|.+++..... ....+++..+..++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 9999999999999976411 1246899999999999999999999 9999999999999999844
Q ss_pred ------CceEEecCCCCccCCCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCC
Q 045067 203 ------YVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN 275 (347)
Q Consensus 203 ------~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~ 275 (347)
..+||+|||++....... ...||+.|+|||.+.+. .+++++|||||||++|+|+ +|.+|+....
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~~~~~~~~~~--- 235 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA-GAEPLPRNGD--- 235 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHT-TCCCCCSSSH---
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHh-cCCCCCcchh---
Confidence 479999999998765432 24589999999988766 6678999999999999999 8887764211
Q ss_pred CCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 276 GDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.... ...+... .+. ...+..+.+++.+||+.||++|||+.|+++
T Consensus 236 --------~~~~-~~~~~~~-----~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 --------QWHE-IRQGRLP-----RIP-----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --------HHHH-HHTTCCC-----CCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHHH-HHcCCCC-----CCC-----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1111 1121111 111 122456889999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=322.19 Aligned_cols=251 Identities=18% Similarity=0.211 Sum_probs=195.6
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
..+.|...+.||+|+||.||+|.. .++..+++|...... ..+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 456788999999999999999999 445555555544332 23678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++++|.+++... ...+++..+..++.+++.||.||| +.+++||||||+||+++.++.+||+|||++.....
T Consensus 105 ~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 105 YCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp CCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred cCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999742 267999999999999999999999 99999999999999999999999999999976643
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
... ......||+.|+|||.+.+..++.++||||||+++|+|+ +|..||..... .......... ..
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~--------~~~~~~~~~~-~~---- 242 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA-EGKPPYADIHP--------MRAIFMIPTN-PP---- 242 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHH-HSSCTTTTSCH--------HHHHHHHHHS-CC----
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHH-hCCCCCCCCCh--------HHHHHHHhcC-CC----
Confidence 322 223457899999999999989999999999999999999 89999964321 1111111111 11
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.... ....+..+.+++.+||+.||.+|||+.++++
T Consensus 243 -~~~~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 243 -PTFRK---PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -CCCSS---GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cccCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11111 1122456889999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=323.36 Aligned_cols=262 Identities=16% Similarity=0.184 Sum_probs=195.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV------- 130 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 130 (347)
.++|...+.||+|+||+||+|.. .++ .+|+|++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46799999999999999999999 444 455554433322 22235688999999999999999999998873
Q ss_pred -CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 131 -EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 131 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
+..++||||+++ +|.+.+... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCC-CHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 468999999985 888887653 256999999999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCc---eeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 210 FSLSASIPEGET---YIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 210 fg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
||++........ .......||+.|+|||++.+ ..++.++|||||||++|+|+ +|.+||..... .......
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~-----~~~~~~i 241 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW-TRSPIMQGNTE-----QHQLALI 241 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH-----HHHHHHH
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHH-hCCCCCCCCCh-----HHHHHHH
Confidence 999987653221 12234678999999998876 56899999999999999999 89999974321 1111111
Q ss_pred HHHHhccCcccccCCccC-------------CchhhHH------HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 286 KKYIENRGFNGIVDPRII-------------GDELLEH------KLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~-------------~~~~~~~------~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... .......+... ....... ..+.+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 242 SQLCG--SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHC--CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhC--CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11111 11000000000 0000001 1346889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=314.97 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=201.6
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---------chhHHHHHHHHHHHHhcC-CCceeeeeeee
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---------FDAYDCCFNNIVFASQMS-HNNVLRLIGCC 127 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 127 (347)
...++|...+.||+|+||.||+|.. .++..+++|.+.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 4457899999999999999999999 555555555554332 122456889999999995 99999999999
Q ss_pred eeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEE
Q 045067 128 LEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207 (347)
Q Consensus 128 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl 207 (347)
.+++..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEE
Confidence 9999999999999999999999875 67999999999999999999999 999999999999999999999999
Q ss_pred ecCCCCccCCCCCceeeccccccCCcccccccc------cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchH
Q 045067 208 FNFSLSASIPEGETYIDDGVKGTSGIVAPEYAR------TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFE 281 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~ 281 (347)
+|||++........ .....||+.|+|||++. ...++.++||||||+++|+|+ +|..||.....
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~-------- 234 (298)
T 1phk_A 166 TDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-AGSPPFWHRKQ-------- 234 (298)
T ss_dssp CCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------
T ss_pred ecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHH-HCCCCCcCccH--------
Confidence 99999987654332 23457899999999875 456889999999999999999 89999864321
Q ss_pred HHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 282 MDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.......... ... ... ......+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~-~~~-~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 235 MLMLRMIMSG-NYQ-FGS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHHT-CCC-CCT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcC-Ccc-cCc------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1222222221 111 000 111233557889999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=331.30 Aligned_cols=261 Identities=17% Similarity=0.242 Sum_probs=192.4
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC----
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV---- 130 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 130 (347)
++...++|...+.||+|+||+||+|.. ++..+|+|++.... ....+|+.+++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345677899999999999999999998 44556666554432 2234799999999999999999998543
Q ss_pred ----------------------------------CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHH
Q 045067 131 ----------------------------------EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVF 176 (347)
Q Consensus 131 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l 176 (347)
...++||||+++ +|.+.+.... .....+++..+..++.|++.||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHH
Confidence 348899999984 8888776421 1236799999999999999999
Q ss_pred HHhhcCCCCCeEeccCCCCCeEEC-CCCceEEecCCCCccCCCCCceeeccccccCCcccccccccC-CCCCccchHHHH
Q 045067 177 AYLHIGFSRPIVFRDLKSSYILVS-ERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFG 254 (347)
Q Consensus 177 ~~lH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G 254 (347)
.||| +.+|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+|
T Consensus 155 ~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 155 GFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 9999 99999999999999998 688999999999987654332 2345789999999988764 589999999999
Q ss_pred HHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh-------------ccCcccccCCccCCch----hhHHHHHHHHH
Q 045067 255 LLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE-------------NRGFNGIVDPRIIGDE----LLEHKLQSSFE 317 (347)
Q Consensus 255 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 317 (347)
|++|+|+ +|++||..... .+....... .....+..-+...... .....+.++.+
T Consensus 230 ~il~ell-~g~~pf~~~~~--------~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (383)
T 3eb0_A 230 CVFGELI-LGKPLFSGETS--------IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300 (383)
T ss_dssp HHHHHHH-HSSCSSCCSSH--------HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred HHHHHHH-hCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence 9999999 89999975322 111111111 0011111111111110 11123456889
Q ss_pred HHHHhccCCCCCCCCHHHHHH
Q 045067 318 LAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 318 l~~~cl~~~P~~RPs~~ell~ 338 (347)
++.+||+.||++|||+.|+++
T Consensus 301 li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 301 LLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHccCChhhCCCHHHHhc
Confidence 999999999999999999984
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=333.86 Aligned_cols=263 Identities=16% Similarity=0.179 Sum_probs=204.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCC-CceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSH-NNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 138 (347)
.++|...+.||+|+||.||+|.+ .++..+++|+...... .+.+.+|+.++..++| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46799999999999999999998 5555555555443322 1458899999999976 566667777778889999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE---CCCCceEEecCCCCcc
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV---SERYVPKLFNFSLSAS 215 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~a~~ 215 (347)
|+ +++|.+++... ...+++..++.++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 84 ~~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CC-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 99 78999999752 267999999999999999999999 9999999999999999 6889999999999987
Q ss_pred CCCCCce------eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 216 IPEGETY------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 216 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
....... ......||+.|+|||.+.+..++.++|||||||++|||+ +|+.||..... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ell-tG~~Pf~~~~~-----~~~~~~~~~i~ 229 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKA-----GTKKQKYEKIS 229 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTSSCCC-----SSHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHH-hCCCCCccccc-----hhHHHHHHHHh
Confidence 6543321 122567999999999999999999999999999999999 89999975322 11111111111
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
... ..... .......+.++.+++.+||+.+|++||++.+|++.|+++...
T Consensus 230 ~~~-~~~~~------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 230 EKK-VATSI------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHH-HHSCH------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hcc-ccccH------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 110 00000 011112245788999999999999999999999999998653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=351.07 Aligned_cols=249 Identities=16% Similarity=0.227 Sum_probs=201.9
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 134 (347)
..++|...++||+|+||.||+|.. .++..+++|++... .....+.+.+|..++..+ +||||+.+++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 456899999999999999999999 55555555554432 122346788999999988 7999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
|||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 419 lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999875 67999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
....... .....+||+.|+|||++.+..++.++|||||||++|||+ +|++||..... ........... .
T Consensus 491 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyell-tG~~Pf~~~~~--------~~~~~~i~~~~-~ 559 (674)
T 3pfq_A 491 ENIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML-AGQAPFEGEDE--------DELFQSIMEHN-V 559 (674)
T ss_dssp ECCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHSSC-C
T ss_pred ccccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHH-cCCCCCCCCCH--------HHHHHHHHhCC-C
Confidence 6443322 234578999999999999999999999999999999999 89999964321 22233332211 1
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM-----IDVAK 338 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~-----~ell~ 338 (347)
. .+...+.++.+|+.+||+.||++||++ .||++
T Consensus 560 ------~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ------A-----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------C-----CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------C-----CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 0 011234568899999999999999997 56553
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=326.75 Aligned_cols=267 Identities=15% Similarity=0.174 Sum_probs=195.6
Q ss_pred CHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCc----------hhHHHHHHHHHHHHhcCCCcee
Q 045067 53 SAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF----------DAYDCCFNNIVFASQMSHNNVL 121 (347)
Q Consensus 53 ~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv 121 (347)
...++....++|...+.||+|+||.||+|.. ++..+|+|++...... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4568888999999999999999999999998 5555666655432221 1236789999999999999999
Q ss_pred eeeeeeeeC-----CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 045067 122 RLIGCCLEV-----EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSY 196 (347)
Q Consensus 122 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~N 196 (347)
++++++... ...++||||++ |+|.+.+... ...+++..+..++.|++.||.||| +.+|+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~N 164 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGN 164 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHH
Confidence 999998543 35799999998 5888888753 357999999999999999999999 9999999999999
Q ss_pred eEECCCCceEEecCCCCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCC
Q 045067 197 ILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN 275 (347)
Q Consensus 197 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~ 275 (347)
|+++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++||||+||++|+|+ +|+.||.....
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~-- 239 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFRGSTF-- 239 (362)
T ss_dssp EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH--
T ss_pred EEEcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH-hCCCCCCCCCH--
Confidence 9999999999999999975443322 234578999999998876 67899999999999999999 89999965321
Q ss_pred CCCchHHHHHHHHHhc---cC---------------cccccCCcc--CCchhhHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 045067 276 GDESFEMDFVKKYIEN---RG---------------FNGIVDPRI--IGDELLEHKLQSSFELAFQCQSASAEDRPTMID 335 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~---~~---------------~~~~~~~~~--~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~e 335 (347)
.......... .. ......... ......+...+.+.+++.+||+.||++|||+.|
T Consensus 240 ------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 313 (362)
T 3pg1_A 240 ------YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313 (362)
T ss_dssp ------HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ------HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 1111111110 00 000000000 000111122456889999999999999999999
Q ss_pred HHH
Q 045067 336 VAK 338 (347)
Q Consensus 336 ll~ 338 (347)
+++
T Consensus 314 ll~ 316 (362)
T 3pg1_A 314 ALR 316 (362)
T ss_dssp HHT
T ss_pred HHc
Confidence 986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=332.65 Aligned_cols=199 Identities=20% Similarity=0.191 Sum_probs=170.1
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc------CCCceeeeeeeeeeCCc
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM------SHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~ 132 (347)
....|...+.||+|+||+||+|.. .++..+++|++.... ...+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 345688899999999999999998 556666666665432 3336678899988887 57799999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc--eEEecC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV--PKLFNF 210 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~--~kl~Df 210 (347)
.++||||+. ++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++. +||+||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN---KFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred EEEEEeccC-CCHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999997 5999999864 2345999999999999999999999 899999999999999999887 999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccC
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMG 271 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~ 271 (347)
|++...... .....||+.|+|||++.+..++.++|||||||++|||+ +|.+||...
T Consensus 247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-tG~~pf~~~ 302 (429)
T 3kvw_A 247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL-TGYPLLPGE 302 (429)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHH-HSSCSSCCS
T ss_pred ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHH-hCCCCCCCC
Confidence 999765432 23457899999999999999999999999999999999 899999653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=316.32 Aligned_cols=253 Identities=16% Similarity=0.196 Sum_probs=184.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHH-HHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYD-CCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~-~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
.++|+..+.||+|+||+||+|.. .++..+++|..... ...... .+..+...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 56789999999999999999999 45555555544432 322223 3444555578889999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR-PIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
||+++ +|.+++.... .....+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||++...
T Consensus 86 e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCSE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhcc-chHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99985 8888876421 12367999999999999999999999 87 9999999999999999999999999999766
Q ss_pred CCCCceeeccccccCCccccccc----ccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYA----RTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
..... .....||+.|+|||.+ .+..++.++||||+||++|+|+ +|+.||..... ............
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~~-------~~~~~~~~~~~~ 230 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA-ILRFPYDSWGT-------PFQQLKQVVEEP 230 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHH-HTSCSSCCCSC-------HHHHHHHHHHSC
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHH-HCCCCccccCc-------hHHHHHHHhccC
Confidence 44322 2334799999999985 5667899999999999999999 99999964211 222222322221
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. .... ...+.++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~------~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 SP------QLPA----DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CC------CCCT----TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC------Cccc----ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11 1111 122456889999999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=320.31 Aligned_cols=256 Identities=16% Similarity=0.215 Sum_probs=195.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeee--CCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLE--VEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 137 (347)
++|+..+.||+|+||+||+|.. .++..+++|++.... .+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6788999999999999999998 555556666555432 367899999999997 9999999999987 56789999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-ceEEecCCCCccC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLFNFSLSASI 216 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~ 216 (347)
||+++++|.+++. .+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||++...
T Consensus 113 e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp ECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 9999999999884 4889999999999999999999 99999999999999999776 8999999999876
Q ss_pred CCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHH--------HHH
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF--------VKK 287 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------~~~ 287 (347)
..... .....||+.|+|||.+.+ ..++.++|||||||++|+|+ +|..||..... ........ ...
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~p~~~~~~---~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI-FRKEPFFHGHD---NYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-HTCSSSSCCSS---HHHHHHHHHHHHCHHHHHH
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHH-hCCCCcccCCc---hHHHHHHHHHhcCCchhhh
Confidence 54332 234578999999998876 67899999999999999999 89988853221 00000000 000
Q ss_pred HHhccCc--------------ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 288 YIENRGF--------------NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 288 ~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
....... ..... ...........+.++.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWE-RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGG-GGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhccccccchhhhhhhccccchh-hhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 00000 00011111224567899999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=320.48 Aligned_cols=260 Identities=19% Similarity=0.185 Sum_probs=199.5
Q ss_pred HHHHHHHhccCCCC-CeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 045067 54 AKELERATNNYHYR-NIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQM-SHNNVLRLIGCCL 128 (347)
Q Consensus 54 ~~e~~~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 128 (347)
+...+...+.|... +.||+|+||.||+|.. .++..+++|++... .......+.+|+.++..+ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33445566677776 8899999999999999 44555555544432 223346789999999999 5799999999999
Q ss_pred eCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC---CCce
Q 045067 129 EVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE---RYVP 205 (347)
Q Consensus 129 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~---~~~~ 205 (347)
+.+..++||||+++|+|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE---LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC---C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcE
Confidence 999999999999999999998643 3367999999999999999999999 999999999999999997 7899
Q ss_pred EEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 206 KLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|+ +|..||..... ....
T Consensus 174 kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~--------~~~~ 242 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL-THTSPFVGEDN--------QETY 242 (327)
T ss_dssp EECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHH
T ss_pred EEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCc--------hHHH
Confidence 9999999987654322 23457999999999999999999999999999999999 89999964321 1111
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...... ... .. .......+..+.+++.+||+.||++|||+.++++
T Consensus 243 ~~i~~~-~~~-~~------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 243 LNISQV-NVD-YS------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHHT-CCC-CC------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHhc-ccc-cC------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111111 100 00 0111123456889999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=313.82 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=190.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.++|...+.||+|+||.||+|.. .++..+++|...... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 35788899999999999999998 344444555443221 22346788999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999875 57999999999999999999999 999999999999999999999999999999776
Q ss_pred CCCCceeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
..... .....+|+.|+|||.+.+..+ +.++||||||+++|+|+ +|..||..... ...... ...+...
T Consensus 162 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~--------~~~~~~-~~~~~~~ 229 (276)
T 2h6d_A 162 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL-CGTLPFDDEHV--------PTLFKK-IRGGVFY 229 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHH-HHHCCCC
T ss_pred CCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHH-hCCCCCCCCcH--------HHHHHH-hhcCccc
Confidence 54322 234568999999999887765 68999999999999999 89999964221 112222 2221110
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
. + ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 230 --~-~--------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 --I-P--------EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --C-C--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --C-c--------hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 0 1123457899999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=329.32 Aligned_cols=263 Identities=16% Similarity=0.164 Sum_probs=198.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC--------CCceeeeeeeee---
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS--------HNNVLRLIGCCL--- 128 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 128 (347)
.++|...+.||+|+||+||+|.. .++..+++|++... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47799999999999999999998 56666666666543 234477899999999985 788999999987
Q ss_pred -eCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCCeEECCCC---
Q 045067 129 -EVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR-PIVFRDLKSSYILVSERY--- 203 (347)
Q Consensus 129 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~dlkp~Nill~~~~--- 203 (347)
+....++||||+. ++|.+.+... ....+++..+..++.|++.||.||| ++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 115 VNGTHICMVFEVLG-HHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp TTEEEEEEEECCCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHH
T ss_pred CCCceEEEEEeccC-ccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhh
Confidence 4568999999995 5777776553 2356999999999999999999999 87 999999999999999775
Q ss_pred ----------------------------------------------ceEEecCCCCccCCCCCceeeccccccCCccccc
Q 045067 204 ----------------------------------------------VPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPE 237 (347)
Q Consensus 204 ----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE 237 (347)
.+||+|||++...... .....||+.|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence 7999999999776432 23357899999999
Q ss_pred ccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh---c--------cCc-ccccCC-----
Q 045067 238 YARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE---N--------RGF-NGIVDP----- 300 (347)
Q Consensus 238 ~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~--------~~~-~~~~~~----- 300 (347)
++.+..++.++|||||||++|+|+ +|+.||...... .............. . +.. ...+..
T Consensus 264 ~~~~~~~~~~~DiwslG~il~ell-tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELA-TGDYLFEPHSGE--EYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHH-HSSCSCCCCCCS--SSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHh-hCCCCCCCCccc--ccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 999999999999999999999999 899999754321 11111111111111 0 000 000000
Q ss_pred -----ccC--------CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 301 -----RII--------GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 301 -----~~~--------~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 00112455678999999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=322.58 Aligned_cols=256 Identities=19% Similarity=0.198 Sum_probs=188.3
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE------ 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 131 (347)
.++|...+.||+|+||.||+|.. .++ .+|+|++.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46789999999999999999998 444 45555544332 2334467889999999999999999999987654
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCCC-CHHHHHh-------hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEee
Confidence 67999999985 8888885 35899999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh-
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE- 290 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 290 (347)
+++...... ......||+.|+|||++.+..++.++||||+||++|+|+ +|+.||..... .........
T Consensus 173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~--------~~~~~~i~~~ 241 (371)
T 2xrw_A 173 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFPGTDH--------IDQWNKVIEQ 241 (371)
T ss_dssp C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHC-
T ss_pred ccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHHH
Confidence 997654322 223467999999999999999999999999999999999 89999965321 111111111
Q ss_pred ---------------------ccC-cc-----cccCCcc-C-CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 ---------------------NRG-FN-----GIVDPRI-I-GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ---------------------~~~-~~-----~~~~~~~-~-~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... .. ....... . ..........++.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000 00 0000000 0 01112234668899999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=324.10 Aligned_cols=267 Identities=21% Similarity=0.269 Sum_probs=183.7
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
....++|...+.||+|+||.||+|.. .++..+++|.... ......+.+.+|+.++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 44567899999999999999999998 4444555554443 223345678899999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 136 VFESAEYGNLHDLLKRSYQ---SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
||||+++++|.+++..... .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999874211 12356899999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCc----eeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 213 SASIPEGET----YIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 213 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
+........ .......||+.|+|||.+.+ ..++.++||||||+++|+|+ +|+.||..... . .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~-----~---~~~~~ 238 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA-TGAAPYHKYPP-----M---KVLML 238 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH-HSSCTTTTSCG-----G---GHHHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH-hCCCCCccCch-----h---hHHHH
Confidence 876643321 11234578999999998865 56899999999999999999 89999965322 0 11111
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... ... ..............+..+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 239 TLQND-PPS-LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHTSS-CCC-TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhccC-CCc-cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11111 000 00000000111122456889999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=318.80 Aligned_cols=253 Identities=19% Similarity=0.199 Sum_probs=194.4
Q ss_pred HHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--------chhHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--------FDAYDCCFNNIVFASQMSHNNVLRLIGCCLE 129 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 129 (347)
...++|...+.||+|+||.||+|.. .++..+++|.+.... ......+.+|+.++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 3456799999999999999999998 555555555544321 1223458899999999999999999999876
Q ss_pred CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc---eE
Q 045067 130 VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV---PK 206 (347)
Q Consensus 130 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~---~k 206 (347)
+. .++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEE
Confidence 54 89999999999999999764 67999999999999999999999 999999999999999987664 99
Q ss_pred EecCCCCccCCCCCceeeccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 207 LFNFSLSASIPEGETYIDDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 207 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
|+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|+ +|..||..... ......
T Consensus 158 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~----~~~~~~ 230 (322)
T 2ycf_A 158 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL-SGYPPFSEHRT----QVSLKD 230 (322)
T ss_dssp ECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH-HSSCSSCSTTC----SSCHHH
T ss_pred EccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH-hCCCCCcccch----HHHHHH
Confidence 99999998764332 123456899999999864 567899999999999999999 99999964322 111111
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
....+... ..+......+..+.+++.+||+.||++|||+.++++
T Consensus 231 ----~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 ----QITSGKYN-------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ----HHHHTCCC-------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHHhCccc-------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11111110 001111223557889999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=329.02 Aligned_cols=257 Identities=19% Similarity=0.212 Sum_probs=193.7
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------cc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE------IP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 133 (347)
..+|...+.||+|+||+||+|.. .++.+++||+...... ..+|+.+++.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 35688999999999999999999 6777888888765432 237999999999999999999986544 37
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC-CCCceEEecCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS-ERYVPKLFNFSL 212 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~ 212 (347)
++||||+++ ++.+.+... ......+++..+..++.|++.||+||| +.+|+||||||+|||++ .++.+||+|||+
T Consensus 114 ~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 114 NLVLEYVPE-TVYRASRHY-AKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEECCSE-EHHHHHHHH-HHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEeeccCc-cHHHHHHHH-HhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 899999987 554444321 112367999999999999999999999 99999999999999999 799999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh-
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE- 290 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 290 (347)
++....... .....||+.|+|||++.+. .++.++||||+||++|||+ +|++||..... ........+
T Consensus 189 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~--------~~~l~~i~~~ 257 (394)
T 4e7w_A 189 AKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM-QGQPLFPGESG--------IDQLVEIIKV 257 (394)
T ss_dssp CEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHH
T ss_pred cccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHHH
Confidence 987654332 2346789999999988764 6899999999999999999 99999975321 111111111
Q ss_pred ------------ccCcccccCCccCCch----hhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 ------------NRGFNGIVDPRIIGDE----LLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ------------~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........-+...... .....++++.+|+.+||+.||++|||+.|+++
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000001111100 11123457899999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=319.28 Aligned_cols=263 Identities=17% Similarity=0.182 Sum_probs=195.6
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----Cc
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV-----EI 132 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 132 (347)
..++|...+.||+|+||.||+|.+ .++..+++|.+. .........+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 356789999999999999999999 445545555444 33344456788999999999999999999988764 67
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.++||||+. |+|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 899999998 599999976 57999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCce---------eeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH
Q 045067 213 SASIPEGETY---------IDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282 (347)
Q Consensus 213 a~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~ 282 (347)
+......... ......||+.|+|||++.+ ..++.++|||||||++|+|+ +|.+||..... ....
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~-----~~~~ 232 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFPGRDY-----RHQL 232 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHH-HSSCSCCCSSH-----HHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHH-hCCCCCCCCCc-----HHHH
Confidence 9876532211 1123468999999997654 78899999999999999999 99999975321 0000
Q ss_pred HHHHHHHhccCccccc-----------------CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 283 DFVKKYIENRGFNGIV-----------------DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 283 ~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
................ .+........+..+..+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111000000000 0000000111233557889999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=324.23 Aligned_cols=255 Identities=20% Similarity=0.244 Sum_probs=178.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCc-eEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC------C
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDR-TISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV------E 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 131 (347)
.++|...+.||+|+||.||+|.. .++ .+|+|++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999998 444 45555443322 233456788999999999999999999998754 5
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
..++|+|++ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 679999999 5799999865 57999999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
+++..... .....||+.|+|||++.+ ..++.++||||+||++|||+ +|++||..... .........
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~--------~~~l~~i~~ 244 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDH--------IDQLKLILR 244 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHHHHHH
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHH
Confidence 99765432 234679999999998876 68899999999999999999 89999965321 111111111
Q ss_pred c-cC-ccccc---------------C--CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 N-RG-FNGIV---------------D--PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ~-~~-~~~~~---------------~--~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. +. ..+.. . +............+.+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0 00 00000 0 000000011122456889999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=312.55 Aligned_cols=252 Identities=16% Similarity=0.178 Sum_probs=194.5
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC----chhHHHHHHHHHHHHhcCCCceeeeeeeee--eCCc
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV----FDAYDCCFNNIVFASQMSHNNVLRLIGCCL--EVEI 132 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 132 (347)
..++|...+.||+|+||.||+|.. .++..+++|+..... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 457899999999999999999999 555555555554321 233467999999999999999999999984 4568
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.++||||++++ |.+++... ....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS---TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhC---cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999975 87877653 3367999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCC-ceeeccccccCCcccccccccCC--CCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 213 SASIPEGE-TYIDDGVKGTSGIVAPEYARTGY--LNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 213 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
+....... ........||+.|+|||++.+.. ++.++||||||+++|+|+ +|..||.... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~-~g~~p~~~~~--------~~~~~~~i~ 226 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNIT-TGLYPFEGDN--------IYKLFENIG 226 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHH-HSSCSCCCSS--------HHHHHHHHH
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHH-hCCCCCCCch--------HHHHHHHHh
Confidence 98765322 22234567999999999887643 478999999999999999 8999996422 112222222
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
.+.. ... ...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 227 -~~~~------~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 227 -KGSY------AIP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -HCCC------CCC-----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -cCCC------CCC-----CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 011 1123467899999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=313.87 Aligned_cols=252 Identities=19% Similarity=0.293 Sum_probs=188.2
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee---------
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE--------- 129 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 129 (347)
..++|+..+.||+|+||.||+|.. .++..+++|..... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 456789999999999999999998 45555555544432 2344778999999999999999999998865
Q ss_pred ----CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 130 ----VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 130 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
....++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+++||||||+||+++.++.+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~ 155 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNV 155 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCE
Confidence 35689999999999999999763 256888999999999999999999 9999999999999999999999
Q ss_pred EEecCCCCccCCCCC-------------ceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccC
Q 045067 206 KLFNFSLSASIPEGE-------------TYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMG 271 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~ 271 (347)
||+|||++....... ........||+.|+|||.+.+. .++.++|||||||++|+|+ + ||...
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~---p~~~~ 231 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI-Y---PFSTG 231 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHH-S---CCSSH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHH-h---ccCCc
Confidence 999999997764321 1112345689999999988764 7899999999999999999 5 44211
Q ss_pred ccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 272 LRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
......... ...... ...+. .....+..+.+++.+||+.||.+|||+.++++
T Consensus 232 -------~~~~~~~~~-~~~~~~--~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 -------MERVNILKK-LRSVSI--EFPPD-----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -------HHHHHHHHH-HHSTTC--CCCTT-----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------hhHHHHHHh-cccccc--ccCcc-----ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 001111111 111110 01111 11223456789999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=320.68 Aligned_cols=266 Identities=17% Similarity=0.188 Sum_probs=200.7
Q ss_pred CHHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC
Q 045067 53 SAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE 131 (347)
Q Consensus 53 ~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 131 (347)
...++....++|...+.||+|+||.||+|...+ .+++|++.... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 334455557889999999999999999999854 45555544322 2223356789999999999999999999999999
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
..++||||+++++|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||+++ ++.+||+|||
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCS
T ss_pred ceEEEeecccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecC
Confidence 999999999999999999763 246899999999999999999999 99999999999999998 6899999999
Q ss_pred CCccCCCCCc----eeeccccccCCccccccccc---------CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCC
Q 045067 212 LSASIPEGET----YIDDGVKGTSGIVAPEYART---------GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278 (347)
Q Consensus 212 ~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~ 278 (347)
++........ .......||+.|+|||.+.+ ..++.++||||||+++|+|+ +|+.||.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~-~g~~p~~~~~~----- 248 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH-AREWPFKTQPA----- 248 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH-HSSCSSSSCCH-----
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH-----
Confidence 9876532111 11233568999999998864 45789999999999999999 89999964321
Q ss_pred chHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
...... ...+........ ..+.++.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 249 ---~~~~~~-~~~~~~~~~~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 249 ---EAIIWQ-MGTGMKPNLSQI---------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ---HHHHHH-HHTTCCCCCCCS---------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ---HHHHHH-hccCCCCCCCcC---------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111111 222211111111 1123577999999999999999999999999987653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=316.62 Aligned_cols=267 Identities=17% Similarity=0.196 Sum_probs=202.1
Q ss_pred hccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCc------eeeeeeeeeeCCc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNN------VLRLIGCCLEVEI 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 132 (347)
.++|...+.||+|+||.||+|.. .++..+++|+..... ...+.+.+|+.+++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45788999999999999999987 356666666665432 33477889999999987665 9999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-----------
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE----------- 201 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~----------- 201 (347)
.++||||+ +++|.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred EEEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 99999999 78999999764 2246899999999999999999999 999999999999999987
Q ss_pred --------CCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCcc
Q 045067 202 --------RYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLR 273 (347)
Q Consensus 202 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~ 273 (347)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||+ +|..||.....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~ 239 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY-LGFTVFPTHDS 239 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHH-HSSCSCCCSCH
T ss_pred ccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCh
Confidence 6789999999997654322 3457899999999999989999999999999999999 99999964321
Q ss_pred CCCCCchHHHHHHHHHhcc--------Ccccc---------------------cCCccCCchhhHHHHHHHHHHHHHhcc
Q 045067 274 LNGDESFEMDFVKKYIENR--------GFNGI---------------------VDPRIIGDELLEHKLQSSFELAFQCQS 324 (347)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~--------~~~~~---------------------~~~~~~~~~~~~~~~~~~~~l~~~cl~ 324 (347)
.............. ..... ..+...........++.+.+++.+||+
T Consensus 240 -----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 240 -----KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp -----HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred -----HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 11111111111000 00000 000000001112346678999999999
Q ss_pred CCCCCCCCHHHHHHH--HHHHHH
Q 045067 325 ASAEDRPTMIDVAKQ--IKKMYK 345 (347)
Q Consensus 325 ~~P~~RPs~~ell~~--L~~i~~ 345 (347)
.||++|||+.|+++. ++++.+
T Consensus 315 ~dP~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 315 YDPAKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp SSTTTSCCHHHHTTSGGGGGGGC
T ss_pred cCcccccCHHHHhcCHHHHHHhc
Confidence 999999999999853 554443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=317.58 Aligned_cols=259 Identities=18% Similarity=0.205 Sum_probs=189.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeee-----------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCL----------- 128 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 128 (347)
.++|...+.||+|+||.||+|.. .++..+++|.+........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 46788899999999999999999 445555555555545555678999999999999999999998873
Q ss_pred ---eCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC-CCCc
Q 045067 129 ---EVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS-ERYV 204 (347)
Q Consensus 129 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~-~~~~ 204 (347)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++ .++.
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCe
Confidence 3467899999998 599999965 57999999999999999999999 99999999999999997 5679
Q ss_pred eEEecCCCCccCCCCCc--eeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchH
Q 045067 205 PKLFNFSLSASIPEGET--YIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFE 281 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~ 281 (347)
+||+|||++........ .......+|+.|+|||.+.+ ..++.++|||||||++|+|+ +|+.||.....
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~-------- 230 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKTLFAGAHE-------- 230 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH-HSSCSSCCSSH--------
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH-hCCCCCCCCCH--------
Confidence 99999999987643221 11234567999999997765 68899999999999999999 89999974321
Q ss_pred HHHHHHHHhccCc-------------c-----cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 282 MDFVKKYIENRGF-------------N-----GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 282 ~~~~~~~~~~~~~-------------~-----~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
............. . ....+...........+.++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111111111000 0 0000000000111223567889999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=327.01 Aligned_cols=256 Identities=19% Similarity=0.225 Sum_probs=190.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC------Ccc
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV------EIP 133 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 133 (347)
..|...+.||+|+||.||+|.+ . +..+|+|++.... ....+|+.++++++||||+++++++... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 4688899999999999999999 4 4556666654432 2234799999999999999999988542 236
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC-CceEEecCCC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-YVPKLFNFSL 212 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~ 212 (347)
++||||+++ +|.+.+... ......+++..+..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 129 ~lv~e~~~~-~l~~~~~~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEECCCE-EHHHHHHHH-HHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred Eeehhcccc-cHHHHHHHH-hhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 799999986 777766532 112367999999999999999999999 9999999999999999965 5789999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh-
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE- 290 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 290 (347)
++....... .....||+.|+|||++.+. .++.++|||||||++|||+ +|++||..... ...+....+
T Consensus 204 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~G~~pf~~~~~--------~~~l~~i~~~ 272 (420)
T 1j1b_A 204 AKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSG--------VDQLVEIIKV 272 (420)
T ss_dssp CEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHH
T ss_pred hhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHHH
Confidence 987654332 2346789999999988764 7899999999999999999 89999975321 111111111
Q ss_pred ------------ccCcccccCCccCCch----hhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 ------------NRGFNGIVDPRIIGDE----LLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ------------~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...+.+...+.+.... .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 273 lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 1111111111111110 01122457899999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=323.94 Aligned_cols=260 Identities=17% Similarity=0.250 Sum_probs=199.3
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCc----------------hhHHHHHHHHHHHHhcCCCceeeee
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVF----------------DAYDCCFNNIVFASQMSHNNVLRLI 124 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~----------------~~~~~~~~E~~~l~~l~h~niv~l~ 124 (347)
.++|...+.||+|+||.||+|..++..+++|.+...... ...+.+.+|+.++++++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 467999999999999999999995555555554332111 0117799999999999999999999
Q ss_pred eeeeeCCccEEEEEeCCCCCHHHH------HhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEeccCCCCCe
Q 045067 125 GCCLEVEIPVLVFESAEYGNLHDL------LKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFS-RPIVFRDLKSSYI 197 (347)
Q Consensus 125 ~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~-~~ivH~dlkp~Ni 197 (347)
+++.+++..++||||+++|+|.++ +... ....+++..+..++.|++.||.||| + .+++||||||+||
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNI 183 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhE
Confidence 999999999999999999999998 5431 2467999999999999999999999 7 9999999999999
Q ss_pred EECCCCceEEecCCCCccCCCCCceeeccccccCCcccccccccC-CCCC-ccchHHHHHHHHHHHhcCCCccccCccCC
Q 045067 198 LVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTG-YLNE-KCDVYSFGLLLLQLLSTGEDLFNMGLRLN 275 (347)
Q Consensus 198 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~G~~l~el~~~g~~p~~~~~~~~ 275 (347)
+++.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++|||||||++|+|+ +|..||.....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~-- 257 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF-YNVVPFSLKIS-- 257 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH-HSSCSSCCSSC--
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH-hCCCCCCCCCc--
Confidence 9999999999999999775433 23456799999999998877 6666 999999999999999 89999974322
Q ss_pred CCCchHHHHHHHHHhccCcccccC------CccC--CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 276 GDESFEMDFVKKYIENRGFNGIVD------PRII--GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~--~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........ ..+...-..+ +... ........+..+.+++.+||+.||.+|||+.|+++
T Consensus 258 -----~~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 258 -----LVELFNNI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -----SHHHHHHH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHHH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11222222 1111110000 0000 00001223457889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=327.10 Aligned_cols=254 Identities=7% Similarity=-0.045 Sum_probs=176.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhc--CCCceeeee-------eee
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQM--SHNNVLRLI-------GCC 127 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 127 (347)
..+|...+.||+|+||+||+|.+ .++..+++|.+.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45688899999999999999998 455555555444432 23345677885555444 699988754 343
Q ss_pred eeC-----------------CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCC
Q 045067 128 LEV-----------------EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR------LKIAMEIANVFAYLHIGFS 184 (347)
Q Consensus 128 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~lH~~~~ 184 (347)
... ...++||||++ |+|.+++.... ..+++..+ ..++.|++.||+||| +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~ 212 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQ---S 212 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHH---H
Confidence 332 33799999999 79999998641 33455555 677899999999999 9
Q ss_pred CCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeeccccccCCccccccccc--CCCCCccchHHHHHHHHHHHh
Q 045067 185 RPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART--GYLNEKCDVYSFGLLLLQLLS 262 (347)
Q Consensus 185 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~~ 262 (347)
.+|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell- 287 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW- 287 (371)
T ss_dssp TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH-
T ss_pred CCCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH-
Confidence 99999999999999999999999999999866432 113457799999999987 68999999999999999999
Q ss_pred cCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 263 TGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 263 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+|+.||.......... +............... ......++.+.+++.+||+.||++|||+.++++
T Consensus 288 tg~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGS----------WKRPSLRVPGTDSLAF-GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HSSCSTTBCCTTCTTC----------CCBCCTTSCCCCSCCC-TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hCCCCCCCcCcccccc----------hhhhhhhhccccccch-hhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 8999997653211000 0000000000001000 011133567889999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=309.26 Aligned_cols=253 Identities=21% Similarity=0.255 Sum_probs=199.7
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
....++|...+.||+|+||.||+|.. .++..+++|+.... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 45567899999999999999999999 44544455544322 1234477899999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC---CceEEecCC
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER---YVPKLFNFS 211 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~---~~~kl~Dfg 211 (347)
+|+||+++++|.+.+... ..+++..+..++.|++.||.||| +.+++||||||+||+++.+ +.+||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999998765 57999999999999999999999 9999999999999999754 479999999
Q ss_pred CCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
++........ .....+|+.|+|||.+.+. ++.++||||||+++|+|+ +|..||..... .........
T Consensus 170 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~-~g~~p~~~~~~--------~~~~~~~~~- 236 (287)
T 2wei_A 170 LSTCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILL-SGTPPFYGKNE--------YDILKRVET- 236 (287)
T ss_dssp GGGTBCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHH-
T ss_pred cceeecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHc-
Confidence 9876654322 2334689999999988764 899999999999999999 89999864321 122222222
Q ss_pred cCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.... + . ......+..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~--~--~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 237 GKYAF--D--L---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCC--C--S---GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCC--C--c---hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 21110 0 0 011123456889999999999999999999997
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=326.04 Aligned_cols=271 Identities=20% Similarity=0.204 Sum_probs=179.9
Q ss_pred hccCCC-CCeecccCceEEEEEEeC---CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccE
Q 045067 61 TNNYHY-RNIITESSIFRLCQGVLP---DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE--VEIPV 134 (347)
Q Consensus 61 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 134 (347)
.+.|.. .++||+|+||+||+|.+. ++..+++|.+.... ....+.+|+.++++++||||+++++++.. +...+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 344554 458999999999999972 34445555544332 22568899999999999999999999964 66899
Q ss_pred EEEEeCCCCCHHHHHhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE----CCCCceE
Q 045067 135 LVFESAEYGNLHDLLKRSYQ----SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV----SERYVPK 206 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill----~~~~~~k 206 (347)
+||||+.+ +|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999985 88888764211 11235999999999999999999999 9999999999999999 7789999
Q ss_pred EecCCCCccCCCCCc--eeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCC-CCCchHH
Q 045067 207 LFNFSLSASIPEGET--YIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN-GDESFEM 282 (347)
Q Consensus 207 l~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~-~~~~~~~ 282 (347)
|+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|+ +|++||....... .......
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHH-HSSCTTCCCC------CCCCH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHH-hCCCCCCCccccccccccchH
Confidence 999999987653321 12234679999999998877 46899999999999999999 9999996543210 0111111
Q ss_pred HHHHHHHhccCcc--cccC-----------------CccCCchhhH-------HHHHHHHHHHHHhccCCCCCCCCHHHH
Q 045067 283 DFVKKYIENRGFN--GIVD-----------------PRIIGDELLE-------HKLQSSFELAFQCQSASAEDRPTMIDV 336 (347)
Q Consensus 283 ~~~~~~~~~~~~~--~~~~-----------------~~~~~~~~~~-------~~~~~~~~l~~~cl~~~P~~RPs~~el 336 (347)
..+.......... ..+. .......... .....+.+|+.+||+.||++|||+.|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 2222222110000 0000 0000000000 003467899999999999999999999
Q ss_pred HH
Q 045067 337 AK 338 (347)
Q Consensus 337 l~ 338 (347)
++
T Consensus 332 L~ 333 (405)
T 3rgf_A 332 MQ 333 (405)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=317.30 Aligned_cols=257 Identities=16% Similarity=0.176 Sum_probs=175.8
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCce-EEEEEEccCCCchhHHHHHHHHH-HHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRT-ISVVKFIDGSVFDAYDCCFNNIV-FASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~-~~v~k~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
.++|...+.||+|+||.||+|.. .++. +++|++...........+.+|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 46788999999999999999999 4455 44444444333334455666666 667789999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR-PIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
||+++ +|.+++..........+++..+..++.+++.||.||| +. +|+||||||+||+++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 8888876432223467999999999999999999999 87 9999999999999999999999999999776
Q ss_pred CCCCceeeccccccCCccccccc----ccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYA----RTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
..... .....||+.|+|||.+ .+..++.++|||||||++|+|+ +|+.||...... .. ....
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~-------~~----~~~~- 241 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA-TGRFPYPKWNSV-------FD----QLTQ- 241 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHH-HSCCCSSCC------------------CC-
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHH-HCCCCCCCcchH-------HH----HHHH-
Confidence 44322 2234689999999988 4567899999999999999999 899999643210 00 0000
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
......+.+.. ......+..+.+++.+||+.||++|||+.++++
T Consensus 242 -~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 242 -VVKGDPPQLSN-SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCSCCCCCCC-CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -HhcCCCCCCCC-cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00000011110 001123456889999999999999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=317.67 Aligned_cols=255 Identities=18% Similarity=0.224 Sum_probs=191.4
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc---
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP--- 133 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 133 (347)
..++|...+.||+|+||.||+|.. .++..+++|.+... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 356788999999999999999998 44544444444432 223356788999999999999999999999877655
Q ss_pred ---EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecC
Q 045067 134 ---VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 134 ---~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
++||||+. ++|.+.+. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEec
Confidence 99999998 58988874 35999999999999999999999 999999999999999999999999999
Q ss_pred CCCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|+ +|+.||..... ........
T Consensus 189 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~-~g~~pf~~~~~--------~~~~~~i~ 255 (371)
T 4exu_A 189 GLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKTLFKGKDY--------LDQLTQIL 255 (371)
T ss_dssp TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHHHHH
T ss_pred CcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHH-hCCCCCCCCCh--------HHHHHHHH
Confidence 999765432 234678999999998877 68899999999999999999 89999964321 11111111
Q ss_pred hcc-Cc-ccc----------------cC-CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 290 ENR-GF-NGI----------------VD-PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 290 ~~~-~~-~~~----------------~~-~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... .. .+. .. +........+..++.+.+|+.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 256 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 100 00 000 00 000000011123567899999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=316.29 Aligned_cols=203 Identities=21% Similarity=0.261 Sum_probs=169.9
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CC-----ceeeeeeeeeeC
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HN-----NVLRLIGCCLEV 130 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 130 (347)
....++|...+.||+|+||+||+|.. .++..+++|++.... ...+.+.+|+.+++.++ |+ +++++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 44567899999999999999999998 556666666665432 33466788999998885 44 499999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC--CCCceEEe
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS--ERYVPKLF 208 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~--~~~~~kl~ 208 (347)
+..++||||++ |+|.+++... ....+++..+..++.|++.||.|||+. +.+|+||||||+|||++ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT---NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhc---CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999997 5999999864 224689999999999999999999932 36899999999999995 57889999
Q ss_pred cCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccC
Q 045067 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMG 271 (347)
Q Consensus 209 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~ 271 (347)
|||+++...... ....||+.|+|||++.+..++.++|||||||++|||+ +|++||...
T Consensus 204 DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-tg~~pf~~~ 261 (382)
T 2vx3_A 204 DFGSSCQLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH-TGEPLFSGA 261 (382)
T ss_dssp CCTTCEETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSSCCS
T ss_pred eccCceeccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHH-hCCCCCCCC
Confidence 999998764322 3467899999999999999999999999999999999 899999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=314.57 Aligned_cols=260 Identities=15% Similarity=0.168 Sum_probs=197.0
Q ss_pred hccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCc------eeeeeeeeeeCCc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNN------VLRLIGCCLEVEI 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 132 (347)
.++|...+.||+|+||+||+|.. .++..+++|+..... ...+.+.+|+.++++++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 46799999999999999999998 344666777665443 33467889999999998766 8999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE-------------
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV------------- 199 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill------------- 199 (347)
.++||||+. ++|.+.+... ....+++..+..++.|++.||.||| +.+|+||||||+|||+
T Consensus 97 ~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 97 MCIAFELLG-KNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEECCC-CBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred EEEEEeccC-CChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccc
Confidence 999999995 6777777653 2346999999999999999999999 9999999999999999
Q ss_pred ------CCCCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCcc
Q 045067 200 ------SERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLR 273 (347)
Q Consensus 200 ------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~ 273 (347)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||+ +|..||.....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~ 244 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY-RGFTLFQTHEN 244 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH
T ss_pred cccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH-hCCCCCCCCCH
Confidence 567899999999997654322 3457999999999999999999999999999999999 89999964321
Q ss_pred CCCCCchHHHHHHHHHhc--------cCcccc-cCCcc--------------------CCchhhHHHHHHHHHHHHHhcc
Q 045067 274 LNGDESFEMDFVKKYIEN--------RGFNGI-VDPRI--------------------IGDELLEHKLQSSFELAFQCQS 324 (347)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~--------~~~~~~-~~~~~--------------------~~~~~~~~~~~~~~~l~~~cl~ 324 (347)
............. ...... ..... ...........++.+++.+||+
T Consensus 245 -----~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 245 -----REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp -----HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred -----HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 0011111111100 000000 00000 0000112335578899999999
Q ss_pred CCCCCCCCHHHHHH
Q 045067 325 ASAEDRPTMIDVAK 338 (347)
Q Consensus 325 ~~P~~RPs~~ell~ 338 (347)
.||++|||+.|+++
T Consensus 320 ~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 320 FDPAQRITLAEALL 333 (355)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=313.12 Aligned_cols=262 Identities=18% Similarity=0.216 Sum_probs=197.3
Q ss_pred HHhccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCCC--chhHHHHHHHHHHHHhc---CCCceeeeeeeee---
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQM---SHNNVLRLIGCCL--- 128 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 128 (347)
...++|...+.||+|+||.||+|.. .++..+++|...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999998 455555555443221 11224577888888776 8999999999987
Q ss_pred --eCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceE
Q 045067 129 --EVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPK 206 (347)
Q Consensus 129 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~k 206 (347)
.....++||||+. |+|.+++... ....+++..+..++.|++.||.||| +.||+||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEE
Confidence 4567899999998 5999999764 2345999999999999999999999 99999999999999999999999
Q ss_pred EecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHH
Q 045067 207 LFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVK 286 (347)
Q Consensus 207 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 286 (347)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|+ +|++||..... .....
T Consensus 161 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~--------~~~~~ 229 (326)
T 1blx_A 161 LADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSD--------VDQLG 229 (326)
T ss_dssp ECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHH
T ss_pred EecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHH-cCCCCCCCCCH--------HHHHH
Confidence 99999997654322 223467899999999999889999999999999999999 99999964321 11122
Q ss_pred HHHhcc------Ccccc-------cCCc--cCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 287 KYIENR------GFNGI-------VDPR--IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 287 ~~~~~~------~~~~~-------~~~~--~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...... .+... +... ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 230 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 221110 00000 0000 0000111233557889999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=321.00 Aligned_cols=263 Identities=16% Similarity=0.168 Sum_probs=195.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-----------CCceeeeeeeee
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-----------HNNVLRLIGCCL 128 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 128 (347)
.++|...+.||+|+||+||+|.. .++..+++|+..... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35788999999999999999998 556666666665433 23467889999999886 899999999988
Q ss_pred eCC----ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCCeEEC---
Q 045067 129 EVE----IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR-PIVFRDLKSSYILVS--- 200 (347)
Q Consensus 129 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~dlkp~Nill~--- 200 (347)
..+ ..++||||+ +++|.+++... ....+++..+..++.|++.||.||| +. +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY---EHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh---hccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccC
Confidence 654 789999999 78999999864 2356999999999999999999999 87 999999999999994
Q ss_pred ---CCCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCC
Q 045067 201 ---ERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD 277 (347)
Q Consensus 201 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~ 277 (347)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+ +|+.||........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~~~~- 243 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI-TGDFLFEPDEGHSY- 243 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHH-HSSCCC---------
T ss_pred CCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHH-hCCCCCCCCccccc-
Confidence 4458999999999776432 22357899999999999999999999999999999999 89999975432111
Q ss_pred CchHHHHHHHHHh-ccCc---------------------ccccCCccC--------CchhhHHHHHHHHHHHHHhccCCC
Q 045067 278 ESFEMDFVKKYIE-NRGF---------------------NGIVDPRII--------GDELLEHKLQSSFELAFQCQSASA 327 (347)
Q Consensus 278 ~~~~~~~~~~~~~-~~~~---------------------~~~~~~~~~--------~~~~~~~~~~~~~~l~~~cl~~~P 327 (347)
............ .+.. ..+...... ........+.++.+|+.+||+.||
T Consensus 244 -~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 244 -TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred -CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 001111111111 0000 000000000 001223556789999999999999
Q ss_pred CCCCCHHHHHH
Q 045067 328 EDRPTMIDVAK 338 (347)
Q Consensus 328 ~~RPs~~ell~ 338 (347)
++|||+.|+++
T Consensus 323 ~~Rpt~~ell~ 333 (373)
T 1q8y_A 323 RKRADAGGLVN 333 (373)
T ss_dssp TTCBCHHHHHT
T ss_pred cccCCHHHHhh
Confidence 99999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=309.33 Aligned_cols=260 Identities=17% Similarity=0.247 Sum_probs=194.4
Q ss_pred cCHHHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCC--CchhHHHHHHHHHHHHhcC--CCceeeeeeee
Q 045067 52 FSAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMS--HNNVLRLIGCC 127 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~ 127 (347)
+.+..+....++|...+.||+|+||.||+|...++..+++|..... .....+.+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 4444555566789999999999999999999954554555544332 2334577899999999997 59999999999
Q ss_pred eeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEE
Q 045067 128 LEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207 (347)
Q Consensus 128 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl 207 (347)
.+++..++||| +.+++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++ ++.+||
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~kL 167 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKL 167 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeEEE
Confidence 99999999999 5567999999874 67899999999999999999999 99999999999999996 489999
Q ss_pred ecCCCCccCCCCCce-eeccccccCCccccccccc-----------CCCCCccchHHHHHHHHHHHhcCCCccccCccCC
Q 045067 208 FNFSLSASIPEGETY-IDDGVKGTSGIVAPEYART-----------GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN 275 (347)
Q Consensus 208 ~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~ 275 (347)
+|||++......... ......||+.|+|||.+.+ ..++.++||||||+++|+|+ +|..||.....
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~-- 244 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT-YGKTPFQQIIN-- 244 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHH-HSSCTTTTCCS--
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHH-hCCCchhhHHH--
Confidence 999999876543321 1234578999999998865 47888999999999999999 99999964321
Q ss_pred CCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 276 GDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
............... ... ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 245 -----~~~~~~~~~~~~~~~-----~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 -----QISKLHAIIDPNHEI-----EFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -----HHHHHHHHHCTTSCC-----CCC-----CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HHHHHHHHHhccccc-----CCc-----ccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111222222111100 000 0113467899999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=315.62 Aligned_cols=268 Identities=13% Similarity=0.147 Sum_probs=186.8
Q ss_pred HHHHHHhccCCCCCeecccCceEEEEEEe-C-CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc
Q 045067 55 KELERATNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI 132 (347)
Q Consensus 55 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 132 (347)
.+.....++|...+.||+|+||+||+|.. . +..+|+|++..... ......+++..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 45677788999999999999999999998 4 44555555543322 22556788888999999999999999876443
Q ss_pred -------cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-CCc
Q 045067 133 -------PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-RYV 204 (347)
Q Consensus 133 -------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-~~~ 204 (347)
.++||||+++ +|.+.+... ......+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNY-YRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHH-HTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHH-hhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCc
Confidence 7899999986 666555432 11336789999999999999999999943 578999999999999996 899
Q ss_pred eEEecCCCCccCCCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 205 PKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|+ +|++||..... ..
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell-~g~~pf~~~~~--------~~ 239 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM-LGEPIFRGDNS--------AG 239 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHH-hCCCCcCCCCh--------HH
Confidence 99999999987654332 2345789999999988654 5899999999999999999 89999975321 11
Q ss_pred HHHHHHhc---------------cCcccccCC-ccCCc----hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 284 FVKKYIEN---------------RGFNGIVDP-RIIGD----ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 284 ~~~~~~~~---------------~~~~~~~~~-~~~~~----~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........ .......+. ..... ......+.++.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111110 000000000 00000 000113567899999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=313.22 Aligned_cols=252 Identities=17% Similarity=0.225 Sum_probs=190.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccC-C-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc-----
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDG-S-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI----- 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 132 (347)
.++|...+.||+|+||.||+|.. .++..+++|.... . .....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46788899999999999999998 4455445554433 2 22334678999999999999999999999987654
Q ss_pred -cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 133 -PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 133 -~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
.++||||+. ++|.+++. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999998 58888774 35899999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
++...... .....+|+.|+|||.+.+ ..++.++||||+||++|+|+ +|+.||..... .........
T Consensus 172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~~--------~~~~~~i~~ 238 (353)
T 3coi_A 172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKTLFKGKDY--------LDQLTQILK 238 (353)
T ss_dssp CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHH-HSSCSSBSSCH--------HHHHHHHHH
T ss_pred cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHH
Confidence 99765432 234578999999998876 67899999999999999999 89999975321 111111111
Q ss_pred c-c--------------------CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 N-R--------------------GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ~-~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. + .......+.. .......+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF--TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT--TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccH--HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0 0000000000 0111233567889999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=315.47 Aligned_cols=252 Identities=17% Similarity=0.224 Sum_probs=169.0
Q ss_pred HhccCCCC-CeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHH-HHHhcCCCceeeeeeeeee----CCc
Q 045067 60 ATNNYHYR-NIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIV-FASQMSHNNVLRLIGCCLE----VEI 132 (347)
Q Consensus 60 ~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~----~~~ 132 (347)
..++|... ++||+|+||+||+|.. .++..+++|++... ....+|+. .++.++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 46678875 4699999999999999 45555555555432 12233333 3566799999999999876 445
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC---CCceEEec
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE---RYVPKLFN 209 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~---~~~~kl~D 209 (347)
.++||||+++|+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEEeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 89999999999999999864 2346999999999999999999999 999999999999999986 45599999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
||++....... .....||+.|+|||++.+..++.++|||||||++|+|+ +|..||........ ........
T Consensus 175 fg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~-----~~~~~~~~ 245 (336)
T 3fhr_A 175 FGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL-CGFPPFYSNTGQAI-----SPGMKRRI 245 (336)
T ss_dssp CTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHH-HSSCCC---------------------
T ss_pred cccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHH-HCCCCCCCccchhh-----hhhHHHhh
Confidence 99997654322 23457899999999998889999999999999999999 89999965332100 00000000
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... .. + .......+..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~-~~--~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 246 RLGQY-GF--P----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------CC--C----TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcccc-cc--C----chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 00 0 0011123556889999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=313.93 Aligned_cols=246 Identities=21% Similarity=0.299 Sum_probs=187.4
Q ss_pred HHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCc------hhHHHHHHHHHHHHhc----CCCceeee
Q 045067 55 KELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF------DAYDCCFNNIVFASQM----SHNNVLRL 123 (347)
Q Consensus 55 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l 123 (347)
.+.....++|...+.||+|+||.||+|.. .++..+++|.+..... .....+.+|+.++.++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 34566678899999999999999999998 5555555555543321 1224466899999998 89999999
Q ss_pred eeeeeeCCccEEEEEe-CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC-C
Q 045067 124 IGCCLEVEIPVLVFES-AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS-E 201 (347)
Q Consensus 124 ~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~-~ 201 (347)
++++.+.+..++|+|+ +.+++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++ .
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLR 175 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCC
Confidence 9999999999999999 7889999999875 57999999999999999999999 99999999999999999 8
Q ss_pred CCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCch
Q 045067 202 RYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESF 280 (347)
Q Consensus 202 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~ 280 (347)
++.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|+ +|+.||....
T Consensus 176 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~-------- 243 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV-CGDIPFERDQ-------- 243 (312)
T ss_dssp TTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH-HSSCSCCSHH--------
T ss_pred CCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH-HCCCCCCChH--------
Confidence 8999999999998765432 234568999999998876665 45899999999999999 8999986321
Q ss_pred HHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 281 EMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... .. .. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ------~~~~~-~~------~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 ------EILEA-EL------HF-----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ------HHHHT-CC------CC-----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------HHhhh-cc------CC-----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111 00 00 0122446789999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=317.57 Aligned_cols=248 Identities=20% Similarity=0.281 Sum_probs=195.2
Q ss_pred CHHHHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC-c-----hhHHHHHHHHHHHHhcC--CCceeee
Q 045067 53 SAKELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV-F-----DAYDCCFNNIVFASQMS--HNNVLRL 123 (347)
Q Consensus 53 ~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~-~-----~~~~~~~~E~~~l~~l~--h~niv~l 123 (347)
+..+.....++|...+.||+|+||.||+|.. .++..+++|.+.... . ...+.+.+|+.++++++ ||||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3345556678899999999999999999998 445544455443221 1 12245778999999996 5999999
Q ss_pred eeeeeeCCccEEEEEeCCC-CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC-C
Q 045067 124 IGCCLEVEIPVLVFESAEY-GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS-E 201 (347)
Q Consensus 124 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~-~ 201 (347)
++++.+++..++|+|++.+ ++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLN 185 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETT
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCC
Confidence 9999999999999999976 8999999875 67999999999999999999999 99999999999999999 7
Q ss_pred CCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCch
Q 045067 202 RYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESF 280 (347)
Q Consensus 202 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~ 280 (347)
++.+||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||+ +|+.||....
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~-~g~~pf~~~~-------- 253 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV-CGDIPFEHDE-------- 253 (320)
T ss_dssp TTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH-HSSCSCCSHH--------
T ss_pred CCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHH-HCCCCCCChh--------
Confidence 8999999999998765432 234569999999998876655 68899999999999999 8999985321
Q ss_pred HHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 281 EMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
....... ...+ ..+.++.+++.+||+.||++|||+.|+++
T Consensus 254 ------~~~~~~~---~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 ------EIIRGQV---FFRQ---------RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------HHHHCCC---CCSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------hhhcccc---cccc---------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111110 0111 12346789999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=323.47 Aligned_cols=249 Identities=19% Similarity=0.289 Sum_probs=184.6
Q ss_pred hccCCCCCeecccCceEE-EEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRL-CQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~V-y~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 138 (347)
..+|...++||+|+||+| |++..++..||+|++..... ..+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 356888899999999985 45555777777777754332 3367899999999 79999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-----CCceEEecCCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-----RYVPKLFNFSLS 213 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~a 213 (347)
|+. |+|.+++... ....+...+..++.|++.||.||| +.+|+||||||+|||++. ...+||+|||++
T Consensus 99 ~~~-g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 99 LCA-ATLQEYVEQK----DFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp CCS-EEHHHHHHSS----SCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred CCC-CCHHHHHHhc----CCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 997 5999999763 234455566789999999999999 999999999999999953 336789999999
Q ss_pred ccCCCCCc--eeeccccccCCcccccccc---cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 214 ASIPEGET--YIDDGVKGTSGIVAPEYAR---TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 214 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
+....... .......||+.|+|||++. ...++.++||||+||++|||++.|..||..... ......
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---------~~~~~~ 241 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---------RQANIL 241 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---------HHHHHH
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---------HHHHHH
Confidence 87654322 1234467999999999887 456788999999999999999449999954321 111111
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...... ... .........+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~-~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSL-DCL-------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCC-TTS-------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCc-ccc-------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111111 000 111233556789999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=323.27 Aligned_cols=252 Identities=23% Similarity=0.254 Sum_probs=181.3
Q ss_pred CCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeCC
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESAE 141 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 141 (347)
|...+.||+|+||+||.+.. ++..+|+|++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44567899999999976555 6666666665432 235678999999887 89999999999999999999999997
Q ss_pred CCCHHHHHhhhccCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCC-------------CceE
Q 045067 142 YGNLHDLLKRSYQSHS--EPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER-------------YVPK 206 (347)
Q Consensus 142 ~g~L~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~-------------~~~k 206 (347)
|+|.+++........ ...++..+..++.|++.||+||| +.+|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 599999976411100 00123345789999999999999 9999999999999999754 4899
Q ss_pred EecCCCCccCCCCCce---eeccccccCCccccccccc-------CCCCCccchHHHHHHHHHHHhcCCCccccCccCCC
Q 045067 207 LFNFSLSASIPEGETY---IDDGVKGTSGIVAPEYART-------GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG 276 (347)
Q Consensus 207 l~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~ 276 (347)
|+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|||+++|..||.....
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--- 245 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS--- 245 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT---
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh---
Confidence 9999999877654322 1234579999999998865 67899999999999999999449999964321
Q ss_pred CCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 277 DESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... ...... .. . +.. ........+.++.+++.+||+.||++|||+.++++
T Consensus 246 ---~~~----~i~~~~-~~-~--~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 ---RES----NIIRGI-FS-L--DEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHH----HHHHTC-CC-C--CCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hHH----HHhcCC-CC-c--ccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111 111111 00 0 000 11112345678899999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=334.28 Aligned_cols=269 Identities=16% Similarity=0.152 Sum_probs=198.1
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee------CCc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE------VEI 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 132 (347)
.++|...+.||+|+||+||+|.. .++..+++|... .......+.+.+|+.++++++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36799999999999999999998 445445555444 3344556779999999999999999999998765 677
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc---eEEec
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV---PKLFN 209 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~---~kl~D 209 (347)
.++||||+++|+|.+++... .....+++..+..++.+++.||+||| +.+|+||||||+||+++.++. +||+|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~--~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSS--SCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred EEEEEEeCCCCCHHHHHHhc--ccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 89999999999999999863 12246889999999999999999999 999999999999999997765 89999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
||++........ .....||+.|+|||.+.+..++.++||||+||++|+|+ +|..||..... ...+.....
T Consensus 168 FG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLl-tG~~Pf~~~~~-------~~~~~~~i~ 237 (676)
T 3qa8_A 168 LGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECI-TGFRPFLPNWQ-------PVQWHGKVR 237 (676)
T ss_dssp CCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHH-SSCSSCCSSCH-------HHHSSTTCC
T ss_pred cccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHH-HCCCCCCcccc-------hhhhhhhhh
Confidence 999987654332 23467999999999999999999999999999999999 99999964211 000000000
Q ss_pred ----hccCcccc------cCCccC-CchhhHHHHHHHHHHHHHhccCCCCCCCCHHH-----HHHHHHHHH
Q 045067 290 ----ENRGFNGI------VDPRII-GDELLEHKLQSSFELAFQCQSASAEDRPTMID-----VAKQIKKMY 344 (347)
Q Consensus 290 ----~~~~~~~~------~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~e-----ll~~L~~i~ 344 (347)
........ +..... ........+..+.+++.+||+.||++|||+.+ ..+.++++.
T Consensus 238 ~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp ------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred cccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 00000000 001111 11122345678899999999999999999988 455555554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=304.66 Aligned_cols=254 Identities=17% Similarity=0.232 Sum_probs=177.1
Q ss_pred HHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhH-HHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAY-DCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
....++|...+.||+|+||.||+|.. .++..+++|.+. ....... +.+..+..+++.++||||+++++++.+++..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 33456788899999999999999999 444444444444 3332222 33444555678889999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR-PIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
+||||+ ++.+..+.... ...+++..+..++.|++.||.||| +. +++||||||+||+++.++.+||+|||++
T Consensus 101 lv~e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp EEECCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 999999 45666665542 267999999999999999999999 85 9999999999999999999999999998
Q ss_pred ccCCCCCceeeccccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
........ .....||+.|+|||.+. +..++.++|||||||++|+|+ +|+.||..... ........
T Consensus 173 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~-------~~~~~~~~ 242 (318)
T 2dyl_A 173 GRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA-TGQFPYKNCKT-------DFEVLTKV 242 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHH-HSSCTTTTCCS-------HHHHHHHH
T ss_pred hhccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHH-hCCCCCCCCCc-------cHHHHHHH
Confidence 76544322 23456899999999884 457889999999999999999 89999964221 22222333
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... . ..... ...+..+.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~~-~-----~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 243 LQEEP-P-----LLPGH---MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHSCC-C-----CCCSS---SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred hccCC-C-----CCCcc---CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 22211 1 01100 012346789999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.63 Aligned_cols=240 Identities=20% Similarity=0.227 Sum_probs=192.4
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-CceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCc-----
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEI----- 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 132 (347)
.++|...+.||+|+||.||+|.+ . ++..+++|.+. .......+.+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 47899999999999999999998 3 45555555544 3334455678999999999999999999999987665
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.||||||+++++|.+++. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.+ .+||+|||+
T Consensus 159 ~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEeccc
Confidence 699999999999998774 36999999999999999999999 9999999999999999875 999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
++..... ....||+.|+|||++.+.. +.++|||||||++|+|+ +|.+||......
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~-~g~~~~~~~~~~------------------ 282 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALT-LDLPTRNGRYVD------------------ 282 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHH-SCCCEETTEECS------------------
T ss_pred chhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHH-hCCCCCcccccc------------------
Confidence 9876543 3357999999999887664 89999999999999999 999888642210
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-MIDVAKQIKKMY 344 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-~~ell~~L~~i~ 344 (347)
.+............+.+++.+||+.||++||+ +.++...|..+.
T Consensus 283 --------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 283 --------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00011112233457889999999999999995 777777777664
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=294.72 Aligned_cols=231 Identities=12% Similarity=0.024 Sum_probs=180.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
.+.|...+.||+|+||.||+|.. .++..+++|++.... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 35699999999999999999999 445556666655432 23346789999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||++|++|.+++.. + .....+.+++.|++.||+||| +.||+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 999999999999964 2 355678899999999999999 9999999999999999999999998543
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
|++ .++.++|||||||++|||+ +|+.||........... ...
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~ell-tg~~Pf~~~~~~~~~~~--------------~~~ 216 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALL-VNRWPLPEAGVRSGLAP--------------AER 216 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHH-HSEECSCCCSBCCCSEE--------------CCB
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHH-HCCCCCCcCCcchhhHH--------------HHH
Confidence 233 2689999999999999999 99999975433110000 000
Q ss_pred ccCCccC-CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 297 IVDPRII-GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 297 ~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
....... ........+.++.+++.+||+.||++| |+.|+++.|+++..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0000000 001112335578899999999999999 99999999998754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=292.82 Aligned_cols=231 Identities=15% Similarity=0.196 Sum_probs=176.2
Q ss_pred HhccCCCC-CeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHH-HhcCCCceeeeeeeeee----CCc
Q 045067 60 ATNNYHYR-NIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFA-SQMSHNNVLRLIGCCLE----VEI 132 (347)
Q Consensus 60 ~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~ 132 (347)
..++|... +.||+|+||.||+|.. .++..+++|.+... ..+.+|+.++ +.++||||+++++++.+ ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 34567666 7899999999999998 55555555555432 4577899988 55589999999999887 678
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC---CCceEEec
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE---RYVPKLFN 209 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~---~~~~kl~D 209 (347)
.++||||+++|+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 89999999999999999874 2346999999999999999999999 999999999999999998 78999999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
||++.... +..++.++||||+||++|+|+ +|+.||........
T Consensus 164 fg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~-tg~~pf~~~~~~~~------------- 206 (299)
T 3m2w_A 164 FGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLAI------------- 206 (299)
T ss_dssp CTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHH-HSSCSCCC-------------------
T ss_pred cccccccc-----------------------cccCCchhhHHHHHHHHHHHH-HCCCCCCCCcchhh-------------
Confidence 99885432 244678999999999999999 89999964322000
Q ss_pred hccCcccccCCccC-CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 290 ENRGFNGIVDPRII-GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 290 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.............. ........+.++.+++.+||+.||++|||+.|+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 207 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000001111110 00111233567899999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=305.41 Aligned_cols=244 Identities=15% Similarity=0.127 Sum_probs=175.2
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCC--chhHHHHHHHHHHHHhcCC-Cceee-------------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSV--FDAYDCCFNNIVFASQMSH-NNVLR------------- 122 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~--~~~~~~~~~E~~~l~~l~h-~niv~------------- 122 (347)
+.+|...++||+|+||+||+|.+ .++..+++|+.. ... ....+.+.+|+.++..++| +|...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577778999999999999998 444444444444 222 2224778999999999976 22111
Q ss_pred --------eeeeeee-----CCccEEEEEeCCCCCHHHHHhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 045067 123 --------LIGCCLE-----VEIPVLVFESAEYGNLHDLLKRSY--QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPI 187 (347)
Q Consensus 123 --------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~i 187 (347)
+..++.. ....+++|+++. ++|.++++... ......+++..+..++.|++.||+||| +.+|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 1111111 124567777765 69999985210 112356888899999999999999999 9999
Q ss_pred EeccCCCCCeEECCCCceEEecCCCCccCCCCCceeeccccccCCccccccc----------ccCCCCCccchHHHHHHH
Q 045067 188 VFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYA----------RTGYLNEKCDVYSFGLLL 257 (347)
Q Consensus 188 vH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~G~~l 257 (347)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999998765432 344567 999999988 555688999999999999
Q ss_pred HHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 045067 258 LQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVA 337 (347)
Q Consensus 258 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell 337 (347)
|||+ +|+.||....... .....+.... ..++.+.+++.+||+.||++|||+.+++
T Consensus 308 ~ell-tg~~Pf~~~~~~~-----------------~~~~~~~~~~-------~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 308 YWIW-CADLPNTDDAALG-----------------GSEWIFRSCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHH-HSSCCCCTTGGGS-----------------CSGGGGSSCC-------CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHH-HCCCCCCCcchhh-----------------hHHHHHhhcc-------cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999 8999996533210 1111111100 1235688999999999999999988876
Q ss_pred H
Q 045067 338 K 338 (347)
Q Consensus 338 ~ 338 (347)
+
T Consensus 363 ~ 363 (413)
T 3dzo_A 363 E 363 (413)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=299.88 Aligned_cols=244 Identities=12% Similarity=0.080 Sum_probs=182.6
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCC-------CchhHHHHHHHHHHHHhcC---------CCceeeee
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGS-------VFDAYDCCFNNIVFASQMS---------HNNVLRLI 124 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~-------~~~~~~~~~~E~~~l~~l~---------h~niv~l~ 124 (347)
.++|...+.||+|+||+||+|+.++..+|+|++.... .....+.+.+|+.++++++ ||||+++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4668889999999999999999976666666665432 1223467899999999886 55555555
Q ss_pred ee-----------------eee-------------CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHH
Q 045067 125 GC-----------------CLE-------------VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174 (347)
Q Consensus 125 ~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~ 174 (347)
++ +.+ .+..++||||+++|++.+.+.+ ..+++..+..++.|++.
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHH
Confidence 54 433 6789999999999987777644 56899999999999999
Q ss_pred HHHHhhcCCCCCeEeccCCCCCeEECCCC--------------------ceEEecCCCCccCCCCCceeeccccccCCcc
Q 045067 175 VFAYLHIGFSRPIVFRDLKSSYILVSERY--------------------VPKLFNFSLSASIPEGETYIDDGVKGTSGIV 234 (347)
Q Consensus 175 ~l~~lH~~~~~~ivH~dlkp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~ 234 (347)
||+|||+ +.+|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+
T Consensus 173 aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 173 SLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 9999993 47899999999999999887 8999999999865432 347999999
Q ss_pred cccccccCCCCCccchHHHHHH-HHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHH
Q 045067 235 APEYARTGYLNEKCDVYSFGLL-LLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQ 313 (347)
Q Consensus 235 aPE~~~~~~~~~~~Dv~s~G~~-l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (347)
|||++.+.. +.++||||+|++ .++++ .|..||.... +............... ...........++
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~-~g~~p~~~~~-------~~~~~~~~~~~~~~~~-----~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRW-GEYHPYSNVL-------WLHYLTDKMLKQMTFK-----TKCNTPAMKQIKR 310 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCT-TSCCTHHHHH-------HHHHHHHHHHHTCCCS-----SCCCSHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccc-cccCCCcchh-------hhhHHHHhhhhhhccC-----cccchhhhhhcCH
Confidence 999998776 899999998877 66677 8888885210 0011111222111111 1112233456778
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHH
Q 045067 314 SSFELAFQCQSASAEDRPTMIDVA 337 (347)
Q Consensus 314 ~~~~l~~~cl~~~P~~RPs~~ell 337 (347)
++.+|+.+||+.| |+.|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 9999999999976 999887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-33 Score=272.81 Aligned_cols=153 Identities=16% Similarity=0.080 Sum_probs=116.9
Q ss_pred HHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 045067 102 YDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLH 180 (347)
Q Consensus 102 ~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH 180 (347)
.+++.+|+.+|+++ .|+||+++++++.+++..||||||++|++|.++|... ++++.. +|+.||+.||+|+|
T Consensus 285 ~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH 356 (569)
T 4azs_A 285 KYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALE 356 (569)
T ss_dssp HHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHH
Confidence 46799999999999 7999999999999999999999999999999999874 567654 58899999999999
Q ss_pred cCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHH
Q 045067 181 IGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQL 260 (347)
Q Consensus 181 ~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el 260 (347)
++|||||||||+|||++.+|.+||+|||+|+....... ...+.+||+.|+|||++.+. +..++|+||+|++++++
T Consensus 357 ---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l 431 (569)
T 4azs_A 357 ---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNL 431 (569)
T ss_dssp ---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHHHHHHHC------------------CCC
T ss_pred ---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhhccHHHhCCC-CCCcccccccccchhhh
Confidence 99999999999999999999999999999987654432 23456799999999998764 56789999999998887
Q ss_pred HhcCCCcc
Q 045067 261 LSTGEDLF 268 (347)
Q Consensus 261 ~~~g~~p~ 268 (347)
. .+..++
T Consensus 432 ~-~~~~~~ 438 (569)
T 4azs_A 432 P-QPWSNW 438 (569)
T ss_dssp C-TTHHHH
T ss_pred c-cccchh
Confidence 6 444443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=248.26 Aligned_cols=185 Identities=12% Similarity=0.099 Sum_probs=146.7
Q ss_pred CCCCeecccCceEEEEEEeCCceEEEEEEccCCCch-------hHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 65 HYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFD-------AYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 65 ~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
...+.||+|+||.||+|...+..+++|+........ ..+.+.+|+.++++++||||+++..++.+.+..+|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 345689999999999998888888888876543211 1345899999999999999997767767888889999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++++|.+++.. +..++.|++.||.||| +++|+||||||+|||++. .+||+|||+++...
T Consensus 419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 99999999999853 4589999999999999 999999999999999998 99999999998875
Q ss_pred CCCcee------eccccccCCccccccccc--CCCCCccchHHHHHHHHHHHhcCCCcc
Q 045067 218 EGETYI------DDGVKGTSGIVAPEYART--GYLNEKCDVYSFGLLLLQLLSTGEDLF 268 (347)
Q Consensus 218 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~el~~~g~~p~ 268 (347)
...... .....||+.|+|||++.+ ..|+..+|+||..+-..+-+ ..+.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v-~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV-ERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH-HTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH-Hhcccc
Confidence 432211 135679999999999987 56788899999998888877 666554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=196.47 Aligned_cols=151 Identities=17% Similarity=0.055 Sum_probs=115.2
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCc------------------hhHHHHHHHHHHHHhcCCC
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVF------------------DAYDCCFNNIVFASQMSHN 118 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~------------------~~~~~~~~E~~~l~~l~h~ 118 (347)
+......|...+.||+|+||.||+|.+.++..+++|....... .....+.+|+.++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344445556699999999999999995455555555543211 13456899999999999
Q ss_pred ceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 045067 119 NVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYIL 198 (347)
Q Consensus 119 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nil 198 (347)
| +++.+++.. +..++||||++||+|.+ +.. .....++.|++.||.||| +.+|+||||||+|||
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NIL 225 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVL 225 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEE
Confidence 4 666665543 56799999999999988 422 123469999999999999 999999999999999
Q ss_pred ECCCCceEEecCCCCccCCCCCceeeccccccCCccccccccc
Q 045067 199 VSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART 241 (347)
Q Consensus 199 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 241 (347)
++ ++.+||+|||+|+. +..++|||++..
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99 99999999999853 334688887753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=164.41 Aligned_cols=137 Identities=12% Similarity=0.024 Sum_probs=101.7
Q ss_pred CCCCCeecccCceEEEEEEe-CCceE--EEEEEccCCCch------------------------hHHHHHHHHHHHHhcC
Q 045067 64 YHYRNIITESSIFRLCQGVL-PDRTI--SVVKFIDGSVFD------------------------AYDCCFNNIVFASQMS 116 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--~v~k~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 116 (347)
|...+.||+|+||.||+|.. .++.. +++|+....... ....+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56678999999999999998 44444 555544322100 1135789999999998
Q ss_pred CCce--eeeeeeeeeCCccEEEEEeCCC-C----CHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 045067 117 HNNV--LRLIGCCLEVEIPVLVFESAEY-G----NLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVF 189 (347)
Q Consensus 117 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH 189 (347)
|+++ ..++++ ...+|||||+.+ | +|.+.... .++..+..++.|++.||.|||. +.+|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~--~~givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQ--EAELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHH--TSCEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHH--HCCEEe
Confidence 8864 333332 367899999942 3 67766532 2344667899999999999994 579999
Q ss_pred ccCCCCCeEECCCCceEEecCCCCccC
Q 045067 190 RDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 190 ~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999988 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-18 Score=157.26 Aligned_cols=139 Identities=10% Similarity=0.085 Sum_probs=94.4
Q ss_pred ccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCc--------------hhHHH--------HHHHHHHHHhcCCCc
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVF--------------DAYDC--------CFNNIVFASQMSHNN 119 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~n 119 (347)
.-|...+.||+|++|.||+|...++..+++|+...... ..... ..+|...|.++.+++
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34888899999999999999995555555555432210 00011 234555666664443
Q ss_pred eeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 045067 120 VLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199 (347)
Q Consensus 120 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill 199 (347)
+.....+.. ...+|||||++|++|..+... .....++.|++.+|.+|| +.|||||||||.|||+
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILI 238 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEE
Confidence 321111111 234799999999887654321 123567899999999999 9999999999999999
Q ss_pred CCCC----------ceEEecCCCCccC
Q 045067 200 SERY----------VPKLFNFSLSASI 216 (347)
Q Consensus 200 ~~~~----------~~kl~Dfg~a~~~ 216 (347)
++++ .+.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 8776 3899999977554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.3e-13 Score=118.25 Aligned_cols=146 Identities=12% Similarity=-0.013 Sum_probs=108.7
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEE
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 135 (347)
+....+.|.....++.|+.+.||++..+++.+++|..... .......+.+|+.+++.+. +.++.++++++.+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~-~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSR-YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGG-GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcc-cCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445567877778888999999999876655555554331 1112246889999999984 6778889999988889999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF-------------------------------- 183 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-------------------------------- 183 (347)
|||+++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 88 v~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 9999999998876321 1123467888999999999510
Q ss_pred ------------------------CCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 184 ------------------------SRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 184 ------------------------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
...++|||++|.||+++++..+.|+||+.+
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 145899999999999987656679999866
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.31 E-value=4.5e-12 Score=115.34 Aligned_cols=143 Identities=13% Similarity=0.078 Sum_probs=104.3
Q ss_pred CCCeecccCceEEEEEEeCCceEEEEEEc--cCCCchhHHHHHHHHHHHHhcC--CCceeeeeeeeeeC---CccEEEEE
Q 045067 66 YRNIITESSIFRLCQGVLPDRTISVVKFI--DGSVFDAYDCCFNNIVFASQMS--HNNVLRLIGCCLEV---EIPVLVFE 138 (347)
Q Consensus 66 ~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e 138 (347)
..+.|+.|.++.||+...+++.+++++.. ..........+.+|+.+++.+. +..+.++++++.+. +..++|||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 35678999999999998876665555543 2221122356889999999996 45678888888776 34899999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF----------------------------------- 183 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~----------------------------------- 183 (347)
|++|.++.+.. -..++......++.+++..|..||+..
T Consensus 122 ~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 122 FVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp CCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred ecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99987764421 134678888899999999999999521
Q ss_pred --------------------CCCeEeccCCCCCeEECCCCc--eEEecCCCCcc
Q 045067 184 --------------------SRPIVFRDLKSSYILVSERYV--PKLFNFSLSAS 215 (347)
Q Consensus 184 --------------------~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~a~~ 215 (347)
...++|||++|.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998854
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.31 E-value=4e-12 Score=110.02 Aligned_cols=135 Identities=13% Similarity=0.032 Sum_probs=93.3
Q ss_pred cCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCc--eeeeeeeeeeCCccEEEEEeC
Q 045067 63 NYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNN--VLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~ 140 (347)
++....+.+.|..+.||++...++..+++|+.... ....+.+|+.+++.+.+.+ +.+++++..+++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34333333456669999998755554555554433 2255789999999985444 456888888777889999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF------------------------------------- 183 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~------------------------------------- 183 (347)
+|.+|. .. ... ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 98 PGQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp SSEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred CCcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 998874 21 111 1256677777788887421
Q ss_pred ------------------CCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 184 ------------------SRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 184 ------------------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
...++|||++|.||++++++.+.|+||+.+
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence 112999999999999987766679999976
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.07 E-value=1.5e-10 Score=102.66 Aligned_cols=184 Identities=16% Similarity=0.105 Sum_probs=117.3
Q ss_pred CCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCc--eeeeeeeeeeCC---ccEEEEEeC
Q 045067 67 RNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNN--VLRLIGCCLEVE---IPVLVFESA 140 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 140 (347)
.+.++.|....||+.. +.++ +|+.... .....+.+|+.+++.+. +.. +.+++.....++ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~---~~~v-lR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN---RDFI-FKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST---TSEE-EEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC---CEEE-EEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 4444 4443322 33467899999998883 333 334444443333 358999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIG-------------------------------------- 182 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~-------------------------------------- 182 (347)
+|.+|.+... ..++..+...++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 99 KGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred CCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9988875432 2466677777778888877777741
Q ss_pred -----------------CCCCeEeccCCCCCeEECC--CCceEEecCCCCccCCCCCceeeccccccCCc---ccccccc
Q 045067 183 -----------------FSRPIVFRDLKSSYILVSE--RYVPKLFNFSLSASIPEGETYIDDGVKGTSGI---VAPEYAR 240 (347)
Q Consensus 183 -----------------~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y---~aPE~~~ 240 (347)
....++|+|++|.||+++. +..+.|+||+.+...... ... .....+ .+|+...
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl----~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDF----ISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHH----HTTCCTTTSCCHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHH----HHHHhhccccCHHHHH
Confidence 1135899999999999998 456789999987553211 000 000111 1222111
Q ss_pred c-----CCC---------CCccchHHHHHHHHHHHhcCCCccc
Q 045067 241 T-----GYL---------NEKCDVYSFGLLLLQLLSTGEDLFN 269 (347)
Q Consensus 241 ~-----~~~---------~~~~Dv~s~G~~l~el~~~g~~p~~ 269 (347)
. +.. ..-.+.|+++.++|.+. +|..+|-
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~-~g~~~~~ 288 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKE-YGYMDWY 288 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHH-TTCHHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHH-cCCHHHH
Confidence 0 000 12258899999999999 8887764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=9.1e-08 Score=83.05 Aligned_cols=133 Identities=10% Similarity=-0.004 Sum_probs=92.5
Q ss_pred eecccCce-EEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 69 IITESSIF-RLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 69 ~lg~G~~g-~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
.+..|..+ .||+... .++..+++|..+.. ....+.+|...|+.+. +-.+.++++++.+++..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 6998877 45555566655432 3356889999998884 33466788888888999999999999888
Q ss_pred HHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc--------------------------------------------
Q 045067 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHI-------------------------------------------- 181 (347)
Q Consensus 146 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-------------------------------------------- 181 (347)
.+..... ......+..+++..|..||+
T Consensus 108 ~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 108 FQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred cccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 7765431 11223455566666666663
Q ss_pred -----------CCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 182 -----------GFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 182 -----------~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
.....++|||+.|.||+++.++.+-|+||+.+
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a 221 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence 00123799999999999998777779999976
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=2.5e-07 Score=81.92 Aligned_cols=136 Identities=11% Similarity=0.013 Sum_probs=88.7
Q ss_pred CCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCC---ceeeeeeeee-eCCccEEEEEeCCC
Q 045067 67 RNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHN---NVLRLIGCCL-EVEIPVLVFESAEY 142 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 142 (347)
.+.++.|....||+. ++.++++. .. .......+.+|+.+|+.+.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~-~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRF-PK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEE-ES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE---CCEEEEEe-cC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 346788888999998 45555554 32 223346789999999999642 3556666654 34567899999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIG---------------------------------------- 182 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---------------------------------------- 182 (347)
.+|.+..- ..++......++.+++..|..||+.
T Consensus 98 ~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 98 QILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp EECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 88766321 1233334444444444444444421
Q ss_pred -----------------CCCCeEeccCCCCCeEECC---CCc-eEEecCCCCcc
Q 045067 183 -----------------FSRPIVFRDLKSSYILVSE---RYV-PKLFNFSLSAS 215 (347)
Q Consensus 183 -----------------~~~~ivH~dlkp~Nill~~---~~~-~kl~Dfg~a~~ 215 (347)
....++|+|+.|.||+++. ++. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1446799999999999987 455 48999997743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=3.3e-07 Score=82.89 Aligned_cols=79 Identities=6% Similarity=-0.178 Sum_probs=52.5
Q ss_pred Cee-cccCceEEEEEEeC-------CceEEEEEEccCCC---chhHHHHHHHHHHHHhcC-C--CceeeeeeeeeeC---
Q 045067 68 NII-TESSIFRLCQGVLP-------DRTISVVKFIDGSV---FDAYDCCFNNIVFASQMS-H--NNVLRLIGCCLEV--- 130 (347)
Q Consensus 68 ~~l-g~G~~g~Vy~~~~~-------~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--- 130 (347)
+.| +.|..+.+|+.... ++.-+|+|+..... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999988764 14456666654432 101245788999998884 3 2466777776654
Q ss_pred CccEEEEEeCCCCCHH
Q 045067 131 EIPVLVFESAEYGNLH 146 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~ 146 (347)
+..++|||+++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999986553
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=2.4e-05 Score=69.92 Aligned_cols=30 Identities=13% Similarity=0.148 Sum_probs=27.5
Q ss_pred CCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 184 SRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 184 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
...++|||+.+.||+++.++.+.|+||+.+
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 578999999999999988889999999966
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=9.7e-06 Score=74.33 Aligned_cols=75 Identities=13% Similarity=0.013 Sum_probs=46.8
Q ss_pred CCeecccCceEEEEEEe--CCceEEEEEEccCCC------chhHHHHHHHHHHHHhcCC--Cc-eeeeeeeeeeCCccEE
Q 045067 67 RNIITESSIFRLCQGVL--PDRTISVVKFIDGSV------FDAYDCCFNNIVFASQMSH--NN-VLRLIGCCLEVEIPVL 135 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~~------~~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 135 (347)
.+.||.|..+.||++.. +++.+++|...+... ....+++..|..+++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 45789999999999976 334555544332111 1123557789999988732 33 4455543 4556789
Q ss_pred EEEeCCCC
Q 045067 136 VFESAEYG 143 (347)
Q Consensus 136 v~e~~~~g 143 (347)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.99 E-value=3.9e-05 Score=66.97 Aligned_cols=78 Identities=14% Similarity=-0.017 Sum_probs=51.7
Q ss_pred CCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-C-C-ceeeeeeeeeeCCccEEEEEeC
Q 045067 64 YHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-H-N-NVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 64 ~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h-~-niv~l~~~~~~~~~~~lv~e~~ 140 (347)
....+.+|.|..+.||+.+..++..+++|..+.........+.+|+..|+.|. . + .+.+++++ + .-++|||++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEee
Confidence 34456789999999999999655555556554433333356789999998884 2 1 23444443 2 347899998
Q ss_pred CCCCH
Q 045067 141 EYGNL 145 (347)
Q Consensus 141 ~~g~L 145 (347)
.++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.95 E-value=6.8e-05 Score=69.24 Aligned_cols=76 Identities=13% Similarity=0.062 Sum_probs=45.2
Q ss_pred CCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCceeeccc-cccCCcccccccccC---CCCCccchHHHHHHHHH
Q 045067 184 SRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGV-KGTSGIVAPEYARTG---YLNEKCDVYSFGLLLLQ 259 (347)
Q Consensus 184 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~e 259 (347)
...++|||++|.||+++.++ +.++||+.+......... .... .-...|++|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 78899999999999998776 999999987553211000 0000 011245566544311 11223455577777777
Q ss_pred HH
Q 045067 260 LL 261 (347)
Q Consensus 260 l~ 261 (347)
.+
T Consensus 309 ~y 310 (420)
T 2pyw_A 309 LF 310 (420)
T ss_dssp HH
T ss_pred HH
Confidence 66
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.93 E-value=7.4e-05 Score=66.01 Aligned_cols=75 Identities=12% Similarity=-0.015 Sum_probs=57.0
Q ss_pred CCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcC---CCceeeeeeeeeeCCccEEEEEeCCCC
Q 045067 67 RNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS---HNNVLRLIGCCLEVEIPVLVFESAEYG 143 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 143 (347)
.+.|+.|....+|+...+++.+++ |+.... ....+.+|...|+.|. ...+.+++++....+..++|||++++.
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vl-K~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFV-KINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEE-EEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEE-EeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 456899999999999876666655 444332 2366889999998884 356778888887778899999999987
Q ss_pred CH
Q 045067 144 NL 145 (347)
Q Consensus 144 ~L 145 (347)
.+
T Consensus 117 ~~ 118 (312)
T 3jr1_A 117 KN 118 (312)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.85 E-value=7.7e-05 Score=65.53 Aligned_cols=71 Identities=8% Similarity=-0.055 Sum_probs=42.2
Q ss_pred CCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEeC-CCCC
Q 045067 67 RNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV-LRLIGCCLEVEIPVLVFESA-EYGN 144 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~ 144 (347)
.+.|+.|....+|+. +. +++|+........ -...+|+.+++.+....+ .+++++ +.+.-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~----~~-~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GD-LCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE----TT-EEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee----ee-EEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567899999999998 44 4455544332111 223568888877742222 345544 344457899999 6544
Q ss_pred H
Q 045067 145 L 145 (347)
Q Consensus 145 L 145 (347)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00087 Score=59.37 Aligned_cols=163 Identities=17% Similarity=0.133 Sum_probs=87.3
Q ss_pred ccccCHHHHHHHhccCCC-----CCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCc--ee
Q 045067 49 IRSFSAKELERATNNYHY-----RNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNN--VL 121 (347)
Q Consensus 49 ~~~~~~~e~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv 121 (347)
...++.+++......|.. ...++ |....||+...+++..+|+|....... ..+.+..|..+++.+.... +.
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp 85 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVA 85 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBC
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeec
Confidence 444666666665555532 23466 788899998775554455555543221 2256777888888774222 33
Q ss_pred eeeee-----eeeCCccEEEEEeCCCCCHH-----H------H---HhhhccC----CCCCCCHHHH-------------
Q 045067 122 RLIGC-----CLEVEIPVLVFESAEYGNLH-----D------L---LKRSYQS----HSEPLLLKHR------------- 165 (347)
Q Consensus 122 ~l~~~-----~~~~~~~~lv~e~~~~g~L~-----~------~---l~~~~~~----~~~~l~~~~~------------- 165 (347)
+++.. ...++..++++|+++|.++. . . ++..... ....+++...
T Consensus 86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 165 (328)
T 1zyl_A 86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL 165 (328)
T ss_dssp CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence 44432 12244567899999874331 1 1 1111000 0111222111
Q ss_pred ---------HHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 166 ---------LKIAMEIANVFAYLHI-GFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 166 ---------~~i~~~i~~~l~~lH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
...+..++..+.-+-. .....++|||+++.||+++ + .+.++||+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1112222222222210 1156789999999999998 4 899999987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00061 Score=60.62 Aligned_cols=33 Identities=15% Similarity=0.107 Sum_probs=28.2
Q ss_pred CCCeEeccCCCCCeEECCC----CceEEecCCCCccC
Q 045067 184 SRPIVFRDLKSSYILVSER----YVPKLFNFSLSASI 216 (347)
Q Consensus 184 ~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~a~~~ 216 (347)
...++|||+.+.||+++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 5689999999999999874 67899999987543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0031 Score=55.61 Aligned_cols=159 Identities=12% Similarity=0.059 Sum_probs=84.0
Q ss_pred cCHHHHHHHhccCCCC-----CeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCc--eeeee
Q 045067 52 FSAKELERATNNYHYR-----NIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNN--VLRLI 124 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 124 (347)
++.+++......|... +.|+.|....+|+...+++.++ +|+..... ..+.+..|+.++..+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~v-lk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLI-LTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEE-EEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEE-EEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 5666777766666542 3456688889999988666554 55544321 1244667888877764222 23333
Q ss_pred ee------eeeCCccEEEEEeCCCCCHHH--------------HHhhhccC---CC-CCC---CHHHHHH----------
Q 045067 125 GC------CLEVEIPVLVFESAEYGNLHD--------------LLKRSYQS---HS-EPL---LLKHRLK---------- 167 (347)
Q Consensus 125 ~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~---~~-~~l---~~~~~~~---------- 167 (347)
.. ....+..++++++++|..+.. .++..... .. ... .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 122355689999998754311 11111000 00 001 1211100
Q ss_pred --HHHHHHHHHHHhhc----CCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 168 --IAMEIANVFAYLHI----GFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 168 --i~~~i~~~l~~lH~----~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
+...+...+..+.. ....+++|+|+.+.||+++.+..+.|+||+.+
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 00112333444431 12457999999999999988766689999866
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00082 Score=55.32 Aligned_cols=101 Identities=16% Similarity=0.137 Sum_probs=65.2
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
-+|.+.|... +.++++.+++.++.|.+.+|.-+-. ...-..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc--------
Confidence 4899999874 4889999999999999999877621 11111222346889999999988764 1110
Q ss_pred eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcC
Q 045067 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG 264 (347)
Q Consensus 223 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g 264 (347)
.....+.|||... ...+.+.=|||+|+++|.-+-.|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1223456888653 34467888999999999998333
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00073 Score=61.26 Aligned_cols=143 Identities=13% Similarity=0.083 Sum_probs=80.4
Q ss_pred CCeecccCceEEEEEEeCC--------ceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEE
Q 045067 67 RNIITESSIFRLCQGVLPD--------RTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~--------~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 137 (347)
.+.|..|-...+|+....+ +..+++|+..... .......+|..+++.+. +.-..++++++.+ .+|+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 3567778888999998742 3456667654322 22355678999998884 3223556666543 3899
Q ss_pred EeCCCCCHHH--------------HHhhhccC---CCCCC--CHHHHHHHHHHHHH-------------------HHHH-
Q 045067 138 ESAEYGNLHD--------------LLKRSYQS---HSEPL--LLKHRLKIAMEIAN-------------------VFAY- 178 (347)
Q Consensus 138 e~~~~g~L~~--------------~l~~~~~~---~~~~l--~~~~~~~i~~~i~~-------------------~l~~- 178 (347)
||++|.+|.. .+.+-... ..... .+.++.++..++.. .+..
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998754431 11111010 01112 24455555544321 1222
Q ss_pred ---hhc-CCCCCeEeccCCCCCeEECCC----CceEEecCCCCc
Q 045067 179 ---LHI-GFSRPIVFRDLKSSYILVSER----YVPKLFNFSLSA 214 (347)
Q Consensus 179 ---lH~-~~~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~a~ 214 (347)
|.. .....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 221 124579999999999999876 789999998773
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00056 Score=63.24 Aligned_cols=72 Identities=11% Similarity=-0.044 Sum_probs=46.8
Q ss_pred CCeecccCceEEEEEEeCC--------ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEE
Q 045067 67 RNIITESSIFRLCQGVLPD--------RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV-LRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~--------~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 137 (347)
.+.|+.|....+|+...++ +..+++|+...... .+.+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567888889999998742 35566776643211 1455689999988853333 466665432 3899
Q ss_pred EeCCCCC
Q 045067 138 ESAEYGN 144 (347)
Q Consensus 138 e~~~~g~ 144 (347)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998633
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0011 Score=61.80 Aligned_cols=74 Identities=8% Similarity=-0.089 Sum_probs=45.8
Q ss_pred CCeecccCceEEEEEEeCC-ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEeCCCCC
Q 045067 67 RNIITESSIFRLCQGVLPD-RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV-LRLIGCCLEVEIPVLVFESAEYGN 144 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~-~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 144 (347)
.+.|+.|-...+|+...++ +..+++|+........ -...+|..+++.+...++ .++++.+. + .+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3567788889999998855 4556667664432211 112589999998864444 46666653 2 35999998744
Q ss_pred H
Q 045067 145 L 145 (347)
Q Consensus 145 L 145 (347)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00084 Score=60.67 Aligned_cols=72 Identities=14% Similarity=-0.006 Sum_probs=42.7
Q ss_pred CeecccCceEEEEEEeCC---------ceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCc-eeeeeeeeeeCCccEEEE
Q 045067 68 NIITESSIFRLCQGVLPD---------RTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNN-VLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~~~---------~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 137 (347)
+.|+.|....+|+...++ +..+++|+........ ....+|..+++.+...+ +.++++.. . -++|+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457788888999998753 1466777765543221 22467888888774333 33555443 2 37899
Q ss_pred EeCCCCC
Q 045067 138 ESAEYGN 144 (347)
Q Consensus 138 e~~~~g~ 144 (347)
||++|.+
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998744
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0049 Score=54.92 Aligned_cols=32 Identities=9% Similarity=0.168 Sum_probs=27.9
Q ss_pred CCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 184 SRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 184 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
...++|+|+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45799999999999999888899999987644
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.021 Score=52.42 Aligned_cols=74 Identities=11% Similarity=-0.109 Sum_probs=46.2
Q ss_pred CCeecccCceEEEEEEeCC--------ceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEE
Q 045067 67 RNIITESSIFRLCQGVLPD--------RTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~--------~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 137 (347)
.+.|..|-...+|+...++ +..+++|+........ -...+|..+++.+. +.-..++++.+ . -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3567778888999998852 3556667665443221 22457888888874 22234555433 2 37899
Q ss_pred EeCCCCCH
Q 045067 138 ESAEYGNL 145 (347)
Q Consensus 138 e~~~~g~L 145 (347)
||++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998553
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.28 E-value=0.065 Score=48.80 Aligned_cols=29 Identities=28% Similarity=0.371 Sum_probs=24.5
Q ss_pred CeEeccCCCCCeEE------CCCCceEEecCCCCc
Q 045067 186 PIVFRDLKSSYILV------SERYVPKLFNFSLSA 214 (347)
Q Consensus 186 ~ivH~dlkp~Nill------~~~~~~kl~Dfg~a~ 214 (347)
.++|+|+.+.||++ +++..+.++||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 456779999999874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=86.88 E-value=1.9 Score=35.32 Aligned_cols=83 Identities=6% Similarity=0.031 Sum_probs=59.6
Q ss_pred CCCceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCCeEeccCCC
Q 045067 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFA-YLHIGFSRPIVFRDLKS 194 (347)
Q Consensus 116 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~-~lH~~~~~~ivH~dlkp 194 (347)
.||++ -..+-.+++.+.+.++.-+++.=+..+ ..++...+++++..++.... +++ .-.|--+.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeC
Confidence 57777 334445667777777766544333344 35788899999999887666 454 346777999
Q ss_pred CCeEECCCCceEEecCCCC
Q 045067 195 SYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 195 ~Nill~~~~~~kl~Dfg~a 213 (347)
+|++++.++.+++.-.|+-
T Consensus 113 ~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GGEEECTTCCEEESCCEET
T ss_pred ceEEEeCCCcEEEEEcCCc
Confidence 9999999999999877753
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.72 E-value=0.11 Score=48.24 Aligned_cols=61 Identities=2% Similarity=-0.148 Sum_probs=16.6
Q ss_pred CCCeecccCceEEEEEEeCC--ceEEE------EEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 045067 66 YRNIITESSIFRLCQGVLPD--RTISV------VKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE 129 (347)
Q Consensus 66 ~~~~lg~G~~g~Vy~~~~~~--~~~~v------~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 129 (347)
..+.|| ||.||+|.+.+ .+||+ |+..... .......+.+|..++..++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345565 99999999943 45655 4433322 12233568889999999999999999887653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.99 E-value=1.4 Score=36.05 Aligned_cols=117 Identities=9% Similarity=0.063 Sum_probs=75.5
Q ss_pred CCCceeeeeeeeeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 045067 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSS 195 (347)
Q Consensus 116 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~ 195 (347)
.||+.+.. .+-.+++.+.+.++.-+ +..++-.- ..++...+++++..|+....+++ .=.|--+.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecc
Confidence 58888765 45555566555555544 22222221 45788999999999988776655 2367779999
Q ss_pred CeEECCCCceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCcccc
Q 045067 196 YILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270 (347)
Q Consensus 196 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~ 270 (347)
|++++.++.+++.--|+...+ +|.- .+...=.-.+=+++..++ .++..|..
T Consensus 109 NL~f~~~~~p~i~~RGik~~l------------------~P~~-----~~ee~fL~qyKAliiall-~~K~~Fe~ 159 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV------------------DPLP-----VSEAEFLTRYKALVICAF-NEKQSFDA 159 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB------------------SCCC-----CCHHHHHHHHHHHHHHHH-CTTCCHHH
T ss_pred eEEEcCCCCEEEEEccCccCC------------------CCCC-----CCHHHHHHHHHHHHHHHH-cCCCCHHH
Confidence 999999999999877653222 2210 111122335667788888 88777764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 347 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-35 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-31 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-31 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-31 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-30 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-30 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-30 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-30 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-28 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-28 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-27 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-27 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-27 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-26 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-26 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-26 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-25 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-24 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-24 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-24 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-23 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-22 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-21 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-21 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-21 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-20 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-20 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-20 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-19 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-19 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-19 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-18 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-18 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-18 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-17 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-17 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-17 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-16 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-16 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-16 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-15 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-15 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-14 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-13 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-13 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-13 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-10 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-09 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-09 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-36
Identities = 62/285 (21%), Positives = 105/285 (36%), Gaps = 27/285 (9%)
Query: 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVL 121
+ + G T VK + D Q+ H ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71
Query: 122 RLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHI 181
RL + I ++ E E G+L D LK L + L +A +IA A++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 182 GFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART 241
R + RDL+++ ILVS+ K+ +F L+ I + E +G K APE
Sbjct: 127 --ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 242 GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301
G K DV+SFG+LL ++++ G + + ++ +V P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPY--------PGMTNPEVIQNLERGY---RMVRPD 233
Query: 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+EL +L C EDRPT + ++ + +
Sbjct: 234 NCPEELY--------QLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-35
Identities = 57/285 (20%), Positives = 109/285 (38%), Gaps = 27/285 (9%)
Query: 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVL 121
+ + I + G ++ +K I D ++SH ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDF-IEEAEVMMKLSHPKLV 63
Query: 122 RLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHI 181
+L G CLE LVFE E+G L D L+ + + L + +++ AYL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAA----ETLLGMCLDVCEGMAYLE- 118
Query: 182 GFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART 241
++ RDL + LV E V K+ +F ++ + + + G K +PE
Sbjct: 119 --EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 242 GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301
+ K DV+SFG+L+ ++ S G ++ + + V+ + PR
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEG--------KIPYENRSNSEVVEDISTGF---RLYKPR 225
Query: 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+ + ++ C EDRP + +Q+ ++ +S
Sbjct: 226 LASTHVY--------QIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 4e-35
Identities = 51/262 (19%), Positives = 103/262 (39%), Gaps = 29/262 (11%)
Query: 91 VKFIDGSVFDA--YDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDL 148
VK ++ + N + + H N+L +G +V + E +L+
Sbjct: 35 VKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHH 93
Query: 149 LKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLF 208
L + + IA + A YLH + I+ RDLKS+ I + E K+
Sbjct: 94 LHI----IETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIG 146
Query: 209 NFSLSASIPEGE-TYIDDGVKGTSGIVAPEYART---GYLNEKCDVYSFGLLLLQLLSTG 264
+F L+ ++ + + G+ +APE R + + DVY+FG++L +L+ TG
Sbjct: 147 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM-TG 205
Query: 265 EDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQS 324
+ + D + + G + P + ++ + ++ L +C
Sbjct: 206 QLPY--------SNINNRDQIIFMVG----RGYLSPDL--SKVRSNCPKAMKRLMAECLK 251
Query: 325 ASAEDRPTMIDVAKQIKKMYKS 346
++RP + I+ + +S
Sbjct: 252 KKRDERPLFPQILASIELLARS 273
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 1e-33
Identities = 48/282 (17%), Positives = 101/282 (35%), Gaps = 27/282 (9%)
Query: 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVL 121
+ + + + G + +K I D +SH ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62
Query: 122 RLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHI 181
+L G C + ++ E G L + L+ + L++ ++ YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT----QQLLEMCKDVCEAMEYLES 118
Query: 182 GFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART 241
+ + RDL + LV+++ V K+ +F LS + + E G K PE
Sbjct: 119 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 242 GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPR 301
+ K D+++FG+L+ ++ S G+ + E F ++I + P
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPY---------ERFTNSETAEHIAQG--LRLYRPH 224
Query: 302 IIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
+ +++ + + C A++RPT + I +
Sbjct: 225 LASEKVY--------TIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-32
Identities = 61/296 (20%), Positives = 104/296 (35%), Gaps = 27/296 (9%)
Query: 51 SFSAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIV 110
+ E + + + + G T +K + +
Sbjct: 6 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQ 64
Query: 111 FASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAM 170
++ H +++L E +V E G+L D LK + L + +A
Sbjct: 65 VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAA 120
Query: 171 EIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGT 230
+IA+ AY+ V RDL+++ ILV E V K+ +F L+ I + E G K
Sbjct: 121 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 231 SGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290
APE A G K DV+SFG+LL +L + G + + + +
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY--------PGMVNREVLDQVER 229
Query: 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
P + L +L QC E+RPT + ++ + S
Sbjct: 230 GYRMP---CPPECPESLH--------DLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-31
Identities = 61/299 (20%), Positives = 115/299 (38%), Gaps = 34/299 (11%)
Query: 55 KELERATNNYHYRNI-ITESSIFRLCQGVLPDRTISV---VKFIDGSVFDAYDCCFNN-I 109
K+L +N +I + + + QGV R + +K + A
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 110 VFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIA 169
Q+ + ++RLIG C + +LV E A G LH L E + + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG----KREEIPVSNVAELL 115
Query: 170 MEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYID--DGV 227
+++ YL + V RDL + +L+ R+ K+ +F LS ++ ++Y
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
Query: 228 KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287
K APE + + DV+S+G+ + + LS G+ + + + +
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY--------KKMKGPEVMAF 224
Query: 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+ + P EL + L C EDRP + V ++++ Y S
Sbjct: 225 IEQGKRME---CPPECPPEL--------YALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-31
Identities = 43/277 (15%), Positives = 94/277 (33%), Gaps = 13/277 (4%)
Query: 57 LERATNNYHYRNIITESSIFRLCQGV-LPDRTISVVKFIDGSVFDAYDCCFNN-IVFASQ 114
+E +++ + + + + + P + K I + A + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 115 MSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIAN 174
+ ++ G + E + G+L +LK++ + + K+++ +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIK 115
Query: 175 VFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIV 234
YL I+ RD+K S ILV+ R KL +F +S + + GT +
Sbjct: 116 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYM 170
Query: 235 APEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294
+PE + + + + D++S GL L+++ G + F E
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMA-VGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229
Query: 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP 331
+ + + FEL + P
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP 266
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 5e-31
Identities = 63/312 (20%), Positives = 126/312 (40%), Gaps = 35/312 (11%)
Query: 45 NYNPIRSFSAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISV----VKFIDGSVFD 100
N +++ + ++ H+ +I + G L D VK ++
Sbjct: 10 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69
Query: 101 AYDCCFNN-IVFASQMSHNNVLRLIGCCLEVE-IPVLVFESAEYGNLHDLLKRSYQSHSE 158
F + SH NVL L+G CL E P++V ++G+L + ++ +
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF----IRNETH 125
Query: 159 PLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218
+K + +++A + S+ V RDL + ++ E++ K+ +F L+ + +
Sbjct: 126 NPTVKDLIGFGLQVA---KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 219 GE---TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLN 275
E + G K +A E +T K DV+SFG+LL +L++ G +
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------- 235
Query: 276 GDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMID 335
+ D ++ R ++ P D L +E+ +C AE RP+ +
Sbjct: 236 -PDVNTFDITVYLLQGR---RLLQPEYCPDPL--------YEVMLKCWHPKAEMRPSFSE 283
Query: 336 VAKQIKKMYKSF 347
+ +I ++ +F
Sbjct: 284 LVSRISAIFSTF 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (292), Expect = 5e-31
Identities = 58/316 (18%), Positives = 107/316 (33%), Gaps = 44/316 (13%)
Query: 49 IRSFSAKELERATNNYHYRNIITESSIFRL---------CQGVLP----DRTISVVKFID 95
I F+ ++ A + I+ I ++ C G L +K +
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 96 GSVFDAYDCCFNN-IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQ 154
+ F + Q H NV+ L G + +++ E E G+L L+++
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123
Query: 155 SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214
+ + + IA YL V RDL + ILV+ V K+ +F LS
Sbjct: 124 QFTV----IQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 215 SIPEGETYID----DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270
+ + + G K APE + DV+S+G+++ +++S GE +
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-- 234
Query: 271 GLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDR 330
+ D + ++ P L +L C R
Sbjct: 235 ------WDMTNQDVINAIEQDYRLP---PPMDCPSALH--------QLMLDCWQKDRNHR 277
Query: 331 PTMIDVAKQIKKMYKS 346
P + + KM ++
Sbjct: 278 PKFGQIVNTLDKMIRN 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-30
Identities = 53/236 (22%), Positives = 97/236 (41%), Gaps = 30/236 (12%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLK 167
+Q+ H+N+++L+G +E + + +V E G+L D L+ +S L LK
Sbjct: 51 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLK 107
Query: 168 IAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGV 227
++++ YL V RDL + +LVSE V K+ +F L+ +
Sbjct: 108 FSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----G 160
Query: 228 KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287
K APE R + K DV+SFG+LL ++ S G + D V +
Sbjct: 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY--------PRIPLKDVVPR 212
Query: 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
+ + + + +E+ C A RP+ + + +Q++ +
Sbjct: 213 VEKGYKM-----------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (288), Expect = 1e-30
Identities = 60/298 (20%), Positives = 120/298 (40%), Gaps = 27/298 (9%)
Query: 50 RSFSAKELERATNNYHYRNIITESSIFRLCQGVLPDRTISV-VKFIDGSVFDAYDCCFNN 108
S + + E + ++ + + +GV +++V VK + + +
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
++ H N+++L+G C ++ E YGNL D L + + + + L +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYM 120
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
A +I++ YL + + RDL + LV E ++ K+ +F LS + G K
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288
APE + K DV++FG+LL ++ + G + ++ V +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------PGIDLSQVYEL 228
Query: 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
+E D R+ E K+ EL C + DRP+ ++ + + M++
Sbjct: 229 LEK-------DYRMERPEGCPEKVY---ELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-30
Identities = 55/260 (21%), Positives = 99/260 (38%), Gaps = 32/260 (12%)
Query: 91 VKFIDGSVFDAY--DCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDL 148
VK + D D Q+ + ++R+IG C E E +LV E AE G L+
Sbjct: 39 VKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKY 97
Query: 149 LKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLF 208
L+++ + K+ +++ +++ YL V RDL + +L+ ++ K+
Sbjct: 98 LQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKIS 149
Query: 209 NFSLSASIPEGETYID--DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGED 266
+F LS ++ E Y K APE + K DV+SFG+L+ + S G+
Sbjct: 150 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209
Query: 267 LFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSAS 326
+ + + P E+ +L C +
Sbjct: 210 PY--------RGMKGSEVTAMLEKGERMG---CPAGCPREMY--------DLMNLCWTYD 250
Query: 327 AEDRPTMIDVAKQIKKMYKS 346
E+RP V +++ Y
Sbjct: 251 VENRPGFAAVELRLRNYYYD 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-30
Identities = 50/257 (19%), Positives = 95/257 (36%), Gaps = 27/257 (10%)
Query: 107 NNIVFASQMSHNNVLRLIGCCLEVEIPV----LVFESAEYGNLHDLLKRSYQSHSEPLLL 162
I + H N+L I + LV + E+G+L D L R + +
Sbjct: 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTV 99
Query: 163 KHRLKIAMEIANVFAYLHIGF-----SRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217
+ +K+A+ A+ A+LH+ I RDLKS ILV + + + L+
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159
Query: 218 EGETYID---DGVKGTSGIVAPEYART------GYLNEKCDVYSFGLLLLQLLSTGEDLF 268
ID + GT +APE ++ D+Y+ GL+ ++ +
Sbjct: 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA-RRCSIG 218
Query: 269 NM--GLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSAS 326
+ +L + D + + + P I L+ ++ +C A+
Sbjct: 219 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278
Query: 327 AEDRPTMIDVAKQIKKM 343
R T + + K + ++
Sbjct: 279 GAARLTALRIKKTLSQL 295
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (286), Expect = 4e-30
Identities = 71/316 (22%), Positives = 118/316 (37%), Gaps = 49/316 (15%)
Query: 55 KELERATNNYHYRNIITESSIFRLCQGVLP------DRTISVVKFIDGSVFDAYDCCFNN 108
LE NN Y I E + R+ Q P T+ VK + F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 109 -IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK----------------- 150
++ + N+++L+G C + L+FE YG+L++ L+
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 151 --RSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLF 208
R PL +L IA ++A AYL R V RDL + LV E V K+
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182
Query: 209 NFSLSASIPEGETYIDDG-VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDL 267
+F LS +I + Y DG + PE + DV+++G++L ++ S G
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 268 FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASA 327
+ + +E + D I+ E+ + L C S
Sbjct: 243 YY---GMAHEEVIYY--------------VRDGNIL--ACPENCPLELYNLMRLCWSKLP 283
Query: 328 EDRPTMIDVAKQIKKM 343
DRP+ + + +++M
Sbjct: 284 ADRPSFCSIHRILQRM 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 5e-30
Identities = 54/274 (19%), Positives = 100/274 (36%), Gaps = 42/274 (15%)
Query: 91 VKFIDGSVFDAYDCCFNN--IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDL 148
VK + + + + SH N++ L+G C L+FE YG+L +
Sbjct: 72 VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 131
Query: 149 LKRSYQSHSE------------------PLLLKHRLKIAMEIANVFAYLHIGFSRPIVFR 190
L+ + SE L + L A ++A +L + V R
Sbjct: 132 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR 188
Query: 191 DLKSSYILVSERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCD 249
DL + +LV+ V K+ +F L+ I Y + + +APE G K D
Sbjct: 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 248
Query: 250 VYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLE 309
V+S+G+LL ++ S G + + + +F K + P +E+
Sbjct: 249 VWSYGILLWEIFSLGVNPYP-------GIPVDANFYKLIQNGFKMD---QPFYATEEI-- 296
Query: 310 HKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343
+ + C + + RP+ ++ +
Sbjct: 297 ------YIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-28
Identities = 47/255 (18%), Positives = 90/255 (35%), Gaps = 35/255 (13%)
Query: 85 DRTISVVKFIDGSVF---DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAE 141
+ I +K + + + S + H N+LRL G + L+ E A
Sbjct: 30 SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89
Query: 142 YGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE 201
G ++ L++ + E+AN +Y H S+ ++ RD+K +L+
Sbjct: 90 LGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGS 141
Query: 202 RYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLL 261
K+ +F S P + GT + PE +EK D++S G+L + L
Sbjct: 142 AGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 198
Query: 262 STGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQ 321
G+ F + + + K+ P + + +L +
Sbjct: 199 -VGKPPF--------EANTYQETYKRISRVE----FTFPDFVTEGAR--------DLISR 237
Query: 322 CQSASAEDRPTMIDV 336
+ RP + +V
Sbjct: 238 LLKHNPSQRPMLREV 252
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 7e-28
Identities = 57/257 (22%), Positives = 108/257 (42%), Gaps = 31/257 (12%)
Query: 91 VKFIDGSVF---DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHD 147
VK + V +A D + + H N++RL G L + +V E A G+L D
Sbjct: 41 VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLD 99
Query: 148 LLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKL 207
+ H LL + A+++A YL S+ + RDL + +L++ R + K+
Sbjct: 100 R----LRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKI 152
Query: 208 FNFSLSASIPEGETY--IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGE 265
+F L ++P+ + + + + K APE +T + D + FG+ L ++ + G+
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
Query: 266 DLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSA 325
+ + LNG + I+ G + P ++ + QC +
Sbjct: 213 EPWI---GLNGSQILHK------IDKEGER-LPRPEDCPQDIY--------NVMVQCWAH 254
Query: 326 SAEDRPTMIDVAKQIKK 342
EDRPT + + + +
Sbjct: 255 KPEDRPTFVALRDFLLE 271
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-27
Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 40/300 (13%)
Query: 62 NNYHYRNIITESSIFRLCQGVLPD----RTISVVKFIDGSVFDAYDCCFNNIVFASQMS- 116
N+ ++++I E + ++ + + ++ + + + D + + ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEP-----------LLLKHR 165
H N++ L+G C L E A +GNL D L++S ++P L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
L A ++A YL + + RDL + ILV E YV K+ +F LS
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285
+ +A E DV+S+G+LL +++S G + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--------CGMTCAELY 236
Query: 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345
+K + P DE+ +L QC +RP+ + + +M +
Sbjct: 237 EKLPQGYRLE---KPLNCDDEVY--------DLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 4e-27
Identities = 53/271 (19%), Positives = 106/271 (39%), Gaps = 36/271 (13%)
Query: 91 VKFIDGSVFDAYDCCFNN--IVFASQMSHNNVLRLIGCCLEVEIPV-LVFESAEYGNLHD 147
VK + + + + H NV+ L+G C + P+ ++ E ++GNL
Sbjct: 48 VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 107
Query: 148 LLKR-----------SYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSY 196
L+ + + L L+H + + ++A +L SR + RDL +
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN 164
Query: 197 ILVSERYVPKLFNFSLSASIPEGETYIDDG-VKGTSGIVAPEYARTGYLNEKCDVYSFGL 255
IL+SE+ V K+ +F L+ I + Y+ G + +APE + DV+SFG+
Sbjct: 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224
Query: 256 LLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSS 315
LL ++ S G + + +F ++ E ++
Sbjct: 225 LLWEIFSLGASPYP-------GVKIDEEFCRRLKEGTRM-----------RAPDYTTPEM 266
Query: 316 FELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346
++ C RPT ++ + + + ++
Sbjct: 267 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 7e-27
Identities = 47/258 (18%), Positives = 100/258 (38%), Gaps = 29/258 (11%)
Query: 90 VVKFIDGSVFDAYDCCFNN-IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDL 148
+K + + + + + + + +V RL+G CL + L+ + +G L D
Sbjct: 42 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDY 100
Query: 149 LKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLF 208
++ + ++ L ++IA YL R +V RDL + +LV K+
Sbjct: 101 VREHKDNIGS----QYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKIT 153
Query: 209 NFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDL 267
+F L+ + E Y +G K +A E + DV+S+G+ + +L++ G
Sbjct: 154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213
Query: 268 FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASA 327
+ + + +E + P I ++ + + +C A
Sbjct: 214 Y---------DGIPASEISSILEKGER--LPQPPICTIDV--------YMIMVKCWMIDA 254
Query: 328 EDRPTMIDVAKQIKKMYK 345
+ RP ++ + KM +
Sbjct: 255 DSRPKFRELIIEFSKMAR 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 7e-27
Identities = 49/260 (18%), Positives = 96/260 (36%), Gaps = 28/260 (10%)
Query: 83 LPDRTISVVKFIDGSVFDAYD--CCFNNIVFASQMSHNNVLRLIGCCLEVE--IPVLVFE 138
D I V K +D + + + ++ H N++R ++ +V E
Sbjct: 26 KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85
Query: 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLH--IGFSRPIVFRDLKSSY 196
E G+L ++ + + + L + L++ ++ H ++ RDLK +
Sbjct: 86 YCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 144
Query: 197 ILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLL 256
+ + + KL +F L+ + ++ GT ++PE NEK D++S G L
Sbjct: 145 VFLDGKQNVKLGDFGLARILNHDTSFAK-AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCL 203
Query: 257 LLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSF 316
L + L F +F + I F I P DEL
Sbjct: 204 LYE-LCALMPPF---------TAFSQKELAGKIREGKFRRI--PYRYSDELN-------- 243
Query: 317 ELAFQCQSASAEDRPTMIDV 336
E+ + + RP++ ++
Sbjct: 244 EIITRMLNLKDYHRPSVEEI 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-26
Identities = 51/256 (19%), Positives = 87/256 (33%), Gaps = 28/256 (10%)
Query: 91 VKFIDGSVFDAYDCCFNN-IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLL 149
+K D+ F + Q H ++++LIG E + ++ E G L
Sbjct: 40 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSF- 97
Query: 150 KRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209
Q L L + A +++ AYL S+ V RD+ + +LVS KL +
Sbjct: 98 ---LQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGD 151
Query: 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFN 269
F LS + + Y K +APE DV+ FG+ + ++L G F
Sbjct: 152 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF- 210
Query: 270 MGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAED 329
D + + P L L +C +
Sbjct: 211 -------QGVKNNDVIGRIENGERLP---MPPNCPPTLY--------SLMTKCWAYDPSR 252
Query: 330 RPTMIDVAKQIKKMYK 345
RP ++ Q+ + +
Sbjct: 253 RPRFTELKAQLSTILE 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-26
Identities = 55/271 (20%), Positives = 100/271 (36%), Gaps = 37/271 (13%)
Query: 91 VKFIDGSVFDAYDCCFNN--IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDL 148
VK + S + V + +H N++ L+G C +++ E YG+L +
Sbjct: 58 VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117
Query: 149 LKRS-------------YQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSS 195
L+R + L L+ L + ++A A+L S+ + RDL +
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR 174
Query: 196 YILVSERYVPKLFNFSLSASIPEGETYIDDG-VKGTSGIVAPEYARTGYLNEKCDVYSFG 254
IL++ + K+ +F L+ I Y+ G + +APE + DV+S+G
Sbjct: 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 234
Query: 255 LLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQS 314
+ L +L S G K I+ ++ P E+
Sbjct: 235 IFLWELFSLG--------SSPYPGMPVDSKFYKMIKEG--FRMLSPEHAPAEMY------ 278
Query: 315 SFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345
++ C A RPT + + I+K
Sbjct: 279 --DIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-26
Identities = 42/246 (17%), Positives = 89/246 (36%), Gaps = 28/246 (11%)
Query: 91 VKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLK 150
++ ++ + N I+ + + N++ + L + +V E G+L D++
Sbjct: 50 IRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109
Query: 151 RSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNF 210
+ + + E +LH S ++ RD+KS IL+ KL +F
Sbjct: 110 ETCMDEGQ------IAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 160
Query: 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNM 270
A I ++ V GT +APE K D++S G++ ++++ GE +
Sbjct: 161 GFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI-EGEPPY-- 216
Query: 271 GLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDR 330
+ + I G + +P + + +C E R
Sbjct: 217 ------LNENPLRALYL-IATNGTPELQNPEKLSAIFR--------DFLNRCLDMDVEKR 261
Query: 331 PTMIDV 336
+ ++
Sbjct: 262 GSAKEL 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (259), Expect = 3e-26
Identities = 47/252 (18%), Positives = 82/252 (32%), Gaps = 31/252 (12%)
Query: 90 VVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLL 149
K ID + + I + H N+++L+ ++ E G + ++
Sbjct: 41 AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 100
Query: 150 KRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209
PL + + + YLH I+ RDLK+ IL + KL +
Sbjct: 101 LE----LERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLAD 153
Query: 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYART-----GYLNEKCDVYSFGLLLLQLLSTG 264
F +SA D + GT +APE + K DV+S G+ L+++
Sbjct: 154 FGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-EI 211
Query: 265 EDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQS 324
E E M + K I + P + +C
Sbjct: 212 EPPH--------HELNPMRVLLK-IAKSEPPTLAQPSRWSSNFK--------DFLKKCLE 254
Query: 325 ASAEDRPTMIDV 336
+ + R T +
Sbjct: 255 KNVDARWTTSQL 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 3e-26
Identities = 55/259 (21%), Positives = 95/259 (36%), Gaps = 29/259 (11%)
Query: 91 VKFIDGSVFDAYDCCFNN-IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLL 149
+K + + F Q SH+N++RL G + + +++ E E G L L
Sbjct: 41 IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 100
Query: 150 KRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209
+ S + + IA YL + V RDL + ILV+ V K+ +
Sbjct: 101 REKDGEFSV----LQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSD 153
Query: 210 FSLSASIPEGE--TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDL 267
F LS + + TY G K APE DV+SFG+++ ++++ GE
Sbjct: 154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213
Query: 268 FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASA 327
+ E + +K + P + +L QC
Sbjct: 214 Y--------WELSNHEVMKAINDGFRLP---TPMDCPSAIY--------QLMMQCWQQER 254
Query: 328 EDRPTMIDVAKQIKKMYKS 346
RP D+ + K+ ++
Sbjct: 255 ARRPKFADIVSILDKLIRA 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 2e-25
Identities = 52/251 (20%), Positives = 89/251 (35%), Gaps = 29/251 (11%)
Query: 91 VKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLL 149
VK +D D + I ++H NV++ G E I L E G L D +
Sbjct: 35 VKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI 94
Query: 150 KRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209
+ + + ++ YLH I RD+K +L+ ER K+ +
Sbjct: 95 EPDI-----GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISD 146
Query: 210 FSLSASI-PEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDL 267
F L+ + + + GT VAPE + + E DV+S G++L +L+
Sbjct: 147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA----- 201
Query: 268 FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASA 327
G S + E + + + + I L L + +
Sbjct: 202 ---GELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDSAPL--------ALLHKILVENP 248
Query: 328 EDRPTMIDVAK 338
R T+ D+ K
Sbjct: 249 SARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-25
Identities = 55/264 (20%), Positives = 112/264 (42%), Gaps = 29/264 (10%)
Query: 91 VKFIDGSVFDAYDCCFNN-IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLL 149
+K ++ + F N + + ++V+RL+G + + +++ E G+L L
Sbjct: 55 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 114
Query: 150 KRSYQSHSE-----PLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV 204
+ + + P L +++A EIA+ AYL+ + V RDL + +V+E +
Sbjct: 115 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT 171
Query: 205 PKLFNFSLSASIPEGETYIDDG-VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLST 263
K+ +F ++ I E + Y G ++PE + G DV+SFG++L ++ +
Sbjct: 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231
Query: 264 GEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQ 323
E + + + V +++ G P D L FEL C
Sbjct: 232 AEQPY---------QGLSNEQVLRFVMEGGLLDK--PDNCPDML--------FELMRMCW 272
Query: 324 SASAEDRPTMIDVAKQIKKMYKSF 347
+ + RP+ +++ IK+ +
Sbjct: 273 QYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 99.3 bits (247), Expect = 2e-24
Identities = 51/260 (19%), Positives = 90/260 (34%), Gaps = 38/260 (14%)
Query: 83 LPDRTISVVKFIDGSVF---DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139
+ + + +K + S + + + F ++ H N ++ GC L LV E
Sbjct: 37 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96
Query: 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199
L H +PL + AYLH S ++ RD+K+ IL+
Sbjct: 97 CLGSASDLLEV-----HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILL 148
Query: 200 SERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYART---GYLNEKCDVYSFGLL 256
SE + KL +F ++ + +++ GT +APE G + K DV+S G+
Sbjct: 149 SEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203
Query: 257 LLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSF 316
++L + M + +N P + E
Sbjct: 204 CIELA-ERKPPL--------FNMNAMSALYHIAQNE------SPALQSGHWSE----YFR 244
Query: 317 ELAFQCQSASAEDRPTMIDV 336
C +DRPT +
Sbjct: 245 NFVDSCLQKIPQDRPTSEVL 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 2e-24
Identities = 54/267 (20%), Positives = 98/267 (36%), Gaps = 36/267 (13%)
Query: 91 VKFIDGSVFDAYDCCFNN--IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDL 148
VK + + + + H N++ L+G C + ++ E A GNL +
Sbjct: 50 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109
Query: 149 LK-----------RSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYI 197
L+ + E L K + A ++A YL S+ + RDL + +
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 166
Query: 198 LVSERYVPKLFNFSLSASIPEGETYID-DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLL 256
LV+E V K+ +F L+ I + Y + +APE + DV+SFG+L
Sbjct: 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 257 LLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSF 316
L ++ + G + + K E + P +EL +
Sbjct: 227 LWEIFTLGGSPY--------PGVPVEELFKLLKEGHRMD---KPSNCTNEL--------Y 267
Query: 317 ELAFQCQSASAEDRPTMIDVAKQIKKM 343
+ C A RPT + + + ++
Sbjct: 268 MMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.8 bits (243), Expect = 4e-24
Identities = 48/229 (20%), Positives = 85/229 (37%), Gaps = 33/229 (14%)
Query: 113 SQMSHNNVLRLIGCCLEV----EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
+ H N++R + VLV E G L LKR + + +K
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSW 117
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILV-SERYVPKLFNFSLSASIPEGETYIDDGV 227
+I +LH + PI+ RDLK I + K+ + L+ V
Sbjct: 118 CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AV 173
Query: 228 KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287
GT +APE Y +E DVY+FG+ +L++ T E + E + +
Sbjct: 174 IGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMA-TSEYPY--------SECQNAAQIYR 223
Query: 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
+ + G ++ E+ E+ C + ++R ++ D+
Sbjct: 224 RVTS-GVKPASFDKVAIPEVK--------EIIEGCIRQNKDERYSIKDL 263
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 96.7 bits (240), Expect = 3e-23
Identities = 37/188 (19%), Positives = 69/188 (36%), Gaps = 12/188 (6%)
Query: 83 LPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142
KF+ + I S + H ++ L + V+++E
Sbjct: 48 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107
Query: 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER 202
G L + + + SE ++ ++ ++H V DLK I+ + +
Sbjct: 108 GELFEKVADEHNKMSE----DEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTK 160
Query: 203 Y--VPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQL 260
KL +F L+A + ++ GT+ APE A + D++S G+L L
Sbjct: 161 RSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 218
Query: 261 LSTGEDLF 268
L +G F
Sbjct: 219 L-SGLSPF 225
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.4 bits (229), Expect = 4e-22
Identities = 36/191 (18%), Positives = 69/191 (36%), Gaps = 13/191 (6%)
Query: 83 LPDRTISVVKFIDGSVF---DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139
L +K ++ + S++ H ++L + E
Sbjct: 30 LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89
Query: 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199
A+ G L ++ EI + YLH + I+ RDLK IL+
Sbjct: 90 AKNGELLKYIR-----KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILL 141
Query: 200 SERYVPKLFNFSLSASI-PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLL 258
+E ++ +F + + PE + + GT+ V+PE + D+++ G ++
Sbjct: 142 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIY 201
Query: 259 QLLSTGEDLFN 269
QL+ G F
Sbjct: 202 QLV-AGLPPFR 211
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 91.7 bits (227), Expect = 2e-21
Identities = 36/189 (19%), Positives = 64/189 (33%), Gaps = 12/189 (6%)
Query: 83 LPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142
+ V KFI+ N I +Q+ H ++ L + VL+ E
Sbjct: 51 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110
Query: 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER 202
G L D + + + + ++H IV D+K I+ +
Sbjct: 111 GELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETK 163
Query: 203 YVP--KLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQL 260
K+ +F L+ + E T+ APE + D+++ G+L L
Sbjct: 164 KASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVL 221
Query: 261 LSTGEDLFN 269
L +G F
Sbjct: 222 L-SGLSPFA 229
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 89.4 bits (221), Expect = 4e-21
Identities = 45/272 (16%), Positives = 102/272 (37%), Gaps = 35/272 (12%)
Query: 83 LPDRTISVVKFIDGSVF---DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE----IPVL 135
L VK + + Y A+ ++H ++ + +P +
Sbjct: 29 LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88
Query: 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSS 195
V E + L D++ P+ K +++ + + H I+ RD+K +
Sbjct: 89 VMEYVDGVTLRDIVH-----TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPA 140
Query: 196 YILVSERYVPKLFNFSLSASIPEGETYIDD--GVKGTSGIVAPEYARTGYLNEKCDVYSF 253
I++S K+ +F ++ +I + + V GT+ ++PE AR ++ + DVYS
Sbjct: 141 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 200
Query: 254 GLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQ 313
G +L ++L TGE F + +++ + +L
Sbjct: 201 GCVLYEVL-TGEPPF--------TGDSPVSVAYQHVREDPIPPSARHEGLSADLD----- 246
Query: 314 SSFELAFQCQSASAEDRP-TMIDVAKQIKKMY 344
+ + + + E+R T ++ + +++
Sbjct: 247 ---AVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.3 bits (221), Expect = 7e-21
Identities = 31/162 (19%), Positives = 63/162 (38%), Gaps = 12/162 (7%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
I + H N+L L +E V++FE ++ + + S +E + +
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNE----REIVSY 107
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVS--ERYVPKLFNFSLSASIPEGETYIDDG 226
++ +LH S I D++ I+ K+ F + + G+ +
Sbjct: 108 VHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RL 162
Query: 227 VKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLF 268
+ APE + ++ D++S G L+ LL +G + F
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL-SGINPF 203
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 87.2 bits (215), Expect = 3e-20
Identities = 44/285 (15%), Positives = 89/285 (31%), Gaps = 18/285 (6%)
Query: 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCC--FNNIVFASQMSHNN 119
YH I E + + + +K I D I ++ H+N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 120 VLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYL 179
+++L + VLVFE + L L +++ N AY
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYC 116
Query: 180 HIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYA 239
H R ++ RDLK +L++ K+ +F L+ + +
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 240 RTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESFEMDFVKKYIEN 291
+ + D++S G + ++++ + D R+ G + + +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 292 RGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
N V + + L+ +S +L + R T
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 86.7 bits (214), Expect = 3e-20
Identities = 50/227 (22%), Positives = 78/227 (34%), Gaps = 33/227 (14%)
Query: 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANV 175
H N+++L LVF+ + G L D L L K KI + V
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEV 122
Query: 176 FAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVA 235
LH IV RDLK IL+ + KL +F S + GE V GT +A
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLA 177
Query: 236 PEYARTG------YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289
PE ++ D++S G+++ LL G F +M ++ +
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-AGSPPF--------WHRKQMLMLRMIM 228
Query: 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
G + D + +L + + R T +
Sbjct: 229 SGNYQFGSPEWDDYSDTVK--------DLVSRFLVVQPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 87.0 bits (215), Expect = 4e-20
Identities = 43/284 (15%), Positives = 85/284 (29%), Gaps = 26/284 (9%)
Query: 55 KELERATNNYHYRNIITESSIFRLCQGV-LPDRTISVVKFIDGSVFDAYDCCFNN-IVFA 112
K+ E + Y +R+++ + + + + +K I + + N I
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
++ H N++ L L+ + G L D + + ++ ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-----KGFYTERDASRLIFQV 116
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
+ YLH + Y + E + +F LS G GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL--STACGTPG 174
Query: 233 IVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292
VAPE ++ D +S G++ LL G F + + ++ ++
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILL-CGYPPF--------YDENDAKLFEQILKAE 225
Query: 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
I D + E R T
Sbjct: 226 YEFDSPYWDDISDSAK--------DFIRHLMEKDPEKRFTCEQA 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 4e-19
Identities = 42/236 (17%), Positives = 67/236 (28%), Gaps = 17/236 (7%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
I ++SH N++ L+ LVF+ E + S L H
Sbjct: 51 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAY 105
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
+ YLH I+ RDLK + +L+ E V KL +F L+ S V
Sbjct: 106 MLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 162
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESF 280
D+++ G +L +LL + D G +
Sbjct: 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT- 221
Query: 281 EMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
E + P I + +L + R T
Sbjct: 222 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.4 bits (208), Expect = 5e-19
Identities = 49/231 (21%), Positives = 81/231 (35%), Gaps = 30/231 (12%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
V + H + + E V E G+L ++ L
Sbjct: 54 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFY 108
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
A EI +LH S+ IV+RDLK IL+ + K+ +F + G+ +
Sbjct: 109 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC- 164
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288
GT +APE N D +SFG+LL ++L G+ F +G + E+
Sbjct: 165 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML-IGQSPF------HGQDEEEL------ 211
Query: 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339
+ + PR + E +L + E R + +Q
Sbjct: 212 FHSIRMDNPFYPRWLEKEAK--------DLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.0 bits (207), Expect = 8e-19
Identities = 34/157 (21%), Positives = 62/157 (39%), Gaps = 13/157 (8%)
Query: 113 SQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEI 172
S ++ + + + + G+LH L + A EI
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFYAAEI 116
Query: 173 ANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSG 232
++H +R +V+RDLK + IL+ E ++ + L+ + + + GT G
Sbjct: 117 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHG 170
Query: 233 IVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLF 268
+APE + G + D +S G +L +LL G F
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLL-RGHSPF 206
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.5 bits (203), Expect = 2e-18
Identities = 37/243 (15%), Positives = 72/243 (29%), Gaps = 21/243 (8%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIP------VLVFESAEYGNLHDLLKRSYQSHSEPLLL 162
+ ++ H N++RL LV + Y + L +
Sbjct: 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPV 121
Query: 163 KHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV-SERYVPKLFNFSLSASIPEGET 221
+ ++ AY+H S I RD+K +L+ + V KL +F + + GE
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLR 273
+ + DV+S G +L +LL +G D ++
Sbjct: 179 NVSY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 274 LNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTM 333
+ G + E + + L + + R T
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
Query: 334 IDV 336
++
Sbjct: 298 LEA 300
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 4e-18
Identities = 42/236 (17%), Positives = 73/236 (30%), Gaps = 22/236 (9%)
Query: 113 SQMSHNNVLRLIGCCLEVEIP-----VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLK 167
H NV+RL C LVFE + L K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT----ETIKD 120
Query: 168 IAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGV 227
+ ++ +LH S +V RDLK ILV+ KL +F L+ V
Sbjct: 121 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--V 175
Query: 228 KGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFN-------MGLRLNGDESF 280
T APE D++S G + ++ + LF +G L+
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSDVDQLGKILDVIGLP 234
Query: 281 EMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
+ + + ++ + + +L +C + + R +
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.5 bits (198), Expect = 9e-18
Identities = 40/190 (21%), Positives = 77/190 (40%), Gaps = 16/190 (8%)
Query: 83 LPDRTISVVKFIDGSVF---DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139
+ +K + + + + + S ++H ++R+ G + + ++ +
Sbjct: 26 RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85
Query: 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199
E G L S+ A E+ YLH S+ I++RDLK IL+
Sbjct: 86 IEGGELFS-----LLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILL 137
Query: 200 SERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQ 259
+ K+ +F + +P+ + GT +APE T N+ D +SFG+L+ +
Sbjct: 138 DKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 193
Query: 260 LLSTGEDLFN 269
+L G F
Sbjct: 194 ML-AGYTPFY 202
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 1e-17
Identities = 47/264 (17%), Positives = 86/264 (32%), Gaps = 27/264 (10%)
Query: 91 VKFIDGSVFDAYDCCFNN-IVFASQMSHNNVLRLIGCCLEVEI----PVLVFESAEYGNL 145
+K I Y I + H N++ + I V + +L
Sbjct: 38 IKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADL 97
Query: 146 HDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205
+ LLK + L H +I Y+H S ++ RDLK S +L++
Sbjct: 98 YKLLKT------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDL 148
Query: 206 KLFNFSLSASIPEGETYID--DGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLS 262
K+ +F L+ + T APE + D++S G +L ++LS
Sbjct: 149 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 208
Query: 263 --------TGEDLFNMGLRLNGDESFEM--DFVKKYIENRGFNGIVDPRIIGDELLEHKL 312
D N L + G S E + N + ++ + L +
Sbjct: 209 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD 268
Query: 313 QSSFELAFQCQSASAEDRPTMIDV 336
+ +L + + + R +
Sbjct: 269 SKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.8 bits (193), Expect = 3e-17
Identities = 33/236 (13%), Positives = 71/236 (30%), Gaps = 15/236 (6%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
I +++H N+++L+ LVFE + + P
Sbjct: 52 ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP----LIKSY 107
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVK 228
++ A+ H S ++ RDLK +L++ KL +F L+ + V
Sbjct: 108 LFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 164
Query: 229 GTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLRLNGDESF 280
Y + D++S G + ++++ + D R G
Sbjct: 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 224
Query: 281 EMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
+ + + + R +++ + L Q R +
Sbjct: 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (191), Expect = 6e-17
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 15/164 (9%)
Query: 109 IVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKI 168
+ ++ H NV+ L +L+ E G L D + + E L + +
Sbjct: 64 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD-----FLAEKESLTEEEATEF 118
Query: 169 AMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP----KLFNFSLSASIPEGETYID 224
+I N YLH S I DLK I++ +R VP K+ +F L+ I G + +
Sbjct: 119 LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 225 DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLF 268
+ GT VAPE L + D++S G++ LL +G F
Sbjct: 176 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL-SGASPF 216
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.1 bits (186), Expect = 2e-16
Identities = 36/240 (15%), Positives = 73/240 (30%), Gaps = 17/240 (7%)
Query: 106 FNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
I ++ H N++RL + LVFE + + S + L +
Sbjct: 49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY-----FDSCNGDLDPEIV 103
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
++ + H R ++ RDLK +L++ KL NF L+ +
Sbjct: 104 KSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTG---------EDLFNMGLRLNG 276
V + D++S G + +L + G +D RL G
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 277 DESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
+ E + + + ++ + +L + R + +
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 75.2 bits (184), Expect = 4e-16
Identities = 27/242 (11%), Positives = 68/242 (28%), Gaps = 32/242 (13%)
Query: 116 SHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANV 175
+ + E VLV + L +K A ++
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL-----DLCGRKFSVKTVAMAAKQMLAR 113
Query: 176 FAYLHIGFSRPIVFRDLKSSYILVSERYVP-----KLFNFSLSASIPEGET------YID 224
+H + +V+RD+K L+ + +F + + T
Sbjct: 114 VQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 225 DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDF 284
+ GT+ ++ + + D+ + G + + L G + G ++
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL-RGSLPW------QGLKAATNKQ 223
Query: 285 VKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMY 344
+ I + EL + ++ ++ + + P + K+
Sbjct: 224 KYERIGEK------KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
Query: 345 KS 346
+
Sbjct: 278 ER 279
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.7 bits (183), Expect = 9e-16
Identities = 31/166 (18%), Positives = 62/166 (37%), Gaps = 16/166 (9%)
Query: 110 VFASQMSHNNVLRLIGCCLEV----EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
+ +++R++ + + ++V E + G L ++ + +
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREA 113
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY---VPKLFNFSLSASIPEGETY 222
+I I YLH S I RD+K +L + + + KL +F + +
Sbjct: 114 SEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
Query: 223 IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLF 268
T VAPE ++ CD++S G+++ L G F
Sbjct: 171 TT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI-LLCGYPPF 213
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.8 bits (178), Expect = 2e-15
Identities = 32/155 (20%), Positives = 56/155 (36%), Gaps = 13/155 (8%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVF 176
+ V+RL+ + VL+ E E + E + ++
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE----ELARSFFWQVLEAV 123
Query: 177 AYLHIGFSRPIVFRDLKSSYILVS-ERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVA 235
+ H + ++ RD+K IL+ R KL +F A + + GT
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSP 177
Query: 236 PEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFN 269
PE+ R Y V+S G+LL ++ G+ F
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMV-CGDIPFE 211
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (179), Expect = 3e-15
Identities = 33/183 (18%), Positives = 57/183 (31%), Gaps = 13/183 (7%)
Query: 90 VVKFIDGSVF---DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLH 146
+K + V D H + L + V E A G L
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93
Query: 147 DLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPK 206
L R + EI + L SR +V+RD+K +++ + K
Sbjct: 94 FHLSRER-----VFTEERARFYGAEIVS---ALEYLHSRDVVYRDIKLENLMLDKDGHIK 145
Query: 207 LFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGED 266
+ +F L + GT +APE D + G+++ +++ G
Sbjct: 146 ITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRL 203
Query: 267 LFN 269
F
Sbjct: 204 PFY 206
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 72.2 bits (176), Expect = 5e-15
Identities = 36/250 (14%), Positives = 76/250 (30%), Gaps = 29/250 (11%)
Query: 106 FNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
M + I C ++ +L DL S LK
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTV 105
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSER---YVPKLFNFSLSASIPEGETY 222
L +A ++ + Y+H S+ + RD+K L+ + + +F L+ + T+
Sbjct: 106 LLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
Query: 223 IDD------GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG 276
+ GT+ + + + D+ S G +L+ G +
Sbjct: 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN-LGSLPWQGLKAATK 221
Query: 277 DESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDV 336
+ +E KK + L + C+S +D+P +
Sbjct: 222 RQKYERISEKKM------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL 269
Query: 337 AKQIKKMYKS 346
+ + ++
Sbjct: 270 RQLFRNLFHR 279
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 7e-14
Identities = 40/242 (16%), Positives = 79/242 (32%), Gaps = 19/242 (7%)
Query: 106 FNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
+ + M H NV+ L+ E + H E L
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRI 123
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
+ ++ Y+H + I+ RDLK + V+E K+ +F L+ T
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---G 177
Query: 226 GVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFN-------MGLRLNGDE 278
V + D++S G ++ +++ TG+ LF + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGSDHLDQLKEIMKVTG 236
Query: 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAF----QCQSASAEDRPTMI 334
+ +FV++ + N + + + L ++ LA + AE R T
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 335 DV 336
+
Sbjct: 297 EA 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.4 bits (166), Expect = 1e-13
Identities = 38/246 (15%), Positives = 79/246 (32%), Gaps = 15/246 (6%)
Query: 106 FNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHR 165
I + H NV+ LI C P + + Y S L+
Sbjct: 57 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL 116
Query: 166 LKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDD 225
+I + + L+ I+ RD+K++ +L++ V KL +F L+ + + +
Sbjct: 117 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176
Query: 226 ---GVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLS--------TGEDLFNMGLR 273
T PE D++ G ++ ++ + T + + +
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236
Query: 274 LNGDESFEM-DFVKKYIENRGFNGIVDPRIIGDELLEHKLQSS--FELAFQCQSASAEDR 330
L G + E+ V Y + + + L+ ++ +L + R
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 296
Query: 331 PTMIDV 336
D
Sbjct: 297 IDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 68.3 bits (166), Expect = 1e-13
Identities = 34/190 (17%), Positives = 69/190 (36%), Gaps = 16/190 (8%)
Query: 83 LPDRTISVVKFIDGSVF---DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139
+K +D + N ++ +++L + +V E
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199
G + L+R H A +I F YLH S +++RDLK +L+
Sbjct: 123 VAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLI 174
Query: 200 SERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQ 259
++ ++ +F + + + GT +APE + N+ D ++ G+L+ +
Sbjct: 175 DQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 260 LLSTGEDLFN 269
+ G F
Sbjct: 231 MA-AGYPPFF 239
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 8e-13
Identities = 36/154 (23%), Positives = 55/154 (35%), Gaps = 11/154 (7%)
Query: 117 HNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVF 176
++ L L+ + G L L + EI
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLAL 142
Query: 177 AYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAP 236
+LH I++RD+K IL+ L +F LS ET GT +AP
Sbjct: 143 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 237 EYARTG--YLNEKCDVYSFGLLLLQLLSTGEDLF 268
+ R G ++ D +S G+L+ +LL TG F
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELL-TGASPF 232
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 64.9 bits (157), Expect = 2e-12
Identities = 38/248 (15%), Positives = 76/248 (30%), Gaps = 34/248 (13%)
Query: 110 VFASQMSHNNVLRLIGCCLEV--EIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLK 167
+ + N++ L + P LVFE + L + L
Sbjct: 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--------LTDYDIRF 133
Query: 168 IAMEIANVFAYLHIGFSRPIVFRDLKSSYILV-SERYVPKLFNFSLSASIPEGETYIDDG 226
EI Y H S I+ RD+K +++ E +L ++ L+ G+ Y
Sbjct: 134 YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV-- 188
Query: 227 VKGTSGIVAPE-YARTGYLNEKCDVYSFGLLLLQLLSTG----------EDLFNMGLRLN 275
+ PE + D++S G +L ++ + L + L
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248
Query: 276 GDESFEMDFVKKYIENRGFNGIVD-------PRIIGDELLEHKLQSSFELAFQCQSASAE 328
++ ++ + FN I+ R + E + + + +
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308
Query: 329 DRPTMIDV 336
R T +
Sbjct: 309 SRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.4 bits (140), Expect = 3e-10
Identities = 46/259 (17%), Positives = 83/259 (32%), Gaps = 21/259 (8%)
Query: 91 VKFIDGSVFDAYDC--CFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDL 148
VK + + + M H NV+ L+ + +L
Sbjct: 48 VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 107
Query: 149 LKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLF 208
+ + L H + +I Y+H S I+ RDLK S + V+E K+
Sbjct: 108 DLNNIV-KCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 163
Query: 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLF 268
+F L+ + T + + N+ D++S G ++ +LL TG LF
Sbjct: 164 DFGLARHTDDEMTGYVATRWYRA---PEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLF 219
Query: 269 N-------MGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAF- 320
+ L L + + +KK N I + + + LA
Sbjct: 220 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 279
Query: 321 ---QCQSASAEDRPTMIDV 336
+ ++ R T
Sbjct: 280 LLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (136), Expect = 1e-09
Identities = 46/284 (16%), Positives = 91/284 (32%), Gaps = 44/284 (15%)
Query: 83 LPDRTISVVKFIDGSVFD--AYDCCFNNIVFASQMSHNNVLRLIGCCL------EVEIPV 134
+K + + + +V ++H N++ L+ E +
Sbjct: 39 AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98
Query: 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKS 194
LV E + + + + ++ +LH S I+ RDLK
Sbjct: 99 LVMELMDANLCQVIQMELDH--------ERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 147
Query: 195 SYILVSERYVPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFG 254
S I+V K+ +F L+ + T APE E D++S G
Sbjct: 148 SNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGMGYKENVDIWSVG 205
Query: 255 LLLLQLLSTGEDLFN--------------MGLRLNGDESFEMDFVKKYIENRG-FNGIVD 299
++ +++ + LF +G V+ Y+ENR + G+
Sbjct: 206 CIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTF 264
Query: 300 PRIIGDELLEHKLQSS-------FELAFQCQSASAEDRPTMIDV 336
P++ D L + + +L + R ++ D
Sbjct: 265 PKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 55.0 bits (131), Expect = 4e-09
Identities = 29/167 (17%), Positives = 58/167 (34%), Gaps = 13/167 (7%)
Query: 108 NIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLK 167
+ M N++L+L+ + +LL + + L + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 168 IAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP------KLFNFSLSASIPEGET 221
I+ ++ Y+H I+ D+K +L+ P K+ + + E T
Sbjct: 130 ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 222 YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLF 268
T +PE D++S L+ +L+ TG+ LF
Sbjct: 188 N----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI-TGDFLF 229
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 347 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.86 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.36 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.14 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.44 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.19 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.14 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-58 Score=401.95 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=199.5
Q ss_pred ccCCCCCeecccCceEEEEEEeC-CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVLP-DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
++|+..+.||+|+||+||+|.+. ++.||+|++ ..... ..+++.+|+.++++++||||++++|++.+++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i-~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEEC-CSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEE-CCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 46788899999999999999994 445555554 43332 3377999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 83 EHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999998763 366899999999999999999999 9999999999999999999999999999998776554
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
........||+.|+|||++.+..++.++|||||||++|||++.|.+||.... ............ ....+
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--------~~~~~~~i~~~~---~~~~p 224 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDISTGF---RLYKP 224 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--------HHHHHHHHHHTC---CCCCC
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--------HHHHHHHHHhcC---CCCCc
Confidence 4444456799999999999999999999999999999999955777775321 122222222211 11111
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
. ..++++.+++.+||+.||++|||++||++.|++|.++
T Consensus 225 ~--------~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 R--------LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp T--------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c--------ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 1 2245678999999999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.6e-58 Score=406.17 Aligned_cols=258 Identities=20% Similarity=0.282 Sum_probs=197.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-C-Cc---eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-P-DR---TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~-~~---~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
++|+..++||+|+||+||+|.+ . ++ .+++|++.........+.|.+|+.+|++++|||||+++|++.+++.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 3455568999999999999998 2 22 24444444444555567899999999999999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
||||++|+|.+++... ...+++.++..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+..
T Consensus 106 ~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999998763 357999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCcee----eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 217 PEGETYI----DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 217 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
....... .....||+.|+|||.+.++.++.++|||||||++|||++.|++||..... ...........
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------~~~~~~i~~~~ 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVINAIEQDY 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCC
Confidence 5433211 12345799999999999999999999999999999999559999964321 22222222211
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
. ... +...++.+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 251 ~--------~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 R--------LPP---PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp C--------CCC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C--------CCC---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1 111 11235568899999999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-58 Score=405.50 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=214.0
Q ss_pred HHHHHhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 56 ELERATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 56 e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
+++...++|+..+.||+|+||+||+|++ .++..+++|.+..... ..+++.+|+.+|++++|||||++++++.+++..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 3444567888899999999999999999 4555555555554433 3478999999999999999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+|||||++|+|.+++... ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+
T Consensus 90 iv~E~~~~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 90 IITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEeecccCcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEcccccee
Confidence 999999999999999763 3467999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
..............||+.|+|||++.+..++.++|||||||++|||++.+.+||.... . .........+..
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--------~-~~~~~~i~~~~~ 234 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------L-SQVYELLEKDYR 234 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--------H-HHHHHHHHTTCC
T ss_pred ecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--------H-HHHHHHHhcCCC
Confidence 8766555555556789999999999999999999999999999999944555554321 1 122222222211
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
. . .+...++++.+|+.+||+.||++|||++||++.|+.+.+
T Consensus 235 ~-----~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 235 M-----E-----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp C-----C-----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred C-----C-----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 1 111234568899999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-58 Score=400.44 Aligned_cols=261 Identities=23% Similarity=0.351 Sum_probs=210.0
Q ss_pred HHHhccCCCCCeecccCceEEEEEEeCCc-eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 58 ERATNNYHYRNIITESSIFRLCQGVLPDR-TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 58 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
+...++|+..+.||+|+||+||+|.+.++ .||||++ ..... ..+.+.+|+.++++++|||||+++|++.+ +..++|
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~-~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEE-CTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEE-ccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 33456788899999999999999999554 5555554 43332 33779999999999999999999998765 567999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|.+++... ....+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+|+..
T Consensus 86 ~Ey~~~g~L~~~~~~~---~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTP---SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EECCTTCBHHHHTTSH---HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEc
Confidence 9999999999988654 2245999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
............||+.|+|||++.+..++.++|||||||++|||++.|.+|+.... ........ ..+..
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--------~~~~~~~i-~~~~~-- 228 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNL-ERGYR-- 228 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHH-HTTCC--
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-HhcCC--
Confidence 76555555567799999999999999999999999999999999955677765322 12222222 22110
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
...+ ...++++.+|+.+||+.||++||||+||++.|+++..+
T Consensus 229 ~~~p--------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 229 MVRP--------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCc--------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 1111 12345688999999999999999999999999998765
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-57 Score=398.02 Aligned_cols=263 Identities=20% Similarity=0.254 Sum_probs=204.4
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccC-CCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDG-SVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
.++|...+.||+|+||+||+|++.+ .+|||++... ......+.|.+|+.++++++||||+++++++.+ +.+++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 5678999999999999999998754 4666554322 234455789999999999999999999998754 568999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
|++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 85 CEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred CCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999753 356999999999999999999999 899999999999999999999999999999876543
Q ss_pred Cc-eeeccccccCCccccccccc---CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 220 ET-YIDDGVKGTSGIVAPEYART---GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 220 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+ +|+.||..... ..........+...
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~-tg~~Pf~~~~~--------~~~~~~~~~~~~~~ 228 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM-TGQLPYSNINN--------RDQIIFMVGRGYLS 228 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHH-HSSCTTTTCCC--------HHHHHHHHHHTSCC
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHH-HCCCCCCCCCh--------HHHHHHHHhcCCCC
Confidence 22 22345679999999998864 35799999999999999999 89999964321 11222222222111
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhC
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~~ 347 (347)
+.. .......++++.+++.+||+.||++|||+.||++.|+.+.+++
T Consensus 229 ----p~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 229 ----PDL--SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp ----CCG--GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ----Ccc--hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 110 0111223557889999999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=398.54 Aligned_cols=252 Identities=21% Similarity=0.270 Sum_probs=199.3
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.++|+..+.||+|+||+||+|++ .++..+++|.+. .......+.+.+|+.++++++||||+++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46799999999999999999998 445544444443 3333344679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
||++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 84 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999999764 67999999999999999999999 99999999999999999999999999999987654
Q ss_pred CCc-eeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 219 GET-YIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 219 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
... .......||+.|+|||++.+..+ +.++||||+||++|||+ +|++||..... .. .............
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml-~G~~pf~~~~~----~~---~~~~~~~~~~~~~- 226 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML-AGELPWDQPSD----SC---QEYSDWKEKKTYL- 226 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHH-HSSCSCSSSST----TS---HHHHHHHTTCTTS-
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHH-hCCCCCCCCCh----HH---HHHHHHhcCCCCC-
Confidence 332 22345789999999999988765 57899999999999999 99999965322 11 1111111111100
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
......++++.+|+.+||+.||++|||++|+++
T Consensus 227 ---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ---------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011223456789999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=393.40 Aligned_cols=249 Identities=17% Similarity=0.207 Sum_probs=204.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
+.|+..+.||+|+||+||+|.. .++..+++|.+........+.+.+|+.++++++||||+++++++.+++.+|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999998 444444444444333334477999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++|+|.+++.+ ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||+|+......
T Consensus 100 ~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 99999998876 57999999999999999999999 9999999999999999999999999999998775433
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
. ......||+.|+|||++.+..++.++||||+||++|+|+ +|++||..... .............
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyeml-tG~~Pf~~~~~--------~~~~~~~~~~~~~------ 234 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI-EGEPPYLNENP--------LRALYLIATNGTP------ 234 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHH-HSSCTTTTSCH--------HHHHHHHHHHCSC------
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHh-hCCCCCCCCCH--------HHHHHHHHhCCCC------
Confidence 2 234567999999999999999999999999999999999 89999964321 1222222222211
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+. .+...++++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~---~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 ELQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCS---SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCC---CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 11233567889999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=387.87 Aligned_cols=254 Identities=18% Similarity=0.297 Sum_probs=209.6
Q ss_pred ccCCCCCeecccCceEEEEEEeCCc-eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDR-TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
++|+..+.||+|+||+||+|++.++ .||+|+ ++..... .+.+.+|+.++++++||||++++|++.+++.+++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~-l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-IKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEE-EESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEE-ECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 6789999999999999999999555 555554 4443333 377999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++|+|.+++... ...+++..+.+++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 82 ANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TTEEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCCcHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999997663 267899999999999999999999 9999999999999999999999999999998776554
Q ss_pred ceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 221 TYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
........||+.|+|||.+.+..++.++|||||||++|||++.|+.||..... .+..... ..+. ....+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------~~~~~~i-~~~~--~~~~p 223 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHI-AQGL--RLYRP 223 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHH-HTTC--CCCCC
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--------HHHHHHH-HhCC--CCCCc
Confidence 44444577999999999999999999999999999999999558999964321 2222222 2221 11111
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
. ..++++.+++.+||+.||++|||++++++.|.+|
T Consensus 224 ~--------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 H--------LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp T--------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred c--------cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1 2235688999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-56 Score=391.81 Aligned_cols=258 Identities=22% Similarity=0.330 Sum_probs=205.9
Q ss_pred ccCCCCC-eecccCceEEEEEEe---CCce-EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRN-IITESSIFRLCQGVL---PDRT-ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~-~lg~G~~g~Vy~~~~---~~~~-~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 136 (347)
++|.... .||+|+||+||+|.+ +++. ||||.+.........+++.+|+.+|++++|||||+++|++.+ +.+++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4455555 499999999999987 2333 455554444444556789999999999999999999999865 568999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
||||++|+|.+++.. ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+..
T Consensus 87 mE~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHhhc----cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999865 2367999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCcee--eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 217 PEGETYI--DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 217 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
....... .....||+.|+|||++.++.++.++|||||||++|||++.|+.||..... .+... ....+..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~~-~i~~~~~ 230 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMA-FIEQGKR 230 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHH-HHHTTCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHHHH-HHHcCCC
Confidence 6543322 23456899999999999999999999999999999999559999974321 12222 2222221
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.. . ++..++++.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus 231 ~~-----~-----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 ME-----C-----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CC-----C-----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC-----C-----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11 1 112345788999999999999999999999999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=389.19 Aligned_cols=245 Identities=19% Similarity=0.285 Sum_probs=203.2
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||+||+|++ .++..+++|++... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5688999999999999999999 55555555554322 1223467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|||++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999999875 67999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... ....||+.|+|||++.+..++.++|||||||++|||+ +|++||..... ......... ...
T Consensus 158 ~~~~---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell-~G~~Pf~~~~~--------~~~~~~i~~-~~~--- 221 (263)
T d2j4za1 158 SSRR---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPFEANTY--------QETYKRISR-VEF--- 221 (263)
T ss_dssp CCCC---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH-HSSCTTCCSSH--------HHHHHHHHT-TCC---
T ss_pred CCcc---cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHh-cCCCCCCCCCH--------HHHHHHHHc-CCC---
Confidence 4332 3467999999999999999999999999999999999 99999964321 122222222 111
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. +...++++.+++.+||+.||++|||+.|+++
T Consensus 222 ---~~-----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ---TF-----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CC-----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 01 1123456889999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-56 Score=389.71 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=200.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc-----eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR-----TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~-----~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
+.|+..++||+|+||+||+|.+ .++ .||+|++...........|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4678889999999999999998 222 3556655444444555679999999999999999999999999999999
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+.+|++.+.+... ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 87 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999988763 367999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCc--eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 216 IPEGET--YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 216 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
...... .......||+.|+|||++.+..++.++|||||||++|||++.+.+|+.... ...... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--------~~~~~~-~i~~~~ 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEVMK-AINDGF 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHH-HHHTTC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--------HHHHHH-HHhccC
Confidence 654322 223345689999999999999999999999999999999954666654321 122222 222221
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
.. . .+...+.++.+|+.+||+.||++||||.||++.|+++.+
T Consensus 231 ~~-----~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 231 RL-----P-----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CC-----C-----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC-----C-----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11 1 111234568899999999999999999999999999865
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-57 Score=396.75 Aligned_cols=251 Identities=18% Similarity=0.210 Sum_probs=204.0
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeC
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESA 140 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 140 (347)
+.|+..+.||+|+||+||+|.+ .++..+++|.+........+.+.+|+.++++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4688889999999999999998 566666666665555556688999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++|+|.+++.+. ...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 92 AGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp TTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 999999998763 257999999999999999999999 9999999999999999999999999999997653221
Q ss_pred ceeeccccccCCcccccccc-----cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 221 TYIDDGVKGTSGIVAPEYAR-----TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 221 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.......||+.|+|||++. +..|+.++||||+||++|||+ +|++||..... ............
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyeml-tg~~Pf~~~~~--------~~~~~~i~~~~~-- 232 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA-EIEPPHHELNP--------MRVLLKIAKSEP-- 232 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHH-HSSCTTTTSCG--------GGHHHHHHHSCC--
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHh-hCCCCCCCCCH--------HHHHHHHHcCCC--
Confidence 1223467999999999874 456899999999999999999 89999965322 112222222211
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
+.+. .+...++++.+|+.+||+.||++|||+.|+++
T Consensus 233 ----~~~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 ----PTLA---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----CCCS---SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCCC---ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 11233567889999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=385.13 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=198.4
Q ss_pred CeecccCceEEEEEEe-C--Cce-EEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEeCCC
Q 045067 68 NIITESSIFRLCQGVL-P--DRT-ISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFESAEY 142 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~--~~~-~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 142 (347)
+.||+|+||+||+|.+ . .+. ||+|++.... .....+.+.+|+.+|++++|||||+++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 5799999999999987 2 233 4455443322 23345679999999999999999999999865 567899999999
Q ss_pred CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCCce
Q 045067 143 GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGETY 222 (347)
Q Consensus 143 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 222 (347)
|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999999875 67999999999999999999999 999999999999999999999999999999877654433
Q ss_pred ee--ccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccCC
Q 045067 223 ID--DGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVDP 300 (347)
Q Consensus 223 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (347)
.. ....||+.|+|||.+.+..++.++|||||||++|||++.|++||..... .+ +......+...
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~-~~~~i~~~~~~----- 229 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SE-VTAMLEKGERM----- 229 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HH-HHHHHHTTCCC-----
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HH-HHHHHHcCCCC-----
Confidence 22 3456899999999999999999999999999999999569999974321 12 22222222111
Q ss_pred ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 301 RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
.. +...++++.+|+.+||+.||++|||+++|++.|+.+..
T Consensus 230 --~~---p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 230 --GC---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp --CC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CC---CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 11 11234578899999999999999999999999988754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=389.09 Aligned_cols=256 Identities=19% Similarity=0.224 Sum_probs=190.2
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeee--CCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE--VEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 135 (347)
.++|+..+.||+|+||+||+|.. .++..+++|.+... .....+.+.+|+.++++++||||+++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36799999999999999999998 55555555544433 23345678999999999999999999999865 456899
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF--SRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
|||||++|+|.+++.+.. .....+++..+..++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+|
T Consensus 83 vmEy~~~g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999987531 12357999999999999999999999311 134999999999999999999999999999
Q ss_pred ccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 214 ASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 214 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
+....... ......||+.|+|||++.+..++.++|||||||++|||+ +|++||..... .+.... ...+.
T Consensus 162 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~-tg~~Pf~~~~~--------~~~~~~-i~~~~ 230 (269)
T d2java1 162 RILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC-ALMPPFTAFSQ--------KELAGK-IREGK 230 (269)
T ss_dssp HHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHHH-HHHTC
T ss_pred eecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHh-hCCCCCCCCCH--------HHHHHH-HHcCC
Confidence 87654332 234568999999999999999999999999999999999 89999964321 222222 22222
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...+ +...++++.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~----------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 FRRI----------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC----------CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2111 0122456889999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=383.09 Aligned_cols=244 Identities=20% Similarity=0.258 Sum_probs=193.5
Q ss_pred CCCCeecccCceEEEEEEe-C-CceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeee----CCccEEEE
Q 045067 65 HYRNIITESSIFRLCQGVL-P-DRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE----VEIPVLVF 137 (347)
Q Consensus 65 ~~~~~lg~G~~g~Vy~~~~-~-~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 137 (347)
...+.||+|+||+||+|++ . +..+|+|++.... .....+.+.+|+.+|++++||||+++++++.+ +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4456799999999999999 3 4456666654433 33445679999999999999999999999875 34689999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEEC-CCCceEEecCCCCc
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRP--IVFRDLKSSYILVS-ERYVPKLFNFSLSA 214 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~a~ 214 (347)
||+++|+|.+++.+. ..+++..+..++.|++.||+||| +++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999875 67999999999999999999999 877 99999999999996 57899999999997
Q ss_pred cCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
...... .....||+.|+|||++.+ .++.++|||||||++|||+ +|+.||..... ..... .....+..
T Consensus 164 ~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~-~g~~Pf~~~~~-------~~~~~-~~i~~~~~ 230 (270)
T d1t4ha_ 164 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA-TSEYPYSECQN-------AAQIY-RRVTSGVK 230 (270)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHH-HSSCTTTTCSS-------HHHHH-HHHTTTCC
T ss_pred eccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHH-HCCCCCCCccc-------HHHHH-HHHHcCCC
Confidence 654332 235689999999998875 5899999999999999999 99999964321 11222 22222111
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. ......++++.+++.+||++||++|||+.|+++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 PA---------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CG---------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cc---------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11 111122456889999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=394.30 Aligned_cols=199 Identities=18% Similarity=0.250 Sum_probs=174.6
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
.++|+..+.||+|+||+||+|.+ .++..+++|.+... .....+.+.+|+.+|++++|||||++++++.+++.+++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57899999999999999999998 56665655555433 34445779999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSR-PIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|+++|+|.+++.+. ..+++..+..++.|++.||.||| ++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 85 y~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp CCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999875 67999999999999999999999 74 89999999999999999999999999998654
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccC
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMG 271 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~ 271 (347)
.. ...+..||+.|+|||++.+..|++++||||+||++|||+ +|+.||...
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell-~G~~Pf~~~ 206 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA-VGRYPIPPP 206 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHH-HSSCCSSCC
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHH-HCCCCCCCC
Confidence 32 123468999999999999999999999999999999999 899999653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=393.85 Aligned_cols=262 Identities=20% Similarity=0.310 Sum_probs=204.7
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCc------eEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCC
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDR------TISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVE 131 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~------~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 131 (347)
..++|+..+.||+|+||+||+|++ ..+ .|++|++.........+.+.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 346788999999999999999998 222 35555554444444557799999999998 8999999999999999
Q ss_pred ccEEEEEeCCCCCHHHHHhhhcc------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQ------------------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLK 193 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlk 193 (347)
..++|||||++|+|.+++..... .....+++..++.++.|++.||+||| +++|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence 99999999999999999976321 11235899999999999999999999 9999999999
Q ss_pred CCCeEECCCCceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCc
Q 045067 194 SSYILVSERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGL 272 (347)
Q Consensus 194 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~ 272 (347)
|+|||++.++.+||+|||+|+........ ...+..||+.|+|||++.+..++.++|||||||++|||++.|++||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544332 23456789999999999999999999999999999999955999996432
Q ss_pred cCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 045067 273 RLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKK 342 (347)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~ 342 (347)
. . .........+.. +.. +...++++.+|+.+||+.||++|||++||++.|..
T Consensus 272 ~----~----~~~~~~~~~~~~-------~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 V----D----ANFYKLIQNGFK-------MDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp C----S----HHHHHHHHTTCC-------CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H----H----HHHHHHHhcCCC-------CCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1 1 112222332211 001 11234578899999999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-55 Score=383.83 Aligned_cols=259 Identities=20% Similarity=0.284 Sum_probs=196.8
Q ss_pred hccCCCCCeecccCceEEEEEEe-C-Cc--e-EEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-P-DR--T-ISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~--~-~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
.++|+..+.||+|+||+||+|++ . ++ . +++|++.........+.+.+|+.++++++||||+++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 46788899999999999999998 2 22 2 44444434444455677999999999999999999999986 467899
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
||||+++|+|.+++... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus 85 v~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEeccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhee
Confidence 99999999999988653 367999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcc
Q 045067 216 IPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFN 295 (347)
Q Consensus 216 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (347)
.............||+.|+|||++.+..++.++|||||||++|||++.|.+||..... ....... ..+...
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--------~~~~~~i-~~~~~~ 228 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRI-ENGERL 228 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHH-HTTCCC
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--------HHHHHHH-HcCCCC
Confidence 6654444445567899999999999999999999999999999999669999975432 1112222 222111
Q ss_pred cccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 296 GIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
. .+...++++.+|+.+||+.||++|||+.||++.|+++.++
T Consensus 229 ~----------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 P----------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C----------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1 1112345688999999999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-54 Score=385.91 Aligned_cols=252 Identities=19% Similarity=0.237 Sum_probs=187.8
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
+.+.|+..+.||+|+||+||+|.. .++..+++|.+. .......+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 346689999999999999999998 455555555444 333333466889999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC---CCCceEEecCCCCc
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS---ERYVPKLFNFSLSA 214 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~a~ 214 (347)
|||+||+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||+. +++.+||+|||+|+
T Consensus 87 E~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp CCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred eccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999764 67999999999999999999999 99999999999999995 57899999999998
Q ss_pred cCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
....... .....||+.|+|||++.+..+++++||||+||++|||+ +|++||..... ........... .
T Consensus 159 ~~~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell-~g~~Pf~~~~~--------~~~~~~i~~~~-~ 226 (307)
T d1a06a_ 159 MEDPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL-CGYPPFYDEND--------AKLFEQILKAE-Y 226 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHHHHHTTC-C
T ss_pred EccCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHH-hCCCCCCCCCH--------HHHHHHHhccC-C
Confidence 6644322 23467999999999999999999999999999999999 89999964321 22222222221 1
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .. .......++++.+++.+||+.||++|||+.|+++
T Consensus 227 ~--~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 E--FD-----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp C--CC-----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C--CC-----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 00 0111233567889999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=385.94 Aligned_cols=260 Identities=23% Similarity=0.297 Sum_probs=200.3
Q ss_pred HHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 59 RATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 59 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
...++|+..+.||+|+||+||+|++.++..+++|.+..... ..+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 33578999999999999999999994443344455554433 34789999999999999999999999854 56799999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+++|+|..++... ....+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 92 y~~~g~l~~~~~~~---~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 92 YMSKGSLLDFLKGE---TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp CCTTCBHHHHHSHH---HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred ecCCCchhhhhhhc---ccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence 99999999998753 2256999999999999999999999 99999999999999999999999999999987755
Q ss_pred CCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIV 298 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (347)
..........||+.|+|||++.++.++.++|||||||++|||++.|.+|+.... ............. .
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--------~~~~~~~i~~~~~-~--- 233 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQVERGYR-M--- 233 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHHTTCC-C---
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhcCC-C---
Confidence 444444456799999999999999999999999999999999955666665321 2222222222111 0
Q ss_pred CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 299 DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
. .....++++.+++.+||+.||++|||+.+|++.|+++..
T Consensus 234 --~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 234 --P-----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp --C-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred --C-----CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 0 111234568899999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=386.47 Aligned_cols=248 Identities=18% Similarity=0.232 Sum_probs=200.2
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||+||+|.+ .++..+++|++... .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6799999999999999999998 45554555544321 1223467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+++|+|.+++... +.+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999999875 78999999999999999999999 9999999999999999999999999999998775
Q ss_pred CCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 218 EGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 218 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
.... .......||+.|+|||++.+..++.++||||+||++|||+ +|++||.... ........... ..
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell-~g~~Pf~~~~--------~~~~~~~i~~~-~~-- 227 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV-AGLPPFRAGN--------EYLIFQKIIKL-EY-- 227 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH-HSSCSSCCSS--------HHHHHHHHHTT-CC--
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHh-hCCCCCCCcC--------HHHHHHHHHcC-CC--
Confidence 4322 2234567999999999999999999999999999999999 9999997432 12222222221 11
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.++ ...++++.+|+.+||+.||++|||++|+++
T Consensus 228 ----~~p-----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 ----DFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----CCC-----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----CCC-----ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 010 122456789999999999999999998754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.5e-54 Score=388.23 Aligned_cols=252 Identities=16% Similarity=0.192 Sum_probs=206.6
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
-++|+..+.||+|+||.||+|.. .++..+++|.+........+.+.+|+.+|++++||||+++++++.+++.+++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999998 55555555555555555567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC--CCCceEEecCCCCccCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS--ERYVPKLFNFSLSASIP 217 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~a~~~~ 217 (347)
|+||+|.+++.+. ...+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+|+...
T Consensus 105 ~~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 105 MSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence 9999999999652 257999999999999999999999 99999999999999996 46789999999998776
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... .....||+.|+|||++.+..++.++||||+||++|+|+ +|+.||.... ............ ..
T Consensus 178 ~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell-~G~~Pf~~~~--------~~~~~~~i~~~~-~~-- 243 (350)
T d1koaa2 178 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL-SGLSPFGGEN--------DDETLRNVKSCD-WN-- 243 (350)
T ss_dssp TTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH-HSSCSSCCSS--------HHHHHHHHHHTC-CC--
T ss_pred cccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHH-hCCCCCCCCC--------HHHHHHHHHhCC-CC--
Confidence 5433 24467999999999999999999999999999999999 8999996432 122233322221 10
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ........++++.+|+.+||+.||++|||++|+++
T Consensus 244 ----~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 244 ----M-DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ----S-CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ----C-CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 01112234567889999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-54 Score=383.91 Aligned_cols=245 Identities=21% Similarity=0.237 Sum_probs=197.9
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
+.|+..+.||+|+||+||+|++ .++..+++|.+.... ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3488899999999999999998 555555555444332 233467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|||++|+|..++... ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+|....
T Consensus 95 E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999998776653 67999999999999999999999 9999999999999999999999999999997654
Q ss_pred CCCceeeccccccCCccccccccc---CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYART---GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
.. ....||+.|+|||++.+ +.|+.++|||||||++|||+ +|..||.... .............
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~-~g~~Pf~~~~--------~~~~~~~i~~~~~- 231 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMN--------AMSALYHIAQNES- 231 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHH-HSSCTTTTSC--------HHHHHHHHHHSCC-
T ss_pred CC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHH-HCCCCCCCCC--------HHHHHHHHHhCCC-
Confidence 32 34579999999998864 46899999999999999999 8999996432 1222223222211
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... ...++++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~---------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PALQS---------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCSC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCC---------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111 122456889999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.4e-55 Score=386.77 Aligned_cols=269 Identities=23% Similarity=0.334 Sum_probs=211.2
Q ss_pred HHHHHHhccCCCCCeecccCceEEEEEEeC------Cc-eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeee
Q 045067 55 KELERATNNYHYRNIITESSIFRLCQGVLP------DR-TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCC 127 (347)
Q Consensus 55 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 127 (347)
.+++...++|+..+.||+|+||+||+|++. ++ .||+|++.........+++.+|+.++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345556778999999999999999999872 23 45555544434444557799999999999999999999999
Q ss_pred eeCCccEEEEEeCCCCCHHHHHhhhc-------------------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 045067 128 LEVEIPVLVFESAEYGNLHDLLKRSY-------------------QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIV 188 (347)
Q Consensus 128 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~iv 188 (347)
.+.+..+++|||+++|+|.+++.... ......+++..++.++.|++.||+||| +.+++
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeE
Confidence 99999999999999999999996521 111235889999999999999999999 99999
Q ss_pred eccCCCCCeEECCCCceEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCc
Q 045067 189 FRDLKSSYILVSERYVPKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDL 267 (347)
Q Consensus 189 H~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p 267 (347)
||||||+|||+|.++.+||+|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||++.+.+|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999999999999999999999999976543322 2234567899999999999999999999999999999999555678
Q ss_pred cccCccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 268 FNMGLRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
|..... .+.... ...+..... +...++++.+|+.+||+.+|++||||.||++.|++|.+
T Consensus 243 ~~~~~~--------~e~~~~-v~~~~~~~~----------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 243 YYGMAH--------EEVIYY-VRDGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTTSCH--------HHHHHH-HHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCH--------HHHHHH-HHcCCCCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 864321 222222 233222111 11234568899999999999999999999999999853
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=377.41 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=198.3
Q ss_pred hccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee-CCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE-VEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 139 (347)
.++|+..+.||+|+||.||+|.+.+..+|+|++... ...+.+.+|+.++++++||||++++|++.+ .+.+++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356788899999999999999998777777665432 234779999999999999999999999865 4568999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+++|+|.+++... ....+++..+++++.|++.||.||| +.+|+||||||+|||++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~---~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CTTEEHHHHHHHH---HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999999753 1235899999999999999999999 999999999999999999999999999999765432
Q ss_pred CceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccccC
Q 045067 220 ETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGIVD 299 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (347)
. ....+|+.|+|||++.+..+++++|||||||++|||++.|++||..... . +.... ...+..
T Consensus 157 ~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~---~~~~~-i~~~~~----- 218 (262)
T d1byga_ 157 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----K---DVVPR-VEKGYK----- 218 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----G---GHHHH-HTTTCC-----
T ss_pred C----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----H---HHHHH-HHcCCC-----
Confidence 2 2356889999999999999999999999999999999558998865322 1 11111 222111
Q ss_pred CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 300 PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
+.. +...++++.+|+.+||+.||.+||||.+|++.|++|+.
T Consensus 219 ~~~-----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 MDA-----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC-----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 111 11234568899999999999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=376.99 Aligned_cols=251 Identities=21% Similarity=0.246 Sum_probs=203.2
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC-C-----chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCcc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS-V-----FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~-~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 133 (347)
.+.|+..+.||+|+||+||+|.+ .++..+++|++... . ....+.+.+|+.+|++++||||+++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46789999999999999999998 45554444444321 1 12347799999999999999999999999999999
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC----ceEEec
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY----VPKLFN 209 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~----~~kl~D 209 (347)
++|||||++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++ .+|++|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecc
Confidence 9999999999999999875 67999999999999999999999 99999999999999998776 599999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYI 289 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 289 (347)
||+|........ .....||+.|+|||++.+..++.++||||+||++|||+ +|+.||..... ........
T Consensus 161 fG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell-~g~~Pf~~~~~--------~~~~~~i~ 229 (293)
T d1jksa_ 161 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILL-SGASPFLGDTK--------QETLANVS 229 (293)
T ss_dssp CTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHH
T ss_pred hhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHH-cCCCCCCCCCH--------HHHHHHHH
Confidence 999987754432 24467999999999999999999999999999999999 89999964321 12222222
Q ss_pred hccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 290 ENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .... .........+..+.+|+.+||+.||++|||++|+++
T Consensus 230 ~-~~~~-------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 230 A-VNYE-------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp T-TCCC-------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h-cCCC-------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1110 011112234567889999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-54 Score=384.53 Aligned_cols=257 Identities=18% Similarity=0.303 Sum_probs=202.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc-----eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR-----TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~-----~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 135 (347)
++|+..++||+|+||+||+|.+ .++ +||+|++.........+++.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 3588999999999999999998 333 36666665544445567899999999999999999999999864 5678
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
++|++.+|+|.+.+... ...+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+.
T Consensus 88 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 89999999999988763 367999999999999999999999 89999999999999999999999999999987
Q ss_pred CCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCc
Q 045067 216 IPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGF 294 (347)
Q Consensus 216 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (347)
....... ......||+.|+|||++.++.++.++|||||||++|||++.|.+||..... . . +......+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----~---~-~~~~i~~~~~ 231 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----S---E-ISSILEKGER 231 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----G---G-HHHHHHHTCC
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----H---H-HHHHHHcCCC
Confidence 7654332 223456899999999999999999999999999999999558999975322 1 1 1122222211
Q ss_pred ccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 295 NGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
+.. +...++++.+++.+||+.||++|||+.||++.|+++.+
T Consensus 232 -------~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 232 -------LPQ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -------CCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCC---CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 111 11234568899999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-53 Score=384.77 Aligned_cols=253 Identities=17% Similarity=0.188 Sum_probs=207.5
Q ss_pred HhccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 60 ATNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 60 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
..+.|+..+.||+|+||+||+|.. .++..+++|++........+.+.+|+.+|++++||||+++++++.+++.+|||||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 346799999999999999999998 5566666666655554555778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEEC--CCCceEEecCCCCccC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVS--ERYVPKLFNFSLSASI 216 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~a~~~ 216 (347)
||+||+|.+.+... ...+++..+..++.||+.||+||| +.||+||||||+|||++ .++.+||+|||+|+..
T Consensus 107 ~~~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 107 FLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp CCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred cCCCChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceec
Confidence 99999999988652 356999999999999999999999 99999999999999998 6789999999999887
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..... .....||+.|+|||++.+..++.++||||+||++|+|+ +|++||..... .......... ...
T Consensus 180 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell-tG~~Pf~~~~~--------~~~~~~i~~~-~~~- 246 (352)
T d1koba_ 180 NPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL-SGLSPFAGEDD--------LETLQNVKRC-DWE- 246 (352)
T ss_dssp CTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH-HSCCSSCCSSH--------HHHHHHHHHC-CCC-
T ss_pred CCCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhC-CCC-
Confidence 65433 24467999999999999999999999999999999999 99999964321 2222222221 111
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. .......++++.+|+.+||+.||.+|||+.|+++
T Consensus 247 -~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 -FD-----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp -CC-----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -CC-----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 1111233557889999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=379.79 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=204.5
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCc---eEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDR---TISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~---~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 136 (347)
++|+..++||+|+||+||+|++ +++ .|+||++.........+.+.+|+.+|+++ +||||++++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6788889999999999999999 333 24455554444444557899999999999 799999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhc-----------cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCce
Q 045067 137 FESAEYGNLHDLLKRSY-----------QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVP 205 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~ 205 (347)
|||+++|+|.+++.... ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 99999999999997531 123467999999999999999999999 9999999999999999999999
Q ss_pred EEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 206 KLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 206 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
||+|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++.+.+||.... .....
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELY 236 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHH
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--------HHHHH
Confidence 9999999976543222 2345689999999999999999999999999999999955667886432 12222
Q ss_pred HHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 286 KKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
... ..+.. +.. +...++++.+|+.+||+.||++||||.||++.|+++.++
T Consensus 237 ~~i-~~~~~-----~~~-----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 EKL-PQGYR-----LEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHG-GGTCC-----CCC-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHH-HhcCC-----CCC-----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 222 22111 111 112345788999999999999999999999999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=378.08 Aligned_cols=273 Identities=19% Similarity=0.313 Sum_probs=203.6
Q ss_pred CHHHHHHHhccCCCCCeecccCceEEEEEEe-C-----CceEEEEEEcc-CCCchhHHHHHHHHHHHHhc-CCCceeeee
Q 045067 53 SAKELERATNNYHYRNIITESSIFRLCQGVL-P-----DRTISVVKFID-GSVFDAYDCCFNNIVFASQM-SHNNVLRLI 124 (347)
Q Consensus 53 ~~~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~-----~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 124 (347)
...+++...++|+..+.||+|+||.||+|.+ . ++..+++|.+. .......+.+.+|..++.++ +||||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 3345555557899999999999999999997 2 22344444444 34444556788899988887 689999999
Q ss_pred eeeeeC-CccEEEEEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 045067 125 GCCLEV-EIPVLVFESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDL 192 (347)
Q Consensus 125 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dl 192 (347)
+++..+ ..+++|||||++|+|.+++..... .....+++..+..++.|++.||+||| +++|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcC
Confidence 987764 468999999999999999975321 01245899999999999999999999 999999999
Q ss_pred CCCCeEECCCCceEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccC
Q 045067 193 KSSYILVSERYVPKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMG 271 (347)
Q Consensus 193 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~ 271 (347)
||+|||++.++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||++.+.+||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 2345679999999999999999999999999999999995567888643
Q ss_pred ccCCCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 272 LRLNGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
.. . .........+..... +...++++.+++.+||+.||++|||+.|+++.|++|.++
T Consensus 241 ~~-------~-~~~~~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 241 KI-------D-EEFCRRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CC-------S-HHHHHHHHHTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CH-------H-HHHHHHHhcCCCCCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 21 1 122222222221111 112345688999999999999999999999999999764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=379.81 Aligned_cols=247 Identities=16% Similarity=0.174 Sum_probs=203.2
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||+|.. .++..+++|++.+. .....+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999998 55555555554432 1223467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|||+||+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.+|.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999876 68999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... .....+||+.|+|||++.+..|+.++||||+||++|||+ +|++||..... .......... ...
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml-~G~~pf~~~~~--------~~~~~~i~~~-~~~-- 223 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM-CGRLPFYNQDH--------ERLFELILME-EIR-- 223 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHC-CCC--
T ss_pred cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHH-HCCCCCCCcCH--------HHHHHHHhcC-CCC--
Confidence 4332 234578999999999999999999999999999999999 89999975321 2222222221 110
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-----MIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-----~~ell~ 338 (347)
. +...++++.+|+.+||++||++||+ +.|+++
T Consensus 224 ----~-----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 ----F-----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----C-----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----C-----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 1123456789999999999999995 777765
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=377.34 Aligned_cols=270 Identities=19% Similarity=0.239 Sum_probs=203.2
Q ss_pred ccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHH--HHHHHHhcCCCceeeeeeeeeeCC----ccEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFN--NIVFASQMSHNNVLRLIGCCLEVE----IPVL 135 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~~~~~~~~----~~~l 135 (347)
.+|...+.||+|+||+||+|++++..||+|++... ..+.+.+ |+..+.+++||||+++++++.+.+ .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 45777789999999999999998888777665322 1233444 444556789999999999998654 5799
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeEeccCCCCCeEECCCCceEEecC
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGF-----SRPIVFRDLKSSYILVSERYVPKLFNF 210 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~-----~~~ivH~dlkp~Nill~~~~~~kl~Df 210 (347)
|||||++|+|.+++++ ..+++..+.+++.+++.||+|||+.. +++|+||||||+|||++.++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 9999999999999987 46999999999999999999999321 269999999999999999999999999
Q ss_pred CCCccCCCCCce---eeccccccCCcccccccccCC------CCCccchHHHHHHHHHHHhcCCCccccCccCCCC----
Q 045067 211 SLSASIPEGETY---IDDGVKGTSGIVAPEYARTGY------LNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGD---- 277 (347)
Q Consensus 211 g~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~---- 277 (347)
|+++........ ......||+.|+|||++.+.. ++.++|||||||++|||+ +|.+||.........
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~-tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA-RRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH-HTBCBTTBCCCCCCTTTTT
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHh-hCCCCCCcccccccchhhc
Confidence 999876544322 223567999999999887643 567899999999999999 888887543321110
Q ss_pred --CchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 278 --ESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 278 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
............... ..++.+.........+..+.+++.+||+.||++|||+.||++.|++|.++
T Consensus 232 ~~~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCSSCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 011112222222222 22233333333345567789999999999999999999999999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-53 Score=374.92 Aligned_cols=255 Identities=22% Similarity=0.378 Sum_probs=200.5
Q ss_pred CCeecccCceEEEEEEe-CC-c---eEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-CccEEEEEeC
Q 045067 67 RNIITESSIFRLCQGVL-PD-R---TISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV-EIPVLVFESA 140 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~-~~-~---~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 140 (347)
.++||+|+||+||+|++ ++ + .+|||++.........+++.+|+.++++++||||++++|++.+. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999998 32 2 35555554444555567899999999999999999999998764 5789999999
Q ss_pred CCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCCC
Q 045067 141 EYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEGE 220 (347)
Q Consensus 141 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 220 (347)
++|+|.+++... ...+++..+++++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999998763 356788999999999999999999 9999999999999999999999999999998765443
Q ss_pred ce---eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 221 TY---IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 221 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.. ......||+.|+|||.+.+..++.++||||||+++|||+ ++..||..... ..+....... +. ..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~-t~~~p~~~~~~-------~~~~~~~i~~-g~--~~ 253 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM-TRGAPPYPDVN-------TFDITVYLLQ-GR--RL 253 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH-TTSCCSCC-------------CHHHHHT-TC--CC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHH-HCCCCCCCCCC-------HHHHHHHHHc-CC--CC
Confidence 22 223456899999999999999999999999999999999 54444432211 1111222222 11 11
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhC
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKSF 347 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~~ 347 (347)
..+ ...++++.+|+.+||+.||++||||.||++.|+++.++|
T Consensus 254 ~~p--------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 254 LQP--------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp CCC--------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCc--------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 111 122456889999999999999999999999999998875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.1e-52 Score=367.37 Aligned_cols=260 Identities=18% Similarity=0.288 Sum_probs=202.2
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC----c
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE----I 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 132 (347)
.++|...+.||+|+||+||+|.+ .++..+++|++.... ....+.+.+|+.++++++||||+++++++.+.+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999998 555555555554332 233467899999999999999999999988654 3
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
+|+||||++||+|.+++... +.+++.++..++.|++.||+||| +.+|+||||||+|||++.++..+++|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhh
Confidence 78999999999999999875 68999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCc--eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 213 SASIPEGET--YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 213 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
+........ .......||+.|+|||++.+..+++++||||+||++|||+ +|++||.... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyell-tG~~Pf~~~~--------~~~~~~~~~~ 228 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL-TGEPPFTGDS--------PVSVAYQHVR 228 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCSCCCSS--------HHHHHHHHHH
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHH-hCCCCCCCcC--------HHHHHHHHHh
Confidence 876543322 2234567999999999999999999999999999999999 9999996432 1223333333
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-TMIDVAKQIKKMYK 345 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-s~~ell~~L~~i~~ 345 (347)
..... + .......++++.+++.+||+.||++|| |++++++.|.++..
T Consensus 229 ~~~~~----~----~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 229 EDPIP----P----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp CCCCC----G----GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred cCCCC----C----chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 32211 0 011112345688999999999999999 89999999998753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-52 Score=373.80 Aligned_cols=244 Identities=20% Similarity=0.287 Sum_probs=201.8
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||+||+|.+ .++..+++|++... .....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5788999999999999999998 55555555554322 1223467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
|||+||+|..++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 999999999999875 67899999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
... ...+||+.|+|||++.+..++.++||||+||++|||+ +|+.||.... ............ ..
T Consensus 156 ~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyeml-tG~~Pf~~~~--------~~~~~~~i~~~~-~~-- 219 (316)
T d1fota_ 156 DVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML-AGYTPFYDSN--------TMKTYEKILNAE-LR-- 219 (316)
T ss_dssp SCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHH-HSSCTTCCSS--------HHHHHHHHHHCC-CC--
T ss_pred ccc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHH-hCCCCCCCcC--------HHHHHHHHHcCC-CC--
Confidence 432 3468999999999999999999999999999999999 8999996432 122223332221 10
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
.. ...++++.+++.+||+.||.+|| |++++++
T Consensus 220 ~p---------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 FP---------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CC---------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CC---------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 01 12245678999999999999996 8999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-52 Score=364.79 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=202.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCc---------hhHHHHHHHHHHHHhcC-CCceeeeeeeeee
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF---------DAYDCCFNNIVFASQMS-HNNVLRLIGCCLE 129 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 129 (347)
.++|+..+.||+|+||+||+|+. .++..+++|++..... ...+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36789999999999999999998 5565555555443221 12346889999999997 9999999999999
Q ss_pred CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 130 VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 130 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
++.+||||||+++|+|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEcc
Confidence 99999999999999999999875 68999999999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCceeeccccccCCccccccccc------CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYART------GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
||+++....... .....||+.|+|||.+.+ ..++.++||||+||++|||+ +|+.||..... ..
T Consensus 154 FG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml-~g~~Pf~~~~~--------~~ 222 (277)
T d1phka_ 154 FGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL-AGSPPFWHRKQ--------ML 222 (277)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HH
T ss_pred chheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhc-cCCCCCCCCCH--------HH
Confidence 999988765432 344679999999998763 35688999999999999999 89999974321 22
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........ ... . ........++++.+++.+||++||++|||+.|+++
T Consensus 223 ~~~~i~~~-~~~-~------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 223 MLRMIMSG-NYQ-F------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHHT-CCC-C------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHhC-CCC-C------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22222222 111 0 01112234567899999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-53 Score=368.02 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=196.2
Q ss_pred ccCCCCCeecccCceEEEEEEe--CCc--eEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL--PDR--TISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~--~~~--~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
++|+..+.||+|+||+||+|.+ +++ ..+++|.+... .....+.|.+|+.++++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5688889999999999999987 222 23344444332 23445789999999999999999999999976 5678
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+||||+++|+|.+.+... ...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhh
Confidence 999999999999988764 256999999999999999999999 8999999999999999999999999999999
Q ss_pred cCCCCCcee--eccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhcc
Q 045067 215 SIPEGETYI--DDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENR 292 (347)
Q Consensus 215 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (347)
......... .....||..|+|||.+.+..++.++|||||||++|||++.|++||.... ...........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--------~~~~~~~i~~~~ 231 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEG 231 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC--------HHHHHHHHHhCC
Confidence 876544322 2345678899999999999999999999999999999955899996432 122333333322
Q ss_pred CcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 045067 293 GFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKM 343 (347)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i 343 (347)
.... .+...+..+.+++.+||+.||++|||+.||++.|++.
T Consensus 232 ~~~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ERLP----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC----------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1110 0112345688999999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=371.18 Aligned_cols=263 Identities=19% Similarity=0.263 Sum_probs=204.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CC-------ceEEEEEEcc-CCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeeeC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PD-------RTISVVKFID-GSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLEV 130 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-------~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 130 (347)
.++|...+.||+|+||.||+|+. .. ...+++|.+. .........+.+|+..+.++ +||||++++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 46788889999999999999987 22 1244445444 34444557789999999998 799999999999999
Q ss_pred CccEEEEEeCCCCCHHHHHhhhcc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEE
Q 045067 131 EIPVLVFESAEYGNLHDLLKRSYQ-----------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILV 199 (347)
Q Consensus 131 ~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill 199 (347)
+..++||||+++|+|.+++..... .....+++.+++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 999999999999999999975311 12346899999999999999999999 9999999999999999
Q ss_pred CCCCceEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCC
Q 045067 200 SERYVPKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDE 278 (347)
Q Consensus 200 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~ 278 (347)
+.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||++.|.+||.....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----- 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-----
Confidence 9999999999999987654332 2234467899999999999999999999999999999999558999864321
Q ss_pred chHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 279 SFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
..+...+..+.... . +...++.+.+|+.+||+.||++|||+.||++.|++|..
T Consensus 244 ----~~~~~~i~~~~~~~-----~-----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 ----EELFKLLKEGHRMD-----K-----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ----HHHHHHHHTTCCCC-----C-----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCCCCC-----C-----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 22223333322111 1 11234568899999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=371.41 Aligned_cols=251 Identities=16% Similarity=0.199 Sum_probs=205.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
.++|...+.||+|+||+||+|.+ .++..+++|.+...... ...+.+|+.+|++++||||+++++++.+++.+|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 46788999999999999999999 56666666766655433 35688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC--CCceEEecCCCCccCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE--RYVPKLFNFSLSASIP 217 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~a~~~~ 217 (347)
|+||+|.+++... ...+++.++..++.|++.||.||| +.+|+||||||+|||++. ...+||+|||+++...
T Consensus 83 ~~gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 83 ISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999753 247999999999999999999999 999999999999999985 4589999999998765
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.... .....+|+.|+|||...+..++.++||||+||++|+|+ +|.+||..... ............
T Consensus 156 ~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll-~G~~Pf~~~~~--------~~~~~~i~~~~~---- 220 (321)
T d1tkia_ 156 PGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL-SGINPFLAETN--------QQIIENIMNAEY---- 220 (321)
T ss_dssp TTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH-HSSCTTCCSSH--------HHHHHHHHHTCC----
T ss_pred cCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHH-hCCCCCCCCCH--------HHHHHHHHhCCC----
Confidence 4432 23467899999999999999999999999999999999 89999964321 223333322211
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.. ........+.++.+|+.+||+.||++|||+.|+++
T Consensus 221 ---~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 221 ---TF-DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---CC-CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CC-ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 11111223557889999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=371.22 Aligned_cols=269 Identities=20% Similarity=0.313 Sum_probs=212.4
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEe------CCc-eEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeee
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVL------PDR-TISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCL 128 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~-~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 128 (347)
++...++|+..+.||+|+||.||+|++ ..+ .+|||++...........+.+|+.+++++ +|||||++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 344457888899999999999999986 233 45555544444444556799999999999 6999999999999
Q ss_pred eCCccEEEEEeCCCCCHHHHHhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 045067 129 EVEIPVLVFESAEYGNLHDLLKRSYQ-------------SHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSS 195 (347)
Q Consensus 129 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~ 195 (347)
+++..++|||||++|+|.+++..... .....+++..+..++.|++.||+||| +++++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccc
Confidence 99999999999999999999976421 12236899999999999999999999 999999999999
Q ss_pred CeEECCCCceEEecCCCCccCCCCCc-eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccC
Q 045067 196 YILVSERYVPKLFNFSLSASIPEGET-YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRL 274 (347)
Q Consensus 196 Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~ 274 (347)
||+++.++.+|++|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++.|.+||.....
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~- 253 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV- 253 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS-
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999987765433 3334567899999999999999999999999999999999557777754321
Q ss_pred CCCCchHHHHHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 275 NGDESFEMDFVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
...+......+... .. +...+..+.+|+.+||+.||++||||++|++.|+++.++
T Consensus 254 -------~~~~~~~i~~~~~~--~~--------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 -------DSKFYKMIKEGFRM--LS--------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -------SHHHHHHHHHTCCC--CC--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHHHHHhcCCCC--CC--------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 11222222222110 00 112345688999999999999999999999999987653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-52 Score=371.74 Aligned_cols=251 Identities=16% Similarity=0.185 Sum_probs=196.7
Q ss_pred hccCCCCC-eecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhc-CCCceeeeeeeeee----CCcc
Q 045067 61 TNNYHYRN-IITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQM-SHNNVLRLIGCCLE----VEIP 133 (347)
Q Consensus 61 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 133 (347)
.++|.... +||+|+||+||+|.+ .++..+++|++... ..+.+|+.++.++ +||||+++++++.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46787764 699999999999998 55555555555432 5578899987665 89999999999876 4578
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC---CCceEEecC
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE---RYVPKLFNF 210 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Df 210 (347)
|+|||||+||+|.+++... ....+++.++..++.|++.||+||| +.+|+||||||+|||++. ++.+||+||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEECCCCCcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccc
Confidence 9999999999999999763 2357999999999999999999999 999999999999999985 567999999
Q ss_pred CCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 211 SLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 211 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
|+|+....... .....||+.|+|||++.+..|+.++||||+||++|+|+ +|++||........ .. ....
T Consensus 159 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ll-tg~~Pf~~~~~~~~-----~~---~~~~ 227 (335)
T d2ozaa1 159 GFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL-CGYPPFYSNHGLAI-----SP---GMKT 227 (335)
T ss_dssp TTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHT-TSSCSCEETTCC----------------
T ss_pred ceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHh-hCCCCCCCCCHHHH-----HH---HHHH
Confidence 99987655433 24567999999999999999999999999999999999 99999975432100 00 0000
Q ss_pred ccCcccccCCccC-CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 NRGFNGIVDPRII-GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+...... ........++++.+|+.+||+.||++|||+.|+++
T Consensus 228 -----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 228 -----RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00001110 11122345678999999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-52 Score=374.16 Aligned_cols=244 Identities=17% Similarity=0.217 Sum_probs=201.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 137 (347)
++|+..+.||+|+||.||+|.+ .++..+++|++... .....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999998 45555555544321 1223467899999999999999999999999999999999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIP 217 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~ 217 (347)
||+.+|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999999875 67999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCcccc
Q 045067 218 EGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNGI 297 (347)
Q Consensus 218 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (347)
.. .....||+.|+|||++.+..++.++|||||||++|||+ +|++||.... ............ ..
T Consensus 193 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyeml-tG~~Pf~~~~--------~~~~~~~i~~~~-~~-- 256 (350)
T d1rdqe_ 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA-AGYPPFFADQ--------PIQIYEKIVSGK-VR-- 256 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSS--------HHHHHHHHHHCC-CC--
T ss_pred cc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHH-hCCCCCCCcC--------HHHHHHHHhcCC-CC--
Confidence 33 23467999999999999999999999999999999999 9999996432 122222222221 10
Q ss_pred cCCccCCchhhHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 045067 298 VDPRIIGDELLEHKLQSSFELAFQCQSASAEDRP-----TMIDVAK 338 (347)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RP-----s~~ell~ 338 (347)
. +...++++.+++.+||+.||.+|+ |++|+++
T Consensus 257 ----~-----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 ----F-----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----C-----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----C-----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0 112345688999999999999994 8999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-52 Score=368.29 Aligned_cols=267 Identities=20% Similarity=0.309 Sum_probs=211.1
Q ss_pred HHHHhccCCCCCeecccCceEEEEEEeC-------CceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeee
Q 045067 57 LERATNNYHYRNIITESSIFRLCQGVLP-------DRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE 129 (347)
Q Consensus 57 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 129 (347)
++...++|...+.||+|+||+||+|.+. +..||||++...........+.+|+.++++++||||+++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3444578888999999999999999872 234566655444444555678999999999999999999999999
Q ss_pred CCccEEEEEeCCCCCHHHHHhhhc-----cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCc
Q 045067 130 VEIPVLVFESAEYGNLHDLLKRSY-----QSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYV 204 (347)
Q Consensus 130 ~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~ 204 (347)
++..++||||+++|+|.+++.... ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCce
Confidence 999999999999999999986431 112234789999999999999999999 999999999999999999999
Q ss_pred eEEecCCCCccCCCCCce-eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHH
Q 045067 205 PKLFNFSLSASIPEGETY-IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMD 283 (347)
Q Consensus 205 ~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 283 (347)
+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||++.+++||.... ...
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--------~~~ 243 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------NEQ 243 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------HHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--------HHH
Confidence 999999999876543322 23345689999999999999999999999999999999965678885432 222
Q ss_pred HHHHHHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 284 FVKKYIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
......+ +..... +...+..+.+++.+||+.+|++|||+.+|++.|++..+
T Consensus 244 ~~~~i~~-~~~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 VLRFVME-GGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HHHHHHT-TCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHh-CCCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 3332222 221110 11234568899999999999999999999999987643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-52 Score=370.37 Aligned_cols=247 Identities=19% Similarity=0.232 Sum_probs=200.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC---CchhHHHHHHHHHHHH-hcCCCceeeeeeeeeeCCccEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS---VFDAYDCCFNNIVFAS-QMSHNNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 136 (347)
++|...+.||+|+||+||+|.+ .++..+++|++... .....+.+.+|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5788999999999999999999 55555555554432 1223456778887765 68999999999999999999999
Q ss_pred EEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccC
Q 045067 137 FESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASI 216 (347)
Q Consensus 137 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~ 216 (347)
|||+++|+|.+++... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999999876 67999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccCccc
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRGFNG 296 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (347)
..... ......||+.|+|||++.+..+++++||||+||++|||+ +|+.||..... ......... +..
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyeml-tG~~PF~~~~~--------~~~~~~i~~-~~~-- 220 (320)
T d1xjda_ 154 MLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML-IGQSPFHGQDE--------EELFHSIRM-DNP-- 220 (320)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHH-CCC--
T ss_pred ccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHH-hCCCCCCCCCH--------HHHHHHHHc-CCC--
Confidence 54332 234568999999999999999999999999999999999 89999974321 122222222 111
Q ss_pred ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 045067 297 IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMI-DVAK 338 (347)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~-ell~ 338 (347)
.. +...++++.+|+.+||+.||++|||+. |+++
T Consensus 221 ----~~-----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ----FY-----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CC-----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CC-----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 112245688999999999999999985 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-51 Score=375.12 Aligned_cols=248 Identities=17% Similarity=0.186 Sum_probs=194.4
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC---chhHHHHHH---HHHHHHhcCCCceeeeeeeeeeCCccE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV---FDAYDCCFN---NIVFASQMSHNNVLRLIGCCLEVEIPV 134 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 134 (347)
++|...++||+|+||.||+|.. .++..+++|++.... ......+.+ |+.+++.++||||+++++++.+++.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5789999999999999999999 555555555543221 111123344 466777788999999999999999999
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
+|||||++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999875 67899999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCceeeccccccCCcccccccc-cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhccC
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIENRG 293 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (347)
...... .....||+.|+|||++. +..+++++||||+||++|||+ +|+.||..... ........... .
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyeml-tG~~Pf~~~~~-----~~~~~~~~~~~-~-- 223 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL-RGHSPFRQHKT-----KDKHEIDRMTL-T-- 223 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHH-HSSCSSCSSCS-----SCHHHHHHHSS-S--
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHH-hCCCCCCCCCH-----HHHHHHHHhcc-c--
Confidence 765432 23467999999999886 457899999999999999999 89999975322 11111111100 0
Q ss_pred cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 045067 294 FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-----MIDVAK 338 (347)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-----~~ell~ 338 (347)
.. ... +...++++.+|+.+||+.||++||| ++|+++
T Consensus 224 ~~----~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 MA----VEL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC----CCC-----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC----CCC-----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00 000 1123456889999999999999999 677764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=364.11 Aligned_cols=255 Identities=19% Similarity=0.143 Sum_probs=192.0
Q ss_pred CCCeecccCceEEEEEEe-CCceEEEEEEccCCCc-----hhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 66 YRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVF-----DAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 66 ~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
..++||+|+||+||+|.+ .++..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 346899999999999998 5555555555443221 1235688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+.++++..+.... ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 82 METDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCC
Confidence 9987777666543 67999999999999999999999 999999999999999999999999999999876543
Q ss_pred CceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc---cCcc
Q 045067 220 ETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN---RGFN 295 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 295 (347)
... .....||+.|+|||++.+ ..++.++||||+||++|||+ +|.+||..... .+......+. ....
T Consensus 154 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~-~g~~pf~~~~~--------~~~l~~i~~~~~~~~~~ 223 (299)
T d1ua2a_ 154 NRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL-LRVPFLPGDSD--------LDQLTRIFETLGTPTEE 223 (299)
T ss_dssp CCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHHHHCCCCTT
T ss_pred ccc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHH-hCcCCCCCCCH--------HHHHHHHHHhcCCCChh
Confidence 322 234679999999998764 56899999999999999999 89999964321 1222222110 0000
Q ss_pred cccC----------CccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 296 GIVD----------PRIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 296 ~~~~----------~~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
...+ ...... ......++++.+|+.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000 000000 011123457899999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=358.84 Aligned_cols=261 Identities=17% Similarity=0.183 Sum_probs=196.3
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++|+..+.||+|+||+||+|.+ .++..+|+|.+.... ....+++.+|+.++++++||||+++++++.+++.+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5789999999999999999998 555555555544332 2234779999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
|+.+ ++.+++... ....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~-~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCC-chhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC
Confidence 9986 555555332 3367999999999999999999999 99999999999999999999999999999977654
Q ss_pred CCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc-cCccc
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN-RGFNG 296 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 296 (347)
... ......||+.|+|||.+... .++.++||||+||++|+|+ +|+.||..... .......... +...+
T Consensus 155 ~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~-~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~ 224 (298)
T d1gz8a_ 155 PVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV-TRRALFPGDSE--------IDQLFRIFRTLGTPDE 224 (298)
T ss_dssp CSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHHHHHHHHCCCCT
T ss_pred Ccc-cceeecccceeeehhhhccccCCCccccccccchhhhHHh-hCCCCCCCCCH--------HHHHHHHHHhcCCCch
Confidence 332 23446799999999976655 4589999999999999999 89999964321 1111111110 10000
Q ss_pred ccCC-------------ccCCc---hhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 045067 297 IVDP-------------RIIGD---ELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQ 339 (347)
Q Consensus 297 ~~~~-------------~~~~~---~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~ 339 (347)
...+ ..... ......++++.+|+.+||+.||++|||+.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 00000 0111224578899999999999999999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=357.83 Aligned_cols=240 Identities=19% Similarity=0.283 Sum_probs=191.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCce-EEEEEEccCCC-----chhHHHHHHHHHHHHhcC--CCceeeeeeeeeeCC
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRT-ISVVKFIDGSV-----FDAYDCCFNNIVFASQMS--HNNVLRLIGCCLEVE 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~-~~v~k~~~~~~-----~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 131 (347)
.++|+..+.||+|+||+||+|++ .++. +|+|++..... ......+.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35788999999999999999999 4444 55554432211 111244678999999996 899999999999999
Q ss_pred ccEEEEEeCCC-CCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-CCceEEec
Q 045067 132 IPVLVFESAEY-GNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-RYVPKLFN 209 (347)
Q Consensus 132 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-~~~~kl~D 209 (347)
..++||||+.+ +++.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECc
Confidence 99999999975 6888888765 67999999999999999999999 999999999999999985 47999999
Q ss_pred CCCCccCCCCCceeeccccccCCcccccccccCCC-CCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 210 FSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYL-NEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 210 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
||+|+...... .+...||+.|+|||++.+..+ +.++||||+||++|||+ +|+.||.... ..
T Consensus 155 FG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell-~g~~Pf~~~~--------------~i 216 (273)
T d1xwsa_ 155 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV-CGDIPFEHDE--------------EI 216 (273)
T ss_dssp CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH-HSSCSCCSHH--------------HH
T ss_pred cccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHh-hCCCCCCCch--------------HH
Confidence 99997654332 245679999999998887654 67799999999999999 9999996421 11
Q ss_pred HhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
..... .+.+ ..++++.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~~---~~~~---------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 217 IRGQV---FFRQ---------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHCCC---CCSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhccc---CCCC---------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11110 1111 12456889999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-49 Score=351.95 Aligned_cols=259 Identities=17% Similarity=0.158 Sum_probs=194.7
Q ss_pred ccCCCCCeecccCceEEEEEEeC-CceEEEEEEccCCC-chhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVLP-DRTISVVKFIDGSV-FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~v~k~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 139 (347)
++|...+.||+|+||+||+|.+. +..+|+|++..... ....+.+.+|+.+|++++||||+++++++.+++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57888999999999999999995 44555555433322 22347799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCCC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPEG 219 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 219 (347)
+.++.+..+.... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||.+......
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9987666666543 77999999999999999999999 999999999999999999999999999998776443
Q ss_pred CceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh---ccC--
Q 045067 220 ETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE---NRG-- 293 (347)
Q Consensus 220 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-- 293 (347)
.. ......+++.|+|||.+.+ ..++.++||||+||++|||+ +|++||..... .+....... ...
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~-~G~~pf~~~~~--------~~~~~~i~~~~~~~~~~ 223 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSE--------ADQLMRIFRILGTPNSK 223 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHHHHHHHHCCCCTT
T ss_pred cc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHH-HCCCCCCCCCH--------HHHHHHHHHhhCCCChh
Confidence 22 2234568999999998765 46799999999999999999 89999974321 111111111 000
Q ss_pred -c------ccc---cC--CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 -F------NGI---VD--PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 -~------~~~---~~--~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. ... .. ............++.+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000 00 000011112233457889999999999999999999984
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=352.98 Aligned_cols=260 Identities=18% Similarity=0.180 Sum_probs=193.7
Q ss_pred hccCCCCCeecccCceEEEEEEe--CCceEEEEEEccCC--CchhHHHHHHHHHHHHhc---CCCceeeeeeeeee----
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL--PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQM---SHNNVLRLIGCCLE---- 129 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 129 (347)
.++|+..+.||+|+||+||+|.+ .++.++++|.+... .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999998 34555555543321 122234577888887766 79999999999864
Q ss_pred -CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEe
Q 045067 130 -VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLF 208 (347)
Q Consensus 130 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~ 208 (347)
....+++|||+.++++...... ....+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeec
Confidence 2468999999998766554433 3367999999999999999999999 9999999999999999999999999
Q ss_pred cCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHH
Q 045067 209 NFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKY 288 (347)
Q Consensus 209 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 288 (347)
|||+++...... ......||+.|+|||++.+..++.++||||+||++|||+ +|++||..... .+.....
T Consensus 159 dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell-~g~~pf~~~~~--------~~~~~~i 227 (305)
T d1blxa_ 159 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFRGSSD--------VDQLGKI 227 (305)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH--------HHHHHHH
T ss_pred chhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHH-HCCCCCCCCCH--------HHHHHHH
Confidence 999987654322 234578999999999999999999999999999999999 89999974321 1112221
Q ss_pred Hhc---c---Ccc------c-ccCC--ccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 289 IEN---R---GFN------G-IVDP--RIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 289 ~~~---~---~~~------~-~~~~--~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... . .+. . .... ...........++.+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 110 0 000 0 0000 00000111223457889999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=355.04 Aligned_cols=263 Identities=16% Similarity=0.172 Sum_probs=191.6
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEcc-CCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC----ccE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFID-GSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE----IPV 134 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 134 (347)
++.|+..+.||+|+||+||+|+. .++..+|+|.+. .......+.+.+|+.+|++++||||+++++++..+. ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45688999999999999999998 455555544444 334445578899999999999999999999987654 234
Q ss_pred EEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCc
Q 045067 135 LVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSA 214 (347)
Q Consensus 135 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~ 214 (347)
++++++.+|+|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||++.
T Consensus 87 ~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 55566778999999976 57999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCce--eeccccccCCcccccccc-cCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 215 SIPEGETY--IDDGVKGTSGIVAPEYAR-TGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 215 ~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
........ ......||+.|+|||++. +..++.++||||+||++|+|+ +|++||..... .............
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml-~g~~pf~~~~~-----~~~~~~~~~~~~~ 231 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHY-----LDQLNHILGILGS 231 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHH-HSSCSCCCSSH-----HHHHHHHHHHHCS
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHh-hCCCCCCCCCH-----HHHHHHHhhhccC
Confidence 76543221 124467999999999874 557789999999999999999 99999965322 0000000000000
Q ss_pred cCcc-----------c--ccCCccCC---chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGFN-----------G--IVDPRIIG---DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~~-----------~--~~~~~~~~---~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.... . ...+.... ....+..+.++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0 00000000 0011122356889999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-48 Score=345.02 Aligned_cols=264 Identities=14% Similarity=0.122 Sum_probs=191.9
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeee--------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE-------- 129 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 129 (347)
.++|+..+.||+|+||+||+|++ .++.++|+|++... .....+.+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46799999999999999999998 55555555554322 23334678999999999999999999998865
Q ss_pred CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEec
Q 045067 130 VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFN 209 (347)
Q Consensus 130 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~D 209 (347)
....++||||+.++.+...... ...++...+..++.|++.||.||| +.+|+||||||+|||++.++.+|++|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~d 160 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD 160 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeee
Confidence 3468999999998666555443 367999999999999999999999 99999999999999999999999999
Q ss_pred CCCCccCCCCCce---eeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHH
Q 045067 210 FSLSASIPEGETY---IDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFV 285 (347)
Q Consensus 210 fg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 285 (347)
||+++........ ......||+.|+|||++.+. .+++++||||+||++|||+ +|++||..... .......
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~-~g~~pf~~~~~-----~~~~~~i 234 (318)
T d3blha1 161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW-TRSPIMQGNTE-----QHQLALI 234 (318)
T ss_dssp CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HSSCSCCCSSH-----HHHHHHH
T ss_pred cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHh-hCCCCCCCCCH-----HHHHHHH
Confidence 9999776543221 22345799999999988765 7899999999999999999 89999964211 1111111
Q ss_pred HHHHhccC---ccccc--------CCccCCchhhH------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 286 KKYIENRG---FNGIV--------DPRIIGDELLE------HKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 286 ~~~~~~~~---~~~~~--------~~~~~~~~~~~------~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........ ..... ........... ...+.+.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11111000 00000 00000000111 11346789999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-48 Score=343.82 Aligned_cols=261 Identities=16% Similarity=0.150 Sum_probs=197.1
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCce-eeeeeeeeeCCccEEEEEe
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV-LRLIGCCLEVEIPVLVFES 139 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 139 (347)
+.|+..+.||+|+||+||+|++ .++..+++|+...... .+++.+|+.+++.++|+|+ +.+.++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5689999999999999999998 5555555565544322 2568899999999987664 5556666778889999999
Q ss_pred CCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC---CCceEEecCCCCccC
Q 045067 140 AEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE---RYVPKLFNFSLSASI 216 (347)
Q Consensus 140 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~a~~~ 216 (347)
+. ++|.+.+.. ....+++..+..++.|++.||+||| +++|+||||||+|||++. +..+|++|||+|+..
T Consensus 85 ~~-~~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 85 LG-PSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CBHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred cC-Cchhhhhhh----ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 96 577776654 2367999999999999999999999 999999999999999863 557999999999877
Q ss_pred CCCCce------eeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 217 PEGETY------IDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 217 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
...... ......||+.|+|||.+.+..++.++|||||||++|||+ +|+.||........... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~-tg~~P~~~~~~~~~~~~-~~~~~~~~~~ 234 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN-LGSLPWQGLKAATKRQK-YERISEKKMS 234 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHH-HSSCTTCCCC--------HHHHHHHHHH
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHH-hCCCcccccchHHHHHH-HHHhhcccCC
Confidence 543321 223467999999999999999999999999999999999 99999975433111111 1011111110
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYK 345 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~ 345 (347)
. . .+......++++.+++.+||+.+|++||+++++.+.|+++..
T Consensus 235 ~-~----------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 T-P----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp S-C----------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred C-C----------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0 0 011112234678899999999999999999999999998754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-47 Score=338.50 Aligned_cols=263 Identities=14% Similarity=0.101 Sum_probs=204.7
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCC-CceeeeeeeeeeCCccEEEEE
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSH-NNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 138 (347)
.++|...+.||+|+||+||+|++ .++..+|+|+...... .+.+.+|+..++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46789999999999999999998 5565555666544321 2457889999999965 899999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECC-----CCceEEecCCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSE-----RYVPKLFNFSLS 213 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~a 213 (347)
|+ +++|.+++... ...++..++..++.|++.||+||| +.||+||||||+|||++. ++.+||+|||+|
T Consensus 82 ~~-~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 82 LL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEccccee
Confidence 99 57999998763 357999999999999999999999 999999999999999974 578999999999
Q ss_pred ccCCCCCc------eeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHH
Q 045067 214 ASIPEGET------YIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKK 287 (347)
Q Consensus 214 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 287 (347)
+....... .......||+.|||||.+.+..++.++|||||||++|||+ +|..||..... .........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~ell-tg~~Pf~~~~~-----~~~~~~~~~ 227 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL-RGSLPWQGLKA-----ATNKQKYER 227 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH-HSSCTTSSCCS-----CCHHHHHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHH-hCCCcCCCccc-----hhHHHHHHH
Confidence 87653321 1123467999999999999999999999999999999999 89999974322 111111111
Q ss_pred HHhccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 045067 288 YIENRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAKQIKKMYKS 346 (347)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~~L~~i~~~ 346 (347)
........ .........++++.+++..|+..+|++||++..+.+.|+++.++
T Consensus 228 i~~~~~~~-------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 228 IGEKKQST-------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HHHHHHHS-------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHhccCCC-------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 11110000 00011112345688999999999999999999999999988654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=350.87 Aligned_cols=256 Identities=19% Similarity=0.198 Sum_probs=187.5
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCceeeeeeeeeeC------CccEE
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV------EIPVL 135 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 135 (347)
+|...++||+|+||+||+|++ .++..+++|.+.... ....+|+.+|++++||||+++++++... .++++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 578889999999999999999 455544444444332 2235799999999999999999998643 35789
Q ss_pred EEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-ceEEecCCCCc
Q 045067 136 VFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLFNFSLSA 214 (347)
Q Consensus 136 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~ 214 (347)
|||||+++.+..+.... .....+++..+..++.|++.||+||| ++||+||||||+|||++.++ .+||+|||+++
T Consensus 97 v~Ey~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEECCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEeccCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 99999875444333221 12367999999999999999999999 99999999999999999775 89999999998
Q ss_pred cCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh---
Q 045067 215 SIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE--- 290 (347)
Q Consensus 215 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 290 (347)
....... .....||+.|+|||.+.+ ..++.++||||+||++|||+ +|.+||..... ........+
T Consensus 172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~-~g~~pf~~~~~--------~~~l~~i~~~~g 240 (350)
T d1q5ka_ 172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL-LGQPIFPGDSG--------VDQLVEIIKVLG 240 (350)
T ss_dssp ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH-HTSCSSCCSSH--------HHHHHHHHHHHC
T ss_pred hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehh-hCCCCCCCCCH--------HHHHHHHHHHhC
Confidence 7654432 234679999999997664 57899999999999999999 89999965322 111111110
Q ss_pred ----------ccCcccccCCccCC----chhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 ----------NRGFNGIVDPRIIG----DELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ----------~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
........-+.... .......++++.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000000 0011123457889999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=347.26 Aligned_cols=253 Identities=19% Similarity=0.218 Sum_probs=189.5
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCC------
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVE------ 131 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 131 (347)
.+.|...+.||+|+||+||+|.. .++..+|+|.+... .....+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46789999999999999999998 55555555554432 2334567899999999999999999999998654
Q ss_pred ccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCC
Q 045067 132 IPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFS 211 (347)
Q Consensus 132 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg 211 (347)
.+++||||++ .+|..+++. ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||
T Consensus 97 ~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFMG-TDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeccc-ccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccc
Confidence 5699999994 588888765 57999999999999999999999 9999999999999999999999999999
Q ss_pred CCccCCCCCceeeccccccCCccccccccc-CCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 212 LSASIPEGETYIDDGVKGTSGIVAPEYART-GYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 212 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
+|+...... +...||+.|+|||.+.+ ..++.++||||+||++|+|+ +|++||..... .........
T Consensus 167 ~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell-~g~~pf~~~~~--------~~~~~~~~~ 233 (346)
T d1cm8a_ 167 LARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFKGSDH--------LDQLKEIMK 233 (346)
T ss_dssp TCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHH-HSSCSSCCSSH--------HHHHHHHHH
T ss_pred ceeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHH-HCcCCCCCCCh--------HHHHHHHHh
Confidence 998765432 34679999999998876 46789999999999999999 99999975321 000000000
Q ss_pred -ccC--------------------cccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 -NRG--------------------FNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 -~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.+. ..+..... .........+.+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD--FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCC--GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccCCCcHHHHhhhcchhhhhhhccCCcccccc--hHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000000 00111223456789999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=347.24 Aligned_cols=252 Identities=17% Similarity=0.193 Sum_probs=200.7
Q ss_pred ccCCCCCeecccCceEEEEEEe----CCceEEEEEEccCC----CchhHHHHHHHHHHHHhcCC-CceeeeeeeeeeCCc
Q 045067 62 NNYHYRNIITESSIFRLCQGVL----PDRTISVVKFIDGS----VFDAYDCCFNNIVFASQMSH-NNVLRLIGCCLEVEI 132 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~~v~k~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 132 (347)
++|+..+.||+|+||+||+|.. .++.++++|.++.. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999987 23455555554432 12234678899999999966 899999999999999
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.+++|||+.+|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999999876 67889999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccC--CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTG--YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE 290 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 290 (347)
++..............|++.|+|||.+.+. .++.++||||+||++|+|+ +|..||..... .............
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyell-tG~~PF~~~~~----~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL-TGASPFTVDGE----KNSQAEISRRILK 250 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH-HSSCTTSCTTS----CCCHHHHHHHHHH
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHH-hCCCCCCCCCH----HHHHHHHHHhccc
Confidence 987765544445567899999999988654 5688999999999999999 89999975432 1112222222222
Q ss_pred ccCcccccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 045067 291 NRGFNGIVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPT-----MIDVAK 338 (347)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs-----~~ell~ 338 (347)
.. +.. +...++++.+++.+||++||.+||| ++|+++
T Consensus 251 ~~-------~~~-----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 251 SE-------PPY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CC-------CCC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CC-------CCC-----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11 001 1123567889999999999999995 788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=336.21 Aligned_cols=260 Identities=15% Similarity=0.120 Sum_probs=198.5
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeeeCCccEEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLEVEIPVLVFE 138 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 138 (347)
++|+..+.||+|+||+||+|++ .++..+|+|++... .....+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4688899999999999999999 55555555544322 23345789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCCCccCCC
Q 045067 139 SAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSLSASIPE 218 (347)
Q Consensus 139 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 218 (347)
++.+++|..++... +.+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|||.++....
T Consensus 82 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eccccccccccccc-----cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999998888764 78899999999999999999999 99999999999999999999999999999987654
Q ss_pred CCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHh---ccC-
Q 045067 219 GETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIE---NRG- 293 (347)
Q Consensus 219 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~- 293 (347)
.... .....+++.|+|||.+.+. .++.++||||+||++|||+ +|+.||..... ..+....... ...
T Consensus 154 ~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell-~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~ 224 (292)
T d1unla_ 154 PVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA-NAGRPLFPGND-------VDDQLKRIFRLLGTPTE 224 (292)
T ss_dssp CCSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT-TTSCCSCCCSS-------HHHHHHHHHHHHCCCCT
T ss_pred CCcc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHh-hCCCCCCCCCC-------HHHHHHHHHhhcCCCCh
Confidence 3322 2335678899999987765 4689999999999999999 77766532111 1122222111 100
Q ss_pred --c------cc-----ccCCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 294 --F------NG-----IVDPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 294 --~------~~-----~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
. .. ................+.+.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 000000111122233457889999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.1e-47 Score=341.00 Aligned_cols=260 Identities=16% Similarity=0.207 Sum_probs=193.9
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeC--CccEEEE
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEV--EIPVLVF 137 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 137 (347)
++|+..+.||+|+||+||+|+. .++..+|+|++.... .+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999999 566666666655432 367889999999995 99999999998754 5689999
Q ss_pred EeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-ceEEecCCCCccC
Q 045067 138 ESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY-VPKLFNFSLSASI 216 (347)
Q Consensus 138 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~a~~~ 216 (347)
||+.+++|.... +.+++..+..++.||+.||+||| +++|+||||||+|||++.++ .+||+|||+|+..
T Consensus 112 e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 112 EHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp ECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred eecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceec
Confidence 999999987654 46999999999999999999999 99999999999999998655 6899999999876
Q ss_pred CCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH-----HHHHHHHh
Q 045067 217 PEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM-----DFVKKYIE 290 (347)
Q Consensus 217 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~ 290 (347)
..... .....+|+.|+|||.+.+. .++.++||||+||++|+|+ +|+.||.............. ........
T Consensus 181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~-~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI-FRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH-HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhc-cCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 54432 2446789999999987764 5799999999999999999 89999864321000000000 00000111
Q ss_pred ccCc------ccccC-------CccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 291 NRGF------NGIVD-------PRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 291 ~~~~------~~~~~-------~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
.... ..... ............++++.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000 001111122233567899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=338.05 Aligned_cols=263 Identities=18% Similarity=0.182 Sum_probs=185.6
Q ss_pred ccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCC--CchhHHHHHHHHHHHHhcCCCceeeeeeeeee------CCc
Q 045067 62 NNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGS--VFDAYDCCFNNIVFASQMSHNNVLRLIGCCLE------VEI 132 (347)
Q Consensus 62 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 132 (347)
+.|...+.||+|+||+||+|.+ .++..+|+|++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5688999999999999999998 44555555544432 23344678999999999999999999999864 367
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
+|+||||+.+ ++.+.+. ..+++..+..++.|++.||.||| +.||+||||||+|||++.++.+|++|||+
T Consensus 97 ~~iv~Ey~~~-~l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eEEEEeccch-HHHHhhh-------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhh
Confidence 8999999986 4555553 46899999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCC----------CCch--
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNG----------DESF-- 280 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~----------~~~~-- 280 (347)
++...... ......+|+.|+|||++.+..+++++||||+||++++|+ +|++||........ ....
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell-~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH-HSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHh-hCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 87655432 234567999999999999999999999999999999999 89999964321000 0000
Q ss_pred --HHHHHHHHHhccC-c-----ccccCCcc-C-CchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 281 --EMDFVKKYIENRG-F-----NGIVDPRI-I-GDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 281 --~~~~~~~~~~~~~-~-----~~~~~~~~-~-~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
............. . ........ . ........++++.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000011111100 0 00000000 0 11223345678999999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=334.75 Aligned_cols=259 Identities=19% Similarity=0.240 Sum_probs=190.8
Q ss_pred hccCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCC--chhHHHHHHHHHHHHhcCCCceeeeeeeeeeC-----Cc
Q 045067 61 TNNYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSV--FDAYDCCFNNIVFASQMSHNNVLRLIGCCLEV-----EI 132 (347)
Q Consensus 61 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 132 (347)
++.|+..+.||+|+||+||+|.. .++..+|+|++.... ....+.+.+|+.+|++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56799999999999999999998 556666666554432 23446789999999999999999999998643 23
Q ss_pred cEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceEEecCCC
Q 045067 133 PVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPKLFNFSL 212 (347)
Q Consensus 133 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 212 (347)
.+++++++.+|+|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccch
Confidence 4667778889999999965 57999999999999999999999 99999999999999999999999999999
Q ss_pred CccCCCCCceeeccccccCCcccccccccC-CCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHHHHHHHHHhc
Q 045067 213 SASIPEGETYIDDGVKGTSGIVAPEYARTG-YLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEMDFVKKYIEN 291 (347)
Q Consensus 213 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 291 (347)
+..... ......||+.|+|||...+. .++.++||||+||++|+|+ +|++||..... .............
T Consensus 168 a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll-~g~~pF~~~~~-----~~~~~~i~~~~~~ 237 (348)
T d2gfsa1 168 ARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDH-----IDQLKLILRLVGT 237 (348)
T ss_dssp --CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHH-HSSCSCCCSSH-----HHHHHHHHHHHCC
T ss_pred hcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHH-hCCCCCCCCCH-----HHHHHHHHHhcCC
Confidence 865432 22346799999999976654 5689999999999999999 99999964321 1111111111000
Q ss_pred cCc---------------cccc-CCccCCchhhHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 045067 292 RGF---------------NGIV-DPRIIGDELLEHKLQSSFELAFQCQSASAEDRPTMIDVAK 338 (347)
Q Consensus 292 ~~~---------------~~~~-~~~~~~~~~~~~~~~~~~~l~~~cl~~~P~~RPs~~ell~ 338 (347)
... .... .+...........++++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000 0000 0000000011123457889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.8e-41 Score=303.88 Aligned_cols=264 Identities=14% Similarity=0.106 Sum_probs=185.6
Q ss_pred cCCCCCeecccCceEEEEEEe-CCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-----------CCceeeeeeeeee-
Q 045067 63 NYHYRNIITESSIFRLCQGVL-PDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-----------HNNVLRLIGCCLE- 129 (347)
Q Consensus 63 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~- 129 (347)
.|+..++||+|+||+||+|+. .++..+|+|+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 488899999999999999998 556666666665443 23367889999998875 5789999988764
Q ss_pred -CCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCC-----
Q 045067 130 -VEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERY----- 203 (347)
Q Consensus 130 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~----- 203 (347)
....+++++++..+......... .....+++..+..++.|++.||+|||+ ..||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence 34566777776555433333221 134678999999999999999999993 38999999999999998665
Q ss_pred -ceEEecCCCCccCCCCCceeeccccccCCcccccccccCCCCCccchHHHHHHHHHHHhcCCCccccCccCCCCCchHH
Q 045067 204 -VPKLFNFSLSASIPEGETYIDDGVKGTSGIVAPEYARTGYLNEKCDVYSFGLLLLQLLSTGEDLFNMGLRLNGDESFEM 282 (347)
Q Consensus 204 -~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~G~~l~el~~~g~~p~~~~~~~~~~~~~~~ 282 (347)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|+ +|+.||.......... ..
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~-~g~~pF~~~~~~~~~~--~~ 241 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI-TGDFLFEPDEGHSYTK--DD 241 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHH-HSSCCC---------C--HH
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHH-HCCCCCCCCccccccc--hh
Confidence 3899999998765432 23467999999999999999999999999999999999 8999997543211111 11
Q ss_pred HHHHHHHh-ccC--------------------cccccCC-ccC--------CchhhHHHHHHHHHHHHHhccCCCCCCCC
Q 045067 283 DFVKKYIE-NRG--------------------FNGIVDP-RII--------GDELLEHKLQSSFELAFQCQSASAEDRPT 332 (347)
Q Consensus 283 ~~~~~~~~-~~~--------------------~~~~~~~-~~~--------~~~~~~~~~~~~~~l~~~cl~~~P~~RPs 332 (347)
........ -+. ....... ... ........++++.+|+.+||+.||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 11111000 000 0000000 000 00122355678999999999999999999
Q ss_pred HHHHHH
Q 045067 333 MIDVAK 338 (347)
Q Consensus 333 ~~ell~ 338 (347)
+.|+++
T Consensus 322 a~e~L~ 327 (362)
T d1q8ya_ 322 AGGLVN 327 (362)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=8.1e-25 Score=180.01 Aligned_cols=161 Identities=17% Similarity=0.072 Sum_probs=114.0
Q ss_pred CCCCeecccCceEEEEEEeCCceEEEEEEccCCCc------------------hhHHHHHHHHHHHHhcCCCceeeeeee
Q 045067 65 HYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVF------------------DAYDCCFNNIVFASQMSHNNVLRLIGC 126 (347)
Q Consensus 65 ~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 126 (347)
...+.||+|+||+||+|...++..+++|+...... .......+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 34678999999999999985444455554432110 112335578889999999999888765
Q ss_pred eeeCCccEEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEECCCCceE
Q 045067 127 CLEVEIPVLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHIGFSRPIVFRDLKSSYILVSERYVPK 206 (347)
Q Consensus 127 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~dlkp~Nill~~~~~~k 206 (347)
. ..+++|||+++..+. .++......++.|++.+|+||| +.+|+||||||+|||++++ .++
T Consensus 83 ~----~~~lvme~~~~~~~~------------~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELY------------RVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGG------------GCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEE
T ss_pred c----CCEEEEEeecccccc------------chhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEE
Confidence 3 237999999875432 2344455678999999999999 9999999999999999865 589
Q ss_pred EecCCCCccCCCCCceeeccccccCCcccc------cccccCCCCCccchHHHHH
Q 045067 207 LFNFSLSASIPEGETYIDDGVKGTSGIVAP------EYARTGYLNEKCDVYSFGL 255 (347)
Q Consensus 207 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~Dv~s~G~ 255 (347)
|+|||+|.....+... .|... +. ..+.|+.++|+||..-
T Consensus 143 liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAID 187 (191)
T ss_dssp ECCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHH
T ss_pred EEECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHH
Confidence 9999998765433211 11111 11 1356788999999654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.86 E-value=7.2e-09 Score=87.54 Aligned_cols=148 Identities=13% Similarity=-0.001 Sum_probs=97.8
Q ss_pred HHHHHHhccCCCCCeecccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCcc
Q 045067 55 KELERATNNYHYRNIITESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIP 133 (347)
Q Consensus 55 ~e~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 133 (347)
.|+....+.|...+..+.++.+.||+...+++.+++|+...... .....+.+|...+..+. +=.+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35666666776555444445578999877777777666544332 22345788998888774 33356777888888889
Q ss_pred EEEEEeCCCCCHHHHHhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhc--------------------------------
Q 045067 134 VLVFESAEYGNLHDLLKRSYQSHSEPLLLKHRLKIAMEIANVFAYLHI-------------------------------- 181 (347)
Q Consensus 134 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-------------------------------- 181 (347)
++||++.+|.++.+.... ... ...++.+++..+..||+
T Consensus 86 ~lv~~~l~G~~~~~~~~~-------~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED-------EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEECCSSEEHHHHTTT-------CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred EEEEEecccccccccccc-------ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 999999999877654421 111 12234444445555552
Q ss_pred ------------------------CCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 182 ------------------------GFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 182 ------------------------~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
.....++|+|+.|.||++++++.+-|+||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a 211 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence 01223799999999999998766779999876
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.36 E-value=8.7e-07 Score=73.92 Aligned_cols=73 Identities=11% Similarity=-0.021 Sum_probs=51.9
Q ss_pred ecccCc-eEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCC--CceeeeeeeeeeCCccEEEEEeCCCCCH
Q 045067 70 ITESSI-FRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSH--NNVLRLIGCCLEVEIPVLVFESAEYGNL 145 (347)
Q Consensus 70 lg~G~~-g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L 145 (347)
+..|.. +.||+...+++..+++|....... ..+..|+..++.+.. -.+.+++++..+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444443 689999887777777776655432 347788888877742 2356678887888889999999987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.14 E-value=1.1e-05 Score=71.66 Aligned_cols=75 Identities=15% Similarity=-0.005 Sum_probs=46.2
Q ss_pred CeecccCceEEEEEEe-CCceEEEEEEccC-------CCchhHHHHHHHHHHHHhcC-C--CceeeeeeeeeeCCccEEE
Q 045067 68 NIITESSIFRLCQGVL-PDRTISVVKFIDG-------SVFDAYDCCFNNIVFASQMS-H--NNVLRLIGCCLEVEIPVLV 136 (347)
Q Consensus 68 ~~lg~G~~g~Vy~~~~-~~~~~~v~k~~~~-------~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 136 (347)
+.||.|....||+... +++..+|+|.... ......++...|...|+.+. + ..+.+++.+ ++...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 4689999999999988 4444455553322 11122345667888887662 2 345555544 55667899
Q ss_pred EEeCCCCC
Q 045067 137 FESAEYGN 144 (347)
Q Consensus 137 ~e~~~~g~ 144 (347)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.44 E-value=0.00084 Score=57.47 Aligned_cols=138 Identities=19% Similarity=0.159 Sum_probs=76.2
Q ss_pred ceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCce--eeeee-----eeeeCCccEEEEEeCCCCCHH-
Q 045067 75 IFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV--LRLIG-----CCLEVEIPVLVFESAEYGNLH- 146 (347)
Q Consensus 75 ~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~g~L~- 146 (347)
-..||++..+++..+|+|+....... .+++..|...+..|....+ +.... .+......+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s-~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWT-ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSC-HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCC-HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 36899999977777777877654332 3668889988888742222 11111 223355678889998763221
Q ss_pred ----HH---------Hhh----hccCCCCCCCHH----------------------HHHHHHHHHHHHHHHh-hcCCCCC
Q 045067 147 ----DL---------LKR----SYQSHSEPLLLK----------------------HRLKIAMEIANVFAYL-HIGFSRP 186 (347)
Q Consensus 147 ----~~---------l~~----~~~~~~~~l~~~----------------------~~~~i~~~i~~~l~~l-H~~~~~~ 186 (347)
.+ ++. ........+++. .....+..+...+.-. .+....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 11 111 000011112211 1122233333333222 2222467
Q ss_pred eEeccCCCCCeEECCCCceEEecCCCCcc
Q 045067 187 IVFRDLKSSYILVSERYVPKLFNFSLSAS 215 (347)
Q Consensus 187 ivH~dlkp~Nill~~~~~~kl~Dfg~a~~ 215 (347)
+||+|+.|.|||++++ ..++||+.+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 9999999999999743 45899997743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.19 E-value=0.00073 Score=59.54 Aligned_cols=73 Identities=12% Similarity=-0.040 Sum_probs=49.2
Q ss_pred CCeecccCceEEEEEEeCC--------ceEEEEEEccCCCchhHHHHHHHHHHHHhcC-CCceeeeeeeeeeCCccEEEE
Q 045067 67 RNIITESSIFRLCQGVLPD--------RTISVVKFIDGSVFDAYDCCFNNIVFASQMS-HNNVLRLIGCCLEVEIPVLVF 137 (347)
Q Consensus 67 ~~~lg~G~~g~Vy~~~~~~--------~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 137 (347)
.+.|+.|-.-.+|+...++ ...+++++..... .. ....+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3578888889999998732 2456777766332 22 34568999998885 4334467777643 6899
Q ss_pred EeCCCCCH
Q 045067 138 ESAEYGNL 145 (347)
Q Consensus 138 e~~~~g~L 145 (347)
||++|.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987433
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.14 E-value=0.0077 Score=50.78 Aligned_cols=159 Identities=9% Similarity=0.021 Sum_probs=82.2
Q ss_pred cCHHHHHHHhccCCCCCeec-----ccCceEEEEEEeCCceEEEEEEccCCCchhHHHHHHHHHHHHhcCCCce--eeee
Q 045067 52 FSAKELERATNNYHYRNIIT-----ESSIFRLCQGVLPDRTISVVKFIDGSVFDAYDCCFNNIVFASQMSHNNV--LRLI 124 (347)
Q Consensus 52 ~~~~e~~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~~v~k~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~ 124 (347)
++.+|++....+|..++... .|--.+.|+...+++. +|+|+..... ..+.+..|+.++..+...++ ....
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 67789999999997755443 4555788999887776 4555554432 12445667777777642222 1111
Q ss_pred e------eeeeCCccEEEEEeCCCCCHHH--------------HHhhhcc----CCCCCCCHH-----------------
Q 045067 125 G------CCLEVEIPVLVFESAEYGNLHD--------------LLKRSYQ----SHSEPLLLK----------------- 163 (347)
Q Consensus 125 ~------~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~----~~~~~l~~~----------------- 163 (347)
. +..-......++.+..+..... .++.... .........
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1112334556666655422210 0110000 000000100
Q ss_pred -HHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEECCCCceEEecCCCC
Q 045067 164 -HRLKIAMEIANVFAYLHI-GFSRPIVFRDLKSSYILVSERYVPKLFNFSLS 213 (347)
Q Consensus 164 -~~~~i~~~i~~~l~~lH~-~~~~~ivH~dlkp~Nill~~~~~~kl~Dfg~a 213 (347)
.....+......+.-.+. ....|+||+|+.+.||+++.+...-|.||+.+
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccc
Confidence 111112222222332221 22578999999999999998877789999976
|